data_2lcs_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2lcs _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 44.9 tp60 . . . . . 0 C--O 1.231 0.13 0 CA-C-O 120.791 0.329 . . . . 75.22 110.926 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 7.6 ptt180 -74.65 162.11 29.05 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.216 -0.447 . . . . 73.03 110.892 -179.896 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -157.1 155.0 30.34 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.195 -0.457 . . . . 74.3 111.105 179.954 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 10.8 p -104.01 150.31 7.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.233 -0.44 . . . . 75.14 111.171 179.959 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -89.13 105.4 17.77 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.175 -0.466 . . . . 75.04 111.027 179.947 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 15.5 mt -70.17 -36.82 74.94 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.2 -0.455 . . . . 75.23 110.937 179.998 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 3.5 m-85 -143.79 156.67 44.57 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.187 -0.461 . . . . 72.21 110.958 179.996 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -79.03 135.53 36.91 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.167 -0.47 . . . . 75.04 110.871 179.938 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 9.3 t80 -135.97 146.0 46.78 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.227 -0.442 . . . . 74.24 110.873 -179.894 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 28.8 tt0 -116.04 136.12 22.9 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-O 121.654 0.74 . . . . 75.22 110.855 -179.917 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.8 146.05 58.78 Favored 'Trans proline' 0 C--N 1.342 0.189 0 C-N-CA 122.661 2.241 . . . . 74.24 112.311 -179.972 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 7.8 mm-40 -107.93 -18.74 13.72 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.196 -0.457 . . . . 74.33 110.853 -179.967 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 35.5 m-80 -111.45 176.06 5.17 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.146 -0.479 . . . . 75.34 110.893 -179.934 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -92.16 20.89 5.51 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.169 -0.469 . . . . 73.13 110.865 179.906 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -138.24 12.29 2.81 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.179 -0.464 . . . . 64.5 110.906 -179.938 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 20.4 mt-10 -105.49 156.17 18.47 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.168 -0.469 . . . . 73.21 110.909 -179.998 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -105.53 151.44 24.29 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.206 -0.452 . . . . 71.25 110.879 -179.943 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 12.6 mtp180 -87.79 150.86 23.3 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.17 -0.468 . . . . 73.2 110.861 179.985 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 2.3 tp -135.17 149.57 49.98 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.242 -0.435 . . . . 72.51 110.927 -179.981 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -140.24 136.81 33.74 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.219 -0.446 . . . . 73.32 111.124 179.798 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 3.0 tt0 -50.45 120.24 4.45 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.218 -0.447 . . . . 72.12 110.889 -179.927 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 96.16 -0.56 62.2 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.696 -0.764 . . . . 64.23 112.499 -179.98 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -87.32 147.46 25.49 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.823 0.344 . . . . 65.52 110.865 -179.975 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 3.2 mm -100.62 141.04 18.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.173 -0.467 . . . . 74.4 111.131 -179.97 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 1.4 m -142.75 158.25 18.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.202 -0.454 . . . . 71.23 111.135 179.879 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 58.4 m-85 -117.19 108.11 15.27 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.165 -0.47 . . . . 70.24 110.905 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 16.6 mm -72.75 102.7 1.52 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.147 -0.479 . . . . 74.45 111.165 179.983 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 4.6 m -64.82 -40.88 95.91 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.19 -0.459 . . . . 72.21 110.861 -179.853 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 36.3 p90 -173.86 149.27 1.52 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.113 -0.494 . . . . 75.05 110.895 -179.931 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 9.4 tttm -80.82 145.09 31.6 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.076 -0.511 . . . . 73.05 110.898 179.892 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 27.5 t60 -132.75 155.9 48.04 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.232 -0.44 . . . . 74.54 110.882 179.85 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -61.75 -174.21 1.65 Allowed Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.675 -0.774 . . . . 75.53 112.514 -179.946 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 57.1 mm-40 64.87 13.28 8.42 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.87 0.367 . . . . 64.33 110.874 -179.909 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 68.16 29.98 73.59 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.737 -0.744 . . . . 75.31 112.473 -179.984 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 98.3 m95 -123.58 137.52 54.74 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.83 0.348 . . . . 73.02 110.921 -179.929 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 1.6 mt -120.57 133.19 55.41 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.247 -0.433 . . . . 74.44 110.951 179.98 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 75.8 t -79.95 109.09 14.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.214 -0.448 . . . . 74.22 111.161 179.851 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -129.46 160.99 31.43 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.243 -0.435 . . . . 52.04 111.07 179.945 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 3.3 pm0 -119.02 159.3 24.12 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.225 -0.443 . . . . 72.04 110.878 -179.933 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -71.95 -175.26 1.39 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.139 -0.482 . . . . 72.53 110.854 -179.924 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -69.63 -38.58 77.24 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.147 -0.479 . . . . 74.31 110.893 -179.989 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 1.5 t -56.03 -22.64 28.45 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.149 -0.478 . . . . 52.42 110.843 -179.77 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 69.76 9.02 61.65 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.814 -0.708 . . . . 74.42 112.474 179.982 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 3.7 t -108.88 -19.86 13.25 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.923 0.392 . . . . 74.12 110.871 -179.755 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 1.1 ttmt -109.85 123.62 49.9 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.134 -0.485 . . . . 74.15 110.94 179.913 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 6.1 m -126.82 152.58 46.77 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.269 -0.423 . . . . 73.32 111.116 -179.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -177.21 -161.16 25.3 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.744 -0.741 . . . . 72.22 112.484 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 4.8 mt -100.7 138.74 37.35 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.835 0.35 . . . . 75.43 110.885 -179.901 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.416 ' HB ' ' HD2' ' A' ' 51' ' ' PRO . 6.1 m -137.36 153.56 74.76 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-O 121.634 0.73 . . . . 74.4 111.143 179.82 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . 0.416 ' HD2' ' HB ' ' A' ' 50' ' ' VAL . 53.8 Cg_endo -69.8 142.9 48.99 Favored 'Trans proline' 0 C--N 1.341 0.184 0 C-N-CA 122.639 2.226 . . . . 73.02 112.332 179.977 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 15.7 tm-20 -89.88 -27.3 19.98 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.18 -0.464 . . . . 74.53 110.92 -179.992 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -87.12 12.08 12.38 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.111 -0.495 . . . . 74.22 110.895 -179.97 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -121.89 -8.81 8.86 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.154 -0.475 . . . . 73.54 110.883 -179.912 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 17.2 m -120.42 169.83 11.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.125 -0.489 . . . . 74.2 111.127 179.968 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 3.8 t -138.69 115.27 10.58 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.19 -0.459 . . . . 64.35 110.869 -179.854 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 3.0 m-85 -54.2 128.8 32.59 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.183 -0.462 . . . . 74.33 110.924 -179.889 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 45.6 mt -97.06 148.65 5.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.114 -0.494 . . . . 74.13 111.15 179.939 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 4.3 mt-30 . . . . . 0 C--N 1.329 -0.297 0 CA-C-O 121.616 0.722 . . . . 74.43 110.873 179.985 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' B' B ' -7' ' ' PHE . . . . . . . . . . . . . 13.5 m-85 . . . . . 0 C--O 1.232 0.165 0 CA-C-O 120.807 0.337 . . . . 74.42 110.888 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' B' B ' -6' ' ' ILE . . . . . . . . . . . . . 2.7 pt -153.21 84.13 4.47 Favored Pre-proline 0 C--N 1.328 -0.344 0 CA-C-O 121.656 0.741 . . . . 74.31 111.12 179.977 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' -5' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.71 134.52 28.3 Favored 'Trans proline' 0 C--N 1.342 0.207 0 C-N-CA 122.682 2.254 . . . . 71.0 112.342 179.857 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' -4' ' ' SER . . . . . . . . . . . . . 26.3 t -131.5 65.4 1.57 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.193 -0.458 . . . . 74.42 110.87 -179.863 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' -3' ' ' ARG . . . . . . . . . . . . . 6.9 ptm180 -178.66 155.0 0.87 Allowed Pre-proline 0 C--N 1.33 -0.282 0 CA-C-O 121.625 0.726 . . . . 75.13 110.84 -179.95 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' -2' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.83 129.3 17.29 Favored 'Trans proline' 0 C--N 1.341 0.17 0 C-N-CA 122.718 2.279 . . . . 71.31 112.313 -179.964 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' -1' ' ' ALA . . . . . . . . . . . . . . . -63.5 154.48 79.27 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-O 121.525 0.678 . . . . 72.44 111.157 179.847 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 0' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.78 176.75 6.36 Favored 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.663 2.242 . . . . 72.11 112.334 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 1' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -125.07 146.99 55.5 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.561 0.696 . . . . 74.22 110.882 179.951 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 2' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo . . . . . 0 C--N 1.341 0.158 0 C-N-CA 122.646 2.231 . . . . 71.35 112.363 179.873 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 51.6 tp60 . . . . . 0 C--O 1.231 0.105 0 CA-C-O 120.821 0.343 . . . . 74.42 110.92 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 5.9 ptt180 -89.58 164.67 14.67 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.202 -0.454 . . . . 73.3 110.896 -179.949 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -155.56 152.39 28.75 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.235 -0.439 . . . . 64.43 111.114 179.98 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 10.7 p -104.17 147.91 9.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.245 -0.434 . . . . 72.23 111.164 179.918 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -87.75 112.61 22.6 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.152 -0.477 . . . . 74.3 111.082 179.913 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 10.4 mt -77.91 -37.77 47.12 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.2 -0.454 . . . . 74.13 110.962 179.987 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 4.0 m-85 -140.59 141.39 35.19 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.171 -0.468 . . . . 74.45 110.908 -179.972 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 2.2 p30 -65.13 132.99 50.59 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.128 -0.487 . . . . 73.3 110.898 179.899 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 2.1 t80 -129.83 146.34 51.57 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.204 -0.453 . . . . 71.24 110.888 -179.89 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 47.2 tt0 -117.03 137.06 23.51 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-O 121.62 0.724 . . . . 73.41 110.864 -179.893 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.79 150.99 68.79 Favored 'Trans proline' 0 C--N 1.342 0.189 0 C-N-CA 122.676 2.25 . . . . 74.25 112.311 -179.96 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 6.3 mm-40 -113.9 -15.82 12.3 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.206 -0.452 . . . . 72.25 110.913 179.981 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 31.2 m-80 -114.92 175.97 5.26 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.208 -0.451 . . . . 70.2 110.863 -179.936 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 27.1 m-20 -91.02 18.39 6.79 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.144 -0.48 . . . . 74.23 110.893 179.927 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -138.22 17.04 2.79 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.163 -0.472 . . . . 74.53 110.946 -179.916 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 24.9 mt-10 -105.49 164.87 11.55 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.132 -0.486 . . . . 74.51 110.93 179.979 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 41.3 tp -115.84 147.06 41.45 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.176 -0.465 . . . . 72.32 110.94 -179.978 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -83.07 159.32 22.16 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.219 -0.446 . . . . 74.34 110.823 179.986 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 3.1 tp -143.87 147.96 34.79 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.179 -0.464 . . . . 74.21 110.939 179.995 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -139.6 138.73 36.42 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.186 -0.461 . . . . 75.41 111.07 179.811 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -51.35 122.53 7.98 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.189 -0.46 . . . . 74.55 110.907 -179.933 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 95.85 -6.7 67.28 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.727 -0.749 . . . . 64.52 112.449 -179.983 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -80.38 145.94 31.76 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.764 0.316 . . . . 54.31 110.887 -179.967 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 3.2 mm -101.96 140.7 19.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.195 -0.457 . . . . 73.35 111.104 -179.957 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 1.5 m -143.23 158.47 17.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.135 -0.484 . . . . 73.01 111.132 179.868 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 57.4 m-85 -115.59 108.92 17.04 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.2 -0.455 . . . . 74.52 110.902 179.996 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 17.2 mm -72.42 102.61 1.41 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.153 -0.476 . . . . 64.31 111.101 179.999 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 8.1 m -65.06 -40.35 94.6 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.191 -0.459 . . . . 64.34 110.901 -179.946 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 33.9 p90 -174.67 148.6 1.15 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.144 -0.48 . . . . 72.55 110.923 -179.881 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 10.3 tttm -81.27 143.94 31.91 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.122 -0.49 . . . . 75.54 110.838 179.942 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 32.0 t60 -132.45 155.13 49.09 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.205 -0.452 . . . . 75.21 110.845 179.879 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -60.49 -174.04 1.01 Allowed Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.755 -0.736 . . . . 63.42 112.481 -179.962 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 16.8 mm100 65.32 12.69 8.27 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.878 0.37 . . . . 71.13 110.947 -179.892 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 68.36 29.31 73.08 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.747 -0.74 . . . . 71.23 112.462 -180.0 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 98.8 m95 -123.55 135.75 54.17 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.781 0.324 . . . . 74.01 110.918 -179.93 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 1.3 mt -120.3 130.62 54.54 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.195 -0.457 . . . . 75.33 110.907 179.987 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 82.6 t -76.18 112.11 13.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.184 -0.462 . . . . 75.21 111.138 179.821 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -133.0 157.9 44.04 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.121 -0.491 . . . . 71.03 111.055 179.892 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -114.41 156.23 24.88 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.196 -0.456 . . . . 65.53 110.88 -179.929 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -71.7 -175.35 1.34 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.16 -0.473 . . . . 51.52 110.9 -179.92 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -70.0 -39.45 75.86 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.208 -0.451 . . . . 74.31 110.915 -179.982 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 14.4 m -55.82 -22.29 24.02 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.177 -0.465 . . . . 75.32 110.892 -179.824 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 66.35 11.77 56.88 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.724 -0.75 . . . . 55.32 112.525 -179.974 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 3.5 m -107.76 -14.98 14.67 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.935 0.398 . . . . 74.33 110.843 -179.714 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -121.43 134.85 55.09 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.112 -0.494 . . . . 74.34 110.868 179.937 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 5.2 m -138.67 137.93 37.31 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.216 -0.447 . . . . 70.2 111.127 179.967 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -158.11 -154.49 7.16 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.75 -0.738 . . . . 62.51 112.502 179.942 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 6.2 mt -104.62 130.95 52.55 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.845 0.355 . . . . 73.41 110.902 -179.881 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 11.7 m -129.0 153.1 80.23 Favored Pre-proline 0 C--N 1.33 -0.264 0 CA-C-O 121.619 0.723 . . . . 65.2 111.141 179.801 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . 0.411 ' HG2' ' HB2' ' A' ' 54' ' ' PHE . 53.8 Cg_endo -69.76 144.72 54.94 Favored 'Trans proline' 0 C--N 1.341 0.166 0 C-N-CA 122.661 2.241 . . . . 62.13 112.319 179.966 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 13.5 tm-20 -90.44 -28.71 18.43 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.218 -0.446 . . . . 71.31 110.922 179.985 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -85.67 10.05 14.5 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.158 -0.474 . . . . 73.44 110.904 -179.954 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . 0.411 ' HB2' ' HG2' ' A' ' 51' ' ' PRO . 1.0 OUTLIER -121.02 -5.8 9.53 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.108 -0.496 . . . . 72.41 110.88 -179.969 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 15.4 m -122.75 167.52 16.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.16 -0.473 . . . . 70.15 111.108 179.998 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 47.9 t -138.27 117.35 12.56 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.158 -0.474 . . . . 70.43 110.85 -179.854 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 2.7 m-85 -53.44 134.12 40.47 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.133 -0.485 . . . . 73.44 110.936 -179.889 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 41.4 mt -104.48 146.54 11.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.098 -0.501 . . . . 74.21 111.123 179.905 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 1.3 mt-30 . . . . . 0 C--N 1.329 -0.283 0 CA-C-O 121.626 0.727 . . . . 71.43 110.889 179.922 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' B' B ' -7' ' ' PHE . . . . . . . . . . . . . 9.0 m-85 . . . . . 0 C--O 1.232 0.152 0 CA-C-O 120.808 0.337 . . . . 74.54 110.864 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' B' B ' -6' ' ' ILE . . . . . . . . . . . . . 37.3 mm -145.62 87.69 6.82 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 121.646 0.736 . . . . 72.51 111.135 179.933 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' -5' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.76 130.99 20.31 Favored 'Trans proline' 0 C--N 1.342 0.192 0 C-N-CA 122.649 2.233 . . . . 64.34 112.347 179.845 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' -4' ' ' SER . . . . . . . . . . . . . 30.9 t -124.27 62.21 1.11 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.164 -0.471 . . . . 75.25 110.879 -179.86 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' -3' ' ' ARG . . . . . . . . . . . . . 9.2 ptm180 -174.63 153.74 1.81 Allowed Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.643 0.735 . . . . 75.04 110.862 -179.93 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' -2' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.74 136.33 32.77 Favored 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.672 2.248 . . . . 73.31 112.343 179.996 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' -1' ' ' ALA . . . . . . . . . . . . . . . -71.84 152.76 93.2 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-O 121.605 0.717 . . . . 62.41 111.083 179.904 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 0' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.81 178.02 5.02 Favored 'Trans proline' 0 C--N 1.342 0.2 0 C-N-CA 122.602 2.201 . . . . 74.4 112.369 -179.965 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 1' ' ' LYS . . . . . . . . . . . . . 9.3 pttm -125.2 154.34 71.8 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-O 121.583 0.706 . . . . 74.25 110.898 179.945 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 2' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo . . . . . 0 C--N 1.341 0.182 0 C-N-CA 122.711 2.274 . . . . 74.24 112.313 179.909 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 57.8 tp60 . . . . . 0 C--O 1.231 0.103 0 CA-C-O 120.766 0.317 . . . . 72.33 110.899 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -79.08 160.67 26.98 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.189 -0.459 . . . . 74.44 110.834 -179.905 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -156.33 153.61 29.29 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.147 -0.478 . . . . 73.41 111.097 179.925 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 10.8 p -104.33 151.16 6.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.23 -0.441 . . . . 74.34 111.099 179.995 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -89.82 106.83 18.73 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.161 -0.472 . . . . 71.23 111.104 179.895 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 16.6 mt -71.4 -39.5 71.11 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.267 -0.424 . . . . 73.13 110.883 -179.951 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 5.6 m-85 -138.84 149.98 45.52 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.224 -0.444 . . . . 71.45 110.875 179.996 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 1.7 p30 -73.74 136.05 43.64 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.066 -0.515 . . . . 72.25 110.88 179.907 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 9.0 t80 -139.83 144.66 37.4 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.192 -0.458 . . . . 75.34 110.881 -179.884 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -113.16 144.75 31.76 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.645 0.736 . . . . 73.45 110.886 -179.907 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.78 141.6 45.61 Favored 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.722 2.281 . . . . 63.4 112.339 -179.981 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 6.3 mm-40 -102.02 -24.05 14.03 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.235 -0.438 . . . . 74.51 110.869 -179.967 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 40.7 m-80 -112.31 175.58 5.37 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.163 -0.471 . . . . 73.04 110.921 -179.963 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -83.07 2.06 37.03 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.204 -0.453 . . . . 74.53 110.869 179.875 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 1.1 p-10 -124.01 23.05 8.65 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.213 -0.448 . . . . 65.43 110.854 -179.903 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 5.4 mt-10 -108.86 156.72 19.34 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.198 -0.455 . . . . 70.4 110.894 179.998 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 54.4 tp -108.05 151.61 25.62 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.162 -0.472 . . . . 73.03 110.876 -179.956 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 9.7 mtt-85 -88.79 154.11 20.53 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.153 -0.476 . . . . 75.13 110.851 179.988 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 2.6 tp -140.51 149.04 41.97 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.177 -0.465 . . . . 75.5 110.945 -179.974 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -141.22 137.52 32.65 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.185 -0.461 . . . . 72.13 111.112 179.798 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -50.76 121.03 5.32 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.224 -0.444 . . . . 75.31 110.902 -179.897 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 96.65 -4.86 64.05 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.717 -0.754 . . . . 74.24 112.512 -179.947 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -82.78 146.74 28.8 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.816 0.341 . . . . 75.52 110.85 -179.972 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 3.2 mm -101.67 141.06 18.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.176 -0.465 . . . . 75.33 111.163 179.989 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 1.3 m -143.23 158.68 17.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.177 -0.465 . . . . 72.2 111.104 179.85 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 37.8 m-85 -115.83 106.71 14.14 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.134 -0.485 . . . . 75.21 110.838 -179.931 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 13.0 mm -72.13 103.3 1.47 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.157 -0.474 . . . . 72.11 111.126 179.959 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 3.4 m -64.55 -39.59 94.04 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.18 -0.464 . . . . 74.34 110.84 -179.891 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 32.8 p90 -174.16 148.06 1.29 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.145 -0.48 . . . . 75.13 110.907 -179.883 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 19.1 tttt -82.57 145.85 29.5 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.089 -0.505 . . . . 71.24 110.919 179.894 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 34.5 t60 -135.49 153.54 51.7 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.236 -0.438 . . . . 72.15 110.842 179.923 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -58.6 -174.44 0.52 Allowed Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.751 -0.738 . . . . 35.53 112.518 -179.973 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 2.5 mt-30 65.78 12.22 8.16 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.803 0.335 . . . . 72.44 110.908 -179.873 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 68.24 28.85 73.14 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.76 -0.733 . . . . 65.21 112.494 -179.955 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 99.1 m95 -123.56 136.0 54.3 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.773 0.32 . . . . 71.44 110.939 -179.919 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -124.11 132.06 53.61 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.261 -0.427 . . . . 75.2 110.938 179.969 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 47.1 t -78.2 116.97 22.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.194 -0.457 . . . . 73.42 111.169 179.807 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -136.66 166.31 23.84 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.178 -0.464 . . . . 73.41 111.085 179.866 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -127.53 153.93 45.76 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.212 -0.449 . . . . 73.03 110.879 -179.911 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -66.32 -174.77 0.3 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.172 -0.467 . . . . 65.41 110.895 -179.962 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -69.62 -37.93 77.03 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.157 -0.474 . . . . 74.4 110.879 -179.97 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 9.5 m -57.0 -22.52 39.23 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.141 -0.481 . . . . 74.04 110.895 -179.827 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 67.54 10.9 58.82 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.713 -0.756 . . . . 75.51 112.5 -179.973 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 1.9 t -106.48 -21.77 12.98 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.966 0.412 . . . . 73.51 110.868 -179.722 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 1.7 ttmt -114.07 124.02 51.08 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.131 -0.486 . . . . 74.33 110.88 179.936 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 15.6 m -133.79 144.52 49.07 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.193 -0.458 . . . . 75.51 111.117 -179.991 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -164.48 -152.96 7.22 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.72 -0.752 . . . . 63.32 112.458 179.971 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 12.6 mt -103.89 134.08 47.78 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.852 0.358 . . . . 75.13 110.876 -179.912 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.411 ' HB ' ' HD2' ' A' ' 51' ' ' PRO . 21.9 m -134.15 154.05 79.89 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-O 121.668 0.746 . . . . 74.14 111.069 179.857 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . 0.411 ' HD2' ' HB ' ' A' ' 50' ' ' VAL . 53.4 Cg_endo -69.77 146.43 60.09 Favored 'Trans proline' 0 C--N 1.342 0.209 0 C-N-CA 122.656 2.237 . . . . 72.33 112.3 179.974 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 28.0 tt0 -91.87 -29.31 16.78 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.187 -0.461 . . . . 74.15 110.903 179.982 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -85.23 9.8 14.16 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.187 -0.46 . . . . 71.14 110.934 -179.964 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -120.19 -7.97 9.76 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.13 -0.486 . . . . 75.33 110.858 -179.932 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 15.8 m -121.21 161.32 21.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.151 -0.477 . . . . 70.21 111.119 179.981 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 25.4 t -131.68 114.74 15.15 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.149 -0.478 . . . . 74.04 110.833 -179.855 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 3.0 m-85 -54.72 127.02 26.36 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.182 -0.463 . . . . 73.44 110.916 -179.877 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 40.6 mt -94.85 143.16 12.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.121 -0.49 . . . . 72.52 111.117 179.953 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--N 1.329 -0.326 0 CA-C-O 121.62 0.724 . . . . 73.44 110.914 179.976 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' -7' ' ' PHE . . . . . . . . . . . . . 6.7 m-85 . . . . . 0 C--O 1.232 0.136 0 CA-C-O 120.79 0.328 . . . . 74.11 110.909 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' B' B ' -6' ' ' ILE . . . . . . . . . . . . . 1.9 pt -152.98 88.28 3.87 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.68 0.752 . . . . 74.22 111.122 179.977 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' -5' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.74 135.64 31.01 Favored 'Trans proline' 0 C--N 1.342 0.227 0 C-N-CA 122.702 2.268 . . . . 72.43 112.368 179.859 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' -4' ' ' SER . . . . . . . . . . . . . 2.9 m -133.88 60.37 1.71 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.228 -0.442 . . . . 72.2 110.825 -179.814 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' -3' ' ' ARG . . . . . . . . . . . . . 9.9 ptt85 -174.62 153.41 1.77 Allowed Pre-proline 0 C--N 1.329 -0.288 0 CA-C-O 121.651 0.739 . . . . 72.25 110.836 -179.951 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' -2' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.75 128.05 15.48 Favored 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.645 2.23 . . . . 74.41 112.383 -179.991 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' -1' ' ' ALA . . . . . . . . . . . . . . . -62.61 155.18 70.46 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-O 121.564 0.697 . . . . 72.3 111.086 179.92 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 0' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.73 -169.24 0.31 Allowed 'Trans proline' 0 C--N 1.341 0.17 0 C-N-CA 122.66 2.24 . . . . 70.11 112.369 179.995 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 1' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -138.88 154.12 72.5 Favored Pre-proline 0 C--N 1.328 -0.347 0 CA-C-O 121.568 0.699 . . . . 75.14 110.89 179.909 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 2' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo . . . . . 0 C--N 1.342 0.185 0 C-N-CA 122.67 2.247 . . . . 74.42 112.354 179.914 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 31.0 tp60 . . . . . 0 C--O 1.231 0.102 0 CA-C-O 120.826 0.346 . . . . 74.4 110.921 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 4.4 ptp180 -89.87 163.1 15.14 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.18 -0.463 . . . . 74.51 110.863 -179.891 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -155.07 153.17 30.49 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.192 -0.458 . . . . 61.03 111.089 179.893 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 10.7 p -103.85 150.02 7.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.221 -0.445 . . . . 75.01 111.179 179.932 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -88.33 105.57 17.66 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.207 -0.452 . . . . 74.11 111.112 179.885 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 15.2 mt -69.68 -37.27 76.6 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.218 -0.446 . . . . 73.52 110.911 -179.95 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 2.9 m-85 -143.92 157.46 44.34 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.147 -0.479 . . . . 72.52 110.92 -179.988 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 3.7 p30 -78.84 134.84 36.92 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.128 -0.487 . . . . 75.34 110.9 179.896 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 2.5 t80 -134.42 146.03 49.45 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.201 -0.454 . . . . 74.53 110.894 -179.902 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 6.6 tt0 -116.5 136.14 23.06 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-O 121.626 0.727 . . . . 63.33 110.907 -179.881 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.81 151.52 68.82 Favored 'Trans proline' 0 C--N 1.341 0.175 0 C-N-CA 122.677 2.251 . . . . 75.32 112.319 -179.939 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 1.9 mm-40 -112.9 -17.28 12.53 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.211 -0.45 . . . . 74.42 110.885 -179.989 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 34.3 m-80 -115.21 176.15 5.19 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.148 -0.478 . . . . 74.0 110.892 -179.958 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 70.3 m-20 -91.86 21.07 5.12 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.222 -0.444 . . . . 74.14 110.898 179.91 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 1.1 p-10 -137.23 12.76 3.05 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.171 -0.468 . . . . 74.51 110.894 -179.984 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 48.7 mt-10 -106.82 160.12 15.73 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.178 -0.464 . . . . 74.31 110.841 -179.969 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 20.7 tp -110.88 147.21 35.08 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.095 -0.502 . . . . 72.14 110.917 179.989 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 1.4 mtt180 -83.28 155.85 23.4 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.166 -0.47 . . . . 73.14 110.849 179.96 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 3.0 tp -139.37 149.71 44.46 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.213 -0.449 . . . . 74.54 110.917 179.984 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -139.96 136.44 33.8 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.155 -0.475 . . . . 74.04 111.082 179.772 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -50.77 120.96 5.24 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.193 -0.458 . . . . 70.33 110.848 -179.913 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 96.86 -3.9 62.9 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.744 -0.741 . . . . 55.23 112.456 179.992 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -84.25 146.34 27.84 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.829 0.347 . . . . 74.22 110.823 -179.932 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 3.3 mm -100.52 142.34 15.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.177 -0.465 . . . . 75.44 111.177 179.957 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 1.7 m -145.14 157.38 13.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.206 -0.452 . . . . 53.34 111.111 179.886 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 61.1 m-85 -115.98 110.69 19.3 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.18 -0.464 . . . . 73.01 110.871 -179.988 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 15.5 mm -72.43 102.27 1.35 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.091 -0.504 . . . . 54.32 111.121 179.964 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 5.0 m -65.07 -40.17 94.31 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.234 -0.439 . . . . 71.15 110.831 -179.924 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 35.9 p90 -174.58 149.24 1.25 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.186 -0.461 . . . . 74.51 110.947 -179.913 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 32.5 tttt -80.87 143.18 32.92 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.124 -0.489 . . . . 73.11 110.863 179.945 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 23.2 t60 -129.44 157.42 42.02 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.238 -0.437 . . . . 73.34 110.891 179.87 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -64.18 -174.66 3.64 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.744 -0.741 . . . . 65.1 112.467 -179.959 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 17.9 mm100 65.47 12.69 8.35 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.836 0.351 . . . . 74.11 110.922 -179.893 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 69.72 29.49 71.16 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.745 -0.74 . . . . 64.42 112.505 -179.949 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 97.0 m95 -122.91 138.35 54.69 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.821 0.343 . . . . 75.14 110.938 -179.935 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 1.3 mt -121.13 133.24 55.2 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.223 -0.444 . . . . 72.32 110.935 179.966 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 95.9 t -80.06 109.37 14.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.21 -0.45 . . . . 72.34 111.124 179.814 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -129.19 158.46 38.95 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.175 -0.466 . . . . 71.52 111.126 179.822 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 1.4 pt-20 -117.05 157.31 26.05 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.234 -0.439 . . . . 63.41 110.843 -179.954 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -71.54 -175.04 1.21 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.126 -0.488 . . . . 75.33 110.891 -179.926 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 2.6 tt0 -69.45 -38.3 77.72 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.199 -0.455 . . . . 71.22 110.919 179.981 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 1.6 t -56.36 -22.58 32.0 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.165 -0.471 . . . . 73.44 110.827 -179.799 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 68.58 10.39 60.45 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.689 -0.767 . . . . 70.24 112.516 -179.933 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 3.1 t -107.14 -22.15 12.73 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.886 0.374 . . . . 74.14 110.83 -179.73 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 3.7 ttpt -110.31 123.9 50.67 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.158 -0.474 . . . . 75.32 110.933 179.932 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 9.3 m -131.89 130.38 41.55 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.24 -0.437 . . . . 63.13 111.136 179.998 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -153.57 -157.05 7.9 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.777 -0.725 . . . . 64.32 112.504 179.979 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 11.9 mt -100.32 133.33 44.88 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.821 0.343 . . . . 73.14 110.909 -179.925 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.415 ' HB ' ' HD2' ' A' ' 51' ' ' PRO . 6.0 m -131.97 153.62 81.45 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 121.685 0.755 . . . . 63.22 111.086 179.838 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . 0.415 ' HD2' ' HB ' ' A' ' 50' ' ' VAL . 54.0 Cg_endo -69.75 144.2 53.3 Favored 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.697 2.265 . . . . 63.24 112.353 179.918 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 6.9 tm-20 -90.63 -27.8 18.83 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.226 -0.443 . . . . 75.25 110.885 -179.982 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -86.76 11.12 13.87 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.165 -0.471 . . . . 70.1 110.93 -179.974 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 1.1 m-85 -121.74 -7.48 9.05 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.139 -0.482 . . . . 74.24 110.854 -179.91 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 16.1 m -121.88 168.08 14.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.161 -0.472 . . . . 72.34 111.13 -179.983 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 43.9 t -136.93 117.06 13.4 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.212 -0.449 . . . . 63.44 110.896 -179.851 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 2.9 m-85 -56.25 124.3 17.49 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.15 -0.477 . . . . 72.22 110.903 -179.849 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 35.3 mt -94.52 141.87 14.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.11 -0.496 . . . . 73.21 111.136 179.931 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.329 -0.298 0 CA-C-O 121.583 0.706 . . . . 74.03 110.922 179.923 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' -7' ' ' PHE . . . . . . . . . . . . . 7.4 m-85 . . . . . 0 C--O 1.231 0.126 0 CA-C-O 120.819 0.342 . . . . 75.42 110.871 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' B' B ' -6' ' ' ILE . . . . . 0.411 ' HA ' ' HD2' ' B' ' -5' ' ' PRO . 30.0 mm -138.22 94.83 10.78 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 121.681 0.753 . . . . 62.32 111.155 179.939 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' -5' ' ' PRO . . . . . 0.411 ' HD2' ' HA ' ' B' ' -6' ' ' ILE . 53.8 Cg_endo -69.76 140.37 42.51 Favored 'Trans proline' 0 C--N 1.342 0.194 0 C-N-CA 122.673 2.249 . . . . 73.55 112.357 179.884 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' -4' ' ' SER . . . . . . . . . . . . . 3.0 m -131.3 60.66 1.66 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.172 -0.467 . . . . 63.12 110.818 -179.811 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' -3' ' ' ARG . . . . . . . . . . . . . 14.2 ptp180 -178.87 154.96 0.83 Allowed Pre-proline 0 C--N 1.328 -0.332 0 CA-C-O 121.628 0.728 . . . . 75.53 110.875 -179.917 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' -2' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.79 140.54 42.83 Favored 'Trans proline' 0 C--N 1.342 0.189 0 C-N-CA 122.665 2.243 . . . . 73.54 112.352 -179.996 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' -1' ' ' ALA . . . . . . . . . . . . . . . -71.93 156.3 91.08 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-O 121.603 0.716 . . . . 73.32 111.094 179.903 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 0' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.79 -177.94 2.12 Favored 'Trans proline' 0 C--O 1.231 0.168 0 C-N-CA 122.696 2.264 . . . . 74.52 112.352 -179.996 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 1' ' ' LYS . . . . . . . . . . . . . 3.5 ttpt -129.31 145.49 57.02 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-O 121.576 0.703 . . . . 72.11 110.915 179.939 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 2' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo . . . . . 0 C--N 1.342 0.185 0 C-N-CA 122.718 2.279 . . . . 74.32 112.322 179.904 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 50.3 tp60 . . . . . 0 C--O 1.231 0.103 0 CA-C-O 120.809 0.338 . . . . 73.14 110.885 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 8.9 ptp180 -87.14 163.69 16.81 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.228 -0.442 . . . . 74.52 110.85 -179.934 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -155.18 154.08 31.72 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.192 -0.458 . . . . 74.13 111.07 179.948 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 11.6 p -104.03 149.26 7.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.187 -0.46 . . . . 73.45 111.088 -179.998 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -88.24 105.03 17.27 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.124 -0.489 . . . . 74.34 111.143 179.863 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 17.6 mt -69.17 -39.21 78.87 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.199 -0.455 . . . . 75.22 110.919 -179.952 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 3.3 m-85 -141.3 156.4 45.86 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.208 -0.451 . . . . 75.41 110.937 179.998 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 1.7 p-10 -79.06 135.05 36.75 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.11 -0.495 . . . . 75.43 110.853 179.914 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 2.1 t80 -134.09 146.06 49.95 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.191 -0.459 . . . . 75.3 110.926 -179.926 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 29.7 tt0 -115.72 135.47 22.68 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.603 0.716 . . . . 74.23 110.922 -179.945 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.76 147.64 63.32 Favored 'Trans proline' 0 C--N 1.341 0.154 0 C-N-CA 122.701 2.267 . . . . 73.02 112.347 -179.969 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 13.6 mt-10 -107.72 -18.82 13.73 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.247 -0.433 . . . . 71.41 110.894 -179.98 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 31.1 m-80 -112.8 175.46 5.43 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.133 -0.485 . . . . 72.02 110.899 -179.933 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 36.5 m-20 -90.05 13.4 14.98 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.191 -0.459 . . . . 72.24 110.836 179.949 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 1.2 p-10 -131.32 14.96 5.07 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.232 -0.44 . . . . 74.43 110.895 -179.901 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 23.9 mt-10 -104.29 159.49 15.67 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.122 -0.49 . . . . 74.22 110.9 -179.993 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -109.62 143.21 39.66 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.213 -0.449 . . . . 75.55 110.924 -179.989 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -81.67 156.37 25.11 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.204 -0.453 . . . . 72.52 110.878 179.951 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 2.7 tp -141.48 148.6 39.72 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.198 -0.455 . . . . 74.44 110.893 -179.976 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -139.87 136.58 34.09 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.197 -0.456 . . . . 65.55 111.041 179.836 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -50.57 121.83 6.32 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.183 -0.462 . . . . 73.12 110.85 -179.912 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 95.53 -0.77 63.54 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.787 -0.721 . . . . 75.52 112.474 -179.982 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -86.27 146.04 26.69 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.753 0.311 . . . . 54.34 110.872 -179.964 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 3.2 mm -101.2 137.93 27.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.183 -0.462 . . . . 72.14 111.137 -179.99 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 1.3 m -141.49 158.96 22.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.2 -0.455 . . . . 71.43 111.13 179.873 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 67.1 m-85 -116.5 108.98 16.68 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.185 -0.462 . . . . 75.32 110.905 179.977 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 11.3 mm -72.17 103.24 1.47 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.115 -0.493 . . . . 74.02 111.139 179.986 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 3.5 m -65.06 -39.96 94.04 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.196 -0.456 . . . . 74.02 110.841 -179.88 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 34.6 p90 -174.0 147.19 1.26 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.143 -0.48 . . . . 73.21 110.95 -179.892 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 21.4 tttt -80.36 146.04 31.74 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.105 -0.498 . . . . 74.23 110.929 179.922 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 36.0 t60 -136.39 152.53 50.72 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.273 -0.421 . . . . 64.1 110.876 179.921 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -58.01 -174.71 0.43 Allowed Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.737 -0.744 . . . . 73.14 112.432 -179.893 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 58.1 mm-40 65.94 12.08 8.16 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.817 0.341 . . . . 74.35 110.899 -179.867 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 68.01 29.07 73.29 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.747 -0.739 . . . . 70.51 112.463 -179.981 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 98.7 m95 -123.19 135.97 54.54 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.792 0.329 . . . . 73.32 110.908 -179.898 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -121.8 130.22 53.24 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.224 -0.444 . . . . 75.44 110.937 179.965 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 39.9 t -78.46 111.33 15.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.197 -0.456 . . . . 72.23 111.142 179.837 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -133.15 167.75 19.78 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.169 -0.469 . . . . 54.34 111.151 179.857 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 1.1 pt-20 -119.12 156.06 30.43 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.283 -0.417 . . . . 73.5 110.901 -179.963 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -71.02 -176.55 1.41 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.125 -0.489 . . . . 72.04 110.904 -179.944 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 4.0 tm-20 -67.51 -38.32 84.11 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.159 -0.473 . . . . 73.13 110.914 179.991 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 1.3 t -57.26 -22.19 39.66 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.166 -0.47 . . . . 74.44 110.831 -179.811 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 65.71 12.89 57.95 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.733 -0.746 . . . . 72.53 112.518 -179.942 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 1.4 t -109.19 -17.31 13.88 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.954 0.407 . . . . 72.35 110.837 -179.733 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -118.89 135.26 54.66 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.121 -0.491 . . . . 72.54 110.87 179.973 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 6.4 m -136.08 144.65 45.27 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.221 -0.445 . . . . 75.25 111.132 179.936 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -166.55 -159.55 12.45 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.76 -0.733 . . . . 60.23 112.449 -180.0 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 6.4 mt -98.96 134.92 41.11 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.913 0.387 . . . . 73.32 110.934 -179.97 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 31.1 m -133.39 153.63 80.58 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-O 121.661 0.743 . . . . 74.15 111.13 179.826 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . 0.4 ' HG2' ' HB2' ' A' ' 54' ' ' PHE . 53.5 Cg_endo -69.82 142.15 46.89 Favored 'Trans proline' 0 C--N 1.341 0.167 0 C-N-CA 122.665 2.243 . . . . 74.2 112.325 -179.995 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 26.9 tt0 -89.29 -27.7 20.37 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.244 -0.434 . . . . 64.44 110.902 -179.983 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -86.22 9.86 16.36 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.15 -0.477 . . . . 74.54 110.921 -179.972 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . 0.4 ' HB2' ' HG2' ' A' ' 51' ' ' PRO . 1.1 m-85 -119.88 -13.53 9.05 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.128 -0.487 . . . . 74.01 110.875 -179.937 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 19.5 m -115.49 166.37 9.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.142 -0.481 . . . . 74.44 111.088 179.987 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 35.1 t -138.25 117.58 12.79 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.125 -0.489 . . . . 74.44 110.884 -179.835 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 2.6 m-85 -52.72 133.25 36.87 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.164 -0.471 . . . . 70.03 110.929 -179.847 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 51.8 mt -102.11 147.73 8.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.121 -0.49 . . . . 74.4 111.082 179.953 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.329 -0.289 0 CA-C-O 121.561 0.696 . . . . 73.42 110.953 179.879 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' -7' ' ' PHE . . . . . . . . . . . . . 7.8 m-85 . . . . . 0 C--O 1.231 0.125 0 CA-C-O 120.779 0.323 . . . . 74.24 110.909 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' B' B ' -6' ' ' ILE . . . . . . . . . . . . . 2.1 pt -153.36 85.36 4.18 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-O 121.56 0.695 . . . . 75.44 111.136 179.998 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' -5' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.76 126.78 13.71 Favored 'Trans proline' 0 C--O 1.231 0.163 0 C-N-CA 122.649 2.233 . . . . 71.24 112.368 179.88 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' -4' ' ' SER . . . . . . . . . . . . . 30.4 t -122.04 57.94 1.04 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.255 -0.43 . . . . 73.41 110.886 -179.852 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' -3' ' ' ARG . . . . . . . . . . . . . 6.9 ptm180 -174.42 153.96 1.94 Allowed Pre-proline 0 C--N 1.329 -0.326 0 CA-C-O 121.602 0.715 . . . . 74.23 110.896 -179.928 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' -2' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.71 142.48 48.25 Favored 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.678 2.252 . . . . 74.41 112.372 179.964 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' -1' ' ' ALA . . . . . . . . . . . . . . . -75.16 154.52 86.4 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.627 0.727 . . . . 65.32 111.076 179.917 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 0' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.78 -177.35 1.84 Allowed 'Trans proline' 0 C--N 1.342 0.213 0 C-N-CA 122.679 2.253 . . . . 73.24 112.375 -179.967 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 1' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -127.56 150.76 73.8 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 121.544 0.688 . . . . 72.34 110.905 179.93 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 2' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo . . . . . 0 C--N 1.342 0.191 0 C-N-CA 122.647 2.231 . . . . 65.54 112.393 179.87 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 52.4 tp60 . . . . . 0 C--O 1.231 0.107 0 CA-C-O 120.765 0.316 . . . . 74.11 110.876 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 5.4 ptp180 -77.56 163.43 26.28 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.209 -0.45 . . . . 71.53 110.873 -179.936 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -158.37 154.73 27.46 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.202 -0.454 . . . . 63.32 111.11 179.981 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 10.8 p -105.66 150.48 8.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.242 -0.435 . . . . 73.34 111.087 179.985 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -89.26 107.86 19.29 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.166 -0.47 . . . . 71.0 111.115 179.859 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 18.4 mt -71.72 -39.25 70.26 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.247 -0.433 . . . . 64.45 110.943 -179.983 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 4.5 m-85 -140.33 152.74 46.07 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.143 -0.48 . . . . 73.32 110.943 -179.989 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 1.1 p30 -75.29 137.33 41.1 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.136 -0.483 . . . . 75.24 110.92 179.891 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 15.0 t80 -140.19 145.81 37.94 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.249 -0.432 . . . . 74.03 110.877 -179.889 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -114.55 142.7 28.61 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 121.634 0.731 . . . . 74.11 110.918 -179.94 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.78 134.21 27.39 Favored 'Trans proline' 0 C--N 1.341 0.16 0 C-N-CA 122.676 2.251 . . . . 72.24 112.336 -179.973 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 5.4 mt-10 -96.57 -16.99 20.76 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.239 -0.437 . . . . 72.22 110.872 -179.993 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 48.3 m-80 -115.55 175.77 5.37 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.165 -0.47 . . . . 61.52 110.865 -179.939 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 84.5 m-20 -88.77 13.36 12.65 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.169 -0.469 . . . . 73.04 110.854 179.972 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -135.37 21.09 3.4 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.171 -0.468 . . . . 74.22 110.869 -179.951 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 13.0 mt-10 -106.86 161.7 14.46 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.176 -0.465 . . . . 72.4 110.888 -179.989 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -111.29 143.42 42.09 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.202 -0.454 . . . . 74.11 110.899 -179.999 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 16.2 mtm180 -79.58 156.68 27.59 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.193 -0.458 . . . . 72.44 110.903 179.941 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 3.2 tp -142.93 148.78 37.47 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.217 -0.447 . . . . 74.33 110.894 -179.942 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -141.25 137.01 32.24 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.152 -0.476 . . . . 75.34 111.109 179.821 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -51.09 121.24 5.82 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.237 -0.438 . . . . 62.13 110.874 -179.899 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 97.03 -6.45 64.06 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.738 -0.744 . . . . 73.14 112.464 -179.979 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -81.04 146.39 30.67 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.76 0.314 . . . . 73.23 110.876 -179.939 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 3.3 mm -100.86 139.79 21.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.211 -0.449 . . . . 74.24 111.139 -179.975 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 1.4 m -143.12 158.17 17.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.192 -0.458 . . . . 74.52 111.104 179.841 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 55.7 m-85 -116.15 108.48 16.22 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.123 -0.49 . . . . 63.41 110.863 -179.959 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 13.4 mm -72.58 103.33 1.62 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.192 -0.458 . . . . 74.42 111.154 179.96 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 3.4 m -64.65 -39.3 93.44 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.12 -0.491 . . . . 72.15 110.897 -179.91 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 32.7 p90 -174.37 146.74 1.1 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.113 -0.494 . . . . 74.4 110.911 -179.863 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 18.7 tttt -82.51 145.73 29.62 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.138 -0.483 . . . . 75.42 110.919 179.886 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 29.8 t60 -134.88 153.08 52.19 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.236 -0.438 . . . . 74.24 110.83 179.952 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -58.52 -174.51 0.51 Allowed Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.738 -0.744 . . . . 75.32 112.532 -179.99 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 71.4 mm-40 65.94 12.15 8.21 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.864 0.364 . . . . 74.25 110.936 -179.909 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 68.16 28.62 73.27 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.735 -0.745 . . . . 64.13 112.533 -179.94 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 98.9 m95 -123.06 135.38 54.39 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.83 0.347 . . . . 74.14 110.907 -179.911 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -123.13 135.85 54.53 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.187 -0.46 . . . . 74.4 110.883 -179.963 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 39.3 t -84.43 114.9 25.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.177 -0.465 . . . . 73.43 111.145 179.814 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -136.4 168.57 19.2 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.189 -0.46 . . . . 71.53 111.15 179.838 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 1.4 pt-20 -125.64 155.01 41.47 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.211 -0.449 . . . . 72.45 110.829 -179.875 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -67.57 -175.19 0.49 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.15 -0.477 . . . . 61.43 110.87 -179.939 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 -68.9 -37.42 78.97 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.187 -0.461 . . . . 65.2 110.881 -179.962 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 1.6 t -57.02 -22.25 37.23 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.171 -0.468 . . . . 73.01 110.866 -179.816 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 66.89 12.42 59.82 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.699 -0.762 . . . . 74.1 112.489 179.986 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -109.65 -21.93 12.19 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.954 0.407 . . . . 63.21 110.871 -179.72 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -112.41 123.92 51.36 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.132 -0.485 . . . . 74.22 110.892 179.962 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 9.7 m -129.69 144.61 51.37 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.247 -0.433 . . . . 72.11 111.117 179.986 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -166.35 -159.22 11.86 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.73 -0.748 . . . . 54.31 112.462 179.98 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 13.5 mt -99.41 134.52 42.15 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.883 0.373 . . . . 73.25 110.885 -179.893 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.408 ' HB ' ' HD2' ' A' ' 51' ' ' PRO . 10.3 m -134.01 153.43 79.73 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-O 121.606 0.717 . . . . 73.4 111.104 179.908 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . 0.408 ' HD2' ' HB ' ' A' ' 50' ' ' VAL . 53.6 Cg_endo -69.8 147.56 62.88 Favored 'Trans proline' 0 N--CA 1.466 -0.134 0 C-N-CA 122.68 2.253 . . . . 75.44 112.357 179.934 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 24.6 tt0 -93.07 -28.34 16.42 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.214 -0.448 . . . . 74.4 110.902 -179.965 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 2.5 mm-40 -87.17 11.17 14.69 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.154 -0.475 . . . . 72.21 110.945 -179.963 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -121.1 -9.9 9.1 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.104 -0.498 . . . . 74.52 110.858 -179.939 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 16.2 m -119.65 166.54 13.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.186 -0.461 . . . . 75.21 111.077 -179.996 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 38.4 t -136.61 119.83 16.7 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.166 -0.47 . . . . 64.02 110.834 -179.859 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 3.1 m-85 -58.33 129.85 43.96 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.118 -0.492 . . . . 74.42 110.892 -179.895 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 39.8 mt -96.51 150.25 4.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.095 -0.502 . . . . 75.1 111.121 179.886 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 1.4 mt-30 . . . . . 0 C--N 1.329 -0.31 0 CA-C-O 121.59 0.71 . . . . 74.21 110.874 179.965 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' B' B ' -7' ' ' PHE . . . . . . . . . . . . . 8.4 m-85 . . . . . 0 C--O 1.232 0.136 0 CA-C-O 120.825 0.345 . . . . 74.12 110.861 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' B' B ' -6' ' ' ILE . . . . . . . . . . . . . 4.1 tp -163.66 88.12 1.21 Allowed Pre-proline 0 C--N 1.328 -0.326 0 CA-C-O 121.662 0.744 . . . . 75.31 111.158 179.922 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' -5' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.78 146.08 58.94 Favored 'Trans proline' 0 C--N 1.341 0.175 0 C-N-CA 122.7 2.267 . . . . 75.43 112.323 179.911 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' -4' ' ' SER . . . . . . . . . . . . . 29.9 t -143.81 67.79 1.28 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.197 -0.456 . . . . 65.33 110.864 -179.845 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' -3' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -179.6 154.75 0.73 Allowed Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.647 0.737 . . . . 74.52 110.855 -179.928 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' -2' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.79 119.76 6.65 Favored 'Trans proline' 0 C--N 1.342 0.188 0 C-N-CA 122.688 2.259 . . . . 74.31 112.37 179.973 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' -1' ' ' ALA . . . . . . . . . . . . . . . -55.54 151.52 20.69 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.572 0.701 . . . . 61.12 111.109 179.886 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 0' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.78 172.3 12.91 Favored 'Trans proline' 0 C--O 1.232 0.197 0 C-N-CA 122.684 2.256 . . . . 55.33 112.365 179.992 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 1' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -120.93 152.87 56.96 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-O 121.553 0.692 . . . . 71.52 110.86 179.943 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 2' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo . . . . . 0 C--N 1.341 0.151 0 C-N-CA 122.703 2.268 . . . . 74.53 112.357 179.872 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 56.6 tp60 . . . . . 0 C--O 1.231 0.112 0 CA-C-O 120.801 0.334 . . . . 64.41 110.95 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 6.8 ptp180 -75.01 162.44 28.57 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.174 -0.466 . . . . 72.51 110.854 -179.905 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -156.59 154.05 29.59 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.189 -0.46 . . . . 55.24 111.119 179.929 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 11.3 p -105.46 148.48 9.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.225 -0.443 . . . . 75.44 111.119 179.973 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -87.4 113.46 23.13 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.165 -0.47 . . . . 71.45 111.088 179.889 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 15.0 mt -79.04 -37.37 39.19 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.186 -0.461 . . . . 74.34 110.956 179.997 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 5.1 m-85 -142.09 143.33 33.01 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.169 -0.469 . . . . 74.13 110.934 -179.967 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 3.2 p-10 -67.03 132.9 48.84 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.158 -0.474 . . . . 71.13 110.858 179.934 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 5.6 t80 -130.53 145.92 51.95 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.177 -0.465 . . . . 72.11 110.886 -179.865 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 3.8 tp10 -117.13 135.91 23.22 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.618 0.723 . . . . 74.42 110.913 -179.958 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.67 141.07 44.6 Favored 'Trans proline' 0 C--N 1.341 0.167 0 C-N-CA 122.716 2.277 . . . . 74.52 112.314 -179.971 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -105.9 -9.29 17.21 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.213 -0.449 . . . . 73.13 110.883 179.96 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 57.5 m-80 -121.66 175.75 6.07 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.18 -0.464 . . . . 73.23 110.902 -179.962 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -92.99 23.33 4.31 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.2 -0.454 . . . . 74.31 110.869 179.905 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 1.1 p-10 -140.92 13.68 2.27 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.16 -0.473 . . . . 53.44 110.864 -179.932 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 28.5 mt-10 -105.1 167.79 9.48 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.186 -0.461 . . . . 73.35 110.874 -179.976 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 30.2 tp -117.3 147.56 42.47 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.166 -0.47 . . . . 74.33 110.938 -179.996 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 1.9 mtt180 -82.68 156.63 23.72 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.21 -0.45 . . . . 73.34 110.824 179.956 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 3.2 tp -143.5 147.86 35.14 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.15 -0.477 . . . . 73.12 110.928 -179.973 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -139.64 138.7 36.33 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.167 -0.469 . . . . 74.25 111.043 179.83 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 -51.15 121.55 6.33 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.21 -0.45 . . . . 71.22 110.905 -179.945 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 96.73 -7.42 65.39 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.77 -0.728 . . . . 74.44 112.508 -179.907 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -79.49 147.73 32.12 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.811 0.338 . . . . 74.03 110.873 -179.982 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 3.2 mm -102.85 140.91 19.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.187 -0.46 . . . . 74.4 111.106 -179.966 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 1.6 m -143.04 158.15 17.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.14 -0.482 . . . . 75.54 111.139 179.803 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 43.7 m-85 -115.62 106.05 13.47 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.183 -0.462 . . . . 74.4 110.884 -179.972 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 22.3 mm -71.02 103.2 1.11 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.152 -0.476 . . . . 64.15 111.095 -179.99 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 3.4 m -64.95 -39.28 93.25 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.186 -0.461 . . . . 60.44 110.872 -179.91 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 34.1 p90 -174.32 147.52 1.18 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.111 -0.495 . . . . 71.34 110.907 -179.917 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 19.7 tttt -81.51 146.29 30.26 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.116 -0.493 . . . . 74.25 110.922 179.877 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 33.2 t60 -134.87 156.52 48.79 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.259 -0.428 . . . . 75.13 110.888 179.856 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -61.15 -174.06 1.25 Allowed Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.719 -0.753 . . . . 54.01 112.511 -179.982 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 45.4 mm-40 64.66 13.23 8.18 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.838 0.352 . . . . 74.14 110.92 -179.899 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 67.99 29.2 73.38 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.725 -0.75 . . . . 75.23 112.485 -179.986 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 98.9 m95 -123.29 138.34 54.64 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.83 0.347 . . . . 73.41 110.891 -179.881 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -126.21 132.26 51.8 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.256 -0.429 . . . . 74.54 110.93 179.964 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 51.8 t -77.38 115.75 19.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.206 -0.452 . . . . 74.22 111.143 179.858 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -133.95 158.86 42.41 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.178 -0.465 . . . . 72.33 111.092 179.886 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 1.9 pt-20 -120.5 153.55 36.51 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.2 -0.455 . . . . 63.15 110.911 -179.943 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -67.94 -175.05 0.52 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.195 -0.457 . . . . 74.13 110.892 -179.971 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -69.81 -38.41 76.59 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.153 -0.476 . . . . 75.25 110.924 179.999 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 15.4 m -56.43 -22.73 33.83 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.111 -0.495 . . . . 64.42 110.916 -179.873 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 68.85 9.27 59.13 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.755 -0.736 . . . . 62.34 112.485 -179.992 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 39.0 m -105.06 -20.21 13.59 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.983 0.421 . . . . 74.32 110.899 -179.767 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -113.24 123.67 50.73 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.092 -0.504 . . . . 74.32 110.882 179.946 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 11.4 m -134.54 127.1 30.65 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.183 -0.462 . . . . 74.52 111.1 -179.992 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -147.34 -154.36 6.2 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.725 -0.75 . . . . 72.32 112.471 179.944 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 6.9 mt -106.1 127.22 53.04 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.878 0.37 . . . . 71.13 110.897 -179.91 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.422 ' HB ' ' HD2' ' A' ' 51' ' ' PRO . 14.4 m -124.5 154.26 69.58 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-O 121.588 0.709 . . . . 70.23 111.186 179.818 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . 0.422 ' HD2' ' HB ' ' A' ' 50' ' ' VAL . 53.3 Cg_endo -69.77 147.12 62.11 Favored 'Trans proline' 0 N--CA 1.465 -0.151 0 C-N-CA 122.722 2.281 . . . . 72.14 112.316 179.997 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 27.8 tt0 -92.02 -29.86 16.37 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.234 -0.439 . . . . 74.44 110.897 -179.997 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -84.91 9.89 13.18 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.132 -0.485 . . . . 74.4 110.878 -179.916 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . 0.41 ' HB2' ' HG2' ' A' ' 51' ' ' PRO . 1.0 OUTLIER -120.78 -8.46 9.44 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.177 -0.465 . . . . 74.53 110.887 -179.901 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 20.4 m -118.86 171.98 6.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.123 -0.49 . . . . 75.02 111.115 179.996 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 35.6 t -143.59 113.51 7.18 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.175 -0.466 . . . . 74.42 110.806 -179.774 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 2.9 m-85 -52.54 133.28 35.89 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.115 -0.493 . . . . 74.21 110.922 -179.914 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 46.0 mt -102.46 148.63 7.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.099 -0.5 . . . . 75.11 111.137 179.899 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 5.0 mt-30 . . . . . 0 C--N 1.329 -0.306 0 CA-C-O 121.632 0.729 . . . . 75.44 110.834 179.971 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' B' B ' -7' ' ' PHE . . . . . . . . . . . . . 11.3 m-85 . . . . . 0 C--O 1.231 0.087 0 CA-C-O 120.862 0.363 . . . . 64.44 110.876 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' B' B ' -6' ' ' ILE . . . . . . . . . . . . . 8.4 tt -133.72 119.16 14.82 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 121.576 0.703 . . . . 75.42 111.171 179.974 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' -5' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.73 154.47 67.83 Favored 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 122.681 2.254 . . . . 73.24 112.318 179.92 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' -4' ' ' SER . . . . . . . . . . . . . 41.3 t -133.78 39.18 3.18 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.19 -0.459 . . . . 62.22 110.853 -179.843 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' -3' ' ' ARG . . . . . . . . . . . . . 5.9 ptm180 -174.48 154.48 1.98 Allowed Pre-proline 0 C--N 1.328 -0.334 0 CA-C-O 121.661 0.744 . . . . 74.52 110.838 -179.894 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' -2' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.79 137.9 36.46 Favored 'Trans proline' 0 C--N 1.342 0.189 0 C-N-CA 122.634 2.223 . . . . 64.33 112.334 179.996 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' -1' ' ' ALA . . . . . . . . . . . . . . . -63.39 154.74 77.84 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.519 0.676 . . . . 74.2 111.086 179.9 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 0' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.76 -170.55 0.4 Allowed 'Trans proline' 0 C--O 1.232 0.176 0 C-N-CA 122.675 2.25 . . . . 64.32 112.325 179.982 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 1' ' ' LYS . . . . . . . . . . . . . 27.8 mtpp -130.11 154.58 81.33 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-O 121.575 0.702 . . . . 73.32 110.87 179.942 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 2' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo . . . . . 0 C--N 1.342 0.186 0 C-N-CA 122.732 2.288 . . . . 74.24 112.33 179.881 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 51.6 tp60 . . . . . 0 C--O 1.23 0.075 0 CA-C-O 120.824 0.345 . . . . 73.22 110.891 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 7.7 ptp180 -86.37 161.78 18.51 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.138 -0.483 . . . . 74.4 110.826 -179.909 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -153.3 154.46 34.63 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.154 -0.476 . . . . 74.12 111.101 179.892 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 9.2 p -103.9 153.09 6.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.226 -0.443 . . . . 75.54 111.115 179.981 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -92.06 113.68 26.02 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.149 -0.478 . . . . 60.14 111.086 179.891 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 13.5 mt -79.59 -36.1 38.63 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.211 -0.449 . . . . 74.25 110.923 -179.977 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 2.8 m-85 -144.09 146.11 32.59 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.179 -0.464 . . . . 74.02 110.941 179.995 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 1.3 p30 -68.47 135.2 51.28 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.091 -0.504 . . . . 64.32 110.869 179.909 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 7.5 t80 -134.24 146.21 49.86 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.156 -0.475 . . . . 74.54 110.87 -179.915 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 68.5 tt0 -115.15 137.59 23.06 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-O 121.66 0.743 . . . . 73.22 110.867 -179.869 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.75 137.25 35.06 Favored 'Trans proline' 0 C--N 1.341 0.155 0 C-N-CA 122.665 2.243 . . . . 75.53 112.34 -179.986 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 7.9 mm-40 -97.66 -20.2 17.78 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.222 -0.445 . . . . 62.33 110.901 -179.987 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 32.2 m-80 -115.15 175.3 5.57 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.134 -0.484 . . . . 65.11 110.869 -179.967 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 26.2 m-20 -87.25 7.97 26.15 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.181 -0.463 . . . . 64.34 110.861 179.912 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -125.13 16.76 8.45 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.23 -0.441 . . . . 75.2 110.915 -179.888 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 16.4 mt-10 -108.37 156.59 19.25 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.164 -0.471 . . . . 75.11 110.888 179.986 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -106.51 150.39 26.16 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.119 -0.491 . . . . 60.11 110.917 -179.969 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 26.1 mtm180 -85.16 153.27 22.76 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.167 -0.469 . . . . 73.3 110.852 179.976 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 1.7 tp -138.09 148.11 44.68 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.199 -0.455 . . . . 72.21 110.941 -179.968 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -140.18 139.24 35.66 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.231 -0.44 . . . . 73.55 111.147 179.786 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -50.29 119.72 3.93 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.249 -0.432 . . . . 74.4 110.88 -179.934 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 98.5 -6.86 61.28 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.773 -0.727 . . . . 61.41 112.456 179.973 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -75.78 152.78 37.29 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.792 0.329 . . . . 74.03 110.845 -179.997 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 1.3 mt -116.77 122.2 69.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.17 -0.468 . . . . 73.34 111.176 179.933 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 3.6 m -124.64 163.41 24.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.168 -0.469 . . . . 74.33 111.132 179.894 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 74.5 m-85 -116.35 110.1 18.24 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.145 -0.479 . . . . 73.2 110.853 -179.994 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 13.4 mm -71.85 103.0 1.31 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.117 -0.492 . . . . 65.22 111.106 179.955 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 5.4 m -65.53 -40.77 93.33 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.192 -0.458 . . . . 73.35 110.822 -179.904 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 33.4 p90 -174.27 149.87 1.43 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.154 -0.476 . . . . 75.34 110.958 -179.899 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 19.1 tttt -81.37 143.1 32.41 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.168 -0.469 . . . . 73.21 110.856 179.928 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 32.9 t60 -131.91 153.35 50.34 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.206 -0.452 . . . . 75.54 110.889 179.872 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -59.24 -174.69 0.69 Allowed Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.732 -0.747 . . . . 62.32 112.486 -179.932 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 29.8 mm-40 66.17 11.76 8.07 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.789 0.328 . . . . 73.43 110.88 -179.897 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 68.69 28.77 72.9 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.767 -0.73 . . . . 65.02 112.484 -179.947 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 98.0 m95 -122.9 136.36 54.83 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.744 0.307 . . . . 73.12 110.953 -179.958 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 1.4 mt -118.71 131.93 56.15 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.297 -0.411 . . . . 73.5 110.85 -179.985 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 23.4 t -81.34 109.35 15.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.151 -0.477 . . . . 73.21 111.116 179.804 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -132.71 165.4 24.59 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.16 -0.473 . . . . 75.33 111.084 179.847 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -115.93 156.32 26.42 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.216 -0.447 . . . . 71.31 110.907 -179.97 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -69.77 179.33 2.23 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.138 -0.483 . . . . 75.52 110.873 -179.904 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 61.3 tt0 -63.5 -39.8 95.4 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.223 -0.444 . . . . 71.41 110.956 179.96 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 1.5 t -55.73 -22.77 25.47 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.085 -0.507 . . . . 75.45 110.861 -179.819 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 66.15 11.87 56.47 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.754 -0.736 . . . . 72.12 112.503 -179.967 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 16.5 m -107.75 -18.72 13.75 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.969 0.414 . . . . 60.04 110.841 -179.73 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 4.0 ptmt -117.16 133.68 55.7 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.142 -0.481 . . . . 74.42 110.871 -179.999 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 4.9 m -129.26 152.68 48.56 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.259 -0.428 . . . . 72.1 111.149 179.991 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -177.35 -161.04 25.15 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.744 -0.741 . . . . 75.2 112.515 179.976 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 6.7 mt -99.53 136.89 38.79 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.833 0.349 . . . . 74.34 110.873 -179.905 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 6.0 m -135.31 153.1 77.81 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.666 0.746 . . . . 53.45 111.116 179.839 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.79 143.85 52.02 Favored 'Trans proline' 0 C--N 1.342 0.195 0 C-N-CA 122.63 2.22 . . . . 74.35 112.325 -179.999 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 10.1 tm-20 -91.0 -27.2 18.81 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.221 -0.445 . . . . 71.23 110.874 -179.972 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -87.51 11.71 14.15 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.19 -0.459 . . . . 64.51 110.871 -179.958 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 1.1 m-85 -121.23 -12.79 8.6 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.141 -0.481 . . . . 74.53 110.833 -179.895 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 17.3 m -116.69 168.73 7.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.141 -0.482 . . . . 72.4 111.14 179.988 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 45.2 t -138.83 116.52 11.43 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.172 -0.467 . . . . 74.23 110.854 -179.834 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 2.8 m-85 -51.87 134.53 31.21 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.1 -0.5 . . . . 70.43 110.909 -179.902 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 54.2 mt -104.04 146.61 11.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.087 -0.506 . . . . 74.43 111.153 179.905 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 2.5 mt-30 . . . . . 0 C--N 1.328 -0.353 0 CA-C-O 121.576 0.703 . . . . 73.31 110.936 179.968 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' B' B ' -7' ' ' PHE . . . . . . . . . . . . . 8.8 m-85 . . . . . 0 C--O 1.231 0.124 0 CA-C-O 120.795 0.331 . . . . 64.43 110.886 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' B' B ' -6' ' ' ILE . . . . . . . . . . . . . 4.5 tt -155.47 84.87 3.47 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-O 121.65 0.738 . . . . 74.55 111.109 179.994 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' -5' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.74 132.21 22.89 Favored 'Trans proline' 0 C--N 1.342 0.202 0 C-N-CA 122.707 2.272 . . . . 74.42 112.351 179.877 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' -4' ' ' SER . . . . . . . . . . . . . 1.4 t -129.74 64.26 1.51 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.224 -0.444 . . . . 74.51 110.866 -179.858 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' -3' ' ' ARG . . . . . . . . . . . . . 4.9 ptm180 -178.32 155.0 0.94 Allowed Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.641 0.734 . . . . 75.42 110.839 -179.91 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' -2' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.76 129.49 17.69 Favored 'Trans proline' 0 C--N 1.342 0.194 0 C-N-CA 122.654 2.236 . . . . 74.32 112.384 179.973 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' -1' ' ' ALA . . . . . . . . . . . . . . . -61.34 157.85 41.95 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-O 121.55 0.691 . . . . 73.41 111.135 179.879 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 0' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.76 -176.24 1.42 Allowed 'Trans proline' 0 C--O 1.231 0.156 0 C-N-CA 122.71 2.273 . . . . 74.34 112.345 -179.985 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 1' ' ' LYS . . . . . . . . . . . . . 37.2 tttp -131.77 137.55 30.55 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-O 121.542 0.687 . . . . 73.23 110.918 179.887 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 2' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo . . . . . 0 C--O 1.232 0.204 0 C-N-CA 122.725 2.283 . . . . 73.55 112.338 179.941 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 51.1 tp60 . . . . . 0 C--O 1.231 0.114 0 CA-C-O 120.827 0.346 . . . . 71.54 110.914 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 5.5 ptp180 -80.19 160.97 25.45 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.213 -0.448 . . . . 72.21 110.867 -179.886 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -155.42 154.43 31.91 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.204 -0.453 . . . . 75.41 111.116 179.955 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 10.7 p -104.28 149.6 7.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.258 -0.428 . . . . 74.22 111.117 -179.988 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -87.3 110.12 19.99 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.195 -0.457 . . . . 74.25 111.091 179.899 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 16.6 mt -74.2 -37.45 63.88 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.226 -0.443 . . . . 73.54 110.912 -179.941 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 5.4 m-85 -142.34 154.87 45.03 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.196 -0.456 . . . . 75.32 110.945 179.992 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 1.6 p30 -78.94 137.49 37.65 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.112 -0.495 . . . . 65.44 110.898 179.882 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 9.9 t80 -138.84 145.49 40.1 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.211 -0.45 . . . . 72.04 110.871 -179.959 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 22.5 tt0 -114.28 135.46 22.2 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 121.617 0.722 . . . . 75.11 110.891 -179.926 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.8 152.62 69.13 Favored 'Trans proline' 0 C--N 1.341 0.162 0 C-N-CA 122.702 2.268 . . . . 71.42 112.353 -179.996 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 22.4 tp10 -116.52 -20.72 9.51 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.205 -0.452 . . . . 72.21 110.898 -179.95 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 7.4 m-80 -106.53 176.04 5.3 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.14 -0.482 . . . . 71.52 110.834 -179.926 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 15.8 m-20 -92.2 21.41 5.15 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.177 -0.465 . . . . 74.34 110.851 179.923 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 1.2 p-10 -141.16 12.51 2.2 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.22 -0.445 . . . . 75.13 110.888 -179.876 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 -101.68 156.05 17.73 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.167 -0.469 . . . . 74.34 110.894 -179.985 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 31.5 tp -108.46 144.94 35.4 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.142 -0.481 . . . . 71.21 110.89 -179.949 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 14.6 mtp180 -81.18 153.09 27.4 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.215 -0.448 . . . . 74.5 110.902 179.935 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 2.6 tp -138.99 148.42 43.44 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.236 -0.438 . . . . 72.24 110.904 -179.944 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -139.92 137.23 34.63 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.197 -0.456 . . . . 72.13 111.131 179.767 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -50.7 120.03 4.37 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.234 -0.439 . . . . 74.14 110.896 -179.91 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 97.9 -5.77 61.9 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.761 -0.733 . . . . 74.24 112.482 -179.945 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -81.77 147.29 29.49 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.785 0.326 . . . . 73.22 110.861 -179.944 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 3.4 mm -100.94 142.46 15.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.224 -0.444 . . . . 73.31 111.086 -179.982 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 1.4 m -145.27 158.24 13.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.181 -0.463 . . . . 55.54 111.128 179.859 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 65.0 m-85 -116.95 108.26 15.57 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.155 -0.475 . . . . 75.1 110.892 -179.964 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 16.5 mm -71.78 103.28 1.36 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.16 -0.473 . . . . 74.22 111.125 179.975 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 11.4 m -65.4 -40.17 93.09 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.119 -0.491 . . . . 72.14 110.833 -179.902 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 36.5 p90 -174.53 150.08 1.36 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.104 -0.498 . . . . 75.42 110.892 -179.873 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 13.4 tttt -82.07 144.44 30.82 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.094 -0.503 . . . . 73.13 110.885 179.903 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 31.7 t60 -132.75 156.15 47.59 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.244 -0.434 . . . . 74.31 110.858 179.919 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -61.21 -174.31 1.34 Allowed Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.771 -0.728 . . . . 50.44 112.42 -179.926 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 63.1 mm-40 65.35 12.84 8.4 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.852 0.358 . . . . 72.33 110.946 -179.885 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 68.41 28.98 72.95 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.697 -0.763 . . . . 54.22 112.499 -179.997 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 98.8 m95 -123.45 137.54 54.77 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.857 0.36 . . . . 75.04 110.894 -179.912 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -121.9 130.47 53.38 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.215 -0.448 . . . . 75.25 110.896 179.979 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 42.8 t -77.32 116.01 20.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.175 -0.466 . . . . 74.45 111.087 179.845 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -138.05 161.79 35.83 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.18 -0.464 . . . . 71.23 111.101 179.85 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 1.2 pt-20 -113.45 156.86 22.76 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.209 -0.45 . . . . 72.52 110.867 -179.923 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -72.4 -176.26 1.82 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.13 -0.486 . . . . 74.04 110.883 -179.932 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 9.6 tt0 -68.16 -38.5 82.18 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.188 -0.46 . . . . 63.01 110.908 -179.975 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 1.5 t -57.02 -22.22 37.08 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.137 -0.483 . . . . 72.13 110.83 -179.827 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 65.8 12.77 57.84 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.737 -0.744 . . . . 75.31 112.483 -179.993 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -109.13 -15.99 14.2 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.972 0.415 . . . . 71.32 110.863 -179.779 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -120.11 135.08 55.08 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.137 -0.483 . . . . 74.0 110.941 179.949 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 5.6 m -136.36 140.28 43.15 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.252 -0.431 . . . . 73.1 111.156 179.985 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -161.8 -153.7 7.19 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.743 -0.741 . . . . 61.03 112.472 -179.997 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 9.0 mt -104.05 135.0 46.37 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.818 0.342 . . . . 75.24 110.928 -179.932 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 10.2 m -133.94 153.02 79.6 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 121.604 0.716 . . . . 72.31 111.152 179.825 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.81 147.78 63.29 Favored 'Trans proline' 0 C--N 1.341 0.161 0 C-N-CA 122.618 2.212 . . . . 75.23 112.337 180.0 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 15.5 tm-20 -92.77 -28.91 16.3 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.211 -0.45 . . . . 64.43 110.886 -179.97 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -86.59 10.55 15.14 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.15 -0.477 . . . . 62.33 110.881 -179.917 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -121.31 -4.31 9.42 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.152 -0.476 . . . . 72.44 110.852 -179.902 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 16.0 m -125.93 166.61 21.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.169 -0.468 . . . . 73.12 111.155 179.94 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 30.0 t -136.21 118.99 16.14 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.166 -0.47 . . . . 73.11 110.888 -179.836 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 -57.71 128.22 35.98 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.161 -0.472 . . . . 65.12 110.901 -179.847 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 49.6 mt -94.69 148.19 5.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.165 -0.47 . . . . 72.25 111.127 179.918 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 2.5 mt-30 . . . . . 0 C--N 1.329 -0.315 0 CA-C-O 121.573 0.702 . . . . 74.41 110.957 179.923 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' B' B ' -7' ' ' PHE . . . . . . . . . . . . . 18.0 m-85 . . . . . 0 C--O 1.231 0.086 0 CA-C-O 120.85 0.357 . . . . 71.11 110.855 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' B' B ' -6' ' ' ILE . . . . . . . . . . . . . 58.8 mt -149.91 93.33 3.96 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 121.59 0.71 . . . . 63.03 111.124 179.954 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' -5' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.75 122.1 8.78 Favored 'Trans proline' 0 C--O 1.232 0.178 0 C-N-CA 122.637 2.225 . . . . 61.1 112.351 179.894 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' -4' ' ' SER . . . . . . . . . . . . . 22.7 m -117.18 59.95 0.76 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.254 -0.43 . . . . 75.24 110.893 -179.868 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' -3' ' ' ARG . . . . . . . . . . . . . 8.8 ptm180 -176.69 153.36 1.15 Allowed Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 121.634 0.731 . . . . 73.3 110.867 -179.927 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' -2' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.77 145.56 57.42 Favored 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.661 2.24 . . . . 73.03 112.323 -179.964 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' -1' ' ' ALA . . . . . . . . . . . . . . . -75.93 141.92 72.18 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.567 0.699 . . . . 72.01 111.105 179.848 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 0' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.75 175.13 8.5 Favored 'Trans proline' 0 C--N 1.341 0.169 0 C-N-CA 122.712 2.275 . . . . 74.11 112.36 179.959 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 1' ' ' LYS . . . . . . . . . . . . . 16.7 ptmt -124.31 152.71 68.27 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-O 121.551 0.691 . . . . 72.25 110.93 179.891 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 2' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo . . . . . 0 C--O 1.232 0.202 0 C-N-CA 122.744 2.296 . . . . 75.24 112.349 179.877 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 40.2 tp60 . . . . . 0 C--O 1.232 0.141 0 CA-C-O 120.755 0.312 . . . . 74.31 110.899 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 5.0 ptp180 -76.83 160.39 29.3 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.189 -0.46 . . . . 75.33 110.835 -179.898 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -155.33 149.83 26.17 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.208 -0.451 . . . . 62.2 111.094 179.913 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 8.7 p -105.41 142.21 19.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.25 -0.432 . . . . 70.11 111.14 179.985 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -82.94 127.74 33.81 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.178 -0.465 . . . . 70.51 111.093 179.866 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 7.6 mt -93.23 -31.68 14.65 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.221 -0.445 . . . . 73.31 110.889 -179.985 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 4.5 m-85 -144.18 136.12 26.22 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.185 -0.461 . . . . 72.33 110.924 -179.96 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 3.4 p30 -62.3 141.68 58.15 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.153 -0.476 . . . . 63.03 110.852 179.911 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 24.1 t80 -141.87 145.87 35.14 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.193 -0.458 . . . . 72.44 110.895 -179.918 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 28.6 tt0 -115.64 137.0 22.91 Favored Pre-proline 0 C--N 1.33 -0.257 0 CA-C-O 121.657 0.741 . . . . 64.04 110.912 -179.945 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.73 146.43 60.31 Favored 'Trans proline' 0 C--N 1.341 0.181 0 C-N-CA 122.687 2.258 . . . . 71.43 112.35 -179.961 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 7.3 mm-40 -107.87 -12.74 15.13 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.267 -0.424 . . . . 75.21 110.886 180.0 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 28.6 m-80 -118.98 175.48 5.74 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.185 -0.461 . . . . 75.14 110.906 -179.97 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 63.7 m-20 -90.83 15.87 10.44 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.206 -0.452 . . . . 73.52 110.833 -179.993 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 1.1 p-10 -134.08 16.74 3.81 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.192 -0.458 . . . . 72.43 110.873 -179.888 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 3.9 mm-40 -106.98 160.84 15.23 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.149 -0.478 . . . . 74.3 110.867 -179.969 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -111.44 142.86 43.15 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.147 -0.479 . . . . 75.15 110.954 179.994 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 36.2 mtm-85 -78.44 156.8 29.21 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.21 -0.45 . . . . 73.42 110.872 179.981 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 3.1 tp -141.65 148.85 39.81 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.165 -0.47 . . . . 74.52 110.914 -179.993 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -138.56 139.9 38.84 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.214 -0.448 . . . . 72.53 111.119 179.73 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -53.64 119.31 4.75 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.215 -0.448 . . . . 74.13 110.888 -179.917 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 93.16 0.83 67.54 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.726 -0.749 . . . . 55.23 112.469 -179.978 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 20.5 t70 -77.2 158.73 30.16 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.809 0.338 . . . . 75.32 110.84 -179.948 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 1.7 mm -111.14 121.32 63.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.164 -0.471 . . . . 74.4 111.168 179.996 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 3.7 m -130.59 155.7 41.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.25 -0.432 . . . . 73.24 111.16 179.827 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 66.2 m-85 -115.56 109.08 17.27 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.218 -0.446 . . . . 72.35 110.895 -179.94 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 16.5 mm -73.0 103.8 1.89 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.133 -0.485 . . . . 71.45 111.11 -179.989 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 2.6 m -64.48 -39.56 94.03 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.196 -0.456 . . . . 64.41 110.848 -179.882 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 32.5 p90 -174.1 146.79 1.19 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.124 -0.489 . . . . 74.44 110.946 -179.902 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 21.0 tttt -80.2 146.27 31.84 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.119 -0.492 . . . . 74.13 110.917 179.935 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 31.8 t60 -136.53 152.74 50.85 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.246 -0.434 . . . . 75.54 110.809 179.941 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -58.19 -174.96 0.48 Allowed Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.76 -0.733 . . . . 73.41 112.491 -179.98 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 56.4 mm-40 65.88 12.2 8.21 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.777 0.322 . . . . 74.21 110.856 -179.92 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 68.12 28.73 73.26 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.721 -0.752 . . . . 71.35 112.475 179.995 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 98.6 m95 -122.76 136.18 54.79 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.797 0.332 . . . . 72.24 110.913 -179.921 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -122.74 130.78 53.33 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.225 -0.443 . . . . 72.34 110.888 179.983 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 40.7 t -78.72 111.71 15.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.155 -0.475 . . . . 74.24 111.152 179.808 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -131.57 168.28 17.95 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.167 -0.469 . . . . 71.14 111.054 179.915 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -121.92 159.39 26.98 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.153 -0.476 . . . . 72.04 110.893 -179.931 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 41.7 p-10 -58.57 -174.82 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.131 -0.486 . . . . 74.43 110.901 -179.936 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 66.5 tt0 -78.03 -37.18 47.48 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.215 -0.448 . . . . 73.14 110.919 179.996 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 37.3 t -70.64 -22.32 62.52 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.146 -0.479 . . . . 60.15 110.892 -179.834 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 75.93 26.52 64.4 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.754 -0.736 . . . . 75.22 112.466 179.985 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 8.6 t -107.18 -20.66 13.23 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.915 0.388 . . . . 72.31 110.872 -179.753 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -127.27 137.58 52.89 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.138 -0.483 . . . . 65.41 110.893 179.924 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 20.9 m -131.27 149.68 52.47 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.193 -0.458 . . . . 74.15 111.148 179.913 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -173.5 -162.16 24.94 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.726 -0.749 . . . . 73.51 112.448 179.975 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 10.4 mt -96.67 139.18 33.12 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.815 0.341 . . . . 74.2 110.972 -179.941 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 11.5 m -137.3 152.96 74.36 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.664 0.745 . . . . 75.43 111.116 179.859 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.81 147.78 63.31 Favored 'Trans proline' 0 C--N 1.341 0.18 0 C-N-CA 122.668 2.246 . . . . 72.5 112.311 179.959 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 23.8 tt0 -93.11 -29.21 15.88 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.204 -0.453 . . . . 75.11 110.88 -179.987 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -85.72 7.97 21.57 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.149 -0.478 . . . . 71.05 110.887 -179.922 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 1.1 m-85 -119.57 3.3 11.21 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.129 -0.487 . . . . 64.22 110.865 -179.902 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 21.3 m -134.62 164.55 33.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.119 -0.492 . . . . 70.33 111.161 179.959 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 32.2 t -136.36 118.61 15.58 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.18 -0.464 . . . . 70.24 110.837 -179.885 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 3.0 m-85 -54.32 135.2 45.08 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.144 -0.48 . . . . 74.14 110.921 -179.886 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 31.0 mt -101.92 150.74 6.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.088 -0.505 . . . . 74.31 111.144 179.918 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 1.6 mt-30 . . . . . 0 C--N 1.329 -0.311 0 CA-C-O 121.672 0.748 . . . . 75.1 110.907 179.93 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' B' B ' -7' ' ' PHE . . . . . . . . . . . . . 5.8 m-85 . . . . . 0 C--O 1.231 0.12 0 CA-C-O 120.858 0.361 . . . . 73.44 110.823 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' B' B ' -6' ' ' ILE . . . . . . . . . . . . . 34.2 mm -145.45 88.57 6.58 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-O 121.673 0.749 . . . . 63.21 111.139 179.967 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' -5' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.82 130.36 19.13 Favored 'Trans proline' 0 C--N 1.342 0.192 0 C-N-CA 122.702 2.268 . . . . 74.23 112.313 179.943 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' -4' ' ' SER . . . . . . . . . . . . . 27.4 t -129.4 65.56 1.47 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.165 -0.47 . . . . 72.22 110.86 -179.819 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' -3' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -179.74 154.98 0.72 Allowed Pre-proline 0 C--N 1.329 -0.326 0 CA-C-O 121.578 0.704 . . . . 71.14 110.914 -179.931 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' -2' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.74 131.74 21.89 Favored 'Trans proline' 0 C--N 1.341 0.155 0 C-N-CA 122.686 2.257 . . . . 72.34 112.347 179.974 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' -1' ' ' ALA . . . . . . . . . . . . . . . -65.16 151.91 92.73 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-O 121.526 0.679 . . . . 75.43 111.094 179.891 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 0' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.75 176.63 6.5 Favored 'Trans proline' 0 C--O 1.232 0.181 0 C-N-CA 122.651 2.234 . . . . 74.44 112.359 -179.989 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 1' ' ' LYS . . . . . . . . . . . . . 12.3 pttp -125.57 155.07 72.7 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.543 0.687 . . . . 74.05 110.91 179.886 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 2' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo . . . . . 0 C--N 1.341 0.183 0 C-N-CA 122.668 2.246 . . . . 73.25 112.35 179.863 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 48.4 tp60 . . . . . 0 C--O 1.231 0.099 0 CA-C-O 120.765 0.317 . . . . 75.44 110.932 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 5.2 ptp180 -73.87 162.99 28.52 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.172 -0.467 . . . . 73.45 110.881 -179.931 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -156.61 153.8 29.18 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.198 -0.455 . . . . 70.51 111.133 179.911 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 10.7 p -103.96 149.63 7.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.224 -0.444 . . . . 75.24 111.169 179.937 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -88.68 106.06 18.09 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.193 -0.458 . . . . 63.12 111.082 179.877 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 15.4 mt -71.33 -36.66 71.63 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.199 -0.455 . . . . 70.32 110.957 179.98 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 4.0 m-85 -143.56 152.65 41.69 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.211 -0.449 . . . . 75.25 110.886 -180.0 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 2.4 p30 -75.29 140.64 43.26 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.069 -0.514 . . . . 64.44 110.903 179.903 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 7.2 t80 -147.18 145.34 29.48 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.195 -0.457 . . . . 75.35 110.904 -179.852 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -114.06 144.61 31.93 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.641 0.734 . . . . 75.12 110.912 -179.949 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.82 148.75 65.36 Favored 'Trans proline' 0 C--N 1.341 0.144 0 C-N-CA 122.688 2.259 . . . . 63.43 112.356 -179.996 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 10.6 tp10 -109.87 -19.72 13.02 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.171 -0.468 . . . . 75.32 110.847 -179.911 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 9.2 m-80 -110.95 176.3 5.08 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.173 -0.467 . . . . 72.54 110.844 -179.905 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -90.84 21.08 4.31 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.136 -0.484 . . . . 73.51 110.918 179.884 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -142.35 13.44 1.98 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.147 -0.479 . . . . 73.33 110.896 -179.893 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 17.0 mt-10 -102.43 158.25 16.34 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.163 -0.471 . . . . 74.32 110.906 -179.981 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -105.9 155.78 19.01 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.204 -0.453 . . . . 75.15 110.909 -179.97 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -92.04 153.69 19.25 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.137 -0.483 . . . . 72.44 110.83 -179.965 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 2.3 tp -137.05 149.72 47.6 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.236 -0.438 . . . . 72.44 110.945 -179.995 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -142.9 136.9 29.1 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.207 -0.451 . . . . 75.44 111.116 179.793 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -50.15 119.98 4.09 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.235 -0.438 . . . . 75.4 110.855 -179.883 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 96.34 -0.91 62.04 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.749 -0.739 . . . . 63.24 112.473 -179.971 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -86.99 147.26 25.81 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.751 0.31 . . . . 70.02 110.853 -179.966 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 3.3 mm -102.59 142.08 17.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.221 -0.445 . . . . 73.02 111.155 179.987 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -143.22 159.45 17.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.196 -0.456 . . . . 75.01 111.145 179.876 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 44.0 m-85 -116.59 107.09 14.28 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.216 -0.447 . . . . 73.21 110.851 -179.953 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 17.6 mm -72.63 103.05 1.55 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.158 -0.474 . . . . 74.45 111.109 179.993 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 3.0 m -64.29 -39.32 93.7 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.161 -0.472 . . . . 62.3 110.861 -179.92 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 32.9 p90 -174.75 147.34 1.02 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.109 -0.496 . . . . 64.4 110.898 -179.828 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 11.9 tttm -81.45 145.98 30.48 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.09 -0.504 . . . . 64.51 110.865 179.922 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 32.1 t60 -135.68 152.04 50.8 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.211 -0.45 . . . . 75.35 110.894 179.873 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -57.78 -175.35 0.44 Allowed Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.728 -0.749 . . . . 71.21 112.511 -179.986 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 4.4 mp0 66.55 11.94 8.42 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.826 0.346 . . . . 75.54 110.869 -179.908 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 68.18 28.82 73.19 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.751 -0.738 . . . . 74.52 112.507 -179.973 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 97.8 m95 -122.74 134.95 54.43 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.796 0.332 . . . . 75.41 110.902 -179.92 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -121.73 132.61 54.72 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.241 -0.436 . . . . 64.14 110.9 179.983 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 46.1 t -79.79 109.59 14.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.207 -0.451 . . . . 73.32 111.125 179.839 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -129.46 161.65 29.9 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.199 -0.455 . . . . 73.21 111.083 179.884 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 2.3 pm0 -118.51 158.38 25.48 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.204 -0.453 . . . . 75.24 110.936 -179.98 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 46.3 p-10 -58.16 -175.08 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.166 -0.47 . . . . 75.14 110.896 -179.946 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 15.6 tm-20 -78.01 -35.44 49.9 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.176 -0.465 . . . . 64.22 110.921 -179.99 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 40.1 t -69.59 -21.89 63.56 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.131 -0.486 . . . . 62.11 110.903 -179.826 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 76.33 26.13 64.39 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.71 -0.757 . . . . 33.04 112.529 -179.968 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -111.98 -22.51 11.01 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.926 0.393 . . . . 65.1 110.881 -179.747 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 3.0 ttmt -117.89 130.24 56.12 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.135 -0.484 . . . . 73.4 110.904 179.93 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 4.6 m -127.77 150.36 49.84 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.251 -0.431 . . . . 74.54 111.163 179.927 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -177.69 -160.18 23.87 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.757 -0.735 . . . . 65.45 112.489 179.994 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 3.6 mt -102.04 141.15 35.33 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.874 0.368 . . . . 73.43 110.892 -179.95 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.431 ' HB ' ' HD2' ' A' ' 51' ' ' PRO . 16.1 m -138.11 154.5 74.17 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.611 0.719 . . . . 63.31 111.138 179.826 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . 0.431 ' HD2' ' HB ' ' A' ' 50' ' ' VAL . 53.3 Cg_endo -69.74 143.14 49.99 Favored 'Trans proline' 0 C--N 1.341 0.132 0 C-N-CA 122.708 2.272 . . . . 73.44 112.315 179.976 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 27.1 tt0 -90.5 -27.55 19.13 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.194 -0.457 . . . . 73.42 110.854 -179.947 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -86.19 9.61 17.04 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.17 -0.468 . . . . 73.41 110.923 -179.969 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 1.1 m-85 -119.85 -13.75 9.04 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.124 -0.489 . . . . 74.45 110.852 -179.912 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 21.8 m -114.7 167.45 7.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.169 -0.469 . . . . 74.31 111.113 179.967 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 42.9 t -139.23 116.27 10.98 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.167 -0.469 . . . . 72.11 110.869 -179.899 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 2.6 m-85 -53.35 133.94 40.0 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.134 -0.484 . . . . 74.33 110.951 -179.913 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 39.4 mt -102.58 150.24 6.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.109 -0.496 . . . . 73.32 111.114 179.975 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.329 -0.283 0 CA-C-O 121.607 0.718 . . . . 71.55 110.94 179.925 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' -7' ' ' PHE . . . . . . . . . . . . . 19.6 m-85 . . . . . 0 C--O 1.231 0.123 0 CA-C-O 120.815 0.341 . . . . 74.33 110.919 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' B' B ' -6' ' ' ILE . . . . . . . . . . . . . 4.5 tt -173.52 90.05 0.37 Allowed Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 121.691 0.758 . . . . 72.54 111.118 179.996 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' -5' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.75 134.48 28.09 Favored 'Trans proline' 0 C--N 1.342 0.209 0 C-N-CA 122.662 2.241 . . . . 72.43 112.382 179.853 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' -4' ' ' SER . . . . . . . . . . . . . 33.1 t -134.37 66.5 1.54 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.214 -0.448 . . . . 74.12 110.834 -179.845 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' -3' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 179.87 155.34 0.69 Allowed Pre-proline 0 C--N 1.328 -0.34 0 CA-C-O 121.609 0.718 . . . . 75.13 110.905 -179.968 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' -2' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.8 123.14 9.79 Favored 'Trans proline' 0 N--CA 1.465 -0.187 0 C-N-CA 122.668 2.246 . . . . 74.31 112.331 -179.95 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' -1' ' ' ALA . . . . . . . . . . . . . . . -50.99 152.6 3.62 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-O 121.561 0.696 . . . . 73.31 111.1 179.886 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 0' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.76 165.15 31.94 Favored 'Trans proline' 0 C--N 1.341 0.166 0 C-N-CA 122.683 2.256 . . . . 73.52 112.367 179.959 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 1' ' ' LYS . . . . . . . . . . . . . 3.9 tppt? -116.02 135.93 22.86 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-O 121.594 0.711 . . . . 75.35 110.87 179.935 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 2' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo . . . . . 0 C--N 1.341 0.179 0 C-N-CA 122.676 2.251 . . . . 72.52 112.337 179.856 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 49.4 tp60 . . . . . 0 C--O 1.231 0.079 0 CA-C-O 120.862 0.363 . . . . 65.01 110.883 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -73.4 158.59 34.71 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.172 -0.467 . . . . 75.21 110.878 -179.917 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -154.72 154.06 32.28 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.19 -0.459 . . . . 73.03 111.066 179.905 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 10.9 p -104.14 152.22 6.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.208 -0.451 . . . . 75.25 111.126 179.984 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -91.83 121.48 33.48 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.198 -0.456 . . . . 74.11 111.129 179.813 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 12.6 mt -85.99 -33.82 20.98 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.22 -0.445 . . . . 75.43 110.886 -179.985 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 5.1 m-85 -144.98 142.59 29.93 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.224 -0.443 . . . . 74.43 110.941 -179.979 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 1.9 p-10 -67.46 140.66 57.11 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.132 -0.486 . . . . 74.14 110.892 179.899 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 15.5 t80 -140.94 146.53 37.48 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.182 -0.463 . . . . 72.51 110.918 -179.906 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -115.58 137.37 23.13 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-O 121.632 0.73 . . . . 74.33 110.866 -179.913 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.79 151.59 68.92 Favored 'Trans proline' 0 N--CA 1.465 -0.154 0 C-N-CA 122.701 2.267 . . . . 63.11 112.373 179.987 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 4.2 mt-10 -109.69 -19.44 13.17 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.232 -0.44 . . . . 75.14 110.917 -179.995 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 48.5 m-80 -123.63 175.0 7.08 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.159 -0.473 . . . . 74.43 110.867 -179.931 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 41.5 m-20 -81.05 -1.14 42.86 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.165 -0.471 . . . . 75.25 110.867 179.937 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -112.47 16.35 19.87 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.216 -0.447 . . . . 72.13 110.885 -179.916 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 6.9 mt-10 -110.39 157.15 19.85 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.181 -0.463 . . . . 71.01 110.871 -179.964 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 41.7 tp -112.19 147.79 35.42 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.145 -0.479 . . . . 74.02 110.9 -179.994 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 32.2 mtm180 -83.17 154.76 24.11 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.196 -0.456 . . . . 75.12 110.86 179.946 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 2.3 tp -142.25 147.94 37.29 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.199 -0.455 . . . . 71.24 110.913 -179.983 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -138.07 139.45 39.54 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.185 -0.461 . . . . 43.34 111.109 179.787 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -51.71 119.58 4.35 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.234 -0.439 . . . . 75.15 110.857 -179.929 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 97.34 -6.72 63.59 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.716 -0.755 . . . . 73.23 112.458 179.987 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -71.39 160.2 33.2 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.752 0.31 . . . . 74.35 110.867 -179.921 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 1.2 mt -123.11 114.04 40.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.205 -0.452 . . . . 74.42 111.122 179.999 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 12.1 m -117.43 166.92 11.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.12 -0.491 . . . . 74.52 111.131 179.863 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 63.7 m-85 -117.95 106.26 12.76 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.167 -0.469 . . . . 73.45 110.854 -179.943 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 21.3 mm -71.62 103.58 1.38 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.15 -0.477 . . . . 75.24 111.114 179.974 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 10.5 m -65.0 -39.55 93.64 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.208 -0.451 . . . . 71.54 110.856 -179.923 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 54.0 p90 -175.41 160.95 2.66 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.116 -0.493 . . . . 75.11 110.88 -179.869 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 16.6 tttt -87.89 146.78 25.4 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.14 -0.482 . . . . 75.15 110.871 179.909 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 35.5 t60 -136.14 155.01 50.78 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.18 -0.463 . . . . 75.51 110.878 179.926 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -60.45 -175.99 1.36 Allowed Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.751 -0.737 . . . . 55.23 112.5 -179.98 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 19.0 mm100 66.53 11.66 8.22 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.898 0.38 . . . . 73.43 110.94 -179.897 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 69.36 27.96 73.06 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.704 -0.76 . . . . 71.13 112.499 -179.95 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 97.6 m95 -122.33 140.99 52.02 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.779 0.323 . . . . 74.44 110.911 -179.892 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -123.9 130.3 52.37 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.227 -0.442 . . . . 74.14 110.935 179.949 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 21.7 t -75.61 116.36 18.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.221 -0.445 . . . . 72.51 111.121 179.863 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -138.45 160.67 38.95 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.212 -0.449 . . . . 72.34 111.104 179.901 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -121.54 155.87 34.06 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.231 -0.441 . . . . 75.34 110.886 -179.916 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -66.45 -175.35 0.36 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.159 -0.473 . . . . 72.33 110.882 -179.952 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 9.7 tt0 -69.98 -38.74 76.13 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.173 -0.467 . . . . 62.51 110.93 179.996 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 2.0 t -56.83 -22.55 37.4 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.102 -0.499 . . . . 75.13 110.862 -179.782 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 66.97 11.65 58.69 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.765 -0.731 . . . . 75.44 112.476 -179.993 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 1.4 p -103.82 -21.85 13.61 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.912 0.386 . . . . 74.44 110.818 -179.745 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -117.63 123.21 45.6 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.156 -0.475 . . . . 74.53 110.89 179.964 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 9.8 m -129.93 133.83 47.08 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.188 -0.46 . . . . 75.24 111.135 179.994 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -152.43 -151.22 5.6 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.779 -0.724 . . . . 74.54 112.481 -179.995 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 18.3 mt -106.94 127.66 53.64 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.872 0.367 . . . . 73.11 110.93 -179.918 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.413 ' HB ' ' HD2' ' A' ' 51' ' ' PRO . 13.3 m -126.31 153.7 74.67 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.675 0.75 . . . . 75.21 111.1 179.872 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . 0.413 ' HD2' ' HB ' ' A' ' 50' ' ' VAL . 53.7 Cg_endo -69.79 152.54 69.16 Favored 'Trans proline' 0 C--N 1.342 0.188 0 C-N-CA 122.675 2.25 . . . . 75.45 112.352 179.955 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 13.9 tm-20 -96.21 -30.48 13.46 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.209 -0.45 . . . . 63.52 110.876 -179.952 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -85.14 8.41 18.26 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.148 -0.478 . . . . 75.15 110.892 -179.941 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -120.12 2.34 10.91 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.165 -0.471 . . . . 74.5 110.897 -179.954 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 15.8 m -132.57 170.85 19.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.162 -0.472 . . . . 71.44 111.118 179.989 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 9.6 t -143.09 120.96 11.97 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.157 -0.474 . . . . 70.11 110.855 -179.862 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 2.8 m-85 -56.82 135.18 55.62 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.129 -0.487 . . . . 73.32 110.913 -179.847 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 47.0 mt -103.51 149.04 7.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.121 -0.49 . . . . 74.12 111.111 179.938 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--N 1.329 -0.293 0 CA-C-O 121.628 0.728 . . . . 74.21 110.894 179.991 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' -7' ' ' PHE . . . . . . . . . . . . . 12.6 m-85 . . . . . 0 C--O 1.232 0.139 0 CA-C-O 120.824 0.345 . . . . 75.24 110.821 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' B' B ' -6' ' ' ILE . . . . . . . . . . . . . 5.2 mp -136.43 113.27 10.23 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.65 0.738 . . . . 74.34 111.128 179.928 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' -5' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.74 160.67 48.84 Favored 'Trans proline' 0 C--N 1.341 0.158 0 C-N-CA 122.739 2.293 . . . . 75.25 112.333 179.883 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' -4' ' ' SER . . . . . . . . . . . . . 43.4 t -147.43 46.14 1.13 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.235 -0.439 . . . . 74.53 110.855 -179.84 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' -3' ' ' ARG . . . . . . . . . . . . . 1.5 ptp85 -179.32 155.15 0.78 Allowed Pre-proline 0 C--N 1.328 -0.331 0 CA-C-O 121.612 0.72 . . . . 74.53 110.861 -179.969 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' -2' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.78 129.26 17.26 Favored 'Trans proline' 0 C--N 1.341 0.148 0 C-N-CA 122.65 2.233 . . . . 73.51 112.349 -179.984 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' -1' ' ' ALA . . . . . . . . . . . . . . . -54.64 153.08 11.3 Favored Pre-proline 0 C--N 1.33 -0.266 0 CA-C-O 121.561 0.696 . . . . 75.31 111.095 179.902 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 0' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_endo -69.78 -174.74 0.97 Allowed 'Trans proline' 0 C--O 1.231 0.162 0 C-N-CA 122.707 2.271 . . . . 72.34 112.325 -179.989 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 1' ' ' LYS . . . . . . . . . . . . . 4.9 mtmp? -130.67 156.92 79.1 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 121.594 0.711 . . . . 73.24 110.887 179.904 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 2' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo . . . . . 0 C--N 1.342 0.192 0 C-N-CA 122.67 2.247 . . . . 72.43 112.365 179.879 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 51.2 tp60 . . . . . 0 C--O 1.231 0.112 0 CA-C-O 120.753 0.311 . . . . 75.33 110.951 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 6.8 ptp180 -90.61 164.6 14.13 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.206 -0.452 . . . . 72.31 110.863 -179.902 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -156.48 152.58 27.56 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.185 -0.461 . . . . 74.03 111.108 179.94 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 10.9 p -104.08 151.84 6.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.231 -0.44 . . . . 73.15 111.15 179.958 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -89.25 116.85 27.79 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.143 -0.48 . . . . 74.11 111.128 179.876 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 10.2 mt -84.52 -36.68 22.02 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.241 -0.436 . . . . 75.31 110.877 -179.955 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 6.4 m-85 -140.32 136.19 32.97 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.232 -0.44 . . . . 73.45 110.952 -179.989 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 1.6 p30 -62.65 139.23 58.64 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.118 -0.492 . . . . 73.24 110.879 179.93 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 10.8 t80 -145.51 145.99 31.27 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.211 -0.45 . . . . 74.15 110.869 -179.886 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -115.96 144.69 33.24 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.674 0.749 . . . . 71.41 110.895 -179.973 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.77 140.63 43.12 Favored 'Trans proline' 0 C--N 1.341 0.158 0 C-N-CA 122.689 2.26 . . . . 70.42 112.368 179.992 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 9.9 mt-10 -101.25 -21.45 14.9 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.194 -0.457 . . . . 74.34 110.875 -179.946 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 34.1 m-80 -110.29 176.66 4.97 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.14 -0.482 . . . . 74.5 110.876 -179.923 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -91.04 20.64 4.76 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.136 -0.484 . . . . 74.3 110.902 179.871 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -140.31 15.37 2.4 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.183 -0.462 . . . . 74.21 110.908 -179.924 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 16.3 mt-10 -107.37 158.07 17.46 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.171 -0.468 . . . . 64.41 110.899 -179.981 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -104.27 161.07 14.36 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.159 -0.473 . . . . 73.32 110.853 -179.902 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -96.57 152.78 18.31 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.184 -0.462 . . . . 74.31 110.864 179.941 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 1.8 tp -137.79 149.49 46.43 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.137 -0.483 . . . . 72.52 110.91 -179.982 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -142.5 138.76 31.18 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.194 -0.457 . . . . 65.12 111.106 179.768 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -50.62 119.86 4.19 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.189 -0.46 . . . . 74.33 110.911 -179.945 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 96.7 -3.45 62.99 Favored Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.74 -0.743 . . . . 70.22 112.445 -179.979 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -84.63 146.45 27.48 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.721 0.296 . . . . 71.24 110.878 -179.943 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 3.5 mm -101.75 144.88 12.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.199 -0.455 . . . . 65.23 111.109 -179.991 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 1.5 m -146.58 158.31 10.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.148 -0.478 . . . . 72.01 111.108 179.848 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 54.3 m-85 -116.54 110.08 18.1 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.142 -0.481 . . . . 72.53 110.907 -179.995 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 14.7 mm -73.29 102.74 1.72 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.133 -0.485 . . . . 73.25 111.125 179.965 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 3.9 m -64.8 -40.35 95.08 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.196 -0.456 . . . . 74.11 110.837 -179.909 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 34.4 p90 -174.68 148.58 1.14 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.149 -0.478 . . . . 73.44 110.905 -179.926 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 13.2 tttt -81.0 145.67 31.06 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.12 -0.491 . . . . 72.41 110.887 179.943 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 33.6 t60 -134.58 153.55 51.9 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.214 -0.448 . . . . 75.43 110.852 179.89 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -59.01 -174.12 0.57 Allowed Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.717 -0.754 . . . . 63.15 112.54 -179.97 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 77.9 mm-40 65.49 12.24 8.02 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.825 0.345 . . . . 75.45 110.911 -179.886 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 68.24 29.51 73.28 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.758 -0.734 . . . . 63.12 112.505 -179.98 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 98.4 m95 -123.51 135.97 54.32 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.81 0.338 . . . . 74.43 110.95 -179.936 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 1.4 mt -119.64 132.3 55.66 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.228 -0.442 . . . . 74.12 110.918 179.986 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 60.0 t -79.27 109.11 13.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.206 -0.452 . . . . 75.31 111.15 179.825 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -129.93 163.02 27.29 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.191 -0.459 . . . . 73.31 111.11 179.924 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 1.5 pt-20 -119.02 156.4 29.7 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.232 -0.44 . . . . 74.22 110.86 -179.903 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -68.6 -175.2 0.64 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.129 -0.487 . . . . 73.32 110.877 -179.954 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 9.1 tm-20 -68.89 -37.81 79.23 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.211 -0.449 . . . . 73.14 110.883 -179.974 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 1.6 t -57.0 -22.61 39.84 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.16 -0.473 . . . . 75.33 110.869 -179.769 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 69.9 8.57 61.24 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.784 -0.722 . . . . 45.45 112.479 -179.97 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 30.9 t -108.15 -22.3 12.44 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.931 0.396 . . . . 54.01 110.86 -179.769 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 2.7 ttmt -107.09 123.84 48.81 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.13 -0.486 . . . . 75.53 110.906 179.977 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 4.3 m -125.7 152.22 45.57 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.244 -0.434 . . . . 70.51 111.142 -179.991 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -177.63 -162.42 27.71 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.746 -0.74 . . . . 54.12 112.476 179.933 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 5.8 mt -99.21 136.87 38.54 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.847 0.356 . . . . 74.05 110.966 -179.938 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 16.8 m -136.36 153.32 76.26 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-O 121.562 0.696 . . . . 73.23 111.183 179.845 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.69 143.5 51.36 Favored 'Trans proline' 0 C--N 1.341 0.152 0 C-N-CA 122.677 2.252 . . . . 72.3 112.362 179.91 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 15.5 tm-20 -90.19 -27.74 19.35 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.209 -0.45 . . . . 61.22 110.901 179.977 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 -86.31 10.44 14.84 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.134 -0.485 . . . . 71.5 110.892 -179.916 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -120.28 -9.56 9.5 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.138 -0.483 . . . . 74.24 110.898 -179.921 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 15.3 m -117.68 172.47 5.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.171 -0.468 . . . . 73.41 111.119 179.989 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 38.4 t -142.56 113.19 7.36 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.193 -0.458 . . . . 74.33 110.864 -179.885 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 3.1 m-85 -52.17 130.1 29.52 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.133 -0.485 . . . . 75.32 110.936 -179.908 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 54.5 mt -99.97 146.91 8.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.145 -0.479 . . . . 70.24 111.152 179.894 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 8.1 mt-30 . . . . . 0 C--N 1.329 -0.284 0 CA-C-O 121.594 0.712 . . . . 73.23 110.903 179.942 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' B' B ' -7' ' ' PHE . . . . . . . . . . . . . 15.2 m-85 . . . . . 0 C--O 1.231 0.117 0 CA-C-O 120.841 0.353 . . . . 75.13 110.877 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' B' B ' -6' ' ' ILE . . . . . . . . . . . . . 2.4 pt -153.36 85.19 4.2 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.668 0.747 . . . . 73.44 111.108 179.956 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' -5' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.82 135.92 31.53 Favored 'Trans proline' 0 C--N 1.342 0.209 0 C-N-CA 122.712 2.275 . . . . 74.34 112.317 179.917 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' -4' ' ' SER . . . . . . . . . . . . . 2.5 m -132.0 62.13 1.64 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.255 -0.429 . . . . 73.44 110.879 -179.856 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' -3' ' ' ARG . . . . . . . . . . . . . 12.8 ptt85 -174.67 153.39 1.75 Allowed Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.669 0.747 . . . . 71.53 110.87 -179.958 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' -2' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.78 128.98 16.79 Favored 'Trans proline' 0 C--N 1.342 0.201 0 C-N-CA 122.665 2.243 . . . . 73.04 112.338 -179.976 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' -1' ' ' ALA . . . . . . . . . . . . . . . -61.74 152.21 76.35 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 121.616 0.722 . . . . 62.22 111.108 179.867 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 0' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.73 -179.85 3.19 Favored 'Trans proline' 0 C--N 1.341 0.181 0 C-N-CA 122.742 2.295 . . . . 73.54 112.331 -179.95 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 1' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -126.58 155.01 75.38 Favored Pre-proline 0 C--N 1.328 -0.362 0 CA-C-O 121.624 0.726 . . . . 72.35 110.857 179.909 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 2' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo . . . . . 0 C--N 1.342 0.225 0 C-N-CA 122.661 2.241 . . . . 73.2 112.329 179.908 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 29.3 tp60 . . . . . 0 C--O 1.231 0.111 0 CA-C-O 120.739 0.304 . . . . 74.43 110.945 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 6.3 ptm180 -76.63 162.43 27.75 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.203 -0.453 . . . . 63.52 110.88 -179.908 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -154.45 154.47 33.26 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.209 -0.451 . . . . 73.42 111.124 179.962 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 9.2 p -109.1 140.58 27.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.24 -0.436 . . . . 71.52 111.135 179.99 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -77.88 122.34 25.34 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.189 -0.46 . . . . 70.44 111.099 179.883 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 16.6 mt -87.48 -34.79 18.54 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.195 -0.457 . . . . 72.34 110.914 -179.936 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 4.3 m-85 -144.58 149.86 36.5 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.161 -0.472 . . . . 73.4 110.871 -179.953 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -70.92 137.66 49.43 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.108 -0.496 . . . . 73.24 110.837 179.934 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 21.4 t80 -142.0 145.65 34.68 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.144 -0.48 . . . . 74.13 110.907 -179.916 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -119.41 137.29 25.22 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-O 121.679 0.752 . . . . 75.31 110.88 -179.929 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . 0.412 ' HG3' ' HG3' ' A' ' 19' ' ' ARG . 53.6 Cg_endo -69.78 150.84 68.64 Favored 'Trans proline' 0 C--N 1.342 0.212 0 C-N-CA 122.636 2.224 . . . . 75.42 112.361 179.962 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 17.8 tp10 -109.28 -15.78 14.2 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.177 -0.465 . . . . 51.22 110.906 -179.98 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 9.8 m-80 -115.17 176.03 5.25 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.137 -0.483 . . . . 74.32 110.911 -179.925 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -92.26 20.87 5.62 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.197 -0.456 . . . . 73.24 110.857 179.948 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 1.2 p-10 -136.46 9.1 3.15 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.189 -0.46 . . . . 74.3 110.871 -179.907 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 12.0 mt-10 -105.63 157.44 17.4 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.177 -0.465 . . . . 61.23 110.908 179.989 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 55.5 tp -107.05 156.59 18.59 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.138 -0.483 . . . . 74.31 110.934 179.999 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . 0.412 ' HG3' ' HG3' ' A' ' 12' ' ' PRO . 0.7 OUTLIER -92.75 160.68 14.85 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.192 -0.458 . . . . 72.31 110.911 179.928 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 3.5 tp -142.27 149.24 39.29 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.196 -0.456 . . . . 73.24 110.946 -179.985 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -140.12 134.43 31.27 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.229 -0.441 . . . . 73.11 111.08 179.888 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -50.4 121.12 5.23 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.211 -0.45 . . . . 75.23 110.874 -179.929 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 96.59 -3.64 63.37 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.765 -0.731 . . . . 54.21 112.478 -179.971 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -85.08 146.9 26.92 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.805 0.336 . . . . 71.41 110.839 -179.944 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 3.3 mm -100.54 141.06 18.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.152 -0.476 . . . . 73.41 111.112 -179.973 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 1.5 m -142.78 158.0 18.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.168 -0.469 . . . . 73.45 111.165 179.821 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 44.6 m-85 -115.42 106.58 14.14 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.181 -0.463 . . . . 74.14 110.86 -179.937 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 19.6 mm -72.01 103.12 1.39 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.145 -0.479 . . . . 75.13 111.128 179.957 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 3.3 m -64.48 -39.47 93.85 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.161 -0.472 . . . . 73.41 110.878 -179.934 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 33.4 p90 -174.53 147.85 1.14 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.111 -0.495 . . . . 71.14 110.889 -179.895 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 18.7 tttt -82.68 145.41 29.63 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.121 -0.491 . . . . 71.44 110.893 179.894 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 29.7 t60 -134.86 153.97 51.84 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.195 -0.457 . . . . 62.1 110.824 179.917 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -59.23 -174.26 0.65 Allowed Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.733 -0.746 . . . . 42.31 112.53 179.977 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 73.8 mm-40 65.59 12.44 8.23 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.803 0.335 . . . . 73.2 110.908 -179.895 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 68.22 28.82 73.16 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.721 -0.752 . . . . 73.54 112.504 -179.956 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 99.0 m95 -123.17 135.64 54.41 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.768 0.318 . . . . 73.22 110.938 -179.928 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -124.46 131.89 53.49 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.254 -0.43 . . . . 71.43 110.902 179.969 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 60.4 t -77.39 116.89 21.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.128 -0.487 . . . . 74.44 111.133 179.82 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -137.28 160.06 40.13 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.181 -0.463 . . . . 61.11 111.08 179.872 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -121.76 160.15 25.18 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.225 -0.443 . . . . 72.15 110.924 -179.976 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -71.78 -175.27 1.35 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.142 -0.481 . . . . 74.11 110.924 -179.93 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -69.61 -38.34 77.23 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.205 -0.452 . . . . 62.52 110.876 -179.97 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 1.5 t -57.1 -22.58 40.75 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.155 -0.475 . . . . 74.23 110.867 -179.794 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 66.46 12.05 57.83 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.681 -0.771 . . . . 52.33 112.516 180.0 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 12.9 m -105.24 -21.06 13.32 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.945 0.402 . . . . 74.31 110.836 -179.707 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 1.4 ttmt -118.53 123.38 44.95 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.148 -0.478 . . . . 71.22 110.889 179.948 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 11.4 m -131.62 143.02 50.01 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.228 -0.442 . . . . 72.33 111.166 179.957 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -160.71 -151.77 6.34 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.788 -0.72 . . . . 44.42 112.511 179.979 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 8.4 mt -107.03 131.69 53.79 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.862 0.363 . . . . 72.31 110.906 -179.942 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.429 ' HB ' ' HD2' ' A' ' 51' ' ' PRO . 18.3 m -129.88 154.45 81.11 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-O 121.606 0.717 . . . . 74.22 111.164 179.829 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . 0.429 ' HD2' ' HB ' ' A' ' 50' ' ' VAL . 53.6 Cg_endo -69.75 148.15 64.53 Favored 'Trans proline' 0 C--O 1.231 0.145 0 C-N-CA 122.713 2.276 . . . . 75.02 112.36 179.96 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 30.1 tt0 -93.07 -29.5 15.76 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.256 -0.429 . . . . 75.41 110.854 -179.962 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -84.39 7.33 19.93 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.199 -0.455 . . . . 74.0 110.879 -179.943 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 1.2 m-85 -120.41 3.47 10.78 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.155 -0.475 . . . . 74.14 110.862 -179.911 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 7.1 m -128.88 172.76 14.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.171 -0.468 . . . . 75.23 111.164 179.966 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 13.1 t -145.55 113.69 6.56 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.188 -0.46 . . . . 73.43 110.87 -179.828 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 2.5 m-85 -51.87 137.05 27.17 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.163 -0.471 . . . . 74.52 110.904 -179.866 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 24.6 mt -104.94 152.52 6.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.114 -0.493 . . . . 73.43 111.14 179.899 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.291 0 CA-C-O 121.577 0.703 . . . . 75.22 110.912 179.986 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' -7' ' ' PHE . . . . . . . . . . . . . 14.0 m-85 . . . . . 0 C--O 1.231 0.125 0 CA-C-O 120.817 0.341 . . . . 72.0 110.89 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' B' B ' -6' ' ' ILE . . . . . . . . . . . . . 60.2 mt -125.64 125.92 24.97 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 121.603 0.716 . . . . 74.12 111.147 179.971 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' -5' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.81 160.09 50.95 Favored 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.658 2.239 . . . . 74.51 112.324 179.902 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' -4' ' ' SER . . . . . . . . . . . . . 7.3 t -136.56 37.25 2.67 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.218 -0.447 . . . . 71.4 110.879 -179.855 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' -3' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -177.56 155.0 1.08 Allowed Pre-proline 0 C--N 1.33 -0.275 0 CA-C-O 121.542 0.687 . . . . 74.11 110.894 -179.919 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' -2' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.77 131.5 21.36 Favored 'Trans proline' 0 C--O 1.231 0.138 0 C-N-CA 122.682 2.254 . . . . 73.13 112.362 -179.971 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' -1' ' ' ALA . . . . . . . . . . . . . . . -55.5 154.47 12.19 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-O 121.591 0.71 . . . . 73.15 111.088 179.884 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 0' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.76 -170.24 0.38 Allowed 'Trans proline' 0 C--N 1.342 0.194 0 C-N-CA 122.66 2.24 . . . . 74.35 112.391 179.959 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 1' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -134.17 148.93 69.94 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-O 121.561 0.696 . . . . 73.3 110.946 179.887 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 2' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo . . . . . 0 C--N 1.341 0.182 0 C-N-CA 122.699 2.266 . . . . 63.0 112.352 179.891 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 33.0 tp60 . . . . . 0 C--O 1.231 0.125 0 CA-C-O 120.768 0.318 . . . . 73.24 110.902 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 5.6 ptp180 -80.7 162.05 24.32 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.216 -0.447 . . . . 74.03 110.863 -179.931 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -155.1 149.96 26.67 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.176 -0.465 . . . . 72.53 111.069 179.932 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 7.3 p -105.83 137.98 33.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.21 -0.45 . . . . 72.33 111.133 179.967 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -78.56 128.3 33.33 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.216 -0.447 . . . . 75.21 111.047 179.91 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 10.5 mt -93.32 -31.89 14.51 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.153 -0.476 . . . . 75.12 110.922 179.986 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 3.8 m-85 -144.37 135.91 25.71 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.193 -0.458 . . . . 74.34 110.934 179.995 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -60.11 149.58 32.17 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.122 -0.49 . . . . 75.51 110.899 179.883 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 30.7 t80 -149.01 147.1 28.16 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.181 -0.463 . . . . 74.32 110.881 -179.871 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 8.5 tm-20 -117.0 134.56 22.98 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 121.649 0.738 . . . . 72.13 110.913 -179.971 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.76 141.57 45.56 Favored 'Trans proline' 0 C--O 1.232 0.19 0 C-N-CA 122.665 2.243 . . . . 73.45 112.353 -179.99 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 13.8 mp0 -102.99 -20.01 14.37 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.249 -0.432 . . . . 71.13 110.927 -179.997 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 34.1 m-80 -111.29 175.7 5.32 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.123 -0.49 . . . . 74.4 110.848 -179.936 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -92.37 19.59 6.98 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.172 -0.467 . . . . 74.11 110.888 179.886 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -135.35 10.92 3.51 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.245 -0.434 . . . . 73.34 110.848 -179.886 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 6.3 mm-40 -101.53 164.39 11.78 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.204 -0.453 . . . . 70.43 110.904 179.977 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 19.3 tp -115.71 141.52 47.97 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.129 -0.487 . . . . 74.51 110.885 -179.935 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 31.5 mtm180 -75.24 155.17 37.06 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.165 -0.471 . . . . 65.51 110.886 179.951 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 3.5 tp -140.7 149.58 42.37 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.213 -0.448 . . . . 71.43 110.889 -179.947 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -139.98 139.76 36.13 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.199 -0.455 . . . . 75.34 111.099 179.786 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -53.91 119.24 4.76 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.194 -0.457 . . . . 63.12 110.917 -179.919 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 93.49 0.19 67.46 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.769 -0.729 . . . . 64.11 112.484 -179.969 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 23.8 t0 -76.88 159.24 30.19 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.798 0.333 . . . . 72.5 110.909 -179.986 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 1.7 mm -110.92 123.1 66.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.154 -0.475 . . . . 75.31 111.109 -179.969 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 3.6 m -132.26 152.82 37.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.166 -0.47 . . . . 74.15 111.121 179.878 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 68.9 m-85 -112.82 109.02 18.22 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.183 -0.462 . . . . 72.41 110.882 -179.976 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 19.0 mm -72.32 103.02 1.45 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.086 -0.506 . . . . 71.44 111.131 -179.997 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 2.9 m -64.59 -40.09 94.9 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.167 -0.47 . . . . 70.31 110.864 -179.893 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 31.7 p90 -173.91 146.09 1.18 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.139 -0.482 . . . . 73.03 110.916 -179.861 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 19.2 tttt -79.87 147.26 31.79 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.148 -0.478 . . . . 75.44 110.925 179.871 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 32.3 t60 -137.4 154.54 49.96 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.227 -0.442 . . . . 70.52 110.85 179.939 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -59.37 -175.02 0.76 Allowed Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.746 -0.74 . . . . 73.12 112.494 -179.95 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 24.0 mm100 65.61 12.78 8.49 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.844 0.354 . . . . 74.44 110.93 -179.89 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 68.14 27.74 73.6 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.691 -0.766 . . . . 75.33 112.475 -179.991 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 98.5 m95 -122.01 137.42 54.81 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.82 0.343 . . . . 75.55 110.948 -179.915 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -125.18 130.52 52.31 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.255 -0.429 . . . . 74.51 110.934 179.982 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 44.1 t -77.27 115.16 18.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.164 -0.471 . . . . 74.45 111.132 179.878 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -137.0 166.16 24.31 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.133 -0.485 . . . . 74.53 111.12 179.919 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -117.62 156.68 27.74 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.233 -0.44 . . . . 74.51 110.886 -179.937 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -71.36 -176.85 1.61 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.151 -0.477 . . . . 70.21 110.852 -179.933 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 20.5 tt0 -67.45 -38.47 84.55 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.124 -0.489 . . . . 71.41 110.921 179.984 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 1.3 t -57.19 -22.14 38.41 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.144 -0.48 . . . . 75.45 110.847 -179.789 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 65.93 12.59 57.67 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.682 -0.771 . . . . 75.44 112.48 -179.995 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 13.4 t -109.42 -15.61 14.19 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.932 0.396 . . . . 74.25 110.885 -179.738 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 7.1 ptmt -119.98 134.85 55.12 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.127 -0.488 . . . . 75.24 110.912 179.935 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 6.4 m -135.06 143.72 46.86 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.252 -0.431 . . . . 71.34 111.162 179.969 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -164.68 -154.94 8.16 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.694 -0.765 . . . . 64.03 112.482 179.972 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 6.7 mt -104.8 129.41 53.09 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.849 0.357 . . . . 75.31 110.889 -179.89 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.43 ' HB ' ' HD2' ' A' ' 51' ' ' PRO . 16.8 m -127.73 154.25 77.89 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.666 0.746 . . . . 72.44 111.095 179.836 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . 0.43 ' HD2' ' HB ' ' A' ' 50' ' ' VAL . 53.5 Cg_endo -69.77 149.45 66.85 Favored 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.666 2.244 . . . . 72.53 112.326 179.962 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 28.3 tt0 -94.36 -30.17 14.64 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.231 -0.44 . . . . 64.32 110.925 -179.983 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -85.24 7.72 21.06 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.093 -0.503 . . . . 74.02 110.899 -179.942 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 1.2 m-85 -119.29 4.57 11.25 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.126 -0.488 . . . . 74.44 110.908 -179.95 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 14.8 m -134.4 164.11 35.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.121 -0.49 . . . . 74.41 111.132 179.975 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 25.7 t -136.24 117.27 14.32 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.222 -0.444 . . . . 75.22 110.869 -179.85 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 2.9 m-85 -52.1 136.95 28.75 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.108 -0.496 . . . . 74.43 110.944 -179.892 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 32.1 mt -104.64 150.32 7.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.146 -0.479 . . . . 75.22 111.102 179.938 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 2.7 mt-30 . . . . . 0 C--N 1.329 -0.291 0 CA-C-O 121.611 0.72 . . . . 73.43 110.95 179.914 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' B' B ' -7' ' ' PHE . . . . . . . . . . . . . 8.4 m-85 . . . . . 0 C--O 1.231 0.125 0 CA-C-O 120.834 0.35 . . . . 71.4 110.853 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' B' B ' -6' ' ' ILE . . . . . . . . . . . . . 3.8 tp -175.89 91.28 0.28 Allowed Pre-proline 0 C--N 1.328 -0.333 0 CA-C-O 121.634 0.731 . . . . 74.41 111.107 179.989 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' -5' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.79 139.4 40.03 Favored 'Trans proline' 0 C--N 1.341 0.156 0 C-N-CA 122.677 2.252 . . . . 74.44 112.344 179.868 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' -4' ' ' SER . . . . . . . . . . . . . 2.6 m -132.55 62.45 1.65 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.212 -0.449 . . . . 64.2 110.877 -179.839 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' -3' ' ' ARG . . . . . . . . . . . . . 13.6 ptp180 -179.63 155.41 0.75 Allowed Pre-proline 0 C--N 1.329 -0.32 0 CA-C-O 121.592 0.71 . . . . 71.1 110.852 -179.928 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' -2' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.72 135.42 30.49 Favored 'Trans proline' 0 C--N 1.341 0.169 0 C-N-CA 122.724 2.283 . . . . 75.42 112.33 179.995 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' -1' ' ' ALA . . . . . . . . . . . . . . . -68.15 153.02 96.04 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.615 0.722 . . . . 75.21 111.085 179.877 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 0' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_endo -69.81 174.63 9.27 Favored 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.672 2.248 . . . . 73.15 112.342 -179.954 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 1' ' ' LYS . . . . . . . . . . . . . 16.5 pttm -122.63 153.21 62.86 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.526 0.679 . . . . 74.12 110.933 179.887 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 2' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo . . . . . 0 C--O 1.232 0.19 0 C-N-CA 122.659 2.239 . . . . 73.23 112.385 179.901 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 56.5 tp60 . . . . . 0 C--O 1.231 0.102 0 CA-C-O 120.757 0.313 . . . . 72.23 110.895 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -83.43 163.9 20.25 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.2 -0.455 . . . . 73.31 110.843 -179.938 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -154.58 152.25 29.8 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.168 -0.469 . . . . 72.55 111.086 179.958 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 10.0 p -104.13 149.08 8.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.262 -0.427 . . . . 71.34 111.15 179.975 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -90.4 117.78 29.37 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.218 -0.446 . . . . 64.04 111.105 179.873 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 7.0 mt -84.52 -35.69 22.7 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.255 -0.429 . . . . 73.52 110.905 -179.963 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 5.4 m-85 -140.75 136.89 32.98 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.185 -0.461 . . . . 75.11 110.909 -179.96 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -64.06 137.88 58.19 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.076 -0.511 . . . . 65.3 110.91 179.924 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 18.5 t80 -137.33 145.37 43.29 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.204 -0.453 . . . . 70.35 110.851 -179.878 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 7.0 tt0 -115.69 136.13 22.78 Favored Pre-proline 0 C--N 1.33 -0.261 0 CA-C-O 121.671 0.748 . . . . 72.22 110.86 -179.925 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . 0.408 ' HD3' ' HA ' ' A' ' 19' ' ' ARG . 53.7 Cg_endo -69.74 143.94 52.53 Favored 'Trans proline' 0 C--N 1.342 0.189 0 C-N-CA 122.718 2.279 . . . . 73.1 112.29 179.999 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -107.38 -7.51 16.63 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.21 -0.45 . . . . 71.43 110.873 179.965 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 59.3 m-80 -124.5 175.78 6.93 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.196 -0.457 . . . . 70.24 110.893 -179.95 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 8.9 p30 -93.58 24.2 4.18 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.205 -0.452 . . . . 64.12 110.887 179.917 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 1.2 p-10 -139.97 11.82 2.43 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.163 -0.471 . . . . 74.3 110.873 -179.899 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 10.0 mm-40 -106.38 163.35 12.92 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.186 -0.461 . . . . 70.12 110.864 -179.978 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 20.7 tp -113.02 142.64 45.48 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.134 -0.485 . . . . 72.44 110.896 -179.951 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . 0.408 ' HA ' ' HD3' ' A' ' 12' ' ' PRO . 6.6 mtp85 -79.03 153.45 30.23 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.192 -0.458 . . . . 75.42 110.89 179.94 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 2.3 tp -138.55 149.07 44.94 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.192 -0.458 . . . . 75.35 110.901 -179.973 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -140.7 139.76 34.78 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.205 -0.452 . . . . 72.42 111.151 179.766 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -50.62 122.85 7.78 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.222 -0.445 . . . . 75.33 110.865 -179.885 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 97.18 -13.48 64.67 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.777 -0.725 . . . . 73.32 112.478 -179.994 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -71.53 149.07 46.11 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.796 0.332 . . . . 72.12 110.87 -179.982 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 1.7 mt -116.62 119.83 63.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.182 -0.463 . . . . 74.41 111.093 -179.955 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 6.4 m -119.14 165.76 14.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.129 -0.487 . . . . 73.42 111.125 179.851 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 46.7 m-85 -114.47 106.92 14.85 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.145 -0.479 . . . . 72.34 110.869 -179.949 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 17.6 mm -70.71 102.91 1.01 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.187 -0.461 . . . . 74.31 111.136 179.967 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 3.6 m -65.19 -39.57 93.03 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.127 -0.488 . . . . 72.52 110.856 -179.898 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 32.1 p90 -174.38 146.83 1.1 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.162 -0.472 . . . . 74.13 110.876 -179.88 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 18.7 tttt -80.77 146.17 31.12 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.122 -0.49 . . . . 74.02 110.906 179.886 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 33.7 t60 -135.27 155.97 49.75 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.223 -0.444 . . . . 74.53 110.86 179.899 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -60.84 -174.22 1.14 Allowed Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.754 -0.736 . . . . 74.33 112.519 -179.967 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 41.9 mm-40 64.79 13.21 8.3 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.859 0.362 . . . . 74.24 110.9 -179.914 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 67.94 28.98 73.3 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.715 -0.755 . . . . 74.53 112.489 -179.969 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 98.7 m95 -122.82 138.11 54.74 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.766 0.317 . . . . 74.12 110.909 -179.871 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -125.96 130.47 51.3 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.25 -0.432 . . . . 74.5 110.931 179.934 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 41.7 t -77.2 115.21 18.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.186 -0.461 . . . . 75.02 111.095 179.868 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -135.54 163.53 29.89 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.187 -0.46 . . . . 72.4 111.09 179.86 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 1.6 pm0 -121.58 160.49 24.23 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.211 -0.449 . . . . 70.51 110.826 -179.928 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 43.4 p-10 -58.91 -174.8 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.088 -0.505 . . . . 74.22 110.893 -179.94 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 15.2 tt0 -78.43 -38.63 40.9 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.188 -0.46 . . . . 75.12 110.914 179.998 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 4.4 m -68.73 -22.55 64.32 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.134 -0.485 . . . . 72.32 110.847 -179.785 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 76.61 26.76 62.38 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.704 -0.76 . . . . 71.33 112.52 -179.977 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 3.5 m -105.48 -22.19 13.06 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.946 0.403 . . . . 73.32 110.875 -179.717 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -125.68 138.05 53.87 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.122 -0.49 . . . . 73.21 110.928 179.904 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 30.7 m -136.8 143.89 43.4 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.243 -0.435 . . . . 70.5 111.149 179.976 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -167.74 -155.62 9.44 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.736 -0.745 . . . . 63.32 112.513 179.938 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 7.0 mt -103.57 132.19 50.04 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.828 0.347 . . . . 73.5 110.908 -179.922 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.404 ' HB ' ' HD2' ' A' ' 51' ' ' PRO . 6.7 m -129.53 153.47 80.67 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 121.592 0.711 . . . . 74.32 111.161 179.85 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . 0.404 ' HD2' ' HB ' ' A' ' 50' ' ' VAL . 54.0 Cg_endo -69.73 150.76 68.82 Favored 'Trans proline' 0 C--N 1.341 0.147 0 C-N-CA 122.741 2.294 . . . . 74.21 112.318 179.968 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 28.2 tt0 -95.74 -28.89 14.56 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.186 -0.461 . . . . 64.14 110.833 -179.982 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -87.3 11.08 15.2 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.195 -0.457 . . . . 70.5 110.907 -179.909 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -121.01 -8.15 9.38 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.122 -0.49 . . . . 74.24 110.891 -179.931 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 12.3 m -120.02 172.84 6.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.154 -0.475 . . . . 75.35 111.153 -179.998 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 3.3 t -143.25 114.3 7.77 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.195 -0.457 . . . . 62.55 110.882 -179.868 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 2.6 m-85 -52.33 127.11 21.14 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.131 -0.486 . . . . 75.33 110.912 -179.868 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 42.6 mt -94.85 149.94 4.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.122 -0.49 . . . . 74.33 111.17 179.887 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.316 0 CA-C-O 121.601 0.715 . . . . 74.44 110.933 179.951 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' -7' ' ' PHE . . . . . . . . . . . . . 10.8 m-85 . . . . . 0 C--O 1.232 0.133 0 CA-C-O 120.788 0.327 . . . . 73.55 110.93 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' B' B ' -6' ' ' ILE . . . . . . . . . . . . . 5.9 tt -138.78 119.3 9.79 Favored Pre-proline 0 C--N 1.328 -0.35 0 CA-C-O 121.615 0.721 . . . . 74.53 111.131 179.985 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' -5' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.82 154.26 67.72 Favored 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.674 2.249 . . . . 75.2 112.372 179.862 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' -4' ' ' SER . . . . . . . . . . . . . 45.2 t -132.45 41.89 3.16 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.246 -0.434 . . . . 71.24 110.877 -179.834 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' -3' ' ' ARG . . . . . . . . . . . . . 1.5 ptm180 -177.45 155.05 1.1 Allowed Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 121.618 0.723 . . . . 75.12 110.886 -179.952 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' -2' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.78 134.37 27.79 Favored 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.68 2.254 . . . . 74.4 112.35 -179.968 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' -1' ' ' ALA . . . . . . . . . . . . . . . -57.99 154.09 30.71 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 121.575 0.702 . . . . 44.35 111.098 179.887 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 0' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.78 -173.3 0.69 Allowed 'Trans proline' 0 C--N 1.342 0.2 0 C-N-CA 122.644 2.229 . . . . 73.52 112.35 -179.986 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 1' ' ' LYS . . . . . . . . . . . . . 33.8 mtpt -127.61 155.77 76.48 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-O 121.628 0.728 . . . . 74.41 110.875 179.908 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 2' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo . . . . . 0 C--N 1.342 0.21 0 C-N-CA 122.643 2.229 . . . . 74.11 112.351 179.912 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 32.8 tp60 . . . . . 0 C--O 1.231 0.09 0 CA-C-O 120.806 0.336 . . . . 73.24 110.931 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 3.2 ptt-85 -84.15 162.4 20.26 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.213 -0.449 . . . . 73.13 110.858 -179.934 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -155.21 150.86 27.47 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.146 -0.479 . . . . 73.42 111.139 179.937 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 11.0 p -104.07 146.31 11.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.229 -0.441 . . . . 74.23 111.133 -179.991 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -84.82 111.14 19.37 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.187 -0.461 . . . . 72.23 111.099 179.88 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 13.9 mt -76.42 -37.04 57.67 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.244 -0.435 . . . . 73.14 110.888 -179.946 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 4.0 m-85 -142.22 147.03 35.86 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.223 -0.444 . . . . 73.32 110.911 -179.96 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 3.5 p-10 -70.47 138.98 51.59 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.125 -0.489 . . . . 74.23 110.864 179.899 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 5.3 t80 -143.82 144.62 31.86 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.215 -0.448 . . . . 73.54 110.878 -179.89 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -112.98 145.2 32.58 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-O 121.688 0.756 . . . . 73.41 110.83 -179.892 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.81 139.7 40.68 Favored 'Trans proline' 0 C--N 1.342 0.226 0 C-N-CA 122.657 2.238 . . . . 74.41 112.347 179.985 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -101.37 -17.09 16.67 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.21 -0.45 . . . . 73.34 110.92 -179.984 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 31.0 m-80 -116.26 176.53 5.06 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.104 -0.498 . . . . 75.21 110.923 -179.953 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 17.7 m-20 -91.51 21.55 4.54 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.218 -0.446 . . . . 61.24 110.894 179.907 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -141.97 17.52 2.12 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.191 -0.459 . . . . 72.03 110.867 -179.879 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 24.1 mt-10 -107.39 165.6 11.27 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.192 -0.458 . . . . 75.43 110.86 -179.976 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 28.7 tp -114.12 148.93 36.37 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.139 -0.482 . . . . 74.35 110.895 -179.931 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -84.8 156.18 21.47 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.2 -0.454 . . . . 75.11 110.807 179.99 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 3.1 tp -140.26 150.17 43.75 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.131 -0.486 . . . . 74.53 110.932 179.984 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -141.42 137.29 32.12 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.191 -0.459 . . . . 64.43 111.102 179.827 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -50.79 121.88 6.54 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.265 -0.425 . . . . 72.11 110.867 -179.928 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 96.28 -6.51 66.05 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.697 -0.763 . . . . 64.44 112.476 -179.956 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -81.46 146.44 30.23 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.85 0.357 . . . . 75.01 110.838 -179.908 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 3.3 mm -100.81 142.52 15.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.186 -0.461 . . . . 73.23 111.165 179.999 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 1.4 m -144.95 158.55 13.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.155 -0.475 . . . . 75.13 111.09 179.918 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 51.6 m-85 -117.3 109.57 17.01 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.154 -0.476 . . . . 73.45 110.882 179.988 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 12.1 mm -73.11 102.7 1.63 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.113 -0.494 . . . . 74.43 111.082 -179.992 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 43.3 m -64.76 -39.57 93.83 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.159 -0.473 . . . . 71.31 110.891 -179.977 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 37.4 p90 -174.87 151.39 1.38 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.139 -0.482 . . . . 74.12 110.941 -179.856 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 17.8 tttt -83.25 145.55 29.06 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.13 -0.486 . . . . 75.04 110.946 179.871 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 34.4 t60 -134.21 152.9 52.06 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.227 -0.442 . . . . 75.23 110.892 179.903 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -58.96 -173.98 0.55 Allowed Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.755 -0.736 . . . . 64.01 112.469 -179.954 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 27.6 mm-40 65.43 12.21 7.96 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.845 0.355 . . . . 73.23 110.943 -179.875 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 68.09 30.14 73.77 Favored Glycine 0 N--CA 1.452 -0.261 0 C-N-CA 120.702 -0.761 . . . . 63.04 112.496 -179.943 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 99.0 m95 -124.15 136.51 54.26 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.796 0.331 . . . . 75.34 110.95 -179.952 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 1.3 mt -120.58 133.36 55.39 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.252 -0.431 . . . . 75.12 110.951 179.962 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 59.9 t -79.75 110.02 14.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.18 -0.464 . . . . 73.33 111.144 179.858 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -129.79 159.36 36.76 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.154 -0.475 . . . . 65.35 111.114 179.869 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 1.4 pt-20 -117.01 156.57 27.27 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.207 -0.451 . . . . 73.34 110.865 -179.919 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -70.18 -175.2 0.92 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.143 -0.48 . . . . 73.44 110.901 -179.983 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 -69.4 -38.21 77.83 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.167 -0.469 . . . . 70.25 110.895 179.965 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 1.5 t -56.37 -22.53 31.8 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.171 -0.468 . . . . 72.43 110.848 -179.786 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 69.16 9.53 60.61 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.757 -0.735 . . . . 64.13 112.476 -179.988 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -108.04 -20.82 13.05 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.947 0.403 . . . . 73.02 110.885 -179.751 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 4.0 ttpt -109.98 123.86 50.4 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.128 -0.487 . . . . 75.01 110.917 179.941 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 3.7 m -129.82 137.47 50.49 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.237 -0.438 . . . . 63.11 111.2 179.981 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -161.02 -157.48 8.77 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.765 -0.731 . . . . 62.45 112.508 179.976 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 8.7 mt -101.68 137.55 39.85 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.886 0.374 . . . . 72.02 110.866 -179.887 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.403 ' HB ' ' HD2' ' A' ' 51' ' ' PRO . 10.3 m -137.16 153.36 74.96 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 121.645 0.736 . . . . 70.45 111.1 179.825 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . 0.403 ' HD2' ' HB ' ' A' ' 50' ' ' VAL . 53.4 Cg_endo -69.85 143.81 51.59 Favored 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 122.657 2.238 . . . . 73.02 112.306 179.961 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 10.9 tm-20 -89.92 -28.09 19.42 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.189 -0.46 . . . . 72.12 110.903 179.983 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -85.97 10.35 14.33 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.17 -0.468 . . . . 75.15 110.847 -179.92 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -120.72 -8.96 9.41 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.174 -0.466 . . . . 72.52 110.875 -179.932 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 15.8 m -119.71 166.33 14.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.123 -0.489 . . . . 75.41 111.167 179.961 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 37.2 t -135.25 117.86 15.95 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.193 -0.458 . . . . 73.31 110.875 -179.868 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 3.3 m-85 -58.32 124.69 20.35 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.171 -0.468 . . . . 72.42 110.935 -179.896 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 22.8 mt -88.26 153.64 3.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.119 -0.491 . . . . 75.04 111.081 179.947 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 8.1 pm0 . . . . . 0 C--N 1.329 -0.314 0 CA-C-O 121.609 0.719 . . . . 74.11 110.929 179.95 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' B' B ' -7' ' ' PHE . . . . . . . . . . . . . 9.1 m-85 . . . . . 0 C--O 1.231 0.095 0 CA-C-O 120.823 0.345 . . . . 74.21 110.913 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' B' B ' -6' ' ' ILE . . . . . . . . . . . . . 37.9 mm -145.51 87.22 7.05 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 121.63 0.729 . . . . 72.34 111.105 -179.997 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' -5' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.74 139.87 41.37 Favored 'Trans proline' 0 C--O 1.231 0.164 0 C-N-CA 122.707 2.272 . . . . 75.34 112.351 179.891 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' -4' ' ' SER . . . . . . . . . . . . . 27.5 t -132.96 66.16 1.57 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.227 -0.442 . . . . 63.42 110.903 -179.872 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' -3' ' ' ARG . . . . . . . . . . . . . 5.8 ptm180 -178.21 155.0 0.96 Allowed Pre-proline 0 C--N 1.329 -0.288 0 CA-C-O 121.6 0.714 . . . . 75.31 110.851 -179.95 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' -2' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.81 131.63 21.55 Favored 'Trans proline' 0 C--N 1.341 0.157 0 C-N-CA 122.654 2.236 . . . . 74.33 112.35 -179.978 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' -1' ' ' ALA . . . . . . . . . . . . . . . -70.47 151.67 95.56 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 121.62 0.724 . . . . 63.24 111.102 179.89 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 0' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.7 173.34 11.07 Favored 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.681 2.254 . . . . 75.14 112.363 -179.98 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 1' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -121.82 154.35 60.58 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 121.579 0.704 . . . . 74.42 110.891 179.865 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 2' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo . . . . . 0 C--O 1.232 0.186 0 C-N-CA 122.716 2.277 . . . . 74.42 112.345 179.89 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 55.0 tp60 . . . . . 0 C--O 1.231 0.087 0 CA-C-O 120.802 0.334 . . . . 75.21 110.945 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 7.7 ptp180 -82.0 164.15 21.64 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.188 -0.46 . . . . 74.51 110.821 -179.873 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -155.67 153.22 29.65 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.188 -0.46 . . . . 74.34 111.111 179.919 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 10.3 p -103.71 152.31 6.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.208 -0.451 . . . . 73.04 111.143 179.972 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -92.89 114.99 27.7 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.199 -0.455 . . . . 74.43 111.09 179.92 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 7.0 mt -82.07 -35.64 28.47 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.224 -0.443 . . . . 73.13 110.925 -179.966 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 5.0 m-85 -141.82 137.83 31.77 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.207 -0.451 . . . . 75.53 110.979 179.965 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 3.0 p-10 -63.0 138.43 58.56 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.121 -0.491 . . . . 73.55 110.847 179.98 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 10.4 t80 -141.86 144.76 34.01 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.205 -0.452 . . . . 74.13 110.915 -179.927 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -113.1 144.33 30.92 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 121.656 0.741 . . . . 71.43 110.899 -179.925 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.75 132.39 23.25 Favored 'Trans proline' 0 C--N 1.342 0.193 0 C-N-CA 122.686 2.257 . . . . 72.31 112.324 179.991 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 15.3 mt-10 -94.47 -20.08 19.99 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.184 -0.462 . . . . 74.45 110.87 179.994 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 33.5 m-80 -114.48 175.66 5.39 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.176 -0.465 . . . . 72.43 110.878 -179.929 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -86.85 8.66 21.98 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.199 -0.455 . . . . 63.22 110.899 179.896 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -129.44 20.52 5.68 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.186 -0.461 . . . . 74.54 110.905 -179.942 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 57.1 mt-10 -109.92 156.37 20.53 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.198 -0.455 . . . . 72.03 110.87 -179.962 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -105.13 153.83 20.99 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.16 -0.473 . . . . 75.13 110.927 -179.999 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 21.6 mtm180 -87.87 151.69 22.65 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.179 -0.464 . . . . 62.33 110.856 179.974 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 1.7 tp -137.47 148.7 46.27 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.171 -0.468 . . . . 64.12 110.94 179.981 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -141.62 140.28 33.27 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.197 -0.456 . . . . 72.13 111.107 179.795 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -50.62 120.28 4.56 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.234 -0.439 . . . . 73.32 110.912 -179.915 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 97.84 -7.11 62.78 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.716 -0.754 . . . . 62.23 112.474 -179.986 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -76.41 150.45 36.76 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.788 0.328 . . . . 54.42 110.84 -179.944 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 1.5 mt -116.91 120.08 63.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.201 -0.454 . . . . 73.32 111.118 -179.965 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 6.0 m -120.61 165.44 16.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.163 -0.472 . . . . 65.32 111.125 179.858 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 54.4 m-85 -115.57 107.4 15.09 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.162 -0.472 . . . . 65.25 110.887 179.987 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 17.4 mm -72.04 103.05 1.38 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.164 -0.471 . . . . 73.52 111.127 179.963 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 3.2 m -64.43 -39.25 93.48 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.196 -0.457 . . . . 72.03 110.856 -179.921 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 31.7 p90 -174.99 145.93 0.85 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.151 -0.477 . . . . 64.15 110.936 -179.862 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 19.1 tttt -79.45 144.94 33.58 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.11 -0.496 . . . . 71.35 110.869 179.937 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 28.8 t60 -134.4 153.47 51.89 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.2 -0.455 . . . . 74.33 110.795 179.926 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -58.89 -174.05 0.54 Allowed Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.766 -0.731 . . . . 60.15 112.515 179.975 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 40.5 mm-40 64.59 13.4 8.24 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.834 0.35 . . . . 71.13 110.896 -179.892 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 67.32 28.57 73.7 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.743 -0.742 . . . . 65.54 112.456 179.975 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 98.5 m95 -121.96 135.82 54.88 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.805 0.336 . . . . 75.13 110.947 -179.951 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -121.97 131.22 53.89 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.234 -0.439 . . . . 74.5 110.961 179.96 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 41.3 t -78.92 109.46 13.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.193 -0.458 . . . . 73.55 111.159 179.825 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -129.73 162.25 28.82 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.192 -0.458 . . . . 52.24 111.137 179.871 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 3.6 pm0 -118.17 159.9 22.5 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.233 -0.44 . . . . 45.44 110.893 -179.966 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 44.9 p-10 -58.88 -174.88 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.127 -0.488 . . . . 73.34 110.896 -179.946 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 6.1 tm-20 -78.05 -37.68 46.21 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.164 -0.471 . . . . 74.33 110.91 179.988 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 67.9 m -68.38 -21.89 64.68 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.127 -0.488 . . . . 72.31 110.863 -179.774 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 75.91 26.01 65.63 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.747 -0.74 . . . . 60.01 112.468 179.976 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 6.6 t -109.66 -21.27 12.51 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.931 0.396 . . . . 71.44 110.889 -179.747 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -121.51 138.98 54.07 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.132 -0.485 . . . . 72.13 110.894 179.926 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 6.1 m -132.58 152.6 51.57 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.231 -0.441 . . . . 71.42 111.159 179.978 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -178.36 -161.91 27.15 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.717 -0.754 . . . . 70.25 112.454 179.938 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 5.8 mt -100.95 141.48 33.78 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.849 0.357 . . . . 74.42 110.915 -179.873 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.41 ' HB ' ' HD2' ' A' ' 51' ' ' PRO . 17.1 m -138.2 153.71 73.36 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-O 121.67 0.748 . . . . 65.53 111.091 179.876 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . 0.41 ' HD2' ' HB ' ' A' ' 50' ' ' VAL . 53.7 Cg_endo -69.8 144.93 55.38 Favored 'Trans proline' 0 C--N 1.342 0.21 0 C-N-CA 122.661 2.241 . . . . 72.42 112.322 179.974 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 25.8 tt0 -91.88 -26.93 18.24 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.22 -0.445 . . . . 70.03 110.914 180.0 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -87.89 10.59 18.18 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.168 -0.469 . . . . 60.32 110.918 -179.928 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -120.04 -14.22 8.91 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.121 -0.491 . . . . 75.33 110.898 -179.96 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 19.2 m -114.82 172.48 3.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.172 -0.467 . . . . 71.31 111.181 179.949 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 32.3 t -144.19 116.7 8.6 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.185 -0.461 . . . . 63.22 110.852 -179.842 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 2.8 m-85 -51.93 134.37 31.69 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.132 -0.486 . . . . 73.11 110.876 -179.827 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 52.2 mt -105.63 145.46 13.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.125 -0.489 . . . . 75.11 111.136 179.91 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 4.6 mt-30 . . . . . 0 C--N 1.329 -0.321 0 CA-C-O 121.613 0.72 . . . . 74.53 110.888 179.994 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' B' B ' -7' ' ' PHE . . . . . . . . . . . . . 14.0 m-85 . . . . . 0 C--O 1.231 0.125 0 CA-C-O 120.885 0.374 . . . . 74.24 110.835 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' B' B ' -6' ' ' ILE . . . . . . . . . . . . . 55.8 mt -149.91 86.28 5.35 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-O 121.615 0.721 . . . . 73.5 111.13 179.921 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' -5' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.8 141.03 43.98 Favored 'Trans proline' 0 C--N 1.341 0.176 0 C-N-CA 122.64 2.226 . . . . 74.11 112.382 179.844 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' -4' ' ' SER . . . . . . . . . . . . . 2.6 t -139.5 65.89 1.42 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.25 -0.432 . . . . 74.31 110.884 -179.822 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' -3' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -178.56 154.51 0.87 Allowed Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.581 0.705 . . . . 74.55 110.9 -179.889 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' -2' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.77 124.2 10.85 Favored 'Trans proline' 0 C--N 1.342 0.2 0 C-N-CA 122.689 2.259 . . . . 70.5 112.333 -179.951 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' -1' ' ' ALA . . . . . . . . . . . . . . . -57.67 152.29 36.69 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.576 0.703 . . . . 62.33 111.099 179.897 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 0' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.77 172.79 12.0 Favored 'Trans proline' 0 C--N 1.342 0.194 0 C-N-CA 122.712 2.275 . . . . 75.44 112.341 -179.966 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 1' ' ' LYS . . . . . . . . . . . . . 12.7 ptmt -119.83 153.45 54.74 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.549 0.69 . . . . 74.21 110.874 179.907 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 2' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo . . . . . 0 C--N 1.341 0.171 0 C-N-CA 122.631 2.221 . . . . 73.5 112.327 179.887 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 55.7 tp60 . . . . . 0 C--O 1.231 0.109 0 CA-C-O 120.791 0.329 . . . . 53.55 110.894 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 5.5 ptm180 -81.99 164.3 21.56 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.233 -0.44 . . . . 75.4 110.883 -179.967 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -156.76 155.33 31.43 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.2 -0.454 . . . . 61.12 111.118 179.939 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 10.5 p -104.95 152.31 6.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.256 -0.429 . . . . 74.22 111.164 179.985 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -90.65 112.27 23.93 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.222 -0.445 . . . . 75.43 111.045 179.919 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 11.6 mt -78.54 -37.64 42.41 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.218 -0.447 . . . . 71.13 110.908 -179.984 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 5.5 m-85 -141.77 146.07 35.53 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.199 -0.455 . . . . 74.11 110.947 -179.957 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 4.0 p-10 -70.61 134.88 48.0 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.115 -0.493 . . . . 71.31 110.909 179.897 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 7.0 t80 -135.15 145.99 48.34 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.199 -0.455 . . . . 73.43 110.893 -179.897 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 5.7 tp10 -115.84 136.04 22.82 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 121.643 0.735 . . . . 74.52 110.892 -179.934 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . 0.402 ' HD3' ' HA ' ' A' ' 19' ' ' ARG . 53.7 Cg_endo -69.8 148.27 64.43 Favored 'Trans proline' 0 C--N 1.341 0.177 0 C-N-CA 122.694 2.263 . . . . 55.15 112.341 -179.998 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -105.94 -21.73 13.08 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.201 -0.454 . . . . 63.33 110.877 -179.977 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 68.1 m-80 -112.07 175.52 5.39 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.187 -0.46 . . . . 65.21 110.949 -179.964 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -88.34 10.34 20.18 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.227 -0.442 . . . . 55.12 110.899 179.905 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -126.22 14.03 7.77 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.169 -0.469 . . . . 73.13 110.936 -179.946 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 25.5 mt-10 -107.62 153.19 23.25 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.178 -0.464 . . . . 75.32 110.88 -179.98 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -103.25 151.56 22.53 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.137 -0.483 . . . . 72.2 110.911 -179.979 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . 0.402 ' HA ' ' HD3' ' A' ' 12' ' ' PRO . 0.3 OUTLIER -88.73 155.26 19.68 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.175 -0.466 . . . . 74.34 110.856 179.997 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 2.0 tp -139.0 148.73 43.83 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.187 -0.46 . . . . 72.32 110.905 -179.959 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -140.46 137.96 34.3 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.185 -0.461 . . . . 74.31 111.101 179.769 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -50.24 120.36 4.45 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.188 -0.46 . . . . 75.21 110.91 -179.902 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 96.09 -0.32 62.18 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.74 -0.743 . . . . 75.24 112.497 -179.952 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -86.6 145.99 26.52 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.81 0.338 . . . . 53.01 110.856 -179.951 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 3.1 mm -102.65 139.9 22.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.176 -0.466 . . . . 60.55 111.138 -179.997 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 1.1 m -141.91 162.44 20.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.204 -0.453 . . . . 74.34 111.125 179.873 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 63.7 m-85 -118.92 108.84 15.27 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.201 -0.454 . . . . 72.54 110.872 -179.987 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 17.2 mm -73.13 103.35 1.82 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.139 -0.482 . . . . 74.34 111.122 179.976 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 5.9 m -64.88 -40.39 95.03 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.184 -0.462 . . . . 74.2 110.892 -179.946 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 36.2 p90 -174.61 149.7 1.28 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.142 -0.481 . . . . 74.4 110.918 -179.897 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 20.5 tttt -81.56 144.24 31.42 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.152 -0.476 . . . . 74.14 110.894 179.919 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 31.5 t60 -133.25 153.34 51.65 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.242 -0.435 . . . . 73.5 110.918 179.849 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -59.09 -174.54 0.62 Allowed Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.778 -0.725 . . . . 74.12 112.42 -179.898 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 5.1 mt-30 65.95 11.99 8.1 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.88 0.371 . . . . 75.03 110.917 -179.909 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 68.36 28.99 72.99 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.753 -0.737 . . . . 54.25 112.502 -179.971 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 98.6 m95 -123.35 136.54 54.71 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.821 0.344 . . . . 75.52 110.941 -179.922 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 1.4 mt -120.24 132.73 55.47 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.249 -0.432 . . . . 63.53 110.926 179.959 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 37.6 t -80.4 109.31 14.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.216 -0.447 . . . . 72.21 111.138 179.829 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -130.56 164.54 24.68 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.167 -0.469 . . . . 71.14 111.142 179.854 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 1.2 pt-20 -119.67 156.06 31.18 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.232 -0.44 . . . . 64.32 110.885 -179.933 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -67.54 -175.06 0.47 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.134 -0.485 . . . . 73.14 110.898 -179.916 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 6.9 tt0 -68.87 -37.62 79.19 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.221 -0.445 . . . . 72.23 110.827 -179.956 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 1.7 t -56.87 -22.46 37.13 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.19 -0.459 . . . . 62.32 110.885 -179.805 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 69.44 9.43 61.34 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.766 -0.73 . . . . 62.52 112.489 -179.996 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 7.4 m -108.78 -24.27 11.37 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.97 0.415 . . . . 73.5 110.853 -179.732 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -105.51 123.61 48.18 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.149 -0.478 . . . . 74.42 110.857 179.932 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 3.4 m -124.47 152.59 43.16 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.223 -0.444 . . . . 74.24 111.175 179.928 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -177.29 -161.71 26.3 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.723 -0.751 . . . . 75.32 112.485 179.968 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 5.5 mt -100.59 134.44 43.55 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.876 0.369 . . . . 73.51 110.885 -179.861 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 10.4 m -133.77 153.23 79.92 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-O 121.632 0.729 . . . . 75.11 111.135 179.866 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.77 144.97 55.66 Favored 'Trans proline' 0 C--N 1.342 0.207 0 C-N-CA 122.667 2.245 . . . . 73.14 112.343 179.928 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 12.0 tm-20 -91.05 -28.85 17.69 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.233 -0.44 . . . . 64.33 110.868 -179.961 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 2.1 mm-40 -85.11 9.05 15.93 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.198 -0.456 . . . . 70.13 110.927 -179.965 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 1.1 m-85 -120.33 -2.76 10.03 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.13 -0.486 . . . . 75.42 110.895 -179.922 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 13.0 m -125.27 171.66 13.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.14 -0.482 . . . . 73.32 111.138 179.949 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 4.1 t -142.94 117.14 9.52 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.179 -0.464 . . . . 72.1 110.86 -179.845 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 3.1 m-85 -55.05 133.39 48.65 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.14 -0.482 . . . . 74.51 110.926 -179.924 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 46.8 mt -103.92 148.59 8.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.105 -0.498 . . . . 72.14 111.142 179.895 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--N 1.33 -0.282 0 CA-C-O 121.646 0.736 . . . . 71.41 110.881 179.939 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' -7' ' ' PHE . . . . . . . . . . . . . 13.4 m-85 . . . . . 0 C--O 1.231 0.129 0 CA-C-O 120.836 0.351 . . . . 74.13 110.904 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' B' B ' -6' ' ' ILE . . . . . . . . . . . . . 4.0 tp -171.9 87.94 0.44 Allowed Pre-proline 0 C--N 1.328 -0.329 0 CA-C-O 121.632 0.73 . . . . 72.53 111.155 179.944 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' -5' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.73 146.33 60.06 Favored 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 122.677 2.251 . . . . 75.41 112.377 179.844 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' -4' ' ' SER . . . . . . . . . . . . . 28.6 t -141.7 63.6 1.42 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.21 -0.45 . . . . 74.45 110.853 -179.841 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' -3' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -179.32 155.42 0.79 Allowed Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.576 0.703 . . . . 73.43 110.886 -179.954 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' -2' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.76 129.13 17.07 Favored 'Trans proline' 0 C--N 1.341 0.175 0 C-N-CA 122.661 2.24 . . . . 75.25 112.337 -179.969 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' -1' ' ' ALA . . . . . . . . . . . . . . . -62.61 152.33 81.49 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-O 121.614 0.721 . . . . 63.3 111.107 179.875 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 0' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.72 175.81 7.58 Favored 'Trans proline' 0 C--N 1.341 0.17 0 C-N-CA 122.696 2.264 . . . . 74.34 112.337 -179.968 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 1' ' ' LYS . . . . . . . . . . . . . 14.2 pttm -123.55 154.36 66.36 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-O 121.647 0.737 . . . . 73.53 110.86 179.92 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 2' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo . . . . . 0 C--N 1.342 0.195 0 C-N-CA 122.722 2.281 . . . . 74.4 112.353 179.899 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 50.8 tp60 . . . . . 0 C--O 1.232 0.165 0 CA-C-O 120.798 0.332 . . . . 73.44 110.932 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 5.6 ptp180 -78.82 161.4 26.81 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.278 -0.419 . . . . 65.11 110.902 -179.931 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -156.24 154.86 31.4 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.233 -0.44 . . . . 74.34 111.122 179.942 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 11.1 p -104.94 151.26 7.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.209 -0.451 . . . . 64.54 111.102 -179.972 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -89.3 111.08 21.81 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.163 -0.471 . . . . 74.3 111.065 179.915 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 11.5 mt -75.82 -38.63 57.95 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.221 -0.445 . . . . 72.52 110.875 -179.949 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 4.1 m-85 -141.86 148.95 39.62 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.172 -0.467 . . . . 75.33 110.892 -179.946 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 3.7 p-10 -71.28 131.49 43.53 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.142 -0.481 . . . . 73.04 110.89 179.894 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 1.8 t80 -129.54 146.15 51.39 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.228 -0.442 . . . . 74.24 110.866 -179.906 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 32.5 tt0 -116.2 137.06 23.18 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-O 121.654 0.74 . . . . 74.41 110.919 -179.911 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.7 148.27 65.1 Favored 'Trans proline' 0 C--N 1.341 0.154 0 C-N-CA 122.689 2.259 . . . . 72.24 112.373 -179.99 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 18.1 mm-40 -110.79 -18.62 13.08 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.264 -0.425 . . . . 71.12 110.903 179.993 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 33.9 m-80 -112.59 176.25 5.09 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.154 -0.475 . . . . 65.4 110.842 -179.925 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 7.9 p-10 -91.54 20.11 5.66 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.162 -0.472 . . . . 74.1 110.848 179.907 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -138.68 14.68 2.72 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.241 -0.436 . . . . 74.42 110.904 -179.907 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 30.3 mt-10 -103.7 164.7 11.5 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.169 -0.469 . . . . 74.31 110.907 -179.966 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 39.2 tp -115.35 146.78 41.22 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.181 -0.463 . . . . 74.13 110.936 -179.975 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 34.6 mtm-85 -82.25 156.8 24.17 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.242 -0.436 . . . . 74.41 110.913 179.93 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 2.9 tp -142.27 147.55 36.62 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.203 -0.453 . . . . 74.03 110.946 179.985 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -138.79 137.77 36.97 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.231 -0.44 . . . . 60.24 111.113 179.791 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -50.82 120.89 5.2 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.228 -0.442 . . . . 75.21 110.883 -179.923 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 97.25 -5.65 63.13 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.722 -0.751 . . . . 72.23 112.457 179.985 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -81.34 147.82 29.67 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.811 0.339 . . . . 70.25 110.862 -179.94 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 3.4 mm -101.46 141.56 17.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.231 -0.44 . . . . 73.35 111.125 -179.977 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 1.5 m -144.79 158.38 14.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.187 -0.461 . . . . 74.43 111.117 179.883 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 57.8 m-85 -117.47 108.38 15.46 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.15 -0.477 . . . . 74.52 110.892 179.965 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 20.1 mm -72.44 103.11 1.51 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.128 -0.487 . . . . 65.34 111.117 -179.996 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 5.7 m -65.05 -40.21 94.44 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.162 -0.472 . . . . 73.5 110.872 -179.922 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 33.9 p90 -174.61 149.11 1.22 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.155 -0.475 . . . . 75.12 110.944 -179.885 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 19.0 tttt -81.32 143.25 32.35 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.192 -0.458 . . . . 71.34 110.94 179.874 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 33.4 t60 -131.73 155.36 47.82 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.241 -0.436 . . . . 74.02 110.823 179.932 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -60.79 -174.11 1.11 Allowed Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.728 -0.749 . . . . 71.01 112.493 -179.958 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 84.7 mm-40 65.43 12.55 8.22 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.833 0.349 . . . . 72.31 110.939 -179.849 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 68.53 29.19 72.89 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.739 -0.743 . . . . 73.13 112.496 -179.955 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 99.0 m95 -123.69 136.8 54.68 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.819 0.342 . . . . 70.45 110.906 -179.929 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 1.3 mt -121.09 130.57 53.81 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.258 -0.428 . . . . 75.11 110.939 179.972 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 47.4 t -76.9 112.36 14.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.197 -0.456 . . . . 71.51 111.139 179.866 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -133.88 159.96 39.1 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.182 -0.463 . . . . 74.41 111.106 179.869 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -114.09 155.57 25.75 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.204 -0.453 . . . . 64.14 110.841 -179.909 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -70.56 -175.32 1.02 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.098 -0.501 . . . . 73.24 110.883 -179.951 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -69.86 -39.13 76.56 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.151 -0.477 . . . . 74.13 110.861 -179.956 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 11.8 m -56.29 -22.51 30.72 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.152 -0.476 . . . . 71.42 110.852 -179.809 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 66.81 11.4 57.69 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.754 -0.736 . . . . 73.25 112.498 -179.972 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 47.5 t -108.22 -14.35 14.72 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.956 0.407 . . . . 74.43 110.838 -179.708 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 6.1 ptmt -121.37 135.43 55.08 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.161 -0.472 . . . . 74.43 110.881 179.991 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 5.4 m -137.15 141.16 42.24 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.233 -0.439 . . . . 75.43 111.146 179.986 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -161.97 -154.81 7.67 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.711 -0.757 . . . . 72.22 112.499 179.947 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 6.8 mt -104.82 131.48 52.24 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.811 0.339 . . . . 75.21 110.936 -179.918 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 10.8 m -129.64 153.13 80.7 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-O 121.606 0.717 . . . . 75.13 111.185 179.812 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . 0.405 ' HG2' ' HB2' ' A' ' 54' ' ' PHE . 53.5 Cg_endo -69.76 144.84 55.31 Favored 'Trans proline' 0 C--N 1.342 0.189 0 C-N-CA 122.691 2.261 . . . . 63.14 112.37 179.957 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 8.3 tm-20 -90.48 -29.11 18.13 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.208 -0.451 . . . . 75.14 110.854 -179.949 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -85.25 9.87 14.03 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.19 -0.459 . . . . 74.13 110.914 -179.932 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . 0.405 ' HB2' ' HG2' ' A' ' 51' ' ' PRO . 1.0 OUTLIER -120.87 -7.82 9.47 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.136 -0.484 . . . . 74.55 110.862 -179.913 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 19.2 m -119.79 170.54 9.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.149 -0.478 . . . . 75.03 111.102 179.983 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 31.2 t -141.61 113.27 7.74 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.143 -0.481 . . . . 75.45 110.878 -179.858 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 3.1 m-85 -52.93 130.79 34.57 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.145 -0.48 . . . . 74.34 110.888 -179.841 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 51.4 mt -99.01 148.19 6.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.123 -0.489 . . . . 64.12 111.17 179.874 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 7.1 pt20 . . . . . 0 C--N 1.329 -0.323 0 CA-C-O 121.634 0.731 . . . . 75.14 110.882 179.975 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' B' B ' -7' ' ' PHE . . . . . . . . . . . . . 9.8 m-85 . . . . . 0 C--O 1.232 0.14 0 CA-C-O 120.821 0.343 . . . . 70.51 110.916 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' B' B ' -6' ' ' ILE . . . . . . . . . . . . . 1.6 pt -153.08 86.14 4.16 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-O 121.627 0.727 . . . . 71.2 111.15 179.995 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' -5' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.74 139.59 40.66 Favored 'Trans proline' 0 C--O 1.231 0.173 0 C-N-CA 122.683 2.256 . . . . 72.33 112.345 179.898 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' -4' ' ' SER . . . . . . . . . . . . . 1.5 t -135.24 65.63 1.55 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.222 -0.445 . . . . 74.31 110.88 -179.845 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' -3' ' ' ARG . . . . . . . . . . . . . 5.4 ptm180 -178.2 154.46 0.93 Allowed Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.569 0.699 . . . . 74.32 110.876 -179.964 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' -2' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.77 131.55 21.47 Favored 'Trans proline' 0 C--N 1.341 0.138 0 C-N-CA 122.682 2.255 . . . . 73.02 112.321 -179.953 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' -1' ' ' ALA . . . . . . . . . . . . . . . -68.84 152.49 96.73 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.526 0.679 . . . . 74.3 111.127 179.859 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 0' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.81 171.51 14.39 Favored 'Trans proline' 0 C--N 1.341 0.157 0 C-N-CA 122.666 2.244 . . . . 65.53 112.318 -179.958 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 1' ' ' LYS . . . . . . . . . . . . . 21.1 mmmt -119.58 153.81 54.3 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.612 0.72 . . . . 74.42 110.835 179.955 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 2' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo . . . . . 0 C--N 1.342 0.205 0 C-N-CA 122.694 2.263 . . . . 75.35 112.358 179.863 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' -4' ' ' MET . . . . . . . . . . . . . 23.2 mmt . . . . . 0 C--O 1.23 0.074 0 CA-C-O 120.756 0.312 . . . . 70.23 110.902 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' -3' ' ' ALA . . . . . . . . . . . . . . . -77.55 69.93 3.86 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.219 -0.446 . . . . 75.41 111.044 179.975 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' -2' ' ' ILE . . . . . . . . . . . . . 60.5 mt -128.34 136.58 59.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.245 -0.434 . . . . 73.25 111.145 179.937 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' -1' ' ' VAL . . . . . . . . . . . . . 54.5 t -104.31 -29.07 2.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.137 -0.483 . . . . 74.14 111.133 179.869 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 15.5 m120 62.19 54.12 2.73 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.132 -0.485 . . . . 65.51 110.948 -179.94 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 44.9 tp60 -109.13 124.3 50.59 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.151 -0.477 . . . . 75.22 110.926 -179.977 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 7.6 ptt180 -74.65 162.11 29.05 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.216 -0.447 . . . . 73.03 110.892 -179.896 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -157.1 155.0 30.34 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.195 -0.457 . . . . 74.3 111.105 179.954 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 10.8 p -104.01 150.31 7.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.233 -0.44 . . . . 75.14 111.171 179.959 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -89.13 105.4 17.77 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.175 -0.466 . . . . 75.04 111.027 179.947 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 15.5 mt -70.17 -36.82 74.94 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.2 -0.455 . . . . 75.23 110.937 179.998 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 3.5 m-85 -143.79 156.67 44.57 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.187 -0.461 . . . . 72.21 110.958 179.996 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -79.03 135.53 36.91 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.167 -0.47 . . . . 75.04 110.871 179.938 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 9.3 t80 -135.97 146.0 46.78 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.227 -0.442 . . . . 74.24 110.873 -179.894 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 28.8 tt0 -116.04 136.12 22.9 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-O 121.654 0.74 . . . . 75.22 110.855 -179.917 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.8 146.05 58.78 Favored 'Trans proline' 0 C--N 1.342 0.189 0 C-N-CA 122.661 2.241 . . . . 74.24 112.311 -179.972 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 7.8 mm-40 -107.93 -18.74 13.72 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.196 -0.457 . . . . 74.33 110.853 -179.967 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 35.5 m-80 -111.45 176.06 5.17 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.146 -0.479 . . . . 75.34 110.893 -179.934 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -92.16 20.89 5.51 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.169 -0.469 . . . . 73.13 110.865 179.906 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -138.24 12.29 2.81 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.179 -0.464 . . . . 64.5 110.906 -179.938 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 20.4 mt-10 -105.49 156.17 18.47 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.168 -0.469 . . . . 73.21 110.909 -179.998 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -105.53 151.44 24.29 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.206 -0.452 . . . . 71.25 110.879 -179.943 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 12.6 mtp180 -87.79 150.86 23.3 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.17 -0.468 . . . . 73.2 110.861 179.985 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 2.3 tp -135.17 149.57 49.98 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.242 -0.435 . . . . 72.51 110.927 -179.981 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -140.24 136.81 33.74 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.219 -0.446 . . . . 73.32 111.124 179.798 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 3.0 tt0 -50.45 120.24 4.45 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.218 -0.447 . . . . 72.12 110.889 -179.927 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 96.16 -0.56 62.2 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.696 -0.764 . . . . 64.23 112.499 -179.98 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -87.32 147.46 25.49 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.823 0.344 . . . . 65.52 110.865 -179.975 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 3.2 mm -100.62 141.04 18.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.173 -0.467 . . . . 74.4 111.131 -179.97 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 1.4 m -142.75 158.25 18.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.202 -0.454 . . . . 71.23 111.135 179.879 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 58.4 m-85 -117.19 108.11 15.27 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.165 -0.47 . . . . 70.24 110.905 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 16.6 mm -72.75 102.7 1.52 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.147 -0.479 . . . . 74.45 111.165 179.983 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 4.6 m -64.82 -40.88 95.91 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.19 -0.459 . . . . 72.21 110.861 -179.853 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 36.3 p90 -173.86 149.27 1.52 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.113 -0.494 . . . . 75.05 110.895 -179.931 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 9.4 tttm -80.82 145.09 31.6 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.076 -0.511 . . . . 73.05 110.898 179.892 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 27.5 t60 -132.75 155.9 48.04 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.232 -0.44 . . . . 74.54 110.882 179.85 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -61.75 -174.21 1.65 Allowed Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.675 -0.774 . . . . 75.53 112.514 -179.946 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 57.1 mm-40 64.87 13.28 8.42 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.87 0.367 . . . . 64.33 110.874 -179.909 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 68.16 29.98 73.59 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.737 -0.744 . . . . 75.31 112.473 -179.984 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 98.3 m95 -123.58 137.52 54.74 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.83 0.348 . . . . 73.02 110.921 -179.929 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 1.6 mt -120.57 133.19 55.41 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.247 -0.433 . . . . 74.44 110.951 179.98 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 75.8 t -79.95 109.09 14.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.214 -0.448 . . . . 74.22 111.161 179.851 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -129.46 160.99 31.43 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.243 -0.435 . . . . 52.04 111.07 179.945 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 3.3 pm0 -119.02 159.3 24.12 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.225 -0.443 . . . . 72.04 110.878 -179.933 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -71.95 -175.26 1.39 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.139 -0.482 . . . . 72.53 110.854 -179.924 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -69.63 -38.58 77.24 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.147 -0.479 . . . . 74.31 110.893 -179.989 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 1.5 t -56.03 -22.64 28.45 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.149 -0.478 . . . . 52.42 110.843 -179.77 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 69.76 9.02 61.65 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.814 -0.708 . . . . 74.42 112.474 179.982 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 3.7 t -108.88 -19.86 13.25 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.923 0.392 . . . . 74.12 110.871 -179.755 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 1.1 ttmt -109.85 123.62 49.9 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.134 -0.485 . . . . 74.15 110.94 179.913 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 6.1 m -126.82 152.58 46.77 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.269 -0.423 . . . . 73.32 111.116 -179.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -177.21 -161.16 25.3 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.744 -0.741 . . . . 72.22 112.484 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 4.8 mt -100.7 138.74 37.35 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.835 0.35 . . . . 75.43 110.885 -179.901 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.416 ' HB ' ' HD2' ' A' ' 51' ' ' PRO . 6.1 m -137.36 153.56 74.76 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-O 121.634 0.73 . . . . 74.4 111.143 179.82 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . 0.416 ' HD2' ' HB ' ' A' ' 50' ' ' VAL . 53.8 Cg_endo -69.8 142.9 48.99 Favored 'Trans proline' 0 C--N 1.341 0.184 0 C-N-CA 122.639 2.226 . . . . 73.02 112.332 179.977 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 15.7 tm-20 -89.88 -27.3 19.98 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.18 -0.464 . . . . 74.53 110.92 -179.992 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -87.12 12.08 12.38 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.111 -0.495 . . . . 74.22 110.895 -179.97 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -121.89 -8.81 8.86 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.154 -0.475 . . . . 73.54 110.883 -179.912 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 17.2 m -120.42 169.83 11.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.125 -0.489 . . . . 74.2 111.127 179.968 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 3.8 t -138.69 115.27 10.58 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.19 -0.459 . . . . 64.35 110.869 -179.854 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 3.0 m-85 -54.2 128.8 32.59 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.183 -0.462 . . . . 74.33 110.924 -179.889 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 45.6 mt -97.06 148.65 5.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.114 -0.494 . . . . 74.13 111.15 179.939 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 4.3 mt-30 -131.17 160.91 64.83 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 121.616 0.722 . . . . 74.43 110.873 179.985 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.76 -48.07 0.8 Allowed 'Trans proline' 0 C--N 1.341 0.175 0 C-N-CA 122.751 2.301 . . . . 65.23 112.352 -179.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 29.6 tt0 -156.57 25.18 0.34 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.17 -0.468 . . . . 70.34 110.892 -179.981 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 8.1 mt -116.92 172.26 7.37 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.178 -0.464 . . . . 73.23 110.936 -179.957 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 . . . . . 0 C--N 1.329 -0.288 0 CA-C-N 116.205 -0.452 . . . . 64.41 110.871 179.918 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' B' B ' -9' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.26 0 N-CA-C 112.49 -0.244 . . . . 73.51 112.49 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' B' B ' -8' ' ' LYS . . . . . . . . . . . . . 19.5 mmtm -74.3 -62.77 1.4 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.793 0.33 . . . . 74.31 110.894 -179.982 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' -7' ' ' PHE . . . . . . . . . . . . . 13.5 m-85 -75.43 142.75 42.96 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.234 -0.439 . . . . 74.42 110.888 179.991 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' -6' ' ' ILE . . . . . . . . . . . . . 2.7 pt -153.21 84.13 4.47 Favored Pre-proline 0 C--N 1.328 -0.344 0 CA-C-O 121.656 0.741 . . . . 74.31 111.12 179.977 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' -5' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.71 134.52 28.3 Favored 'Trans proline' 0 C--N 1.342 0.207 0 C-N-CA 122.682 2.254 . . . . 71.0 112.342 179.857 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' -4' ' ' SER . . . . . . . . . . . . . 26.3 t -131.5 65.4 1.57 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.193 -0.458 . . . . 74.42 110.87 -179.863 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' -3' ' ' ARG . . . . . . . . . . . . . 6.9 ptm180 -178.66 155.0 0.87 Allowed Pre-proline 0 C--N 1.33 -0.282 0 CA-C-O 121.625 0.726 . . . . 75.13 110.84 -179.95 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' -2' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.83 129.3 17.29 Favored 'Trans proline' 0 C--N 1.341 0.17 0 C-N-CA 122.718 2.279 . . . . 71.31 112.313 -179.964 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' -1' ' ' ALA . . . . . . . . . . . . . . . -63.5 154.48 79.27 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-O 121.525 0.678 . . . . 72.44 111.157 179.847 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 0' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.78 176.75 6.36 Favored 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.663 2.242 . . . . 72.11 112.334 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 1' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -125.07 146.99 55.5 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.561 0.696 . . . . 74.22 110.882 179.951 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 2' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.72 163.27 38.86 Favored 'Trans proline' 0 C--N 1.341 0.158 0 C-N-CA 122.646 2.231 . . . . 71.35 112.363 179.873 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 3' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.78 -170.02 0.37 Allowed 'Trans proline' 0 C--N 1.341 0.157 0 C-N-CA 122.711 2.274 . . . . 72.51 112.339 179.939 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 4' ' ' SER . . . . . . . . . . . . . 13.6 p -113.35 -29.81 7.11 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.19 -0.459 . . . . 72.23 110.825 -179.815 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 5' ' ' SER . . . . . . . . . . . . . 3.5 t -56.89 -67.27 0.33 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.152 -0.476 . . . . 73.54 110.843 -179.792 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 6' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.328 -0.334 0 CA-C-N 116.134 -0.484 . . . . 75.14 111.098 179.892 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' -4' ' ' MET . . . . . . . . . . . . . 5.8 mmt . . . . . 0 C--O 1.231 0.102 0 CA-C-O 120.81 0.338 . . . . 64.34 110.864 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' -3' ' ' ALA . . . . . . . . . . . . . . . -108.05 114.12 27.79 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.243 -0.435 . . . . 70.23 111.074 179.93 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' -2' ' ' ILE . . . . . . . . . . . . . 91.6 mt -84.36 131.31 34.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.213 -0.448 . . . . 75.1 111.17 179.945 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' -1' ' ' VAL . . . . . . . . . . . . . 42.4 t -117.21 131.58 69.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.19 -0.459 . . . . 74.24 111.081 179.912 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 18.6 m120 -94.77 60.04 2.46 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.162 -0.472 . . . . 71.45 110.887 179.944 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 51.6 tp60 -103.35 134.5 46.63 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.193 -0.458 . . . . 74.42 110.92 179.96 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 5.9 ptt180 -89.58 164.67 14.67 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.202 -0.454 . . . . 73.3 110.896 -179.949 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -155.56 152.39 28.75 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.235 -0.439 . . . . 64.43 111.114 179.98 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 10.7 p -104.17 147.91 9.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.245 -0.434 . . . . 72.23 111.164 179.918 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -87.75 112.61 22.6 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.152 -0.477 . . . . 74.3 111.082 179.913 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 10.4 mt -77.91 -37.77 47.12 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.2 -0.454 . . . . 74.13 110.962 179.987 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 4.0 m-85 -140.59 141.39 35.19 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.171 -0.468 . . . . 74.45 110.908 -179.972 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 2.2 p30 -65.13 132.99 50.59 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.128 -0.487 . . . . 73.3 110.898 179.899 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 2.1 t80 -129.83 146.34 51.57 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.204 -0.453 . . . . 71.24 110.888 -179.89 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 47.2 tt0 -117.03 137.06 23.51 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-O 121.62 0.724 . . . . 73.41 110.864 -179.893 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.79 150.99 68.79 Favored 'Trans proline' 0 C--N 1.342 0.189 0 C-N-CA 122.676 2.25 . . . . 74.25 112.311 -179.96 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 6.3 mm-40 -113.9 -15.82 12.3 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.206 -0.452 . . . . 72.25 110.913 179.981 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 31.2 m-80 -114.92 175.97 5.26 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.208 -0.451 . . . . 70.2 110.863 -179.936 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 27.1 m-20 -91.02 18.39 6.79 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.144 -0.48 . . . . 74.23 110.893 179.927 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -138.22 17.04 2.79 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.163 -0.472 . . . . 74.53 110.946 -179.916 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 24.9 mt-10 -105.49 164.87 11.55 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.132 -0.486 . . . . 74.51 110.93 179.979 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 41.3 tp -115.84 147.06 41.45 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.176 -0.465 . . . . 72.32 110.94 -179.978 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -83.07 159.32 22.16 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.219 -0.446 . . . . 74.34 110.823 179.986 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 3.1 tp -143.87 147.96 34.79 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.179 -0.464 . . . . 74.21 110.939 179.995 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -139.6 138.73 36.42 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.186 -0.461 . . . . 75.41 111.07 179.811 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -51.35 122.53 7.98 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.189 -0.46 . . . . 74.55 110.907 -179.933 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 95.85 -6.7 67.28 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.727 -0.749 . . . . 64.52 112.449 -179.983 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -80.38 145.94 31.76 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.764 0.316 . . . . 54.31 110.887 -179.967 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 3.2 mm -101.96 140.7 19.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.195 -0.457 . . . . 73.35 111.104 -179.957 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 1.5 m -143.23 158.47 17.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.135 -0.484 . . . . 73.01 111.132 179.868 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 57.4 m-85 -115.59 108.92 17.04 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.2 -0.455 . . . . 74.52 110.902 179.996 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 17.2 mm -72.42 102.61 1.41 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.153 -0.476 . . . . 64.31 111.101 179.999 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 8.1 m -65.06 -40.35 94.6 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.191 -0.459 . . . . 64.34 110.901 -179.946 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 33.9 p90 -174.67 148.6 1.15 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.144 -0.48 . . . . 72.55 110.923 -179.881 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 10.3 tttm -81.27 143.94 31.91 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.122 -0.49 . . . . 75.54 110.838 179.942 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 32.0 t60 -132.45 155.13 49.09 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.205 -0.452 . . . . 75.21 110.845 179.879 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -60.49 -174.04 1.01 Allowed Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.755 -0.736 . . . . 63.42 112.481 -179.962 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 16.8 mm100 65.32 12.69 8.27 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.878 0.37 . . . . 71.13 110.947 -179.892 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 68.36 29.31 73.08 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.747 -0.74 . . . . 71.23 112.462 -180.0 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 98.8 m95 -123.55 135.75 54.17 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.781 0.324 . . . . 74.01 110.918 -179.93 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 1.3 mt -120.3 130.62 54.54 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.195 -0.457 . . . . 75.33 110.907 179.987 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 82.6 t -76.18 112.11 13.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.184 -0.462 . . . . 75.21 111.138 179.821 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -133.0 157.9 44.04 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.121 -0.491 . . . . 71.03 111.055 179.892 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -114.41 156.23 24.88 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.196 -0.456 . . . . 65.53 110.88 -179.929 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -71.7 -175.35 1.34 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.16 -0.473 . . . . 51.52 110.9 -179.92 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -70.0 -39.45 75.86 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.208 -0.451 . . . . 74.31 110.915 -179.982 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 14.4 m -55.82 -22.29 24.02 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.177 -0.465 . . . . 75.32 110.892 -179.824 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 66.35 11.77 56.88 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.724 -0.75 . . . . 55.32 112.525 -179.974 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 3.5 m -107.76 -14.98 14.67 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.935 0.398 . . . . 74.33 110.843 -179.714 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -121.43 134.85 55.09 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.112 -0.494 . . . . 74.34 110.868 179.937 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 5.2 m -138.67 137.93 37.31 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.216 -0.447 . . . . 70.2 111.127 179.967 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -158.11 -154.49 7.16 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.75 -0.738 . . . . 62.51 112.502 179.942 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 6.2 mt -104.62 130.95 52.55 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.845 0.355 . . . . 73.41 110.902 -179.881 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 11.7 m -129.0 153.1 80.23 Favored Pre-proline 0 C--N 1.33 -0.264 0 CA-C-O 121.619 0.723 . . . . 65.2 111.141 179.801 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . 0.411 ' HG2' ' HB2' ' A' ' 54' ' ' PHE . 53.8 Cg_endo -69.76 144.72 54.94 Favored 'Trans proline' 0 C--N 1.341 0.166 0 C-N-CA 122.661 2.241 . . . . 62.13 112.319 179.966 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 13.5 tm-20 -90.44 -28.71 18.43 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.218 -0.446 . . . . 71.31 110.922 179.985 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -85.67 10.05 14.5 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.158 -0.474 . . . . 73.44 110.904 -179.954 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . 0.411 ' HB2' ' HG2' ' A' ' 51' ' ' PRO . 1.0 OUTLIER -121.02 -5.8 9.53 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.108 -0.496 . . . . 72.41 110.88 -179.969 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 15.4 m -122.75 167.52 16.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.16 -0.473 . . . . 70.15 111.108 179.998 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 47.9 t -138.27 117.35 12.56 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.158 -0.474 . . . . 70.43 110.85 -179.854 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 2.7 m-85 -53.44 134.12 40.47 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.133 -0.485 . . . . 73.44 110.936 -179.889 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 41.4 mt -104.48 146.54 11.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.098 -0.501 . . . . 74.21 111.123 179.905 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 1.3 mt-30 -131.2 160.67 65.96 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-O 121.626 0.727 . . . . 71.43 110.889 179.922 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.78 -48.87 0.63 Allowed 'Trans proline' 0 C--N 1.342 0.208 0 C-N-CA 122.658 2.239 . . . . 72.01 112.348 -179.992 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 20.6 mm-40 -151.27 23.56 0.73 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.219 -0.446 . . . . 74.34 110.888 -179.979 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 6.5 mt -113.93 166.97 11.05 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.151 -0.477 . . . . 74.51 110.923 -179.979 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 16.9 pt-20 . . . . . 0 C--N 1.329 -0.295 0 CA-C-N 116.202 -0.454 . . . . 64.43 110.884 179.928 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' B' B ' -9' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.304 0 N-CA-C 112.504 -0.238 . . . . 74.13 112.504 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' B' B ' -8' ' ' LYS . . . . . . . . . . . . . 23.0 mttt -113.73 79.45 1.25 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.811 0.338 . . . . 74.13 110.865 -179.934 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' -7' ' ' PHE . . . . . . . . . . . . . 9.0 m-85 -82.34 139.82 33.89 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.211 -0.449 . . . . 74.54 110.864 179.986 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' -6' ' ' ILE . . . . . . . . . . . . . 37.3 mm -145.62 87.69 6.82 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 121.646 0.736 . . . . 72.51 111.135 179.933 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' -5' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.76 130.99 20.31 Favored 'Trans proline' 0 C--N 1.342 0.192 0 C-N-CA 122.649 2.233 . . . . 64.34 112.347 179.845 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' -4' ' ' SER . . . . . . . . . . . . . 30.9 t -124.27 62.21 1.11 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.164 -0.471 . . . . 75.25 110.879 -179.86 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' -3' ' ' ARG . . . . . . . . . . . . . 9.2 ptm180 -174.63 153.74 1.81 Allowed Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.643 0.735 . . . . 75.04 110.862 -179.93 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' -2' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.74 136.33 32.77 Favored 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.672 2.248 . . . . 73.31 112.343 179.996 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' -1' ' ' ALA . . . . . . . . . . . . . . . -71.84 152.76 93.2 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-O 121.605 0.717 . . . . 62.41 111.083 179.904 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 0' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.81 178.02 5.02 Favored 'Trans proline' 0 C--N 1.342 0.2 0 C-N-CA 122.602 2.201 . . . . 74.4 112.369 -179.965 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 1' ' ' LYS . . . . . . . . . . . . . 9.3 pttm -125.2 154.34 71.8 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-O 121.583 0.706 . . . . 74.25 110.898 179.945 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 2' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.7 164.0 36.13 Favored 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.711 2.274 . . . . 74.24 112.313 179.909 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 3' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.74 174.99 8.68 Favored 'Trans proline' 0 C--N 1.342 0.213 0 C-N-CA 122.694 2.262 . . . . 71.44 112.334 179.924 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 4' ' ' SER . . . . . . . . . . . . . 16.5 m -117.84 140.83 49.15 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.219 -0.446 . . . . 64.42 110.871 -179.872 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 5' ' ' SER . . . . . . . . . . . . . 10.0 t -100.68 146.93 26.58 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.142 -0.481 . . . . 72.42 110.856 -179.82 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 6' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.313 0 CA-C-N 116.104 -0.498 . . . . 73.55 111.106 179.95 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' -4' ' ' MET . . . . . . . . . . . . . 42.1 mmm . . . . . 0 C--O 1.231 0.113 0 CA-C-O 120.795 0.331 . . . . 73.13 110.882 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' -3' ' ' ALA . . . . . . . . . . . . . . . -107.14 63.73 0.63 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.266 -0.425 . . . . 73.03 111.073 179.942 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' -2' ' ' ILE . . . . . . . . . . . . . 5.3 mp -125.79 118.04 50.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.217 -0.447 . . . . 71.12 111.145 179.939 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' -1' ' ' VAL . . . . . . . . . . . . . 12.1 p -69.54 -29.65 42.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.202 -0.453 . . . . 74.15 111.151 179.83 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 1.9 t-20 63.25 50.43 2.99 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.156 -0.474 . . . . 63.42 110.929 179.998 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 57.8 tp60 -105.64 127.24 52.94 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.172 -0.467 . . . . 72.33 110.899 -179.966 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -79.08 160.67 26.98 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.189 -0.459 . . . . 74.44 110.834 -179.905 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -156.33 153.61 29.29 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.147 -0.478 . . . . 73.41 111.097 179.925 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 10.8 p -104.33 151.16 6.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.23 -0.441 . . . . 74.34 111.099 179.995 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -89.82 106.83 18.73 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.161 -0.472 . . . . 71.23 111.104 179.895 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 16.6 mt -71.4 -39.5 71.11 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.267 -0.424 . . . . 73.13 110.883 -179.951 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 5.6 m-85 -138.84 149.98 45.52 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.224 -0.444 . . . . 71.45 110.875 179.996 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 1.7 p30 -73.74 136.05 43.64 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.066 -0.515 . . . . 72.25 110.88 179.907 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 9.0 t80 -139.83 144.66 37.4 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.192 -0.458 . . . . 75.34 110.881 -179.884 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -113.16 144.75 31.76 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.645 0.736 . . . . 73.45 110.886 -179.907 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.78 141.6 45.61 Favored 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.722 2.281 . . . . 63.4 112.339 -179.981 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 6.3 mm-40 -102.02 -24.05 14.03 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.235 -0.438 . . . . 74.51 110.869 -179.967 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 40.7 m-80 -112.31 175.58 5.37 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.163 -0.471 . . . . 73.04 110.921 -179.963 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -83.07 2.06 37.03 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.204 -0.453 . . . . 74.53 110.869 179.875 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 1.1 p-10 -124.01 23.05 8.65 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.213 -0.448 . . . . 65.43 110.854 -179.903 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 5.4 mt-10 -108.86 156.72 19.34 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.198 -0.455 . . . . 70.4 110.894 179.998 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 54.4 tp -108.05 151.61 25.62 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.162 -0.472 . . . . 73.03 110.876 -179.956 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 9.7 mtt-85 -88.79 154.11 20.53 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.153 -0.476 . . . . 75.13 110.851 179.988 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 2.6 tp -140.51 149.04 41.97 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.177 -0.465 . . . . 75.5 110.945 -179.974 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -141.22 137.52 32.65 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.185 -0.461 . . . . 72.13 111.112 179.798 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -50.76 121.03 5.32 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.224 -0.444 . . . . 75.31 110.902 -179.897 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 96.65 -4.86 64.05 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.717 -0.754 . . . . 74.24 112.512 -179.947 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -82.78 146.74 28.8 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.816 0.341 . . . . 75.52 110.85 -179.972 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 3.2 mm -101.67 141.06 18.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.176 -0.465 . . . . 75.33 111.163 179.989 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 1.3 m -143.23 158.68 17.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.177 -0.465 . . . . 72.2 111.104 179.85 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 37.8 m-85 -115.83 106.71 14.14 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.134 -0.485 . . . . 75.21 110.838 -179.931 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 13.0 mm -72.13 103.3 1.47 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.157 -0.474 . . . . 72.11 111.126 179.959 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 3.4 m -64.55 -39.59 94.04 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.18 -0.464 . . . . 74.34 110.84 -179.891 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 32.8 p90 -174.16 148.06 1.29 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.145 -0.48 . . . . 75.13 110.907 -179.883 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 19.1 tttt -82.57 145.85 29.5 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.089 -0.505 . . . . 71.24 110.919 179.894 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 34.5 t60 -135.49 153.54 51.7 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.236 -0.438 . . . . 72.15 110.842 179.923 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -58.6 -174.44 0.52 Allowed Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.751 -0.738 . . . . 35.53 112.518 -179.973 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 2.5 mt-30 65.78 12.22 8.16 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.803 0.335 . . . . 72.44 110.908 -179.873 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 68.24 28.85 73.14 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.76 -0.733 . . . . 65.21 112.494 -179.955 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 99.1 m95 -123.56 136.0 54.3 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.773 0.32 . . . . 71.44 110.939 -179.919 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -124.11 132.06 53.61 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.261 -0.427 . . . . 75.2 110.938 179.969 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 47.1 t -78.2 116.97 22.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.194 -0.457 . . . . 73.42 111.169 179.807 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -136.66 166.31 23.84 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.178 -0.464 . . . . 73.41 111.085 179.866 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -127.53 153.93 45.76 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.212 -0.449 . . . . 73.03 110.879 -179.911 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -66.32 -174.77 0.3 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.172 -0.467 . . . . 65.41 110.895 -179.962 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -69.62 -37.93 77.03 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.157 -0.474 . . . . 74.4 110.879 -179.97 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 9.5 m -57.0 -22.52 39.23 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.141 -0.481 . . . . 74.04 110.895 -179.827 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 67.54 10.9 58.82 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.713 -0.756 . . . . 75.51 112.5 -179.973 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 1.9 t -106.48 -21.77 12.98 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.966 0.412 . . . . 73.51 110.868 -179.722 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 1.7 ttmt -114.07 124.02 51.08 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.131 -0.486 . . . . 74.33 110.88 179.936 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 15.6 m -133.79 144.52 49.07 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.193 -0.458 . . . . 75.51 111.117 -179.991 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -164.48 -152.96 7.22 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.72 -0.752 . . . . 63.32 112.458 179.971 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 12.6 mt -103.89 134.08 47.78 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.852 0.358 . . . . 75.13 110.876 -179.912 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.411 ' HB ' ' HD2' ' A' ' 51' ' ' PRO . 21.9 m -134.15 154.05 79.89 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-O 121.668 0.746 . . . . 74.14 111.069 179.857 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . 0.411 ' HD2' ' HB ' ' A' ' 50' ' ' VAL . 53.4 Cg_endo -69.77 146.43 60.09 Favored 'Trans proline' 0 C--N 1.342 0.209 0 C-N-CA 122.656 2.237 . . . . 72.33 112.3 179.974 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 28.0 tt0 -91.87 -29.31 16.78 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.187 -0.461 . . . . 74.15 110.903 179.982 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -85.23 9.8 14.16 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.187 -0.46 . . . . 71.14 110.934 -179.964 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -120.19 -7.97 9.76 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.13 -0.486 . . . . 75.33 110.858 -179.932 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 15.8 m -121.21 161.32 21.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.151 -0.477 . . . . 70.21 111.119 179.981 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 25.4 t -131.68 114.74 15.15 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.149 -0.478 . . . . 74.04 110.833 -179.855 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 3.0 m-85 -54.72 127.02 26.36 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.182 -0.463 . . . . 73.44 110.916 -179.877 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 40.6 mt -94.85 143.16 12.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.121 -0.49 . . . . 72.52 111.117 179.953 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -131.3 161.01 64.48 Favored Pre-proline 0 C--N 1.329 -0.326 0 CA-C-O 121.62 0.724 . . . . 73.44 110.914 179.976 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.77 -48.6 0.68 Allowed 'Trans proline' 0 C--N 1.341 0.181 0 C-N-CA 122.682 2.255 . . . . 72.02 112.355 179.956 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -158.65 26.9 0.23 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.255 -0.43 . . . . 72.25 110.905 -179.976 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 16.9 mt -112.35 139.25 48.06 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.187 -0.461 . . . . 75.41 110.916 -179.956 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.304 0 CA-C-N 116.183 -0.462 . . . . 54.44 110.871 179.941 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' -9' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.346 0 N-CA-C 112.512 -0.235 . . . . 64.42 112.512 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' B' B ' -8' ' ' LYS . . . . . . . . . . . . . 5.0 mtpm? -73.12 -49.85 26.09 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.848 0.356 . . . . 75.53 110.904 -179.994 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' -7' ' ' PHE . . . . . . . . . . . . . 6.7 m-85 -67.44 143.08 56.43 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.175 -0.466 . . . . 74.11 110.909 179.977 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' -6' ' ' ILE . . . . . . . . . . . . . 1.9 pt -152.98 88.28 3.87 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.68 0.752 . . . . 74.22 111.122 179.977 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' -5' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.74 135.64 31.01 Favored 'Trans proline' 0 C--N 1.342 0.227 0 C-N-CA 122.702 2.268 . . . . 72.43 112.368 179.859 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' -4' ' ' SER . . . . . . . . . . . . . 2.9 m -133.88 60.37 1.71 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.228 -0.442 . . . . 72.2 110.825 -179.814 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' -3' ' ' ARG . . . . . . . . . . . . . 9.9 ptt85 -174.62 153.41 1.77 Allowed Pre-proline 0 C--N 1.329 -0.288 0 CA-C-O 121.651 0.739 . . . . 72.25 110.836 -179.951 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' -2' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.75 128.05 15.48 Favored 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.645 2.23 . . . . 74.41 112.383 -179.991 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' -1' ' ' ALA . . . . . . . . . . . . . . . -62.61 155.18 70.46 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-O 121.564 0.697 . . . . 72.3 111.086 179.92 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 0' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.73 -169.24 0.31 Allowed 'Trans proline' 0 C--N 1.341 0.17 0 C-N-CA 122.66 2.24 . . . . 70.11 112.369 179.995 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 1' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -138.88 154.12 72.5 Favored Pre-proline 0 C--N 1.328 -0.347 0 CA-C-O 121.568 0.699 . . . . 75.14 110.89 179.909 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 2' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.76 163.29 38.83 Favored 'Trans proline' 0 C--N 1.342 0.185 0 C-N-CA 122.67 2.247 . . . . 74.42 112.354 179.914 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 3' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.76 -35.48 12.57 Favored 'Trans proline' 0 C--N 1.341 0.148 0 C-N-CA 122.707 2.271 . . . . 54.23 112.316 179.988 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 4' ' ' SER . . . . . . . . . . . . . 2.1 m 63.0 43.6 6.52 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.229 -0.442 . . . . 72.5 110.843 -179.872 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 5' ' ' SER . . . . . . . . . . . . . 2.2 p -93.16 -43.52 8.81 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.126 -0.488 . . . . 60.43 110.868 -179.836 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 6' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.306 0 CA-C-N 116.182 -0.463 . . . . 64.0 111.098 179.862 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' -4' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--O 1.23 0.053 0 CA-C-O 120.788 0.328 . . . . 75.52 110.864 . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' -3' ' ' ALA . . . . . . . . . . . . . . . -70.21 -31.84 69.47 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.203 -0.453 . . . . 53.34 111.111 179.903 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' -2' ' ' ILE . . . . . . . . . . . . . 58.5 mt -87.88 131.14 36.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.212 -0.449 . . . . 74.43 111.146 179.97 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' -1' ' ' VAL . . . . . . . . . . . . . 12.0 p -112.88 130.91 65.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.221 -0.445 . . . . 75.21 111.105 179.872 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 1.8 m120 -93.59 59.45 2.89 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.147 -0.478 . . . . 75.32 110.872 179.999 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 31.0 tp60 -101.62 134.3 44.97 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.17 -0.468 . . . . 74.4 110.921 179.993 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 4.4 ptp180 -89.87 163.1 15.14 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.18 -0.463 . . . . 74.51 110.863 -179.891 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -155.07 153.17 30.49 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.192 -0.458 . . . . 61.03 111.089 179.893 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 10.7 p -103.85 150.02 7.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.221 -0.445 . . . . 75.01 111.179 179.932 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -88.33 105.57 17.66 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.207 -0.452 . . . . 74.11 111.112 179.885 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 15.2 mt -69.68 -37.27 76.6 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.218 -0.446 . . . . 73.52 110.911 -179.95 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 2.9 m-85 -143.92 157.46 44.34 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.147 -0.479 . . . . 72.52 110.92 -179.988 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 3.7 p30 -78.84 134.84 36.92 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.128 -0.487 . . . . 75.34 110.9 179.896 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 2.5 t80 -134.42 146.03 49.45 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.201 -0.454 . . . . 74.53 110.894 -179.902 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 6.6 tt0 -116.5 136.14 23.06 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-O 121.626 0.727 . . . . 63.33 110.907 -179.881 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.81 151.52 68.82 Favored 'Trans proline' 0 C--N 1.341 0.175 0 C-N-CA 122.677 2.251 . . . . 75.32 112.319 -179.939 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 1.9 mm-40 -112.9 -17.28 12.53 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.211 -0.45 . . . . 74.42 110.885 -179.989 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 34.3 m-80 -115.21 176.15 5.19 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.148 -0.478 . . . . 74.0 110.892 -179.958 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 70.3 m-20 -91.86 21.07 5.12 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.222 -0.444 . . . . 74.14 110.898 179.91 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 1.1 p-10 -137.23 12.76 3.05 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.171 -0.468 . . . . 74.51 110.894 -179.984 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 48.7 mt-10 -106.82 160.12 15.73 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.178 -0.464 . . . . 74.31 110.841 -179.969 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 20.7 tp -110.88 147.21 35.08 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.095 -0.502 . . . . 72.14 110.917 179.989 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 1.4 mtt180 -83.28 155.85 23.4 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.166 -0.47 . . . . 73.14 110.849 179.96 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 3.0 tp -139.37 149.71 44.46 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.213 -0.449 . . . . 74.54 110.917 179.984 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -139.96 136.44 33.8 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.155 -0.475 . . . . 74.04 111.082 179.772 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -50.77 120.96 5.24 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.193 -0.458 . . . . 70.33 110.848 -179.913 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 96.86 -3.9 62.9 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.744 -0.741 . . . . 55.23 112.456 179.992 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -84.25 146.34 27.84 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.829 0.347 . . . . 74.22 110.823 -179.932 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 3.3 mm -100.52 142.34 15.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.177 -0.465 . . . . 75.44 111.177 179.957 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 1.7 m -145.14 157.38 13.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.206 -0.452 . . . . 53.34 111.111 179.886 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 61.1 m-85 -115.98 110.69 19.3 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.18 -0.464 . . . . 73.01 110.871 -179.988 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 15.5 mm -72.43 102.27 1.35 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.091 -0.504 . . . . 54.32 111.121 179.964 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 5.0 m -65.07 -40.17 94.31 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.234 -0.439 . . . . 71.15 110.831 -179.924 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 35.9 p90 -174.58 149.24 1.25 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.186 -0.461 . . . . 74.51 110.947 -179.913 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 32.5 tttt -80.87 143.18 32.92 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.124 -0.489 . . . . 73.11 110.863 179.945 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 23.2 t60 -129.44 157.42 42.02 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.238 -0.437 . . . . 73.34 110.891 179.87 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -64.18 -174.66 3.64 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.744 -0.741 . . . . 65.1 112.467 -179.959 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 17.9 mm100 65.47 12.69 8.35 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.836 0.351 . . . . 74.11 110.922 -179.893 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 69.72 29.49 71.16 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.745 -0.74 . . . . 64.42 112.505 -179.949 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 97.0 m95 -122.91 138.35 54.69 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.821 0.343 . . . . 75.14 110.938 -179.935 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 1.3 mt -121.13 133.24 55.2 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.223 -0.444 . . . . 72.32 110.935 179.966 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 95.9 t -80.06 109.37 14.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.21 -0.45 . . . . 72.34 111.124 179.814 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -129.19 158.46 38.95 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.175 -0.466 . . . . 71.52 111.126 179.822 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 1.4 pt-20 -117.05 157.31 26.05 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.234 -0.439 . . . . 63.41 110.843 -179.954 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -71.54 -175.04 1.21 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.126 -0.488 . . . . 75.33 110.891 -179.926 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 2.6 tt0 -69.45 -38.3 77.72 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.199 -0.455 . . . . 71.22 110.919 179.981 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 1.6 t -56.36 -22.58 32.0 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.165 -0.471 . . . . 73.44 110.827 -179.799 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 68.58 10.39 60.45 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.689 -0.767 . . . . 70.24 112.516 -179.933 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 3.1 t -107.14 -22.15 12.73 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.886 0.374 . . . . 74.14 110.83 -179.73 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 3.7 ttpt -110.31 123.9 50.67 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.158 -0.474 . . . . 75.32 110.933 179.932 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 9.3 m -131.89 130.38 41.55 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.24 -0.437 . . . . 63.13 111.136 179.998 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -153.57 -157.05 7.9 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.777 -0.725 . . . . 64.32 112.504 179.979 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 11.9 mt -100.32 133.33 44.88 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.821 0.343 . . . . 73.14 110.909 -179.925 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.415 ' HB ' ' HD2' ' A' ' 51' ' ' PRO . 6.0 m -131.97 153.62 81.45 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 121.685 0.755 . . . . 63.22 111.086 179.838 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . 0.415 ' HD2' ' HB ' ' A' ' 50' ' ' VAL . 54.0 Cg_endo -69.75 144.2 53.3 Favored 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.697 2.265 . . . . 63.24 112.353 179.918 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 6.9 tm-20 -90.63 -27.8 18.83 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.226 -0.443 . . . . 75.25 110.885 -179.982 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -86.76 11.12 13.87 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.165 -0.471 . . . . 70.1 110.93 -179.974 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 1.1 m-85 -121.74 -7.48 9.05 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.139 -0.482 . . . . 74.24 110.854 -179.91 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 16.1 m -121.88 168.08 14.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.161 -0.472 . . . . 72.34 111.13 -179.983 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 43.9 t -136.93 117.06 13.4 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.212 -0.449 . . . . 63.44 110.896 -179.851 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 2.9 m-85 -56.25 124.3 17.49 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.15 -0.477 . . . . 72.22 110.903 -179.849 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 35.3 mt -94.52 141.87 14.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.11 -0.496 . . . . 73.21 111.136 179.931 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -131.09 160.96 64.51 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.583 0.706 . . . . 74.03 110.922 179.923 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.77 -48.43 0.72 Allowed 'Trans proline' 0 C--N 1.341 0.161 0 C-N-CA 122.661 2.241 . . . . 74.13 112.381 179.968 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 29.1 mt-10 -150.78 22.23 0.79 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.172 -0.467 . . . . 61.53 110.867 -179.991 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 5.3 mt -112.56 168.99 9.21 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.162 -0.472 . . . . 65.1 110.845 -179.949 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 3.7 pt-20 . . . . . 0 C--N 1.33 -0.261 0 CA-C-N 116.141 -0.481 . . . . 64.23 110.882 179.927 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' B' B ' -9' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.32 0 N-CA-C 112.52 -0.232 . . . . 74.03 112.52 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' B' B ' -8' ' ' LYS . . . . . . . . . . . . . 52.0 mttt -88.34 -28.8 20.77 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.836 0.35 . . . . 71.2 110.918 -179.963 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' -7' ' ' PHE . . . . . . . . . . . . . 7.4 m-85 -67.83 127.18 31.85 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.214 -0.448 . . . . 75.42 110.871 179.954 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' -6' ' ' ILE . . . . . 0.411 ' HA ' ' HD2' ' B' ' -5' ' ' PRO . 30.0 mm -138.22 94.83 10.78 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 121.681 0.753 . . . . 62.32 111.155 179.939 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' -5' ' ' PRO . . . . . 0.411 ' HD2' ' HA ' ' B' ' -6' ' ' ILE . 53.8 Cg_endo -69.76 140.37 42.51 Favored 'Trans proline' 0 C--N 1.342 0.194 0 C-N-CA 122.673 2.249 . . . . 73.55 112.357 179.884 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' -4' ' ' SER . . . . . . . . . . . . . 3.0 m -131.3 60.66 1.66 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.172 -0.467 . . . . 63.12 110.818 -179.811 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' -3' ' ' ARG . . . . . . . . . . . . . 14.2 ptp180 -178.87 154.96 0.83 Allowed Pre-proline 0 C--N 1.328 -0.332 0 CA-C-O 121.628 0.728 . . . . 75.53 110.875 -179.917 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' -2' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.79 140.54 42.83 Favored 'Trans proline' 0 C--N 1.342 0.189 0 C-N-CA 122.665 2.243 . . . . 73.54 112.352 -179.996 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' -1' ' ' ALA . . . . . . . . . . . . . . . -71.93 156.3 91.08 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-O 121.603 0.716 . . . . 73.32 111.094 179.903 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 0' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.79 -177.94 2.12 Favored 'Trans proline' 0 C--O 1.231 0.168 0 C-N-CA 122.696 2.264 . . . . 74.52 112.352 -179.996 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 1' ' ' LYS . . . . . . . . . . . . . 3.5 ttpt -129.31 145.49 57.02 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-O 121.576 0.703 . . . . 72.11 110.915 179.939 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 2' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.73 163.53 37.9 Favored 'Trans proline' 0 C--N 1.342 0.185 0 C-N-CA 122.718 2.279 . . . . 74.32 112.322 179.904 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 3' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.72 -178.48 2.35 Favored 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.712 2.275 . . . . 63.11 112.376 179.901 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 4' ' ' SER . . . . . . . . . . . . . 1.5 t -86.66 141.98 28.55 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.225 -0.443 . . . . 71.41 110.865 -179.84 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 5' ' ' SER . . . . . . . . . . . . . 35.3 t -162.24 142.3 9.9 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.129 -0.487 . . . . 74.3 110.878 -179.835 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 6' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.328 -0.326 0 CA-C-N 116.147 -0.479 . . . . 65.12 111.109 179.929 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' -4' ' ' MET . . . . . . . . . . . . . 6.4 mmm . . . . . 0 C--O 1.231 0.082 0 CA-C-O 120.8 0.333 . . . . 72.5 110.873 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' -3' ' ' ALA . . . . . . . . . . . . . . . 56.81 45.61 21.33 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.249 -0.432 . . . . 72.44 111.121 179.905 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' -2' ' ' ILE . . . . . . . . . . . . . 91.9 mt -115.87 128.09 73.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.235 -0.439 . . . . 74.43 111.158 179.974 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' -1' ' ' VAL . . . . . . . . . . . . . 70.9 t -114.78 131.14 67.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.144 -0.48 . . . . 71.1 111.114 179.847 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 1.6 m120 -94.06 60.78 2.86 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.137 -0.483 . . . . 71.51 110.848 -179.993 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 50.3 tp60 -101.51 133.47 46.11 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.205 -0.452 . . . . 73.14 110.885 179.989 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 8.9 ptp180 -87.14 163.69 16.81 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.228 -0.442 . . . . 74.52 110.85 -179.934 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -155.18 154.08 31.72 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.192 -0.458 . . . . 74.13 111.07 179.948 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 11.6 p -104.03 149.26 7.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.187 -0.46 . . . . 73.45 111.088 -179.998 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -88.24 105.03 17.27 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.124 -0.489 . . . . 74.34 111.143 179.863 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 17.6 mt -69.17 -39.21 78.87 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.199 -0.455 . . . . 75.22 110.919 -179.952 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 3.3 m-85 -141.3 156.4 45.86 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.208 -0.451 . . . . 75.41 110.937 179.998 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 1.7 p-10 -79.06 135.05 36.75 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.11 -0.495 . . . . 75.43 110.853 179.914 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 2.1 t80 -134.09 146.06 49.95 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.191 -0.459 . . . . 75.3 110.926 -179.926 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 29.7 tt0 -115.72 135.47 22.68 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.603 0.716 . . . . 74.23 110.922 -179.945 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.76 147.64 63.32 Favored 'Trans proline' 0 C--N 1.341 0.154 0 C-N-CA 122.701 2.267 . . . . 73.02 112.347 -179.969 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 13.6 mt-10 -107.72 -18.82 13.73 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.247 -0.433 . . . . 71.41 110.894 -179.98 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 31.1 m-80 -112.8 175.46 5.43 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.133 -0.485 . . . . 72.02 110.899 -179.933 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 36.5 m-20 -90.05 13.4 14.98 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.191 -0.459 . . . . 72.24 110.836 179.949 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 1.2 p-10 -131.32 14.96 5.07 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.232 -0.44 . . . . 74.43 110.895 -179.901 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 23.9 mt-10 -104.29 159.49 15.67 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.122 -0.49 . . . . 74.22 110.9 -179.993 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -109.62 143.21 39.66 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.213 -0.449 . . . . 75.55 110.924 -179.989 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -81.67 156.37 25.11 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.204 -0.453 . . . . 72.52 110.878 179.951 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 2.7 tp -141.48 148.6 39.72 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.198 -0.455 . . . . 74.44 110.893 -179.976 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -139.87 136.58 34.09 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.197 -0.456 . . . . 65.55 111.041 179.836 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -50.57 121.83 6.32 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.183 -0.462 . . . . 73.12 110.85 -179.912 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 95.53 -0.77 63.54 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.787 -0.721 . . . . 75.52 112.474 -179.982 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -86.27 146.04 26.69 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.753 0.311 . . . . 54.34 110.872 -179.964 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 3.2 mm -101.2 137.93 27.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.183 -0.462 . . . . 72.14 111.137 -179.99 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 1.3 m -141.49 158.96 22.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.2 -0.455 . . . . 71.43 111.13 179.873 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 67.1 m-85 -116.5 108.98 16.68 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.185 -0.462 . . . . 75.32 110.905 179.977 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 11.3 mm -72.17 103.24 1.47 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.115 -0.493 . . . . 74.02 111.139 179.986 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 3.5 m -65.06 -39.96 94.04 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.196 -0.456 . . . . 74.02 110.841 -179.88 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 34.6 p90 -174.0 147.19 1.26 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.143 -0.48 . . . . 73.21 110.95 -179.892 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 21.4 tttt -80.36 146.04 31.74 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.105 -0.498 . . . . 74.23 110.929 179.922 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 36.0 t60 -136.39 152.53 50.72 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.273 -0.421 . . . . 64.1 110.876 179.921 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -58.01 -174.71 0.43 Allowed Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.737 -0.744 . . . . 73.14 112.432 -179.893 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 58.1 mm-40 65.94 12.08 8.16 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.817 0.341 . . . . 74.35 110.899 -179.867 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 68.01 29.07 73.29 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.747 -0.739 . . . . 70.51 112.463 -179.981 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 98.7 m95 -123.19 135.97 54.54 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.792 0.329 . . . . 73.32 110.908 -179.898 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -121.8 130.22 53.24 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.224 -0.444 . . . . 75.44 110.937 179.965 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 39.9 t -78.46 111.33 15.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.197 -0.456 . . . . 72.23 111.142 179.837 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -133.15 167.75 19.78 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.169 -0.469 . . . . 54.34 111.151 179.857 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 1.1 pt-20 -119.12 156.06 30.43 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.283 -0.417 . . . . 73.5 110.901 -179.963 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -71.02 -176.55 1.41 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.125 -0.489 . . . . 72.04 110.904 -179.944 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 4.0 tm-20 -67.51 -38.32 84.11 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.159 -0.473 . . . . 73.13 110.914 179.991 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 1.3 t -57.26 -22.19 39.66 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.166 -0.47 . . . . 74.44 110.831 -179.811 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 65.71 12.89 57.95 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.733 -0.746 . . . . 72.53 112.518 -179.942 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 1.4 t -109.19 -17.31 13.88 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.954 0.407 . . . . 72.35 110.837 -179.733 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -118.89 135.26 54.66 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.121 -0.491 . . . . 72.54 110.87 179.973 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 6.4 m -136.08 144.65 45.27 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.221 -0.445 . . . . 75.25 111.132 179.936 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -166.55 -159.55 12.45 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.76 -0.733 . . . . 60.23 112.449 -180.0 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 6.4 mt -98.96 134.92 41.11 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.913 0.387 . . . . 73.32 110.934 -179.97 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 31.1 m -133.39 153.63 80.58 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-O 121.661 0.743 . . . . 74.15 111.13 179.826 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . 0.4 ' HG2' ' HB2' ' A' ' 54' ' ' PHE . 53.5 Cg_endo -69.82 142.15 46.89 Favored 'Trans proline' 0 C--N 1.341 0.167 0 C-N-CA 122.665 2.243 . . . . 74.2 112.325 -179.995 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 26.9 tt0 -89.29 -27.7 20.37 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.244 -0.434 . . . . 64.44 110.902 -179.983 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -86.22 9.86 16.36 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.15 -0.477 . . . . 74.54 110.921 -179.972 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . 0.4 ' HB2' ' HG2' ' A' ' 51' ' ' PRO . 1.1 m-85 -119.88 -13.53 9.05 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.128 -0.487 . . . . 74.01 110.875 -179.937 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 19.5 m -115.49 166.37 9.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.142 -0.481 . . . . 74.44 111.088 179.987 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 35.1 t -138.25 117.58 12.79 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.125 -0.489 . . . . 74.44 110.884 -179.835 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 2.6 m-85 -52.72 133.25 36.87 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.164 -0.471 . . . . 70.03 110.929 -179.847 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 51.8 mt -102.11 147.73 8.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.121 -0.49 . . . . 74.4 111.082 179.953 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -131.14 160.97 64.55 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 121.561 0.696 . . . . 73.42 110.953 179.879 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.77 -48.52 0.7 Allowed 'Trans proline' 0 C--N 1.341 0.149 0 C-N-CA 122.711 2.274 . . . . 70.2 112.333 179.988 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 3.5 mp0 -153.57 25.78 0.51 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.237 -0.438 . . . . 73.03 110.879 -179.95 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 8.1 mt -115.23 172.01 7.34 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.17 -0.468 . . . . 74.52 110.917 -179.984 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 23.0 mt-10 . . . . . 0 C--N 1.329 -0.291 0 CA-C-N 116.169 -0.469 . . . . 73.43 110.897 179.959 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' B' B ' -9' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.346 0 N-CA-C 112.48 -0.248 . . . . 72.31 112.48 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' B' B ' -8' ' ' LYS . . . . . . . . . . . . . 38.6 mttt -129.49 23.67 5.48 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.786 0.327 . . . . 71.12 110.847 -179.938 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' -7' ' ' PHE . . . . . . . . . . . . . 7.8 m-85 -62.58 141.25 58.56 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.259 -0.428 . . . . 74.24 110.909 179.967 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' -6' ' ' ILE . . . . . . . . . . . . . 2.1 pt -153.36 85.36 4.18 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-O 121.56 0.695 . . . . 75.44 111.136 179.998 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' -5' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.76 126.78 13.71 Favored 'Trans proline' 0 C--O 1.231 0.163 0 C-N-CA 122.649 2.233 . . . . 71.24 112.368 179.88 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' -4' ' ' SER . . . . . . . . . . . . . 30.4 t -122.04 57.94 1.04 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.255 -0.43 . . . . 73.41 110.886 -179.852 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' -3' ' ' ARG . . . . . . . . . . . . . 6.9 ptm180 -174.42 153.96 1.94 Allowed Pre-proline 0 C--N 1.329 -0.326 0 CA-C-O 121.602 0.715 . . . . 74.23 110.896 -179.928 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' -2' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.71 142.48 48.25 Favored 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.678 2.252 . . . . 74.41 112.372 179.964 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' -1' ' ' ALA . . . . . . . . . . . . . . . -75.16 154.52 86.4 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.627 0.727 . . . . 65.32 111.076 179.917 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 0' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.78 -177.35 1.84 Allowed 'Trans proline' 0 C--N 1.342 0.213 0 C-N-CA 122.679 2.253 . . . . 73.24 112.375 -179.967 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 1' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -127.56 150.76 73.8 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 121.544 0.688 . . . . 72.34 110.905 179.93 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 2' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.8 164.7 33.6 Favored 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.647 2.231 . . . . 65.54 112.393 179.87 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 3' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.71 173.81 10.38 Favored 'Trans proline' 0 C--O 1.231 0.17 0 C-N-CA 122.718 2.279 . . . . 75.14 112.38 179.938 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 4' ' ' SER . . . . . . . . . . . . . 48.1 t -104.84 87.82 2.75 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.227 -0.442 . . . . 74.03 110.838 -179.851 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 5' ' ' SER . . . . . . . . . . . . . 1.7 m -91.27 79.48 5.67 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.127 -0.488 . . . . 74.42 110.935 -179.88 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 6' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.304 0 CA-C-N 116.134 -0.485 . . . . 74.43 111.087 179.964 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' -4' ' ' MET . . . . . . . . . . . . . 4.9 ppp? . . . . . 0 C--O 1.23 0.053 0 CA-C-O 120.791 0.329 . . . . 74.35 110.861 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' -3' ' ' ALA . . . . . . . . . . . . . . . -90.02 106.16 18.29 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.188 -0.46 . . . . 73.42 111.075 179.965 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' -2' ' ' ILE . . . . . . . . . . . . . 57.1 mt -79.07 114.38 19.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.198 -0.456 . . . . 73.52 111.144 179.961 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' -1' ' ' VAL . . . . . . . . . . . . . 7.6 p -73.78 -28.66 24.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.196 -0.456 . . . . 73.34 111.117 179.827 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 1.8 t-20 63.6 54.71 1.84 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.189 -0.459 . . . . 75.22 110.865 -179.975 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 52.4 tp60 -108.7 127.2 53.78 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.17 -0.468 . . . . 74.11 110.876 -179.951 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 5.4 ptp180 -77.56 163.43 26.28 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.209 -0.45 . . . . 71.53 110.873 -179.936 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -158.37 154.73 27.46 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.202 -0.454 . . . . 63.32 111.11 179.981 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 10.8 p -105.66 150.48 8.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.242 -0.435 . . . . 73.34 111.087 179.985 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -89.26 107.86 19.29 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.166 -0.47 . . . . 71.0 111.115 179.859 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 18.4 mt -71.72 -39.25 70.26 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.247 -0.433 . . . . 64.45 110.943 -179.983 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 4.5 m-85 -140.33 152.74 46.07 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.143 -0.48 . . . . 73.32 110.943 -179.989 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 1.1 p30 -75.29 137.33 41.1 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.136 -0.483 . . . . 75.24 110.92 179.891 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 15.0 t80 -140.19 145.81 37.94 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.249 -0.432 . . . . 74.03 110.877 -179.889 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -114.55 142.7 28.61 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 121.634 0.731 . . . . 74.11 110.918 -179.94 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.78 134.21 27.39 Favored 'Trans proline' 0 C--N 1.341 0.16 0 C-N-CA 122.676 2.251 . . . . 72.24 112.336 -179.973 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 5.4 mt-10 -96.57 -16.99 20.76 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.239 -0.437 . . . . 72.22 110.872 -179.993 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 48.3 m-80 -115.55 175.77 5.37 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.165 -0.47 . . . . 61.52 110.865 -179.939 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 84.5 m-20 -88.77 13.36 12.65 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.169 -0.469 . . . . 73.04 110.854 179.972 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -135.37 21.09 3.4 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.171 -0.468 . . . . 74.22 110.869 -179.951 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 13.0 mt-10 -106.86 161.7 14.46 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.176 -0.465 . . . . 72.4 110.888 -179.989 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -111.29 143.42 42.09 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.202 -0.454 . . . . 74.11 110.899 -179.999 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 16.2 mtm180 -79.58 156.68 27.59 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.193 -0.458 . . . . 72.44 110.903 179.941 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 3.2 tp -142.93 148.78 37.47 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.217 -0.447 . . . . 74.33 110.894 -179.942 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -141.25 137.01 32.24 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.152 -0.476 . . . . 75.34 111.109 179.821 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -51.09 121.24 5.82 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.237 -0.438 . . . . 62.13 110.874 -179.899 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 97.03 -6.45 64.06 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.738 -0.744 . . . . 73.14 112.464 -179.979 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -81.04 146.39 30.67 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.76 0.314 . . . . 73.23 110.876 -179.939 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 3.3 mm -100.86 139.79 21.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.211 -0.449 . . . . 74.24 111.139 -179.975 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 1.4 m -143.12 158.17 17.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.192 -0.458 . . . . 74.52 111.104 179.841 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 55.7 m-85 -116.15 108.48 16.22 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.123 -0.49 . . . . 63.41 110.863 -179.959 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 13.4 mm -72.58 103.33 1.62 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.192 -0.458 . . . . 74.42 111.154 179.96 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 3.4 m -64.65 -39.3 93.44 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.12 -0.491 . . . . 72.15 110.897 -179.91 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 32.7 p90 -174.37 146.74 1.1 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.113 -0.494 . . . . 74.4 110.911 -179.863 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 18.7 tttt -82.51 145.73 29.62 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.138 -0.483 . . . . 75.42 110.919 179.886 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 29.8 t60 -134.88 153.08 52.19 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.236 -0.438 . . . . 74.24 110.83 179.952 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -58.52 -174.51 0.51 Allowed Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.738 -0.744 . . . . 75.32 112.532 -179.99 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 71.4 mm-40 65.94 12.15 8.21 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.864 0.364 . . . . 74.25 110.936 -179.909 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 68.16 28.62 73.27 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.735 -0.745 . . . . 64.13 112.533 -179.94 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 98.9 m95 -123.06 135.38 54.39 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.83 0.347 . . . . 74.14 110.907 -179.911 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -123.13 135.85 54.53 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.187 -0.46 . . . . 74.4 110.883 -179.963 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 39.3 t -84.43 114.9 25.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.177 -0.465 . . . . 73.43 111.145 179.814 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -136.4 168.57 19.2 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.189 -0.46 . . . . 71.53 111.15 179.838 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 1.4 pt-20 -125.64 155.01 41.47 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.211 -0.449 . . . . 72.45 110.829 -179.875 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -67.57 -175.19 0.49 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.15 -0.477 . . . . 61.43 110.87 -179.939 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 -68.9 -37.42 78.97 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.187 -0.461 . . . . 65.2 110.881 -179.962 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 1.6 t -57.02 -22.25 37.23 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.171 -0.468 . . . . 73.01 110.866 -179.816 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 66.89 12.42 59.82 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.699 -0.762 . . . . 74.1 112.489 179.986 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -109.65 -21.93 12.19 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.954 0.407 . . . . 63.21 110.871 -179.72 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -112.41 123.92 51.36 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.132 -0.485 . . . . 74.22 110.892 179.962 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 9.7 m -129.69 144.61 51.37 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.247 -0.433 . . . . 72.11 111.117 179.986 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -166.35 -159.22 11.86 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.73 -0.748 . . . . 54.31 112.462 179.98 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 13.5 mt -99.41 134.52 42.15 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.883 0.373 . . . . 73.25 110.885 -179.893 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.408 ' HB ' ' HD2' ' A' ' 51' ' ' PRO . 10.3 m -134.01 153.43 79.73 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-O 121.606 0.717 . . . . 73.4 111.104 179.908 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . 0.408 ' HD2' ' HB ' ' A' ' 50' ' ' VAL . 53.6 Cg_endo -69.8 147.56 62.88 Favored 'Trans proline' 0 N--CA 1.466 -0.134 0 C-N-CA 122.68 2.253 . . . . 75.44 112.357 179.934 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 24.6 tt0 -93.07 -28.34 16.42 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.214 -0.448 . . . . 74.4 110.902 -179.965 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 2.5 mm-40 -87.17 11.17 14.69 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.154 -0.475 . . . . 72.21 110.945 -179.963 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -121.1 -9.9 9.1 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.104 -0.498 . . . . 74.52 110.858 -179.939 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 16.2 m -119.65 166.54 13.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.186 -0.461 . . . . 75.21 111.077 -179.996 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 38.4 t -136.61 119.83 16.7 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.166 -0.47 . . . . 64.02 110.834 -179.859 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 3.1 m-85 -58.33 129.85 43.96 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.118 -0.492 . . . . 74.42 110.892 -179.895 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 39.8 mt -96.51 150.25 4.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.095 -0.502 . . . . 75.1 111.121 179.886 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 1.4 mt-30 -130.97 160.95 64.41 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 121.59 0.71 . . . . 74.21 110.874 179.965 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.76 -48.89 0.62 Allowed 'Trans proline' 0 C--N 1.341 0.169 0 C-N-CA 122.705 2.27 . . . . 74.32 112.326 179.967 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -152.64 25.26 0.58 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.215 -0.448 . . . . 71.11 110.869 -179.949 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 5.8 mt -115.71 112.2 21.71 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.142 -0.481 . . . . 74.33 110.893 -179.947 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 16.3 pt-20 . . . . . 0 C--N 1.329 -0.297 0 CA-C-N 116.179 -0.464 . . . . 75.44 110.872 179.89 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' B' B ' -9' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.301 0 N-CA-C 112.463 -0.255 . . . . 71.21 112.463 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' B' B ' -8' ' ' LYS . . . . . . . . . . . . . 25.7 ttpt -125.83 67.32 1.18 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.86 0.362 . . . . 73.32 110.951 -180.0 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' -7' ' ' PHE . . . . . . . . . . . . . 8.4 m-85 -86.26 157.61 19.89 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.205 -0.452 . . . . 74.12 110.861 -179.998 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' -6' ' ' ILE . . . . . . . . . . . . . 4.1 tp -163.66 88.12 1.21 Allowed Pre-proline 0 C--N 1.328 -0.326 0 CA-C-O 121.662 0.744 . . . . 75.31 111.158 179.922 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' -5' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.78 146.08 58.94 Favored 'Trans proline' 0 C--N 1.341 0.175 0 C-N-CA 122.7 2.267 . . . . 75.43 112.323 179.911 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' -4' ' ' SER . . . . . . . . . . . . . 29.9 t -143.81 67.79 1.28 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.197 -0.456 . . . . 65.33 110.864 -179.845 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' -3' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -179.6 154.75 0.73 Allowed Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.647 0.737 . . . . 74.52 110.855 -179.928 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' -2' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.79 119.76 6.65 Favored 'Trans proline' 0 C--N 1.342 0.188 0 C-N-CA 122.688 2.259 . . . . 74.31 112.37 179.973 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' -1' ' ' ALA . . . . . . . . . . . . . . . -55.54 151.52 20.69 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.572 0.701 . . . . 61.12 111.109 179.886 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 0' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.78 172.3 12.91 Favored 'Trans proline' 0 C--O 1.232 0.197 0 C-N-CA 122.684 2.256 . . . . 55.33 112.365 179.992 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 1' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -120.93 152.87 56.96 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-O 121.553 0.692 . . . . 71.52 110.86 179.943 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 2' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.75 164.45 34.49 Favored 'Trans proline' 0 C--N 1.341 0.151 0 C-N-CA 122.703 2.268 . . . . 74.53 112.357 179.872 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 3' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.79 -171.87 0.52 Allowed 'Trans proline' 0 C--N 1.341 0.177 0 C-N-CA 122.687 2.258 . . . . 72.14 112.313 179.97 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 4' ' ' SER . . . . . . . . . . . . . 85.2 p -137.98 151.15 47.64 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.185 -0.461 . . . . 72.14 110.86 -179.858 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 5' ' ' SER . . . . . . . . . . . . . 1.2 m 63.14 29.37 16.12 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.113 -0.494 . . . . 74.02 110.893 -179.821 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 6' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.33 -0.279 0 CA-C-N 116.103 -0.499 . . . . 73.32 111.068 179.906 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' -4' ' ' MET . . . . . . . . . . . . . 1.8 mmt . . . . . 0 C--O 1.231 0.092 0 CA-C-O 120.839 0.352 . . . . 64.53 110.885 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' -3' ' ' ALA . . . . . . . . . . . . . . . -73.75 -24.4 59.87 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.236 -0.438 . . . . 74.21 111.095 179.962 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' -2' ' ' ILE . . . . . . . . . . . . . 64.3 mt -92.27 113.11 26.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.214 -0.448 . . . . 73.45 111.127 179.959 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' -1' ' ' VAL . . . . . . . . . . . . . 9.0 p -64.97 -30.42 50.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.161 -0.472 . . . . 74.25 111.125 179.868 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 2.2 t-20 63.37 58.64 1.35 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.186 -0.461 . . . . 72.3 110.916 -179.978 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 56.6 tp60 -114.49 124.01 50.83 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.157 -0.474 . . . . 64.41 110.95 179.972 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 6.8 ptp180 -75.01 162.44 28.57 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.174 -0.466 . . . . 72.51 110.854 -179.905 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -156.59 154.05 29.59 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.189 -0.46 . . . . 55.24 111.119 179.929 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 11.3 p -105.46 148.48 9.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.225 -0.443 . . . . 75.44 111.119 179.973 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -87.4 113.46 23.13 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.165 -0.47 . . . . 71.45 111.088 179.889 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 15.0 mt -79.04 -37.37 39.19 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.186 -0.461 . . . . 74.34 110.956 179.997 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 5.1 m-85 -142.09 143.33 33.01 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.169 -0.469 . . . . 74.13 110.934 -179.967 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 3.2 p-10 -67.03 132.9 48.84 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.158 -0.474 . . . . 71.13 110.858 179.934 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 5.6 t80 -130.53 145.92 51.95 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.177 -0.465 . . . . 72.11 110.886 -179.865 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 3.8 tp10 -117.13 135.91 23.22 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.618 0.723 . . . . 74.42 110.913 -179.958 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.67 141.07 44.6 Favored 'Trans proline' 0 C--N 1.341 0.167 0 C-N-CA 122.716 2.277 . . . . 74.52 112.314 -179.971 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -105.9 -9.29 17.21 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.213 -0.449 . . . . 73.13 110.883 179.96 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 57.5 m-80 -121.66 175.75 6.07 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.18 -0.464 . . . . 73.23 110.902 -179.962 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -92.99 23.33 4.31 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.2 -0.454 . . . . 74.31 110.869 179.905 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 1.1 p-10 -140.92 13.68 2.27 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.16 -0.473 . . . . 53.44 110.864 -179.932 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 28.5 mt-10 -105.1 167.79 9.48 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.186 -0.461 . . . . 73.35 110.874 -179.976 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 30.2 tp -117.3 147.56 42.47 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.166 -0.47 . . . . 74.33 110.938 -179.996 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 1.9 mtt180 -82.68 156.63 23.72 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.21 -0.45 . . . . 73.34 110.824 179.956 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 3.2 tp -143.5 147.86 35.14 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.15 -0.477 . . . . 73.12 110.928 -179.973 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -139.64 138.7 36.33 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.167 -0.469 . . . . 74.25 111.043 179.83 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 -51.15 121.55 6.33 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.21 -0.45 . . . . 71.22 110.905 -179.945 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 96.73 -7.42 65.39 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.77 -0.728 . . . . 74.44 112.508 -179.907 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -79.49 147.73 32.12 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.811 0.338 . . . . 74.03 110.873 -179.982 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 3.2 mm -102.85 140.91 19.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.187 -0.46 . . . . 74.4 111.106 -179.966 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 1.6 m -143.04 158.15 17.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.14 -0.482 . . . . 75.54 111.139 179.803 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 43.7 m-85 -115.62 106.05 13.47 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.183 -0.462 . . . . 74.4 110.884 -179.972 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 22.3 mm -71.02 103.2 1.11 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.152 -0.476 . . . . 64.15 111.095 -179.99 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 3.4 m -64.95 -39.28 93.25 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.186 -0.461 . . . . 60.44 110.872 -179.91 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 34.1 p90 -174.32 147.52 1.18 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.111 -0.495 . . . . 71.34 110.907 -179.917 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 19.7 tttt -81.51 146.29 30.26 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.116 -0.493 . . . . 74.25 110.922 179.877 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 33.2 t60 -134.87 156.52 48.79 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.259 -0.428 . . . . 75.13 110.888 179.856 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -61.15 -174.06 1.25 Allowed Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.719 -0.753 . . . . 54.01 112.511 -179.982 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 45.4 mm-40 64.66 13.23 8.18 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.838 0.352 . . . . 74.14 110.92 -179.899 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 67.99 29.2 73.38 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.725 -0.75 . . . . 75.23 112.485 -179.986 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 98.9 m95 -123.29 138.34 54.64 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.83 0.347 . . . . 73.41 110.891 -179.881 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -126.21 132.26 51.8 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.256 -0.429 . . . . 74.54 110.93 179.964 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 51.8 t -77.38 115.75 19.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.206 -0.452 . . . . 74.22 111.143 179.858 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -133.95 158.86 42.41 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.178 -0.465 . . . . 72.33 111.092 179.886 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 1.9 pt-20 -120.5 153.55 36.51 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.2 -0.455 . . . . 63.15 110.911 -179.943 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -67.94 -175.05 0.52 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.195 -0.457 . . . . 74.13 110.892 -179.971 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -69.81 -38.41 76.59 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.153 -0.476 . . . . 75.25 110.924 179.999 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 15.4 m -56.43 -22.73 33.83 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.111 -0.495 . . . . 64.42 110.916 -179.873 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 68.85 9.27 59.13 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.755 -0.736 . . . . 62.34 112.485 -179.992 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 39.0 m -105.06 -20.21 13.59 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.983 0.421 . . . . 74.32 110.899 -179.767 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -113.24 123.67 50.73 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.092 -0.504 . . . . 74.32 110.882 179.946 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 11.4 m -134.54 127.1 30.65 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.183 -0.462 . . . . 74.52 111.1 -179.992 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -147.34 -154.36 6.2 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.725 -0.75 . . . . 72.32 112.471 179.944 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 6.9 mt -106.1 127.22 53.04 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.878 0.37 . . . . 71.13 110.897 -179.91 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.422 ' HB ' ' HD2' ' A' ' 51' ' ' PRO . 14.4 m -124.5 154.26 69.58 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-O 121.588 0.709 . . . . 70.23 111.186 179.818 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . 0.422 ' HD2' ' HB ' ' A' ' 50' ' ' VAL . 53.3 Cg_endo -69.77 147.12 62.11 Favored 'Trans proline' 0 N--CA 1.465 -0.151 0 C-N-CA 122.722 2.281 . . . . 72.14 112.316 179.997 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 27.8 tt0 -92.02 -29.86 16.37 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.234 -0.439 . . . . 74.44 110.897 -179.997 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -84.91 9.89 13.18 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.132 -0.485 . . . . 74.4 110.878 -179.916 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . 0.41 ' HB2' ' HG2' ' A' ' 51' ' ' PRO . 1.0 OUTLIER -120.78 -8.46 9.44 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.177 -0.465 . . . . 74.53 110.887 -179.901 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 20.4 m -118.86 171.98 6.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.123 -0.49 . . . . 75.02 111.115 179.996 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 35.6 t -143.59 113.51 7.18 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.175 -0.466 . . . . 74.42 110.806 -179.774 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 2.9 m-85 -52.54 133.28 35.89 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.115 -0.493 . . . . 74.21 110.922 -179.914 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 46.0 mt -102.46 148.63 7.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.099 -0.5 . . . . 75.11 111.137 179.899 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 5.0 mt-30 -131.11 160.71 65.7 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 121.632 0.729 . . . . 75.44 110.834 179.971 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.78 -48.73 0.65 Allowed 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.705 2.27 . . . . 72.21 112.348 179.993 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 6.8 pt-20 -153.54 22.15 0.54 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.156 -0.475 . . . . 74.04 110.909 179.992 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 8.0 mt -112.5 162.79 15.23 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.165 -0.47 . . . . 71.14 110.914 -179.995 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 47.5 mm-40 . . . . . 0 C--N 1.329 -0.31 0 CA-C-N 116.188 -0.46 . . . . 72.45 110.869 179.93 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' B' B ' -9' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.339 0 N-CA-C 112.475 -0.25 . . . . 65.25 112.475 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' B' B ' -8' ' ' LYS . . . . . . . . . . . . . 66.6 mttt -123.06 47.35 1.99 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.795 0.331 . . . . 75.15 110.881 -179.987 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' -7' ' ' PHE . . . . . . . . . . . . . 11.3 m-85 -92.37 119.91 32.38 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.239 -0.437 . . . . 64.44 110.876 179.989 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' -6' ' ' ILE . . . . . . . . . . . . . 8.4 tt -133.72 119.16 14.82 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 121.576 0.703 . . . . 75.42 111.171 179.974 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' -5' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.73 154.47 67.83 Favored 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 122.681 2.254 . . . . 73.24 112.318 179.92 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' -4' ' ' SER . . . . . . . . . . . . . 41.3 t -133.78 39.18 3.18 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.19 -0.459 . . . . 62.22 110.853 -179.843 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' -3' ' ' ARG . . . . . . . . . . . . . 5.9 ptm180 -174.48 154.48 1.98 Allowed Pre-proline 0 C--N 1.328 -0.334 0 CA-C-O 121.661 0.744 . . . . 74.52 110.838 -179.894 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' -2' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.79 137.9 36.46 Favored 'Trans proline' 0 C--N 1.342 0.189 0 C-N-CA 122.634 2.223 . . . . 64.33 112.334 179.996 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' -1' ' ' ALA . . . . . . . . . . . . . . . -63.39 154.74 77.84 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.519 0.676 . . . . 74.2 111.086 179.9 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 0' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.76 -170.55 0.4 Allowed 'Trans proline' 0 C--O 1.232 0.176 0 C-N-CA 122.675 2.25 . . . . 64.32 112.325 179.982 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 1' ' ' LYS . . . . . . . . . . . . . 27.8 mtpp -130.11 154.58 81.33 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-O 121.575 0.702 . . . . 73.32 110.87 179.942 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 2' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.74 165.55 30.57 Favored 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.732 2.288 . . . . 74.24 112.33 179.881 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 3' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.76 158.82 55.63 Favored 'Trans proline' 0 C--N 1.342 0.189 0 C-N-CA 122.71 2.273 . . . . 75.12 112.359 179.902 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 4' ' ' SER . . . . . . . . . . . . . 22.9 t -162.0 124.68 2.95 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.19 -0.459 . . . . 73.3 110.832 -179.863 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 5' ' ' SER . . . . . . . . . . . . . 11.5 p -127.49 126.97 43.24 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.118 -0.492 . . . . 73.33 110.821 -179.793 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 6' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.307 0 CA-C-N 116.158 -0.474 . . . . 74.11 111.078 179.924 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' -4' ' ' MET . . . . . . . . . . . . . 3.3 ttt . . . . . 0 C--O 1.23 0.075 0 CA-C-O 120.775 0.322 . . . . 75.14 110.86 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' -3' ' ' ALA . . . . . . . . . . . . . . . 57.73 64.26 1.6 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.205 -0.452 . . . . 63.42 111.102 179.932 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' -2' ' ' ILE . . . . . . . . . . . . . 4.5 mp -76.85 129.54 37.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.223 -0.444 . . . . 75.32 111.118 179.983 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' -1' ' ' VAL . . . . . . . . . . . . . 22.1 t -113.84 132.25 63.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.192 -0.458 . . . . 72.14 111.132 179.853 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 1.6 m120 -93.89 60.19 2.86 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.193 -0.458 . . . . 74.23 110.905 179.976 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 51.6 tp60 -99.38 131.16 45.59 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.137 -0.483 . . . . 73.22 110.891 -179.986 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 7.7 ptp180 -86.37 161.78 18.51 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.138 -0.483 . . . . 74.4 110.826 -179.909 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -153.3 154.46 34.63 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.154 -0.476 . . . . 74.12 111.101 179.892 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 9.2 p -103.9 153.09 6.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.226 -0.443 . . . . 75.54 111.115 179.981 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -92.06 113.68 26.02 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.149 -0.478 . . . . 60.14 111.086 179.891 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 13.5 mt -79.59 -36.1 38.63 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.211 -0.449 . . . . 74.25 110.923 -179.977 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 2.8 m-85 -144.09 146.11 32.59 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.179 -0.464 . . . . 74.02 110.941 179.995 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 1.3 p30 -68.47 135.2 51.28 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.091 -0.504 . . . . 64.32 110.869 179.909 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 7.5 t80 -134.24 146.21 49.86 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.156 -0.475 . . . . 74.54 110.87 -179.915 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 68.5 tt0 -115.15 137.59 23.06 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-O 121.66 0.743 . . . . 73.22 110.867 -179.869 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.75 137.25 35.06 Favored 'Trans proline' 0 C--N 1.341 0.155 0 C-N-CA 122.665 2.243 . . . . 75.53 112.34 -179.986 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 7.9 mm-40 -97.66 -20.2 17.78 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.222 -0.445 . . . . 62.33 110.901 -179.987 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 32.2 m-80 -115.15 175.3 5.57 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.134 -0.484 . . . . 65.11 110.869 -179.967 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 26.2 m-20 -87.25 7.97 26.15 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.181 -0.463 . . . . 64.34 110.861 179.912 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -125.13 16.76 8.45 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.23 -0.441 . . . . 75.2 110.915 -179.888 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 16.4 mt-10 -108.37 156.59 19.25 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.164 -0.471 . . . . 75.11 110.888 179.986 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -106.51 150.39 26.16 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.119 -0.491 . . . . 60.11 110.917 -179.969 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 26.1 mtm180 -85.16 153.27 22.76 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.167 -0.469 . . . . 73.3 110.852 179.976 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 1.7 tp -138.09 148.11 44.68 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.199 -0.455 . . . . 72.21 110.941 -179.968 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -140.18 139.24 35.66 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.231 -0.44 . . . . 73.55 111.147 179.786 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -50.29 119.72 3.93 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.249 -0.432 . . . . 74.4 110.88 -179.934 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 98.5 -6.86 61.28 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.773 -0.727 . . . . 61.41 112.456 179.973 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -75.78 152.78 37.29 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.792 0.329 . . . . 74.03 110.845 -179.997 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 1.3 mt -116.77 122.2 69.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.17 -0.468 . . . . 73.34 111.176 179.933 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 3.6 m -124.64 163.41 24.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.168 -0.469 . . . . 74.33 111.132 179.894 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 74.5 m-85 -116.35 110.1 18.24 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.145 -0.479 . . . . 73.2 110.853 -179.994 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 13.4 mm -71.85 103.0 1.31 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.117 -0.492 . . . . 65.22 111.106 179.955 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 5.4 m -65.53 -40.77 93.33 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.192 -0.458 . . . . 73.35 110.822 -179.904 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 33.4 p90 -174.27 149.87 1.43 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.154 -0.476 . . . . 75.34 110.958 -179.899 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 19.1 tttt -81.37 143.1 32.41 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.168 -0.469 . . . . 73.21 110.856 179.928 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 32.9 t60 -131.91 153.35 50.34 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.206 -0.452 . . . . 75.54 110.889 179.872 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -59.24 -174.69 0.69 Allowed Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.732 -0.747 . . . . 62.32 112.486 -179.932 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 29.8 mm-40 66.17 11.76 8.07 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.789 0.328 . . . . 73.43 110.88 -179.897 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 68.69 28.77 72.9 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.767 -0.73 . . . . 65.02 112.484 -179.947 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 98.0 m95 -122.9 136.36 54.83 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.744 0.307 . . . . 73.12 110.953 -179.958 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 1.4 mt -118.71 131.93 56.15 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.297 -0.411 . . . . 73.5 110.85 -179.985 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 23.4 t -81.34 109.35 15.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.151 -0.477 . . . . 73.21 111.116 179.804 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -132.71 165.4 24.59 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.16 -0.473 . . . . 75.33 111.084 179.847 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -115.93 156.32 26.42 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.216 -0.447 . . . . 71.31 110.907 -179.97 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -69.77 179.33 2.23 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.138 -0.483 . . . . 75.52 110.873 -179.904 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 61.3 tt0 -63.5 -39.8 95.4 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.223 -0.444 . . . . 71.41 110.956 179.96 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 1.5 t -55.73 -22.77 25.47 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.085 -0.507 . . . . 75.45 110.861 -179.819 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 66.15 11.87 56.47 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.754 -0.736 . . . . 72.12 112.503 -179.967 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 16.5 m -107.75 -18.72 13.75 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.969 0.414 . . . . 60.04 110.841 -179.73 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 4.0 ptmt -117.16 133.68 55.7 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.142 -0.481 . . . . 74.42 110.871 -179.999 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 4.9 m -129.26 152.68 48.56 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.259 -0.428 . . . . 72.1 111.149 179.991 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -177.35 -161.04 25.15 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.744 -0.741 . . . . 75.2 112.515 179.976 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 6.7 mt -99.53 136.89 38.79 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.833 0.349 . . . . 74.34 110.873 -179.905 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 6.0 m -135.31 153.1 77.81 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.666 0.746 . . . . 53.45 111.116 179.839 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.79 143.85 52.02 Favored 'Trans proline' 0 C--N 1.342 0.195 0 C-N-CA 122.63 2.22 . . . . 74.35 112.325 -179.999 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 10.1 tm-20 -91.0 -27.2 18.81 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.221 -0.445 . . . . 71.23 110.874 -179.972 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -87.51 11.71 14.15 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.19 -0.459 . . . . 64.51 110.871 -179.958 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 1.1 m-85 -121.23 -12.79 8.6 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.141 -0.481 . . . . 74.53 110.833 -179.895 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 17.3 m -116.69 168.73 7.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.141 -0.482 . . . . 72.4 111.14 179.988 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 45.2 t -138.83 116.52 11.43 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.172 -0.467 . . . . 74.23 110.854 -179.834 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 2.8 m-85 -51.87 134.53 31.21 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.1 -0.5 . . . . 70.43 110.909 -179.902 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 54.2 mt -104.04 146.61 11.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.087 -0.506 . . . . 74.43 111.153 179.905 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 2.5 mt-30 -131.18 160.56 66.44 Favored Pre-proline 0 C--N 1.328 -0.353 0 CA-C-O 121.576 0.703 . . . . 73.31 110.936 179.968 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.81 -48.67 0.66 Allowed 'Trans proline' 0 C--N 1.34 0.129 0 C-N-CA 122.716 2.278 . . . . 73.35 112.332 179.986 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 35.0 mt-10 -154.27 25.01 0.48 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.21 -0.45 . . . . 62.14 110.876 -179.991 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 7.1 mt -115.62 137.8 51.71 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.158 -0.473 . . . . 70.44 110.858 -179.933 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--N 1.33 -0.267 0 CA-C-N 116.17 -0.468 . . . . 74.42 110.917 179.888 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' -9' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.312 0 N-CA-C 112.489 -0.244 . . . . 74.44 112.489 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' B' B ' -8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 57.28 33.78 23.8 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.776 0.322 . . . . 74.4 110.883 -179.982 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' -7' ' ' PHE . . . . . . . . . . . . . 8.8 m-85 -67.78 144.53 55.34 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.255 -0.43 . . . . 64.43 110.886 179.965 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' -6' ' ' ILE . . . . . . . . . . . . . 4.5 tt -155.47 84.87 3.47 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-O 121.65 0.738 . . . . 74.55 111.109 179.994 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' -5' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.74 132.21 22.89 Favored 'Trans proline' 0 C--N 1.342 0.202 0 C-N-CA 122.707 2.272 . . . . 74.42 112.351 179.877 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' -4' ' ' SER . . . . . . . . . . . . . 1.4 t -129.74 64.26 1.51 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.224 -0.444 . . . . 74.51 110.866 -179.858 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' -3' ' ' ARG . . . . . . . . . . . . . 4.9 ptm180 -178.32 155.0 0.94 Allowed Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.641 0.734 . . . . 75.42 110.839 -179.91 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' -2' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.76 129.49 17.69 Favored 'Trans proline' 0 C--N 1.342 0.194 0 C-N-CA 122.654 2.236 . . . . 74.32 112.384 179.973 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' -1' ' ' ALA . . . . . . . . . . . . . . . -61.34 157.85 41.95 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-O 121.55 0.691 . . . . 73.41 111.135 179.879 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 0' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.76 -176.24 1.42 Allowed 'Trans proline' 0 C--O 1.231 0.156 0 C-N-CA 122.71 2.273 . . . . 74.34 112.345 -179.985 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 1' ' ' LYS . . . . . . . . . . . . . 37.2 tttp -131.77 137.55 30.55 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-O 121.542 0.687 . . . . 73.23 110.918 179.887 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 2' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.75 162.01 43.73 Favored 'Trans proline' 0 C--O 1.232 0.204 0 C-N-CA 122.725 2.283 . . . . 73.55 112.338 179.941 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 3' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.8 102.55 1.05 Allowed 'Trans proline' 0 C--N 1.341 0.162 0 C-N-CA 122.684 2.256 . . . . 74.33 112.347 179.954 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 4' ' ' SER . . . . . . . . . . . . . 76.3 p -57.65 115.57 2.87 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.199 -0.455 . . . . 74.22 110.868 -179.819 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 5' ' ' SER . . . . . . . . . . . . . 3.3 p -83.52 178.34 8.04 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.119 -0.491 . . . . 74.45 110.872 -179.834 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 6' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.29 0 CA-C-N 116.103 -0.498 . . . . 62.31 111.056 179.909 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' -4' ' ' MET . . . . . . . . . . . . . 2.4 mpp? . . . . . 0 C--O 1.23 0.056 0 CA-C-O 120.825 0.345 . . . . 74.32 110.859 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' -3' ' ' ALA . . . . . . . . . . . . . . . -76.66 -30.63 56.87 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.205 -0.452 . . . . 63.14 111.087 179.892 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' -2' ' ' ILE . . . . . . . . . . . . . 5.3 mp -85.6 126.41 40.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.207 -0.451 . . . . 74.51 111.142 -179.997 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' -1' ' ' VAL . . . . . . . . . . . . . 11.9 p -84.26 -27.4 7.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.192 -0.458 . . . . 73.21 111.123 179.877 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 14.1 m120 61.72 60.96 1.51 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.215 -0.448 . . . . 75.22 110.904 179.998 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 51.1 tp60 -120.29 127.26 52.21 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.186 -0.461 . . . . 71.54 110.914 -179.967 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 5.5 ptp180 -80.19 160.97 25.45 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.213 -0.448 . . . . 72.21 110.867 -179.886 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -155.42 154.43 31.91 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.204 -0.453 . . . . 75.41 111.116 179.955 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 10.7 p -104.28 149.6 7.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.258 -0.428 . . . . 74.22 111.117 -179.988 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -87.3 110.12 19.99 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.195 -0.457 . . . . 74.25 111.091 179.899 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 16.6 mt -74.2 -37.45 63.88 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.226 -0.443 . . . . 73.54 110.912 -179.941 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 5.4 m-85 -142.34 154.87 45.03 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.196 -0.456 . . . . 75.32 110.945 179.992 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 1.6 p30 -78.94 137.49 37.65 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.112 -0.495 . . . . 65.44 110.898 179.882 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 9.9 t80 -138.84 145.49 40.1 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.211 -0.45 . . . . 72.04 110.871 -179.959 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 22.5 tt0 -114.28 135.46 22.2 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 121.617 0.722 . . . . 75.11 110.891 -179.926 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.8 152.62 69.13 Favored 'Trans proline' 0 C--N 1.341 0.162 0 C-N-CA 122.702 2.268 . . . . 71.42 112.353 -179.996 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 22.4 tp10 -116.52 -20.72 9.51 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.205 -0.452 . . . . 72.21 110.898 -179.95 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 7.4 m-80 -106.53 176.04 5.3 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.14 -0.482 . . . . 71.52 110.834 -179.926 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 15.8 m-20 -92.2 21.41 5.15 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.177 -0.465 . . . . 74.34 110.851 179.923 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 1.2 p-10 -141.16 12.51 2.2 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.22 -0.445 . . . . 75.13 110.888 -179.876 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 -101.68 156.05 17.73 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.167 -0.469 . . . . 74.34 110.894 -179.985 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 31.5 tp -108.46 144.94 35.4 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.142 -0.481 . . . . 71.21 110.89 -179.949 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 14.6 mtp180 -81.18 153.09 27.4 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.215 -0.448 . . . . 74.5 110.902 179.935 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 2.6 tp -138.99 148.42 43.44 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.236 -0.438 . . . . 72.24 110.904 -179.944 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -139.92 137.23 34.63 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.197 -0.456 . . . . 72.13 111.131 179.767 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -50.7 120.03 4.37 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.234 -0.439 . . . . 74.14 110.896 -179.91 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 97.9 -5.77 61.9 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.761 -0.733 . . . . 74.24 112.482 -179.945 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -81.77 147.29 29.49 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.785 0.326 . . . . 73.22 110.861 -179.944 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 3.4 mm -100.94 142.46 15.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.224 -0.444 . . . . 73.31 111.086 -179.982 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 1.4 m -145.27 158.24 13.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.181 -0.463 . . . . 55.54 111.128 179.859 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 65.0 m-85 -116.95 108.26 15.57 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.155 -0.475 . . . . 75.1 110.892 -179.964 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 16.5 mm -71.78 103.28 1.36 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.16 -0.473 . . . . 74.22 111.125 179.975 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 11.4 m -65.4 -40.17 93.09 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.119 -0.491 . . . . 72.14 110.833 -179.902 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 36.5 p90 -174.53 150.08 1.36 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.104 -0.498 . . . . 75.42 110.892 -179.873 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 13.4 tttt -82.07 144.44 30.82 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.094 -0.503 . . . . 73.13 110.885 179.903 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 31.7 t60 -132.75 156.15 47.59 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.244 -0.434 . . . . 74.31 110.858 179.919 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -61.21 -174.31 1.34 Allowed Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.771 -0.728 . . . . 50.44 112.42 -179.926 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 63.1 mm-40 65.35 12.84 8.4 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.852 0.358 . . . . 72.33 110.946 -179.885 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 68.41 28.98 72.95 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.697 -0.763 . . . . 54.22 112.499 -179.997 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 98.8 m95 -123.45 137.54 54.77 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.857 0.36 . . . . 75.04 110.894 -179.912 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -121.9 130.47 53.38 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.215 -0.448 . . . . 75.25 110.896 179.979 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 42.8 t -77.32 116.01 20.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.175 -0.466 . . . . 74.45 111.087 179.845 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -138.05 161.79 35.83 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.18 -0.464 . . . . 71.23 111.101 179.85 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 1.2 pt-20 -113.45 156.86 22.76 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.209 -0.45 . . . . 72.52 110.867 -179.923 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -72.4 -176.26 1.82 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.13 -0.486 . . . . 74.04 110.883 -179.932 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 9.6 tt0 -68.16 -38.5 82.18 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.188 -0.46 . . . . 63.01 110.908 -179.975 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 1.5 t -57.02 -22.22 37.08 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.137 -0.483 . . . . 72.13 110.83 -179.827 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 65.8 12.77 57.84 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.737 -0.744 . . . . 75.31 112.483 -179.993 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -109.13 -15.99 14.2 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.972 0.415 . . . . 71.32 110.863 -179.779 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -120.11 135.08 55.08 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.137 -0.483 . . . . 74.0 110.941 179.949 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 5.6 m -136.36 140.28 43.15 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.252 -0.431 . . . . 73.1 111.156 179.985 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -161.8 -153.7 7.19 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.743 -0.741 . . . . 61.03 112.472 -179.997 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 9.0 mt -104.05 135.0 46.37 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.818 0.342 . . . . 75.24 110.928 -179.932 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 10.2 m -133.94 153.02 79.6 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 121.604 0.716 . . . . 72.31 111.152 179.825 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.81 147.78 63.29 Favored 'Trans proline' 0 C--N 1.341 0.161 0 C-N-CA 122.618 2.212 . . . . 75.23 112.337 180.0 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 15.5 tm-20 -92.77 -28.91 16.3 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.211 -0.45 . . . . 64.43 110.886 -179.97 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -86.59 10.55 15.14 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.15 -0.477 . . . . 62.33 110.881 -179.917 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -121.31 -4.31 9.42 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.152 -0.476 . . . . 72.44 110.852 -179.902 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 16.0 m -125.93 166.61 21.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.169 -0.468 . . . . 73.12 111.155 179.94 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 30.0 t -136.21 118.99 16.14 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.166 -0.47 . . . . 73.11 110.888 -179.836 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 -57.71 128.22 35.98 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.161 -0.472 . . . . 65.12 110.901 -179.847 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 49.6 mt -94.69 148.19 5.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.165 -0.47 . . . . 72.25 111.127 179.918 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 2.5 mt-30 -131.12 160.75 65.51 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.573 0.702 . . . . 74.41 110.957 179.923 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.77 -49.0 0.6 Allowed 'Trans proline' 0 C--N 1.341 0.162 0 C-N-CA 122.691 2.26 . . . . 73.45 112.345 -179.995 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 61.0 mt-10 -153.03 24.23 0.56 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.249 -0.432 . . . . 71.21 110.886 -179.997 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 6.8 mt -115.5 27.17 9.52 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.153 -0.476 . . . . 74.45 110.92 -179.999 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 29.5 tt0 . . . . . 0 C--N 1.329 -0.288 0 CA-C-N 116.135 -0.484 . . . . 74.43 110.852 179.897 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' B' B ' -9' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.314 0 N-CA-C 112.467 -0.253 . . . . 73.43 112.467 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' B' B ' -8' ' ' LYS . . . . . . . . . . . . . 23.2 mtmm -93.61 -44.23 8.3 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.768 0.318 . . . . 75.32 110.85 -179.954 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' -7' ' ' PHE . . . . . . . . . . . . . 18.0 m-85 -84.04 154.42 23.26 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.232 -0.44 . . . . 71.11 110.855 179.994 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' -6' ' ' ILE . . . . . . . . . . . . . 58.8 mt -149.91 93.33 3.96 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 121.59 0.71 . . . . 63.03 111.124 179.954 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' -5' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.75 122.1 8.78 Favored 'Trans proline' 0 C--O 1.232 0.178 0 C-N-CA 122.637 2.225 . . . . 61.1 112.351 179.894 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' -4' ' ' SER . . . . . . . . . . . . . 22.7 m -117.18 59.95 0.76 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.254 -0.43 . . . . 75.24 110.893 -179.868 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' -3' ' ' ARG . . . . . . . . . . . . . 8.8 ptm180 -176.69 153.36 1.15 Allowed Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 121.634 0.731 . . . . 73.3 110.867 -179.927 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' -2' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.77 145.56 57.42 Favored 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.661 2.24 . . . . 73.03 112.323 -179.964 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' -1' ' ' ALA . . . . . . . . . . . . . . . -75.93 141.92 72.18 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.567 0.699 . . . . 72.01 111.105 179.848 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 0' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.75 175.13 8.5 Favored 'Trans proline' 0 C--N 1.341 0.169 0 C-N-CA 122.712 2.275 . . . . 74.11 112.36 179.959 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 1' ' ' LYS . . . . . . . . . . . . . 16.7 ptmt -124.31 152.71 68.27 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-O 121.551 0.691 . . . . 72.25 110.93 179.891 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 2' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.7 163.54 37.83 Favored 'Trans proline' 0 C--O 1.232 0.202 0 C-N-CA 122.744 2.296 . . . . 75.24 112.349 179.877 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 3' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.71 167.96 22.87 Favored 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.741 2.294 . . . . 62.24 112.341 179.906 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 4' ' ' SER . . . . . . . . . . . . . 55.3 p -70.4 131.47 44.14 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.202 -0.453 . . . . 64.33 110.842 -179.86 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 5' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -127.85 128.21 44.81 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.139 -0.482 . . . . 63.44 110.847 -179.849 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 6' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.295 0 CA-C-N 116.115 -0.493 . . . . 72.1 111.087 179.875 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' -4' ' ' MET . . . . . . . . . . . . . 2.7 ptt? . . . . . 0 C--O 1.23 0.058 0 CA-C-O 120.777 0.322 . . . . 73.33 110.869 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' -3' ' ' ALA . . . . . . . . . . . . . . . -97.64 54.83 1.19 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.23 -0.441 . . . . 61.2 111.086 179.937 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' -2' ' ' ILE . . . . . . . . . . . . . 5.4 mp -136.5 129.25 45.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.212 -0.449 . . . . 74.21 111.139 179.997 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' -1' ' ' VAL . . . . . . . . . . . . . 14.9 p -97.35 -25.18 4.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.194 -0.457 . . . . 75.3 111.151 179.83 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 16.4 m120 60.02 60.32 2.16 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.162 -0.472 . . . . 72.52 110.892 -179.982 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 40.2 tp60 -115.41 128.49 56.09 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.148 -0.478 . . . . 74.31 110.899 -179.965 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 5.0 ptp180 -76.83 160.39 29.3 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.189 -0.46 . . . . 75.33 110.835 -179.898 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -155.33 149.83 26.17 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.208 -0.451 . . . . 62.2 111.094 179.913 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 8.7 p -105.41 142.21 19.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.25 -0.432 . . . . 70.11 111.14 179.985 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -82.94 127.74 33.81 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.178 -0.465 . . . . 70.51 111.093 179.866 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 7.6 mt -93.23 -31.68 14.65 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.221 -0.445 . . . . 73.31 110.889 -179.985 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 4.5 m-85 -144.18 136.12 26.22 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.185 -0.461 . . . . 72.33 110.924 -179.96 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 3.4 p30 -62.3 141.68 58.15 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.153 -0.476 . . . . 63.03 110.852 179.911 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 24.1 t80 -141.87 145.87 35.14 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.193 -0.458 . . . . 72.44 110.895 -179.918 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 28.6 tt0 -115.64 137.0 22.91 Favored Pre-proline 0 C--N 1.33 -0.257 0 CA-C-O 121.657 0.741 . . . . 64.04 110.912 -179.945 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.73 146.43 60.31 Favored 'Trans proline' 0 C--N 1.341 0.181 0 C-N-CA 122.687 2.258 . . . . 71.43 112.35 -179.961 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 7.3 mm-40 -107.87 -12.74 15.13 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.267 -0.424 . . . . 75.21 110.886 180.0 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 28.6 m-80 -118.98 175.48 5.74 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.185 -0.461 . . . . 75.14 110.906 -179.97 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 63.7 m-20 -90.83 15.87 10.44 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.206 -0.452 . . . . 73.52 110.833 -179.993 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 1.1 p-10 -134.08 16.74 3.81 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.192 -0.458 . . . . 72.43 110.873 -179.888 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 3.9 mm-40 -106.98 160.84 15.23 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.149 -0.478 . . . . 74.3 110.867 -179.969 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -111.44 142.86 43.15 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.147 -0.479 . . . . 75.15 110.954 179.994 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 36.2 mtm-85 -78.44 156.8 29.21 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.21 -0.45 . . . . 73.42 110.872 179.981 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 3.1 tp -141.65 148.85 39.81 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.165 -0.47 . . . . 74.52 110.914 -179.993 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -138.56 139.9 38.84 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.214 -0.448 . . . . 72.53 111.119 179.73 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -53.64 119.31 4.75 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.215 -0.448 . . . . 74.13 110.888 -179.917 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 93.16 0.83 67.54 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.726 -0.749 . . . . 55.23 112.469 -179.978 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 20.5 t70 -77.2 158.73 30.16 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.809 0.338 . . . . 75.32 110.84 -179.948 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 1.7 mm -111.14 121.32 63.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.164 -0.471 . . . . 74.4 111.168 179.996 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 3.7 m -130.59 155.7 41.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.25 -0.432 . . . . 73.24 111.16 179.827 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 66.2 m-85 -115.56 109.08 17.27 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.218 -0.446 . . . . 72.35 110.895 -179.94 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 16.5 mm -73.0 103.8 1.89 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.133 -0.485 . . . . 71.45 111.11 -179.989 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 2.6 m -64.48 -39.56 94.03 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.196 -0.456 . . . . 64.41 110.848 -179.882 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 32.5 p90 -174.1 146.79 1.19 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.124 -0.489 . . . . 74.44 110.946 -179.902 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 21.0 tttt -80.2 146.27 31.84 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.119 -0.492 . . . . 74.13 110.917 179.935 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 31.8 t60 -136.53 152.74 50.85 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.246 -0.434 . . . . 75.54 110.809 179.941 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -58.19 -174.96 0.48 Allowed Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.76 -0.733 . . . . 73.41 112.491 -179.98 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 56.4 mm-40 65.88 12.2 8.21 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.777 0.322 . . . . 74.21 110.856 -179.92 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 68.12 28.73 73.26 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.721 -0.752 . . . . 71.35 112.475 179.995 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 98.6 m95 -122.76 136.18 54.79 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.797 0.332 . . . . 72.24 110.913 -179.921 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -122.74 130.78 53.33 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.225 -0.443 . . . . 72.34 110.888 179.983 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 40.7 t -78.72 111.71 15.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.155 -0.475 . . . . 74.24 111.152 179.808 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -131.57 168.28 17.95 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.167 -0.469 . . . . 71.14 111.054 179.915 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -121.92 159.39 26.98 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.153 -0.476 . . . . 72.04 110.893 -179.931 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 41.7 p-10 -58.57 -174.82 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.131 -0.486 . . . . 74.43 110.901 -179.936 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 66.5 tt0 -78.03 -37.18 47.48 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.215 -0.448 . . . . 73.14 110.919 179.996 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 37.3 t -70.64 -22.32 62.52 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.146 -0.479 . . . . 60.15 110.892 -179.834 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 75.93 26.52 64.4 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.754 -0.736 . . . . 75.22 112.466 179.985 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 8.6 t -107.18 -20.66 13.23 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.915 0.388 . . . . 72.31 110.872 -179.753 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -127.27 137.58 52.89 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.138 -0.483 . . . . 65.41 110.893 179.924 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 20.9 m -131.27 149.68 52.47 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.193 -0.458 . . . . 74.15 111.148 179.913 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -173.5 -162.16 24.94 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.726 -0.749 . . . . 73.51 112.448 179.975 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 10.4 mt -96.67 139.18 33.12 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.815 0.341 . . . . 74.2 110.972 -179.941 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 11.5 m -137.3 152.96 74.36 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.664 0.745 . . . . 75.43 111.116 179.859 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.81 147.78 63.31 Favored 'Trans proline' 0 C--N 1.341 0.18 0 C-N-CA 122.668 2.246 . . . . 72.5 112.311 179.959 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 23.8 tt0 -93.11 -29.21 15.88 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.204 -0.453 . . . . 75.11 110.88 -179.987 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -85.72 7.97 21.57 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.149 -0.478 . . . . 71.05 110.887 -179.922 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 1.1 m-85 -119.57 3.3 11.21 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.129 -0.487 . . . . 64.22 110.865 -179.902 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 21.3 m -134.62 164.55 33.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.119 -0.492 . . . . 70.33 111.161 179.959 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 32.2 t -136.36 118.61 15.58 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.18 -0.464 . . . . 70.24 110.837 -179.885 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 3.0 m-85 -54.32 135.2 45.08 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.144 -0.48 . . . . 74.14 110.921 -179.886 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 31.0 mt -101.92 150.74 6.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.088 -0.505 . . . . 74.31 111.144 179.918 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 1.6 mt-30 -131.11 161.0 64.35 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.672 0.748 . . . . 75.1 110.907 179.93 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.76 -48.4 0.73 Allowed 'Trans proline' 0 C--N 1.342 0.219 0 C-N-CA 122.684 2.256 . . . . 74.0 112.353 -179.98 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 6.0 tp10 -153.93 26.14 0.49 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.186 -0.461 . . . . 74.22 110.886 179.999 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 7.4 mt -114.87 155.34 27.01 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.125 -0.489 . . . . 73.24 110.918 -179.978 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--N 1.329 -0.285 0 CA-C-N 116.193 -0.458 . . . . 74.55 110.851 179.921 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' -9' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.368 0 N-CA-C 112.519 -0.232 . . . . 75.33 112.519 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' B' B ' -8' ' ' LYS . . . . . . . . . . . . . 45.6 tttm -120.13 54.0 1.05 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.808 0.337 . . . . 73.25 110.931 -179.976 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' -7' ' ' PHE . . . . . . . . . . . . . 5.8 m-85 -105.1 131.64 52.35 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.231 -0.44 . . . . 73.44 110.823 -179.95 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' -6' ' ' ILE . . . . . . . . . . . . . 34.2 mm -145.45 88.57 6.58 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-O 121.673 0.749 . . . . 63.21 111.139 179.967 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' -5' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.82 130.36 19.13 Favored 'Trans proline' 0 C--N 1.342 0.192 0 C-N-CA 122.702 2.268 . . . . 74.23 112.313 179.943 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' -4' ' ' SER . . . . . . . . . . . . . 27.4 t -129.4 65.56 1.47 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.165 -0.47 . . . . 72.22 110.86 -179.819 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' -3' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -179.74 154.98 0.72 Allowed Pre-proline 0 C--N 1.329 -0.326 0 CA-C-O 121.578 0.704 . . . . 71.14 110.914 -179.931 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' -2' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.74 131.74 21.89 Favored 'Trans proline' 0 C--N 1.341 0.155 0 C-N-CA 122.686 2.257 . . . . 72.34 112.347 179.974 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' -1' ' ' ALA . . . . . . . . . . . . . . . -65.16 151.91 92.73 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-O 121.526 0.679 . . . . 75.43 111.094 179.891 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 0' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.75 176.63 6.5 Favored 'Trans proline' 0 C--O 1.232 0.181 0 C-N-CA 122.651 2.234 . . . . 74.44 112.359 -179.989 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 1' ' ' LYS . . . . . . . . . . . . . 12.3 pttp -125.57 155.07 72.7 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.543 0.687 . . . . 74.05 110.91 179.886 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 2' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -69.74 163.89 36.57 Favored 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.668 2.246 . . . . 73.25 112.35 179.863 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 3' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.74 -26.91 27.22 Favored 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.691 2.26 . . . . 75.5 112.342 179.92 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 4' ' ' SER . . . . . . . . . . . . . 15.0 t -94.19 159.03 15.32 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.267 -0.424 . . . . 71.24 110.86 -179.856 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 5' ' ' SER . . . . . . . . . . . . . 13.6 t -134.77 144.22 47.56 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.106 -0.497 . . . . 71.03 110.84 -179.828 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 6' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.33 -0.272 0 CA-C-N 116.113 -0.494 . . . . 71.42 111.086 179.897 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' -4' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.23 0.073 0 CA-C-O 120.771 0.319 . . . . 73.23 110.834 . . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' -3' ' ' ALA . . . . . . . . . . . . . . . -78.19 90.49 4.3 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.248 -0.433 . . . . 72.51 111.141 179.897 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' -2' ' ' ILE . . . . . . . . . . . . . 76.7 mt -139.65 116.48 9.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.208 -0.451 . . . . 75.01 111.119 -179.996 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' -1' ' ' VAL . . . . . . . . . . . . . 51.6 t -68.02 -30.89 49.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.163 -0.471 . . . . 72.33 111.189 179.826 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 2.4 t-20 63.05 54.03 2.21 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.126 -0.488 . . . . 65.2 110.893 -179.985 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 48.4 tp60 -109.36 123.66 49.69 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.17 -0.468 . . . . 75.44 110.932 179.964 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 5.2 ptp180 -73.87 162.99 28.52 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.172 -0.467 . . . . 73.45 110.881 -179.931 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -156.61 153.8 29.18 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.198 -0.455 . . . . 70.51 111.133 179.911 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 10.7 p -103.96 149.63 7.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.224 -0.444 . . . . 75.24 111.169 179.937 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -88.68 106.06 18.09 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.193 -0.458 . . . . 63.12 111.082 179.877 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 15.4 mt -71.33 -36.66 71.63 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.199 -0.455 . . . . 70.32 110.957 179.98 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 4.0 m-85 -143.56 152.65 41.69 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.211 -0.449 . . . . 75.25 110.886 -180.0 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 2.4 p30 -75.29 140.64 43.26 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.069 -0.514 . . . . 64.44 110.903 179.903 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 7.2 t80 -147.18 145.34 29.48 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.195 -0.457 . . . . 75.35 110.904 -179.852 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -114.06 144.61 31.93 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.641 0.734 . . . . 75.12 110.912 -179.949 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.82 148.75 65.36 Favored 'Trans proline' 0 C--N 1.341 0.144 0 C-N-CA 122.688 2.259 . . . . 63.43 112.356 -179.996 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 10.6 tp10 -109.87 -19.72 13.02 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.171 -0.468 . . . . 75.32 110.847 -179.911 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 9.2 m-80 -110.95 176.3 5.08 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.173 -0.467 . . . . 72.54 110.844 -179.905 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -90.84 21.08 4.31 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.136 -0.484 . . . . 73.51 110.918 179.884 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -142.35 13.44 1.98 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.147 -0.479 . . . . 73.33 110.896 -179.893 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 17.0 mt-10 -102.43 158.25 16.34 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.163 -0.471 . . . . 74.32 110.906 -179.981 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -105.9 155.78 19.01 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.204 -0.453 . . . . 75.15 110.909 -179.97 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -92.04 153.69 19.25 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.137 -0.483 . . . . 72.44 110.83 -179.965 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 2.3 tp -137.05 149.72 47.6 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.236 -0.438 . . . . 72.44 110.945 -179.995 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -142.9 136.9 29.1 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.207 -0.451 . . . . 75.44 111.116 179.793 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -50.15 119.98 4.09 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.235 -0.438 . . . . 75.4 110.855 -179.883 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 96.34 -0.91 62.04 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.749 -0.739 . . . . 63.24 112.473 -179.971 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -86.99 147.26 25.81 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.751 0.31 . . . . 70.02 110.853 -179.966 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 3.3 mm -102.59 142.08 17.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.221 -0.445 . . . . 73.02 111.155 179.987 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -143.22 159.45 17.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.196 -0.456 . . . . 75.01 111.145 179.876 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 44.0 m-85 -116.59 107.09 14.28 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.216 -0.447 . . . . 73.21 110.851 -179.953 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 17.6 mm -72.63 103.05 1.55 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.158 -0.474 . . . . 74.45 111.109 179.993 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 3.0 m -64.29 -39.32 93.7 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.161 -0.472 . . . . 62.3 110.861 -179.92 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 32.9 p90 -174.75 147.34 1.02 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.109 -0.496 . . . . 64.4 110.898 -179.828 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 11.9 tttm -81.45 145.98 30.48 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.09 -0.504 . . . . 64.51 110.865 179.922 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 32.1 t60 -135.68 152.04 50.8 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.211 -0.45 . . . . 75.35 110.894 179.873 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -57.78 -175.35 0.44 Allowed Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.728 -0.749 . . . . 71.21 112.511 -179.986 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 4.4 mp0 66.55 11.94 8.42 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.826 0.346 . . . . 75.54 110.869 -179.908 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 68.18 28.82 73.19 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.751 -0.738 . . . . 74.52 112.507 -179.973 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 97.8 m95 -122.74 134.95 54.43 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.796 0.332 . . . . 75.41 110.902 -179.92 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -121.73 132.61 54.72 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.241 -0.436 . . . . 64.14 110.9 179.983 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 46.1 t -79.79 109.59 14.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.207 -0.451 . . . . 73.32 111.125 179.839 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -129.46 161.65 29.9 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.199 -0.455 . . . . 73.21 111.083 179.884 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 2.3 pm0 -118.51 158.38 25.48 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.204 -0.453 . . . . 75.24 110.936 -179.98 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 46.3 p-10 -58.16 -175.08 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.166 -0.47 . . . . 75.14 110.896 -179.946 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 15.6 tm-20 -78.01 -35.44 49.9 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.176 -0.465 . . . . 64.22 110.921 -179.99 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 40.1 t -69.59 -21.89 63.56 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.131 -0.486 . . . . 62.11 110.903 -179.826 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 76.33 26.13 64.39 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.71 -0.757 . . . . 33.04 112.529 -179.968 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -111.98 -22.51 11.01 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.926 0.393 . . . . 65.1 110.881 -179.747 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 3.0 ttmt -117.89 130.24 56.12 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.135 -0.484 . . . . 73.4 110.904 179.93 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 4.6 m -127.77 150.36 49.84 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.251 -0.431 . . . . 74.54 111.163 179.927 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -177.69 -160.18 23.87 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.757 -0.735 . . . . 65.45 112.489 179.994 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 3.6 mt -102.04 141.15 35.33 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.874 0.368 . . . . 73.43 110.892 -179.95 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.431 ' HB ' ' HD2' ' A' ' 51' ' ' PRO . 16.1 m -138.11 154.5 74.17 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.611 0.719 . . . . 63.31 111.138 179.826 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . 0.431 ' HD2' ' HB ' ' A' ' 50' ' ' VAL . 53.3 Cg_endo -69.74 143.14 49.99 Favored 'Trans proline' 0 C--N 1.341 0.132 0 C-N-CA 122.708 2.272 . . . . 73.44 112.315 179.976 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 27.1 tt0 -90.5 -27.55 19.13 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.194 -0.457 . . . . 73.42 110.854 -179.947 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -86.19 9.61 17.04 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.17 -0.468 . . . . 73.41 110.923 -179.969 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 1.1 m-85 -119.85 -13.75 9.04 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.124 -0.489 . . . . 74.45 110.852 -179.912 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 21.8 m -114.7 167.45 7.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.169 -0.469 . . . . 74.31 111.113 179.967 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 42.9 t -139.23 116.27 10.98 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.167 -0.469 . . . . 72.11 110.869 -179.899 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 2.6 m-85 -53.35 133.94 40.0 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.134 -0.484 . . . . 74.33 110.951 -179.913 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 39.4 mt -102.58 150.24 6.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.109 -0.496 . . . . 73.32 111.114 179.975 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -95.31 154.97 39.31 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-O 121.607 0.718 . . . . 71.55 110.94 179.925 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.76 -47.62 0.89 Allowed 'Trans proline' 0 C--N 1.341 0.165 0 C-N-CA 122.69 2.26 . . . . 75.43 112.321 179.985 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -161.39 39.02 0.14 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.262 -0.427 . . . . 72.11 110.912 -179.969 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 17.9 mt -102.98 -173.58 2.35 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.143 -0.481 . . . . 74.25 110.892 -179.969 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 3.0 tt0 . . . . . 0 C--N 1.33 -0.259 0 CA-C-N 116.175 -0.466 . . . . 74.32 110.913 179.92 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' B' B ' -9' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.339 0 N-CA-C 112.487 -0.245 . . . . 54.4 112.487 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' B' B ' -8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -114.86 -22.09 9.8 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.769 0.318 . . . . 73.5 110.893 -179.957 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' -7' ' ' PHE . . . . . . . . . . . . . 19.6 m-85 -57.49 168.46 0.81 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.232 -0.44 . . . . 74.33 110.919 179.954 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' -6' ' ' ILE . . . . . . . . . . . . . 4.5 tt -173.52 90.05 0.37 Allowed Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 121.691 0.758 . . . . 72.54 111.118 179.996 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' -5' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.75 134.48 28.09 Favored 'Trans proline' 0 C--N 1.342 0.209 0 C-N-CA 122.662 2.241 . . . . 72.43 112.382 179.853 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' -4' ' ' SER . . . . . . . . . . . . . 33.1 t -134.37 66.5 1.54 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.214 -0.448 . . . . 74.12 110.834 -179.845 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' -3' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 179.87 155.34 0.69 Allowed Pre-proline 0 C--N 1.328 -0.34 0 CA-C-O 121.609 0.718 . . . . 75.13 110.905 -179.968 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' -2' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.8 123.14 9.79 Favored 'Trans proline' 0 N--CA 1.465 -0.187 0 C-N-CA 122.668 2.246 . . . . 74.31 112.331 -179.95 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' -1' ' ' ALA . . . . . . . . . . . . . . . -50.99 152.6 3.62 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-O 121.561 0.696 . . . . 73.31 111.1 179.886 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 0' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.76 165.15 31.94 Favored 'Trans proline' 0 C--N 1.341 0.166 0 C-N-CA 122.683 2.256 . . . . 73.52 112.367 179.959 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 1' ' ' LYS . . . . . . . . . . . . . 3.9 tppt? -116.02 135.93 22.86 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-O 121.594 0.711 . . . . 75.35 110.87 179.935 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 2' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.7 159.82 52.04 Favored 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.676 2.251 . . . . 72.52 112.337 179.856 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 3' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.78 -171.81 0.51 Allowed 'Trans proline' 0 C--N 1.342 0.212 0 C-N-CA 122.654 2.236 . . . . 74.42 112.373 179.903 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 4' ' ' SER . . . . . . . . . . . . . 57.7 m -98.33 122.77 41.91 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.228 -0.442 . . . . 73.15 110.881 -179.867 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 5' ' ' SER . . . . . . . . . . . . . 28.9 t -146.91 129.93 16.37 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.133 -0.485 . . . . 74.3 110.871 -179.824 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 6' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.307 0 CA-C-N 116.135 -0.484 . . . . 74.4 111.049 179.964 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' -4' ' ' MET . . . . . . . . . . . . . 4.0 mmt . . . . . 0 C--O 1.23 0.078 0 CA-C-O 120.763 0.316 . . . . 74.24 110.911 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' -3' ' ' ALA . . . . . . . . . . . . . . . -133.94 41.32 3.01 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.253 -0.431 . . . . 75.32 111.121 179.873 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' -2' ' ' ILE . . . . . . . . . . . . . 37.7 mm -106.24 123.18 60.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.246 -0.434 . . . . 75.2 111.127 -179.988 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' -1' ' ' VAL . . . . . . . . . . . . . 25.0 t -75.85 -36.48 32.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.2 -0.454 . . . . 74.34 111.169 179.816 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 63.84 50.07 2.71 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.177 -0.465 . . . . 74.21 110.892 179.993 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 49.4 tp60 -103.24 127.95 50.39 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.203 -0.453 . . . . 65.01 110.883 -179.978 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -73.4 158.59 34.71 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.172 -0.467 . . . . 75.21 110.878 -179.917 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -154.72 154.06 32.28 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.19 -0.459 . . . . 73.03 111.066 179.905 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 10.9 p -104.14 152.22 6.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.208 -0.451 . . . . 75.25 111.126 179.984 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -91.83 121.48 33.48 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.198 -0.456 . . . . 74.11 111.129 179.813 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 12.6 mt -85.99 -33.82 20.98 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.22 -0.445 . . . . 75.43 110.886 -179.985 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 5.1 m-85 -144.98 142.59 29.93 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.224 -0.443 . . . . 74.43 110.941 -179.979 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 1.9 p-10 -67.46 140.66 57.11 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.132 -0.486 . . . . 74.14 110.892 179.899 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 15.5 t80 -140.94 146.53 37.48 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.182 -0.463 . . . . 72.51 110.918 -179.906 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -115.58 137.37 23.13 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-O 121.632 0.73 . . . . 74.33 110.866 -179.913 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.79 151.59 68.92 Favored 'Trans proline' 0 N--CA 1.465 -0.154 0 C-N-CA 122.701 2.267 . . . . 63.11 112.373 179.987 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 4.2 mt-10 -109.69 -19.44 13.17 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.232 -0.44 . . . . 75.14 110.917 -179.995 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 48.5 m-80 -123.63 175.0 7.08 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.159 -0.473 . . . . 74.43 110.867 -179.931 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 41.5 m-20 -81.05 -1.14 42.86 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.165 -0.471 . . . . 75.25 110.867 179.937 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -112.47 16.35 19.87 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.216 -0.447 . . . . 72.13 110.885 -179.916 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 6.9 mt-10 -110.39 157.15 19.85 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.181 -0.463 . . . . 71.01 110.871 -179.964 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 41.7 tp -112.19 147.79 35.42 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.145 -0.479 . . . . 74.02 110.9 -179.994 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 32.2 mtm180 -83.17 154.76 24.11 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.196 -0.456 . . . . 75.12 110.86 179.946 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 2.3 tp -142.25 147.94 37.29 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.199 -0.455 . . . . 71.24 110.913 -179.983 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -138.07 139.45 39.54 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.185 -0.461 . . . . 43.34 111.109 179.787 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -51.71 119.58 4.35 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.234 -0.439 . . . . 75.15 110.857 -179.929 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 97.34 -6.72 63.59 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.716 -0.755 . . . . 73.23 112.458 179.987 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -71.39 160.2 33.2 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.752 0.31 . . . . 74.35 110.867 -179.921 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 1.2 mt -123.11 114.04 40.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.205 -0.452 . . . . 74.42 111.122 179.999 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 12.1 m -117.43 166.92 11.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.12 -0.491 . . . . 74.52 111.131 179.863 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 63.7 m-85 -117.95 106.26 12.76 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.167 -0.469 . . . . 73.45 110.854 -179.943 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 21.3 mm -71.62 103.58 1.38 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.15 -0.477 . . . . 75.24 111.114 179.974 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 10.5 m -65.0 -39.55 93.64 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.208 -0.451 . . . . 71.54 110.856 -179.923 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 54.0 p90 -175.41 160.95 2.66 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.116 -0.493 . . . . 75.11 110.88 -179.869 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 16.6 tttt -87.89 146.78 25.4 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.14 -0.482 . . . . 75.15 110.871 179.909 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 35.5 t60 -136.14 155.01 50.78 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.18 -0.463 . . . . 75.51 110.878 179.926 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -60.45 -175.99 1.36 Allowed Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.751 -0.737 . . . . 55.23 112.5 -179.98 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 19.0 mm100 66.53 11.66 8.22 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.898 0.38 . . . . 73.43 110.94 -179.897 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 69.36 27.96 73.06 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.704 -0.76 . . . . 71.13 112.499 -179.95 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 97.6 m95 -122.33 140.99 52.02 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.779 0.323 . . . . 74.44 110.911 -179.892 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -123.9 130.3 52.37 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.227 -0.442 . . . . 74.14 110.935 179.949 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 21.7 t -75.61 116.36 18.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.221 -0.445 . . . . 72.51 111.121 179.863 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -138.45 160.67 38.95 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.212 -0.449 . . . . 72.34 111.104 179.901 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -121.54 155.87 34.06 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.231 -0.441 . . . . 75.34 110.886 -179.916 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -66.45 -175.35 0.36 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.159 -0.473 . . . . 72.33 110.882 -179.952 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 9.7 tt0 -69.98 -38.74 76.13 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.173 -0.467 . . . . 62.51 110.93 179.996 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 2.0 t -56.83 -22.55 37.4 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.102 -0.499 . . . . 75.13 110.862 -179.782 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 66.97 11.65 58.69 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.765 -0.731 . . . . 75.44 112.476 -179.993 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 1.4 p -103.82 -21.85 13.61 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.912 0.386 . . . . 74.44 110.818 -179.745 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -117.63 123.21 45.6 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.156 -0.475 . . . . 74.53 110.89 179.964 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 9.8 m -129.93 133.83 47.08 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.188 -0.46 . . . . 75.24 111.135 179.994 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -152.43 -151.22 5.6 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.779 -0.724 . . . . 74.54 112.481 -179.995 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 18.3 mt -106.94 127.66 53.64 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.872 0.367 . . . . 73.11 110.93 -179.918 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.413 ' HB ' ' HD2' ' A' ' 51' ' ' PRO . 13.3 m -126.31 153.7 74.67 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.675 0.75 . . . . 75.21 111.1 179.872 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . 0.413 ' HD2' ' HB ' ' A' ' 50' ' ' VAL . 53.7 Cg_endo -69.79 152.54 69.16 Favored 'Trans proline' 0 C--N 1.342 0.188 0 C-N-CA 122.675 2.25 . . . . 75.45 112.352 179.955 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 13.9 tm-20 -96.21 -30.48 13.46 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.209 -0.45 . . . . 63.52 110.876 -179.952 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -85.14 8.41 18.26 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.148 -0.478 . . . . 75.15 110.892 -179.941 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -120.12 2.34 10.91 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.165 -0.471 . . . . 74.5 110.897 -179.954 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 15.8 m -132.57 170.85 19.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.162 -0.472 . . . . 71.44 111.118 179.989 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 9.6 t -143.09 120.96 11.97 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.157 -0.474 . . . . 70.11 110.855 -179.862 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 2.8 m-85 -56.82 135.18 55.62 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.129 -0.487 . . . . 73.32 110.913 -179.847 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 47.0 mt -103.51 149.04 7.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.121 -0.49 . . . . 74.12 111.111 179.938 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -130.95 160.99 64.2 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-O 121.628 0.728 . . . . 74.21 110.894 179.991 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.81 -48.28 0.74 Allowed 'Trans proline' 0 C--N 1.342 0.2 0 C-N-CA 122.694 2.262 . . . . 55.02 112.355 179.988 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 13.6 tt0 -157.09 36.41 0.29 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.235 -0.439 . . . . 73.23 110.879 179.975 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 10.0 mt -121.84 168.99 11.22 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.151 -0.477 . . . . 75.52 110.891 -179.974 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 57.8 mm-40 . . . . . 0 C--N 1.329 -0.296 0 CA-C-N 116.191 -0.459 . . . . 74.34 110.912 179.955 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' B' B ' -9' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.28 0 N-CA-C 112.466 -0.254 . . . . 75.44 112.466 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' B' B ' -8' ' ' LYS . . . . . . . . . . . . . 28.3 mmtp -98.81 -59.35 1.75 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.778 0.323 . . . . 73.52 110.885 -179.943 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' -7' ' ' PHE . . . . . . . . . . . . . 12.6 m-85 -103.67 115.51 30.63 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.236 -0.438 . . . . 75.24 110.821 -179.989 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' -6' ' ' ILE . . . . . . . . . . . . . 5.2 mp -136.43 113.27 10.23 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.65 0.738 . . . . 74.34 111.128 179.928 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' -5' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.74 160.67 48.84 Favored 'Trans proline' 0 C--N 1.341 0.158 0 C-N-CA 122.739 2.293 . . . . 75.25 112.333 179.883 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' -4' ' ' SER . . . . . . . . . . . . . 43.4 t -147.43 46.14 1.13 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.235 -0.439 . . . . 74.53 110.855 -179.84 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' -3' ' ' ARG . . . . . . . . . . . . . 1.5 ptp85 -179.32 155.15 0.78 Allowed Pre-proline 0 C--N 1.328 -0.331 0 CA-C-O 121.612 0.72 . . . . 74.53 110.861 -179.969 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' -2' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.78 129.26 17.26 Favored 'Trans proline' 0 C--N 1.341 0.148 0 C-N-CA 122.65 2.233 . . . . 73.51 112.349 -179.984 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' -1' ' ' ALA . . . . . . . . . . . . . . . -54.64 153.08 11.3 Favored Pre-proline 0 C--N 1.33 -0.266 0 CA-C-O 121.561 0.696 . . . . 75.31 111.095 179.902 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 0' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_endo -69.78 -174.74 0.97 Allowed 'Trans proline' 0 C--O 1.231 0.162 0 C-N-CA 122.707 2.271 . . . . 72.34 112.325 -179.989 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 1' ' ' LYS . . . . . . . . . . . . . 4.9 mtmp? -130.67 156.92 79.1 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 121.594 0.711 . . . . 73.24 110.887 179.904 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 2' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.8 166.12 28.73 Favored 'Trans proline' 0 C--N 1.342 0.192 0 C-N-CA 122.67 2.247 . . . . 72.43 112.365 179.879 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 3' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.71 80.74 0.85 Allowed 'Trans proline' 0 C--O 1.231 0.16 0 C-N-CA 122.666 2.244 . . . . 71.43 112.389 179.937 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 4' ' ' SER . . . . . . . . . . . . . 3.1 m -52.84 -65.83 0.49 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.238 -0.437 . . . . 74.43 110.823 -179.815 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 5' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER 56.37 40.52 29.72 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.098 -0.501 . . . . 65.23 110.849 -179.813 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 6' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.304 0 CA-C-N 116.123 -0.489 . . . . 74.33 111.084 179.888 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' -4' ' ' MET . . . . . . . . . . . . . 5.7 ttm . . . . . 0 C--O 1.231 0.093 0 CA-C-O 120.738 0.304 . . . . 70.24 110.887 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' -3' ' ' ALA . . . . . . . . . . . . . . . -108.07 27.43 9.27 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.235 -0.438 . . . . 72.41 111.111 179.919 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' -2' ' ' ILE . . . . . . . . . . . . . 56.0 mt -128.91 131.29 68.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.18 -0.464 . . . . 62.11 111.117 179.948 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' -1' ' ' VAL . . . . . . . . . . . . . 54.5 t -114.15 131.3 66.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.172 -0.467 . . . . 71.32 111.153 179.825 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 2.4 m120 -94.14 59.83 2.71 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.22 -0.446 . . . . 71.15 110.869 -179.988 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 51.2 tp60 -101.91 134.86 44.44 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.191 -0.459 . . . . 75.33 110.951 179.959 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 6.8 ptp180 -90.61 164.6 14.13 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.206 -0.452 . . . . 72.31 110.863 -179.902 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -156.48 152.58 27.56 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.185 -0.461 . . . . 74.03 111.108 179.94 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 10.9 p -104.08 151.84 6.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.231 -0.44 . . . . 73.15 111.15 179.958 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -89.25 116.85 27.79 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.143 -0.48 . . . . 74.11 111.128 179.876 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 10.2 mt -84.52 -36.68 22.02 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.241 -0.436 . . . . 75.31 110.877 -179.955 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 6.4 m-85 -140.32 136.19 32.97 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.232 -0.44 . . . . 73.45 110.952 -179.989 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 1.6 p30 -62.65 139.23 58.64 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.118 -0.492 . . . . 73.24 110.879 179.93 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 10.8 t80 -145.51 145.99 31.27 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.211 -0.45 . . . . 74.15 110.869 -179.886 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -115.96 144.69 33.24 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.674 0.749 . . . . 71.41 110.895 -179.973 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.77 140.63 43.12 Favored 'Trans proline' 0 C--N 1.341 0.158 0 C-N-CA 122.689 2.26 . . . . 70.42 112.368 179.992 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 9.9 mt-10 -101.25 -21.45 14.9 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.194 -0.457 . . . . 74.34 110.875 -179.946 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 34.1 m-80 -110.29 176.66 4.97 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.14 -0.482 . . . . 74.5 110.876 -179.923 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -91.04 20.64 4.76 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.136 -0.484 . . . . 74.3 110.902 179.871 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -140.31 15.37 2.4 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.183 -0.462 . . . . 74.21 110.908 -179.924 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 16.3 mt-10 -107.37 158.07 17.46 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.171 -0.468 . . . . 64.41 110.899 -179.981 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -104.27 161.07 14.36 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.159 -0.473 . . . . 73.32 110.853 -179.902 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -96.57 152.78 18.31 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.184 -0.462 . . . . 74.31 110.864 179.941 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 1.8 tp -137.79 149.49 46.43 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.137 -0.483 . . . . 72.52 110.91 -179.982 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -142.5 138.76 31.18 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.194 -0.457 . . . . 65.12 111.106 179.768 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -50.62 119.86 4.19 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.189 -0.46 . . . . 74.33 110.911 -179.945 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 96.7 -3.45 62.99 Favored Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.74 -0.743 . . . . 70.22 112.445 -179.979 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -84.63 146.45 27.48 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.721 0.296 . . . . 71.24 110.878 -179.943 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 3.5 mm -101.75 144.88 12.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.199 -0.455 . . . . 65.23 111.109 -179.991 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 1.5 m -146.58 158.31 10.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.148 -0.478 . . . . 72.01 111.108 179.848 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 54.3 m-85 -116.54 110.08 18.1 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.142 -0.481 . . . . 72.53 110.907 -179.995 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 14.7 mm -73.29 102.74 1.72 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.133 -0.485 . . . . 73.25 111.125 179.965 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 3.9 m -64.8 -40.35 95.08 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.196 -0.456 . . . . 74.11 110.837 -179.909 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 34.4 p90 -174.68 148.58 1.14 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.149 -0.478 . . . . 73.44 110.905 -179.926 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 13.2 tttt -81.0 145.67 31.06 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.12 -0.491 . . . . 72.41 110.887 179.943 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 33.6 t60 -134.58 153.55 51.9 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.214 -0.448 . . . . 75.43 110.852 179.89 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -59.01 -174.12 0.57 Allowed Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.717 -0.754 . . . . 63.15 112.54 -179.97 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 77.9 mm-40 65.49 12.24 8.02 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.825 0.345 . . . . 75.45 110.911 -179.886 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 68.24 29.51 73.28 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.758 -0.734 . . . . 63.12 112.505 -179.98 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 98.4 m95 -123.51 135.97 54.32 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.81 0.338 . . . . 74.43 110.95 -179.936 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 1.4 mt -119.64 132.3 55.66 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.228 -0.442 . . . . 74.12 110.918 179.986 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 60.0 t -79.27 109.11 13.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.206 -0.452 . . . . 75.31 111.15 179.825 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -129.93 163.02 27.29 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.191 -0.459 . . . . 73.31 111.11 179.924 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 1.5 pt-20 -119.02 156.4 29.7 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.232 -0.44 . . . . 74.22 110.86 -179.903 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -68.6 -175.2 0.64 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.129 -0.487 . . . . 73.32 110.877 -179.954 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 9.1 tm-20 -68.89 -37.81 79.23 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.211 -0.449 . . . . 73.14 110.883 -179.974 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 1.6 t -57.0 -22.61 39.84 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.16 -0.473 . . . . 75.33 110.869 -179.769 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 69.9 8.57 61.24 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.784 -0.722 . . . . 45.45 112.479 -179.97 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 30.9 t -108.15 -22.3 12.44 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.931 0.396 . . . . 54.01 110.86 -179.769 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 2.7 ttmt -107.09 123.84 48.81 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.13 -0.486 . . . . 75.53 110.906 179.977 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 4.3 m -125.7 152.22 45.57 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.244 -0.434 . . . . 70.51 111.142 -179.991 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -177.63 -162.42 27.71 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.746 -0.74 . . . . 54.12 112.476 179.933 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 5.8 mt -99.21 136.87 38.54 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.847 0.356 . . . . 74.05 110.966 -179.938 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 16.8 m -136.36 153.32 76.26 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-O 121.562 0.696 . . . . 73.23 111.183 179.845 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.69 143.5 51.36 Favored 'Trans proline' 0 C--N 1.341 0.152 0 C-N-CA 122.677 2.252 . . . . 72.3 112.362 179.91 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 15.5 tm-20 -90.19 -27.74 19.35 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.209 -0.45 . . . . 61.22 110.901 179.977 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 -86.31 10.44 14.84 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.134 -0.485 . . . . 71.5 110.892 -179.916 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -120.28 -9.56 9.5 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.138 -0.483 . . . . 74.24 110.898 -179.921 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 15.3 m -117.68 172.47 5.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.171 -0.468 . . . . 73.41 111.119 179.989 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 38.4 t -142.56 113.19 7.36 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.193 -0.458 . . . . 74.33 110.864 -179.885 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 3.1 m-85 -52.17 130.1 29.52 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.133 -0.485 . . . . 75.32 110.936 -179.908 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 54.5 mt -99.97 146.91 8.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.145 -0.479 . . . . 70.24 111.152 179.894 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 8.1 mt-30 -131.02 160.94 64.53 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-O 121.594 0.712 . . . . 73.23 110.903 179.942 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . 0.411 ' HG2' ' H ' ' A' ' 61' ' ' GLU . 53.8 Cg_endo -69.77 -86.58 0.0 OUTLIER 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 122.655 2.236 . . . . 73.34 112.319 -179.981 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . 0.411 ' H ' ' HG2' ' A' ' 60' ' ' PRO . 7.3 tt0 -117.37 23.64 11.66 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.188 -0.46 . . . . 74.24 110.871 -179.966 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -134.4 168.52 18.77 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.187 -0.461 . . . . 71.54 110.867 -179.949 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 . . . . . 0 C--N 1.329 -0.284 0 CA-C-N 116.147 -0.479 . . . . 72.24 110.875 179.953 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' B' B ' -9' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.315 0 N-CA-C 112.484 -0.246 . . . . 41.15 112.484 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' B' B ' -8' ' ' LYS . . . . . . . . . . . . . 18.0 mmmt -111.2 121.08 44.36 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.784 0.326 . . . . 74.41 110.912 179.994 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' -7' ' ' PHE . . . . . . . . . . . . . 15.2 m-85 -74.4 144.56 44.29 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.253 -0.43 . . . . 75.13 110.877 179.983 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' -6' ' ' ILE . . . . . . . . . . . . . 2.4 pt -153.36 85.19 4.2 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.668 0.747 . . . . 73.44 111.108 179.956 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' -5' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.82 135.92 31.53 Favored 'Trans proline' 0 C--N 1.342 0.209 0 C-N-CA 122.712 2.275 . . . . 74.34 112.317 179.917 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' -4' ' ' SER . . . . . . . . . . . . . 2.5 m -132.0 62.13 1.64 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.255 -0.429 . . . . 73.44 110.879 -179.856 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' -3' ' ' ARG . . . . . . . . . . . . . 12.8 ptt85 -174.67 153.39 1.75 Allowed Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.669 0.747 . . . . 71.53 110.87 -179.958 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' -2' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.78 128.98 16.79 Favored 'Trans proline' 0 C--N 1.342 0.201 0 C-N-CA 122.665 2.243 . . . . 73.04 112.338 -179.976 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' -1' ' ' ALA . . . . . . . . . . . . . . . -61.74 152.21 76.35 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 121.616 0.722 . . . . 62.22 111.108 179.867 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 0' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.73 -179.85 3.19 Favored 'Trans proline' 0 C--N 1.341 0.181 0 C-N-CA 122.742 2.295 . . . . 73.54 112.331 -179.95 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 1' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -126.58 155.01 75.38 Favored Pre-proline 0 C--N 1.328 -0.362 0 CA-C-O 121.624 0.726 . . . . 72.35 110.857 179.909 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 2' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.76 163.55 37.85 Favored 'Trans proline' 0 C--N 1.342 0.225 0 C-N-CA 122.661 2.241 . . . . 73.2 112.329 179.908 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 3' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.76 104.94 1.4 Allowed 'Trans proline' 0 C--N 1.341 0.166 0 C-N-CA 122.712 2.275 . . . . 71.53 112.36 179.939 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 4' ' ' SER . . . . . . . . . . . . . 15.1 m -71.53 167.36 19.86 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.214 -0.448 . . . . 72.34 110.845 -179.827 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 5' ' ' SER . . . . . . . . . . . . . 6.0 p 54.8 30.82 14.36 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.154 -0.475 . . . . 73.53 110.879 -179.815 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 6' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.297 0 CA-C-N 116.138 -0.483 . . . . 75.01 111.115 179.906 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' -4' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.098 0 CA-C-O 120.766 0.317 . . . . 71.43 110.865 . . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' -3' ' ' ALA . . . . . . . . . . . . . . . -105.37 59.08 0.67 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.221 -0.445 . . . . 75.23 111.096 179.904 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' -2' ' ' ILE . . . . . . . . . . . . . 5.3 mp -104.6 125.72 59.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.218 -0.446 . . . . 74.54 111.088 179.983 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' -1' ' ' VAL . . . . . . . . . . . . . 7.7 p -103.39 -24.35 4.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.133 -0.485 . . . . 74.11 111.133 179.857 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 13.0 m120 61.93 59.11 1.77 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.14 -0.482 . . . . 74.54 110.915 -179.969 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 29.3 tp60 -111.88 127.42 55.83 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.135 -0.484 . . . . 74.43 110.945 179.983 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 6.3 ptm180 -76.63 162.43 27.75 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.203 -0.453 . . . . 63.52 110.88 -179.908 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -154.45 154.47 33.26 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.209 -0.451 . . . . 73.42 111.124 179.962 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 9.2 p -109.1 140.58 27.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.24 -0.436 . . . . 71.52 111.135 179.99 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -77.88 122.34 25.34 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.189 -0.46 . . . . 70.44 111.099 179.883 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 16.6 mt -87.48 -34.79 18.54 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.195 -0.457 . . . . 72.34 110.914 -179.936 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 4.3 m-85 -144.58 149.86 36.5 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.161 -0.472 . . . . 73.4 110.871 -179.953 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -70.92 137.66 49.43 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.108 -0.496 . . . . 73.24 110.837 179.934 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 21.4 t80 -142.0 145.65 34.68 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.144 -0.48 . . . . 74.13 110.907 -179.916 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -119.41 137.29 25.22 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-O 121.679 0.752 . . . . 75.31 110.88 -179.929 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . 0.412 ' HG3' ' HG3' ' A' ' 19' ' ' ARG . 53.6 Cg_endo -69.78 150.84 68.64 Favored 'Trans proline' 0 C--N 1.342 0.212 0 C-N-CA 122.636 2.224 . . . . 75.42 112.361 179.962 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 17.8 tp10 -109.28 -15.78 14.2 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.177 -0.465 . . . . 51.22 110.906 -179.98 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 9.8 m-80 -115.17 176.03 5.25 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.137 -0.483 . . . . 74.32 110.911 -179.925 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -92.26 20.87 5.62 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.197 -0.456 . . . . 73.24 110.857 179.948 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 1.2 p-10 -136.46 9.1 3.15 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.189 -0.46 . . . . 74.3 110.871 -179.907 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 12.0 mt-10 -105.63 157.44 17.4 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.177 -0.465 . . . . 61.23 110.908 179.989 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 55.5 tp -107.05 156.59 18.59 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.138 -0.483 . . . . 74.31 110.934 179.999 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . 0.412 ' HG3' ' HG3' ' A' ' 12' ' ' PRO . 0.7 OUTLIER -92.75 160.68 14.85 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.192 -0.458 . . . . 72.31 110.911 179.928 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 3.5 tp -142.27 149.24 39.29 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.196 -0.456 . . . . 73.24 110.946 -179.985 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -140.12 134.43 31.27 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.229 -0.441 . . . . 73.11 111.08 179.888 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -50.4 121.12 5.23 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.211 -0.45 . . . . 75.23 110.874 -179.929 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 96.59 -3.64 63.37 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.765 -0.731 . . . . 54.21 112.478 -179.971 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -85.08 146.9 26.92 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.805 0.336 . . . . 71.41 110.839 -179.944 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 3.3 mm -100.54 141.06 18.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.152 -0.476 . . . . 73.41 111.112 -179.973 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 1.5 m -142.78 158.0 18.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.168 -0.469 . . . . 73.45 111.165 179.821 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 44.6 m-85 -115.42 106.58 14.14 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.181 -0.463 . . . . 74.14 110.86 -179.937 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 19.6 mm -72.01 103.12 1.39 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.145 -0.479 . . . . 75.13 111.128 179.957 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 3.3 m -64.48 -39.47 93.85 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.161 -0.472 . . . . 73.41 110.878 -179.934 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' TYR . . . . . 0.46 ' HH ' ' N ' ' B' ' -9' ' ' GLY . 33.4 p90 -174.53 147.85 1.14 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.111 -0.495 . . . . 71.14 110.889 -179.895 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 18.7 tttt -82.68 145.41 29.63 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.121 -0.491 . . . . 71.44 110.893 179.894 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 29.7 t60 -134.86 153.97 51.84 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.195 -0.457 . . . . 62.1 110.824 179.917 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -59.23 -174.26 0.65 Allowed Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.733 -0.746 . . . . 42.31 112.53 179.977 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 73.8 mm-40 65.59 12.44 8.23 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.803 0.335 . . . . 73.2 110.908 -179.895 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 68.22 28.82 73.16 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.721 -0.752 . . . . 73.54 112.504 -179.956 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 99.0 m95 -123.17 135.64 54.41 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.768 0.318 . . . . 73.22 110.938 -179.928 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -124.46 131.89 53.49 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.254 -0.43 . . . . 71.43 110.902 179.969 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 60.4 t -77.39 116.89 21.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.128 -0.487 . . . . 74.44 111.133 179.82 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -137.28 160.06 40.13 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.181 -0.463 . . . . 61.11 111.08 179.872 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -121.76 160.15 25.18 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.225 -0.443 . . . . 72.15 110.924 -179.976 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -71.78 -175.27 1.35 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.142 -0.481 . . . . 74.11 110.924 -179.93 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -69.61 -38.34 77.23 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.205 -0.452 . . . . 62.52 110.876 -179.97 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 1.5 t -57.1 -22.58 40.75 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.155 -0.475 . . . . 74.23 110.867 -179.794 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 66.46 12.05 57.83 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.681 -0.771 . . . . 52.33 112.516 180.0 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 12.9 m -105.24 -21.06 13.32 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.945 0.402 . . . . 74.31 110.836 -179.707 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 1.4 ttmt -118.53 123.38 44.95 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.148 -0.478 . . . . 71.22 110.889 179.948 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 11.4 m -131.62 143.02 50.01 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.228 -0.442 . . . . 72.33 111.166 179.957 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -160.71 -151.77 6.34 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.788 -0.72 . . . . 44.42 112.511 179.979 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 8.4 mt -107.03 131.69 53.79 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.862 0.363 . . . . 72.31 110.906 -179.942 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.429 ' HB ' ' HD2' ' A' ' 51' ' ' PRO . 18.3 m -129.88 154.45 81.11 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-O 121.606 0.717 . . . . 74.22 111.164 179.829 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . 0.429 ' HD2' ' HB ' ' A' ' 50' ' ' VAL . 53.6 Cg_endo -69.75 148.15 64.53 Favored 'Trans proline' 0 C--O 1.231 0.145 0 C-N-CA 122.713 2.276 . . . . 75.02 112.36 179.96 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 30.1 tt0 -93.07 -29.5 15.76 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.256 -0.429 . . . . 75.41 110.854 -179.962 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -84.39 7.33 19.93 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.199 -0.455 . . . . 74.0 110.879 -179.943 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 1.2 m-85 -120.41 3.47 10.78 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.155 -0.475 . . . . 74.14 110.862 -179.911 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 7.1 m -128.88 172.76 14.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.171 -0.468 . . . . 75.23 111.164 179.966 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 13.1 t -145.55 113.69 6.56 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.188 -0.46 . . . . 73.43 110.87 -179.828 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 2.5 m-85 -51.87 137.05 27.17 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.163 -0.471 . . . . 74.52 110.904 -179.866 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 24.6 mt -104.94 152.52 6.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.114 -0.493 . . . . 73.43 111.14 179.899 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -131.24 160.89 65.0 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-O 121.577 0.703 . . . . 75.22 110.912 179.986 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.74 -48.85 0.63 Allowed 'Trans proline' 0 C--N 1.341 0.165 0 C-N-CA 122.7 2.267 . . . . 73.1 112.357 179.94 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -151.67 21.33 0.71 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.228 -0.442 . . . . 74.31 110.889 -179.998 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 7.3 mt -111.54 169.82 8.55 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.162 -0.472 . . . . 74.45 110.892 -179.981 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 14.5 tt0 . . . . . 0 C--N 1.33 -0.25 0 CA-C-N 116.198 -0.456 . . . . 73.4 110.885 179.936 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' B' B ' -9' ' ' GLY . . . . . 0.46 ' N ' ' HH ' ' A' ' 30' ' ' TYR . . . . . . . . 0 N--CA 1.451 -0.323 0 N-CA-C 112.487 -0.245 . . . . 75.11 112.487 . . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' -8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -114.39 32.8 5.69 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.779 0.324 . . . . 74.22 110.867 -179.93 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' -7' ' ' PHE . . . . . . . . . . . . . 14.0 m-85 -128.47 114.32 16.63 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.245 -0.434 . . . . 72.0 110.89 179.989 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' -6' ' ' ILE . . . . . . . . . . . . . 60.2 mt -125.64 125.92 24.97 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 121.603 0.716 . . . . 74.12 111.147 179.971 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' -5' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.81 160.09 50.95 Favored 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.658 2.239 . . . . 74.51 112.324 179.902 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' -4' ' ' SER . . . . . . . . . . . . . 7.3 t -136.56 37.25 2.67 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.218 -0.447 . . . . 71.4 110.879 -179.855 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' -3' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -177.56 155.0 1.08 Allowed Pre-proline 0 C--N 1.33 -0.275 0 CA-C-O 121.542 0.687 . . . . 74.11 110.894 -179.919 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' -2' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.77 131.5 21.36 Favored 'Trans proline' 0 C--O 1.231 0.138 0 C-N-CA 122.682 2.254 . . . . 73.13 112.362 -179.971 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' -1' ' ' ALA . . . . . . . . . . . . . . . -55.5 154.47 12.19 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-O 121.591 0.71 . . . . 73.15 111.088 179.884 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 0' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.76 -170.24 0.38 Allowed 'Trans proline' 0 C--N 1.342 0.194 0 C-N-CA 122.66 2.24 . . . . 74.35 112.391 179.959 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 1' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -134.17 148.93 69.94 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-O 121.561 0.696 . . . . 73.3 110.946 179.887 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 2' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.8 163.35 38.63 Favored 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.699 2.266 . . . . 63.0 112.352 179.891 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 3' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.7 -178.89 2.53 Favored 'Trans proline' 0 C--N 1.342 0.198 0 C-N-CA 122.68 2.254 . . . . 72.3 112.367 179.971 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 4' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 51.67 53.31 12.94 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.236 -0.438 . . . . 62.41 110.891 -179.83 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 5' ' ' SER . . . . . . . . . . . . . 2.0 m -64.27 127.0 29.56 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.151 -0.477 . . . . 71.23 110.883 -179.834 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 6' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.33 -0.279 0 CA-C-N 116.131 -0.486 . . . . 75.31 111.123 179.899 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' -4' ' ' MET . . . . . . . . . . . . . 1.7 mpt? . . . . . 0 C--O 1.231 0.084 0 CA-C-O 120.758 0.313 . . . . 74.11 110.901 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' -3' ' ' ALA . . . . . . . . . . . . . . . 59.3 37.18 23.63 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.232 -0.44 . . . . 70.34 111.103 179.905 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' -2' ' ' ILE . . . . . . . . . . . . . 69.7 mt -133.31 119.56 35.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.243 -0.435 . . . . 75.31 111.17 -179.966 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' -1' ' ' VAL . . . . . . . . . . . . . 26.1 t -108.17 129.25 62.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.243 -0.435 . . . . 73.41 111.159 179.87 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 2.1 m-80 -91.29 60.87 4.31 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.177 -0.465 . . . . 71.31 110.884 -179.983 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 33.0 tp60 -96.7 127.31 42.55 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.211 -0.45 . . . . 73.24 110.902 -179.993 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 5.6 ptp180 -80.7 162.05 24.32 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.216 -0.447 . . . . 74.03 110.863 -179.931 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -155.1 149.96 26.67 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.176 -0.465 . . . . 72.53 111.069 179.932 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 7.3 p -105.83 137.98 33.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.21 -0.45 . . . . 72.33 111.133 179.967 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -78.56 128.3 33.33 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.216 -0.447 . . . . 75.21 111.047 179.91 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 10.5 mt -93.32 -31.89 14.51 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.153 -0.476 . . . . 75.12 110.922 179.986 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 3.8 m-85 -144.37 135.91 25.71 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.193 -0.458 . . . . 74.34 110.934 179.995 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -60.11 149.58 32.17 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.122 -0.49 . . . . 75.51 110.899 179.883 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 30.7 t80 -149.01 147.1 28.16 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.181 -0.463 . . . . 74.32 110.881 -179.871 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 8.5 tm-20 -117.0 134.56 22.98 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 121.649 0.738 . . . . 72.13 110.913 -179.971 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.76 141.57 45.56 Favored 'Trans proline' 0 C--O 1.232 0.19 0 C-N-CA 122.665 2.243 . . . . 73.45 112.353 -179.99 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 13.8 mp0 -102.99 -20.01 14.37 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.249 -0.432 . . . . 71.13 110.927 -179.997 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 34.1 m-80 -111.29 175.7 5.32 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.123 -0.49 . . . . 74.4 110.848 -179.936 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -92.37 19.59 6.98 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.172 -0.467 . . . . 74.11 110.888 179.886 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -135.35 10.92 3.51 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.245 -0.434 . . . . 73.34 110.848 -179.886 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 6.3 mm-40 -101.53 164.39 11.78 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.204 -0.453 . . . . 70.43 110.904 179.977 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 19.3 tp -115.71 141.52 47.97 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.129 -0.487 . . . . 74.51 110.885 -179.935 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 31.5 mtm180 -75.24 155.17 37.06 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.165 -0.471 . . . . 65.51 110.886 179.951 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 3.5 tp -140.7 149.58 42.37 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.213 -0.448 . . . . 71.43 110.889 -179.947 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -139.98 139.76 36.13 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.199 -0.455 . . . . 75.34 111.099 179.786 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -53.91 119.24 4.76 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.194 -0.457 . . . . 63.12 110.917 -179.919 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 93.49 0.19 67.46 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.769 -0.729 . . . . 64.11 112.484 -179.969 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 23.8 t0 -76.88 159.24 30.19 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.798 0.333 . . . . 72.5 110.909 -179.986 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 1.7 mm -110.92 123.1 66.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.154 -0.475 . . . . 75.31 111.109 -179.969 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 3.6 m -132.26 152.82 37.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.166 -0.47 . . . . 74.15 111.121 179.878 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 68.9 m-85 -112.82 109.02 18.22 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.183 -0.462 . . . . 72.41 110.882 -179.976 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 19.0 mm -72.32 103.02 1.45 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.086 -0.506 . . . . 71.44 111.131 -179.997 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 2.9 m -64.59 -40.09 94.9 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.167 -0.47 . . . . 70.31 110.864 -179.893 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 31.7 p90 -173.91 146.09 1.18 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.139 -0.482 . . . . 73.03 110.916 -179.861 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 19.2 tttt -79.87 147.26 31.79 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.148 -0.478 . . . . 75.44 110.925 179.871 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 32.3 t60 -137.4 154.54 49.96 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.227 -0.442 . . . . 70.52 110.85 179.939 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -59.37 -175.02 0.76 Allowed Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.746 -0.74 . . . . 73.12 112.494 -179.95 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 24.0 mm100 65.61 12.78 8.49 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.844 0.354 . . . . 74.44 110.93 -179.89 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 68.14 27.74 73.6 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.691 -0.766 . . . . 75.33 112.475 -179.991 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 98.5 m95 -122.01 137.42 54.81 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.82 0.343 . . . . 75.55 110.948 -179.915 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -125.18 130.52 52.31 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.255 -0.429 . . . . 74.51 110.934 179.982 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 44.1 t -77.27 115.16 18.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.164 -0.471 . . . . 74.45 111.132 179.878 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -137.0 166.16 24.31 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.133 -0.485 . . . . 74.53 111.12 179.919 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -117.62 156.68 27.74 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.233 -0.44 . . . . 74.51 110.886 -179.937 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -71.36 -176.85 1.61 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.151 -0.477 . . . . 70.21 110.852 -179.933 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 20.5 tt0 -67.45 -38.47 84.55 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.124 -0.489 . . . . 71.41 110.921 179.984 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 1.3 t -57.19 -22.14 38.41 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.144 -0.48 . . . . 75.45 110.847 -179.789 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 65.93 12.59 57.67 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.682 -0.771 . . . . 75.44 112.48 -179.995 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 13.4 t -109.42 -15.61 14.19 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.932 0.396 . . . . 74.25 110.885 -179.738 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 7.1 ptmt -119.98 134.85 55.12 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.127 -0.488 . . . . 75.24 110.912 179.935 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 6.4 m -135.06 143.72 46.86 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.252 -0.431 . . . . 71.34 111.162 179.969 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -164.68 -154.94 8.16 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.694 -0.765 . . . . 64.03 112.482 179.972 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 6.7 mt -104.8 129.41 53.09 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.849 0.357 . . . . 75.31 110.889 -179.89 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.43 ' HB ' ' HD2' ' A' ' 51' ' ' PRO . 16.8 m -127.73 154.25 77.89 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.666 0.746 . . . . 72.44 111.095 179.836 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . 0.43 ' HD2' ' HB ' ' A' ' 50' ' ' VAL . 53.5 Cg_endo -69.77 149.45 66.85 Favored 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.666 2.244 . . . . 72.53 112.326 179.962 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 28.3 tt0 -94.36 -30.17 14.64 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.231 -0.44 . . . . 64.32 110.925 -179.983 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -85.24 7.72 21.06 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.093 -0.503 . . . . 74.02 110.899 -179.942 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 1.2 m-85 -119.29 4.57 11.25 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.126 -0.488 . . . . 74.44 110.908 -179.95 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 14.8 m -134.4 164.11 35.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.121 -0.49 . . . . 74.41 111.132 179.975 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 25.7 t -136.24 117.27 14.32 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.222 -0.444 . . . . 75.22 110.869 -179.85 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 2.9 m-85 -52.1 136.95 28.75 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.108 -0.496 . . . . 74.43 110.944 -179.892 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 32.1 mt -104.64 150.32 7.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.146 -0.479 . . . . 75.22 111.102 179.938 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 2.7 mt-30 -131.14 160.8 65.33 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-O 121.611 0.72 . . . . 73.43 110.95 179.914 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.72 -48.63 0.69 Allowed 'Trans proline' 0 C--N 1.341 0.159 0 C-N-CA 122.711 2.274 . . . . 74.34 112.32 -179.966 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -159.27 25.78 0.2 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.221 -0.445 . . . . 72.24 110.891 -179.956 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 11.4 mt -110.4 155.39 22.24 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.155 -0.475 . . . . 65.15 110.908 -179.981 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 10.9 tt0 . . . . . 0 C--N 1.329 -0.287 0 CA-C-N 116.188 -0.46 . . . . 72.22 110.892 179.942 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' B' B ' -9' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.351 0 N-CA-C 112.449 -0.26 . . . . 61.52 112.449 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' B' B ' -8' ' ' LYS . . . . . . . . . . . . . 14.7 mmmt -55.27 -55.26 33.41 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.787 0.327 . . . . 75.13 110.905 -179.985 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' -7' ' ' PHE . . . . . . . . . . . . . 8.4 m-85 -66.81 171.08 5.64 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.223 -0.444 . . . . 71.4 110.853 179.983 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' -6' ' ' ILE . . . . . . . . . . . . . 3.8 tp -175.89 91.28 0.28 Allowed Pre-proline 0 C--N 1.328 -0.333 0 CA-C-O 121.634 0.731 . . . . 74.41 111.107 179.989 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' -5' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.79 139.4 40.03 Favored 'Trans proline' 0 C--N 1.341 0.156 0 C-N-CA 122.677 2.252 . . . . 74.44 112.344 179.868 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' -4' ' ' SER . . . . . . . . . . . . . 2.6 m -132.55 62.45 1.65 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.212 -0.449 . . . . 64.2 110.877 -179.839 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' -3' ' ' ARG . . . . . . . . . . . . . 13.6 ptp180 -179.63 155.41 0.75 Allowed Pre-proline 0 C--N 1.329 -0.32 0 CA-C-O 121.592 0.71 . . . . 71.1 110.852 -179.928 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' -2' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.72 135.42 30.49 Favored 'Trans proline' 0 C--N 1.341 0.169 0 C-N-CA 122.724 2.283 . . . . 75.42 112.33 179.995 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' -1' ' ' ALA . . . . . . . . . . . . . . . -68.15 153.02 96.04 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.615 0.722 . . . . 75.21 111.085 179.877 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 0' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_endo -69.81 174.63 9.27 Favored 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.672 2.248 . . . . 73.15 112.342 -179.954 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 1' ' ' LYS . . . . . . . . . . . . . 16.5 pttm -122.63 153.21 62.86 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.526 0.679 . . . . 74.12 110.933 179.887 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 2' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.76 164.16 35.58 Favored 'Trans proline' 0 C--O 1.232 0.19 0 C-N-CA 122.659 2.239 . . . . 73.23 112.385 179.901 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 3' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.71 -23.24 31.23 Favored 'Trans proline' 0 C--O 1.231 0.157 0 C-N-CA 122.692 2.261 . . . . 71.51 112.356 179.955 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 4' ' ' SER . . . . . . . . . . . . . 7.5 p -59.05 156.86 11.09 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.209 -0.451 . . . . 61.32 110.896 -179.885 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 5' ' ' SER . . . . . . . . . . . . . 42.0 p -64.92 -41.44 95.54 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.127 -0.488 . . . . 73.53 110.875 -179.815 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 6' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.321 0 CA-C-N 116.182 -0.463 . . . . 74.14 111.078 179.893 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' -4' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.232 0.136 0 CA-C-O 120.775 0.321 . . . . 74.54 110.885 . . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' -3' ' ' ALA . . . . . . . . . . . . . . . -127.64 63.37 1.37 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.269 -0.423 . . . . 63.41 111.094 179.93 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' -2' ' ' ILE . . . . . . . . . . . . . 4.3 mp -121.59 126.72 75.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.206 -0.452 . . . . 73.21 111.116 179.982 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' -1' ' ' VAL . . . . . . . . . . . . . 25.3 t -109.72 131.8 59.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.207 -0.451 . . . . 74.43 111.125 179.828 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 5.3 m-80 -92.3 60.02 3.58 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.16 -0.473 . . . . 74.03 110.913 179.958 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 56.5 tp60 -99.48 128.77 45.61 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.192 -0.458 . . . . 72.23 110.895 -179.977 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -83.43 163.9 20.25 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.2 -0.455 . . . . 73.31 110.843 -179.938 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -154.58 152.25 29.8 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.168 -0.469 . . . . 72.55 111.086 179.958 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 10.0 p -104.13 149.08 8.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.262 -0.427 . . . . 71.34 111.15 179.975 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -90.4 117.78 29.37 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.218 -0.446 . . . . 64.04 111.105 179.873 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 7.0 mt -84.52 -35.69 22.7 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.255 -0.429 . . . . 73.52 110.905 -179.963 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 5.4 m-85 -140.75 136.89 32.98 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.185 -0.461 . . . . 75.11 110.909 -179.96 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -64.06 137.88 58.19 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.076 -0.511 . . . . 65.3 110.91 179.924 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 18.5 t80 -137.33 145.37 43.29 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.204 -0.453 . . . . 70.35 110.851 -179.878 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 7.0 tt0 -115.69 136.13 22.78 Favored Pre-proline 0 C--N 1.33 -0.261 0 CA-C-O 121.671 0.748 . . . . 72.22 110.86 -179.925 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . 0.408 ' HD3' ' HA ' ' A' ' 19' ' ' ARG . 53.7 Cg_endo -69.74 143.94 52.53 Favored 'Trans proline' 0 C--N 1.342 0.189 0 C-N-CA 122.718 2.279 . . . . 73.1 112.29 179.999 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -107.38 -7.51 16.63 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.21 -0.45 . . . . 71.43 110.873 179.965 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 59.3 m-80 -124.5 175.78 6.93 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.196 -0.457 . . . . 70.24 110.893 -179.95 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 8.9 p30 -93.58 24.2 4.18 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.205 -0.452 . . . . 64.12 110.887 179.917 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 1.2 p-10 -139.97 11.82 2.43 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.163 -0.471 . . . . 74.3 110.873 -179.899 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 10.0 mm-40 -106.38 163.35 12.92 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.186 -0.461 . . . . 70.12 110.864 -179.978 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 20.7 tp -113.02 142.64 45.48 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.134 -0.485 . . . . 72.44 110.896 -179.951 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . 0.408 ' HA ' ' HD3' ' A' ' 12' ' ' PRO . 6.6 mtp85 -79.03 153.45 30.23 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.192 -0.458 . . . . 75.42 110.89 179.94 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 2.3 tp -138.55 149.07 44.94 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.192 -0.458 . . . . 75.35 110.901 -179.973 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -140.7 139.76 34.78 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.205 -0.452 . . . . 72.42 111.151 179.766 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -50.62 122.85 7.78 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.222 -0.445 . . . . 75.33 110.865 -179.885 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 97.18 -13.48 64.67 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.777 -0.725 . . . . 73.32 112.478 -179.994 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -71.53 149.07 46.11 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.796 0.332 . . . . 72.12 110.87 -179.982 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 1.7 mt -116.62 119.83 63.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.182 -0.463 . . . . 74.41 111.093 -179.955 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 6.4 m -119.14 165.76 14.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.129 -0.487 . . . . 73.42 111.125 179.851 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 46.7 m-85 -114.47 106.92 14.85 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.145 -0.479 . . . . 72.34 110.869 -179.949 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 17.6 mm -70.71 102.91 1.01 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.187 -0.461 . . . . 74.31 111.136 179.967 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 3.6 m -65.19 -39.57 93.03 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.127 -0.488 . . . . 72.52 110.856 -179.898 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 32.1 p90 -174.38 146.83 1.1 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.162 -0.472 . . . . 74.13 110.876 -179.88 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 18.7 tttt -80.77 146.17 31.12 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.122 -0.49 . . . . 74.02 110.906 179.886 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 33.7 t60 -135.27 155.97 49.75 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.223 -0.444 . . . . 74.53 110.86 179.899 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -60.84 -174.22 1.14 Allowed Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.754 -0.736 . . . . 74.33 112.519 -179.967 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 41.9 mm-40 64.79 13.21 8.3 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.859 0.362 . . . . 74.24 110.9 -179.914 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 67.94 28.98 73.3 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.715 -0.755 . . . . 74.53 112.489 -179.969 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 98.7 m95 -122.82 138.11 54.74 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.766 0.317 . . . . 74.12 110.909 -179.871 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -125.96 130.47 51.3 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.25 -0.432 . . . . 74.5 110.931 179.934 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 41.7 t -77.2 115.21 18.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.186 -0.461 . . . . 75.02 111.095 179.868 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -135.54 163.53 29.89 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.187 -0.46 . . . . 72.4 111.09 179.86 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 1.6 pm0 -121.58 160.49 24.23 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.211 -0.449 . . . . 70.51 110.826 -179.928 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 43.4 p-10 -58.91 -174.8 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.088 -0.505 . . . . 74.22 110.893 -179.94 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 15.2 tt0 -78.43 -38.63 40.9 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.188 -0.46 . . . . 75.12 110.914 179.998 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 4.4 m -68.73 -22.55 64.32 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.134 -0.485 . . . . 72.32 110.847 -179.785 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 76.61 26.76 62.38 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.704 -0.76 . . . . 71.33 112.52 -179.977 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 3.5 m -105.48 -22.19 13.06 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.946 0.403 . . . . 73.32 110.875 -179.717 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -125.68 138.05 53.87 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.122 -0.49 . . . . 73.21 110.928 179.904 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 30.7 m -136.8 143.89 43.4 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.243 -0.435 . . . . 70.5 111.149 179.976 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -167.74 -155.62 9.44 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.736 -0.745 . . . . 63.32 112.513 179.938 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 7.0 mt -103.57 132.19 50.04 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.828 0.347 . . . . 73.5 110.908 -179.922 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.404 ' HB ' ' HD2' ' A' ' 51' ' ' PRO . 6.7 m -129.53 153.47 80.67 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 121.592 0.711 . . . . 74.32 111.161 179.85 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . 0.404 ' HD2' ' HB ' ' A' ' 50' ' ' VAL . 54.0 Cg_endo -69.73 150.76 68.82 Favored 'Trans proline' 0 C--N 1.341 0.147 0 C-N-CA 122.741 2.294 . . . . 74.21 112.318 179.968 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 28.2 tt0 -95.74 -28.89 14.56 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.186 -0.461 . . . . 64.14 110.833 -179.982 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -87.3 11.08 15.2 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.195 -0.457 . . . . 70.5 110.907 -179.909 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -121.01 -8.15 9.38 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.122 -0.49 . . . . 74.24 110.891 -179.931 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 12.3 m -120.02 172.84 6.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.154 -0.475 . . . . 75.35 111.153 -179.998 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 3.3 t -143.25 114.3 7.77 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.195 -0.457 . . . . 62.55 110.882 -179.868 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 2.6 m-85 -52.33 127.11 21.14 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.131 -0.486 . . . . 75.33 110.912 -179.868 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 42.6 mt -94.85 149.94 4.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.122 -0.49 . . . . 74.33 111.17 179.887 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -96.92 154.6 38.2 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.601 0.715 . . . . 74.44 110.933 179.951 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.72 -48.56 0.7 Allowed 'Trans proline' 0 C--N 1.341 0.157 0 C-N-CA 122.726 2.284 . . . . 72.22 112.352 179.992 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 18.9 tt0 -161.73 35.31 0.13 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.221 -0.445 . . . . 74.44 110.854 -179.978 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 14.4 mt -98.8 -179.76 4.39 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.165 -0.47 . . . . 74.44 110.906 179.993 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 75.3 mt-10 . . . . . 0 C--N 1.33 -0.262 0 CA-C-N 116.196 -0.457 . . . . 72.12 110.855 179.969 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' B' B ' -9' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.32 0 N-CA-C 112.518 -0.233 . . . . 73.24 112.518 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' B' B ' -8' ' ' LYS . . . . . . . . . . . . . 17.8 mmmt -121.17 -49.57 2.17 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.816 0.341 . . . . 74.52 110.904 -179.975 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' -7' ' ' PHE . . . . . . . . . . . . . 10.8 m-85 -108.2 124.0 49.61 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.18 -0.464 . . . . 73.55 110.93 179.979 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' -6' ' ' ILE . . . . . . . . . . . . . 5.9 tt -138.78 119.3 9.79 Favored Pre-proline 0 C--N 1.328 -0.35 0 CA-C-O 121.615 0.721 . . . . 74.53 111.131 179.985 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' -5' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.82 154.26 67.72 Favored 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.674 2.249 . . . . 75.2 112.372 179.862 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' -4' ' ' SER . . . . . . . . . . . . . 45.2 t -132.45 41.89 3.16 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.246 -0.434 . . . . 71.24 110.877 -179.834 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' -3' ' ' ARG . . . . . . . . . . . . . 1.5 ptm180 -177.45 155.05 1.1 Allowed Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 121.618 0.723 . . . . 75.12 110.886 -179.952 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' -2' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.78 134.37 27.79 Favored 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.68 2.254 . . . . 74.4 112.35 -179.968 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' -1' ' ' ALA . . . . . . . . . . . . . . . -57.99 154.09 30.71 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 121.575 0.702 . . . . 44.35 111.098 179.887 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 0' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.78 -173.3 0.69 Allowed 'Trans proline' 0 C--N 1.342 0.2 0 C-N-CA 122.644 2.229 . . . . 73.52 112.35 -179.986 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 1' ' ' LYS . . . . . . . . . . . . . 33.8 mtpt -127.61 155.77 76.48 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-O 121.628 0.728 . . . . 74.41 110.875 179.908 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 2' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.79 165.07 32.23 Favored 'Trans proline' 0 C--N 1.342 0.21 0 C-N-CA 122.643 2.229 . . . . 74.11 112.351 179.912 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 3' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.79 -41.87 3.86 Favored 'Trans proline' 0 C--N 1.341 0.176 0 C-N-CA 122.686 2.258 . . . . 64.53 112.323 179.991 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 4' ' ' SER . . . . . . . . . . . . . 41.2 m -88.06 136.12 33.11 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.206 -0.452 . . . . 65.13 110.852 -179.836 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 5' ' ' SER . . . . . . . . . . . . . 1.8 t -126.25 102.03 7.0 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.146 -0.479 . . . . 75.55 110.873 -179.847 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 6' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.33 -0.282 0 CA-C-N 116.156 -0.474 . . . . 74.13 111.114 179.881 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' -4' ' ' MET . . . . . . . . . . . . . 40.3 mtp . . . . . 0 C--O 1.23 0.054 0 CA-C-O 120.762 0.315 . . . . 64.12 110.854 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' -3' ' ' ALA . . . . . . . . . . . . . . . -80.84 -32.86 34.92 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.234 -0.439 . . . . 54.44 111.134 179.898 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' -2' ' ' ILE . . . . . . . . . . . . . 85.0 mt -60.76 117.79 2.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.154 -0.475 . . . . 74.01 111.138 179.981 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' -1' ' ' VAL . . . . . . . . . . . . . 61.8 t -61.0 -34.88 61.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.174 -0.466 . . . . 72.33 111.142 179.89 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 2.6 t-20 63.82 45.19 4.52 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.172 -0.467 . . . . 71.31 110.896 180.0 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 32.8 tp60 -109.51 134.06 52.35 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.168 -0.469 . . . . 73.24 110.931 179.965 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 3.2 ptt-85 -84.15 162.4 20.26 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.213 -0.449 . . . . 73.13 110.858 -179.934 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -155.21 150.86 27.47 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.146 -0.479 . . . . 73.42 111.139 179.937 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 11.0 p -104.07 146.31 11.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.229 -0.441 . . . . 74.23 111.133 -179.991 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -84.82 111.14 19.37 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.187 -0.461 . . . . 72.23 111.099 179.88 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 13.9 mt -76.42 -37.04 57.67 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.244 -0.435 . . . . 73.14 110.888 -179.946 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 4.0 m-85 -142.22 147.03 35.86 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.223 -0.444 . . . . 73.32 110.911 -179.96 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 3.5 p-10 -70.47 138.98 51.59 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.125 -0.489 . . . . 74.23 110.864 179.899 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 5.3 t80 -143.82 144.62 31.86 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.215 -0.448 . . . . 73.54 110.878 -179.89 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -112.98 145.2 32.58 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-O 121.688 0.756 . . . . 73.41 110.83 -179.892 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.81 139.7 40.68 Favored 'Trans proline' 0 C--N 1.342 0.226 0 C-N-CA 122.657 2.238 . . . . 74.41 112.347 179.985 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -101.37 -17.09 16.67 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.21 -0.45 . . . . 73.34 110.92 -179.984 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 31.0 m-80 -116.26 176.53 5.06 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.104 -0.498 . . . . 75.21 110.923 -179.953 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 17.7 m-20 -91.51 21.55 4.54 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.218 -0.446 . . . . 61.24 110.894 179.907 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -141.97 17.52 2.12 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.191 -0.459 . . . . 72.03 110.867 -179.879 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 24.1 mt-10 -107.39 165.6 11.27 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.192 -0.458 . . . . 75.43 110.86 -179.976 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 28.7 tp -114.12 148.93 36.37 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.139 -0.482 . . . . 74.35 110.895 -179.931 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -84.8 156.18 21.47 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.2 -0.454 . . . . 75.11 110.807 179.99 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 3.1 tp -140.26 150.17 43.75 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.131 -0.486 . . . . 74.53 110.932 179.984 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -141.42 137.29 32.12 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.191 -0.459 . . . . 64.43 111.102 179.827 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -50.79 121.88 6.54 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.265 -0.425 . . . . 72.11 110.867 -179.928 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 96.28 -6.51 66.05 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.697 -0.763 . . . . 64.44 112.476 -179.956 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -81.46 146.44 30.23 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.85 0.357 . . . . 75.01 110.838 -179.908 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 3.3 mm -100.81 142.52 15.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.186 -0.461 . . . . 73.23 111.165 179.999 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 1.4 m -144.95 158.55 13.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.155 -0.475 . . . . 75.13 111.09 179.918 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 51.6 m-85 -117.3 109.57 17.01 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.154 -0.476 . . . . 73.45 110.882 179.988 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 12.1 mm -73.11 102.7 1.63 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.113 -0.494 . . . . 74.43 111.082 -179.992 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 43.3 m -64.76 -39.57 93.83 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.159 -0.473 . . . . 71.31 110.891 -179.977 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 37.4 p90 -174.87 151.39 1.38 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.139 -0.482 . . . . 74.12 110.941 -179.856 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 17.8 tttt -83.25 145.55 29.06 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.13 -0.486 . . . . 75.04 110.946 179.871 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 34.4 t60 -134.21 152.9 52.06 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.227 -0.442 . . . . 75.23 110.892 179.903 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -58.96 -173.98 0.55 Allowed Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.755 -0.736 . . . . 64.01 112.469 -179.954 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 27.6 mm-40 65.43 12.21 7.96 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.845 0.355 . . . . 73.23 110.943 -179.875 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 68.09 30.14 73.77 Favored Glycine 0 N--CA 1.452 -0.261 0 C-N-CA 120.702 -0.761 . . . . 63.04 112.496 -179.943 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 99.0 m95 -124.15 136.51 54.26 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.796 0.331 . . . . 75.34 110.95 -179.952 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 1.3 mt -120.58 133.36 55.39 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.252 -0.431 . . . . 75.12 110.951 179.962 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 59.9 t -79.75 110.02 14.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.18 -0.464 . . . . 73.33 111.144 179.858 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -129.79 159.36 36.76 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.154 -0.475 . . . . 65.35 111.114 179.869 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 1.4 pt-20 -117.01 156.57 27.27 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.207 -0.451 . . . . 73.34 110.865 -179.919 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -70.18 -175.2 0.92 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.143 -0.48 . . . . 73.44 110.901 -179.983 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 -69.4 -38.21 77.83 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.167 -0.469 . . . . 70.25 110.895 179.965 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 1.5 t -56.37 -22.53 31.8 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.171 -0.468 . . . . 72.43 110.848 -179.786 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 69.16 9.53 60.61 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.757 -0.735 . . . . 64.13 112.476 -179.988 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -108.04 -20.82 13.05 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.947 0.403 . . . . 73.02 110.885 -179.751 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 4.0 ttpt -109.98 123.86 50.4 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.128 -0.487 . . . . 75.01 110.917 179.941 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 3.7 m -129.82 137.47 50.49 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.237 -0.438 . . . . 63.11 111.2 179.981 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -161.02 -157.48 8.77 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.765 -0.731 . . . . 62.45 112.508 179.976 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 8.7 mt -101.68 137.55 39.85 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.886 0.374 . . . . 72.02 110.866 -179.887 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.403 ' HB ' ' HD2' ' A' ' 51' ' ' PRO . 10.3 m -137.16 153.36 74.96 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 121.645 0.736 . . . . 70.45 111.1 179.825 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . 0.403 ' HD2' ' HB ' ' A' ' 50' ' ' VAL . 53.4 Cg_endo -69.85 143.81 51.59 Favored 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 122.657 2.238 . . . . 73.02 112.306 179.961 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 10.9 tm-20 -89.92 -28.09 19.42 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.189 -0.46 . . . . 72.12 110.903 179.983 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -85.97 10.35 14.33 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.17 -0.468 . . . . 75.15 110.847 -179.92 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -120.72 -8.96 9.41 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.174 -0.466 . . . . 72.52 110.875 -179.932 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 15.8 m -119.71 166.33 14.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.123 -0.489 . . . . 75.41 111.167 179.961 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 37.2 t -135.25 117.86 15.95 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.193 -0.458 . . . . 73.31 110.875 -179.868 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 3.3 m-85 -58.32 124.69 20.35 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.171 -0.468 . . . . 72.42 110.935 -179.896 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 22.8 mt -88.26 153.64 3.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.119 -0.491 . . . . 75.04 111.081 179.947 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . 0.401 ' HB2' ' HD2' ' A' ' 60' ' ' PRO . 8.1 pm0 -110.7 154.86 43.02 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 121.609 0.719 . . . . 74.11 110.929 179.95 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . 0.434 ' HG2' ' H ' ' A' ' 61' ' ' GLU . 53.6 Cg_endo -69.77 -84.13 0.01 OUTLIER 'Trans proline' 0 C--N 1.341 0.148 0 C-N-CA 122.708 2.272 . . . . 62.12 112.346 -179.99 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . 0.434 ' H ' ' HG2' ' A' ' 60' ' ' PRO . 72.1 mt-10 -140.3 39.68 1.91 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.203 -0.453 . . . . 73.53 110.885 -179.989 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 1.7 pp -133.53 -179.09 5.31 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.125 -0.489 . . . . 74.24 110.904 -179.989 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 18.0 tp10 . . . . . 0 C--N 1.33 -0.271 0 CA-C-N 116.212 -0.449 . . . . 72.51 110.905 179.925 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' B' B ' -9' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.303 0 N-CA-C 112.457 -0.257 . . . . 75.4 112.457 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' B' B ' -8' ' ' LYS . . . . . . . . . . . . . 34.0 mtmt -91.5 -41.92 10.56 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.83 0.348 . . . . 75.04 110.91 -179.958 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' -7' ' ' PHE . . . . . . . . . . . . . 9.1 m-85 -88.01 133.6 33.92 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.229 -0.441 . . . . 74.21 110.913 179.926 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' -6' ' ' ILE . . . . . . . . . . . . . 37.9 mm -145.51 87.22 7.05 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 121.63 0.729 . . . . 72.34 111.105 -179.997 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' -5' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.74 139.87 41.37 Favored 'Trans proline' 0 C--O 1.231 0.164 0 C-N-CA 122.707 2.272 . . . . 75.34 112.351 179.891 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' -4' ' ' SER . . . . . . . . . . . . . 27.5 t -132.96 66.16 1.57 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.227 -0.442 . . . . 63.42 110.903 -179.872 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' -3' ' ' ARG . . . . . . . . . . . . . 5.8 ptm180 -178.21 155.0 0.96 Allowed Pre-proline 0 C--N 1.329 -0.288 0 CA-C-O 121.6 0.714 . . . . 75.31 110.851 -179.95 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' -2' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.81 131.63 21.55 Favored 'Trans proline' 0 C--N 1.341 0.157 0 C-N-CA 122.654 2.236 . . . . 74.33 112.35 -179.978 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' -1' ' ' ALA . . . . . . . . . . . . . . . -70.47 151.67 95.56 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 121.62 0.724 . . . . 63.24 111.102 179.89 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 0' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.7 173.34 11.07 Favored 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.681 2.254 . . . . 75.14 112.363 -179.98 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 1' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -121.82 154.35 60.58 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 121.579 0.704 . . . . 74.42 110.891 179.865 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 2' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.74 159.82 51.99 Favored 'Trans proline' 0 C--O 1.232 0.186 0 C-N-CA 122.716 2.277 . . . . 74.42 112.345 179.89 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 3' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.73 -171.99 0.53 Allowed 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.735 2.29 . . . . 73.34 112.355 179.914 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 4' ' ' SER . . . . . . . . . . . . . 26.5 t -80.72 147.27 30.65 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.247 -0.433 . . . . 70.42 110.871 -179.835 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 5' ' ' SER . . . . . . . . . . . . . 12.6 t -143.85 123.66 13.43 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.152 -0.476 . . . . 72.32 110.807 -179.793 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 6' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.297 0 CA-C-N 116.103 -0.499 . . . . 73.41 111.128 179.888 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' -4' ' ' MET . . . . . . . . . . . . . 24.6 ttm . . . . . 0 C--O 1.23 0.079 0 CA-C-O 120.779 0.323 . . . . 62.42 110.861 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' -3' ' ' ALA . . . . . . . . . . . . . . . -124.66 117.15 23.62 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.25 -0.432 . . . . 75.11 111.108 179.902 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' -2' ' ' ILE . . . . . . . . . . . . . 85.7 mt -121.56 119.5 59.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.233 -0.44 . . . . 74.43 111.141 179.942 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' -1' ' ' VAL . . . . . . . . . . . . . 21.7 t -109.22 129.78 63.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.165 -0.47 . . . . 74.22 111.113 179.886 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 2.0 m120 -91.94 59.9 3.73 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.155 -0.475 . . . . 73.34 110.913 179.986 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 55.0 tp60 -96.71 127.92 43.16 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.18 -0.464 . . . . 75.21 110.945 179.988 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 7.7 ptp180 -82.0 164.15 21.64 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.188 -0.46 . . . . 74.51 110.821 -179.873 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -155.67 153.22 29.65 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.188 -0.46 . . . . 74.34 111.111 179.919 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 10.3 p -103.71 152.31 6.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.208 -0.451 . . . . 73.04 111.143 179.972 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -92.89 114.99 27.7 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.199 -0.455 . . . . 74.43 111.09 179.92 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 7.0 mt -82.07 -35.64 28.47 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.224 -0.443 . . . . 73.13 110.925 -179.966 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 5.0 m-85 -141.82 137.83 31.77 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.207 -0.451 . . . . 75.53 110.979 179.965 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 3.0 p-10 -63.0 138.43 58.56 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.121 -0.491 . . . . 73.55 110.847 179.98 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 10.4 t80 -141.86 144.76 34.01 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.205 -0.452 . . . . 74.13 110.915 -179.927 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -113.1 144.33 30.92 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 121.656 0.741 . . . . 71.43 110.899 -179.925 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.75 132.39 23.25 Favored 'Trans proline' 0 C--N 1.342 0.193 0 C-N-CA 122.686 2.257 . . . . 72.31 112.324 179.991 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 15.3 mt-10 -94.47 -20.08 19.99 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.184 -0.462 . . . . 74.45 110.87 179.994 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 33.5 m-80 -114.48 175.66 5.39 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.176 -0.465 . . . . 72.43 110.878 -179.929 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -86.85 8.66 21.98 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.199 -0.455 . . . . 63.22 110.899 179.896 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -129.44 20.52 5.68 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.186 -0.461 . . . . 74.54 110.905 -179.942 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 57.1 mt-10 -109.92 156.37 20.53 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.198 -0.455 . . . . 72.03 110.87 -179.962 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -105.13 153.83 20.99 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.16 -0.473 . . . . 75.13 110.927 -179.999 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 21.6 mtm180 -87.87 151.69 22.65 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.179 -0.464 . . . . 62.33 110.856 179.974 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 1.7 tp -137.47 148.7 46.27 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.171 -0.468 . . . . 64.12 110.94 179.981 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -141.62 140.28 33.27 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.197 -0.456 . . . . 72.13 111.107 179.795 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -50.62 120.28 4.56 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.234 -0.439 . . . . 73.32 110.912 -179.915 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 97.84 -7.11 62.78 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.716 -0.754 . . . . 62.23 112.474 -179.986 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -76.41 150.45 36.76 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.788 0.328 . . . . 54.42 110.84 -179.944 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 1.5 mt -116.91 120.08 63.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.201 -0.454 . . . . 73.32 111.118 -179.965 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 6.0 m -120.61 165.44 16.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.163 -0.472 . . . . 65.32 111.125 179.858 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 54.4 m-85 -115.57 107.4 15.09 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.162 -0.472 . . . . 65.25 110.887 179.987 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 17.4 mm -72.04 103.05 1.38 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.164 -0.471 . . . . 73.52 111.127 179.963 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 3.2 m -64.43 -39.25 93.48 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.196 -0.457 . . . . 72.03 110.856 -179.921 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 31.7 p90 -174.99 145.93 0.85 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.151 -0.477 . . . . 64.15 110.936 -179.862 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 19.1 tttt -79.45 144.94 33.58 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.11 -0.496 . . . . 71.35 110.869 179.937 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 28.8 t60 -134.4 153.47 51.89 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.2 -0.455 . . . . 74.33 110.795 179.926 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -58.89 -174.05 0.54 Allowed Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.766 -0.731 . . . . 60.15 112.515 179.975 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 40.5 mm-40 64.59 13.4 8.24 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.834 0.35 . . . . 71.13 110.896 -179.892 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 67.32 28.57 73.7 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.743 -0.742 . . . . 65.54 112.456 179.975 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 98.5 m95 -121.96 135.82 54.88 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.805 0.336 . . . . 75.13 110.947 -179.951 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -121.97 131.22 53.89 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.234 -0.439 . . . . 74.5 110.961 179.96 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 41.3 t -78.92 109.46 13.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.193 -0.458 . . . . 73.55 111.159 179.825 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -129.73 162.25 28.82 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.192 -0.458 . . . . 52.24 111.137 179.871 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 3.6 pm0 -118.17 159.9 22.5 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.233 -0.44 . . . . 45.44 110.893 -179.966 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 44.9 p-10 -58.88 -174.88 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.127 -0.488 . . . . 73.34 110.896 -179.946 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 6.1 tm-20 -78.05 -37.68 46.21 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.164 -0.471 . . . . 74.33 110.91 179.988 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 67.9 m -68.38 -21.89 64.68 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.127 -0.488 . . . . 72.31 110.863 -179.774 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 75.91 26.01 65.63 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.747 -0.74 . . . . 60.01 112.468 179.976 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 6.6 t -109.66 -21.27 12.51 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.931 0.396 . . . . 71.44 110.889 -179.747 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -121.51 138.98 54.07 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.132 -0.485 . . . . 72.13 110.894 179.926 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 6.1 m -132.58 152.6 51.57 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.231 -0.441 . . . . 71.42 111.159 179.978 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -178.36 -161.91 27.15 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.717 -0.754 . . . . 70.25 112.454 179.938 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 5.8 mt -100.95 141.48 33.78 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.849 0.357 . . . . 74.42 110.915 -179.873 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.41 ' HB ' ' HD2' ' A' ' 51' ' ' PRO . 17.1 m -138.2 153.71 73.36 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-O 121.67 0.748 . . . . 65.53 111.091 179.876 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . 0.41 ' HD2' ' HB ' ' A' ' 50' ' ' VAL . 53.7 Cg_endo -69.8 144.93 55.38 Favored 'Trans proline' 0 C--N 1.342 0.21 0 C-N-CA 122.661 2.241 . . . . 72.42 112.322 179.974 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 25.8 tt0 -91.88 -26.93 18.24 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.22 -0.445 . . . . 70.03 110.914 180.0 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -87.89 10.59 18.18 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.168 -0.469 . . . . 60.32 110.918 -179.928 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -120.04 -14.22 8.91 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.121 -0.491 . . . . 75.33 110.898 -179.96 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 19.2 m -114.82 172.48 3.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.172 -0.467 . . . . 71.31 111.181 179.949 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 32.3 t -144.19 116.7 8.6 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.185 -0.461 . . . . 63.22 110.852 -179.842 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 2.8 m-85 -51.93 134.37 31.69 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.132 -0.486 . . . . 73.11 110.876 -179.827 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 52.2 mt -105.63 145.46 13.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.125 -0.489 . . . . 75.11 111.136 179.91 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 4.6 mt-30 -130.88 160.53 66.24 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 121.613 0.72 . . . . 74.53 110.888 179.994 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . 0.406 ' HG2' ' H ' ' A' ' 61' ' ' GLU . 53.7 Cg_endo -69.75 -85.55 0.0 OUTLIER 'Trans proline' 0 C--N 1.341 0.165 0 C-N-CA 122.726 2.284 . . . . 73.5 112.348 179.982 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . 0.406 ' H ' ' HG2' ' A' ' 60' ' ' PRO . 30.9 tt0 -133.82 39.24 3.17 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.232 -0.44 . . . . 75.35 110.873 -179.981 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 12.5 mt -120.31 165.46 14.83 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.14 -0.482 . . . . 74.33 110.922 179.997 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 19.8 tt0 . . . . . 0 C--N 1.329 -0.283 0 CA-C-N 116.169 -0.469 . . . . 74.3 110.915 179.921 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' B' B ' -9' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.331 0 N-CA-C 112.517 -0.233 . . . . 51.35 112.517 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' B' B ' -8' ' ' LYS . . . . . . . . . . . . . 10.7 mptt -87.32 -59.94 2.11 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.823 0.344 . . . . 75.22 110.919 179.984 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' -7' ' ' PHE . . . . . . . . . . . . . 14.0 m-85 -68.43 137.92 54.88 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.243 -0.435 . . . . 74.24 110.835 179.981 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' -6' ' ' ILE . . . . . . . . . . . . . 55.8 mt -149.91 86.28 5.35 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-O 121.615 0.721 . . . . 73.5 111.13 179.921 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' -5' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.8 141.03 43.98 Favored 'Trans proline' 0 C--N 1.341 0.176 0 C-N-CA 122.64 2.226 . . . . 74.11 112.382 179.844 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' -4' ' ' SER . . . . . . . . . . . . . 2.6 t -139.5 65.89 1.42 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.25 -0.432 . . . . 74.31 110.884 -179.822 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' -3' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -178.56 154.51 0.87 Allowed Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.581 0.705 . . . . 74.55 110.9 -179.889 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' -2' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.77 124.2 10.85 Favored 'Trans proline' 0 C--N 1.342 0.2 0 C-N-CA 122.689 2.259 . . . . 70.5 112.333 -179.951 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' -1' ' ' ALA . . . . . . . . . . . . . . . -57.67 152.29 36.69 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.576 0.703 . . . . 62.33 111.099 179.897 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 0' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.77 172.79 12.0 Favored 'Trans proline' 0 C--N 1.342 0.194 0 C-N-CA 122.712 2.275 . . . . 75.44 112.341 -179.966 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 1' ' ' LYS . . . . . . . . . . . . . 12.7 ptmt -119.83 153.45 54.74 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.549 0.69 . . . . 74.21 110.874 179.907 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 2' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.81 162.53 41.76 Favored 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.631 2.221 . . . . 73.5 112.327 179.887 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 3' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.76 155.42 65.99 Favored 'Trans proline' 0 C--N 1.342 0.205 0 C-N-CA 122.655 2.236 . . . . 73.11 112.367 179.938 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 4' ' ' SER . . . . . . . . . . . . . 11.2 t -82.91 89.12 6.82 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.226 -0.443 . . . . 74.42 110.823 -179.827 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 5' ' ' SER . . . . . . . . . . . . . 11.4 t -127.9 164.98 21.08 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.146 -0.479 . . . . 70.12 110.848 -179.833 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 6' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.312 0 CA-C-N 116.123 -0.489 . . . . 74.2 111.117 179.893 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' -4' ' ' MET . . . . . . . . . . . . . 1.1 mpp? . . . . . 0 C--O 1.231 0.118 0 CA-C-O 120.811 0.339 . . . . 70.14 110.842 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' -3' ' ' ALA . . . . . . . . . . . . . . . -160.32 154.82 23.74 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.257 -0.428 . . . . 75.34 111.084 179.954 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' -2' ' ' ILE . . . . . . . . . . . . . 5.4 mp -115.61 125.98 72.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.205 -0.452 . . . . 73.34 111.14 179.948 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' -1' ' ' VAL . . . . . . . . . . . . . 14.5 p -91.78 -27.02 4.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.177 -0.465 . . . . 73.11 111.114 179.85 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 6.4 m-80 61.72 45.78 7.61 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.165 -0.471 . . . . 72.23 110.84 -179.992 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 55.7 tp60 -101.4 131.82 47.29 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.218 -0.446 . . . . 53.55 110.894 179.962 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 5.5 ptm180 -81.99 164.3 21.56 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.233 -0.44 . . . . 75.4 110.883 -179.967 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -156.76 155.33 31.43 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.2 -0.454 . . . . 61.12 111.118 179.939 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 10.5 p -104.95 152.31 6.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.256 -0.429 . . . . 74.22 111.164 179.985 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -90.65 112.27 23.93 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.222 -0.445 . . . . 75.43 111.045 179.919 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 11.6 mt -78.54 -37.64 42.41 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.218 -0.447 . . . . 71.13 110.908 -179.984 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 5.5 m-85 -141.77 146.07 35.53 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.199 -0.455 . . . . 74.11 110.947 -179.957 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 4.0 p-10 -70.61 134.88 48.0 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.115 -0.493 . . . . 71.31 110.909 179.897 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 7.0 t80 -135.15 145.99 48.34 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.199 -0.455 . . . . 73.43 110.893 -179.897 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 5.7 tp10 -115.84 136.04 22.82 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 121.643 0.735 . . . . 74.52 110.892 -179.934 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . 0.402 ' HD3' ' HA ' ' A' ' 19' ' ' ARG . 53.7 Cg_endo -69.8 148.27 64.43 Favored 'Trans proline' 0 C--N 1.341 0.177 0 C-N-CA 122.694 2.263 . . . . 55.15 112.341 -179.998 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -105.94 -21.73 13.08 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.201 -0.454 . . . . 63.33 110.877 -179.977 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 68.1 m-80 -112.07 175.52 5.39 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.187 -0.46 . . . . 65.21 110.949 -179.964 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -88.34 10.34 20.18 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.227 -0.442 . . . . 55.12 110.899 179.905 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -126.22 14.03 7.77 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.169 -0.469 . . . . 73.13 110.936 -179.946 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 25.5 mt-10 -107.62 153.19 23.25 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.178 -0.464 . . . . 75.32 110.88 -179.98 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -103.25 151.56 22.53 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.137 -0.483 . . . . 72.2 110.911 -179.979 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . 0.402 ' HA ' ' HD3' ' A' ' 12' ' ' PRO . 0.3 OUTLIER -88.73 155.26 19.68 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.175 -0.466 . . . . 74.34 110.856 179.997 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 2.0 tp -139.0 148.73 43.83 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.187 -0.46 . . . . 72.32 110.905 -179.959 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -140.46 137.96 34.3 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.185 -0.461 . . . . 74.31 111.101 179.769 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -50.24 120.36 4.45 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.188 -0.46 . . . . 75.21 110.91 -179.902 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 96.09 -0.32 62.18 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.74 -0.743 . . . . 75.24 112.497 -179.952 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -86.6 145.99 26.52 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.81 0.338 . . . . 53.01 110.856 -179.951 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 3.1 mm -102.65 139.9 22.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.176 -0.466 . . . . 60.55 111.138 -179.997 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 1.1 m -141.91 162.44 20.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.204 -0.453 . . . . 74.34 111.125 179.873 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 63.7 m-85 -118.92 108.84 15.27 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.201 -0.454 . . . . 72.54 110.872 -179.987 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 17.2 mm -73.13 103.35 1.82 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.139 -0.482 . . . . 74.34 111.122 179.976 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 5.9 m -64.88 -40.39 95.03 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.184 -0.462 . . . . 74.2 110.892 -179.946 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 36.2 p90 -174.61 149.7 1.28 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.142 -0.481 . . . . 74.4 110.918 -179.897 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 20.5 tttt -81.56 144.24 31.42 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.152 -0.476 . . . . 74.14 110.894 179.919 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 31.5 t60 -133.25 153.34 51.65 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.242 -0.435 . . . . 73.5 110.918 179.849 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -59.09 -174.54 0.62 Allowed Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.778 -0.725 . . . . 74.12 112.42 -179.898 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 5.1 mt-30 65.95 11.99 8.1 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.88 0.371 . . . . 75.03 110.917 -179.909 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 68.36 28.99 72.99 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.753 -0.737 . . . . 54.25 112.502 -179.971 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 98.6 m95 -123.35 136.54 54.71 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.821 0.344 . . . . 75.52 110.941 -179.922 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 1.4 mt -120.24 132.73 55.47 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.249 -0.432 . . . . 63.53 110.926 179.959 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 37.6 t -80.4 109.31 14.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.216 -0.447 . . . . 72.21 111.138 179.829 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -130.56 164.54 24.68 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.167 -0.469 . . . . 71.14 111.142 179.854 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 1.2 pt-20 -119.67 156.06 31.18 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.232 -0.44 . . . . 64.32 110.885 -179.933 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -67.54 -175.06 0.47 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.134 -0.485 . . . . 73.14 110.898 -179.916 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 6.9 tt0 -68.87 -37.62 79.19 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.221 -0.445 . . . . 72.23 110.827 -179.956 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 1.7 t -56.87 -22.46 37.13 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.19 -0.459 . . . . 62.32 110.885 -179.805 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 69.44 9.43 61.34 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.766 -0.73 . . . . 62.52 112.489 -179.996 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 7.4 m -108.78 -24.27 11.37 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.97 0.415 . . . . 73.5 110.853 -179.732 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -105.51 123.61 48.18 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.149 -0.478 . . . . 74.42 110.857 179.932 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 3.4 m -124.47 152.59 43.16 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.223 -0.444 . . . . 74.24 111.175 179.928 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -177.29 -161.71 26.3 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.723 -0.751 . . . . 75.32 112.485 179.968 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 5.5 mt -100.59 134.44 43.55 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.876 0.369 . . . . 73.51 110.885 -179.861 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 10.4 m -133.77 153.23 79.92 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-O 121.632 0.729 . . . . 75.11 111.135 179.866 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.77 144.97 55.66 Favored 'Trans proline' 0 C--N 1.342 0.207 0 C-N-CA 122.667 2.245 . . . . 73.14 112.343 179.928 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 12.0 tm-20 -91.05 -28.85 17.69 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.233 -0.44 . . . . 64.33 110.868 -179.961 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 2.1 mm-40 -85.11 9.05 15.93 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.198 -0.456 . . . . 70.13 110.927 -179.965 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 1.1 m-85 -120.33 -2.76 10.03 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.13 -0.486 . . . . 75.42 110.895 -179.922 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 13.0 m -125.27 171.66 13.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.14 -0.482 . . . . 73.32 111.138 179.949 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 4.1 t -142.94 117.14 9.52 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.179 -0.464 . . . . 72.1 110.86 -179.845 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 3.1 m-85 -55.05 133.39 48.65 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.14 -0.482 . . . . 74.51 110.926 -179.924 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 46.8 mt -103.92 148.59 8.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.105 -0.498 . . . . 72.14 111.142 179.895 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -131.01 160.81 65.12 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-O 121.646 0.736 . . . . 71.41 110.881 179.939 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . 0.422 ' HG2' ' H ' ' A' ' 61' ' ' GLU . 53.7 Cg_endo -69.78 -85.81 0.0 OUTLIER 'Trans proline' 0 C--N 1.342 0.215 0 C-N-CA 122.71 2.273 . . . . 75.15 112.328 -179.981 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . 0.422 ' H ' ' HG2' ' A' ' 60' ' ' PRO . 23.3 mt-10 -128.77 23.74 5.76 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.234 -0.439 . . . . 74.43 110.874 -179.969 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 3.2 pp -136.53 177.64 7.69 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.174 -0.467 . . . . 73.25 110.937 -179.989 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 14.5 tp10 . . . . . 0 C--N 1.329 -0.298 0 CA-C-N 116.197 -0.456 . . . . 73.42 110.903 179.955 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' B' B ' -9' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.316 0 N-CA-C 112.497 -0.241 . . . . 71.11 112.497 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' B' B ' -8' ' ' LYS . . . . . . . . . . . . . 12.3 pttt -52.87 -42.84 65.63 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.788 0.328 . . . . 74.41 110.872 -179.953 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' -7' ' ' PHE . . . . . . . . . . . . . 13.4 m-85 -98.34 162.87 12.95 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.223 -0.444 . . . . 74.13 110.904 179.965 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' -6' ' ' ILE . . . . . . . . . . . . . 4.0 tp -171.9 87.94 0.44 Allowed Pre-proline 0 C--N 1.328 -0.329 0 CA-C-O 121.632 0.73 . . . . 72.53 111.155 179.944 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' -5' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.73 146.33 60.06 Favored 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 122.677 2.251 . . . . 75.41 112.377 179.844 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' -4' ' ' SER . . . . . . . . . . . . . 28.6 t -141.7 63.6 1.42 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.21 -0.45 . . . . 74.45 110.853 -179.841 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' -3' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -179.32 155.42 0.79 Allowed Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.576 0.703 . . . . 73.43 110.886 -179.954 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' -2' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.76 129.13 17.07 Favored 'Trans proline' 0 C--N 1.341 0.175 0 C-N-CA 122.661 2.24 . . . . 75.25 112.337 -179.969 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' -1' ' ' ALA . . . . . . . . . . . . . . . -62.61 152.33 81.49 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-O 121.614 0.721 . . . . 63.3 111.107 179.875 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 0' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.72 175.81 7.58 Favored 'Trans proline' 0 C--N 1.341 0.17 0 C-N-CA 122.696 2.264 . . . . 74.34 112.337 -179.968 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 1' ' ' LYS . . . . . . . . . . . . . 14.2 pttm -123.55 154.36 66.36 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-O 121.647 0.737 . . . . 73.53 110.86 179.92 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 2' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.72 163.41 38.34 Favored 'Trans proline' 0 C--N 1.342 0.195 0 C-N-CA 122.722 2.281 . . . . 74.4 112.353 179.899 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 3' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.72 -170.69 0.41 Allowed 'Trans proline' 0 C--N 1.341 0.152 0 C-N-CA 122.7 2.266 . . . . 65.21 112.332 179.961 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 4' ' ' SER . . . . . . . . . . . . . 1.7 t -98.19 123.63 42.35 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.208 -0.451 . . . . 61.14 110.89 -179.886 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 5' ' ' SER . . . . . . . . . . . . . 47.3 t -122.5 158.24 30.24 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.152 -0.476 . . . . 75.41 110.872 -179.835 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 6' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.328 -0.329 0 CA-C-N 116.139 -0.482 . . . . 72.34 111.073 179.904 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' -4' ' ' MET . . . . . . . . . . . . . 6.1 tpp . . . . . 0 C--O 1.231 0.106 0 CA-C-O 120.784 0.326 . . . . 74.3 110.865 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' -3' ' ' ALA . . . . . . . . . . . . . . . -99.99 27.56 5.45 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.245 -0.434 . . . . 75.44 111.101 179.894 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' -2' ' ' ILE . . . . . . . . . . . . . 78.3 mt -116.3 129.02 73.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.226 -0.443 . . . . 70.22 111.082 179.998 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' -1' ' ' VAL . . . . . . . . . . . . . 14.7 p -86.16 -27.13 6.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.119 -0.491 . . . . 74.31 111.069 179.895 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 20.9 m120 59.83 54.08 4.51 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.205 -0.452 . . . . 75.01 110.862 -179.992 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 50.8 tp60 -112.91 126.64 55.69 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.206 -0.452 . . . . 73.44 110.932 -179.999 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 5.6 ptp180 -78.82 161.4 26.81 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.278 -0.419 . . . . 65.11 110.902 -179.931 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -156.24 154.86 31.4 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.233 -0.44 . . . . 74.34 111.122 179.942 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 11.1 p -104.94 151.26 7.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.209 -0.451 . . . . 64.54 111.102 -179.972 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -89.3 111.08 21.81 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.163 -0.471 . . . . 74.3 111.065 179.915 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 11.5 mt -75.82 -38.63 57.95 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.221 -0.445 . . . . 72.52 110.875 -179.949 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 4.1 m-85 -141.86 148.95 39.62 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.172 -0.467 . . . . 75.33 110.892 -179.946 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 3.7 p-10 -71.28 131.49 43.53 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.142 -0.481 . . . . 73.04 110.89 179.894 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 1.8 t80 -129.54 146.15 51.39 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.228 -0.442 . . . . 74.24 110.866 -179.906 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 32.5 tt0 -116.2 137.06 23.18 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-O 121.654 0.74 . . . . 74.41 110.919 -179.911 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.7 148.27 65.1 Favored 'Trans proline' 0 C--N 1.341 0.154 0 C-N-CA 122.689 2.259 . . . . 72.24 112.373 -179.99 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 18.1 mm-40 -110.79 -18.62 13.08 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.264 -0.425 . . . . 71.12 110.903 179.993 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 33.9 m-80 -112.59 176.25 5.09 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.154 -0.475 . . . . 65.4 110.842 -179.925 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 7.9 p-10 -91.54 20.11 5.66 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.162 -0.472 . . . . 74.1 110.848 179.907 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -138.68 14.68 2.72 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.241 -0.436 . . . . 74.42 110.904 -179.907 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 30.3 mt-10 -103.7 164.7 11.5 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.169 -0.469 . . . . 74.31 110.907 -179.966 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 39.2 tp -115.35 146.78 41.22 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.181 -0.463 . . . . 74.13 110.936 -179.975 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 34.6 mtm-85 -82.25 156.8 24.17 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.242 -0.436 . . . . 74.41 110.913 179.93 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 2.9 tp -142.27 147.55 36.62 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.203 -0.453 . . . . 74.03 110.946 179.985 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -138.79 137.77 36.97 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.231 -0.44 . . . . 60.24 111.113 179.791 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -50.82 120.89 5.2 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.228 -0.442 . . . . 75.21 110.883 -179.923 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 97.25 -5.65 63.13 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.722 -0.751 . . . . 72.23 112.457 179.985 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -81.34 147.82 29.67 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.811 0.339 . . . . 70.25 110.862 -179.94 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 3.4 mm -101.46 141.56 17.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.231 -0.44 . . . . 73.35 111.125 -179.977 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 1.5 m -144.79 158.38 14.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.187 -0.461 . . . . 74.43 111.117 179.883 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 57.8 m-85 -117.47 108.38 15.46 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.15 -0.477 . . . . 74.52 110.892 179.965 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 20.1 mm -72.44 103.11 1.51 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.128 -0.487 . . . . 65.34 111.117 -179.996 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 5.7 m -65.05 -40.21 94.44 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.162 -0.472 . . . . 73.5 110.872 -179.922 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 33.9 p90 -174.61 149.11 1.22 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.155 -0.475 . . . . 75.12 110.944 -179.885 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 19.0 tttt -81.32 143.25 32.35 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.192 -0.458 . . . . 71.34 110.94 179.874 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 33.4 t60 -131.73 155.36 47.82 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.241 -0.436 . . . . 74.02 110.823 179.932 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -60.79 -174.11 1.11 Allowed Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.728 -0.749 . . . . 71.01 112.493 -179.958 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 84.7 mm-40 65.43 12.55 8.22 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.833 0.349 . . . . 72.31 110.939 -179.849 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 68.53 29.19 72.89 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.739 -0.743 . . . . 73.13 112.496 -179.955 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 99.0 m95 -123.69 136.8 54.68 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.819 0.342 . . . . 70.45 110.906 -179.929 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 1.3 mt -121.09 130.57 53.81 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.258 -0.428 . . . . 75.11 110.939 179.972 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 47.4 t -76.9 112.36 14.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.197 -0.456 . . . . 71.51 111.139 179.866 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -133.88 159.96 39.1 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.182 -0.463 . . . . 74.41 111.106 179.869 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -114.09 155.57 25.75 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.204 -0.453 . . . . 64.14 110.841 -179.909 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -70.56 -175.32 1.02 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.098 -0.501 . . . . 73.24 110.883 -179.951 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -69.86 -39.13 76.56 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.151 -0.477 . . . . 74.13 110.861 -179.956 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 11.8 m -56.29 -22.51 30.72 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.152 -0.476 . . . . 71.42 110.852 -179.809 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 66.81 11.4 57.69 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.754 -0.736 . . . . 73.25 112.498 -179.972 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 47.5 t -108.22 -14.35 14.72 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.956 0.407 . . . . 74.43 110.838 -179.708 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 6.1 ptmt -121.37 135.43 55.08 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.161 -0.472 . . . . 74.43 110.881 179.991 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 5.4 m -137.15 141.16 42.24 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.233 -0.439 . . . . 75.43 111.146 179.986 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -161.97 -154.81 7.67 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.711 -0.757 . . . . 72.22 112.499 179.947 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 6.8 mt -104.82 131.48 52.24 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.811 0.339 . . . . 75.21 110.936 -179.918 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 10.8 m -129.64 153.13 80.7 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-O 121.606 0.717 . . . . 75.13 111.185 179.812 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . 0.405 ' HG2' ' HB2' ' A' ' 54' ' ' PHE . 53.5 Cg_endo -69.76 144.84 55.31 Favored 'Trans proline' 0 C--N 1.342 0.189 0 C-N-CA 122.691 2.261 . . . . 63.14 112.37 179.957 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 8.3 tm-20 -90.48 -29.11 18.13 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.208 -0.451 . . . . 75.14 110.854 -179.949 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -85.25 9.87 14.03 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.19 -0.459 . . . . 74.13 110.914 -179.932 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . 0.405 ' HB2' ' HG2' ' A' ' 51' ' ' PRO . 1.0 OUTLIER -120.87 -7.82 9.47 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.136 -0.484 . . . . 74.55 110.862 -179.913 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 19.2 m -119.79 170.54 9.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.149 -0.478 . . . . 75.03 111.102 179.983 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 31.2 t -141.61 113.27 7.74 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.143 -0.481 . . . . 75.45 110.878 -179.858 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 3.1 m-85 -52.93 130.79 34.57 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.145 -0.48 . . . . 74.34 110.888 -179.841 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 51.4 mt -99.01 148.19 6.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.123 -0.489 . . . . 64.12 111.17 179.874 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 7.1 pt20 -114.87 154.88 46.94 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 121.634 0.731 . . . . 75.14 110.882 179.975 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . 0.431 ' HG2' ' H ' ' A' ' 61' ' ' GLU . 53.7 Cg_endo -69.79 -85.23 0.0 OUTLIER 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.699 2.266 . . . . 61.53 112.301 179.991 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . 0.431 ' H ' ' HG2' ' A' ' 60' ' ' PRO . 30.6 mt-10 -133.61 46.91 2.51 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.242 -0.435 . . . . 75.34 110.889 -179.967 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 18.6 mt -98.91 160.02 14.55 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.16 -0.473 . . . . 62.32 110.9 -179.972 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 . . . . . 0 C--N 1.329 -0.286 0 CA-C-N 116.185 -0.461 . . . . 70.43 110.945 179.975 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' B' B ' -9' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.302 0 N-CA-C 112.507 -0.237 . . . . 62.14 112.507 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' B' B ' -8' ' ' LYS . . . . . . . . . . . . . 22.4 ttpt -94.47 -36.48 11.85 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.81 0.338 . . . . 74.2 110.9 -179.967 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' -7' ' ' PHE . . . . . . . . . . . . . 9.8 m-85 -79.57 151.29 30.75 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.183 -0.462 . . . . 70.51 110.916 179.946 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' -6' ' ' ILE . . . . . . . . . . . . . 1.6 pt -153.08 86.14 4.16 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-O 121.627 0.727 . . . . 71.2 111.15 179.995 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' -5' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.74 139.59 40.66 Favored 'Trans proline' 0 C--O 1.231 0.173 0 C-N-CA 122.683 2.256 . . . . 72.33 112.345 179.898 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' -4' ' ' SER . . . . . . . . . . . . . 1.5 t -135.24 65.63 1.55 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.222 -0.445 . . . . 74.31 110.88 -179.845 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' -3' ' ' ARG . . . . . . . . . . . . . 5.4 ptm180 -178.2 154.46 0.93 Allowed Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.569 0.699 . . . . 74.32 110.876 -179.964 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' -2' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.77 131.55 21.47 Favored 'Trans proline' 0 C--N 1.341 0.138 0 C-N-CA 122.682 2.255 . . . . 73.02 112.321 -179.953 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' -1' ' ' ALA . . . . . . . . . . . . . . . -68.84 152.49 96.73 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.526 0.679 . . . . 74.3 111.127 179.859 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 0' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.81 171.51 14.39 Favored 'Trans proline' 0 C--N 1.341 0.157 0 C-N-CA 122.666 2.244 . . . . 65.53 112.318 -179.958 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 1' ' ' LYS . . . . . . . . . . . . . 21.1 mmmt -119.58 153.81 54.3 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.612 0.72 . . . . 74.42 110.835 179.955 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 2' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.72 163.5 37.99 Favored 'Trans proline' 0 C--N 1.342 0.205 0 C-N-CA 122.694 2.263 . . . . 75.35 112.358 179.863 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 3' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.71 150.56 68.7 Favored 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.728 2.286 . . . . 73.25 112.333 179.937 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 4' ' ' SER . . . . . . . . . . . . . 1.7 t -81.96 -28.57 32.65 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.195 -0.457 . . . . 73.34 110.87 -179.873 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 5' ' ' SER . . . . . . . . . . . . . 43.9 p -58.46 -33.74 70.09 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.172 -0.467 . . . . 72.13 110.848 -179.843 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 6' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.308 0 CA-C-N 116.167 -0.47 . . . . 72.53 111.142 179.873 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 44.9 tp60 . . . . . 0 C--O 1.231 0.13 0 CA-C-O 120.791 0.329 . . . . 75.22 110.926 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 7.6 ptt180 -74.65 162.11 29.05 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.216 -0.447 . . . . 61.12 110.892 -179.896 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -157.1 155.0 30.34 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.195 -0.457 . . . . 74.3 111.105 179.954 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.485 ' HB ' HD11 ' A' ' 58' ' ' ILE . 10.8 p -104.01 150.31 7.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.233 -0.44 . . . . 62.42 111.171 179.959 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -89.13 105.4 17.77 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.175 -0.466 . . . . 75.04 111.027 179.947 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 0.771 HD21 ' HB3' ' A' ' 56' ' ' SER . 15.5 mt -70.17 -36.82 74.94 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.2 -0.455 . . . . 75.23 110.937 179.998 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 3.5 m-85 -143.79 156.67 44.57 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.187 -0.461 . . . . 63.34 110.958 179.996 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -79.03 135.53 36.91 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.167 -0.47 . . . . 75.04 110.871 179.938 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 9.3 t80 -135.97 146.0 46.78 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.227 -0.442 . . . . 74.24 110.873 -179.894 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 28.8 tt0 -116.04 136.12 22.9 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-O 121.654 0.74 . . . . 75.22 110.855 -179.917 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.8 146.05 58.78 Favored 'Trans proline' 0 C--N 1.342 0.189 0 C-N-CA 122.661 2.241 . . . . 73.52 112.311 -179.972 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 7.8 mm-40 -107.93 -18.74 13.72 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.196 -0.457 . . . . 74.33 110.853 -179.967 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 35.5 m-80 -111.45 176.06 5.17 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.146 -0.479 . . . . 73.13 110.893 -179.934 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -92.16 20.89 5.51 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.169 -0.469 . . . . 73.13 110.865 179.906 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -138.24 12.29 2.81 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.179 -0.464 . . . . 64.21 110.906 -179.938 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 20.4 mt-10 -105.49 156.17 18.47 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.168 -0.469 . . . . 73.21 110.909 -179.998 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.53 HD23 ' O ' ' A' ' 19' ' ' ARG . 0.3 OUTLIER -105.53 151.44 24.29 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.206 -0.452 . . . . 71.25 110.879 -179.943 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 19' ' ' ARG . . . . . 0.53 ' O ' HD23 ' A' ' 18' ' ' LEU . 12.6 mtp180 -87.79 150.86 23.3 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.17 -0.468 . . . . 73.2 110.861 179.985 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.562 HD11 HG11 ' A' ' 26' ' ' VAL . 2.3 tp -135.17 149.57 49.98 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.242 -0.435 . . . . 71.14 110.927 -179.981 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.664 ' HB3' ' CG ' ' A' ' 24' ' ' ASP . . . -140.24 136.81 33.74 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.219 -0.446 . . . . 61.25 111.124 179.798 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 3.0 tt0 -50.45 120.24 4.45 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.218 -0.447 . . . . 51.2 110.889 -179.927 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 96.16 -0.56 62.2 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.696 -0.764 . . . . 53.45 112.499 -179.98 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 24' ' ' ASP . . . . . 0.664 ' CG ' ' HB3' ' A' ' 21' ' ' ALA . 1.1 m-20 -87.32 147.46 25.49 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.823 0.344 . . . . 65.52 110.865 -179.975 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 3.2 mm -100.62 141.04 18.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.173 -0.467 . . . . 74.4 111.131 -179.97 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.562 HG11 HD11 ' A' ' 20' ' ' LEU . 1.4 m -142.75 158.25 18.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.202 -0.454 . . . . 71.14 111.135 179.879 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 58.4 m-85 -117.19 108.11 15.27 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.165 -0.47 . . . . 70.24 110.905 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.724 HD13 ' HB2' ' A' ' 39' ' ' ALA . 16.6 mm -72.75 102.7 1.52 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.147 -0.479 . . . . 65.21 111.165 179.983 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 4.6 m -64.82 -40.88 95.91 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.19 -0.459 . . . . 71.35 110.861 -179.853 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 30' ' ' TYR . . . . . 0.518 ' CZ ' HG21 ' A' ' 38' ' ' VAL . 36.3 p90 -173.86 149.27 1.52 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.113 -0.494 . . . . 75.05 110.895 -179.931 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 31' ' ' LYS . . . . . 0.447 ' HG3' HD22 ' A' ' 37' ' ' LEU . 9.4 tttm -80.82 145.09 31.6 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.076 -0.511 . . . . 51.12 110.898 179.892 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 27.5 t60 -132.75 155.9 48.04 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.232 -0.44 . . . . 74.54 110.882 179.85 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -61.75 -174.21 1.65 Allowed Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.675 -0.774 . . . . 75.53 112.514 -179.946 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 57.1 mm-40 64.87 13.28 8.42 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.87 0.367 . . . . 64.33 110.874 -179.909 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 68.16 29.98 73.59 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.737 -0.744 . . . . 71.44 112.473 -179.984 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 36' ' ' TRP . . . . . 0.643 ' C ' HD23 ' A' ' 37' ' ' LEU . 98.3 m95 -123.58 137.52 54.74 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.83 0.348 . . . . 73.02 110.921 -179.929 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.715 HD11 ' CG ' ' A' ' 52' ' ' GLU . 1.6 mt -120.57 133.19 55.41 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.247 -0.433 . . . . 74.44 110.951 179.98 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.518 HG21 ' CZ ' ' A' ' 30' ' ' TYR . 75.8 t -79.95 109.09 14.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.214 -0.448 . . . . 73.31 111.161 179.851 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 39' ' ' ALA . . . . . 0.724 ' HB2' HD13 ' A' ' 28' ' ' ILE . . . -129.46 160.99 31.43 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.243 -0.435 . . . . 44.33 111.07 179.945 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 3.3 pm0 -119.02 159.3 24.12 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.225 -0.443 . . . . 71.01 110.878 -179.933 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -71.95 -175.26 1.39 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.139 -0.482 . . . . 53.34 110.854 -179.924 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -69.63 -38.58 77.24 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.147 -0.479 . . . . 63.41 110.893 -179.989 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 1.5 t -56.03 -22.64 28.45 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.149 -0.478 . . . . 52.42 110.843 -179.77 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 69.76 9.02 61.65 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.814 -0.708 . . . . 74.42 112.474 179.982 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 3.7 t -108.88 -19.86 13.25 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.923 0.392 . . . . 74.12 110.871 -179.755 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.449 ' HG2' HD11 ' A' ' 18' ' ' LEU . 1.1 ttmt -109.85 123.62 49.9 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.134 -0.485 . . . . 72.44 110.94 179.913 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 6.1 m -126.82 152.58 46.77 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.269 -0.423 . . . . 71.24 111.116 -179.99 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -177.21 -161.16 25.3 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.744 -0.741 . . . . 63.43 112.484 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.464 HD23 HG22 ' A' ' 38' ' ' VAL . 4.8 mt -100.7 138.74 37.35 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.835 0.35 . . . . 75.43 110.885 -179.901 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.42 ' HB ' ' HD2' ' A' ' 51' ' ' PRO . 6.1 m -137.36 153.56 74.76 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-O 121.634 0.73 . . . . 72.1 111.143 179.82 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 51' ' ' PRO . . . . . 0.42 ' HD2' ' HB ' ' A' ' 50' ' ' VAL . 53.8 Cg_endo -69.8 142.9 48.99 Favored 'Trans proline' 0 C--N 1.341 0.184 0 C-N-CA 122.639 2.226 . . . . 73.02 112.332 179.977 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 52' ' ' GLU . . . . . 0.715 ' CG ' HD11 ' A' ' 37' ' ' LEU . 15.7 tm-20 -89.88 -27.3 19.98 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.18 -0.464 . . . . 64.11 110.92 -179.992 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -87.12 12.08 12.38 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.111 -0.495 . . . . 74.22 110.895 -179.97 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 54' ' ' PHE . . . . . 0.42 ' HB2' ' HG2' ' A' ' 51' ' ' PRO . 1.0 OUTLIER -121.89 -8.81 8.86 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.154 -0.475 . . . . 73.54 110.883 -179.912 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.538 ' CG1' HD21 ' A' ' 20' ' ' LEU . 17.2 m -120.42 169.83 11.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.125 -0.489 . . . . 74.2 111.127 179.968 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 56' ' ' SER . . . . . 0.771 ' HB3' HD21 ' A' ' 7' ' ' LEU . 3.8 t -138.69 115.27 10.58 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.19 -0.459 . . . . 64.35 110.869 -179.854 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 3.0 m-85 -54.2 128.8 32.59 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.183 -0.462 . . . . 74.33 110.924 -179.889 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.485 HD11 ' HB ' ' A' ' 5' ' ' VAL . 45.6 mt -97.06 148.65 5.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.114 -0.494 . . . . 64.2 111.15 179.939 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 4.3 mt-30 . . . . . 0 C--N 1.329 -0.297 0 CA-C-O 121.616 0.722 . . . . 74.43 110.873 179.985 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' B' B ' -7' ' ' PHE . . . . . 0.444 ' HB3' HD11 ' A' ' 49' ' ' LEU . 13.5 m-85 . . . . . 0 C--O 1.232 0.165 0 CA-C-O 120.807 0.337 . . . . 74.42 110.888 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' -6' ' ' ILE . . . . . . . . . . . . . 2.7 pt -153.21 84.13 4.47 Favored Pre-proline 0 C--N 1.328 -0.344 0 CA-C-O 121.656 0.741 . . . . 74.22 111.12 179.977 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' -5' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.71 134.52 28.3 Favored 'Trans proline' 0 C--N 1.342 0.207 0 C-N-CA 122.682 2.254 . . . . 71.0 112.342 179.857 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' -4' ' ' SER . . . . . . . . . . . . . 26.3 t -131.5 65.4 1.57 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.193 -0.458 . . . . 74.42 110.87 -179.863 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' -3' ' ' ARG . . . . . . . . . . . . . 6.9 ptm180 -178.66 155.0 0.87 Allowed Pre-proline 0 C--N 1.33 -0.282 0 CA-C-O 121.625 0.726 . . . . 75.13 110.84 -179.95 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' -2' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.83 129.3 17.29 Favored 'Trans proline' 0 C--N 1.341 0.17 0 C-N-CA 122.718 2.279 . . . . 62.11 112.313 -179.964 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' -1' ' ' ALA . . . . . . . . . . . . . . . -63.5 154.48 79.27 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-O 121.525 0.678 . . . . 71.53 111.157 179.847 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 0' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.78 176.75 6.36 Favored 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.663 2.242 . . . . 72.11 112.334 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 1' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -125.07 146.99 55.5 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.561 0.696 . . . . 73.33 110.882 179.951 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 2' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo . . . . . 0 C--N 1.341 0.158 0 C-N-CA 122.646 2.231 . . . . 71.35 112.363 179.873 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 51.6 tp60 . . . . . 0 C--O 1.231 0.105 0 CA-C-O 120.821 0.343 . . . . 74.42 110.92 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 5.9 ptt180 -89.58 164.67 14.67 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.202 -0.454 . . . . 71.43 110.896 -179.949 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -155.56 152.39 28.75 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.235 -0.439 . . . . 64.43 111.114 179.98 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.66 ' HB ' HD11 ' A' ' 58' ' ' ILE . 10.7 p -104.17 147.91 9.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.245 -0.434 . . . . 62.43 111.164 179.918 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 6' ' ' ALA . . . . . 0.423 ' HB3' ' O ' ' A' ' 21' ' ' ALA . . . -87.75 112.61 22.6 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.152 -0.477 . . . . 74.3 111.082 179.913 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 0.703 HD21 ' CB ' ' A' ' 56' ' ' SER . 10.4 mt -77.91 -37.77 47.12 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.2 -0.454 . . . . 74.13 110.962 179.987 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 4.0 m-85 -140.59 141.39 35.19 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.171 -0.468 . . . . 72.41 110.908 -179.972 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 2.2 p30 -65.13 132.99 50.59 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.128 -0.487 . . . . 73.3 110.898 179.899 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 2.1 t80 -129.83 146.34 51.57 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.204 -0.453 . . . . 65.51 110.888 -179.89 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 47.2 tt0 -117.03 137.06 23.51 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-O 121.62 0.724 . . . . 53.14 110.864 -179.893 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.79 150.99 68.79 Favored 'Trans proline' 0 C--N 1.342 0.189 0 C-N-CA 122.676 2.25 . . . . 74.25 112.311 -179.96 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 6.3 mm-40 -113.9 -15.82 12.3 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.206 -0.452 . . . . 72.25 110.913 179.981 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 31.2 m-80 -114.92 175.97 5.26 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.208 -0.451 . . . . 70.2 110.863 -179.936 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 27.1 m-20 -91.02 18.39 6.79 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.144 -0.48 . . . . 74.23 110.893 179.927 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -138.22 17.04 2.79 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.163 -0.472 . . . . 53.04 110.946 -179.916 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 24.9 mt-10 -105.49 164.87 11.55 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.132 -0.486 . . . . 74.41 110.93 179.979 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.558 HD12 ' H ' ' A' ' 19' ' ' ARG . 41.3 tp -115.84 147.06 41.45 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.176 -0.465 . . . . 64.4 110.94 -179.978 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 19' ' ' ARG . . . . . 0.558 ' H ' HD12 ' A' ' 18' ' ' LEU . 0.5 OUTLIER -83.07 159.32 22.16 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.219 -0.446 . . . . 71.0 110.823 179.986 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.556 HD21 ' CG1' ' A' ' 55' ' ' VAL . 3.1 tp -143.87 147.96 34.79 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.179 -0.464 . . . . 64.21 110.939 179.995 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.652 ' HB3' ' CG ' ' A' ' 24' ' ' ASP . . . -139.6 138.73 36.42 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.186 -0.461 . . . . 75.41 111.07 179.811 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -51.35 122.53 7.98 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.189 -0.46 . . . . 72.3 110.907 -179.933 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 95.85 -6.7 67.28 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.727 -0.749 . . . . 64.01 112.449 -179.983 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 24' ' ' ASP . . . . . 0.652 ' CG ' ' HB3' ' A' ' 21' ' ' ALA . 1.1 m-20 -80.38 145.94 31.76 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.764 0.316 . . . . 54.31 110.887 -179.967 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 3.2 mm -101.96 140.7 19.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.195 -0.457 . . . . 70.24 111.104 -179.957 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 1.5 m -143.23 158.47 17.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.135 -0.484 . . . . 63.44 111.132 179.868 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 57.4 m-85 -115.59 108.92 17.04 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.2 -0.455 . . . . 74.52 110.902 179.996 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.684 HD13 ' HB2' ' A' ' 39' ' ' ALA . 17.2 mm -72.42 102.61 1.41 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.153 -0.476 . . . . 64.31 111.101 179.999 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 8.1 m -65.06 -40.35 94.6 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.191 -0.459 . . . . 64.34 110.901 -179.946 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 30' ' ' TYR . . . . . 0.525 ' CZ ' HG21 ' A' ' 38' ' ' VAL . 33.9 p90 -174.67 148.6 1.15 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.144 -0.48 . . . . 64.34 110.923 -179.881 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 31' ' ' LYS . . . . . 0.528 ' HG3' HD22 ' A' ' 37' ' ' LEU . 10.3 tttm -81.27 143.94 31.91 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.122 -0.49 . . . . 75.54 110.838 179.942 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 32.0 t60 -132.45 155.13 49.09 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.205 -0.452 . . . . 75.21 110.845 179.879 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -60.49 -174.04 1.01 Allowed Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.755 -0.736 . . . . 63.42 112.481 -179.962 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 16.8 mm100 65.32 12.69 8.27 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.878 0.37 . . . . 64.14 110.947 -179.892 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 68.36 29.31 73.08 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.747 -0.74 . . . . 71.23 112.462 -180.0 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 36' ' ' TRP . . . . . 0.639 ' C ' HD23 ' A' ' 37' ' ' LEU . 98.8 m95 -123.55 135.75 54.17 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.781 0.324 . . . . 74.01 110.918 -179.93 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.714 HD11 ' CG ' ' A' ' 52' ' ' GLU . 1.3 mt -120.3 130.62 54.54 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.195 -0.457 . . . . 75.33 110.907 179.987 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.525 HG21 ' CZ ' ' A' ' 30' ' ' TYR . 82.6 t -76.18 112.11 13.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.184 -0.462 . . . . 75.2 111.138 179.821 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 39' ' ' ALA . . . . . 0.684 ' HB2' HD13 ' A' ' 28' ' ' ILE . . . -133.0 157.9 44.04 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.121 -0.491 . . . . 62.41 111.055 179.892 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -114.41 156.23 24.88 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.196 -0.456 . . . . 64.4 110.88 -179.929 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -71.7 -175.35 1.34 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.16 -0.473 . . . . 51.24 110.9 -179.92 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -70.0 -39.45 75.86 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.208 -0.451 . . . . 74.31 110.915 -179.982 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 14.4 m -55.82 -22.29 24.02 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.177 -0.465 . . . . 75.32 110.892 -179.824 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 66.35 11.77 56.88 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.724 -0.75 . . . . 32.24 112.525 -179.974 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 3.5 m -107.76 -14.98 14.67 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.935 0.398 . . . . 74.33 110.843 -179.714 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -121.43 134.85 55.09 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.112 -0.494 . . . . 74.3 110.868 179.937 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 5.2 m -138.67 137.93 37.31 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.216 -0.447 . . . . 60.02 111.127 179.967 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -158.11 -154.49 7.16 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.75 -0.738 . . . . 43.45 112.502 179.942 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.491 HD11 ' HB3' ' B' ' -7' ' ' PHE . 6.2 mt -104.62 130.95 52.55 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.845 0.355 . . . . 64.12 110.902 -179.881 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 11.7 m -129.0 153.1 80.23 Favored Pre-proline 0 C--N 1.33 -0.264 0 CA-C-O 121.619 0.723 . . . . 45.2 111.141 179.801 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 51' ' ' PRO . . . . . 0.437 ' HG2' ' HB2' ' A' ' 54' ' ' PHE . 53.8 Cg_endo -69.76 144.72 54.94 Favored 'Trans proline' 0 C--N 1.341 0.166 0 C-N-CA 122.661 2.241 . . . . 62.13 112.319 179.966 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 52' ' ' GLU . . . . . 0.714 ' CG ' HD11 ' A' ' 37' ' ' LEU . 13.5 tm-20 -90.44 -28.71 18.43 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.218 -0.446 . . . . 71.31 110.922 179.985 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -85.67 10.05 14.5 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.158 -0.474 . . . . 73.44 110.904 -179.954 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 54' ' ' PHE . . . . . 0.437 ' HB2' ' HG2' ' A' ' 51' ' ' PRO . 1.0 OUTLIER -121.02 -5.8 9.53 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.108 -0.496 . . . . 65.05 110.88 -179.969 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.556 ' CG1' HD21 ' A' ' 20' ' ' LEU . 15.4 m -122.75 167.52 16.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.16 -0.473 . . . . 70.15 111.108 179.998 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 56' ' ' SER . . . . . 0.703 ' CB ' HD21 ' A' ' 7' ' ' LEU . 47.9 t -138.27 117.35 12.56 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.158 -0.474 . . . . 70.43 110.85 -179.854 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 2.7 m-85 -53.44 134.12 40.47 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.133 -0.485 . . . . 73.44 110.936 -179.889 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.66 HD11 ' HB ' ' A' ' 5' ' ' VAL . 41.4 mt -104.48 146.54 11.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.098 -0.501 . . . . 44.32 111.123 179.905 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 1.3 mt-30 . . . . . 0 C--N 1.329 -0.283 0 CA-C-O 121.626 0.727 . . . . 71.43 110.889 179.922 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' B' B ' -7' ' ' PHE . . . . . 0.491 ' HB3' HD11 ' A' ' 49' ' ' LEU . 9.0 m-85 . . . . . 0 C--O 1.232 0.152 0 CA-C-O 120.808 0.337 . . . . 74.54 110.864 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' -6' ' ' ILE . . . . . 0.423 HD13 ' O ' ' B' ' -7' ' ' PHE . 37.3 mm -145.62 87.69 6.82 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 121.646 0.736 . . . . 71.53 111.135 179.933 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' -5' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.76 130.99 20.31 Favored 'Trans proline' 0 C--N 1.342 0.192 0 C-N-CA 122.649 2.233 . . . . 62.21 112.347 179.845 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' -4' ' ' SER . . . . . . . . . . . . . 30.9 t -124.27 62.21 1.11 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.164 -0.471 . . . . 75.25 110.879 -179.86 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' -3' ' ' ARG . . . . . . . . . . . . . 9.2 ptm180 -174.63 153.74 1.81 Allowed Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.643 0.735 . . . . 71.04 110.862 -179.93 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' -2' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.74 136.33 32.77 Favored 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.672 2.248 . . . . 73.31 112.343 179.996 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' -1' ' ' ALA . . . . . . . . . . . . . . . -71.84 152.76 93.2 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-O 121.605 0.717 . . . . 34.54 111.083 179.904 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 0' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.81 178.02 5.02 Favored 'Trans proline' 0 C--N 1.342 0.2 0 C-N-CA 122.602 2.201 . . . . 74.4 112.369 -179.965 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 1' ' ' LYS . . . . . . . . . . . . . 9.3 pttm -125.2 154.34 71.8 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-O 121.583 0.706 . . . . 74.01 110.898 179.945 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 2' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo . . . . . 0 C--N 1.341 0.182 0 C-N-CA 122.711 2.274 . . . . 74.24 112.313 179.909 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 57.8 tp60 . . . . . 0 C--O 1.231 0.103 0 CA-C-O 120.766 0.317 . . . . 71.23 110.899 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -79.08 160.67 26.98 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.189 -0.459 . . . . 73.13 110.834 -179.905 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -156.33 153.61 29.29 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.147 -0.478 . . . . 64.33 111.097 179.925 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.553 ' HB ' HD11 ' A' ' 58' ' ' ILE . 10.8 p -104.33 151.16 6.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.23 -0.441 . . . . 63.02 111.099 179.995 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -89.82 106.83 18.73 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.161 -0.472 . . . . 71.23 111.104 179.895 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 0.723 HD21 ' CB ' ' A' ' 56' ' ' SER . 16.6 mt -71.4 -39.5 71.11 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.267 -0.424 . . . . 73.13 110.883 -179.951 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 5.6 m-85 -138.84 149.98 45.52 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.224 -0.444 . . . . 70.34 110.875 179.996 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 1.7 p30 -73.74 136.05 43.64 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.066 -0.515 . . . . 65.1 110.88 179.907 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 9.0 t80 -139.83 144.66 37.4 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.192 -0.458 . . . . 75.34 110.881 -179.884 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -113.16 144.75 31.76 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.645 0.736 . . . . 73.45 110.886 -179.907 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.78 141.6 45.61 Favored 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.722 2.281 . . . . 63.13 112.339 -179.981 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 6.3 mm-40 -102.02 -24.05 14.03 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.235 -0.438 . . . . 53.41 110.869 -179.967 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 40.7 m-80 -112.31 175.58 5.37 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.163 -0.471 . . . . 73.04 110.921 -179.963 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -83.07 2.06 37.03 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.204 -0.453 . . . . 34.5 110.869 179.875 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 1.1 p-10 -124.01 23.05 8.65 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.213 -0.448 . . . . 52.35 110.854 -179.903 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 5.4 mt-10 -108.86 156.72 19.34 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.198 -0.455 . . . . 70.4 110.894 179.998 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.485 HD12 ' H ' ' A' ' 19' ' ' ARG . 54.4 tp -108.05 151.61 25.62 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.162 -0.472 . . . . 42.05 110.876 -179.956 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 19' ' ' ARG . . . . . 0.485 ' H ' HD12 ' A' ' 18' ' ' LEU . 9.7 mtt-85 -88.79 154.11 20.53 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.153 -0.476 . . . . 75.13 110.851 179.988 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.567 HD21 ' CG1' ' A' ' 55' ' ' VAL . 2.6 tp -140.51 149.04 41.97 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.177 -0.465 . . . . 73.41 110.945 -179.974 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.659 ' HB3' ' CG ' ' A' ' 24' ' ' ASP . . . -141.22 137.52 32.65 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.185 -0.461 . . . . 72.13 111.112 179.798 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -50.76 121.03 5.32 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.224 -0.444 . . . . 75.31 110.902 -179.897 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 96.65 -4.86 64.05 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.717 -0.754 . . . . 73.55 112.512 -179.947 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 24' ' ' ASP . . . . . 0.659 ' CG ' ' HB3' ' A' ' 21' ' ' ALA . 1.1 m-20 -82.78 146.74 28.8 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.816 0.341 . . . . 75.52 110.85 -179.972 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 3.2 mm -101.67 141.06 18.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.176 -0.465 . . . . 65.15 111.163 179.989 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 1.3 m -143.23 158.68 17.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.177 -0.465 . . . . 65.15 111.104 179.85 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 37.8 m-85 -115.83 106.71 14.14 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.134 -0.485 . . . . 73.31 110.838 -179.931 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.657 HD13 ' HB2' ' A' ' 39' ' ' ALA . 13.0 mm -72.13 103.3 1.47 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.157 -0.474 . . . . 72.11 111.126 179.959 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 3.4 m -64.55 -39.59 94.04 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.18 -0.464 . . . . 73.02 110.84 -179.891 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 30' ' ' TYR . . . . . 0.478 ' CZ ' HG21 ' A' ' 38' ' ' VAL . 32.8 p90 -174.16 148.06 1.29 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.145 -0.48 . . . . 70.01 110.907 -179.883 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 31' ' ' LYS . . . . . 0.565 ' HG3' HD22 ' A' ' 37' ' ' LEU . 19.1 tttt -82.57 145.85 29.5 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.089 -0.505 . . . . 62.23 110.919 179.894 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 34.5 t60 -135.49 153.54 51.7 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.236 -0.438 . . . . 72.11 110.842 179.923 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -58.6 -174.44 0.52 Allowed Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.751 -0.738 . . . . 31.34 112.518 -179.973 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 2.5 mt-30 65.78 12.22 8.16 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.803 0.335 . . . . 71.1 110.908 -179.873 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 68.24 28.85 73.14 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.76 -0.733 . . . . 61.31 112.494 -179.955 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 36' ' ' TRP . . . . . 0.628 ' C ' HD23 ' A' ' 37' ' ' LEU . 99.1 m95 -123.56 136.0 54.3 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.773 0.32 . . . . 71.44 110.939 -179.919 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.681 HD11 ' CG ' ' A' ' 52' ' ' GLU . 0.4 OUTLIER -124.11 132.06 53.61 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.261 -0.427 . . . . 65.42 110.938 179.969 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.489 HG22 HD23 ' A' ' 49' ' ' LEU . 47.1 t -78.2 116.97 22.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.194 -0.457 . . . . 62.12 111.169 179.807 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 39' ' ' ALA . . . . . 0.657 ' HB2' HD13 ' A' ' 28' ' ' ILE . . . -136.66 166.31 23.84 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.178 -0.464 . . . . 73.41 111.085 179.866 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -127.53 153.93 45.76 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.212 -0.449 . . . . 62.35 110.879 -179.911 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -66.32 -174.77 0.3 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.172 -0.467 . . . . 63.44 110.895 -179.962 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -69.62 -37.93 77.03 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.157 -0.474 . . . . 74.4 110.879 -179.97 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 9.5 m -57.0 -22.52 39.23 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.141 -0.481 . . . . 72.4 110.895 -179.827 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 67.54 10.9 58.82 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.713 -0.756 . . . . 75.51 112.5 -179.973 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 1.9 t -106.48 -21.77 12.98 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.966 0.412 . . . . 62.33 110.868 -179.722 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 1.7 ttmt -114.07 124.02 51.08 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.131 -0.486 . . . . 74.33 110.88 179.936 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 15.6 m -133.79 144.52 49.07 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.193 -0.458 . . . . 75.51 111.117 -179.991 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -164.48 -152.96 7.22 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.72 -0.752 . . . . 63.32 112.458 179.971 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.489 HD23 HG22 ' A' ' 38' ' ' VAL . 12.6 mt -103.89 134.08 47.78 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.852 0.358 . . . . 74.31 110.876 -179.912 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.423 ' HB ' ' HD2' ' A' ' 51' ' ' PRO . 21.9 m -134.15 154.05 79.89 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-O 121.668 0.746 . . . . 74.14 111.069 179.857 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 51' ' ' PRO . . . . . 0.423 ' HD2' ' HB ' ' A' ' 50' ' ' VAL . 53.4 Cg_endo -69.77 146.43 60.09 Favored 'Trans proline' 0 C--N 1.342 0.209 0 C-N-CA 122.656 2.237 . . . . 72.33 112.3 179.974 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 52' ' ' GLU . . . . . 0.681 ' CG ' HD11 ' A' ' 37' ' ' LEU . 28.0 tt0 -91.87 -29.31 16.78 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.187 -0.461 . . . . 73.32 110.903 179.982 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -85.23 9.8 14.16 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.187 -0.46 . . . . 71.14 110.934 -179.964 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 54' ' ' PHE . . . . . 0.418 ' HB2' ' HG2' ' A' ' 51' ' ' PRO . 1.0 OUTLIER -120.19 -7.97 9.76 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.13 -0.486 . . . . 73.25 110.858 -179.932 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.567 ' CG1' HD21 ' A' ' 20' ' ' LEU . 15.8 m -121.21 161.32 21.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.151 -0.477 . . . . 62.51 111.119 179.981 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 56' ' ' SER . . . . . 0.723 ' CB ' HD21 ' A' ' 7' ' ' LEU . 25.4 t -131.68 114.74 15.15 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.149 -0.478 . . . . 74.04 110.833 -179.855 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 3.0 m-85 -54.72 127.02 26.36 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.182 -0.463 . . . . 63.02 110.916 -179.877 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.553 HD11 ' HB ' ' A' ' 5' ' ' VAL . 40.6 mt -94.85 143.16 12.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.121 -0.49 . . . . 72.52 111.117 179.953 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--N 1.329 -0.326 0 CA-C-O 121.62 0.724 . . . . 42.0 110.914 179.976 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' -7' ' ' PHE . . . . . . . . . . . . . 6.7 m-85 . . . . . 0 C--O 1.232 0.136 0 CA-C-O 120.79 0.328 . . . . 74.11 110.909 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' B' B ' -6' ' ' ILE . . . . . . . . . . . . . 1.9 pt -152.98 88.28 3.87 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.68 0.752 . . . . 74.22 111.122 179.977 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' -5' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.74 135.64 31.01 Favored 'Trans proline' 0 C--N 1.342 0.227 0 C-N-CA 122.702 2.268 . . . . 63.02 112.368 179.859 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' -4' ' ' SER . . . . . . . . . . . . . 2.9 m -133.88 60.37 1.71 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.228 -0.442 . . . . 65.43 110.825 -179.814 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' -3' ' ' ARG . . . . . . . . . . . . . 9.9 ptt85 -174.62 153.41 1.77 Allowed Pre-proline 0 C--N 1.329 -0.288 0 CA-C-O 121.651 0.739 . . . . 72.25 110.836 -179.951 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' -2' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.75 128.05 15.48 Favored 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.645 2.23 . . . . 61.22 112.383 -179.991 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' -1' ' ' ALA . . . . . . . . . . . . . . . -62.61 155.18 70.46 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-O 121.564 0.697 . . . . 72.3 111.086 179.92 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 0' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.73 -169.24 0.31 Allowed 'Trans proline' 0 C--N 1.341 0.17 0 C-N-CA 122.66 2.24 . . . . 70.11 112.369 179.995 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 1' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -138.88 154.12 72.5 Favored Pre-proline 0 C--N 1.328 -0.347 0 CA-C-O 121.568 0.699 . . . . 74.34 110.89 179.909 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 2' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo . . . . . 0 C--N 1.342 0.185 0 C-N-CA 122.67 2.247 . . . . 74.42 112.354 179.914 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 31.0 tp60 . . . . . 0 C--O 1.231 0.102 0 CA-C-O 120.826 0.346 . . . . 74.4 110.921 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 4.4 ptp180 -89.87 163.1 15.14 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.18 -0.463 . . . . 74.51 110.863 -179.891 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -155.07 153.17 30.49 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.192 -0.458 . . . . 41.2 111.089 179.893 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.694 ' HB ' HD11 ' A' ' 58' ' ' ILE . 10.7 p -103.85 150.02 7.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.221 -0.445 . . . . 75.01 111.179 179.932 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -88.33 105.57 17.66 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.207 -0.452 . . . . 74.11 111.112 179.885 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 0.734 HD21 ' HB2' ' A' ' 56' ' ' SER . 15.2 mt -69.68 -37.27 76.6 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.218 -0.446 . . . . 64.24 110.911 -179.95 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 2.9 m-85 -143.92 157.46 44.34 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.147 -0.479 . . . . 72.52 110.92 -179.988 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 3.7 p30 -78.84 134.84 36.92 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.128 -0.487 . . . . 74.41 110.9 179.896 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 2.5 t80 -134.42 146.03 49.45 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.201 -0.454 . . . . 74.53 110.894 -179.902 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 6.6 tt0 -116.5 136.14 23.06 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-O 121.626 0.727 . . . . 63.33 110.907 -179.881 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 12' ' ' PRO . . . . . 0.409 ' HD3' ' HA ' ' A' ' 19' ' ' ARG . 53.3 Cg_endo -69.81 151.52 68.82 Favored 'Trans proline' 0 C--N 1.341 0.175 0 C-N-CA 122.677 2.251 . . . . 75.32 112.319 -179.939 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 1.9 mm-40 -112.9 -17.28 12.53 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.211 -0.45 . . . . 74.41 110.885 -179.989 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 9.7 m120 -115.21 176.15 5.19 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.148 -0.478 . . . . 74.0 110.892 -179.958 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 70.3 m-20 -91.86 21.07 5.12 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.222 -0.444 . . . . 62.42 110.898 179.91 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 1.1 p-10 -137.23 12.76 3.05 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.171 -0.468 . . . . 61.21 110.894 -179.984 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 48.7 mt-10 -106.82 160.12 15.73 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.178 -0.464 . . . . 74.31 110.841 -179.969 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.599 HD12 ' H ' ' A' ' 19' ' ' ARG . 20.7 tp -110.88 147.21 35.08 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.095 -0.502 . . . . 72.14 110.917 179.989 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 19' ' ' ARG . . . . . 0.599 ' H ' HD12 ' A' ' 18' ' ' LEU . 1.4 mtt180 -83.28 155.85 23.4 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.166 -0.47 . . . . 73.14 110.849 179.96 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.553 HD21 ' CG1' ' A' ' 55' ' ' VAL . 3.0 tp -139.37 149.71 44.46 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.213 -0.449 . . . . 64.33 110.917 179.984 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.657 ' HB3' ' CG ' ' A' ' 24' ' ' ASP . . . -139.96 136.44 33.8 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.155 -0.475 . . . . 74.04 111.082 179.772 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -50.77 120.96 5.24 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.193 -0.458 . . . . 61.5 110.848 -179.913 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 96.86 -3.9 62.9 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.744 -0.741 . . . . 44.23 112.456 179.992 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 24' ' ' ASP . . . . . 0.657 ' CG ' ' HB3' ' A' ' 21' ' ' ALA . 1.0 OUTLIER -84.25 146.34 27.84 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.829 0.347 . . . . 74.22 110.823 -179.932 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 3.3 mm -100.52 142.34 15.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.177 -0.465 . . . . 74.3 111.177 179.957 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 1.7 m -145.14 157.38 13.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.206 -0.452 . . . . 53.34 111.111 179.886 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 61.1 m-85 -115.98 110.69 19.3 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.18 -0.464 . . . . 72.11 110.871 -179.988 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.698 HD13 ' HB2' ' A' ' 39' ' ' ALA . 15.5 mm -72.43 102.27 1.35 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.091 -0.504 . . . . 45.01 111.121 179.964 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 5.0 m -65.07 -40.17 94.31 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.234 -0.439 . . . . 71.15 110.831 -179.924 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 30' ' ' TYR . . . . . 0.541 ' CZ ' HG21 ' A' ' 38' ' ' VAL . 35.9 p90 -174.58 149.24 1.25 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.186 -0.461 . . . . 74.31 110.947 -179.913 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 32.5 tttt -80.87 143.18 32.92 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.124 -0.489 . . . . 73.11 110.863 179.945 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 23.2 t60 -129.44 157.42 42.02 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.238 -0.437 . . . . 73.34 110.891 179.87 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -64.18 -174.66 3.64 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.744 -0.741 . . . . 65.1 112.467 -179.959 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 17.9 mm100 65.47 12.69 8.35 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.836 0.351 . . . . 74.11 110.922 -179.893 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 69.72 29.49 71.16 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.745 -0.74 . . . . 50.13 112.505 -179.949 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 36' ' ' TRP . . . . . 0.654 ' C ' HD23 ' A' ' 37' ' ' LEU . 97.0 m95 -122.91 138.35 54.69 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.821 0.343 . . . . 75.14 110.938 -179.935 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.707 HD11 ' CG ' ' A' ' 52' ' ' GLU . 1.3 mt -121.13 133.24 55.2 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.223 -0.444 . . . . 64.21 110.935 179.966 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.541 HG21 ' CZ ' ' A' ' 30' ' ' TYR . 95.9 t -80.06 109.37 14.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.21 -0.45 . . . . 72.34 111.124 179.814 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 39' ' ' ALA . . . . . 0.698 ' HB2' HD13 ' A' ' 28' ' ' ILE . . . -129.19 158.46 38.95 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.175 -0.466 . . . . 50.44 111.126 179.822 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 1.4 pt-20 -117.05 157.31 26.05 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.234 -0.439 . . . . 55.22 110.843 -179.954 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -71.54 -175.04 1.21 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.126 -0.488 . . . . 75.33 110.891 -179.926 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 2.6 tt0 -69.45 -38.3 77.72 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.199 -0.455 . . . . 52.21 110.919 179.981 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 1.6 t -56.36 -22.58 32.0 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.165 -0.471 . . . . 73.12 110.827 -179.799 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 68.58 10.39 60.45 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.689 -0.767 . . . . 70.24 112.516 -179.933 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 3.1 t -107.14 -22.15 12.73 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.886 0.374 . . . . 74.14 110.83 -179.73 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.427 ' HE3' HD11 ' A' ' 18' ' ' LEU . 3.7 ttpt -110.31 123.9 50.67 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.158 -0.474 . . . . 74.0 110.933 179.932 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 9.3 m -131.89 130.38 41.55 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.24 -0.437 . . . . 52.4 111.136 179.998 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -153.57 -157.05 7.9 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.777 -0.725 . . . . 64.32 112.504 179.979 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 11.9 mt -100.32 133.33 44.88 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.821 0.343 . . . . 44.32 110.909 -179.925 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.458 ' CG1' HD23 ' A' ' 18' ' ' LEU . 6.0 m -131.97 153.62 81.45 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 121.685 0.755 . . . . 63.22 111.086 179.838 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 51' ' ' PRO . . . . . 0.417 ' HD2' ' HB ' ' A' ' 50' ' ' VAL . 54.0 Cg_endo -69.75 144.2 53.3 Favored 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.697 2.265 . . . . 63.24 112.353 179.918 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 52' ' ' GLU . . . . . 0.707 ' CG ' HD11 ' A' ' 37' ' ' LEU . 6.9 tm-20 -90.63 -27.8 18.83 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.226 -0.443 . . . . 74.11 110.885 -179.982 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -86.76 11.12 13.87 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.165 -0.471 . . . . 70.1 110.93 -179.974 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 54' ' ' PHE . . . . . 0.408 ' HB2' ' HG2' ' A' ' 51' ' ' PRO . 1.1 m-85 -121.74 -7.48 9.05 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.139 -0.482 . . . . 74.24 110.854 -179.91 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.553 ' CG1' HD21 ' A' ' 20' ' ' LEU . 16.1 m -121.88 168.08 14.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.161 -0.472 . . . . 72.34 111.13 -179.983 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 56' ' ' SER . . . . . 0.734 ' HB2' HD21 ' A' ' 7' ' ' LEU . 43.9 t -136.93 117.06 13.4 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.212 -0.449 . . . . 61.3 110.896 -179.851 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 2.9 m-85 -56.25 124.3 17.49 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.15 -0.477 . . . . 72.22 110.903 -179.849 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.694 HD11 ' HB ' ' A' ' 5' ' ' VAL . 35.3 mt -94.52 141.87 14.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.11 -0.496 . . . . 73.21 111.136 179.931 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.329 -0.298 0 CA-C-O 121.583 0.706 . . . . 74.03 110.922 179.923 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' -7' ' ' PHE . . . . . 0.573 ' O ' HD13 ' B' ' -6' ' ' ILE . 7.4 m-85 . . . . . 0 C--O 1.231 0.126 0 CA-C-O 120.819 0.342 . . . . 75.42 110.871 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' -6' ' ' ILE . . . . . 0.573 HD13 ' O ' ' B' ' -7' ' ' PHE . 30.0 mm -138.22 94.83 10.78 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 121.681 0.753 . . . . 62.32 111.155 179.939 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' -5' ' ' PRO . . . . . 0.43 ' HD2' ' HA ' ' B' ' -6' ' ' ILE . 53.8 Cg_endo -69.76 140.37 42.51 Favored 'Trans proline' 0 C--N 1.342 0.194 0 C-N-CA 122.673 2.249 . . . . 73.55 112.357 179.884 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' -4' ' ' SER . . . . . . . . . . . . . 3.0 m -131.3 60.66 1.66 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.172 -0.467 . . . . 63.12 110.818 -179.811 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' -3' ' ' ARG . . . . . . . . . . . . . 14.2 ptp180 -178.87 154.96 0.83 Allowed Pre-proline 0 C--N 1.328 -0.332 0 CA-C-O 121.628 0.728 . . . . 75.53 110.875 -179.917 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' -2' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.79 140.54 42.83 Favored 'Trans proline' 0 C--N 1.342 0.189 0 C-N-CA 122.665 2.243 . . . . 52.43 112.352 -179.996 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' -1' ' ' ALA . . . . . 0.438 ' HB1' ' HD2' ' B' ' 0' ' ' PRO . . . -71.93 156.3 91.08 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-O 121.603 0.716 . . . . 73.32 111.094 179.903 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 0' ' ' PRO . . . . . 0.438 ' HD2' ' HB1' ' B' ' -1' ' ' ALA . 54.0 Cg_endo -69.79 -177.94 2.12 Favored 'Trans proline' 0 C--O 1.231 0.168 0 C-N-CA 122.696 2.264 . . . . 71.35 112.352 -179.996 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 1' ' ' LYS . . . . . . . . . . . . . 3.5 ttpt -129.31 145.49 57.02 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-O 121.576 0.703 . . . . 72.11 110.915 179.939 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 2' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo . . . . . 0 C--N 1.342 0.185 0 C-N-CA 122.718 2.279 . . . . 73.4 112.322 179.904 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 50.3 tp60 . . . . . 0 C--O 1.231 0.103 0 CA-C-O 120.809 0.338 . . . . 73.14 110.885 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 8.9 ptp180 -87.14 163.69 16.81 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.228 -0.442 . . . . 74.52 110.85 -179.934 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -155.18 154.08 31.72 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.192 -0.458 . . . . 73.53 111.07 179.948 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.622 ' HB ' HD11 ' A' ' 58' ' ' ILE . 11.6 p -104.03 149.26 7.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.187 -0.46 . . . . 65.22 111.088 -179.998 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -88.24 105.03 17.27 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.124 -0.489 . . . . 50.13 111.143 179.863 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 0.686 HD21 ' HB2' ' A' ' 56' ' ' SER . 17.6 mt -69.17 -39.21 78.87 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.199 -0.455 . . . . 75.22 110.919 -179.952 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 3.3 m-85 -141.3 156.4 45.86 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.208 -0.451 . . . . 55.14 110.937 179.998 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 1.7 p-10 -79.06 135.05 36.75 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.11 -0.495 . . . . 75.43 110.853 179.914 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 2.1 t80 -134.09 146.06 49.95 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.191 -0.459 . . . . 75.3 110.926 -179.926 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 29.7 tt0 -115.72 135.47 22.68 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.603 0.716 . . . . 74.22 110.922 -179.945 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 12' ' ' PRO . . . . . 0.404 ' HD3' ' HA ' ' A' ' 19' ' ' ARG . 53.3 Cg_endo -69.76 147.64 63.32 Favored 'Trans proline' 0 C--N 1.341 0.154 0 C-N-CA 122.701 2.267 . . . . 73.02 112.347 -179.969 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 13.6 mt-10 -107.72 -18.82 13.73 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.247 -0.433 . . . . 71.41 110.894 -179.98 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 31.1 m-80 -112.8 175.46 5.43 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.133 -0.485 . . . . 70.04 110.899 -179.933 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 36.5 m-20 -90.05 13.4 14.98 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.191 -0.459 . . . . 72.24 110.836 179.949 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 1.2 p-10 -131.32 14.96 5.07 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.232 -0.44 . . . . 74.43 110.895 -179.901 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 23.9 mt-10 -104.29 159.49 15.67 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.122 -0.49 . . . . 74.22 110.9 -179.993 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.508 HD12 ' H ' ' A' ' 48' ' ' GLY . 0.4 OUTLIER -109.62 143.21 39.66 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.213 -0.449 . . . . 75.55 110.924 -179.989 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 19' ' ' ARG . . . . . 0.404 ' HA ' ' HD3' ' A' ' 12' ' ' PRO . 0.0 OUTLIER -81.67 156.37 25.11 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.204 -0.453 . . . . 72.52 110.878 179.951 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.552 HD21 ' CG1' ' A' ' 55' ' ' VAL . 2.7 tp -141.48 148.6 39.72 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.198 -0.455 . . . . 74.43 110.893 -179.976 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.646 ' HB3' ' CG ' ' A' ' 24' ' ' ASP . . . -139.87 136.58 34.09 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.197 -0.456 . . . . 42.14 111.041 179.836 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -50.57 121.83 6.32 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.183 -0.462 . . . . 61.31 110.85 -179.912 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 95.53 -0.77 63.54 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.787 -0.721 . . . . 74.54 112.474 -179.982 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 24' ' ' ASP . . . . . 0.646 ' CG ' ' HB3' ' A' ' 21' ' ' ALA . 1.4 m-20 -86.27 146.04 26.69 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.753 0.311 . . . . 54.34 110.872 -179.964 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 3.2 mm -101.2 137.93 27.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.183 -0.462 . . . . 71.42 111.137 -179.99 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 1.3 m -141.49 158.96 22.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.2 -0.455 . . . . 52.14 111.13 179.873 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 67.1 m-85 -116.5 108.98 16.68 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.185 -0.462 . . . . 72.54 110.905 179.977 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.614 HD13 ' HB2' ' A' ' 39' ' ' ALA . 11.3 mm -72.17 103.24 1.47 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.115 -0.493 . . . . 74.02 111.139 179.986 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 3.5 m -65.06 -39.96 94.04 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.196 -0.456 . . . . 54.21 110.841 -179.88 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 30' ' ' TYR . . . . . 0.496 ' CZ ' HG21 ' A' ' 38' ' ' VAL . 34.6 p90 -174.0 147.19 1.26 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.143 -0.48 . . . . 63.14 110.95 -179.892 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 31' ' ' LYS . . . . . 0.502 ' HG3' HD22 ' A' ' 37' ' ' LEU . 21.4 tttt -80.36 146.04 31.74 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.105 -0.498 . . . . 74.12 110.929 179.922 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 36.0 t60 -136.39 152.53 50.72 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.273 -0.421 . . . . 55.21 110.876 179.921 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -58.01 -174.71 0.43 Allowed Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.737 -0.744 . . . . 73.14 112.432 -179.893 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 58.1 mm-40 65.94 12.08 8.16 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.817 0.341 . . . . 74.35 110.899 -179.867 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 68.01 29.07 73.29 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.747 -0.739 . . . . 70.51 112.463 -179.981 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 36' ' ' TRP . . . . . 0.606 ' C ' HD23 ' A' ' 37' ' ' LEU . 98.7 m95 -123.19 135.97 54.54 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.792 0.329 . . . . 73.32 110.908 -179.898 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.685 HD11 ' CG ' ' A' ' 52' ' ' GLU . 0.7 OUTLIER -121.8 130.22 53.24 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.224 -0.444 . . . . 73.43 110.937 179.965 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.544 HG22 HD23 ' A' ' 49' ' ' LEU . 39.9 t -78.46 111.33 15.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.197 -0.456 . . . . 52.1 111.142 179.837 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 39' ' ' ALA . . . . . 0.614 ' HB2' HD13 ' A' ' 28' ' ' ILE . . . -133.15 167.75 19.78 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.169 -0.469 . . . . 54.34 111.151 179.857 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 1.1 pt-20 -119.12 156.06 30.43 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.283 -0.417 . . . . 73.5 110.901 -179.963 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -71.02 -176.55 1.41 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.125 -0.489 . . . . 72.04 110.904 -179.944 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 4.0 tm-20 -67.51 -38.32 84.11 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.159 -0.473 . . . . 72.41 110.914 179.991 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 1.3 t -57.26 -22.19 39.66 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.166 -0.47 . . . . 74.44 110.831 -179.811 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 65.71 12.89 57.95 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.733 -0.746 . . . . 55.4 112.518 -179.942 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 1.4 t -109.19 -17.31 13.88 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.954 0.407 . . . . 50.15 110.837 -179.733 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -118.89 135.26 54.66 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.121 -0.491 . . . . 72.54 110.87 179.973 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 6.4 m -136.08 144.65 45.27 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.221 -0.445 . . . . 75.25 111.132 179.936 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 48' ' ' GLY . . . . . 0.508 ' H ' HD12 ' A' ' 18' ' ' LEU . . . -166.55 -159.55 12.45 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.76 -0.733 . . . . 54.33 112.449 -180.0 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.544 HD23 HG22 ' A' ' 38' ' ' VAL . 6.4 mt -98.96 134.92 41.11 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.913 0.387 . . . . 70.25 110.934 -179.97 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.45 HG22 ' O ' ' A' ' 37' ' ' LEU . 31.1 m -133.39 153.63 80.58 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-O 121.661 0.743 . . . . 64.03 111.13 179.826 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 51' ' ' PRO . . . . . 0.429 ' HD2' HD22 ' A' ' 20' ' ' LEU . 53.5 Cg_endo -69.82 142.15 46.89 Favored 'Trans proline' 0 C--N 1.341 0.167 0 C-N-CA 122.665 2.243 . . . . 74.2 112.325 -179.995 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 52' ' ' GLU . . . . . 0.685 ' CG ' HD11 ' A' ' 37' ' ' LEU . 26.9 tt0 -89.29 -27.7 20.37 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.244 -0.434 . . . . 62.11 110.902 -179.983 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -86.22 9.86 16.36 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.15 -0.477 . . . . 74.54 110.921 -179.972 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 54' ' ' PHE . . . . . 0.421 ' HB2' ' HG2' ' A' ' 51' ' ' PRO . 1.1 m-85 -119.88 -13.53 9.05 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.128 -0.487 . . . . 74.01 110.875 -179.937 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.552 ' CG1' HD21 ' A' ' 20' ' ' LEU . 19.5 m -115.49 166.37 9.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.142 -0.481 . . . . 74.32 111.088 179.987 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 56' ' ' SER . . . . . 0.686 ' HB2' HD21 ' A' ' 7' ' ' LEU . 35.1 t -138.25 117.58 12.79 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.125 -0.489 . . . . 74.44 110.884 -179.835 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 2.6 m-85 -52.72 133.25 36.87 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.164 -0.471 . . . . 70.03 110.929 -179.847 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.622 HD11 ' HB ' ' A' ' 5' ' ' VAL . 51.8 mt -102.11 147.73 8.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.121 -0.49 . . . . 74.4 111.082 179.953 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.329 -0.289 0 CA-C-O 121.561 0.696 . . . . 73.42 110.953 179.879 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' -7' ' ' PHE . . . . . 0.421 ' HB3' HD11 ' A' ' 49' ' ' LEU . 7.8 m-85 . . . . . 0 C--O 1.231 0.125 0 CA-C-O 120.779 0.323 . . . . 74.24 110.909 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' -6' ' ' ILE . . . . . . . . . . . . . 2.1 pt -153.36 85.36 4.18 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-O 121.56 0.695 . . . . 75.44 111.136 179.998 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' -5' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.76 126.78 13.71 Favored 'Trans proline' 0 C--O 1.231 0.163 0 C-N-CA 122.649 2.233 . . . . 61.34 112.368 179.88 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' -4' ' ' SER . . . . . . . . . . . . . 30.4 t -122.04 57.94 1.04 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.255 -0.43 . . . . 53.42 110.886 -179.852 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' -3' ' ' ARG . . . . . . . . . . . . . 6.9 ptm180 -174.42 153.96 1.94 Allowed Pre-proline 0 C--N 1.329 -0.326 0 CA-C-O 121.602 0.715 . . . . 71.43 110.896 -179.928 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' -2' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.71 142.48 48.25 Favored 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.678 2.252 . . . . 64.13 112.372 179.964 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' -1' ' ' ALA . . . . . . . . . . . . . . . -75.16 154.52 86.4 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.627 0.727 . . . . 65.32 111.076 179.917 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 0' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.78 -177.35 1.84 Allowed 'Trans proline' 0 C--N 1.342 0.213 0 C-N-CA 122.679 2.253 . . . . 62.35 112.375 -179.967 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 1' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -127.56 150.76 73.8 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 121.544 0.688 . . . . 72.34 110.905 179.93 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 2' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo . . . . . 0 C--N 1.342 0.191 0 C-N-CA 122.647 2.231 . . . . 65.54 112.393 179.87 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 52.4 tp60 . . . . . 0 C--O 1.231 0.107 0 CA-C-O 120.765 0.316 . . . . 74.11 110.876 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 5.4 ptp180 -77.56 163.43 26.28 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.209 -0.45 . . . . 64.44 110.873 -179.936 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -158.37 154.73 27.46 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.202 -0.454 . . . . 63.32 111.11 179.981 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.488 ' HB ' HD11 ' A' ' 58' ' ' ILE . 10.8 p -105.66 150.48 8.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.242 -0.435 . . . . 73.34 111.087 179.985 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -89.26 107.86 19.29 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.166 -0.47 . . . . 55.54 111.115 179.859 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 0.728 HD21 ' CB ' ' A' ' 56' ' ' SER . 18.4 mt -71.72 -39.25 70.26 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.247 -0.433 . . . . 60.12 110.943 -179.983 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 4.5 m-85 -140.33 152.74 46.07 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.143 -0.48 . . . . 73.32 110.943 -179.989 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 1.1 p30 -75.29 137.33 41.1 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.136 -0.483 . . . . 75.24 110.92 179.891 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 15.0 t80 -140.19 145.81 37.94 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.249 -0.432 . . . . 63.41 110.877 -179.889 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -114.55 142.7 28.61 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 121.634 0.731 . . . . 74.11 110.918 -179.94 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.78 134.21 27.39 Favored 'Trans proline' 0 C--N 1.341 0.16 0 C-N-CA 122.676 2.251 . . . . 50.25 112.336 -179.973 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 5.4 mt-10 -96.57 -16.99 20.76 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.239 -0.437 . . . . 72.22 110.872 -179.993 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 48.3 m-80 -115.55 175.77 5.37 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.165 -0.47 . . . . 61.52 110.865 -179.939 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 84.5 m-20 -88.77 13.36 12.65 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.169 -0.469 . . . . 73.04 110.854 179.972 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -135.37 21.09 3.4 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.171 -0.468 . . . . 71.12 110.869 -179.951 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 13.0 mt-10 -106.86 161.7 14.46 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.176 -0.465 . . . . 72.4 110.888 -179.989 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.557 HD21 ' HD3' ' A' ' 46' ' ' LYS . 0.4 OUTLIER -111.29 143.42 42.09 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.202 -0.454 . . . . 74.11 110.899 -179.999 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 19' ' ' ARG . . . . . 0.438 ' H ' HD23 ' A' ' 18' ' ' LEU . 16.2 mtm180 -79.58 156.68 27.59 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.193 -0.458 . . . . 71.31 110.903 179.941 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.594 HD21 ' CG1' ' A' ' 55' ' ' VAL . 3.2 tp -142.93 148.78 37.47 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.217 -0.447 . . . . 72.03 110.894 -179.942 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.668 ' HB3' ' CG ' ' A' ' 24' ' ' ASP . . . -141.25 137.01 32.24 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.152 -0.476 . . . . 74.13 111.109 179.821 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -51.09 121.24 5.82 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.237 -0.438 . . . . 62.13 110.874 -179.899 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 97.03 -6.45 64.06 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.738 -0.744 . . . . 54.11 112.464 -179.979 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 24' ' ' ASP . . . . . 0.668 ' CG ' ' HB3' ' A' ' 21' ' ' ALA . 1.1 m-20 -81.04 146.39 30.67 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.76 0.314 . . . . 71.21 110.876 -179.939 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 3.3 mm -100.86 139.79 21.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.211 -0.449 . . . . 74.24 111.139 -179.975 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 1.4 m -143.12 158.17 17.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.192 -0.458 . . . . 74.52 111.104 179.841 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 55.7 m-85 -116.15 108.48 16.22 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.123 -0.49 . . . . 61.21 110.863 -179.959 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.693 HD13 ' HB2' ' A' ' 39' ' ' ALA . 13.4 mm -72.58 103.33 1.62 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.192 -0.458 . . . . 74.42 111.154 179.96 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 3.4 m -64.65 -39.3 93.44 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.12 -0.491 . . . . 64.23 110.897 -179.91 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 30' ' ' TYR . . . . . 0.476 ' CZ ' HG21 ' A' ' 38' ' ' VAL . 32.7 p90 -174.37 146.74 1.1 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.113 -0.494 . . . . 74.4 110.911 -179.863 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 31' ' ' LYS . . . . . 0.535 ' HG3' HD22 ' A' ' 37' ' ' LEU . 18.7 tttt -82.51 145.73 29.62 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.138 -0.483 . . . . 71.32 110.919 179.886 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 29.8 t60 -134.88 153.08 52.19 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.236 -0.438 . . . . 72.45 110.83 179.952 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -58.52 -174.51 0.51 Allowed Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.738 -0.744 . . . . 54.4 112.532 -179.99 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 71.4 mm-40 65.94 12.15 8.21 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.864 0.364 . . . . 74.25 110.936 -179.909 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 68.16 28.62 73.27 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.735 -0.745 . . . . 62.32 112.533 -179.94 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 36' ' ' TRP . . . . . 0.615 ' C ' HD23 ' A' ' 37' ' ' LEU . 98.9 m95 -123.06 135.38 54.39 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.83 0.347 . . . . 74.14 110.907 -179.911 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.668 HD11 ' CG ' ' A' ' 52' ' ' GLU . 0.4 OUTLIER -123.13 135.85 54.53 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.187 -0.46 . . . . 74.4 110.883 -179.963 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.557 HG22 HD23 ' A' ' 49' ' ' LEU . 39.3 t -84.43 114.9 25.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.177 -0.465 . . . . 73.43 111.145 179.814 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 39' ' ' ALA . . . . . 0.693 ' HB2' HD13 ' A' ' 28' ' ' ILE . . . -136.4 168.57 19.2 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.189 -0.46 . . . . 61.42 111.15 179.838 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 1.4 pt-20 -125.64 155.01 41.47 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.211 -0.449 . . . . 64.14 110.829 -179.875 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -67.57 -175.19 0.49 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.15 -0.477 . . . . 61.43 110.87 -179.939 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 -68.9 -37.42 78.97 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.187 -0.461 . . . . 65.2 110.881 -179.962 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 1.6 t -57.02 -22.25 37.23 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.171 -0.468 . . . . 73.01 110.866 -179.816 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 66.89 12.42 59.82 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.699 -0.762 . . . . 74.1 112.489 179.986 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -109.65 -21.93 12.19 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.954 0.407 . . . . 63.21 110.871 -179.72 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.557 ' HD3' HD21 ' A' ' 18' ' ' LEU . 0.1 OUTLIER -112.41 123.92 51.36 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.132 -0.485 . . . . 73.2 110.892 179.962 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 9.7 m -129.69 144.61 51.37 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.247 -0.433 . . . . 72.11 111.117 179.986 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 48' ' ' GLY . . . . . 0.536 ' H ' HD12 ' A' ' 18' ' ' LEU . . . -166.35 -159.22 11.86 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.73 -0.748 . . . . 54.31 112.462 179.98 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.557 HD23 HG22 ' A' ' 38' ' ' VAL . 13.5 mt -99.41 134.52 42.15 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.883 0.373 . . . . 73.25 110.885 -179.893 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.411 ' HB ' ' HD2' ' A' ' 51' ' ' PRO . 10.3 m -134.01 153.43 79.73 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-O 121.606 0.717 . . . . 65.42 111.104 179.908 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 51' ' ' PRO . . . . . 0.419 ' HG2' ' HB2' ' A' ' 54' ' ' PHE . 53.6 Cg_endo -69.8 147.56 62.88 Favored 'Trans proline' 0 N--CA 1.466 -0.134 0 C-N-CA 122.68 2.253 . . . . 75.44 112.357 179.934 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 52' ' ' GLU . . . . . 0.668 ' CG ' HD11 ' A' ' 37' ' ' LEU . 24.6 tt0 -93.07 -28.34 16.42 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.214 -0.448 . . . . 70.43 110.902 -179.965 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 2.5 mm-40 -87.17 11.17 14.69 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.154 -0.475 . . . . 72.21 110.945 -179.963 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 54' ' ' PHE . . . . . 0.419 ' HB2' ' HG2' ' A' ' 51' ' ' PRO . 0.9 OUTLIER -121.1 -9.9 9.1 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.104 -0.498 . . . . 71.4 110.858 -179.939 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.594 ' CG1' HD21 ' A' ' 20' ' ' LEU . 16.2 m -119.65 166.54 13.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.186 -0.461 . . . . 75.21 111.077 -179.996 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 56' ' ' SER . . . . . 0.728 ' CB ' HD21 ' A' ' 7' ' ' LEU . 38.4 t -136.61 119.83 16.7 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.166 -0.47 . . . . 64.02 110.834 -179.859 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 3.1 m-85 -58.33 129.85 43.96 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.118 -0.492 . . . . 74.42 110.892 -179.895 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.488 HD11 ' HB ' ' A' ' 5' ' ' VAL . 39.8 mt -96.51 150.25 4.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.095 -0.502 . . . . 73.04 111.121 179.886 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 1.4 mt-30 . . . . . 0 C--N 1.329 -0.31 0 CA-C-O 121.59 0.71 . . . . 73.53 110.874 179.965 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' B' B ' -7' ' ' PHE . . . . . 0.446 ' HB3' HD11 ' A' ' 49' ' ' LEU . 8.4 m-85 . . . . . 0 C--O 1.232 0.136 0 CA-C-O 120.825 0.345 . . . . 70.15 110.861 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' -6' ' ' ILE . . . . . 0.51 ' O ' HG23 ' B' ' -6' ' ' ILE . 4.1 tp -163.66 88.12 1.21 Allowed Pre-proline 0 C--N 1.328 -0.326 0 CA-C-O 121.662 0.744 . . . . 75.31 111.158 179.922 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' -5' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.78 146.08 58.94 Favored 'Trans proline' 0 C--N 1.341 0.175 0 C-N-CA 122.7 2.267 . . . . 71.2 112.323 179.911 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' -4' ' ' SER . . . . . . . . . . . . . 29.9 t -143.81 67.79 1.28 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.197 -0.456 . . . . 65.33 110.864 -179.845 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' -3' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -179.6 154.75 0.73 Allowed Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.647 0.737 . . . . 74.52 110.855 -179.928 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' -2' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.79 119.76 6.65 Favored 'Trans proline' 0 C--N 1.342 0.188 0 C-N-CA 122.688 2.259 . . . . 74.31 112.37 179.973 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' -1' ' ' ALA . . . . . . . . . . . . . . . -55.54 151.52 20.69 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.572 0.701 . . . . 45.02 111.109 179.886 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 0' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.78 172.3 12.91 Favored 'Trans proline' 0 C--O 1.232 0.197 0 C-N-CA 122.684 2.256 . . . . 55.33 112.365 179.992 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 1' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -120.93 152.87 56.96 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-O 121.553 0.692 . . . . 71.52 110.86 179.943 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 2' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo . . . . . 0 C--N 1.341 0.151 0 C-N-CA 122.703 2.268 . . . . 71.43 112.357 179.872 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 56.6 tp60 . . . . . 0 C--O 1.231 0.112 0 CA-C-O 120.801 0.334 . . . . 41.15 110.95 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 6.8 ptp180 -75.01 162.44 28.57 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.174 -0.466 . . . . 71.14 110.854 -179.905 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -156.59 154.05 29.59 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.189 -0.46 . . . . 52.52 111.119 179.929 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.607 ' HB ' HD11 ' A' ' 58' ' ' ILE . 11.3 p -105.46 148.48 9.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.225 -0.443 . . . . 52.45 111.119 179.973 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -87.4 113.46 23.13 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.165 -0.47 . . . . 34.03 111.088 179.889 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 0.693 HD21 ' HB2' ' A' ' 56' ' ' SER . 15.0 mt -79.04 -37.37 39.19 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.186 -0.461 . . . . 62.24 110.956 179.997 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 5.1 m-85 -142.09 143.33 33.01 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.169 -0.469 . . . . 74.13 110.934 -179.967 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 3.2 p-10 -67.03 132.9 48.84 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.158 -0.474 . . . . 71.13 110.858 179.934 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 5.6 t80 -130.53 145.92 51.95 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.177 -0.465 . . . . 72.11 110.886 -179.865 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 3.8 tp10 -117.13 135.91 23.22 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.618 0.723 . . . . 74.42 110.913 -179.958 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.67 141.07 44.6 Favored 'Trans proline' 0 C--N 1.341 0.167 0 C-N-CA 122.716 2.277 . . . . 74.52 112.314 -179.971 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -105.9 -9.29 17.21 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.213 -0.449 . . . . 72.31 110.883 179.96 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 57.5 m-80 -121.66 175.75 6.07 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.18 -0.464 . . . . 73.23 110.902 -179.962 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -92.99 23.33 4.31 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.2 -0.454 . . . . 72.3 110.869 179.905 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 1.1 p-10 -140.92 13.68 2.27 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.16 -0.473 . . . . 53.44 110.864 -179.932 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 28.5 mt-10 -105.1 167.79 9.48 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.186 -0.461 . . . . 73.34 110.874 -179.976 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.572 HD12 ' H ' ' A' ' 19' ' ' ARG . 30.2 tp -117.3 147.56 42.47 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.166 -0.47 . . . . 65.23 110.938 -179.996 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 19' ' ' ARG . . . . . 0.572 ' H ' HD12 ' A' ' 18' ' ' LEU . 1.9 mtt180 -82.68 156.63 23.72 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.21 -0.45 . . . . 73.34 110.824 179.956 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.548 HD21 ' CG1' ' A' ' 55' ' ' VAL . 3.2 tp -143.5 147.86 35.14 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.15 -0.477 . . . . 71.21 110.928 -179.973 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.655 ' HB3' ' CG ' ' A' ' 24' ' ' ASP . . . -139.64 138.7 36.33 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.167 -0.469 . . . . 74.25 111.043 179.83 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 -51.15 121.55 6.33 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.21 -0.45 . . . . 71.22 110.905 -179.945 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 96.73 -7.42 65.39 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.77 -0.728 . . . . 74.44 112.508 -179.907 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 24' ' ' ASP . . . . . 0.655 ' CG ' ' HB3' ' A' ' 21' ' ' ALA . 1.1 m-20 -79.49 147.73 32.12 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.811 0.338 . . . . 42.5 110.873 -179.982 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 3.2 mm -102.85 140.91 19.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.187 -0.46 . . . . 73.51 111.106 -179.966 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 1.6 m -143.04 158.15 17.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.14 -0.482 . . . . 75.54 111.139 179.803 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 43.7 m-85 -115.62 106.05 13.47 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.183 -0.462 . . . . 64.12 110.884 -179.972 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.886 HD13 ' HB2' ' A' ' 39' ' ' ALA . 22.3 mm -71.02 103.2 1.11 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.152 -0.476 . . . . 50.23 111.095 -179.99 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 3.4 m -64.95 -39.28 93.25 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.186 -0.461 . . . . 60.44 110.872 -179.91 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 30' ' ' TYR . . . . . 0.472 ' CZ ' HG21 ' A' ' 38' ' ' VAL . 34.1 p90 -174.32 147.52 1.18 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.111 -0.495 . . . . 71.34 110.907 -179.917 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 31' ' ' LYS . . . . . 0.549 ' HG3' HD22 ' A' ' 37' ' ' LEU . 19.7 tttt -81.51 146.29 30.26 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.116 -0.493 . . . . 74.25 110.922 179.877 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 33.2 t60 -134.87 156.52 48.79 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.259 -0.428 . . . . 75.13 110.888 179.856 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -61.15 -174.06 1.25 Allowed Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.719 -0.753 . . . . 54.01 112.511 -179.982 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 45.4 mm-40 64.66 13.23 8.18 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.838 0.352 . . . . 74.14 110.92 -179.899 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 67.99 29.2 73.38 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.725 -0.75 . . . . 75.23 112.485 -179.986 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 36' ' ' TRP . . . . . 0.654 ' C ' HD23 ' A' ' 37' ' ' LEU . 98.9 m95 -123.29 138.34 54.64 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.83 0.347 . . . . 73.41 110.891 -179.881 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.71 HD11 ' CG ' ' A' ' 52' ' ' GLU . 0.5 OUTLIER -126.21 132.26 51.8 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.256 -0.429 . . . . 74.54 110.93 179.964 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.472 HG21 ' CZ ' ' A' ' 30' ' ' TYR . 51.8 t -77.38 115.75 19.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.206 -0.452 . . . . 74.22 111.143 179.858 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 39' ' ' ALA . . . . . 0.886 ' HB2' HD13 ' A' ' 28' ' ' ILE . . . -133.95 158.86 42.41 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.178 -0.465 . . . . 62.02 111.092 179.886 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 1.9 pt-20 -120.5 153.55 36.51 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.2 -0.455 . . . . 63.15 110.911 -179.943 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -67.94 -175.05 0.52 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.195 -0.457 . . . . 74.04 110.892 -179.971 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -69.81 -38.41 76.59 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.153 -0.476 . . . . 73.43 110.924 179.999 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 15.4 m -56.43 -22.73 33.83 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.111 -0.495 . . . . 64.42 110.916 -179.873 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 68.85 9.27 59.13 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.755 -0.736 . . . . 60.52 112.485 -179.992 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 39.0 m -105.06 -20.21 13.59 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.983 0.421 . . . . 62.24 110.899 -179.767 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.521 ' HE2' HD11 ' A' ' 18' ' ' LEU . 0.1 OUTLIER -113.24 123.67 50.73 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.092 -0.504 . . . . 72.22 110.882 179.946 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 11.4 m -134.54 127.1 30.65 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.183 -0.462 . . . . 60.4 111.1 -179.992 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -147.34 -154.36 6.2 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.725 -0.75 . . . . 53.42 112.471 179.944 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 6.9 mt -106.1 127.22 53.04 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.878 0.37 . . . . 65.13 110.897 -179.91 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.45 ' CG1' HD23 ' A' ' 18' ' ' LEU . 14.4 m -124.5 154.26 69.58 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-O 121.588 0.709 . . . . 54.11 111.186 179.818 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 51' ' ' PRO . . . . . 0.435 ' HG2' ' HB2' ' A' ' 54' ' ' PHE . 53.3 Cg_endo -69.77 147.12 62.11 Favored 'Trans proline' 0 N--CA 1.465 -0.151 0 C-N-CA 122.722 2.281 . . . . 71.25 112.316 179.997 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 52' ' ' GLU . . . . . 0.71 ' CG ' HD11 ' A' ' 37' ' ' LEU . 27.8 tt0 -92.02 -29.86 16.37 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.234 -0.439 . . . . 74.1 110.897 -179.997 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -84.91 9.89 13.18 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.132 -0.485 . . . . 74.4 110.878 -179.916 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 54' ' ' PHE . . . . . 0.435 ' HB2' ' HG2' ' A' ' 51' ' ' PRO . 1.0 OUTLIER -120.78 -8.46 9.44 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.177 -0.465 . . . . 73.42 110.887 -179.901 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.548 ' CG1' HD21 ' A' ' 20' ' ' LEU . 20.4 m -118.86 171.98 6.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.123 -0.49 . . . . 75.02 111.115 179.996 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 56' ' ' SER . . . . . 0.693 ' HB2' HD21 ' A' ' 7' ' ' LEU . 35.6 t -143.59 113.51 7.18 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.175 -0.466 . . . . 74.42 110.806 -179.774 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 2.9 m-85 -52.54 133.28 35.89 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.115 -0.493 . . . . 73.0 110.922 -179.914 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.607 HD11 ' HB ' ' A' ' 5' ' ' VAL . 46.0 mt -102.46 148.63 7.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.099 -0.5 . . . . 75.11 111.137 179.899 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 5.0 mt-30 . . . . . 0 C--N 1.329 -0.306 0 CA-C-O 121.632 0.729 . . . . 75.44 110.834 179.971 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' B' B ' -7' ' ' PHE . . . . . . . . . . . . . 11.3 m-85 . . . . . 0 C--O 1.231 0.087 0 CA-C-O 120.862 0.363 . . . . 63.11 110.876 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' B' B ' -6' ' ' ILE . . . . . 0.414 ' O ' HG23 ' B' ' -6' ' ' ILE . 8.4 tt -133.72 119.16 14.82 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 121.576 0.703 . . . . 75.42 111.171 179.974 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' -5' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.73 154.47 67.83 Favored 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 122.681 2.254 . . . . 72.02 112.318 179.92 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' -4' ' ' SER . . . . . . . . . . . . . 41.3 t -133.78 39.18 3.18 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.19 -0.459 . . . . 62.22 110.853 -179.843 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' -3' ' ' ARG . . . . . . . . . . . . . 5.9 ptm180 -174.48 154.48 1.98 Allowed Pre-proline 0 C--N 1.328 -0.334 0 CA-C-O 121.661 0.744 . . . . 73.23 110.838 -179.894 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' -2' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.79 137.9 36.46 Favored 'Trans proline' 0 C--N 1.342 0.189 0 C-N-CA 122.634 2.223 . . . . 62.01 112.334 179.996 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' -1' ' ' ALA . . . . . . . . . . . . . . . -63.39 154.74 77.84 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.519 0.676 . . . . 52.14 111.086 179.9 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 0' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.76 -170.55 0.4 Allowed 'Trans proline' 0 C--O 1.232 0.176 0 C-N-CA 122.675 2.25 . . . . 64.32 112.325 179.982 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 1' ' ' LYS . . . . . . . . . . . . . 27.8 mtpp -130.11 154.58 81.33 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-O 121.575 0.702 . . . . 73.32 110.87 179.942 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 2' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo . . . . . 0 C--N 1.342 0.186 0 C-N-CA 122.732 2.288 . . . . 72.34 112.33 179.881 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 51.6 tp60 . . . . . 0 C--O 1.23 0.075 0 CA-C-O 120.824 0.345 . . . . 73.22 110.891 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 7.7 ptp180 -86.37 161.78 18.51 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.138 -0.483 . . . . 65.43 110.826 -179.909 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -153.3 154.46 34.63 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.154 -0.476 . . . . 71.15 111.101 179.892 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.641 ' HB ' HD11 ' A' ' 58' ' ' ILE . 9.2 p -103.9 153.09 6.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.226 -0.443 . . . . 75.54 111.115 179.981 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -92.06 113.68 26.02 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.149 -0.478 . . . . 60.14 111.086 179.891 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 0.663 HD21 ' HB2' ' A' ' 56' ' ' SER . 13.5 mt -79.59 -36.1 38.63 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.211 -0.449 . . . . 74.25 110.923 -179.977 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 2.8 m-85 -144.09 146.11 32.59 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.179 -0.464 . . . . 64.42 110.941 179.995 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 1.3 p30 -68.47 135.2 51.28 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.091 -0.504 . . . . 64.32 110.869 179.909 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 7.5 t80 -134.24 146.21 49.86 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.156 -0.475 . . . . 74.54 110.87 -179.915 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 68.5 tt0 -115.15 137.59 23.06 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-O 121.66 0.743 . . . . 62.24 110.867 -179.869 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.75 137.25 35.06 Favored 'Trans proline' 0 C--N 1.341 0.155 0 C-N-CA 122.665 2.243 . . . . 75.53 112.34 -179.986 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 7.9 mm-40 -97.66 -20.2 17.78 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.222 -0.445 . . . . 62.15 110.901 -179.987 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 32.2 m-80 -115.15 175.3 5.57 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.134 -0.484 . . . . 63.34 110.869 -179.967 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 26.2 m-20 -87.25 7.97 26.15 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.181 -0.463 . . . . 64.34 110.861 179.912 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -125.13 16.76 8.45 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.23 -0.441 . . . . 75.2 110.915 -179.888 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 16.4 mt-10 -108.37 156.59 19.25 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.164 -0.471 . . . . 73.31 110.888 179.986 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.631 HD11 ' HG3' ' A' ' 46' ' ' LYS . 0.5 OUTLIER -106.51 150.39 26.16 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.119 -0.491 . . . . 60.11 110.917 -179.969 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 19' ' ' ARG . . . . . 0.617 ' O ' HD23 ' A' ' 18' ' ' LEU . 26.1 mtm180 -85.16 153.27 22.76 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.167 -0.469 . . . . 70.23 110.852 179.976 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.548 HD21 ' CG1' ' A' ' 55' ' ' VAL . 1.7 tp -138.09 148.11 44.68 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.199 -0.455 . . . . 72.21 110.941 -179.968 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.612 ' HB3' ' CG ' ' A' ' 24' ' ' ASP . . . -140.18 139.24 35.66 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.231 -0.44 . . . . 52.42 111.147 179.786 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -50.29 119.72 3.93 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.249 -0.432 . . . . 74.4 110.88 -179.934 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 98.5 -6.86 61.28 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.773 -0.727 . . . . 61.41 112.456 179.973 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 24' ' ' ASP . . . . . 0.612 ' CG ' ' HB3' ' A' ' 21' ' ' ALA . 2.9 m-20 -75.78 152.78 37.29 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.792 0.329 . . . . 74.03 110.845 -179.997 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 1.3 mt -116.77 122.2 69.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.17 -0.468 . . . . 73.34 111.176 179.933 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.633 HG12 ' HA ' ' A' ' 41' ' ' ASN . 3.6 m -124.64 163.41 24.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.168 -0.469 . . . . 54.21 111.132 179.894 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 74.5 m-85 -116.35 110.1 18.24 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.145 -0.479 . . . . 72.43 110.853 -179.994 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.633 HD13 ' HB2' ' A' ' 39' ' ' ALA . 13.4 mm -71.85 103.0 1.31 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.117 -0.492 . . . . 65.22 111.106 179.955 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 5.4 m -65.53 -40.77 93.33 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.192 -0.458 . . . . 73.35 110.822 -179.904 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 30' ' ' TYR . . . . . 0.517 ' CZ ' HG21 ' A' ' 38' ' ' VAL . 33.4 p90 -174.27 149.87 1.43 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.154 -0.476 . . . . 75.34 110.958 -179.899 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 19.1 tttt -81.37 143.1 32.41 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.168 -0.469 . . . . 63.54 110.856 179.928 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 32.9 t60 -131.91 153.35 50.34 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.206 -0.452 . . . . 75.54 110.889 179.872 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -59.24 -174.69 0.69 Allowed Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.732 -0.747 . . . . 52.15 112.486 -179.932 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 29.8 mm-40 66.17 11.76 8.07 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.789 0.328 . . . . 73.43 110.88 -179.897 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 68.69 28.77 72.9 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.767 -0.73 . . . . 55.32 112.484 -179.947 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 36' ' ' TRP . . . . . 0.598 ' C ' HD23 ' A' ' 37' ' ' LEU . 98.0 m95 -122.9 136.36 54.83 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.744 0.307 . . . . 64.52 110.953 -179.958 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.712 HD11 ' CG ' ' A' ' 52' ' ' GLU . 1.4 mt -118.71 131.93 56.15 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.297 -0.411 . . . . 73.5 110.85 -179.985 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.657 HG22 HD23 ' A' ' 49' ' ' LEU . 23.4 t -81.34 109.35 15.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.151 -0.477 . . . . 71.11 111.116 179.804 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 39' ' ' ALA . . . . . 0.633 ' HB2' HD13 ' A' ' 28' ' ' ILE . . . -132.71 165.4 24.59 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.16 -0.473 . . . . 75.33 111.084 179.847 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -115.93 156.32 26.42 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.216 -0.447 . . . . 71.31 110.907 -179.97 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 41' ' ' ASN . . . . . 0.633 ' HA ' HG12 ' A' ' 26' ' ' VAL . 0.0 OUTLIER -69.77 179.33 2.23 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.138 -0.483 . . . . 74.12 110.873 -179.904 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 61.3 tt0 -63.5 -39.8 95.4 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.223 -0.444 . . . . 63.53 110.956 179.96 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 1.5 t -55.73 -22.77 25.47 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.085 -0.507 . . . . 75.45 110.861 -179.819 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 66.15 11.87 56.47 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.754 -0.736 . . . . 33.22 112.503 -179.967 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 16.5 m -107.75 -18.72 13.75 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.969 0.414 . . . . 60.04 110.841 -179.73 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.631 ' HG3' HD11 ' A' ' 18' ' ' LEU . 4.0 ptmt -117.16 133.68 55.7 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.142 -0.481 . . . . 73.44 110.871 -179.999 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 47' ' ' THR . . . . . 0.423 ' C ' HD12 ' A' ' 18' ' ' LEU . 4.9 m -129.26 152.68 48.56 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.259 -0.428 . . . . 72.1 111.149 179.991 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -177.35 -161.04 25.15 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.744 -0.741 . . . . 75.2 112.515 179.976 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.657 HD23 HG22 ' A' ' 38' ' ' VAL . 6.7 mt -99.53 136.89 38.79 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.833 0.349 . . . . 63.23 110.873 -179.905 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 6.0 m -135.31 153.1 77.81 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.666 0.746 . . . . 51.43 111.116 179.839 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 51' ' ' PRO . . . . . 0.423 ' HD2' HD22 ' A' ' 20' ' ' LEU . 53.6 Cg_endo -69.79 143.85 52.02 Favored 'Trans proline' 0 C--N 1.342 0.195 0 C-N-CA 122.63 2.22 . . . . 73.21 112.325 -179.999 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 52' ' ' GLU . . . . . 0.712 ' CG ' HD11 ' A' ' 37' ' ' LEU . 10.1 tm-20 -91.0 -27.2 18.81 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.221 -0.445 . . . . 71.23 110.874 -179.972 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -87.51 11.71 14.15 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.19 -0.459 . . . . 61.1 110.871 -179.958 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 54' ' ' PHE . . . . . 0.413 ' HB2' ' HG2' ' A' ' 51' ' ' PRO . 1.1 m-85 -121.23 -12.79 8.6 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.141 -0.481 . . . . 74.53 110.833 -179.895 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.548 ' CG1' HD21 ' A' ' 20' ' ' LEU . 17.3 m -116.69 168.73 7.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.141 -0.482 . . . . 71.14 111.14 179.988 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 56' ' ' SER . . . . . 0.663 ' HB2' HD21 ' A' ' 7' ' ' LEU . 45.2 t -138.83 116.52 11.43 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.172 -0.467 . . . . 74.23 110.854 -179.834 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 2.8 m-85 -51.87 134.53 31.21 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.1 -0.5 . . . . 70.43 110.909 -179.902 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.641 HD11 ' HB ' ' A' ' 5' ' ' VAL . 54.2 mt -104.04 146.61 11.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.087 -0.506 . . . . 73.32 111.153 179.905 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 2.5 mt-30 . . . . . 0 C--N 1.328 -0.353 0 CA-C-O 121.576 0.703 . . . . 73.31 110.936 179.968 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' B' B ' -7' ' ' PHE . . . . . 0.42 ' HB3' HD11 ' A' ' 49' ' ' LEU . 8.8 m-85 . . . . . 0 C--O 1.231 0.124 0 CA-C-O 120.795 0.331 . . . . 54.5 110.886 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' -6' ' ' ILE . . . . . 0.466 ' O ' HG23 ' B' ' -6' ' ' ILE . 4.5 tt -155.47 84.87 3.47 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-O 121.65 0.738 . . . . 74.55 111.109 179.994 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' -5' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.74 132.21 22.89 Favored 'Trans proline' 0 C--N 1.342 0.202 0 C-N-CA 122.707 2.272 . . . . 63.43 112.351 179.877 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' -4' ' ' SER . . . . . . . . . . . . . 1.4 t -129.74 64.26 1.51 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.224 -0.444 . . . . 74.51 110.866 -179.858 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' -3' ' ' ARG . . . . . . . . . . . . . 4.9 ptm180 -178.32 155.0 0.94 Allowed Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.641 0.734 . . . . 73.42 110.839 -179.91 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' -2' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.76 129.49 17.69 Favored 'Trans proline' 0 C--N 1.342 0.194 0 C-N-CA 122.654 2.236 . . . . 74.32 112.384 179.973 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' -1' ' ' ALA . . . . . 0.506 ' HB1' ' HD2' ' B' ' 0' ' ' PRO . . . -61.34 157.85 41.95 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-O 121.55 0.691 . . . . 73.41 111.135 179.879 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 0' ' ' PRO . . . . . 0.506 ' HD2' ' HB1' ' B' ' -1' ' ' ALA . 53.7 Cg_endo -69.76 -176.24 1.42 Allowed 'Trans proline' 0 C--O 1.231 0.156 0 C-N-CA 122.71 2.273 . . . . 74.34 112.345 -179.985 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 1' ' ' LYS . . . . . . . . . . . . . 37.2 tttp -131.77 137.55 30.55 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-O 121.542 0.687 . . . . 73.23 110.918 179.887 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 2' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo . . . . . 0 C--O 1.232 0.204 0 C-N-CA 122.725 2.283 . . . . 72.14 112.338 179.941 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 51.1 tp60 . . . . . 0 C--O 1.231 0.114 0 CA-C-O 120.827 0.346 . . . . 70.12 110.914 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 5.5 ptp180 -80.19 160.97 25.45 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.213 -0.448 . . . . 71.21 110.867 -179.886 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -155.42 154.43 31.91 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.204 -0.453 . . . . 74.04 111.116 179.955 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.493 ' HB ' HD11 ' A' ' 58' ' ' ILE . 10.7 p -104.28 149.6 7.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.258 -0.428 . . . . 60.4 111.117 -179.988 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -87.3 110.12 19.99 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.195 -0.457 . . . . 74.25 111.091 179.899 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 0.749 HD21 ' CB ' ' A' ' 56' ' ' SER . 16.6 mt -74.2 -37.45 63.88 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.226 -0.443 . . . . 60.12 110.912 -179.941 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 5.4 m-85 -142.34 154.87 45.03 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.196 -0.456 . . . . 72.41 110.945 179.992 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 1.6 p30 -78.94 137.49 37.65 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.112 -0.495 . . . . 53.11 110.898 179.882 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 9.9 t80 -138.84 145.49 40.1 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.211 -0.45 . . . . 64.02 110.871 -179.959 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 22.5 tt0 -114.28 135.46 22.2 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 121.617 0.722 . . . . 75.11 110.891 -179.926 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 12' ' ' PRO . . . . . 0.409 ' HD3' ' HA ' ' A' ' 19' ' ' ARG . 53.2 Cg_endo -69.8 152.62 69.13 Favored 'Trans proline' 0 C--N 1.341 0.162 0 C-N-CA 122.702 2.268 . . . . 71.42 112.353 -179.996 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 22.4 tp10 -116.52 -20.72 9.51 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.205 -0.452 . . . . 72.21 110.898 -179.95 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 7.4 m-80 -106.53 176.04 5.3 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.14 -0.482 . . . . 71.52 110.834 -179.926 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 15.8 m-20 -92.2 21.41 5.15 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.177 -0.465 . . . . 74.34 110.851 179.923 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 1.2 p-10 -141.16 12.51 2.2 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.22 -0.445 . . . . 75.13 110.888 -179.876 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 -101.68 156.05 17.73 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.167 -0.469 . . . . 74.34 110.894 -179.985 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.619 HD12 ' H ' ' A' ' 19' ' ' ARG . 31.5 tp -108.46 144.94 35.4 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.142 -0.481 . . . . 71.21 110.89 -179.949 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 19' ' ' ARG . . . . . 0.619 ' H ' HD12 ' A' ' 18' ' ' LEU . 14.6 mtp180 -81.18 153.09 27.4 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.215 -0.448 . . . . 74.5 110.902 179.935 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.535 HD21 ' CG1' ' A' ' 55' ' ' VAL . 2.6 tp -138.99 148.42 43.44 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.236 -0.438 . . . . 72.24 110.904 -179.944 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.669 ' HB3' ' CG ' ' A' ' 24' ' ' ASP . . . -139.92 137.23 34.63 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.197 -0.456 . . . . 63.3 111.131 179.767 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -50.7 120.03 4.37 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.234 -0.439 . . . . 63.2 110.896 -179.91 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 97.9 -5.77 61.9 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.761 -0.733 . . . . 50.13 112.482 -179.945 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 24' ' ' ASP . . . . . 0.669 ' CG ' ' HB3' ' A' ' 21' ' ' ALA . 1.1 m-20 -81.77 147.29 29.49 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.785 0.326 . . . . 73.22 110.861 -179.944 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 3.4 mm -100.94 142.46 15.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.224 -0.444 . . . . 62.23 111.086 -179.982 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.425 HG11 HD11 ' A' ' 20' ' ' LEU . 1.4 m -145.27 158.24 13.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.181 -0.463 . . . . 43.33 111.128 179.859 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 65.0 m-85 -116.95 108.26 15.57 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.155 -0.475 . . . . 61.35 110.892 -179.964 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.732 HD13 ' HB2' ' A' ' 39' ' ' ALA . 16.5 mm -71.78 103.28 1.36 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.16 -0.473 . . . . 63.32 111.125 179.975 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 11.4 m -65.4 -40.17 93.09 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.119 -0.491 . . . . 72.14 110.833 -179.902 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 30' ' ' TYR . . . . . 0.508 ' CZ ' HG21 ' A' ' 38' ' ' VAL . 36.5 p90 -174.53 150.08 1.36 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.104 -0.498 . . . . 75.42 110.892 -179.873 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 31' ' ' LYS . . . . . 0.448 ' HG3' HD22 ' A' ' 37' ' ' LEU . 13.4 tttt -82.07 144.44 30.82 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.094 -0.503 . . . . 73.13 110.885 179.903 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 31.7 t60 -132.75 156.15 47.59 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.244 -0.434 . . . . 74.31 110.858 179.919 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -61.21 -174.31 1.34 Allowed Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.771 -0.728 . . . . 43.42 112.42 -179.926 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 63.1 mm-40 65.35 12.84 8.4 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.852 0.358 . . . . 64.43 110.946 -179.885 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 68.41 28.98 72.95 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.697 -0.763 . . . . 54.22 112.499 -179.997 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 36' ' ' TRP . . . . . 0.616 ' C ' HD23 ' A' ' 37' ' ' LEU . 98.8 m95 -123.45 137.54 54.77 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.857 0.36 . . . . 75.04 110.894 -179.912 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.748 HD11 ' CG ' ' A' ' 52' ' ' GLU . 0.6 OUTLIER -121.9 130.47 53.38 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.215 -0.448 . . . . 75.25 110.896 179.979 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.508 HG21 ' CZ ' ' A' ' 30' ' ' TYR . 42.8 t -77.32 116.01 20.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.175 -0.466 . . . . 61.24 111.087 179.845 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 39' ' ' ALA . . . . . 0.732 ' HB2' HD13 ' A' ' 28' ' ' ILE . . . -138.05 161.79 35.83 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.18 -0.464 . . . . 65.21 111.101 179.85 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 1.2 pt-20 -113.45 156.86 22.76 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.209 -0.45 . . . . 72.52 110.867 -179.923 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -72.4 -176.26 1.82 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.13 -0.486 . . . . 74.04 110.883 -179.932 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 9.6 tt0 -68.16 -38.5 82.18 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.188 -0.46 . . . . 63.01 110.908 -179.975 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 1.5 t -57.02 -22.22 37.08 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.137 -0.483 . . . . 50.03 110.83 -179.827 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 65.8 12.77 57.84 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.737 -0.744 . . . . 75.31 112.483 -179.993 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -109.13 -15.99 14.2 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.972 0.415 . . . . 71.32 110.863 -179.779 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -120.11 135.08 55.08 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.137 -0.483 . . . . 74.0 110.941 179.949 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 5.6 m -136.36 140.28 43.15 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.252 -0.431 . . . . 72.11 111.156 179.985 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -161.8 -153.7 7.19 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.743 -0.741 . . . . 61.03 112.472 -179.997 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.448 HD11 ' HB3' ' B' ' -7' ' ' PHE . 9.0 mt -104.05 135.0 46.37 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.818 0.342 . . . . 71.14 110.928 -179.932 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 10.2 m -133.94 153.02 79.6 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 121.604 0.716 . . . . 54.5 111.152 179.825 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 51' ' ' PRO . . . . . 0.414 ' HG2' ' HB2' ' A' ' 54' ' ' PHE . 53.3 Cg_endo -69.81 147.78 63.29 Favored 'Trans proline' 0 C--N 1.341 0.161 0 C-N-CA 122.618 2.212 . . . . 71.32 112.337 180.0 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 52' ' ' GLU . . . . . 0.748 ' CG ' HD11 ' A' ' 37' ' ' LEU . 15.5 tm-20 -92.77 -28.91 16.3 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.211 -0.45 . . . . 61.21 110.886 -179.97 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -86.59 10.55 15.14 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.15 -0.477 . . . . 62.33 110.881 -179.917 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 54' ' ' PHE . . . . . 0.414 ' HB2' ' HG2' ' A' ' 51' ' ' PRO . 0.9 OUTLIER -121.31 -4.31 9.42 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.152 -0.476 . . . . 72.44 110.852 -179.902 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.535 ' CG1' HD21 ' A' ' 20' ' ' LEU . 16.0 m -125.93 166.61 21.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.169 -0.468 . . . . 63.21 111.155 179.94 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 56' ' ' SER . . . . . 0.749 ' CB ' HD21 ' A' ' 7' ' ' LEU . 30.0 t -136.21 118.99 16.14 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.166 -0.47 . . . . 71.31 110.888 -179.836 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 -57.71 128.22 35.98 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.161 -0.472 . . . . 65.12 110.901 -179.847 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.493 HD11 ' HB ' ' A' ' 5' ' ' VAL . 49.6 mt -94.69 148.19 5.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.165 -0.47 . . . . 55.04 111.127 179.918 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 2.5 mt-30 . . . . . 0 C--N 1.329 -0.315 0 CA-C-O 121.573 0.702 . . . . 74.41 110.957 179.923 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' B' B ' -7' ' ' PHE . . . . . 0.448 ' HB3' HD11 ' A' ' 49' ' ' LEU . 18.0 m-85 . . . . . 0 C--O 1.231 0.086 0 CA-C-O 120.85 0.357 . . . . 60.14 110.855 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' -6' ' ' ILE . . . . . . . . . . . . . 58.8 mt -149.91 93.33 3.96 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 121.59 0.71 . . . . 55.42 111.124 179.954 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' -5' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.75 122.1 8.78 Favored 'Trans proline' 0 C--O 1.232 0.178 0 C-N-CA 122.637 2.225 . . . . 61.1 112.351 179.894 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' -4' ' ' SER . . . . . . . . . . . . . 22.7 m -117.18 59.95 0.76 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.254 -0.43 . . . . 41.5 110.893 -179.868 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' -3' ' ' ARG . . . . . . . . . . . . . 8.8 ptm180 -176.69 153.36 1.15 Allowed Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 121.634 0.731 . . . . 73.3 110.867 -179.927 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' -2' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.77 145.56 57.42 Favored 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.661 2.24 . . . . 73.03 112.323 -179.964 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' -1' ' ' ALA . . . . . . . . . . . . . . . -75.93 141.92 72.18 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.567 0.699 . . . . 34.34 111.105 179.848 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 0' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.75 175.13 8.5 Favored 'Trans proline' 0 C--N 1.341 0.169 0 C-N-CA 122.712 2.275 . . . . 74.11 112.36 179.959 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 1' ' ' LYS . . . . . . . . . . . . . 16.7 ptmt -124.31 152.71 68.27 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-O 121.551 0.691 . . . . 72.25 110.93 179.891 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 2' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo . . . . . 0 C--O 1.232 0.202 0 C-N-CA 122.744 2.296 . . . . 71.41 112.349 179.877 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 40.2 tp60 . . . . . 0 C--O 1.232 0.141 0 CA-C-O 120.755 0.312 . . . . 71.41 110.899 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 5.0 ptp180 -76.83 160.39 29.3 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.189 -0.46 . . . . 75.33 110.835 -179.898 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -155.33 149.83 26.17 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.208 -0.451 . . . . 51.14 111.094 179.913 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.611 ' HB ' HD11 ' A' ' 58' ' ' ILE . 8.7 p -105.41 142.21 19.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.25 -0.432 . . . . 70.11 111.14 179.985 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 6' ' ' ALA . . . . . 0.439 ' HA ' HG12 ' A' ' 55' ' ' VAL . . . -82.94 127.74 33.81 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.178 -0.465 . . . . 65.35 111.093 179.866 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 0.512 HD21 ' CB ' ' A' ' 56' ' ' SER . 7.6 mt -93.23 -31.68 14.65 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.221 -0.445 . . . . 72.23 110.889 -179.985 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 4.5 m-85 -144.18 136.12 26.22 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.185 -0.461 . . . . 50.44 110.924 -179.96 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 3.4 p30 -62.3 141.68 58.15 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.153 -0.476 . . . . 63.03 110.852 179.911 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 24.1 t80 -141.87 145.87 35.14 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.193 -0.458 . . . . 63.34 110.895 -179.918 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 28.6 tt0 -115.64 137.0 22.91 Favored Pre-proline 0 C--N 1.33 -0.257 0 CA-C-O 121.657 0.741 . . . . 64.04 110.912 -179.945 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.73 146.43 60.31 Favored 'Trans proline' 0 C--N 1.341 0.181 0 C-N-CA 122.687 2.258 . . . . 71.23 112.35 -179.961 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 7.3 mm-40 -107.87 -12.74 15.13 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.267 -0.424 . . . . 75.21 110.886 180.0 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 28.6 m-80 -118.98 175.48 5.74 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.185 -0.461 . . . . 71.44 110.906 -179.97 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 63.7 m-20 -90.83 15.87 10.44 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.206 -0.452 . . . . 53.53 110.833 -179.993 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 1.1 p-10 -134.08 16.74 3.81 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.192 -0.458 . . . . 72.43 110.873 -179.888 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 3.9 mm-40 -106.98 160.84 15.23 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.149 -0.478 . . . . 74.3 110.867 -179.969 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.649 HD21 ' HD2' ' A' ' 46' ' ' LYS . 0.5 OUTLIER -111.44 142.86 43.15 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.147 -0.479 . . . . 75.15 110.954 179.994 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 19' ' ' ARG . . . . . 0.553 ' H ' HD23 ' A' ' 18' ' ' LEU . 36.2 mtm-85 -78.44 156.8 29.21 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.21 -0.45 . . . . 73.42 110.872 179.981 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.539 HD22 ' HD2' ' A' ' 51' ' ' PRO . 3.1 tp -141.65 148.85 39.81 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.165 -0.47 . . . . 74.52 110.914 -179.993 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.436 ' O ' ' HB3' ' A' ' 6' ' ' ALA . . . -138.56 139.9 38.84 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.214 -0.448 . . . . 72.42 111.119 179.73 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -53.64 119.31 4.75 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.215 -0.448 . . . . 73.24 110.888 -179.917 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 93.16 0.83 67.54 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.726 -0.749 . . . . 55.23 112.469 -179.978 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 20.5 t70 -77.2 158.73 30.16 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.809 0.338 . . . . 75.32 110.84 -179.948 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 1.7 mm -111.14 121.32 63.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.164 -0.471 . . . . 74.4 111.168 179.996 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.523 HG11 HD11 ' A' ' 20' ' ' LEU . 3.7 m -130.59 155.7 41.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.25 -0.432 . . . . 72.34 111.16 179.827 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 66.2 m-85 -115.56 109.08 17.27 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.218 -0.446 . . . . 72.35 110.895 -179.94 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.744 HD13 ' HB2' ' A' ' 39' ' ' ALA . 16.5 mm -73.0 103.8 1.89 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.133 -0.485 . . . . 63.34 111.11 -179.989 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 2.6 m -64.48 -39.56 94.03 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.196 -0.456 . . . . 55.12 110.848 -179.882 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 30' ' ' TYR . . . . . 0.482 ' CZ ' HG21 ' A' ' 38' ' ' VAL . 32.5 p90 -174.1 146.79 1.19 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.124 -0.489 . . . . 73.2 110.946 -179.902 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 31' ' ' LYS . . . . . 0.489 ' HG3' HD22 ' A' ' 37' ' ' LEU . 21.0 tttt -80.2 146.27 31.84 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.119 -0.492 . . . . 74.13 110.917 179.935 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 31.8 t60 -136.53 152.74 50.85 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.246 -0.434 . . . . 63.14 110.809 179.941 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -58.19 -174.96 0.48 Allowed Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.76 -0.733 . . . . 51.12 112.491 -179.98 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 56.4 mm-40 65.88 12.2 8.21 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.777 0.322 . . . . 74.21 110.856 -179.92 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 68.12 28.73 73.26 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.721 -0.752 . . . . 62.03 112.475 179.995 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 36' ' ' TRP . . . . . 0.612 ' C ' HD23 ' A' ' 37' ' ' LEU . 98.6 m95 -122.76 136.18 54.79 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.797 0.332 . . . . 71.23 110.913 -179.921 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.684 HD11 ' CG ' ' A' ' 52' ' ' GLU . 0.6 OUTLIER -122.74 130.78 53.33 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.225 -0.443 . . . . 72.34 110.888 179.983 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.482 HG21 ' CZ ' ' A' ' 30' ' ' TYR . 40.7 t -78.72 111.71 15.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.155 -0.475 . . . . 63.12 111.152 179.808 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 39' ' ' ALA . . . . . 0.744 ' HB2' HD13 ' A' ' 28' ' ' ILE . . . -131.57 168.28 17.95 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.167 -0.469 . . . . 62.13 111.054 179.915 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 40' ' ' GLU . . . . . 0.407 ' HA ' ' HA ' ' A' ' 47' ' ' THR . 0.8 OUTLIER -121.92 159.39 26.98 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.153 -0.476 . . . . 72.04 110.893 -179.931 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 41.7 p-10 -58.57 -174.82 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.131 -0.486 . . . . 74.43 110.901 -179.936 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 66.5 tt0 -78.03 -37.18 47.48 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.215 -0.448 . . . . 73.14 110.919 179.996 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 37.3 t -70.64 -22.32 62.52 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.146 -0.479 . . . . 60.15 110.892 -179.834 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 75.93 26.52 64.4 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.754 -0.736 . . . . 75.22 112.466 179.985 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 8.6 t -107.18 -20.66 13.23 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.915 0.388 . . . . 72.31 110.872 -179.753 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.649 ' HD2' HD21 ' A' ' 18' ' ' LEU . 0.0 OUTLIER -127.27 137.58 52.89 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.138 -0.483 . . . . 55.42 110.893 179.924 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 47' ' ' THR . . . . . 0.407 ' HA ' ' HA ' ' A' ' 40' ' ' GLU . 20.9 m -131.27 149.68 52.47 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.193 -0.458 . . . . 74.15 111.148 179.913 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 48' ' ' GLY . . . . . 0.557 ' N ' HD12 ' A' ' 18' ' ' LEU . . . -173.5 -162.16 24.94 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.726 -0.749 . . . . 73.51 112.448 179.975 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.445 HD23 HG22 ' A' ' 38' ' ' VAL . 10.4 mt -96.67 139.18 33.12 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.815 0.341 . . . . 74.2 110.972 -179.941 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.414 HG22 ' O ' ' A' ' 37' ' ' LEU . 11.5 m -137.3 152.96 74.36 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.664 0.745 . . . . 73.15 111.116 179.859 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 51' ' ' PRO . . . . . 0.539 ' HD2' HD22 ' A' ' 20' ' ' LEU . 53.9 Cg_endo -69.81 147.78 63.31 Favored 'Trans proline' 0 C--N 1.341 0.18 0 C-N-CA 122.668 2.246 . . . . 72.5 112.311 179.959 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 52' ' ' GLU . . . . . 0.684 ' CG ' HD11 ' A' ' 37' ' ' LEU . 23.8 tt0 -93.11 -29.21 15.88 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.204 -0.453 . . . . 75.11 110.88 -179.987 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -85.72 7.97 21.57 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.149 -0.478 . . . . 65.1 110.887 -179.922 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 54' ' ' PHE . . . . . 0.428 ' HB2' ' HG2' ' A' ' 51' ' ' PRO . 1.1 m-85 -119.57 3.3 11.21 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.129 -0.487 . . . . 64.22 110.865 -179.902 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.532 ' CG1' HD21 ' A' ' 20' ' ' LEU . 21.3 m -134.62 164.55 33.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.119 -0.492 . . . . 55.3 111.161 179.959 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 56' ' ' SER . . . . . 0.512 ' CB ' HD21 ' A' ' 7' ' ' LEU . 32.2 t -136.36 118.61 15.58 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.18 -0.464 . . . . 65.45 110.837 -179.885 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 3.0 m-85 -54.32 135.2 45.08 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.144 -0.48 . . . . 74.14 110.921 -179.886 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.611 HD11 ' HB ' ' A' ' 5' ' ' VAL . 31.0 mt -101.92 150.74 6.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.088 -0.505 . . . . 74.25 111.144 179.918 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 1.6 mt-30 . . . . . 0 C--N 1.329 -0.311 0 CA-C-O 121.672 0.748 . . . . 75.1 110.907 179.93 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' B' B ' -7' ' ' PHE . . . . . 0.401 ' O ' HD13 ' B' ' -6' ' ' ILE . 5.8 m-85 . . . . . 0 C--O 1.231 0.12 0 CA-C-O 120.858 0.361 . . . . 63.42 110.823 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' -6' ' ' ILE . . . . . 0.401 HD13 ' O ' ' B' ' -7' ' ' PHE . 34.2 mm -145.45 88.57 6.58 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-O 121.673 0.749 . . . . 63.14 111.139 179.967 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' -5' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.82 130.36 19.13 Favored 'Trans proline' 0 C--N 1.342 0.192 0 C-N-CA 122.702 2.268 . . . . 32.43 112.313 179.943 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' -4' ' ' SER . . . . . . . . . . . . . 27.4 t -129.4 65.56 1.47 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.165 -0.47 . . . . 72.22 110.86 -179.819 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' -3' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -179.74 154.98 0.72 Allowed Pre-proline 0 C--N 1.329 -0.326 0 CA-C-O 121.578 0.704 . . . . 71.14 110.914 -179.931 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' -2' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.74 131.74 21.89 Favored 'Trans proline' 0 C--N 1.341 0.155 0 C-N-CA 122.686 2.257 . . . . 72.34 112.347 179.974 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' -1' ' ' ALA . . . . . . . . . . . . . . . -65.16 151.91 92.73 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-O 121.526 0.679 . . . . 73.23 111.094 179.891 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 0' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.75 176.63 6.5 Favored 'Trans proline' 0 C--O 1.232 0.181 0 C-N-CA 122.651 2.234 . . . . 74.44 112.359 -179.989 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 1' ' ' LYS . . . . . . . . . . . . . 12.3 pttp -125.57 155.07 72.7 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.543 0.687 . . . . 74.05 110.91 179.886 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 2' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo . . . . . 0 C--N 1.341 0.183 0 C-N-CA 122.668 2.246 . . . . 73.25 112.35 179.863 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 48.4 tp60 . . . . . 0 C--O 1.231 0.099 0 CA-C-O 120.765 0.317 . . . . 75.44 110.932 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 5.2 ptp180 -73.87 162.99 28.52 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.172 -0.467 . . . . 73.45 110.881 -179.931 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -156.61 153.8 29.18 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.198 -0.455 . . . . 62.13 111.133 179.911 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.516 ' HB ' HD11 ' A' ' 58' ' ' ILE . 10.7 p -103.96 149.63 7.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.224 -0.444 . . . . 64.51 111.169 179.937 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -88.68 106.06 18.09 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.193 -0.458 . . . . 51.22 111.082 179.877 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 0.726 HD21 ' CB ' ' A' ' 56' ' ' SER . 15.4 mt -71.33 -36.66 71.63 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.199 -0.455 . . . . 64.22 110.957 179.98 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 4.0 m-85 -143.56 152.65 41.69 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.211 -0.449 . . . . 61.53 110.886 -180.0 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 2.4 p30 -75.29 140.64 43.26 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.069 -0.514 . . . . 64.44 110.903 179.903 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 7.2 t80 -147.18 145.34 29.48 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.195 -0.457 . . . . 75.35 110.904 -179.852 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -114.06 144.61 31.93 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.641 0.734 . . . . 75.12 110.912 -179.949 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.82 148.75 65.36 Favored 'Trans proline' 0 C--N 1.341 0.144 0 C-N-CA 122.688 2.259 . . . . 61.52 112.356 -179.996 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 10.6 tp10 -109.87 -19.72 13.02 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.171 -0.468 . . . . 75.32 110.847 -179.911 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 10.7 m120 -110.95 176.3 5.08 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.173 -0.467 . . . . 63.11 110.844 -179.905 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -90.84 21.08 4.31 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.136 -0.484 . . . . 73.51 110.918 179.884 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -142.35 13.44 1.98 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.147 -0.479 . . . . 73.33 110.896 -179.893 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 17.0 mt-10 -102.43 158.25 16.34 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.163 -0.471 . . . . 74.32 110.906 -179.981 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.612 HD23 ' O ' ' A' ' 19' ' ' ARG . 0.4 OUTLIER -105.9 155.78 19.01 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.204 -0.453 . . . . 75.15 110.909 -179.97 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 19' ' ' ARG . . . . . 0.612 ' O ' HD23 ' A' ' 18' ' ' LEU . 0.9 OUTLIER -92.04 153.69 19.25 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.137 -0.483 . . . . 72.44 110.83 -179.965 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.589 HD21 ' CG1' ' A' ' 55' ' ' VAL . 2.3 tp -137.05 149.72 47.6 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.236 -0.438 . . . . 72.44 110.945 -179.995 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.679 ' HB3' ' CG ' ' A' ' 24' ' ' ASP . . . -142.9 136.9 29.1 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.207 -0.451 . . . . 44.21 111.116 179.793 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -50.15 119.98 4.09 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.235 -0.438 . . . . 75.12 110.855 -179.883 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 96.34 -0.91 62.04 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.749 -0.739 . . . . 54.23 112.473 -179.971 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 24' ' ' ASP . . . . . 0.679 ' CG ' ' HB3' ' A' ' 21' ' ' ALA . 1.1 m-20 -86.99 147.26 25.81 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.751 0.31 . . . . 70.02 110.853 -179.966 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 3.3 mm -102.59 142.08 17.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.221 -0.445 . . . . 73.02 111.155 179.987 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -143.22 159.45 17.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.196 -0.456 . . . . 72.2 111.145 179.876 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 44.0 m-85 -116.59 107.09 14.28 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.216 -0.447 . . . . 73.21 110.851 -179.953 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.792 HD13 ' HB2' ' A' ' 39' ' ' ALA . 17.6 mm -72.63 103.05 1.55 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.158 -0.474 . . . . 74.45 111.109 179.993 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 3.0 m -64.29 -39.32 93.7 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.161 -0.472 . . . . 52.41 110.861 -179.92 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 30' ' ' TYR . . . . . 0.498 ' CZ ' HG21 ' A' ' 38' ' ' VAL . 32.9 p90 -174.75 147.34 1.02 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.109 -0.496 . . . . 64.4 110.898 -179.828 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 31' ' ' LYS . . . . . 0.512 ' HG3' HD22 ' A' ' 37' ' ' LEU . 11.9 tttm -81.45 145.98 30.48 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.09 -0.504 . . . . 42.13 110.865 179.922 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 32.1 t60 -135.68 152.04 50.8 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.211 -0.45 . . . . 75.35 110.894 179.873 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -57.78 -175.35 0.44 Allowed Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.728 -0.749 . . . . 32.04 112.511 -179.986 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 4.4 mp0 66.55 11.94 8.42 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.826 0.346 . . . . 64.3 110.869 -179.908 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 68.18 28.82 73.19 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.751 -0.738 . . . . 74.52 112.507 -179.973 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 36' ' ' TRP . . . . . 0.58 ' C ' HD23 ' A' ' 37' ' ' LEU . 97.8 m95 -122.74 134.95 54.43 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.796 0.332 . . . . 75.31 110.902 -179.92 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.685 HD11 ' CG ' ' A' ' 52' ' ' GLU . 0.9 OUTLIER -121.73 132.61 54.72 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.241 -0.436 . . . . 63.23 110.9 179.983 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.498 HG21 ' CZ ' ' A' ' 30' ' ' TYR . 46.1 t -79.79 109.59 14.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.207 -0.451 . . . . 73.04 111.125 179.839 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 39' ' ' ALA . . . . . 0.792 ' HB2' HD13 ' A' ' 28' ' ' ILE . . . -129.46 161.65 29.9 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.199 -0.455 . . . . 73.21 111.083 179.884 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 2.3 pm0 -118.51 158.38 25.48 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.204 -0.453 . . . . 75.24 110.936 -179.98 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 46.3 p-10 -58.16 -175.08 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.166 -0.47 . . . . 51.24 110.896 -179.946 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 15.6 tm-20 -78.01 -35.44 49.9 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.176 -0.465 . . . . 62.53 110.921 -179.99 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 40.1 t -69.59 -21.89 63.56 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.131 -0.486 . . . . 62.11 110.903 -179.826 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 76.33 26.13 64.39 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.71 -0.757 . . . . 33.04 112.529 -179.968 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -111.98 -22.51 11.01 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.926 0.393 . . . . 65.1 110.881 -179.747 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.601 ' HG2' HD11 ' A' ' 18' ' ' LEU . 3.0 ttmt -117.89 130.24 56.12 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.135 -0.484 . . . . 65.22 110.904 179.93 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 47' ' ' THR . . . . . 0.422 ' C ' HD12 ' A' ' 18' ' ' LEU . 4.6 m -127.77 150.36 49.84 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.251 -0.431 . . . . 74.54 111.163 179.927 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -177.69 -160.18 23.87 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.757 -0.735 . . . . 65.45 112.489 179.994 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.475 HD11 ' HB3' ' B' ' -7' ' ' PHE . 3.6 mt -102.04 141.15 35.33 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.874 0.368 . . . . 73.43 110.892 -179.95 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.442 ' HB ' ' HD2' ' A' ' 51' ' ' PRO . 16.1 m -138.11 154.5 74.17 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.611 0.719 . . . . 61.53 111.138 179.826 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 51' ' ' PRO . . . . . 0.442 ' HD2' ' HB ' ' A' ' 50' ' ' VAL . 53.3 Cg_endo -69.74 143.14 49.99 Favored 'Trans proline' 0 C--N 1.341 0.132 0 C-N-CA 122.708 2.272 . . . . 73.35 112.315 179.976 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 52' ' ' GLU . . . . . 0.685 ' CG ' HD11 ' A' ' 37' ' ' LEU . 27.1 tt0 -90.5 -27.55 19.13 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.194 -0.457 . . . . 73.42 110.854 -179.947 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -86.19 9.61 17.04 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.17 -0.468 . . . . 73.41 110.923 -179.969 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 54' ' ' PHE . . . . . 0.407 ' HB2' ' HG2' ' A' ' 51' ' ' PRO . 1.1 m-85 -119.85 -13.75 9.04 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.124 -0.489 . . . . 63.25 110.852 -179.912 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.589 ' CG1' HD21 ' A' ' 20' ' ' LEU . 21.8 m -114.7 167.45 7.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.169 -0.469 . . . . 74.31 111.113 179.967 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 56' ' ' SER . . . . . 0.726 ' CB ' HD21 ' A' ' 7' ' ' LEU . 42.9 t -139.23 116.27 10.98 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.167 -0.469 . . . . 70.45 110.869 -179.899 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 2.6 m-85 -53.35 133.94 40.0 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.134 -0.484 . . . . 74.33 110.951 -179.913 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.516 HD11 ' HB ' ' A' ' 5' ' ' VAL . 39.4 mt -102.58 150.24 6.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.109 -0.496 . . . . 71.45 111.114 179.975 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.329 -0.283 0 CA-C-O 121.607 0.718 . . . . 71.55 110.94 179.925 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' -7' ' ' PHE . . . . . 0.475 ' HB3' HD11 ' A' ' 49' ' ' LEU . 19.6 m-85 . . . . . 0 C--O 1.231 0.123 0 CA-C-O 120.815 0.341 . . . . 74.33 110.919 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' -6' ' ' ILE . . . . . 0.442 ' O ' HG23 ' B' ' -6' ' ' ILE . 4.5 tt -173.52 90.05 0.37 Allowed Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 121.691 0.758 . . . . 72.54 111.118 179.996 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' -5' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.75 134.48 28.09 Favored 'Trans proline' 0 C--N 1.342 0.209 0 C-N-CA 122.662 2.241 . . . . 63.4 112.382 179.853 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' -4' ' ' SER . . . . . . . . . . . . . 33.1 t -134.37 66.5 1.54 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.214 -0.448 . . . . 53.33 110.834 -179.845 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' -3' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 179.87 155.34 0.69 Allowed Pre-proline 0 C--N 1.328 -0.34 0 CA-C-O 121.609 0.718 . . . . 75.13 110.905 -179.968 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' -2' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.8 123.14 9.79 Favored 'Trans proline' 0 N--CA 1.465 -0.187 0 C-N-CA 122.668 2.246 . . . . 64.55 112.331 -179.95 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' -1' ' ' ALA . . . . . . . . . . . . . . . -50.99 152.6 3.62 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-O 121.561 0.696 . . . . 53.53 111.1 179.886 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 0' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.76 165.15 31.94 Favored 'Trans proline' 0 C--N 1.341 0.166 0 C-N-CA 122.683 2.256 . . . . 73.52 112.367 179.959 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 1' ' ' LYS . . . . . . . . . . . . . 3.9 tppt? -116.02 135.93 22.86 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-O 121.594 0.711 . . . . 75.35 110.87 179.935 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 2' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo . . . . . 0 C--N 1.341 0.179 0 C-N-CA 122.676 2.251 . . . . 72.52 112.337 179.856 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 49.4 tp60 . . . . . 0 C--O 1.231 0.079 0 CA-C-O 120.862 0.363 . . . . 53.41 110.883 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -73.4 158.59 34.71 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.172 -0.467 . . . . 72.04 110.878 -179.917 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -154.72 154.06 32.28 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.19 -0.459 . . . . 73.03 111.066 179.905 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.517 ' HB ' HD11 ' A' ' 58' ' ' ILE . 10.9 p -104.14 152.22 6.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.208 -0.451 . . . . 73.52 111.126 179.984 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -91.83 121.48 33.48 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.198 -0.456 . . . . 65.43 111.129 179.813 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 0.597 HD21 ' HB3' ' A' ' 56' ' ' SER . 12.6 mt -85.99 -33.82 20.98 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.22 -0.445 . . . . 73.35 110.886 -179.985 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 5.1 m-85 -144.98 142.59 29.93 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.224 -0.443 . . . . 72.01 110.941 -179.979 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 1.9 p-10 -67.46 140.66 57.11 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.132 -0.486 . . . . 74.14 110.892 179.899 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 15.5 t80 -140.94 146.53 37.48 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.182 -0.463 . . . . 72.51 110.918 -179.906 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -115.58 137.37 23.13 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-O 121.632 0.73 . . . . 74.33 110.866 -179.913 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.79 151.59 68.92 Favored 'Trans proline' 0 N--CA 1.465 -0.154 0 C-N-CA 122.701 2.267 . . . . 63.11 112.373 179.987 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 4.2 mt-10 -109.69 -19.44 13.17 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.232 -0.44 . . . . 64.44 110.917 -179.995 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 15.4 m120 -123.63 175.0 7.08 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.159 -0.473 . . . . 74.43 110.867 -179.931 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 41.5 m-20 -81.05 -1.14 42.86 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.165 -0.471 . . . . 75.25 110.867 179.937 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -112.47 16.35 19.87 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.216 -0.447 . . . . 72.13 110.885 -179.916 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 6.9 mt-10 -110.39 157.15 19.85 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.181 -0.463 . . . . 70.3 110.871 -179.964 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.554 HD12 ' H ' ' A' ' 19' ' ' ARG . 41.7 tp -112.19 147.79 35.42 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.145 -0.479 . . . . 74.02 110.9 -179.994 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 19' ' ' ARG . . . . . 0.554 ' H ' HD12 ' A' ' 18' ' ' LEU . 32.2 mtm180 -83.17 154.76 24.11 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.196 -0.456 . . . . 75.12 110.86 179.946 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.513 HD21 ' CG1' ' A' ' 55' ' ' VAL . 2.3 tp -142.25 147.94 37.29 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.199 -0.455 . . . . 71.24 110.913 -179.983 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -138.07 139.45 39.54 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.185 -0.461 . . . . 43.34 111.109 179.787 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -51.71 119.58 4.35 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.234 -0.439 . . . . 75.15 110.857 -179.929 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 97.34 -6.72 63.59 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.716 -0.755 . . . . 73.23 112.458 179.987 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -71.39 160.2 33.2 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.752 0.31 . . . . 74.35 110.867 -179.921 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 1.2 mt -123.11 114.04 40.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.205 -0.452 . . . . 74.04 111.122 179.999 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.401 HG11 HD11 ' A' ' 20' ' ' LEU . 12.1 m -117.43 166.92 11.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.12 -0.491 . . . . 73.33 111.131 179.863 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 63.7 m-85 -117.95 106.26 12.76 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.167 -0.469 . . . . 73.45 110.854 -179.943 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.85 HD13 ' HB2' ' A' ' 39' ' ' ALA . 21.3 mm -71.62 103.58 1.38 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.15 -0.477 . . . . 72.24 111.114 179.974 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 10.5 m -65.0 -39.55 93.64 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.208 -0.451 . . . . 71.54 110.856 -179.923 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 30' ' ' TYR . . . . . 0.527 ' CZ ' HG21 ' A' ' 38' ' ' VAL . 54.0 p90 -175.41 160.95 2.66 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.116 -0.493 . . . . 70.31 110.88 -179.869 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 16.6 tttt -87.89 146.78 25.4 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.14 -0.482 . . . . 75.15 110.871 179.909 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 35.5 t60 -136.14 155.01 50.78 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.18 -0.463 . . . . 73.2 110.878 179.926 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -60.45 -175.99 1.36 Allowed Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.751 -0.737 . . . . 55.23 112.5 -179.98 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 19.0 mm100 66.53 11.66 8.22 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.898 0.38 . . . . 73.43 110.94 -179.897 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 69.36 27.96 73.06 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.704 -0.76 . . . . 52.43 112.499 -179.95 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 36' ' ' TRP . . . . . 0.678 ' C ' HD23 ' A' ' 37' ' ' LEU . 97.6 m95 -122.33 140.99 52.02 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.779 0.323 . . . . 74.13 110.911 -179.892 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.721 HD11 ' CG ' ' A' ' 52' ' ' GLU . 0.9 OUTLIER -123.9 130.3 52.37 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.227 -0.442 . . . . 55.34 110.935 179.949 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.527 HG21 ' CZ ' ' A' ' 30' ' ' TYR . 21.7 t -75.61 116.36 18.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.221 -0.445 . . . . 64.11 111.121 179.863 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 39' ' ' ALA . . . . . 0.85 ' HB2' HD13 ' A' ' 28' ' ' ILE . . . -138.45 160.67 38.95 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.212 -0.449 . . . . 54.11 111.104 179.901 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 40' ' ' GLU . . . . . 0.469 ' HB3' HG23 ' A' ' 47' ' ' THR . 0.4 OUTLIER -121.54 155.87 34.06 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.231 -0.441 . . . . 75.34 110.886 -179.916 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -66.45 -175.35 0.36 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.159 -0.473 . . . . 70.13 110.882 -179.952 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 9.7 tt0 -69.98 -38.74 76.13 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.173 -0.467 . . . . 62.51 110.93 179.996 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 2.0 t -56.83 -22.55 37.4 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.102 -0.499 . . . . 52.42 110.862 -179.782 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 66.97 11.65 58.69 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.765 -0.731 . . . . 75.44 112.476 -179.993 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 1.4 p -103.82 -21.85 13.61 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.912 0.386 . . . . 71.14 110.818 -179.745 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.541 ' HE3' HD11 ' A' ' 18' ' ' LEU . 0.8 OUTLIER -117.63 123.21 45.6 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.156 -0.475 . . . . 74.53 110.89 179.964 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 47' ' ' THR . . . . . 0.469 HG23 ' HB3' ' A' ' 40' ' ' GLU . 9.8 m -129.93 133.83 47.08 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.188 -0.46 . . . . 73.21 111.135 179.994 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -152.43 -151.22 5.6 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.779 -0.724 . . . . 63.24 112.481 -179.995 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 18.3 mt -106.94 127.66 53.64 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.872 0.367 . . . . 61.12 110.93 -179.918 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.416 ' HB ' ' HD2' ' A' ' 51' ' ' PRO . 13.3 m -126.31 153.7 74.67 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.675 0.75 . . . . 73.34 111.1 179.872 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 51' ' ' PRO . . . . . 0.493 ' HD2' HD22 ' A' ' 20' ' ' LEU . 53.7 Cg_endo -69.79 152.54 69.16 Favored 'Trans proline' 0 C--N 1.342 0.188 0 C-N-CA 122.675 2.25 . . . . 75.11 112.352 179.955 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 52' ' ' GLU . . . . . 0.721 ' CG ' HD11 ' A' ' 37' ' ' LEU . 13.9 tm-20 -96.21 -30.48 13.46 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.209 -0.45 . . . . 63.52 110.876 -179.952 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -85.14 8.41 18.26 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.148 -0.478 . . . . 75.15 110.892 -179.941 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 54' ' ' PHE . . . . . 0.415 ' HB2' ' HG2' ' A' ' 51' ' ' PRO . 1.0 OUTLIER -120.12 2.34 10.91 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.165 -0.471 . . . . 74.5 110.897 -179.954 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.513 ' CG1' HD21 ' A' ' 20' ' ' LEU . 15.8 m -132.57 170.85 19.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.162 -0.472 . . . . 71.44 111.118 179.989 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 56' ' ' SER . . . . . 0.597 ' HB3' HD21 ' A' ' 7' ' ' LEU . 9.6 t -143.09 120.96 11.97 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.157 -0.474 . . . . 43.13 110.855 -179.862 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 2.8 m-85 -56.82 135.18 55.62 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.129 -0.487 . . . . 62.51 110.913 -179.847 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.517 HD11 ' HB ' ' A' ' 5' ' ' VAL . 47.0 mt -103.51 149.04 7.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.121 -0.49 . . . . 72.44 111.111 179.938 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--N 1.329 -0.293 0 CA-C-O 121.628 0.728 . . . . 74.21 110.894 179.991 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' -7' ' ' PHE . . . . . . . . . . . . . 12.6 m-85 . . . . . 0 C--O 1.232 0.139 0 CA-C-O 120.824 0.345 . . . . 72.43 110.821 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' B' B ' -6' ' ' ILE . . . . . . . . . . . . . 5.2 mp -136.43 113.27 10.23 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.65 0.738 . . . . 45.3 111.128 179.928 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' -5' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.74 160.67 48.84 Favored 'Trans proline' 0 C--N 1.341 0.158 0 C-N-CA 122.739 2.293 . . . . 64.24 112.333 179.883 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' -4' ' ' SER . . . . . . . . . . . . . 43.4 t -147.43 46.14 1.13 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.235 -0.439 . . . . 54.23 110.855 -179.84 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' -3' ' ' ARG . . . . . . . . . . . . . 1.5 ptp85 -179.32 155.15 0.78 Allowed Pre-proline 0 C--N 1.328 -0.331 0 CA-C-O 121.612 0.72 . . . . 74.53 110.861 -179.969 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' -2' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.78 129.26 17.26 Favored 'Trans proline' 0 C--N 1.341 0.148 0 C-N-CA 122.65 2.233 . . . . 73.51 112.349 -179.984 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' -1' ' ' ALA . . . . . . . . . . . . . . . -54.64 153.08 11.3 Favored Pre-proline 0 C--N 1.33 -0.266 0 CA-C-O 121.561 0.696 . . . . 75.31 111.095 179.902 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 0' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_endo -69.78 -174.74 0.97 Allowed 'Trans proline' 0 C--O 1.231 0.162 0 C-N-CA 122.707 2.271 . . . . 65.32 112.325 -179.989 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 1' ' ' LYS . . . . . . . . . . . . . 4.9 mtmp? -130.67 156.92 79.1 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 121.594 0.711 . . . . 71.44 110.887 179.904 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 2' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo . . . . . 0 C--N 1.342 0.192 0 C-N-CA 122.67 2.247 . . . . 65.25 112.365 179.879 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 51.2 tp60 . . . . . 0 C--O 1.231 0.112 0 CA-C-O 120.753 0.311 . . . . 61.12 110.951 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 6.8 ptp180 -90.61 164.6 14.13 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.206 -0.452 . . . . 71.04 110.863 -179.902 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -156.48 152.58 27.56 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.185 -0.461 . . . . 73.1 111.108 179.94 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.682 ' HB ' HD11 ' A' ' 58' ' ' ILE . 10.9 p -104.08 151.84 6.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.231 -0.44 . . . . 53.23 111.15 179.958 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -89.25 116.85 27.79 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.143 -0.48 . . . . 74.11 111.128 179.876 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 0.732 HD21 ' HB2' ' A' ' 56' ' ' SER . 10.2 mt -84.52 -36.68 22.02 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.241 -0.436 . . . . 65.13 110.877 -179.955 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 6.4 m-85 -140.32 136.19 32.97 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.232 -0.44 . . . . 73.45 110.952 -179.989 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 1.6 p30 -62.65 139.23 58.64 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.118 -0.492 . . . . 73.24 110.879 179.93 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 10.8 t80 -145.51 145.99 31.27 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.211 -0.45 . . . . 74.15 110.869 -179.886 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -115.96 144.69 33.24 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.674 0.749 . . . . 71.41 110.895 -179.973 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.77 140.63 43.12 Favored 'Trans proline' 0 C--N 1.341 0.158 0 C-N-CA 122.689 2.26 . . . . 70.42 112.368 179.992 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 9.9 mt-10 -101.25 -21.45 14.9 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.194 -0.457 . . . . 63.23 110.875 -179.946 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 34.1 m-80 -110.29 176.66 4.97 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.14 -0.482 . . . . 74.33 110.876 -179.923 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -91.04 20.64 4.76 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.136 -0.484 . . . . 74.3 110.902 179.871 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -140.31 15.37 2.4 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.183 -0.462 . . . . 74.21 110.908 -179.924 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 16.3 mt-10 -107.37 158.07 17.46 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.171 -0.468 . . . . 64.41 110.899 -179.981 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.612 HD23 ' O ' ' A' ' 19' ' ' ARG . 0.3 OUTLIER -104.27 161.07 14.36 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.159 -0.473 . . . . 73.32 110.853 -179.902 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 19' ' ' ARG . . . . . 0.612 ' O ' HD23 ' A' ' 18' ' ' LEU . 0.9 OUTLIER -96.57 152.78 18.31 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.184 -0.462 . . . . 74.31 110.864 179.941 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.57 HD21 ' CG1' ' A' ' 55' ' ' VAL . 1.8 tp -137.79 149.49 46.43 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.137 -0.483 . . . . 71.04 110.91 -179.982 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.676 ' HB3' ' CG ' ' A' ' 24' ' ' ASP . . . -142.5 138.76 31.18 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.194 -0.457 . . . . 62.12 111.106 179.768 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -50.62 119.86 4.19 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.189 -0.46 . . . . 74.33 110.911 -179.945 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 96.7 -3.45 62.99 Favored Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.74 -0.743 . . . . 64.11 112.445 -179.979 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 24' ' ' ASP . . . . . 0.676 ' CG ' ' HB3' ' A' ' 21' ' ' ALA . 1.0 OUTLIER -84.63 146.45 27.48 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.721 0.296 . . . . 71.24 110.878 -179.943 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 3.5 mm -101.75 144.88 12.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.199 -0.455 . . . . 63.04 111.109 -179.991 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.418 HG11 HD11 ' A' ' 20' ' ' LEU . 1.5 m -146.58 158.31 10.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.148 -0.478 . . . . 72.01 111.108 179.848 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 54.3 m-85 -116.54 110.08 18.1 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.142 -0.481 . . . . 72.53 110.907 -179.995 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.686 HD13 ' HB2' ' A' ' 39' ' ' ALA . 14.7 mm -73.29 102.74 1.72 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.133 -0.485 . . . . 73.25 111.125 179.965 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 3.9 m -64.8 -40.35 95.08 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.196 -0.456 . . . . 74.11 110.837 -179.909 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 30' ' ' TYR . . . . . 0.524 ' CZ ' HG21 ' A' ' 38' ' ' VAL . 34.4 p90 -174.68 148.58 1.14 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.149 -0.478 . . . . 73.41 110.905 -179.926 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 31' ' ' LYS . . . . . 0.505 ' HG3' HD22 ' A' ' 37' ' ' LEU . 13.2 tttt -81.0 145.67 31.06 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.12 -0.491 . . . . 72.41 110.887 179.943 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 33.6 t60 -134.58 153.55 51.9 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.214 -0.448 . . . . 75.43 110.852 179.89 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -59.01 -174.12 0.57 Allowed Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.717 -0.754 . . . . 63.15 112.54 -179.97 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 77.9 mm-40 65.49 12.24 8.02 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.825 0.345 . . . . 61.34 110.911 -179.886 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 68.24 29.51 73.28 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.758 -0.734 . . . . 63.12 112.505 -179.98 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 36' ' ' TRP . . . . . 0.625 ' C ' HD23 ' A' ' 37' ' ' LEU . 98.4 m95 -123.51 135.97 54.32 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.81 0.338 . . . . 74.43 110.95 -179.936 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.708 HD11 ' CG ' ' A' ' 52' ' ' GLU . 1.4 mt -119.64 132.3 55.66 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.228 -0.442 . . . . 63.2 110.918 179.986 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.524 HG21 ' CZ ' ' A' ' 30' ' ' TYR . 60.0 t -79.27 109.11 13.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.206 -0.452 . . . . 75.31 111.15 179.825 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 39' ' ' ALA . . . . . 0.686 ' HB2' HD13 ' A' ' 28' ' ' ILE . . . -129.93 163.02 27.29 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.191 -0.459 . . . . 73.31 111.11 179.924 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 1.5 pt-20 -119.02 156.4 29.7 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.232 -0.44 . . . . 74.22 110.86 -179.903 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -68.6 -175.2 0.64 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.129 -0.487 . . . . 64.42 110.877 -179.954 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 9.1 tm-20 -68.89 -37.81 79.23 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.211 -0.449 . . . . 73.14 110.883 -179.974 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 1.6 t -57.0 -22.61 39.84 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.16 -0.473 . . . . 75.33 110.869 -179.769 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 69.9 8.57 61.24 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.784 -0.722 . . . . 40.42 112.479 -179.97 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 30.9 t -108.15 -22.3 12.44 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.931 0.396 . . . . 54.01 110.86 -179.769 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.457 ' HG2' HD11 ' A' ' 18' ' ' LEU . 2.7 ttmt -107.09 123.84 48.81 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.13 -0.486 . . . . 75.53 110.906 179.977 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 4.3 m -125.7 152.22 45.57 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.244 -0.434 . . . . 70.23 111.142 -179.991 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -177.63 -162.42 27.71 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.746 -0.74 . . . . 24.41 112.476 179.933 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.485 HD23 HG22 ' A' ' 38' ' ' VAL . 5.8 mt -99.21 136.87 38.54 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.847 0.356 . . . . 73.33 110.966 -179.938 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 16.8 m -136.36 153.32 76.26 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-O 121.562 0.696 . . . . 64.53 111.183 179.845 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 51' ' ' PRO . . . . . 0.428 ' HG2' ' HB2' ' A' ' 54' ' ' PHE . 54.2 Cg_endo -69.69 143.5 51.36 Favored 'Trans proline' 0 C--N 1.341 0.152 0 C-N-CA 122.677 2.252 . . . . 72.3 112.362 179.91 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 52' ' ' GLU . . . . . 0.708 ' CG ' HD11 ' A' ' 37' ' ' LEU . 15.5 tm-20 -90.19 -27.74 19.35 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.209 -0.45 . . . . 61.22 110.901 179.977 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 -86.31 10.44 14.84 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.134 -0.485 . . . . 71.5 110.892 -179.916 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 54' ' ' PHE . . . . . 0.428 ' HB2' ' HG2' ' A' ' 51' ' ' PRO . 1.0 OUTLIER -120.28 -9.56 9.5 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.138 -0.483 . . . . 74.14 110.898 -179.921 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.57 ' CG1' HD21 ' A' ' 20' ' ' LEU . 15.3 m -117.68 172.47 5.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.171 -0.468 . . . . 73.41 111.119 179.989 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 56' ' ' SER . . . . . 0.732 ' HB2' HD21 ' A' ' 7' ' ' LEU . 38.4 t -142.56 113.19 7.36 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.193 -0.458 . . . . 62.32 110.864 -179.885 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 3.1 m-85 -52.17 130.1 29.52 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.133 -0.485 . . . . 75.32 110.936 -179.908 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.682 HD11 ' HB ' ' A' ' 5' ' ' VAL . 54.5 mt -99.97 146.91 8.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.145 -0.479 . . . . 70.24 111.152 179.894 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 8.1 mt-30 . . . . . 0 C--N 1.329 -0.284 0 CA-C-O 121.594 0.712 . . . . 73.23 110.903 179.942 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' B' B ' -7' ' ' PHE . . . . . 0.448 ' HB3' HD11 ' A' ' 49' ' ' LEU . 15.2 m-85 . . . . . 0 C--O 1.231 0.117 0 CA-C-O 120.841 0.353 . . . . 75.13 110.877 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' -6' ' ' ILE . . . . . . . . . . . . . 2.4 pt -153.36 85.19 4.2 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.668 0.747 . . . . 73.44 111.108 179.956 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' -5' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.82 135.92 31.53 Favored 'Trans proline' 0 C--N 1.342 0.209 0 C-N-CA 122.712 2.275 . . . . 74.34 112.317 179.917 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' -4' ' ' SER . . . . . . . . . . . . . 2.5 m -132.0 62.13 1.64 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.255 -0.429 . . . . 63.22 110.879 -179.856 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' -3' ' ' ARG . . . . . . . . . . . . . 12.8 ptt85 -174.67 153.39 1.75 Allowed Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.669 0.747 . . . . 71.53 110.87 -179.958 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' -2' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.78 128.98 16.79 Favored 'Trans proline' 0 C--N 1.342 0.201 0 C-N-CA 122.665 2.243 . . . . 70.3 112.338 -179.976 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' -1' ' ' ALA . . . . . . . . . . . . . . . -61.74 152.21 76.35 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 121.616 0.722 . . . . 62.22 111.108 179.867 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 0' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.73 -179.85 3.19 Favored 'Trans proline' 0 C--N 1.341 0.181 0 C-N-CA 122.742 2.295 . . . . 73.54 112.331 -179.95 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 1' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -126.58 155.01 75.38 Favored Pre-proline 0 C--N 1.328 -0.362 0 CA-C-O 121.624 0.726 . . . . 72.35 110.857 179.909 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 2' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo . . . . . 0 C--N 1.342 0.225 0 C-N-CA 122.661 2.241 . . . . 71.23 112.329 179.908 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 29.3 tp60 . . . . . 0 C--O 1.231 0.111 0 CA-C-O 120.739 0.304 . . . . 61.24 110.945 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 6.3 ptm180 -76.63 162.43 27.75 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.203 -0.453 . . . . 63.44 110.88 -179.908 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -154.45 154.47 33.26 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.209 -0.451 . . . . 73.42 111.124 179.962 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.549 ' HB ' HD11 ' A' ' 58' ' ' ILE . 9.2 p -109.1 140.58 27.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.24 -0.436 . . . . 71.52 111.135 179.99 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -77.88 122.34 25.34 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.189 -0.46 . . . . 70.44 111.099 179.883 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 0.763 HD21 ' CB ' ' A' ' 56' ' ' SER . 16.6 mt -87.48 -34.79 18.54 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.195 -0.457 . . . . 72.34 110.914 -179.936 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 4.3 m-85 -144.58 149.86 36.5 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.161 -0.472 . . . . 73.4 110.871 -179.953 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -70.92 137.66 49.43 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.108 -0.496 . . . . 73.24 110.837 179.934 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 21.4 t80 -142.0 145.65 34.68 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.144 -0.48 . . . . 74.13 110.907 -179.916 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -119.41 137.29 25.22 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-O 121.679 0.752 . . . . 75.31 110.88 -179.929 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 12' ' ' PRO . . . . . 0.433 ' HG3' ' HG3' ' A' ' 19' ' ' ARG . 53.6 Cg_endo -69.78 150.84 68.64 Favored 'Trans proline' 0 C--N 1.342 0.212 0 C-N-CA 122.636 2.224 . . . . 75.42 112.361 179.962 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 17.8 tp10 -109.28 -15.78 14.2 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.177 -0.465 . . . . 51.22 110.906 -179.98 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 9.8 m-80 -115.17 176.03 5.25 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.137 -0.483 . . . . 73.31 110.911 -179.925 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -92.26 20.87 5.62 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.197 -0.456 . . . . 73.24 110.857 179.948 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 1.2 p-10 -136.46 9.1 3.15 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.189 -0.46 . . . . 74.24 110.871 -179.907 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 12.0 mt-10 -105.63 157.44 17.4 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.177 -0.465 . . . . 61.23 110.908 179.989 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 55.5 tp -107.05 156.59 18.59 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.138 -0.483 . . . . 74.31 110.934 179.999 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 19' ' ' ARG . . . . . 0.433 ' HG3' ' HG3' ' A' ' 12' ' ' PRO . 0.7 OUTLIER -92.75 160.68 14.85 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.192 -0.458 . . . . 62.3 110.911 179.928 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.612 HD21 ' CG1' ' A' ' 55' ' ' VAL . 3.5 tp -142.27 149.24 39.29 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.196 -0.456 . . . . 70.21 110.946 -179.985 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.686 ' HB3' ' CG ' ' A' ' 24' ' ' ASP . . . -140.12 134.43 31.27 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.229 -0.441 . . . . 73.11 111.08 179.888 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -50.4 121.12 5.23 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.211 -0.45 . . . . 73.0 110.874 -179.929 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 96.59 -3.64 63.37 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.765 -0.731 . . . . 54.21 112.478 -179.971 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 24' ' ' ASP . . . . . 0.686 ' CG ' ' HB3' ' A' ' 21' ' ' ALA . 1.0 OUTLIER -85.08 146.9 26.92 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.805 0.336 . . . . 55.54 110.839 -179.944 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 3.3 mm -100.54 141.06 18.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.152 -0.476 . . . . 73.41 111.112 -179.973 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 1.5 m -142.78 158.0 18.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.168 -0.469 . . . . 65.45 111.165 179.821 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 44.6 m-85 -115.42 106.58 14.14 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.181 -0.463 . . . . 74.14 110.86 -179.937 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.836 HD13 ' HB2' ' A' ' 39' ' ' ALA . 19.6 mm -72.01 103.12 1.39 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.145 -0.479 . . . . 64.12 111.128 179.957 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 3.3 m -64.48 -39.47 93.85 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.161 -0.472 . . . . 73.41 110.878 -179.934 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 30' ' ' TYR . . . . . 0.47 ' CZ ' HG21 ' A' ' 38' ' ' VAL . 33.4 p90 -174.53 147.85 1.14 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.111 -0.495 . . . . 71.13 110.889 -179.895 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 31' ' ' LYS . . . . . 0.57 ' HG3' HD22 ' A' ' 37' ' ' LEU . 18.7 tttt -82.68 145.41 29.63 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.121 -0.491 . . . . 51.34 110.893 179.894 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 29.7 t60 -134.86 153.97 51.84 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.195 -0.457 . . . . 62.1 110.824 179.917 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -59.23 -174.26 0.65 Allowed Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.733 -0.746 . . . . 41.32 112.53 179.977 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 73.8 mm-40 65.59 12.44 8.23 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.803 0.335 . . . . 73.2 110.908 -179.895 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 68.22 28.82 73.16 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.721 -0.752 . . . . 60.31 112.504 -179.956 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 36' ' ' TRP . . . . . 0.638 ' C ' HD23 ' A' ' 37' ' ' LEU . 99.0 m95 -123.17 135.64 54.41 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.768 0.318 . . . . 64.24 110.938 -179.928 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.695 HD11 ' CG ' ' A' ' 52' ' ' GLU . 0.4 OUTLIER -124.46 131.89 53.49 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.254 -0.43 . . . . 61.5 110.902 179.969 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.47 HG21 ' CZ ' ' A' ' 30' ' ' TYR . 60.4 t -77.39 116.89 21.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.128 -0.487 . . . . 61.14 111.133 179.82 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 39' ' ' ALA . . . . . 0.836 ' HB2' HD13 ' A' ' 28' ' ' ILE . . . -137.28 160.06 40.13 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.181 -0.463 . . . . 60.13 111.08 179.872 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 40' ' ' GLU . . . . . 0.449 ' HB3' HG23 ' A' ' 47' ' ' THR . 0.5 OUTLIER -121.76 160.15 25.18 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.225 -0.443 . . . . 72.15 110.924 -179.976 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -71.78 -175.27 1.35 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.142 -0.481 . . . . 74.11 110.924 -179.93 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -69.61 -38.34 77.23 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.205 -0.452 . . . . 62.52 110.876 -179.97 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 1.5 t -57.1 -22.58 40.75 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.155 -0.475 . . . . 74.23 110.867 -179.794 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 66.46 12.05 57.83 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.681 -0.771 . . . . 52.33 112.516 180.0 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 12.9 m -105.24 -21.06 13.32 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.945 0.402 . . . . 52.32 110.836 -179.707 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 1.4 ttmt -118.53 123.38 44.95 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.148 -0.478 . . . . 63.24 110.889 179.948 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 47' ' ' THR . . . . . 0.449 HG23 ' HB3' ' A' ' 40' ' ' GLU . 11.4 m -131.62 143.02 50.01 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.228 -0.442 . . . . 51.1 111.166 179.957 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -160.71 -151.77 6.34 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.788 -0.72 . . . . 44.42 112.511 179.979 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 8.4 mt -107.03 131.69 53.79 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.862 0.363 . . . . 72.31 110.906 -179.942 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.432 ' HB ' ' HD2' ' A' ' 51' ' ' PRO . 18.3 m -129.88 154.45 81.11 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-O 121.606 0.717 . . . . 70.14 111.164 179.829 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 51' ' ' PRO . . . . . 0.432 ' HD2' ' HB ' ' A' ' 50' ' ' VAL . 53.6 Cg_endo -69.75 148.15 64.53 Favored 'Trans proline' 0 C--O 1.231 0.145 0 C-N-CA 122.713 2.276 . . . . 75.02 112.36 179.96 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 52' ' ' GLU . . . . . 0.695 ' CG ' HD11 ' A' ' 37' ' ' LEU . 30.1 tt0 -93.07 -29.5 15.76 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.256 -0.429 . . . . 75.41 110.854 -179.962 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -84.39 7.33 19.93 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.199 -0.455 . . . . 74.0 110.879 -179.943 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 54' ' ' PHE . . . . . 0.418 ' HB2' ' HG2' ' A' ' 51' ' ' PRO . 1.2 m-85 -120.41 3.47 10.78 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.155 -0.475 . . . . 74.14 110.862 -179.911 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.612 ' CG1' HD21 ' A' ' 20' ' ' LEU . 7.1 m -128.88 172.76 14.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.171 -0.468 . . . . 75.23 111.164 179.966 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 56' ' ' SER . . . . . 0.763 ' CB ' HD21 ' A' ' 7' ' ' LEU . 13.1 t -145.55 113.69 6.56 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.188 -0.46 . . . . 73.43 110.87 -179.828 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 2.5 m-85 -51.87 137.05 27.17 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.163 -0.471 . . . . 65.12 110.904 -179.866 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.549 HD11 ' HB ' ' A' ' 5' ' ' VAL . 24.6 mt -104.94 152.52 6.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.114 -0.493 . . . . 73.43 111.14 179.899 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.291 0 CA-C-O 121.577 0.703 . . . . 73.21 110.912 179.986 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' -7' ' ' PHE . . . . . . . . . . . . . 14.0 m-85 . . . . . 0 C--O 1.231 0.125 0 CA-C-O 120.817 0.341 . . . . 54.0 110.89 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' B' B ' -6' ' ' ILE . . . . . . . . . . . . . 60.2 mt -125.64 125.92 24.97 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 121.603 0.716 . . . . 53.42 111.147 179.971 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' -5' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.81 160.09 50.95 Favored 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.658 2.239 . . . . 74.32 112.324 179.902 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' -4' ' ' SER . . . . . . . . . . . . . 7.3 t -136.56 37.25 2.67 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.218 -0.447 . . . . 64.14 110.879 -179.855 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' -3' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -177.56 155.0 1.08 Allowed Pre-proline 0 C--N 1.33 -0.275 0 CA-C-O 121.542 0.687 . . . . 61.44 110.894 -179.919 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' -2' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.77 131.5 21.36 Favored 'Trans proline' 0 C--O 1.231 0.138 0 C-N-CA 122.682 2.254 . . . . 73.13 112.362 -179.971 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' -1' ' ' ALA . . . . . . . . . . . . . . . -55.5 154.47 12.19 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-O 121.591 0.71 . . . . 73.15 111.088 179.884 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 0' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.76 -170.24 0.38 Allowed 'Trans proline' 0 C--N 1.342 0.194 0 C-N-CA 122.66 2.24 . . . . 64.32 112.391 179.959 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 1' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -134.17 148.93 69.94 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-O 121.561 0.696 . . . . 65.2 110.946 179.887 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 2' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo . . . . . 0 C--N 1.341 0.182 0 C-N-CA 122.699 2.266 . . . . 51.11 112.352 179.891 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 33.0 tp60 . . . . . 0 C--O 1.231 0.125 0 CA-C-O 120.768 0.318 . . . . 73.14 110.902 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 5.6 ptp180 -80.7 162.05 24.32 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.216 -0.447 . . . . 74.03 110.863 -179.931 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -155.1 149.96 26.67 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.176 -0.465 . . . . 60.53 111.069 179.932 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.675 ' HB ' HD11 ' A' ' 58' ' ' ILE . 7.3 p -105.83 137.98 33.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.21 -0.45 . . . . 72.33 111.133 179.967 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 6' ' ' ALA . . . . . 0.459 ' HA ' HG12 ' A' ' 55' ' ' VAL . . . -78.56 128.3 33.33 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.216 -0.447 . . . . 64.44 111.047 179.91 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 0.568 HD21 ' HB3' ' A' ' 56' ' ' SER . 10.5 mt -93.32 -31.89 14.51 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.153 -0.476 . . . . 75.12 110.922 179.986 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 3.8 m-85 -144.37 135.91 25.71 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.193 -0.458 . . . . 72.51 110.934 179.995 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -60.11 149.58 32.17 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.122 -0.49 . . . . 75.51 110.899 179.883 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 30.7 t80 -149.01 147.1 28.16 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.181 -0.463 . . . . 74.12 110.881 -179.871 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 8.5 tm-20 -117.0 134.56 22.98 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 121.649 0.738 . . . . 71.04 110.913 -179.971 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 12' ' ' PRO . . . . . 0.4 ' HD3' ' HA ' ' A' ' 19' ' ' ARG . 53.4 Cg_endo -69.76 141.57 45.56 Favored 'Trans proline' 0 C--O 1.232 0.19 0 C-N-CA 122.665 2.243 . . . . 53.22 112.353 -179.99 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 13.8 mp0 -102.99 -20.01 14.37 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.249 -0.432 . . . . 71.13 110.927 -179.997 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 9.8 m120 -111.29 175.7 5.32 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.123 -0.49 . . . . 74.4 110.848 -179.936 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -92.37 19.59 6.98 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.172 -0.467 . . . . 74.11 110.888 179.886 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -135.35 10.92 3.51 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.245 -0.434 . . . . 73.34 110.848 -179.886 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 6.3 mm-40 -101.53 164.39 11.78 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.204 -0.453 . . . . 70.43 110.904 179.977 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.638 HD12 ' H ' ' A' ' 19' ' ' ARG . 19.3 tp -115.71 141.52 47.97 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.129 -0.487 . . . . 62.3 110.885 -179.935 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 19' ' ' ARG . . . . . 0.638 ' H ' HD12 ' A' ' 18' ' ' LEU . 31.5 mtm180 -75.24 155.17 37.06 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.165 -0.471 . . . . 63.44 110.886 179.951 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.585 HD22 ' HD2' ' A' ' 51' ' ' PRO . 3.5 tp -140.7 149.58 42.37 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.213 -0.448 . . . . 71.43 110.889 -179.947 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.447 ' O ' ' HB3' ' A' ' 6' ' ' ALA . . . -139.98 139.76 36.13 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.199 -0.455 . . . . 62.31 111.099 179.786 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -53.91 119.24 4.76 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.194 -0.457 . . . . 63.12 110.917 -179.919 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 93.49 0.19 67.46 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.769 -0.729 . . . . 54.14 112.484 -179.969 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 23.8 t0 -76.88 159.24 30.19 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.798 0.333 . . . . 72.5 110.909 -179.986 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 1.7 mm -110.92 123.1 66.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.154 -0.475 . . . . 75.31 111.109 -179.969 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.468 HG11 HD11 ' A' ' 20' ' ' LEU . 3.6 m -132.26 152.82 37.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.166 -0.47 . . . . 65.14 111.121 179.878 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 68.9 m-85 -112.82 109.02 18.22 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.183 -0.462 . . . . 71.13 110.882 -179.976 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.705 HD13 ' HB2' ' A' ' 39' ' ' ALA . 19.0 mm -72.32 103.02 1.45 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.086 -0.506 . . . . 71.44 111.131 -179.997 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 2.9 m -64.59 -40.09 94.9 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.167 -0.47 . . . . 70.31 110.864 -179.893 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 30' ' ' TYR . . . . . 0.474 ' CZ ' HG21 ' A' ' 38' ' ' VAL . 31.7 p90 -173.91 146.09 1.18 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.139 -0.482 . . . . 73.03 110.916 -179.861 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 31' ' ' LYS . . . . . 0.525 ' HG3' HD22 ' A' ' 37' ' ' LEU . 19.2 tttt -79.87 147.26 31.79 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.148 -0.478 . . . . 75.44 110.925 179.871 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 32.3 t60 -137.4 154.54 49.96 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.227 -0.442 . . . . 65.32 110.85 179.939 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -59.37 -175.02 0.76 Allowed Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.746 -0.74 . . . . 61.22 112.494 -179.95 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 24.0 mm100 65.61 12.78 8.49 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.844 0.354 . . . . 74.44 110.93 -179.89 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 68.14 27.74 73.6 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.691 -0.766 . . . . 75.33 112.475 -179.991 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 36' ' ' TRP . . . . . 0.606 ' C ' HD23 ' A' ' 37' ' ' LEU . 98.5 m95 -122.01 137.42 54.81 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.82 0.343 . . . . 75.55 110.948 -179.915 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.683 HD11 ' CG ' ' A' ' 52' ' ' GLU . 0.5 OUTLIER -125.18 130.52 52.31 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.255 -0.429 . . . . 53.41 110.934 179.982 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.474 HG21 ' CZ ' ' A' ' 30' ' ' TYR . 44.1 t -77.27 115.16 18.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.164 -0.471 . . . . 74.45 111.132 179.878 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 39' ' ' ALA . . . . . 0.705 ' HB2' HD13 ' A' ' 28' ' ' ILE . . . -137.0 166.16 24.31 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.133 -0.485 . . . . 72.21 111.12 179.919 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -117.62 156.68 27.74 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.233 -0.44 . . . . 64.52 110.886 -179.937 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -71.36 -176.85 1.61 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.151 -0.477 . . . . 70.21 110.852 -179.933 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 20.5 tt0 -67.45 -38.47 84.55 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.124 -0.489 . . . . 71.41 110.921 179.984 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 1.3 t -57.19 -22.14 38.41 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.144 -0.48 . . . . 75.45 110.847 -179.789 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 65.93 12.59 57.67 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.682 -0.771 . . . . 75.44 112.48 -179.995 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 13.4 t -109.42 -15.61 14.19 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.932 0.396 . . . . 74.25 110.885 -179.738 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 7.1 ptmt -119.98 134.85 55.12 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.127 -0.488 . . . . 62.43 110.912 179.935 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 6.4 m -135.06 143.72 46.86 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.252 -0.431 . . . . 63.12 111.162 179.969 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -164.68 -154.94 8.16 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.694 -0.765 . . . . 54.4 112.482 179.972 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.516 HD11 ' HB3' ' B' ' -7' ' ' PHE . 6.7 mt -104.8 129.41 53.09 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.849 0.357 . . . . 42.41 110.889 -179.89 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.44 ' HB ' ' HD2' ' A' ' 51' ' ' PRO . 16.8 m -127.73 154.25 77.89 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.666 0.746 . . . . 60.13 111.095 179.836 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 51' ' ' PRO . . . . . 0.585 ' HD2' HD22 ' A' ' 20' ' ' LEU . 53.5 Cg_endo -69.77 149.45 66.85 Favored 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.666 2.244 . . . . 53.21 112.326 179.962 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 52' ' ' GLU . . . . . 0.683 ' CG ' HD11 ' A' ' 37' ' ' LEU . 28.3 tt0 -94.36 -30.17 14.64 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.231 -0.44 . . . . 64.32 110.925 -179.983 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -85.24 7.72 21.06 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.093 -0.503 . . . . 74.02 110.899 -179.942 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 54' ' ' PHE . . . . . 0.407 ' HB2' ' HG2' ' A' ' 51' ' ' PRO . 1.2 m-85 -119.29 4.57 11.25 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.126 -0.488 . . . . 65.14 110.908 -179.95 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.459 HG12 ' HA ' ' A' ' 6' ' ' ALA . 14.8 m -134.4 164.11 35.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.121 -0.49 . . . . 71.32 111.132 179.975 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 56' ' ' SER . . . . . 0.568 ' HB3' HD21 ' A' ' 7' ' ' LEU . 25.7 t -136.24 117.27 14.32 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.222 -0.444 . . . . 75.22 110.869 -179.85 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 2.9 m-85 -52.1 136.95 28.75 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.108 -0.496 . . . . 71.52 110.944 -179.892 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.675 HD11 ' HB ' ' A' ' 5' ' ' VAL . 32.1 mt -104.64 150.32 7.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.146 -0.479 . . . . 63.35 111.102 179.938 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 2.7 mt-30 . . . . . 0 C--N 1.329 -0.291 0 CA-C-O 121.611 0.72 . . . . 73.43 110.95 179.914 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' B' B ' -7' ' ' PHE . . . . . 0.516 ' HB3' HD11 ' A' ' 49' ' ' LEU . 8.4 m-85 . . . . . 0 C--O 1.231 0.125 0 CA-C-O 120.834 0.35 . . . . 71.4 110.853 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' -6' ' ' ILE . . . . . 0.478 ' O ' HG23 ' B' ' -6' ' ' ILE . 3.8 tp -175.89 91.28 0.28 Allowed Pre-proline 0 C--N 1.328 -0.333 0 CA-C-O 121.634 0.731 . . . . 42.15 111.107 179.989 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' -5' ' ' PRO . . . . . 0.414 ' HD2' ' HA ' ' B' ' -6' ' ' ILE . 53.4 Cg_endo -69.79 139.4 40.03 Favored 'Trans proline' 0 C--N 1.341 0.156 0 C-N-CA 122.677 2.252 . . . . 74.44 112.344 179.868 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' -4' ' ' SER . . . . . . . . . . . . . 2.6 m -132.55 62.45 1.65 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.212 -0.449 . . . . 53.33 110.877 -179.839 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' -3' ' ' ARG . . . . . . . . . . . . . 13.6 ptp180 -179.63 155.41 0.75 Allowed Pre-proline 0 C--N 1.329 -0.32 0 CA-C-O 121.592 0.71 . . . . 71.1 110.852 -179.928 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' -2' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.72 135.42 30.49 Favored 'Trans proline' 0 C--N 1.341 0.169 0 C-N-CA 122.724 2.283 . . . . 75.42 112.33 179.995 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' -1' ' ' ALA . . . . . . . . . . . . . . . -68.15 153.02 96.04 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.615 0.722 . . . . 62.44 111.085 179.877 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 0' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_endo -69.81 174.63 9.27 Favored 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.672 2.248 . . . . 73.15 112.342 -179.954 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 1' ' ' LYS . . . . . . . . . . . . . 16.5 pttm -122.63 153.21 62.86 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.526 0.679 . . . . 74.12 110.933 179.887 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 2' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo . . . . . 0 C--O 1.232 0.19 0 C-N-CA 122.659 2.239 . . . . 73.23 112.385 179.901 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 56.5 tp60 . . . . . 0 C--O 1.231 0.102 0 CA-C-O 120.757 0.313 . . . . 70.02 110.895 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -83.43 163.9 20.25 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.2 -0.455 . . . . 64.51 110.843 -179.938 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -154.58 152.25 29.8 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.168 -0.469 . . . . 62.31 111.086 179.958 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.534 ' HB ' HD11 ' A' ' 58' ' ' ILE . 10.0 p -104.13 149.08 8.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.262 -0.427 . . . . 54.24 111.15 179.975 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 6' ' ' ALA . . . . . 0.415 ' HB3' ' O ' ' A' ' 21' ' ' ALA . . . -90.4 117.78 29.37 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.218 -0.446 . . . . 64.04 111.105 179.873 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 0.744 HD21 ' HB3' ' A' ' 56' ' ' SER . 7.0 mt -84.52 -35.69 22.7 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.255 -0.429 . . . . 43.22 110.905 -179.963 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 5.4 m-85 -140.75 136.89 32.98 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.185 -0.461 . . . . 75.11 110.909 -179.96 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -64.06 137.88 58.19 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.076 -0.511 . . . . 65.3 110.91 179.924 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 18.5 t80 -137.33 145.37 43.29 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.204 -0.453 . . . . 63.22 110.851 -179.878 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 7.0 tt0 -115.69 136.13 22.78 Favored Pre-proline 0 C--N 1.33 -0.261 0 CA-C-O 121.671 0.748 . . . . 63.24 110.86 -179.925 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 12' ' ' PRO . . . . . 0.42 ' HD3' ' HA ' ' A' ' 19' ' ' ARG . 53.7 Cg_endo -69.74 143.94 52.53 Favored 'Trans proline' 0 C--N 1.342 0.189 0 C-N-CA 122.718 2.279 . . . . 71.45 112.29 179.999 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -107.38 -7.51 16.63 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.21 -0.45 . . . . 71.43 110.873 179.965 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 59.3 m-80 -124.5 175.78 6.93 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.196 -0.457 . . . . 45.44 110.893 -179.95 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 8.9 p30 -93.58 24.2 4.18 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.205 -0.452 . . . . 64.12 110.887 179.917 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 1.2 p-10 -139.97 11.82 2.43 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.163 -0.471 . . . . 74.3 110.873 -179.899 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 10.0 mm-40 -106.38 163.35 12.92 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.186 -0.461 . . . . 70.12 110.864 -179.978 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.648 HD12 ' H ' ' A' ' 19' ' ' ARG . 20.7 tp -113.02 142.64 45.48 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.134 -0.485 . . . . 72.44 110.896 -179.951 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 19' ' ' ARG . . . . . 0.648 ' H ' HD12 ' A' ' 18' ' ' LEU . 6.6 mtp85 -79.03 153.45 30.23 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.192 -0.458 . . . . 75.32 110.89 179.94 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.553 HD21 ' CG1' ' A' ' 55' ' ' VAL . 2.3 tp -138.55 149.07 44.94 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.192 -0.458 . . . . 75.35 110.901 -179.973 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.687 ' HB3' ' OD2' ' A' ' 24' ' ' ASP . . . -140.7 139.76 34.78 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.205 -0.452 . . . . 42.2 111.151 179.766 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -50.62 122.85 7.78 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.222 -0.445 . . . . 75.33 110.865 -179.885 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 97.18 -13.48 64.67 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.777 -0.725 . . . . 73.32 112.478 -179.994 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 24' ' ' ASP . . . . . 0.687 ' OD2' ' HB3' ' A' ' 21' ' ' ALA . 7.2 m-20 -71.53 149.07 46.11 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.796 0.332 . . . . 72.12 110.87 -179.982 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 1.7 mt -116.62 119.83 63.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.182 -0.463 . . . . 74.41 111.093 -179.955 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 6.4 m -119.14 165.76 14.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.129 -0.487 . . . . 73.42 111.125 179.851 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 46.7 m-85 -114.47 106.92 14.85 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.145 -0.479 . . . . 64.45 110.869 -179.949 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.744 HD13 ' HB2' ' A' ' 39' ' ' ALA . 17.6 mm -70.71 102.91 1.01 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.187 -0.461 . . . . 64.34 111.136 179.967 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 3.6 m -65.19 -39.57 93.03 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.127 -0.488 . . . . 64.35 110.856 -179.898 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 30' ' ' TYR . . . . . 0.492 ' CZ ' HG21 ' A' ' 38' ' ' VAL . 32.1 p90 -174.38 146.83 1.1 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.162 -0.472 . . . . 74.13 110.876 -179.88 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 31' ' ' LYS . . . . . 0.512 ' HG3' HD22 ' A' ' 37' ' ' LEU . 18.7 tttt -80.77 146.17 31.12 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.122 -0.49 . . . . 52.32 110.906 179.886 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 33.7 t60 -135.27 155.97 49.75 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.223 -0.444 . . . . 70.32 110.86 179.899 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -60.84 -174.22 1.14 Allowed Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.754 -0.736 . . . . 74.33 112.519 -179.967 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 41.9 mm-40 64.79 13.21 8.3 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.859 0.362 . . . . 65.13 110.9 -179.914 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 67.94 28.98 73.3 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.715 -0.755 . . . . 72.14 112.489 -179.969 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 36' ' ' TRP . . . . . 0.637 ' C ' HD23 ' A' ' 37' ' ' LEU . 98.7 m95 -122.82 138.11 54.74 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.766 0.317 . . . . 74.12 110.909 -179.871 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.695 HD11 ' CG ' ' A' ' 52' ' ' GLU . 0.5 OUTLIER -125.96 130.47 51.3 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.25 -0.432 . . . . 74.5 110.931 179.934 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.492 HG21 ' CZ ' ' A' ' 30' ' ' TYR . 41.7 t -77.2 115.21 18.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.186 -0.461 . . . . 75.02 111.095 179.868 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 39' ' ' ALA . . . . . 0.744 ' HB2' HD13 ' A' ' 28' ' ' ILE . . . -135.54 163.53 29.89 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.187 -0.46 . . . . 72.4 111.09 179.86 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 1.6 pm0 -121.58 160.49 24.23 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.211 -0.449 . . . . 53.54 110.826 -179.928 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 43.4 p-10 -58.91 -174.8 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.088 -0.505 . . . . 74.22 110.893 -179.94 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 15.2 tt0 -78.43 -38.63 40.9 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.188 -0.46 . . . . 74.13 110.914 179.998 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 4.4 m -68.73 -22.55 64.32 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.134 -0.485 . . . . 72.22 110.847 -179.785 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 76.61 26.76 62.38 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.704 -0.76 . . . . 71.33 112.52 -179.977 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 3.5 m -105.48 -22.19 13.06 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.946 0.403 . . . . 73.32 110.875 -179.717 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.401 ' HD2' HD11 ' A' ' 18' ' ' LEU . 0.0 OUTLIER -125.68 138.05 53.87 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.122 -0.49 . . . . 70.02 110.928 179.904 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 30.7 m -136.8 143.89 43.4 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.243 -0.435 . . . . 41.33 111.149 179.976 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -167.74 -155.62 9.44 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.736 -0.745 . . . . 63.32 112.513 179.938 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 7.0 mt -103.57 132.19 50.04 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.828 0.347 . . . . 72.1 110.908 -179.922 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.413 ' HB ' ' HD2' ' A' ' 51' ' ' PRO . 6.7 m -129.53 153.47 80.67 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 121.592 0.711 . . . . 62.24 111.161 179.85 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 51' ' ' PRO . . . . . 0.448 ' HD2' HD22 ' A' ' 20' ' ' LEU . 54.0 Cg_endo -69.73 150.76 68.82 Favored 'Trans proline' 0 C--N 1.341 0.147 0 C-N-CA 122.741 2.294 . . . . 74.21 112.318 179.968 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 52' ' ' GLU . . . . . 0.695 ' CG ' HD11 ' A' ' 37' ' ' LEU . 28.2 tt0 -95.74 -28.89 14.56 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.186 -0.461 . . . . 54.14 110.833 -179.982 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -87.3 11.08 15.2 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.195 -0.457 . . . . 70.5 110.907 -179.909 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -121.01 -8.15 9.38 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.122 -0.49 . . . . 72.33 110.891 -179.931 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.553 ' CG1' HD21 ' A' ' 20' ' ' LEU . 12.3 m -120.02 172.84 6.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.154 -0.475 . . . . 73.34 111.153 -179.998 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 56' ' ' SER . . . . . 0.744 ' HB3' HD21 ' A' ' 7' ' ' LEU . 3.3 t -143.25 114.3 7.77 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.195 -0.457 . . . . 33.31 110.882 -179.868 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 2.6 m-85 -52.33 127.11 21.14 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.131 -0.486 . . . . 75.33 110.912 -179.868 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.534 HD11 ' HB ' ' A' ' 5' ' ' VAL . 42.6 mt -94.85 149.94 4.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.122 -0.49 . . . . 71.21 111.17 179.887 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.316 0 CA-C-O 121.601 0.715 . . . . 73.32 110.933 179.951 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' -7' ' ' PHE . . . . . . . . . . . . . 10.8 m-85 . . . . . 0 C--O 1.232 0.133 0 CA-C-O 120.788 0.327 . . . . 73.55 110.93 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' B' B ' -6' ' ' ILE . . . . . 0.411 ' O ' HG23 ' B' ' -6' ' ' ILE . 5.9 tt -138.78 119.3 9.79 Favored Pre-proline 0 C--N 1.328 -0.35 0 CA-C-O 121.615 0.721 . . . . 74.53 111.131 179.985 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' -5' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.82 154.26 67.72 Favored 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.674 2.249 . . . . 63.52 112.372 179.862 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' -4' ' ' SER . . . . . . . . . . . . . 45.2 t -132.45 41.89 3.16 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.246 -0.434 . . . . 54.42 110.877 -179.834 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' -3' ' ' ARG . . . . . . . . . . . . . 1.5 ptm180 -177.45 155.05 1.1 Allowed Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 121.618 0.723 . . . . 75.12 110.886 -179.952 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' -2' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.78 134.37 27.79 Favored 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.68 2.254 . . . . 74.21 112.35 -179.968 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' -1' ' ' ALA . . . . . . . . . . . . . . . -57.99 154.09 30.71 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 121.575 0.702 . . . . 44.35 111.098 179.887 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 0' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.78 -173.3 0.69 Allowed 'Trans proline' 0 C--N 1.342 0.2 0 C-N-CA 122.644 2.229 . . . . 73.52 112.35 -179.986 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 1' ' ' LYS . . . . . . . . . . . . . 33.8 mtpt -127.61 155.77 76.48 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-O 121.628 0.728 . . . . 73.4 110.875 179.908 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 2' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo . . . . . 0 C--N 1.342 0.21 0 C-N-CA 122.643 2.229 . . . . 74.11 112.351 179.912 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 7.9 tp-100 . . . . . 0 C--O 1.231 0.09 0 CA-C-O 120.806 0.336 . . . . 73.24 110.931 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 3' ' ' ARG . . . . . 0.475 ' HG3' HD12 ' A' ' 58' ' ' ILE . 3.2 ptt-85 -84.15 162.4 20.26 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.213 -0.449 . . . . 71.34 110.858 -179.934 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -155.21 150.86 27.47 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.146 -0.479 . . . . 73.42 111.139 179.937 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 11.0 p -104.07 146.31 11.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.229 -0.441 . . . . 51.55 111.133 -179.991 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -84.82 111.14 19.37 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.187 -0.461 . . . . 21.02 111.099 179.88 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 0.743 HD21 ' CB ' ' A' ' 56' ' ' SER . 13.9 mt -76.42 -37.04 57.67 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.244 -0.435 . . . . 43.24 110.888 -179.946 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 4.0 m-85 -142.22 147.03 35.86 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.223 -0.444 . . . . 73.32 110.911 -179.96 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 3.5 p-10 -70.47 138.98 51.59 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.125 -0.489 . . . . 74.23 110.864 179.899 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 5.3 t80 -143.82 144.62 31.86 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.215 -0.448 . . . . 72.54 110.878 -179.89 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -112.98 145.2 32.58 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-O 121.688 0.756 . . . . 72.12 110.83 -179.892 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.81 139.7 40.68 Favored 'Trans proline' 0 C--N 1.342 0.226 0 C-N-CA 122.657 2.238 . . . . 74.41 112.347 179.985 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -101.37 -17.09 16.67 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.21 -0.45 . . . . 73.34 110.92 -179.984 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 9.0 m120 -116.26 176.53 5.06 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.104 -0.498 . . . . 71.35 110.923 -179.953 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 17.7 m-20 -91.51 21.55 4.54 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.218 -0.446 . . . . 61.24 110.894 179.907 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -141.97 17.52 2.12 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.191 -0.459 . . . . 65.42 110.867 -179.879 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 24.1 mt-10 -107.39 165.6 11.27 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.192 -0.458 . . . . 74.32 110.86 -179.976 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.553 HD11 ' HE3' ' A' ' 46' ' ' LYS . 28.7 tp -114.12 148.93 36.37 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.139 -0.482 . . . . 73.32 110.895 -179.931 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 19' ' ' ARG . . . . . 0.542 ' H ' HD12 ' A' ' 18' ' ' LEU . 0.8 OUTLIER -84.8 156.18 21.47 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.2 -0.454 . . . . 72.33 110.807 179.99 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.562 HD21 ' CG1' ' A' ' 55' ' ' VAL . 3.1 tp -140.26 150.17 43.75 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.131 -0.486 . . . . 42.42 110.932 179.984 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.666 ' HB3' ' CG ' ' A' ' 24' ' ' ASP . . . -141.42 137.29 32.12 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.191 -0.459 . . . . 52.01 111.102 179.827 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -50.79 121.88 6.54 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.265 -0.425 . . . . 55.23 110.867 -179.928 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 96.28 -6.51 66.05 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.697 -0.763 . . . . 54.52 112.476 -179.956 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 24' ' ' ASP . . . . . 0.666 ' CG ' ' HB3' ' A' ' 21' ' ' ALA . 1.0 OUTLIER -81.46 146.44 30.23 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.85 0.357 . . . . 75.01 110.838 -179.908 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 3.3 mm -100.81 142.52 15.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.186 -0.461 . . . . 73.22 111.165 179.999 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 1.4 m -144.95 158.55 13.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.155 -0.475 . . . . 64.41 111.09 179.918 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 51.6 m-85 -117.3 109.57 17.01 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.154 -0.476 . . . . 71.42 110.882 179.988 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.662 HD13 ' HB2' ' A' ' 39' ' ' ALA . 12.1 mm -73.11 102.7 1.63 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.113 -0.494 . . . . 63.51 111.082 -179.992 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 43.3 m -64.76 -39.57 93.83 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.159 -0.473 . . . . 71.31 110.891 -179.977 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 30' ' ' TYR . . . . . 0.54 ' CZ ' HG21 ' A' ' 38' ' ' VAL . 37.4 p90 -174.87 151.39 1.38 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.139 -0.482 . . . . 73.2 110.941 -179.856 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 31' ' ' LYS . . . . . 0.494 ' HG3' HD22 ' A' ' 37' ' ' LEU . 17.8 tttt -83.25 145.55 29.06 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.13 -0.486 . . . . 75.04 110.946 179.871 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 34.4 t60 -134.21 152.9 52.06 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.227 -0.442 . . . . 75.23 110.892 179.903 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -58.96 -173.98 0.55 Allowed Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.755 -0.736 . . . . 64.01 112.469 -179.954 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 27.6 mm-40 65.43 12.21 7.96 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.845 0.355 . . . . 73.23 110.943 -179.875 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 68.09 30.14 73.77 Favored Glycine 0 N--CA 1.452 -0.261 0 C-N-CA 120.702 -0.761 . . . . 63.04 112.496 -179.943 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 36' ' ' TRP . . . . . 0.633 ' C ' HD23 ' A' ' 37' ' ' LEU . 99.0 m95 -124.15 136.51 54.26 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.796 0.331 . . . . 62.04 110.95 -179.952 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.717 HD11 ' CG ' ' A' ' 52' ' ' GLU . 1.3 mt -120.58 133.36 55.39 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.252 -0.431 . . . . 35.31 110.951 179.962 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.54 HG21 ' CZ ' ' A' ' 30' ' ' TYR . 59.9 t -79.75 110.02 14.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.18 -0.464 . . . . 73.33 111.144 179.858 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 39' ' ' ALA . . . . . 0.662 ' HB2' HD13 ' A' ' 28' ' ' ILE . . . -129.79 159.36 36.76 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.154 -0.475 . . . . 64.02 111.114 179.869 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 1.4 pt-20 -117.01 156.57 27.27 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.207 -0.451 . . . . 73.34 110.865 -179.919 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -70.18 -175.2 0.92 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.143 -0.48 . . . . 73.44 110.901 -179.983 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 -69.4 -38.21 77.83 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.167 -0.469 . . . . 70.25 110.895 179.965 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 1.5 t -56.37 -22.53 31.8 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.171 -0.468 . . . . 72.43 110.848 -179.786 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 69.16 9.53 60.61 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.757 -0.735 . . . . 62.12 112.476 -179.988 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -108.04 -20.82 13.05 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.947 0.403 . . . . 73.02 110.885 -179.751 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.553 ' HE3' HD11 ' A' ' 18' ' ' LEU . 4.0 ttpt -109.98 123.86 50.4 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.128 -0.487 . . . . 75.01 110.917 179.941 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 3.7 m -129.82 137.47 50.49 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.237 -0.438 . . . . 52.34 111.2 179.981 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -161.02 -157.48 8.77 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.765 -0.731 . . . . 62.45 112.508 179.976 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.454 HD23 HG22 ' A' ' 38' ' ' VAL . 8.7 mt -101.68 137.55 39.85 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.886 0.374 . . . . 72.02 110.866 -179.887 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.404 ' HB ' ' HD2' ' A' ' 51' ' ' PRO . 10.3 m -137.16 153.36 74.96 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 121.645 0.736 . . . . 70.45 111.1 179.825 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 51' ' ' PRO . . . . . 0.427 ' HG2' ' HB2' ' A' ' 54' ' ' PHE . 53.4 Cg_endo -69.85 143.81 51.59 Favored 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 122.657 2.238 . . . . 73.02 112.306 179.961 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 52' ' ' GLU . . . . . 0.717 ' CG ' HD11 ' A' ' 37' ' ' LEU . 10.9 tm-20 -89.92 -28.09 19.42 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.189 -0.46 . . . . 72.05 110.903 179.983 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -85.97 10.35 14.33 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.17 -0.468 . . . . 73.02 110.847 -179.92 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 54' ' ' PHE . . . . . 0.427 ' HB2' ' HG2' ' A' ' 51' ' ' PRO . 0.9 OUTLIER -120.72 -8.96 9.41 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.174 -0.466 . . . . 72.52 110.875 -179.932 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.562 ' CG1' HD21 ' A' ' 20' ' ' LEU . 15.8 m -119.71 166.33 14.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.123 -0.489 . . . . 71.43 111.167 179.961 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 56' ' ' SER . . . . . 0.743 ' CB ' HD21 ' A' ' 7' ' ' LEU . 37.2 t -135.25 117.86 15.95 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.193 -0.458 . . . . 71.4 110.875 -179.868 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 3.3 m-85 -58.32 124.69 20.35 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.171 -0.468 . . . . 72.42 110.935 -179.896 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.475 HD12 ' HG3' ' A' ' 3' ' ' ARG . 22.8 mt -88.26 153.64 3.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.119 -0.491 . . . . 71.33 111.081 179.947 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 8.1 pm0 . . . . . 0 C--N 1.329 -0.314 0 CA-C-O 121.609 0.719 . . . . 72.31 110.929 179.95 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' B' B ' -7' ' ' PHE . . . . . 0.425 ' HB3' HD11 ' A' ' 49' ' ' LEU . 9.1 m-85 . . . . . 0 C--O 1.231 0.095 0 CA-C-O 120.823 0.345 . . . . 73.54 110.913 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' -6' ' ' ILE . . . . . 0.416 HD13 ' O ' ' B' ' -7' ' ' PHE . 37.9 mm -145.51 87.22 7.05 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 121.63 0.729 . . . . 72.34 111.105 -179.997 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' -5' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.74 139.87 41.37 Favored 'Trans proline' 0 C--O 1.231 0.164 0 C-N-CA 122.707 2.272 . . . . 75.34 112.351 179.891 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' -4' ' ' SER . . . . . . . . . . . . . 27.5 t -132.96 66.16 1.57 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.227 -0.442 . . . . 61.13 110.903 -179.872 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' -3' ' ' ARG . . . . . . . . . . . . . 5.8 ptm180 -178.21 155.0 0.96 Allowed Pre-proline 0 C--N 1.329 -0.288 0 CA-C-O 121.6 0.714 . . . . 74.43 110.851 -179.95 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' -2' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.81 131.63 21.55 Favored 'Trans proline' 0 C--N 1.341 0.157 0 C-N-CA 122.654 2.236 . . . . 73.01 112.35 -179.978 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' -1' ' ' ALA . . . . . . . . . . . . . . . -70.47 151.67 95.56 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 121.62 0.724 . . . . 63.24 111.102 179.89 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 0' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.7 173.34 11.07 Favored 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.681 2.254 . . . . 75.14 112.363 -179.98 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 1' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -121.82 154.35 60.58 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 121.579 0.704 . . . . 74.42 110.891 179.865 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 2' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo . . . . . 0 C--O 1.232 0.186 0 C-N-CA 122.716 2.277 . . . . 74.42 112.345 179.89 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 55.0 tp60 . . . . . 0 C--O 1.231 0.087 0 CA-C-O 120.802 0.334 . . . . 74.45 110.945 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 7.7 ptp180 -82.0 164.15 21.64 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.188 -0.46 . . . . 74.51 110.821 -179.873 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -155.67 153.22 29.65 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.188 -0.46 . . . . 63.41 111.111 179.919 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.716 ' HB ' HD11 ' A' ' 58' ' ' ILE . 10.3 p -103.71 152.31 6.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.208 -0.451 . . . . 73.04 111.143 179.972 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -92.89 114.99 27.7 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.199 -0.455 . . . . 63.43 111.09 179.92 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 0.63 HD21 ' HB2' ' A' ' 56' ' ' SER . 7.0 mt -82.07 -35.64 28.47 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.224 -0.443 . . . . 71.54 110.925 -179.966 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 5.0 m-85 -141.82 137.83 31.77 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.207 -0.451 . . . . 75.53 110.979 179.965 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 3.0 p-10 -63.0 138.43 58.56 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.121 -0.491 . . . . 73.55 110.847 179.98 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 10.4 t80 -141.86 144.76 34.01 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.205 -0.452 . . . . 73.03 110.915 -179.927 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -113.1 144.33 30.92 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 121.656 0.741 . . . . 71.43 110.899 -179.925 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.75 132.39 23.25 Favored 'Trans proline' 0 C--N 1.342 0.193 0 C-N-CA 122.686 2.257 . . . . 65.03 112.324 179.991 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 15.3 mt-10 -94.47 -20.08 19.99 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.184 -0.462 . . . . 74.45 110.87 179.994 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 9.5 m120 -114.48 175.66 5.39 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.176 -0.465 . . . . 71.25 110.878 -179.929 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -86.85 8.66 21.98 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.199 -0.455 . . . . 52.23 110.899 179.896 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -129.44 20.52 5.68 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.186 -0.461 . . . . 71.53 110.905 -179.942 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 57.1 mt-10 -109.92 156.37 20.53 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.198 -0.455 . . . . 63.21 110.87 -179.962 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.535 HD23 ' O ' ' A' ' 19' ' ' ARG . 0.4 OUTLIER -105.13 153.83 20.99 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.16 -0.473 . . . . 74.23 110.927 -179.999 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 19' ' ' ARG . . . . . 0.535 ' O ' HD23 ' A' ' 18' ' ' LEU . 21.6 mtm180 -87.87 151.69 22.65 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.179 -0.464 . . . . 61.12 110.856 179.974 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.546 HD21 ' CG1' ' A' ' 55' ' ' VAL . 1.7 tp -137.47 148.7 46.27 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.171 -0.468 . . . . 64.12 110.94 179.981 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.612 ' HB3' ' CG ' ' A' ' 24' ' ' ASP . . . -141.62 140.28 33.27 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.197 -0.456 . . . . 72.13 111.107 179.795 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -50.62 120.28 4.56 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.234 -0.439 . . . . 73.32 110.912 -179.915 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 97.84 -7.11 62.78 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.716 -0.754 . . . . 62.05 112.474 -179.986 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 24' ' ' ASP . . . . . 0.612 ' CG ' ' HB3' ' A' ' 21' ' ' ALA . 2.1 m-20 -76.41 150.45 36.76 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.788 0.328 . . . . 54.11 110.84 -179.944 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 1.5 mt -116.91 120.08 63.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.201 -0.454 . . . . 73.32 111.118 -179.965 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 6.0 m -120.61 165.44 16.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.163 -0.472 . . . . 65.32 111.125 179.858 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 54.4 m-85 -115.57 107.4 15.09 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.162 -0.472 . . . . 65.25 110.887 179.987 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.782 HD13 ' HB2' ' A' ' 39' ' ' ALA . 17.4 mm -72.04 103.05 1.38 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.164 -0.471 . . . . 71.25 111.127 179.963 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 3.2 m -64.43 -39.25 93.48 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.196 -0.457 . . . . 72.03 110.856 -179.921 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 30' ' ' TYR . . . . . 0.507 ' CZ ' HG21 ' A' ' 38' ' ' VAL . 31.7 p90 -174.99 145.93 0.85 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.151 -0.477 . . . . 64.03 110.936 -179.862 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 31' ' ' LYS . . . . . 0.476 ' HG3' HD22 ' A' ' 37' ' ' LEU . 19.1 tttt -79.45 144.94 33.58 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.11 -0.496 . . . . 64.53 110.869 179.937 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 28.8 t60 -134.4 153.47 51.89 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.2 -0.455 . . . . 74.33 110.795 179.926 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -58.89 -174.05 0.54 Allowed Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.766 -0.731 . . . . 60.15 112.515 179.975 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 40.5 mm-40 64.59 13.4 8.24 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.834 0.35 . . . . 71.13 110.896 -179.892 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 67.32 28.57 73.7 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.743 -0.742 . . . . 33.53 112.456 179.975 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 36' ' ' TRP . . . . . 0.591 ' C ' HD23 ' A' ' 37' ' ' LEU . 98.5 m95 -121.96 135.82 54.88 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.805 0.336 . . . . 75.13 110.947 -179.951 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.673 HD11 ' CG ' ' A' ' 52' ' ' GLU . 0.9 OUTLIER -121.97 131.22 53.89 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.234 -0.439 . . . . 74.5 110.961 179.96 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.528 HG22 HD23 ' A' ' 49' ' ' LEU . 41.3 t -78.92 109.46 13.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.193 -0.458 . . . . 73.23 111.159 179.825 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 39' ' ' ALA . . . . . 0.782 ' HB2' HD13 ' A' ' 28' ' ' ILE . . . -129.73 162.25 28.82 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.192 -0.458 . . . . 52.24 111.137 179.871 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 3.6 pm0 -118.17 159.9 22.5 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.233 -0.44 . . . . 43.41 110.893 -179.966 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 44.9 p-10 -58.88 -174.88 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.127 -0.488 . . . . 63.42 110.896 -179.946 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 6.1 tm-20 -78.05 -37.68 46.21 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.164 -0.471 . . . . 74.32 110.91 179.988 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 67.9 m -68.38 -21.89 64.68 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.127 -0.488 . . . . 72.31 110.863 -179.774 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 75.91 26.01 65.63 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.747 -0.74 . . . . 60.01 112.468 179.976 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 6.6 t -109.66 -21.27 12.51 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.931 0.396 . . . . 51.51 110.889 -179.747 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.511 ' HG3' HD11 ' A' ' 18' ' ' LEU . 0.9 OUTLIER -121.51 138.98 54.07 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.132 -0.485 . . . . 62.15 110.894 179.926 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 6.1 m -132.58 152.6 51.57 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.231 -0.441 . . . . 71.42 111.159 179.978 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -178.36 -161.91 27.15 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.717 -0.754 . . . . 63.03 112.454 179.938 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.528 HD23 HG22 ' A' ' 38' ' ' VAL . 5.8 mt -100.95 141.48 33.78 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.849 0.357 . . . . 74.24 110.915 -179.873 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.422 ' HB ' ' HD2' ' A' ' 51' ' ' PRO . 17.1 m -138.2 153.71 73.36 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-O 121.67 0.748 . . . . 63.03 111.091 179.876 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 51' ' ' PRO . . . . . 0.451 ' HD2' HD22 ' A' ' 20' ' ' LEU . 53.7 Cg_endo -69.8 144.93 55.38 Favored 'Trans proline' 0 C--N 1.342 0.21 0 C-N-CA 122.661 2.241 . . . . 62.44 112.322 179.974 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 52' ' ' GLU . . . . . 0.673 ' CG ' HD11 ' A' ' 37' ' ' LEU . 25.8 tt0 -91.88 -26.93 18.24 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.22 -0.445 . . . . 62.04 110.914 180.0 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -87.89 10.59 18.18 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.168 -0.469 . . . . 35.15 110.918 -179.928 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 54' ' ' PHE . . . . . 0.421 ' HB2' ' HG2' ' A' ' 51' ' ' PRO . 1.0 OUTLIER -120.04 -14.22 8.91 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.121 -0.491 . . . . 75.33 110.898 -179.96 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.546 ' CG1' HD21 ' A' ' 20' ' ' LEU . 19.2 m -114.82 172.48 3.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.172 -0.467 . . . . 71.25 111.181 179.949 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 56' ' ' SER . . . . . 0.63 ' HB2' HD21 ' A' ' 7' ' ' LEU . 32.3 t -144.19 116.7 8.6 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.185 -0.461 . . . . 54.35 110.852 -179.842 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 2.8 m-85 -51.93 134.37 31.69 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.132 -0.486 . . . . 71.42 110.876 -179.827 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.716 HD11 ' HB ' ' A' ' 5' ' ' VAL . 52.2 mt -105.63 145.46 13.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.125 -0.489 . . . . 75.11 111.136 179.91 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 4.6 mt-30 . . . . . 0 C--N 1.329 -0.321 0 CA-C-O 121.613 0.72 . . . . 74.53 110.888 179.994 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' B' B ' -7' ' ' PHE . . . . . . . . . . . . . 14.0 m-85 . . . . . 0 C--O 1.231 0.125 0 CA-C-O 120.885 0.374 . . . . 74.11 110.835 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' B' B ' -6' ' ' ILE . . . . . . . . . . . . . 55.8 mt -149.91 86.28 5.35 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-O 121.615 0.721 . . . . 73.5 111.13 179.921 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' -5' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.8 141.03 43.98 Favored 'Trans proline' 0 C--N 1.341 0.176 0 C-N-CA 122.64 2.226 . . . . 74.11 112.382 179.844 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' -4' ' ' SER . . . . . . . . . . . . . 2.6 t -139.5 65.89 1.42 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.25 -0.432 . . . . 73.41 110.884 -179.822 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' -3' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -178.56 154.51 0.87 Allowed Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.581 0.705 . . . . 74.55 110.9 -179.889 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' -2' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.77 124.2 10.85 Favored 'Trans proline' 0 C--N 1.342 0.2 0 C-N-CA 122.689 2.259 . . . . 63.22 112.333 -179.951 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' -1' ' ' ALA . . . . . . . . . . . . . . . -57.67 152.29 36.69 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.576 0.703 . . . . 52.24 111.099 179.897 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 0' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.77 172.79 12.0 Favored 'Trans proline' 0 C--N 1.342 0.194 0 C-N-CA 122.712 2.275 . . . . 75.44 112.341 -179.966 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 1' ' ' LYS . . . . . . . . . . . . . 12.7 ptmt -119.83 153.45 54.74 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.549 0.69 . . . . 74.21 110.874 179.907 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 2' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo . . . . . 0 C--N 1.341 0.171 0 C-N-CA 122.631 2.221 . . . . 63.1 112.327 179.887 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 55.7 tp60 . . . . . 0 C--O 1.231 0.109 0 CA-C-O 120.791 0.329 . . . . 53.05 110.894 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 5.5 ptm180 -81.99 164.3 21.56 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.233 -0.44 . . . . 72.52 110.883 -179.967 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -156.76 155.33 31.43 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.2 -0.454 . . . . 61.12 111.118 179.939 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.639 ' HB ' HD11 ' A' ' 58' ' ' ILE . 10.5 p -104.95 152.31 6.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.256 -0.429 . . . . 74.11 111.164 179.985 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -90.65 112.27 23.93 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.222 -0.445 . . . . 75.43 111.045 179.919 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 0.757 HD21 ' HB3' ' A' ' 56' ' ' SER . 11.6 mt -78.54 -37.64 42.41 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.218 -0.447 . . . . 71.13 110.908 -179.984 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 5.5 m-85 -141.77 146.07 35.53 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.199 -0.455 . . . . 74.11 110.947 -179.957 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 4.0 p-10 -70.61 134.88 48.0 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.115 -0.493 . . . . 62.31 110.909 179.897 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 7.0 t80 -135.15 145.99 48.34 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.199 -0.455 . . . . 73.43 110.893 -179.897 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 5.7 tp10 -115.84 136.04 22.82 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 121.643 0.735 . . . . 74.52 110.892 -179.934 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 12' ' ' PRO . . . . . 0.415 ' HD3' ' HA ' ' A' ' 19' ' ' ARG . 53.7 Cg_endo -69.8 148.27 64.43 Favored 'Trans proline' 0 C--N 1.341 0.177 0 C-N-CA 122.694 2.263 . . . . 43.13 112.341 -179.998 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -105.94 -21.73 13.08 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.201 -0.454 . . . . 61.45 110.877 -179.977 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 26.2 m120 -112.07 175.52 5.39 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.187 -0.46 . . . . 44.41 110.949 -179.964 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -88.34 10.34 20.18 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.227 -0.442 . . . . 55.12 110.899 179.905 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -126.22 14.03 7.77 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.169 -0.469 . . . . 73.13 110.936 -179.946 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 25.5 mt-10 -107.62 153.19 23.25 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.178 -0.464 . . . . 71.35 110.88 -179.98 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.544 HD23 ' O ' ' A' ' 19' ' ' ARG . 0.3 OUTLIER -103.25 151.56 22.53 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.137 -0.483 . . . . 72.02 110.911 -179.979 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 19' ' ' ARG . . . . . 0.544 ' O ' HD23 ' A' ' 18' ' ' LEU . 0.3 OUTLIER -88.73 155.26 19.68 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.175 -0.466 . . . . 74.34 110.856 179.997 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.541 HD21 ' CG1' ' A' ' 55' ' ' VAL . 2.0 tp -139.0 148.73 43.83 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.187 -0.46 . . . . 62.11 110.905 -179.959 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.648 ' HB3' ' CG ' ' A' ' 24' ' ' ASP . . . -140.46 137.96 34.3 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.185 -0.461 . . . . 74.31 111.101 179.769 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -50.24 120.36 4.45 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.188 -0.46 . . . . 75.21 110.91 -179.902 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 96.09 -0.32 62.18 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.74 -0.743 . . . . 75.24 112.497 -179.952 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 24' ' ' ASP . . . . . 0.648 ' CG ' ' HB3' ' A' ' 21' ' ' ALA . 1.3 m-20 -86.6 145.99 26.52 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.81 0.338 . . . . 51.51 110.856 -179.951 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 3.1 mm -102.65 139.9 22.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.176 -0.466 . . . . 60.55 111.138 -179.997 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 1.1 m -141.91 162.44 20.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.204 -0.453 . . . . 62.22 111.125 179.873 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 63.7 m-85 -118.92 108.84 15.27 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.201 -0.454 . . . . 72.54 110.872 -179.987 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.776 HD13 ' HB2' ' A' ' 39' ' ' ALA . 17.2 mm -73.13 103.35 1.82 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.139 -0.482 . . . . 64.2 111.122 179.976 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 5.9 m -64.88 -40.39 95.03 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.184 -0.462 . . . . 74.2 110.892 -179.946 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 30' ' ' TYR . . . . . 0.511 ' CZ ' HG21 ' A' ' 38' ' ' VAL . 36.2 p90 -174.61 149.7 1.28 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.142 -0.481 . . . . 74.4 110.918 -179.897 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 31' ' ' LYS . . . . . 0.491 ' HG3' HD22 ' A' ' 37' ' ' LEU . 20.5 tttt -81.56 144.24 31.42 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.152 -0.476 . . . . 74.14 110.894 179.919 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 31.5 t60 -133.25 153.34 51.65 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.242 -0.435 . . . . 73.5 110.918 179.849 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -59.09 -174.54 0.62 Allowed Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.778 -0.725 . . . . 74.12 112.42 -179.898 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 5.1 mt-30 65.95 11.99 8.1 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.88 0.371 . . . . 75.03 110.917 -179.909 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 68.36 28.99 72.99 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.753 -0.737 . . . . 51.54 112.502 -179.971 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 36' ' ' TRP . . . . . 0.634 ' C ' HD23 ' A' ' 37' ' ' LEU . 98.6 m95 -123.35 136.54 54.71 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.821 0.344 . . . . 75.52 110.941 -179.922 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.695 HD11 ' CG ' ' A' ' 52' ' ' GLU . 1.4 mt -120.24 132.73 55.47 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.249 -0.432 . . . . 63.42 110.926 179.959 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.511 HG21 ' CZ ' ' A' ' 30' ' ' TYR . 37.6 t -80.4 109.31 14.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.216 -0.447 . . . . 64.33 111.138 179.829 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 39' ' ' ALA . . . . . 0.776 ' HB2' HD13 ' A' ' 28' ' ' ILE . . . -130.56 164.54 24.68 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.167 -0.469 . . . . 51.54 111.142 179.854 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 1.2 pt-20 -119.67 156.06 31.18 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.232 -0.44 . . . . 64.32 110.885 -179.933 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -67.54 -175.06 0.47 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.134 -0.485 . . . . 72.23 110.898 -179.916 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 6.9 tt0 -68.87 -37.62 79.19 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.221 -0.445 . . . . 72.23 110.827 -179.956 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 1.7 t -56.87 -22.46 37.13 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.19 -0.459 . . . . 62.32 110.885 -179.805 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 69.44 9.43 61.34 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.766 -0.73 . . . . 52.33 112.489 -179.996 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 7.4 m -108.78 -24.27 11.37 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.97 0.415 . . . . 73.5 110.853 -179.732 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.463 ' HG2' HD11 ' A' ' 18' ' ' LEU . 0.1 OUTLIER -105.51 123.61 48.18 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.149 -0.478 . . . . 74.42 110.857 179.932 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 3.4 m -124.47 152.59 43.16 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.223 -0.444 . . . . 74.24 111.175 179.928 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -177.29 -161.71 26.3 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.723 -0.751 . . . . 73.53 112.485 179.968 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.49 HD23 HG22 ' A' ' 38' ' ' VAL . 5.5 mt -100.59 134.44 43.55 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.876 0.369 . . . . 72.02 110.885 -179.861 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.403 ' HB ' ' HD2' ' A' ' 51' ' ' PRO . 10.4 m -133.77 153.23 79.92 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-O 121.632 0.729 . . . . 61.42 111.135 179.866 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 51' ' ' PRO . . . . . 0.411 ' HG2' ' HB2' ' A' ' 54' ' ' PHE . 53.8 Cg_endo -69.77 144.97 55.66 Favored 'Trans proline' 0 C--N 1.342 0.207 0 C-N-CA 122.667 2.245 . . . . 73.14 112.343 179.928 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 52' ' ' GLU . . . . . 0.695 ' CG ' HD11 ' A' ' 37' ' ' LEU . 12.0 tm-20 -91.05 -28.85 17.69 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.233 -0.44 . . . . 64.33 110.868 -179.961 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 2.1 mm-40 -85.11 9.05 15.93 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.198 -0.456 . . . . 54.31 110.927 -179.965 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 54' ' ' PHE . . . . . 0.411 ' HB2' ' HG2' ' A' ' 51' ' ' PRO . 1.1 m-85 -120.33 -2.76 10.03 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.13 -0.486 . . . . 75.42 110.895 -179.922 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.541 ' CG1' HD21 ' A' ' 20' ' ' LEU . 13.0 m -125.27 171.66 13.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.14 -0.482 . . . . 71.22 111.138 179.949 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 56' ' ' SER . . . . . 0.757 ' HB3' HD21 ' A' ' 7' ' ' LEU . 4.1 t -142.94 117.14 9.52 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.179 -0.464 . . . . 72.1 110.86 -179.845 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 3.1 m-85 -55.05 133.39 48.65 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.14 -0.482 . . . . 72.41 110.926 -179.924 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.639 HD11 ' HB ' ' A' ' 5' ' ' VAL . 46.8 mt -103.92 148.59 8.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.105 -0.498 . . . . 72.14 111.142 179.895 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--N 1.33 -0.282 0 CA-C-O 121.646 0.736 . . . . 71.41 110.881 179.939 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' -7' ' ' PHE . . . . . 0.474 ' HB3' HD11 ' A' ' 49' ' ' LEU . 13.4 m-85 . . . . . 0 C--O 1.231 0.129 0 CA-C-O 120.836 0.351 . . . . 65.31 110.904 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' -6' ' ' ILE . . . . . 0.51 ' O ' HG23 ' B' ' -6' ' ' ILE . 4.0 tp -171.9 87.94 0.44 Allowed Pre-proline 0 C--N 1.328 -0.329 0 CA-C-O 121.632 0.73 . . . . 72.53 111.155 179.944 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' -5' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.73 146.33 60.06 Favored 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 122.677 2.251 . . . . 75.41 112.377 179.844 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' -4' ' ' SER . . . . . . . . . . . . . 28.6 t -141.7 63.6 1.42 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.21 -0.45 . . . . 74.45 110.853 -179.841 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' -3' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -179.32 155.42 0.79 Allowed Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.576 0.703 . . . . 73.43 110.886 -179.954 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' -2' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.76 129.13 17.07 Favored 'Trans proline' 0 C--N 1.341 0.175 0 C-N-CA 122.661 2.24 . . . . 74.24 112.337 -179.969 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' -1' ' ' ALA . . . . . . . . . . . . . . . -62.61 152.33 81.49 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-O 121.614 0.721 . . . . 51.41 111.107 179.875 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 0' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.72 175.81 7.58 Favored 'Trans proline' 0 C--N 1.341 0.17 0 C-N-CA 122.696 2.264 . . . . 44.35 112.337 -179.968 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 1' ' ' LYS . . . . . . . . . . . . . 14.2 pttm -123.55 154.36 66.36 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-O 121.647 0.737 . . . . 70.3 110.86 179.92 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 2' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo . . . . . 0 C--N 1.342 0.195 0 C-N-CA 122.722 2.281 . . . . 55.32 112.353 179.899 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 50.8 tp60 . . . . . 0 C--O 1.232 0.165 0 CA-C-O 120.798 0.332 . . . . 62.31 110.932 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 5.6 ptp180 -78.82 161.4 26.81 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.278 -0.419 . . . . 60.24 110.902 -179.931 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -156.24 154.86 31.4 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.233 -0.44 . . . . 53.33 111.122 179.942 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.574 ' HB ' HD11 ' A' ' 58' ' ' ILE . 11.1 p -104.94 151.26 7.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.209 -0.451 . . . . 54.11 111.102 -179.972 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -89.3 111.08 21.81 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.163 -0.471 . . . . 74.3 111.065 179.915 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 0.721 HD21 ' HB2' ' A' ' 56' ' ' SER . 11.5 mt -75.82 -38.63 57.95 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.221 -0.445 . . . . 63.35 110.875 -179.949 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 4.1 m-85 -141.86 148.95 39.62 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.172 -0.467 . . . . 75.33 110.892 -179.946 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 3.7 p-10 -71.28 131.49 43.53 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.142 -0.481 . . . . 60.14 110.89 179.894 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 1.8 t80 -129.54 146.15 51.39 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.228 -0.442 . . . . 74.24 110.866 -179.906 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 32.5 tt0 -116.2 137.06 23.18 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-O 121.654 0.74 . . . . 74.41 110.919 -179.911 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.7 148.27 65.1 Favored 'Trans proline' 0 C--N 1.341 0.154 0 C-N-CA 122.689 2.259 . . . . 72.24 112.373 -179.99 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 18.1 mm-40 -110.79 -18.62 13.08 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.264 -0.425 . . . . 71.12 110.903 179.993 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 9.8 m120 -112.59 176.25 5.09 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.154 -0.475 . . . . 65.24 110.842 -179.925 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 7.9 p-10 -91.54 20.11 5.66 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.162 -0.472 . . . . 65.13 110.848 179.907 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -138.68 14.68 2.72 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.241 -0.436 . . . . 74.42 110.904 -179.907 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 30.3 mt-10 -103.7 164.7 11.5 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.169 -0.469 . . . . 73.15 110.907 -179.966 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.568 HD12 ' H ' ' A' ' 19' ' ' ARG . 39.2 tp -115.35 146.78 41.22 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.181 -0.463 . . . . 40.13 110.936 -179.975 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 19' ' ' ARG . . . . . 0.568 ' H ' HD12 ' A' ' 18' ' ' LEU . 34.6 mtm-85 -82.25 156.8 24.17 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.242 -0.436 . . . . 62.24 110.913 179.93 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.54 HD21 ' CG1' ' A' ' 55' ' ' VAL . 2.9 tp -142.27 147.55 36.62 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.203 -0.453 . . . . 53.32 110.946 179.985 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.716 ' HB3' ' OD2' ' A' ' 24' ' ' ASP . . . -138.79 137.77 36.97 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.231 -0.44 . . . . 60.24 111.113 179.791 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -50.82 120.89 5.2 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.228 -0.442 . . . . 75.21 110.883 -179.923 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 97.25 -5.65 63.13 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.722 -0.751 . . . . 52.32 112.457 179.985 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 24' ' ' ASP . . . . . 0.716 ' OD2' ' HB3' ' A' ' 21' ' ' ALA . 5.7 m-20 -81.34 147.82 29.67 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.811 0.339 . . . . 50.13 110.862 -179.94 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 3.4 mm -101.46 141.56 17.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.231 -0.44 . . . . 71.53 111.125 -179.977 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.413 HG11 HD11 ' A' ' 20' ' ' LEU . 1.5 m -144.79 158.38 14.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.187 -0.461 . . . . 71.1 111.117 179.883 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 57.8 m-85 -117.47 108.38 15.46 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.15 -0.477 . . . . 74.52 110.892 179.965 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.857 HD13 ' HB2' ' A' ' 39' ' ' ALA . 20.1 mm -72.44 103.11 1.51 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.128 -0.487 . . . . 65.03 111.117 -179.996 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 5.7 m -65.05 -40.21 94.44 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.162 -0.472 . . . . 73.5 110.872 -179.922 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 30' ' ' TYR . . . . . 0.513 ' CZ ' HG21 ' A' ' 38' ' ' VAL . 33.9 p90 -174.61 149.11 1.22 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.155 -0.475 . . . . 74.24 110.944 -179.885 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 31' ' ' LYS . . . . . 0.528 ' HG3' HD22 ' A' ' 37' ' ' LEU . 19.0 tttt -81.32 143.25 32.35 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.192 -0.458 . . . . 71.34 110.94 179.874 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 33.4 t60 -131.73 155.36 47.82 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.241 -0.436 . . . . 70.43 110.823 179.932 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -60.79 -174.11 1.11 Allowed Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.728 -0.749 . . . . 51.35 112.493 -179.958 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 84.7 mm-40 65.43 12.55 8.22 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.833 0.349 . . . . 72.31 110.939 -179.849 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 68.53 29.19 72.89 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.739 -0.743 . . . . 73.13 112.496 -179.955 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 36' ' ' TRP . . . . . 0.652 ' C ' HD23 ' A' ' 37' ' ' LEU . 99.0 m95 -123.69 136.8 54.68 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.819 0.342 . . . . 70.45 110.906 -179.929 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.709 HD11 ' CG ' ' A' ' 52' ' ' GLU . 1.3 mt -121.09 130.57 53.81 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.258 -0.428 . . . . 72.11 110.939 179.972 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.513 HG21 ' CZ ' ' A' ' 30' ' ' TYR . 47.4 t -76.9 112.36 14.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.197 -0.456 . . . . 51.31 111.139 179.866 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 39' ' ' ALA . . . . . 0.857 ' HB2' HD13 ' A' ' 28' ' ' ILE . . . -133.88 159.96 39.1 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.182 -0.463 . . . . 73.41 111.106 179.869 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -114.09 155.57 25.75 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.204 -0.453 . . . . 64.14 110.841 -179.909 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -70.56 -175.32 1.02 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.098 -0.501 . . . . 52.41 110.883 -179.951 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -69.86 -39.13 76.56 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.151 -0.477 . . . . 74.13 110.861 -179.956 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 11.8 m -56.29 -22.51 30.72 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.152 -0.476 . . . . 71.42 110.852 -179.809 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 66.81 11.4 57.69 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.754 -0.736 . . . . 50.32 112.498 -179.972 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 47.5 t -108.22 -14.35 14.72 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.956 0.407 . . . . 74.43 110.838 -179.708 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 6.1 ptmt -121.37 135.43 55.08 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.161 -0.472 . . . . 74.43 110.881 179.991 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 5.4 m -137.15 141.16 42.24 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.233 -0.439 . . . . 75.43 111.146 179.986 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -161.97 -154.81 7.67 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.711 -0.757 . . . . 72.22 112.499 179.947 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.506 HD11 ' HB3' ' B' ' -7' ' ' PHE . 6.8 mt -104.82 131.48 52.24 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.811 0.339 . . . . 53.53 110.936 -179.918 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.4 ' HB ' ' HD2' ' A' ' 51' ' ' PRO . 10.8 m -129.64 153.13 80.7 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-O 121.606 0.717 . . . . 63.21 111.185 179.812 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 51' ' ' PRO . . . . . 0.429 ' HG2' ' HB2' ' A' ' 54' ' ' PHE . 53.5 Cg_endo -69.76 144.84 55.31 Favored 'Trans proline' 0 C--N 1.342 0.189 0 C-N-CA 122.691 2.261 . . . . 63.14 112.37 179.957 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 52' ' ' GLU . . . . . 0.709 ' CG ' HD11 ' A' ' 37' ' ' LEU . 8.3 tm-20 -90.48 -29.11 18.13 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.208 -0.451 . . . . 61.52 110.854 -179.949 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -85.25 9.87 14.03 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.19 -0.459 . . . . 74.13 110.914 -179.932 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 54' ' ' PHE . . . . . 0.429 ' HB2' ' HG2' ' A' ' 51' ' ' PRO . 1.0 OUTLIER -120.87 -7.82 9.47 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.136 -0.484 . . . . 74.55 110.862 -179.913 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.54 ' CG1' HD21 ' A' ' 20' ' ' LEU . 19.2 m -119.79 170.54 9.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.149 -0.478 . . . . 75.03 111.102 179.983 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 56' ' ' SER . . . . . 0.721 ' HB2' HD21 ' A' ' 7' ' ' LEU . 31.2 t -141.61 113.27 7.74 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.143 -0.481 . . . . 54.3 110.878 -179.858 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 3.1 m-85 -52.93 130.79 34.57 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.145 -0.48 . . . . 74.34 110.888 -179.841 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.574 HD11 ' HB ' ' A' ' 5' ' ' VAL . 51.4 mt -99.01 148.19 6.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.123 -0.489 . . . . 52.55 111.17 179.874 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 7.1 pt20 . . . . . 0 C--N 1.329 -0.323 0 CA-C-O 121.634 0.731 . . . . 75.14 110.882 179.975 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' B' B ' -7' ' ' PHE . . . . . 0.506 ' HB3' HD11 ' A' ' 49' ' ' LEU . 9.8 m-85 . . . . . 0 C--O 1.232 0.14 0 CA-C-O 120.821 0.343 . . . . 64.21 110.916 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' -6' ' ' ILE . . . . . . . . . . . . . 1.6 pt -153.08 86.14 4.16 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-O 121.627 0.727 . . . . 63.0 111.15 179.995 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' -5' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.74 139.59 40.66 Favored 'Trans proline' 0 C--O 1.231 0.173 0 C-N-CA 122.683 2.256 . . . . 72.33 112.345 179.898 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' -4' ' ' SER . . . . . . . . . . . . . 1.5 t -135.24 65.63 1.55 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.222 -0.445 . . . . 71.41 110.88 -179.845 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' -3' ' ' ARG . . . . . . . . . . . . . 5.4 ptm180 -178.2 154.46 0.93 Allowed Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.569 0.699 . . . . 74.32 110.876 -179.964 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' -2' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.77 131.55 21.47 Favored 'Trans proline' 0 C--N 1.341 0.138 0 C-N-CA 122.682 2.255 . . . . 73.02 112.321 -179.953 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' -1' ' ' ALA . . . . . . . . . . . . . . . -68.84 152.49 96.73 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.526 0.679 . . . . 45.43 111.127 179.859 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 0' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.81 171.51 14.39 Favored 'Trans proline' 0 C--N 1.341 0.157 0 C-N-CA 122.666 2.244 . . . . 65.53 112.318 -179.958 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 1' ' ' LYS . . . . . . . . . . . . . 21.1 mmmt -119.58 153.81 54.3 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.612 0.72 . . . . 50.01 110.835 179.955 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 2' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo . . . . . 0 C--N 1.342 0.205 0 C-N-CA 122.694 2.263 . . . . 75.35 112.358 179.863 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' -4' ' ' MET . . . . . . . . . . . . . 23.2 mmt . . . . . 0 C--O 1.23 0.074 0 CA-C-O 120.756 0.312 . . . . 52.33 110.902 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' -3' ' ' ALA . . . . . . . . . . . . . . . -77.55 69.93 3.86 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.219 -0.446 . . . . 75.41 111.044 179.975 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' -2' ' ' ILE . . . . . . . . . . . . . 60.5 mt -128.34 136.58 59.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.245 -0.434 . . . . 65.2 111.145 179.937 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' -1' ' ' VAL . . . . . . . . . . . . . 54.5 t -104.31 -29.07 2.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.137 -0.483 . . . . 74.14 111.133 179.869 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 21.7 m-80 62.19 54.12 2.73 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.132 -0.485 . . . . 65.51 110.948 -179.94 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 44.9 tp60 -109.13 124.3 50.59 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.151 -0.477 . . . . 75.22 110.926 -179.977 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 7.6 ptt180 -74.65 162.11 29.05 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.216 -0.447 . . . . 61.12 110.892 -179.896 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -157.1 155.0 30.34 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.195 -0.457 . . . . 74.3 111.105 179.954 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.485 ' HB ' HD11 ' A' ' 58' ' ' ILE . 10.8 p -104.01 150.31 7.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.233 -0.44 . . . . 62.42 111.171 179.959 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -89.13 105.4 17.77 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.175 -0.466 . . . . 75.04 111.027 179.947 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.771 HD21 ' HB3' ' A' ' 56' ' ' SER . 15.5 mt -70.17 -36.82 74.94 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.2 -0.455 . . . . 75.23 110.937 179.998 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 3.5 m-85 -143.79 156.67 44.57 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.187 -0.461 . . . . 63.34 110.958 179.996 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -79.03 135.53 36.91 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.167 -0.47 . . . . 75.04 110.871 179.938 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 9.3 t80 -135.97 146.0 46.78 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.227 -0.442 . . . . 74.24 110.873 -179.894 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 28.8 tt0 -116.04 136.12 22.9 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-O 121.654 0.74 . . . . 75.22 110.855 -179.917 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.8 146.05 58.78 Favored 'Trans proline' 0 C--N 1.342 0.189 0 C-N-CA 122.661 2.241 . . . . 73.52 112.311 -179.972 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 7.8 mm-40 -107.93 -18.74 13.72 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.196 -0.457 . . . . 74.33 110.853 -179.967 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 35.5 m-80 -111.45 176.06 5.17 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.146 -0.479 . . . . 73.13 110.893 -179.934 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -92.16 20.89 5.51 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.169 -0.469 . . . . 73.13 110.865 179.906 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -138.24 12.29 2.81 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.179 -0.464 . . . . 64.21 110.906 -179.938 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 20.4 mt-10 -105.49 156.17 18.47 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.168 -0.469 . . . . 73.21 110.909 -179.998 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.53 HD23 ' O ' ' A' ' 19' ' ' ARG . 0.3 OUTLIER -105.53 151.44 24.29 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.206 -0.452 . . . . 71.25 110.879 -179.943 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 19' ' ' ARG . . . . . 0.53 ' O ' HD23 ' A' ' 18' ' ' LEU . 12.6 mtp180 -87.79 150.86 23.3 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.17 -0.468 . . . . 73.2 110.861 179.985 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.562 HD11 HG11 ' A' ' 26' ' ' VAL . 2.3 tp -135.17 149.57 49.98 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.242 -0.435 . . . . 71.14 110.927 -179.981 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.664 ' HB3' ' CG ' ' A' ' 24' ' ' ASP . . . -140.24 136.81 33.74 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.219 -0.446 . . . . 61.25 111.124 179.798 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 3.0 tt0 -50.45 120.24 4.45 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.218 -0.447 . . . . 51.2 110.889 -179.927 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 96.16 -0.56 62.2 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.696 -0.764 . . . . 53.45 112.499 -179.98 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' ASP . . . . . 0.664 ' CG ' ' HB3' ' A' ' 21' ' ' ALA . 1.1 m-20 -87.32 147.46 25.49 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.823 0.344 . . . . 65.52 110.865 -179.975 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 3.2 mm -100.62 141.04 18.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.173 -0.467 . . . . 74.4 111.131 -179.97 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.562 HG11 HD11 ' A' ' 20' ' ' LEU . 1.4 m -142.75 158.25 18.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.202 -0.454 . . . . 71.14 111.135 179.879 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 58.4 m-85 -117.19 108.11 15.27 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.165 -0.47 . . . . 70.24 110.905 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.724 HD13 ' HB2' ' A' ' 39' ' ' ALA . 16.6 mm -72.75 102.7 1.52 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.147 -0.479 . . . . 65.21 111.165 179.983 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 4.6 m -64.82 -40.88 95.91 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.19 -0.459 . . . . 71.35 110.861 -179.853 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' TYR . . . . . 0.518 ' CZ ' HG21 ' A' ' 38' ' ' VAL . 36.3 p90 -173.86 149.27 1.52 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.113 -0.494 . . . . 75.05 110.895 -179.931 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 31' ' ' LYS . . . . . 0.447 ' HG3' HD22 ' A' ' 37' ' ' LEU . 9.4 tttm -80.82 145.09 31.6 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.076 -0.511 . . . . 51.12 110.898 179.892 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 27.5 t60 -132.75 155.9 48.04 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.232 -0.44 . . . . 74.54 110.882 179.85 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -61.75 -174.21 1.65 Allowed Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.675 -0.774 . . . . 75.53 112.514 -179.946 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 57.1 mm-40 64.87 13.28 8.42 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.87 0.367 . . . . 64.33 110.874 -179.909 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 68.16 29.98 73.59 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.737 -0.744 . . . . 71.44 112.473 -179.984 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' TRP . . . . . 0.643 ' C ' HD23 ' A' ' 37' ' ' LEU . 98.3 m95 -123.58 137.52 54.74 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.83 0.348 . . . . 73.02 110.921 -179.929 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.715 HD11 ' CG ' ' A' ' 52' ' ' GLU . 1.6 mt -120.57 133.19 55.41 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.247 -0.433 . . . . 74.44 110.951 179.98 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.518 HG21 ' CZ ' ' A' ' 30' ' ' TYR . 75.8 t -79.95 109.09 14.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.214 -0.448 . . . . 73.31 111.161 179.851 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.724 ' HB2' HD13 ' A' ' 28' ' ' ILE . . . -129.46 160.99 31.43 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.243 -0.435 . . . . 44.33 111.07 179.945 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 3.3 pm0 -119.02 159.3 24.12 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.225 -0.443 . . . . 71.01 110.878 -179.933 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -71.95 -175.26 1.39 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.139 -0.482 . . . . 53.34 110.854 -179.924 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -69.63 -38.58 77.24 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.147 -0.479 . . . . 63.41 110.893 -179.989 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 1.5 t -56.03 -22.64 28.45 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.149 -0.478 . . . . 52.42 110.843 -179.77 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 69.76 9.02 61.65 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.814 -0.708 . . . . 74.42 112.474 179.982 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 3.7 t -108.88 -19.86 13.25 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.923 0.392 . . . . 74.12 110.871 -179.755 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.449 ' HG2' HD11 ' A' ' 18' ' ' LEU . 1.1 ttmt -109.85 123.62 49.9 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.134 -0.485 . . . . 72.44 110.94 179.913 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 6.1 m -126.82 152.58 46.77 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.269 -0.423 . . . . 71.24 111.116 -179.99 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -177.21 -161.16 25.3 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.744 -0.741 . . . . 63.43 112.484 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.464 HD23 HG22 ' A' ' 38' ' ' VAL . 4.8 mt -100.7 138.74 37.35 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.835 0.35 . . . . 75.43 110.885 -179.901 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.42 ' HB ' ' HD2' ' A' ' 51' ' ' PRO . 6.1 m -137.36 153.56 74.76 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-O 121.634 0.73 . . . . 72.1 111.143 179.82 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 0.42 ' HD2' ' HB ' ' A' ' 50' ' ' VAL . 53.8 Cg_endo -69.8 142.9 48.99 Favored 'Trans proline' 0 C--N 1.341 0.184 0 C-N-CA 122.639 2.226 . . . . 73.02 112.332 179.977 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 52' ' ' GLU . . . . . 0.715 ' CG ' HD11 ' A' ' 37' ' ' LEU . 15.7 tm-20 -89.88 -27.3 19.98 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.18 -0.464 . . . . 64.11 110.92 -179.992 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -87.12 12.08 12.38 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.111 -0.495 . . . . 74.22 110.895 -179.97 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 54' ' ' PHE . . . . . 0.42 ' HB2' ' HG2' ' A' ' 51' ' ' PRO . 1.0 OUTLIER -121.89 -8.81 8.86 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.154 -0.475 . . . . 73.54 110.883 -179.912 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.538 ' CG1' HD21 ' A' ' 20' ' ' LEU . 17.2 m -120.42 169.83 11.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.125 -0.489 . . . . 74.2 111.127 179.968 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 56' ' ' SER . . . . . 0.771 ' HB3' HD21 ' A' ' 7' ' ' LEU . 3.8 t -138.69 115.27 10.58 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.19 -0.459 . . . . 64.35 110.869 -179.854 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 3.0 m-85 -54.2 128.8 32.59 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.183 -0.462 . . . . 74.33 110.924 -179.889 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.485 HD11 ' HB ' ' A' ' 5' ' ' VAL . 45.6 mt -97.06 148.65 5.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.114 -0.494 . . . . 64.2 111.15 179.939 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 4.3 mt-30 -131.17 160.91 64.83 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 121.616 0.722 . . . . 74.43 110.873 179.985 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.76 -48.07 0.8 Allowed 'Trans proline' 0 C--N 1.341 0.175 0 C-N-CA 122.751 2.301 . . . . 65.23 112.352 -179.99 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 29.6 tt0 -156.57 25.18 0.34 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.17 -0.468 . . . . 61.02 110.892 -179.981 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 8.1 mt -116.92 172.26 7.37 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.178 -0.464 . . . . 73.23 110.936 -179.957 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 . . . . . 0 C--N 1.329 -0.288 0 CA-C-N 116.205 -0.452 . . . . 40.42 110.871 179.918 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' B' B ' -9' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.26 0 N-CA-C 112.49 -0.244 . . . . 73.22 112.49 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' B' B ' -8' ' ' LYS . . . . . . . . . . . . . 19.5 mmtm -74.3 -62.77 1.4 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.793 0.33 . . . . 74.11 110.894 -179.982 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' -7' ' ' PHE . . . . . 0.444 ' HB3' HD11 ' A' ' 49' ' ' LEU . 13.5 m-85 -75.43 142.75 42.96 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.234 -0.439 . . . . 74.42 110.888 179.991 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' -6' ' ' ILE . . . . . . . . . . . . . 2.7 pt -153.21 84.13 4.47 Favored Pre-proline 0 C--N 1.328 -0.344 0 CA-C-O 121.656 0.741 . . . . 74.22 111.12 179.977 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' -5' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.71 134.52 28.3 Favored 'Trans proline' 0 C--N 1.342 0.207 0 C-N-CA 122.682 2.254 . . . . 71.0 112.342 179.857 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' -4' ' ' SER . . . . . . . . . . . . . 26.3 t -131.5 65.4 1.57 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.193 -0.458 . . . . 74.42 110.87 -179.863 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' -3' ' ' ARG . . . . . . . . . . . . . 6.9 ptm180 -178.66 155.0 0.87 Allowed Pre-proline 0 C--N 1.33 -0.282 0 CA-C-O 121.625 0.726 . . . . 75.13 110.84 -179.95 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' -2' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.83 129.3 17.29 Favored 'Trans proline' 0 C--N 1.341 0.17 0 C-N-CA 122.718 2.279 . . . . 62.11 112.313 -179.964 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' -1' ' ' ALA . . . . . . . . . . . . . . . -63.5 154.48 79.27 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-O 121.525 0.678 . . . . 71.53 111.157 179.847 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 0' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.78 176.75 6.36 Favored 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.663 2.242 . . . . 72.11 112.334 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 1' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -125.07 146.99 55.5 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.561 0.696 . . . . 73.33 110.882 179.951 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 2' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.72 163.27 38.86 Favored 'Trans proline' 0 C--N 1.341 0.158 0 C-N-CA 122.646 2.231 . . . . 71.35 112.363 179.873 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 3' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.78 -170.02 0.37 Allowed 'Trans proline' 0 C--N 1.341 0.157 0 C-N-CA 122.711 2.274 . . . . 71.2 112.339 179.939 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 4' ' ' SER . . . . . . . . . . . . . 13.6 p -113.35 -29.81 7.11 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.19 -0.459 . . . . 72.23 110.825 -179.815 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 5' ' ' SER . . . . . . . . . . . . . 3.5 t -56.89 -67.27 0.33 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.152 -0.476 . . . . 73.54 110.843 -179.792 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 6' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.328 -0.334 0 CA-C-N 116.134 -0.484 . . . . 75.14 111.098 179.892 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' -4' ' ' MET . . . . . . . . . . . . . 5.8 mmt . . . . . 0 C--O 1.231 0.102 0 CA-C-O 120.81 0.338 . . . . 61.51 110.864 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' -3' ' ' ALA . . . . . . . . . . . . . . . -108.05 114.12 27.79 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.243 -0.435 . . . . 61.52 111.074 179.93 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' -2' ' ' ILE . . . . . . . . . . . . . 91.6 mt -84.36 131.31 34.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.213 -0.448 . . . . 62.41 111.17 179.945 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' -1' ' ' VAL . . . . . . . . . . . . . 42.4 t -117.21 131.58 69.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.19 -0.459 . . . . 74.24 111.081 179.912 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 18.6 m120 -94.77 60.04 2.46 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.162 -0.472 . . . . 71.45 110.887 179.944 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 51.6 tp60 -103.35 134.5 46.63 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.193 -0.458 . . . . 74.42 110.92 179.96 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 5.9 ptt180 -89.58 164.67 14.67 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.202 -0.454 . . . . 71.43 110.896 -179.949 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -155.56 152.39 28.75 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.235 -0.439 . . . . 64.43 111.114 179.98 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.66 ' HB ' HD11 ' A' ' 58' ' ' ILE . 10.7 p -104.17 147.91 9.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.245 -0.434 . . . . 62.43 111.164 179.918 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 6' ' ' ALA . . . . . 0.423 ' HB3' ' O ' ' A' ' 21' ' ' ALA . . . -87.75 112.61 22.6 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.152 -0.477 . . . . 74.3 111.082 179.913 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.703 HD21 ' CB ' ' A' ' 56' ' ' SER . 10.4 mt -77.91 -37.77 47.12 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.2 -0.454 . . . . 74.13 110.962 179.987 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 4.0 m-85 -140.59 141.39 35.19 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.171 -0.468 . . . . 72.41 110.908 -179.972 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 2.2 p30 -65.13 132.99 50.59 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.128 -0.487 . . . . 73.3 110.898 179.899 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 2.1 t80 -129.83 146.34 51.57 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.204 -0.453 . . . . 65.51 110.888 -179.89 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 47.2 tt0 -117.03 137.06 23.51 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-O 121.62 0.724 . . . . 53.14 110.864 -179.893 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.79 150.99 68.79 Favored 'Trans proline' 0 C--N 1.342 0.189 0 C-N-CA 122.676 2.25 . . . . 74.25 112.311 -179.96 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 6.3 mm-40 -113.9 -15.82 12.3 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.206 -0.452 . . . . 72.25 110.913 179.981 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 31.2 m-80 -114.92 175.97 5.26 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.208 -0.451 . . . . 70.2 110.863 -179.936 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 27.1 m-20 -91.02 18.39 6.79 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.144 -0.48 . . . . 74.23 110.893 179.927 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -138.22 17.04 2.79 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.163 -0.472 . . . . 53.04 110.946 -179.916 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 24.9 mt-10 -105.49 164.87 11.55 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.132 -0.486 . . . . 74.41 110.93 179.979 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.558 HD12 ' H ' ' A' ' 19' ' ' ARG . 41.3 tp -115.84 147.06 41.45 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.176 -0.465 . . . . 64.4 110.94 -179.978 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 19' ' ' ARG . . . . . 0.558 ' H ' HD12 ' A' ' 18' ' ' LEU . 0.5 OUTLIER -83.07 159.32 22.16 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.219 -0.446 . . . . 71.0 110.823 179.986 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.556 HD21 ' CG1' ' A' ' 55' ' ' VAL . 3.1 tp -143.87 147.96 34.79 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.179 -0.464 . . . . 64.21 110.939 179.995 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.652 ' HB3' ' CG ' ' A' ' 24' ' ' ASP . . . -139.6 138.73 36.42 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.186 -0.461 . . . . 75.41 111.07 179.811 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -51.35 122.53 7.98 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.189 -0.46 . . . . 72.3 110.907 -179.933 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 95.85 -6.7 67.28 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.727 -0.749 . . . . 64.01 112.449 -179.983 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' ASP . . . . . 0.652 ' CG ' ' HB3' ' A' ' 21' ' ' ALA . 1.1 m-20 -80.38 145.94 31.76 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.764 0.316 . . . . 54.31 110.887 -179.967 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 3.2 mm -101.96 140.7 19.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.195 -0.457 . . . . 70.24 111.104 -179.957 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 1.5 m -143.23 158.47 17.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.135 -0.484 . . . . 63.44 111.132 179.868 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 57.4 m-85 -115.59 108.92 17.04 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.2 -0.455 . . . . 74.52 110.902 179.996 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.684 HD13 ' HB2' ' A' ' 39' ' ' ALA . 17.2 mm -72.42 102.61 1.41 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.153 -0.476 . . . . 64.31 111.101 179.999 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 8.1 m -65.06 -40.35 94.6 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.191 -0.459 . . . . 64.34 110.901 -179.946 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' TYR . . . . . 0.525 ' CZ ' HG21 ' A' ' 38' ' ' VAL . 33.9 p90 -174.67 148.6 1.15 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.144 -0.48 . . . . 64.34 110.923 -179.881 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 31' ' ' LYS . . . . . 0.528 ' HG3' HD22 ' A' ' 37' ' ' LEU . 10.3 tttm -81.27 143.94 31.91 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.122 -0.49 . . . . 75.54 110.838 179.942 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 32.0 t60 -132.45 155.13 49.09 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.205 -0.452 . . . . 75.21 110.845 179.879 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -60.49 -174.04 1.01 Allowed Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.755 -0.736 . . . . 63.42 112.481 -179.962 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 16.8 mm100 65.32 12.69 8.27 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.878 0.37 . . . . 64.14 110.947 -179.892 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 68.36 29.31 73.08 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.747 -0.74 . . . . 71.23 112.462 -180.0 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' TRP . . . . . 0.639 ' C ' HD23 ' A' ' 37' ' ' LEU . 98.8 m95 -123.55 135.75 54.17 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.781 0.324 . . . . 74.01 110.918 -179.93 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.714 HD11 ' CG ' ' A' ' 52' ' ' GLU . 1.3 mt -120.3 130.62 54.54 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.195 -0.457 . . . . 75.33 110.907 179.987 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.525 HG21 ' CZ ' ' A' ' 30' ' ' TYR . 82.6 t -76.18 112.11 13.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.184 -0.462 . . . . 75.2 111.138 179.821 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.684 ' HB2' HD13 ' A' ' 28' ' ' ILE . . . -133.0 157.9 44.04 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.121 -0.491 . . . . 62.41 111.055 179.892 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -114.41 156.23 24.88 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.196 -0.456 . . . . 64.4 110.88 -179.929 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -71.7 -175.35 1.34 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.16 -0.473 . . . . 51.24 110.9 -179.92 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -70.0 -39.45 75.86 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.208 -0.451 . . . . 74.31 110.915 -179.982 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 14.4 m -55.82 -22.29 24.02 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.177 -0.465 . . . . 75.32 110.892 -179.824 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 66.35 11.77 56.88 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.724 -0.75 . . . . 32.24 112.525 -179.974 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 3.5 m -107.76 -14.98 14.67 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.935 0.398 . . . . 74.33 110.843 -179.714 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -121.43 134.85 55.09 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.112 -0.494 . . . . 74.3 110.868 179.937 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 5.2 m -138.67 137.93 37.31 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.216 -0.447 . . . . 60.02 111.127 179.967 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -158.11 -154.49 7.16 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.75 -0.738 . . . . 43.45 112.502 179.942 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.491 HD11 ' HB3' ' B' ' -7' ' ' PHE . 6.2 mt -104.62 130.95 52.55 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.845 0.355 . . . . 64.12 110.902 -179.881 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 11.7 m -129.0 153.1 80.23 Favored Pre-proline 0 C--N 1.33 -0.264 0 CA-C-O 121.619 0.723 . . . . 45.2 111.141 179.801 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 0.437 ' HG2' ' HB2' ' A' ' 54' ' ' PHE . 53.8 Cg_endo -69.76 144.72 54.94 Favored 'Trans proline' 0 C--N 1.341 0.166 0 C-N-CA 122.661 2.241 . . . . 62.13 112.319 179.966 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 52' ' ' GLU . . . . . 0.714 ' CG ' HD11 ' A' ' 37' ' ' LEU . 13.5 tm-20 -90.44 -28.71 18.43 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.218 -0.446 . . . . 71.31 110.922 179.985 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -85.67 10.05 14.5 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.158 -0.474 . . . . 73.44 110.904 -179.954 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 54' ' ' PHE . . . . . 0.437 ' HB2' ' HG2' ' A' ' 51' ' ' PRO . 1.0 OUTLIER -121.02 -5.8 9.53 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.108 -0.496 . . . . 65.05 110.88 -179.969 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.556 ' CG1' HD21 ' A' ' 20' ' ' LEU . 15.4 m -122.75 167.52 16.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.16 -0.473 . . . . 70.15 111.108 179.998 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 56' ' ' SER . . . . . 0.703 ' CB ' HD21 ' A' ' 7' ' ' LEU . 47.9 t -138.27 117.35 12.56 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.158 -0.474 . . . . 70.43 110.85 -179.854 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 2.7 m-85 -53.44 134.12 40.47 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.133 -0.485 . . . . 73.44 110.936 -179.889 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.66 HD11 ' HB ' ' A' ' 5' ' ' VAL . 41.4 mt -104.48 146.54 11.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.098 -0.501 . . . . 44.32 111.123 179.905 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 1.3 mt-30 -131.2 160.67 65.96 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-O 121.626 0.727 . . . . 71.43 110.889 179.922 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.78 -48.87 0.63 Allowed 'Trans proline' 0 C--N 1.342 0.208 0 C-N-CA 122.658 2.239 . . . . 72.01 112.348 -179.992 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 20.6 mm-40 -151.27 23.56 0.73 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.219 -0.446 . . . . 74.34 110.888 -179.979 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 6.5 mt -113.93 166.97 11.05 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.151 -0.477 . . . . 73.31 110.923 -179.979 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 16.9 pt-20 . . . . . 0 C--N 1.329 -0.295 0 CA-C-N 116.202 -0.454 . . . . 61.0 110.884 179.928 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' B' B ' -9' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.304 0 N-CA-C 112.504 -0.238 . . . . 70.11 112.504 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' B' B ' -8' ' ' LYS . . . . . . . . . . . . . 23.0 mttt -113.73 79.45 1.25 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.811 0.338 . . . . 53.32 110.865 -179.934 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' -7' ' ' PHE . . . . . 0.491 ' HB3' HD11 ' A' ' 49' ' ' LEU . 9.0 m-85 -82.34 139.82 33.89 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.211 -0.449 . . . . 74.54 110.864 179.986 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' -6' ' ' ILE . . . . . 0.423 HD13 ' O ' ' B' ' -7' ' ' PHE . 37.3 mm -145.62 87.69 6.82 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 121.646 0.736 . . . . 71.53 111.135 179.933 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' -5' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.76 130.99 20.31 Favored 'Trans proline' 0 C--N 1.342 0.192 0 C-N-CA 122.649 2.233 . . . . 62.21 112.347 179.845 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' -4' ' ' SER . . . . . . . . . . . . . 30.9 t -124.27 62.21 1.11 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.164 -0.471 . . . . 75.25 110.879 -179.86 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' -3' ' ' ARG . . . . . . . . . . . . . 9.2 ptm180 -174.63 153.74 1.81 Allowed Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.643 0.735 . . . . 71.04 110.862 -179.93 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' -2' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.74 136.33 32.77 Favored 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.672 2.248 . . . . 73.31 112.343 179.996 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' -1' ' ' ALA . . . . . . . . . . . . . . . -71.84 152.76 93.2 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-O 121.605 0.717 . . . . 34.54 111.083 179.904 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 0' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.81 178.02 5.02 Favored 'Trans proline' 0 C--N 1.342 0.2 0 C-N-CA 122.602 2.201 . . . . 74.4 112.369 -179.965 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 1' ' ' LYS . . . . . . . . . . . . . 9.3 pttm -125.2 154.34 71.8 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-O 121.583 0.706 . . . . 74.01 110.898 179.945 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 2' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.7 164.0 36.13 Favored 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.711 2.274 . . . . 74.24 112.313 179.909 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 3' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.74 174.99 8.68 Favored 'Trans proline' 0 C--N 1.342 0.213 0 C-N-CA 122.694 2.262 . . . . 71.44 112.334 179.924 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 4' ' ' SER . . . . . . . . . . . . . 16.5 m -117.84 140.83 49.15 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.219 -0.446 . . . . 62.24 110.871 -179.872 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 5' ' ' SER . . . . . . . . . . . . . 10.0 t -100.68 146.93 26.58 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.142 -0.481 . . . . 55.03 110.856 -179.82 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 6' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.313 0 CA-C-N 116.104 -0.498 . . . . 73.55 111.106 179.95 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' -4' ' ' MET . . . . . . . . . . . . . 42.1 mmm . . . . . 0 C--O 1.231 0.113 0 CA-C-O 120.795 0.331 . . . . 73.13 110.882 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' -3' ' ' ALA . . . . . . . . . . . . . . . -107.14 63.73 0.63 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.266 -0.425 . . . . 73.03 111.073 179.942 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' -2' ' ' ILE . . . . . . . . . . . . . 5.3 mp -125.79 118.04 50.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.217 -0.447 . . . . 60.01 111.145 179.939 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' -1' ' ' VAL . . . . . . . . . . . . . 12.1 p -69.54 -29.65 42.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.202 -0.453 . . . . 73.42 111.151 179.83 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 1.9 t-20 63.25 50.43 2.99 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.156 -0.474 . . . . 63.42 110.929 179.998 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 57.8 tp60 -105.64 127.24 52.94 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.172 -0.467 . . . . 71.23 110.899 -179.966 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -79.08 160.67 26.98 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.189 -0.459 . . . . 73.13 110.834 -179.905 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -156.33 153.61 29.29 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.147 -0.478 . . . . 64.33 111.097 179.925 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.553 ' HB ' HD11 ' A' ' 58' ' ' ILE . 10.8 p -104.33 151.16 6.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.23 -0.441 . . . . 63.02 111.099 179.995 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -89.82 106.83 18.73 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.161 -0.472 . . . . 71.23 111.104 179.895 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.723 HD21 ' CB ' ' A' ' 56' ' ' SER . 16.6 mt -71.4 -39.5 71.11 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.267 -0.424 . . . . 73.13 110.883 -179.951 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 5.6 m-85 -138.84 149.98 45.52 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.224 -0.444 . . . . 70.34 110.875 179.996 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 1.7 p30 -73.74 136.05 43.64 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.066 -0.515 . . . . 65.1 110.88 179.907 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 9.0 t80 -139.83 144.66 37.4 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.192 -0.458 . . . . 75.34 110.881 -179.884 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -113.16 144.75 31.76 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.645 0.736 . . . . 73.45 110.886 -179.907 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.78 141.6 45.61 Favored 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.722 2.281 . . . . 63.13 112.339 -179.981 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 6.3 mm-40 -102.02 -24.05 14.03 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.235 -0.438 . . . . 53.41 110.869 -179.967 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 40.7 m-80 -112.31 175.58 5.37 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.163 -0.471 . . . . 73.04 110.921 -179.963 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -83.07 2.06 37.03 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.204 -0.453 . . . . 34.5 110.869 179.875 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 1.1 p-10 -124.01 23.05 8.65 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.213 -0.448 . . . . 52.35 110.854 -179.903 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 5.4 mt-10 -108.86 156.72 19.34 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.198 -0.455 . . . . 70.4 110.894 179.998 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.485 HD12 ' H ' ' A' ' 19' ' ' ARG . 54.4 tp -108.05 151.61 25.62 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.162 -0.472 . . . . 42.05 110.876 -179.956 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 19' ' ' ARG . . . . . 0.485 ' H ' HD12 ' A' ' 18' ' ' LEU . 9.7 mtt-85 -88.79 154.11 20.53 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.153 -0.476 . . . . 75.13 110.851 179.988 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.567 HD21 ' CG1' ' A' ' 55' ' ' VAL . 2.6 tp -140.51 149.04 41.97 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.177 -0.465 . . . . 73.41 110.945 -179.974 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.659 ' HB3' ' CG ' ' A' ' 24' ' ' ASP . . . -141.22 137.52 32.65 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.185 -0.461 . . . . 72.13 111.112 179.798 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -50.76 121.03 5.32 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.224 -0.444 . . . . 75.31 110.902 -179.897 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 96.65 -4.86 64.05 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.717 -0.754 . . . . 73.55 112.512 -179.947 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' ASP . . . . . 0.659 ' CG ' ' HB3' ' A' ' 21' ' ' ALA . 1.1 m-20 -82.78 146.74 28.8 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.816 0.341 . . . . 75.52 110.85 -179.972 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 3.2 mm -101.67 141.06 18.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.176 -0.465 . . . . 65.15 111.163 179.989 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 1.3 m -143.23 158.68 17.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.177 -0.465 . . . . 65.15 111.104 179.85 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 37.8 m-85 -115.83 106.71 14.14 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.134 -0.485 . . . . 73.31 110.838 -179.931 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.657 HD13 ' HB2' ' A' ' 39' ' ' ALA . 13.0 mm -72.13 103.3 1.47 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.157 -0.474 . . . . 72.11 111.126 179.959 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 3.4 m -64.55 -39.59 94.04 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.18 -0.464 . . . . 73.02 110.84 -179.891 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' TYR . . . . . 0.478 ' CZ ' HG21 ' A' ' 38' ' ' VAL . 32.8 p90 -174.16 148.06 1.29 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.145 -0.48 . . . . 70.01 110.907 -179.883 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 31' ' ' LYS . . . . . 0.565 ' HG3' HD22 ' A' ' 37' ' ' LEU . 19.1 tttt -82.57 145.85 29.5 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.089 -0.505 . . . . 62.23 110.919 179.894 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 34.5 t60 -135.49 153.54 51.7 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.236 -0.438 . . . . 72.11 110.842 179.923 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -58.6 -174.44 0.52 Allowed Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.751 -0.738 . . . . 31.34 112.518 -179.973 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 2.5 mt-30 65.78 12.22 8.16 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.803 0.335 . . . . 71.1 110.908 -179.873 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 68.24 28.85 73.14 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.76 -0.733 . . . . 61.31 112.494 -179.955 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' TRP . . . . . 0.628 ' C ' HD23 ' A' ' 37' ' ' LEU . 99.1 m95 -123.56 136.0 54.3 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.773 0.32 . . . . 71.44 110.939 -179.919 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.681 HD11 ' CG ' ' A' ' 52' ' ' GLU . 0.4 OUTLIER -124.11 132.06 53.61 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.261 -0.427 . . . . 65.42 110.938 179.969 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.489 HG22 HD23 ' A' ' 49' ' ' LEU . 47.1 t -78.2 116.97 22.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.194 -0.457 . . . . 62.12 111.169 179.807 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.657 ' HB2' HD13 ' A' ' 28' ' ' ILE . . . -136.66 166.31 23.84 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.178 -0.464 . . . . 73.41 111.085 179.866 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -127.53 153.93 45.76 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.212 -0.449 . . . . 62.35 110.879 -179.911 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -66.32 -174.77 0.3 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.172 -0.467 . . . . 63.44 110.895 -179.962 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -69.62 -37.93 77.03 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.157 -0.474 . . . . 74.4 110.879 -179.97 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 9.5 m -57.0 -22.52 39.23 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.141 -0.481 . . . . 72.4 110.895 -179.827 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 67.54 10.9 58.82 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.713 -0.756 . . . . 75.51 112.5 -179.973 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 1.9 t -106.48 -21.77 12.98 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.966 0.412 . . . . 62.33 110.868 -179.722 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 1.7 ttmt -114.07 124.02 51.08 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.131 -0.486 . . . . 74.33 110.88 179.936 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 15.6 m -133.79 144.52 49.07 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.193 -0.458 . . . . 75.51 111.117 -179.991 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -164.48 -152.96 7.22 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.72 -0.752 . . . . 63.32 112.458 179.971 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.489 HD23 HG22 ' A' ' 38' ' ' VAL . 12.6 mt -103.89 134.08 47.78 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.852 0.358 . . . . 74.31 110.876 -179.912 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.423 ' HB ' ' HD2' ' A' ' 51' ' ' PRO . 21.9 m -134.15 154.05 79.89 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-O 121.668 0.746 . . . . 74.14 111.069 179.857 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 0.423 ' HD2' ' HB ' ' A' ' 50' ' ' VAL . 53.4 Cg_endo -69.77 146.43 60.09 Favored 'Trans proline' 0 C--N 1.342 0.209 0 C-N-CA 122.656 2.237 . . . . 72.33 112.3 179.974 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 52' ' ' GLU . . . . . 0.681 ' CG ' HD11 ' A' ' 37' ' ' LEU . 28.0 tt0 -91.87 -29.31 16.78 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.187 -0.461 . . . . 73.32 110.903 179.982 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -85.23 9.8 14.16 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.187 -0.46 . . . . 71.14 110.934 -179.964 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 54' ' ' PHE . . . . . 0.418 ' HB2' ' HG2' ' A' ' 51' ' ' PRO . 1.0 OUTLIER -120.19 -7.97 9.76 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.13 -0.486 . . . . 73.25 110.858 -179.932 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.567 ' CG1' HD21 ' A' ' 20' ' ' LEU . 15.8 m -121.21 161.32 21.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.151 -0.477 . . . . 62.51 111.119 179.981 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 56' ' ' SER . . . . . 0.723 ' CB ' HD21 ' A' ' 7' ' ' LEU . 25.4 t -131.68 114.74 15.15 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.149 -0.478 . . . . 74.04 110.833 -179.855 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 3.0 m-85 -54.72 127.02 26.36 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.182 -0.463 . . . . 63.02 110.916 -179.877 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.553 HD11 ' HB ' ' A' ' 5' ' ' VAL . 40.6 mt -94.85 143.16 12.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.121 -0.49 . . . . 72.52 111.117 179.953 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -131.3 161.01 64.48 Favored Pre-proline 0 C--N 1.329 -0.326 0 CA-C-O 121.62 0.724 . . . . 42.0 110.914 179.976 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.77 -48.6 0.68 Allowed 'Trans proline' 0 C--N 1.341 0.181 0 C-N-CA 122.682 2.255 . . . . 70.11 112.355 179.956 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -158.65 26.9 0.23 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.255 -0.43 . . . . 72.25 110.905 -179.976 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 16.9 mt -112.35 139.25 48.06 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.187 -0.461 . . . . 73.5 110.916 -179.956 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.304 0 CA-C-N 116.183 -0.462 . . . . 54.44 110.871 179.941 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' -9' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.346 0 N-CA-C 112.512 -0.235 . . . . 35.5 112.512 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' B' B ' -8' ' ' LYS . . . . . . . . . . . . . 5.0 mtpm? -73.12 -49.85 26.09 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.848 0.356 . . . . 61.15 110.904 -179.994 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' -7' ' ' PHE . . . . . . . . . . . . . 6.7 m-85 -67.44 143.08 56.43 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.175 -0.466 . . . . 74.11 110.909 179.977 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' -6' ' ' ILE . . . . . . . . . . . . . 1.9 pt -152.98 88.28 3.87 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.68 0.752 . . . . 74.22 111.122 179.977 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' -5' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.74 135.64 31.01 Favored 'Trans proline' 0 C--N 1.342 0.227 0 C-N-CA 122.702 2.268 . . . . 63.02 112.368 179.859 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' -4' ' ' SER . . . . . . . . . . . . . 2.9 m -133.88 60.37 1.71 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.228 -0.442 . . . . 65.43 110.825 -179.814 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' -3' ' ' ARG . . . . . . . . . . . . . 9.9 ptt85 -174.62 153.41 1.77 Allowed Pre-proline 0 C--N 1.329 -0.288 0 CA-C-O 121.651 0.739 . . . . 72.25 110.836 -179.951 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' -2' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.75 128.05 15.48 Favored 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.645 2.23 . . . . 61.22 112.383 -179.991 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' -1' ' ' ALA . . . . . . . . . . . . . . . -62.61 155.18 70.46 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-O 121.564 0.697 . . . . 72.3 111.086 179.92 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 0' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.73 -169.24 0.31 Allowed 'Trans proline' 0 C--N 1.341 0.17 0 C-N-CA 122.66 2.24 . . . . 70.11 112.369 179.995 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 1' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -138.88 154.12 72.5 Favored Pre-proline 0 C--N 1.328 -0.347 0 CA-C-O 121.568 0.699 . . . . 74.34 110.89 179.909 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 2' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.76 163.29 38.83 Favored 'Trans proline' 0 C--N 1.342 0.185 0 C-N-CA 122.67 2.247 . . . . 74.42 112.354 179.914 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 3' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.76 -35.48 12.57 Favored 'Trans proline' 0 C--N 1.341 0.148 0 C-N-CA 122.707 2.271 . . . . 54.23 112.316 179.988 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 4' ' ' SER . . . . . . . . . . . . . 2.1 m 63.0 43.6 6.52 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.229 -0.442 . . . . 70.05 110.843 -179.872 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 5' ' ' SER . . . . . . . . . . . . . 2.2 p -93.16 -43.52 8.81 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.126 -0.488 . . . . 60.43 110.868 -179.836 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 6' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.306 0 CA-C-N 116.182 -0.463 . . . . 55.2 111.098 179.862 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' -4' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--O 1.23 0.053 0 CA-C-O 120.788 0.328 . . . . 51.13 110.864 . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' -3' ' ' ALA . . . . . . . . . . . . . . . -70.21 -31.84 69.47 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.203 -0.453 . . . . 44.44 111.111 179.903 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' -2' ' ' ILE . . . . . . . . . . . . . 58.5 mt -87.88 131.14 36.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.212 -0.449 . . . . 62.43 111.146 179.97 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' -1' ' ' VAL . . . . . . . . . . . . . 12.0 p -112.88 130.91 65.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.221 -0.445 . . . . 74.1 111.105 179.872 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 1.8 m120 -93.59 59.45 2.89 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.147 -0.478 . . . . 65.42 110.872 179.999 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 31.0 tp60 -101.62 134.3 44.97 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.17 -0.468 . . . . 74.4 110.921 179.993 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 4.4 ptp180 -89.87 163.1 15.14 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.18 -0.463 . . . . 74.51 110.863 -179.891 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -155.07 153.17 30.49 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.192 -0.458 . . . . 41.2 111.089 179.893 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.694 ' HB ' HD11 ' A' ' 58' ' ' ILE . 10.7 p -103.85 150.02 7.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.221 -0.445 . . . . 75.01 111.179 179.932 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -88.33 105.57 17.66 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.207 -0.452 . . . . 74.11 111.112 179.885 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.734 HD21 ' HB2' ' A' ' 56' ' ' SER . 15.2 mt -69.68 -37.27 76.6 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.218 -0.446 . . . . 64.24 110.911 -179.95 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 2.9 m-85 -143.92 157.46 44.34 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.147 -0.479 . . . . 72.52 110.92 -179.988 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 3.7 p30 -78.84 134.84 36.92 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.128 -0.487 . . . . 74.41 110.9 179.896 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 2.5 t80 -134.42 146.03 49.45 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.201 -0.454 . . . . 74.53 110.894 -179.902 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 6.6 tt0 -116.5 136.14 23.06 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-O 121.626 0.727 . . . . 63.33 110.907 -179.881 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.409 ' HD3' ' HA ' ' A' ' 19' ' ' ARG . 53.3 Cg_endo -69.81 151.52 68.82 Favored 'Trans proline' 0 C--N 1.341 0.175 0 C-N-CA 122.677 2.251 . . . . 75.32 112.319 -179.939 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 1.9 mm-40 -112.9 -17.28 12.53 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.211 -0.45 . . . . 74.41 110.885 -179.989 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 9.7 m120 -115.21 176.15 5.19 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.148 -0.478 . . . . 74.0 110.892 -179.958 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 70.3 m-20 -91.86 21.07 5.12 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.222 -0.444 . . . . 62.42 110.898 179.91 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 1.1 p-10 -137.23 12.76 3.05 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.171 -0.468 . . . . 61.21 110.894 -179.984 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 48.7 mt-10 -106.82 160.12 15.73 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.178 -0.464 . . . . 74.31 110.841 -179.969 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.599 HD12 ' H ' ' A' ' 19' ' ' ARG . 20.7 tp -110.88 147.21 35.08 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.095 -0.502 . . . . 72.14 110.917 179.989 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 19' ' ' ARG . . . . . 0.599 ' H ' HD12 ' A' ' 18' ' ' LEU . 1.4 mtt180 -83.28 155.85 23.4 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.166 -0.47 . . . . 73.14 110.849 179.96 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.553 HD21 ' CG1' ' A' ' 55' ' ' VAL . 3.0 tp -139.37 149.71 44.46 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.213 -0.449 . . . . 64.33 110.917 179.984 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.657 ' HB3' ' CG ' ' A' ' 24' ' ' ASP . . . -139.96 136.44 33.8 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.155 -0.475 . . . . 74.04 111.082 179.772 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -50.77 120.96 5.24 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.193 -0.458 . . . . 61.5 110.848 -179.913 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 96.86 -3.9 62.9 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.744 -0.741 . . . . 44.23 112.456 179.992 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' ASP . . . . . 0.657 ' CG ' ' HB3' ' A' ' 21' ' ' ALA . 1.0 OUTLIER -84.25 146.34 27.84 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.829 0.347 . . . . 74.22 110.823 -179.932 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 3.3 mm -100.52 142.34 15.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.177 -0.465 . . . . 74.3 111.177 179.957 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 1.7 m -145.14 157.38 13.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.206 -0.452 . . . . 53.34 111.111 179.886 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 61.1 m-85 -115.98 110.69 19.3 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.18 -0.464 . . . . 72.11 110.871 -179.988 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.698 HD13 ' HB2' ' A' ' 39' ' ' ALA . 15.5 mm -72.43 102.27 1.35 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.091 -0.504 . . . . 45.01 111.121 179.964 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 5.0 m -65.07 -40.17 94.31 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.234 -0.439 . . . . 71.15 110.831 -179.924 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' TYR . . . . . 0.541 ' CZ ' HG21 ' A' ' 38' ' ' VAL . 35.9 p90 -174.58 149.24 1.25 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.186 -0.461 . . . . 74.31 110.947 -179.913 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 32.5 tttt -80.87 143.18 32.92 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.124 -0.489 . . . . 73.11 110.863 179.945 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 23.2 t60 -129.44 157.42 42.02 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.238 -0.437 . . . . 73.34 110.891 179.87 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -64.18 -174.66 3.64 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.744 -0.741 . . . . 65.1 112.467 -179.959 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 17.9 mm100 65.47 12.69 8.35 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.836 0.351 . . . . 74.11 110.922 -179.893 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 69.72 29.49 71.16 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.745 -0.74 . . . . 50.13 112.505 -179.949 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' TRP . . . . . 0.654 ' C ' HD23 ' A' ' 37' ' ' LEU . 97.0 m95 -122.91 138.35 54.69 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.821 0.343 . . . . 75.14 110.938 -179.935 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.707 HD11 ' CG ' ' A' ' 52' ' ' GLU . 1.3 mt -121.13 133.24 55.2 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.223 -0.444 . . . . 64.21 110.935 179.966 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.541 HG21 ' CZ ' ' A' ' 30' ' ' TYR . 95.9 t -80.06 109.37 14.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.21 -0.45 . . . . 72.34 111.124 179.814 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.698 ' HB2' HD13 ' A' ' 28' ' ' ILE . . . -129.19 158.46 38.95 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.175 -0.466 . . . . 50.44 111.126 179.822 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 1.4 pt-20 -117.05 157.31 26.05 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.234 -0.439 . . . . 55.22 110.843 -179.954 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -71.54 -175.04 1.21 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.126 -0.488 . . . . 75.33 110.891 -179.926 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 2.6 tt0 -69.45 -38.3 77.72 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.199 -0.455 . . . . 52.21 110.919 179.981 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 1.6 t -56.36 -22.58 32.0 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.165 -0.471 . . . . 73.12 110.827 -179.799 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 68.58 10.39 60.45 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.689 -0.767 . . . . 70.24 112.516 -179.933 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 3.1 t -107.14 -22.15 12.73 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.886 0.374 . . . . 74.14 110.83 -179.73 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.427 ' HE3' HD11 ' A' ' 18' ' ' LEU . 3.7 ttpt -110.31 123.9 50.67 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.158 -0.474 . . . . 74.0 110.933 179.932 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 9.3 m -131.89 130.38 41.55 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.24 -0.437 . . . . 52.4 111.136 179.998 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -153.57 -157.05 7.9 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.777 -0.725 . . . . 64.32 112.504 179.979 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 11.9 mt -100.32 133.33 44.88 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.821 0.343 . . . . 44.32 110.909 -179.925 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.458 ' CG1' HD23 ' A' ' 18' ' ' LEU . 6.0 m -131.97 153.62 81.45 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 121.685 0.755 . . . . 63.22 111.086 179.838 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 0.417 ' HD2' ' HB ' ' A' ' 50' ' ' VAL . 54.0 Cg_endo -69.75 144.2 53.3 Favored 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.697 2.265 . . . . 63.24 112.353 179.918 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 52' ' ' GLU . . . . . 0.707 ' CG ' HD11 ' A' ' 37' ' ' LEU . 6.9 tm-20 -90.63 -27.8 18.83 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.226 -0.443 . . . . 74.11 110.885 -179.982 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -86.76 11.12 13.87 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.165 -0.471 . . . . 70.1 110.93 -179.974 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 54' ' ' PHE . . . . . 0.408 ' HB2' ' HG2' ' A' ' 51' ' ' PRO . 1.1 m-85 -121.74 -7.48 9.05 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.139 -0.482 . . . . 74.24 110.854 -179.91 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.553 ' CG1' HD21 ' A' ' 20' ' ' LEU . 16.1 m -121.88 168.08 14.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.161 -0.472 . . . . 72.34 111.13 -179.983 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 56' ' ' SER . . . . . 0.734 ' HB2' HD21 ' A' ' 7' ' ' LEU . 43.9 t -136.93 117.06 13.4 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.212 -0.449 . . . . 61.3 110.896 -179.851 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 2.9 m-85 -56.25 124.3 17.49 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.15 -0.477 . . . . 72.22 110.903 -179.849 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.694 HD11 ' HB ' ' A' ' 5' ' ' VAL . 35.3 mt -94.52 141.87 14.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.11 -0.496 . . . . 73.21 111.136 179.931 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -131.09 160.96 64.51 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.583 0.706 . . . . 74.03 110.922 179.923 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.77 -48.43 0.72 Allowed 'Trans proline' 0 C--N 1.341 0.161 0 C-N-CA 122.661 2.241 . . . . 64.02 112.381 179.968 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 29.1 mt-10 -150.78 22.23 0.79 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.172 -0.467 . . . . 61.53 110.867 -179.991 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 5.3 mt -112.56 168.99 9.21 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.162 -0.472 . . . . 51.45 110.845 -179.949 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 3.7 pt-20 . . . . . 0 C--N 1.33 -0.261 0 CA-C-N 116.141 -0.481 . . . . 61.52 110.882 179.927 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' B' B ' -9' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.32 0 N-CA-C 112.52 -0.232 . . . . 63.34 112.52 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' B' B ' -8' ' ' LYS . . . . . . . . . . . . . 52.0 mttt -88.34 -28.8 20.77 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.836 0.35 . . . . 64.42 110.918 -179.963 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' -7' ' ' PHE . . . . . 0.573 ' O ' HD13 ' B' ' -6' ' ' ILE . 7.4 m-85 -67.83 127.18 31.85 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.214 -0.448 . . . . 75.42 110.871 179.954 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' -6' ' ' ILE . . . . . 0.573 HD13 ' O ' ' B' ' -7' ' ' PHE . 30.0 mm -138.22 94.83 10.78 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 121.681 0.753 . . . . 62.32 111.155 179.939 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' -5' ' ' PRO . . . . . 0.43 ' HD2' ' HA ' ' B' ' -6' ' ' ILE . 53.8 Cg_endo -69.76 140.37 42.51 Favored 'Trans proline' 0 C--N 1.342 0.194 0 C-N-CA 122.673 2.249 . . . . 73.55 112.357 179.884 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' -4' ' ' SER . . . . . . . . . . . . . 3.0 m -131.3 60.66 1.66 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.172 -0.467 . . . . 63.12 110.818 -179.811 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' -3' ' ' ARG . . . . . . . . . . . . . 14.2 ptp180 -178.87 154.96 0.83 Allowed Pre-proline 0 C--N 1.328 -0.332 0 CA-C-O 121.628 0.728 . . . . 75.53 110.875 -179.917 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' -2' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.79 140.54 42.83 Favored 'Trans proline' 0 C--N 1.342 0.189 0 C-N-CA 122.665 2.243 . . . . 52.43 112.352 -179.996 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' -1' ' ' ALA . . . . . 0.438 ' HB1' ' HD2' ' B' ' 0' ' ' PRO . . . -71.93 156.3 91.08 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-O 121.603 0.716 . . . . 73.32 111.094 179.903 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 0' ' ' PRO . . . . . 0.438 ' HD2' ' HB1' ' B' ' -1' ' ' ALA . 54.0 Cg_endo -69.79 -177.94 2.12 Favored 'Trans proline' 0 C--O 1.231 0.168 0 C-N-CA 122.696 2.264 . . . . 71.35 112.352 -179.996 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 1' ' ' LYS . . . . . . . . . . . . . 3.5 ttpt -129.31 145.49 57.02 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-O 121.576 0.703 . . . . 72.11 110.915 179.939 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 2' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.73 163.53 37.9 Favored 'Trans proline' 0 C--N 1.342 0.185 0 C-N-CA 122.718 2.279 . . . . 73.4 112.322 179.904 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 3' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.72 -178.48 2.35 Favored 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.712 2.275 . . . . 63.11 112.376 179.901 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 4' ' ' SER . . . . . . . . . . . . . 1.5 t -86.66 141.98 28.55 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.225 -0.443 . . . . 54.41 110.865 -179.84 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 5' ' ' SER . . . . . . . . . . . . . 35.3 t -162.24 142.3 9.9 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.129 -0.487 . . . . 74.3 110.878 -179.835 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 6' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.328 -0.326 0 CA-C-N 116.147 -0.479 . . . . 65.02 111.109 179.929 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' -4' ' ' MET . . . . . . . . . . . . . 6.4 mmm . . . . . 0 C--O 1.231 0.082 0 CA-C-O 120.8 0.333 . . . . 72.5 110.873 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' -3' ' ' ALA . . . . . . . . . . . . . . . 56.81 45.61 21.33 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.249 -0.432 . . . . 54.34 111.121 179.905 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' -2' ' ' ILE . . . . . . . . . . . . . 91.9 mt -115.87 128.09 73.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.235 -0.439 . . . . 74.43 111.158 179.974 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' -1' ' ' VAL . . . . . . . . . . . . . 70.9 t -114.78 131.14 67.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.144 -0.48 . . . . 71.1 111.114 179.847 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 1.6 m120 -94.06 60.78 2.86 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.137 -0.483 . . . . 71.21 110.848 -179.993 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 50.3 tp60 -101.51 133.47 46.11 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.205 -0.452 . . . . 73.14 110.885 179.989 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 8.9 ptp180 -87.14 163.69 16.81 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.228 -0.442 . . . . 74.52 110.85 -179.934 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -155.18 154.08 31.72 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.192 -0.458 . . . . 73.53 111.07 179.948 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.622 ' HB ' HD11 ' A' ' 58' ' ' ILE . 11.6 p -104.03 149.26 7.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.187 -0.46 . . . . 65.22 111.088 -179.998 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -88.24 105.03 17.27 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.124 -0.489 . . . . 50.13 111.143 179.863 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.686 HD21 ' HB2' ' A' ' 56' ' ' SER . 17.6 mt -69.17 -39.21 78.87 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.199 -0.455 . . . . 75.22 110.919 -179.952 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 3.3 m-85 -141.3 156.4 45.86 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.208 -0.451 . . . . 55.14 110.937 179.998 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 1.7 p-10 -79.06 135.05 36.75 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.11 -0.495 . . . . 75.43 110.853 179.914 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 2.1 t80 -134.09 146.06 49.95 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.191 -0.459 . . . . 75.3 110.926 -179.926 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 29.7 tt0 -115.72 135.47 22.68 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.603 0.716 . . . . 74.22 110.922 -179.945 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.404 ' HD3' ' HA ' ' A' ' 19' ' ' ARG . 53.3 Cg_endo -69.76 147.64 63.32 Favored 'Trans proline' 0 C--N 1.341 0.154 0 C-N-CA 122.701 2.267 . . . . 73.02 112.347 -179.969 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 13.6 mt-10 -107.72 -18.82 13.73 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.247 -0.433 . . . . 71.41 110.894 -179.98 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 31.1 m-80 -112.8 175.46 5.43 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.133 -0.485 . . . . 70.04 110.899 -179.933 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 36.5 m-20 -90.05 13.4 14.98 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.191 -0.459 . . . . 72.24 110.836 179.949 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 1.2 p-10 -131.32 14.96 5.07 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.232 -0.44 . . . . 74.43 110.895 -179.901 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 23.9 mt-10 -104.29 159.49 15.67 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.122 -0.49 . . . . 74.22 110.9 -179.993 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.508 HD12 ' H ' ' A' ' 48' ' ' GLY . 0.4 OUTLIER -109.62 143.21 39.66 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.213 -0.449 . . . . 75.55 110.924 -179.989 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 19' ' ' ARG . . . . . 0.404 ' HA ' ' HD3' ' A' ' 12' ' ' PRO . 0.0 OUTLIER -81.67 156.37 25.11 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.204 -0.453 . . . . 72.52 110.878 179.951 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.552 HD21 ' CG1' ' A' ' 55' ' ' VAL . 2.7 tp -141.48 148.6 39.72 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.198 -0.455 . . . . 74.43 110.893 -179.976 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.646 ' HB3' ' CG ' ' A' ' 24' ' ' ASP . . . -139.87 136.58 34.09 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.197 -0.456 . . . . 42.14 111.041 179.836 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -50.57 121.83 6.32 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.183 -0.462 . . . . 61.31 110.85 -179.912 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 95.53 -0.77 63.54 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.787 -0.721 . . . . 74.54 112.474 -179.982 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' ASP . . . . . 0.646 ' CG ' ' HB3' ' A' ' 21' ' ' ALA . 1.4 m-20 -86.27 146.04 26.69 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.753 0.311 . . . . 54.34 110.872 -179.964 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 3.2 mm -101.2 137.93 27.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.183 -0.462 . . . . 71.42 111.137 -179.99 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 1.3 m -141.49 158.96 22.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.2 -0.455 . . . . 52.14 111.13 179.873 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 67.1 m-85 -116.5 108.98 16.68 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.185 -0.462 . . . . 72.54 110.905 179.977 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.614 HD13 ' HB2' ' A' ' 39' ' ' ALA . 11.3 mm -72.17 103.24 1.47 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.115 -0.493 . . . . 74.02 111.139 179.986 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 3.5 m -65.06 -39.96 94.04 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.196 -0.456 . . . . 54.21 110.841 -179.88 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' TYR . . . . . 0.496 ' CZ ' HG21 ' A' ' 38' ' ' VAL . 34.6 p90 -174.0 147.19 1.26 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.143 -0.48 . . . . 63.14 110.95 -179.892 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 31' ' ' LYS . . . . . 0.502 ' HG3' HD22 ' A' ' 37' ' ' LEU . 21.4 tttt -80.36 146.04 31.74 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.105 -0.498 . . . . 74.12 110.929 179.922 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 36.0 t60 -136.39 152.53 50.72 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.273 -0.421 . . . . 55.21 110.876 179.921 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -58.01 -174.71 0.43 Allowed Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.737 -0.744 . . . . 73.14 112.432 -179.893 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 58.1 mm-40 65.94 12.08 8.16 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.817 0.341 . . . . 74.35 110.899 -179.867 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 68.01 29.07 73.29 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.747 -0.739 . . . . 70.51 112.463 -179.981 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' TRP . . . . . 0.606 ' C ' HD23 ' A' ' 37' ' ' LEU . 98.7 m95 -123.19 135.97 54.54 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.792 0.329 . . . . 73.32 110.908 -179.898 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.685 HD11 ' CG ' ' A' ' 52' ' ' GLU . 0.7 OUTLIER -121.8 130.22 53.24 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.224 -0.444 . . . . 73.43 110.937 179.965 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.544 HG22 HD23 ' A' ' 49' ' ' LEU . 39.9 t -78.46 111.33 15.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.197 -0.456 . . . . 52.1 111.142 179.837 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.614 ' HB2' HD13 ' A' ' 28' ' ' ILE . . . -133.15 167.75 19.78 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.169 -0.469 . . . . 54.34 111.151 179.857 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 1.1 pt-20 -119.12 156.06 30.43 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.283 -0.417 . . . . 73.5 110.901 -179.963 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -71.02 -176.55 1.41 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.125 -0.489 . . . . 72.04 110.904 -179.944 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 4.0 tm-20 -67.51 -38.32 84.11 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.159 -0.473 . . . . 72.41 110.914 179.991 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 1.3 t -57.26 -22.19 39.66 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.166 -0.47 . . . . 74.44 110.831 -179.811 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 65.71 12.89 57.95 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.733 -0.746 . . . . 55.4 112.518 -179.942 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 1.4 t -109.19 -17.31 13.88 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.954 0.407 . . . . 50.15 110.837 -179.733 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -118.89 135.26 54.66 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.121 -0.491 . . . . 72.54 110.87 179.973 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 6.4 m -136.08 144.65 45.27 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.221 -0.445 . . . . 75.25 111.132 179.936 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' GLY . . . . . 0.508 ' H ' HD12 ' A' ' 18' ' ' LEU . . . -166.55 -159.55 12.45 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.76 -0.733 . . . . 54.33 112.449 -180.0 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.544 HD23 HG22 ' A' ' 38' ' ' VAL . 6.4 mt -98.96 134.92 41.11 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.913 0.387 . . . . 70.25 110.934 -179.97 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.45 HG22 ' O ' ' A' ' 37' ' ' LEU . 31.1 m -133.39 153.63 80.58 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-O 121.661 0.743 . . . . 64.03 111.13 179.826 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 0.429 ' HD2' HD22 ' A' ' 20' ' ' LEU . 53.5 Cg_endo -69.82 142.15 46.89 Favored 'Trans proline' 0 C--N 1.341 0.167 0 C-N-CA 122.665 2.243 . . . . 74.2 112.325 -179.995 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 52' ' ' GLU . . . . . 0.685 ' CG ' HD11 ' A' ' 37' ' ' LEU . 26.9 tt0 -89.29 -27.7 20.37 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.244 -0.434 . . . . 62.11 110.902 -179.983 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -86.22 9.86 16.36 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.15 -0.477 . . . . 74.54 110.921 -179.972 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 54' ' ' PHE . . . . . 0.421 ' HB2' ' HG2' ' A' ' 51' ' ' PRO . 1.1 m-85 -119.88 -13.53 9.05 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.128 -0.487 . . . . 74.01 110.875 -179.937 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.552 ' CG1' HD21 ' A' ' 20' ' ' LEU . 19.5 m -115.49 166.37 9.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.142 -0.481 . . . . 74.32 111.088 179.987 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 56' ' ' SER . . . . . 0.686 ' HB2' HD21 ' A' ' 7' ' ' LEU . 35.1 t -138.25 117.58 12.79 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.125 -0.489 . . . . 74.44 110.884 -179.835 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 2.6 m-85 -52.72 133.25 36.87 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.164 -0.471 . . . . 70.03 110.929 -179.847 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.622 HD11 ' HB ' ' A' ' 5' ' ' VAL . 51.8 mt -102.11 147.73 8.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.121 -0.49 . . . . 74.4 111.082 179.953 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -131.14 160.97 64.55 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 121.561 0.696 . . . . 73.42 110.953 179.879 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.77 -48.52 0.7 Allowed 'Trans proline' 0 C--N 1.341 0.149 0 C-N-CA 122.711 2.274 . . . . 70.2 112.333 179.988 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 3.5 mp0 -153.57 25.78 0.51 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.237 -0.438 . . . . 73.03 110.879 -179.95 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 8.1 mt -115.23 172.01 7.34 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.17 -0.468 . . . . 71.33 110.917 -179.984 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 23.0 mt-10 . . . . . 0 C--N 1.329 -0.291 0 CA-C-N 116.169 -0.469 . . . . 53.44 110.897 179.959 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' B' B ' -9' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.346 0 N-CA-C 112.48 -0.248 . . . . 72.31 112.48 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' B' B ' -8' ' ' LYS . . . . . . . . . . . . . 38.6 mttt -129.49 23.67 5.48 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.786 0.327 . . . . 64.43 110.847 -179.938 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' -7' ' ' PHE . . . . . 0.421 ' HB3' HD11 ' A' ' 49' ' ' LEU . 7.8 m-85 -62.58 141.25 58.56 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.259 -0.428 . . . . 74.24 110.909 179.967 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' -6' ' ' ILE . . . . . . . . . . . . . 2.1 pt -153.36 85.36 4.18 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-O 121.56 0.695 . . . . 75.44 111.136 179.998 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' -5' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.76 126.78 13.71 Favored 'Trans proline' 0 C--O 1.231 0.163 0 C-N-CA 122.649 2.233 . . . . 61.34 112.368 179.88 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' -4' ' ' SER . . . . . . . . . . . . . 30.4 t -122.04 57.94 1.04 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.255 -0.43 . . . . 53.42 110.886 -179.852 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' -3' ' ' ARG . . . . . . . . . . . . . 6.9 ptm180 -174.42 153.96 1.94 Allowed Pre-proline 0 C--N 1.329 -0.326 0 CA-C-O 121.602 0.715 . . . . 71.43 110.896 -179.928 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' -2' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.71 142.48 48.25 Favored 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.678 2.252 . . . . 64.13 112.372 179.964 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' -1' ' ' ALA . . . . . . . . . . . . . . . -75.16 154.52 86.4 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.627 0.727 . . . . 65.32 111.076 179.917 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 0' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.78 -177.35 1.84 Allowed 'Trans proline' 0 C--N 1.342 0.213 0 C-N-CA 122.679 2.253 . . . . 62.35 112.375 -179.967 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 1' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -127.56 150.76 73.8 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 121.544 0.688 . . . . 72.34 110.905 179.93 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 2' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.8 164.7 33.6 Favored 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.647 2.231 . . . . 65.54 112.393 179.87 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 3' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.71 173.81 10.38 Favored 'Trans proline' 0 C--O 1.231 0.17 0 C-N-CA 122.718 2.279 . . . . 75.14 112.38 179.938 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 4' ' ' SER . . . . . . . . . . . . . 48.1 t -104.84 87.82 2.75 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.227 -0.442 . . . . 70.32 110.838 -179.851 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 5' ' ' SER . . . . . . . . . . . . . 1.7 m -91.27 79.48 5.67 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.127 -0.488 . . . . 62.13 110.935 -179.88 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 6' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.304 0 CA-C-N 116.134 -0.485 . . . . 74.43 111.087 179.964 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' -4' ' ' MET . . . . . . . . . . . . . 4.9 ppp? . . . . . 0 C--O 1.23 0.053 0 CA-C-O 120.791 0.329 . . . . 65.13 110.861 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' -3' ' ' ALA . . . . . . . . . . . . . . . -90.02 106.16 18.29 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.188 -0.46 . . . . 62.03 111.075 179.965 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' -2' ' ' ILE . . . . . . . . . . . . . 57.1 mt -79.07 114.38 19.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.198 -0.456 . . . . 73.52 111.144 179.961 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' -1' ' ' VAL . . . . . . . . . . . . . 7.6 p -73.78 -28.66 24.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.196 -0.456 . . . . 60.44 111.117 179.827 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 1.8 t-20 63.6 54.71 1.84 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.189 -0.459 . . . . 72.33 110.865 -179.975 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 52.4 tp60 -108.7 127.2 53.78 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.17 -0.468 . . . . 74.11 110.876 -179.951 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 5.4 ptp180 -77.56 163.43 26.28 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.209 -0.45 . . . . 64.44 110.873 -179.936 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -158.37 154.73 27.46 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.202 -0.454 . . . . 63.32 111.11 179.981 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.488 ' HB ' HD11 ' A' ' 58' ' ' ILE . 10.8 p -105.66 150.48 8.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.242 -0.435 . . . . 73.34 111.087 179.985 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -89.26 107.86 19.29 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.166 -0.47 . . . . 55.54 111.115 179.859 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.728 HD21 ' CB ' ' A' ' 56' ' ' SER . 18.4 mt -71.72 -39.25 70.26 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.247 -0.433 . . . . 60.12 110.943 -179.983 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 4.5 m-85 -140.33 152.74 46.07 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.143 -0.48 . . . . 73.32 110.943 -179.989 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 1.1 p30 -75.29 137.33 41.1 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.136 -0.483 . . . . 75.24 110.92 179.891 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 15.0 t80 -140.19 145.81 37.94 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.249 -0.432 . . . . 63.41 110.877 -179.889 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -114.55 142.7 28.61 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 121.634 0.731 . . . . 74.11 110.918 -179.94 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.78 134.21 27.39 Favored 'Trans proline' 0 C--N 1.341 0.16 0 C-N-CA 122.676 2.251 . . . . 50.25 112.336 -179.973 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 5.4 mt-10 -96.57 -16.99 20.76 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.239 -0.437 . . . . 72.22 110.872 -179.993 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 48.3 m-80 -115.55 175.77 5.37 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.165 -0.47 . . . . 61.52 110.865 -179.939 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 84.5 m-20 -88.77 13.36 12.65 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.169 -0.469 . . . . 73.04 110.854 179.972 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -135.37 21.09 3.4 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.171 -0.468 . . . . 71.12 110.869 -179.951 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 13.0 mt-10 -106.86 161.7 14.46 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.176 -0.465 . . . . 72.4 110.888 -179.989 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.557 HD21 ' HD3' ' A' ' 46' ' ' LYS . 0.4 OUTLIER -111.29 143.42 42.09 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.202 -0.454 . . . . 74.11 110.899 -179.999 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 19' ' ' ARG . . . . . 0.438 ' H ' HD23 ' A' ' 18' ' ' LEU . 16.2 mtm180 -79.58 156.68 27.59 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.193 -0.458 . . . . 71.31 110.903 179.941 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.594 HD21 ' CG1' ' A' ' 55' ' ' VAL . 3.2 tp -142.93 148.78 37.47 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.217 -0.447 . . . . 72.03 110.894 -179.942 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.668 ' HB3' ' CG ' ' A' ' 24' ' ' ASP . . . -141.25 137.01 32.24 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.152 -0.476 . . . . 74.13 111.109 179.821 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -51.09 121.24 5.82 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.237 -0.438 . . . . 62.13 110.874 -179.899 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 97.03 -6.45 64.06 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.738 -0.744 . . . . 54.11 112.464 -179.979 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' ASP . . . . . 0.668 ' CG ' ' HB3' ' A' ' 21' ' ' ALA . 1.1 m-20 -81.04 146.39 30.67 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.76 0.314 . . . . 71.21 110.876 -179.939 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 3.3 mm -100.86 139.79 21.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.211 -0.449 . . . . 74.24 111.139 -179.975 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 1.4 m -143.12 158.17 17.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.192 -0.458 . . . . 74.52 111.104 179.841 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 55.7 m-85 -116.15 108.48 16.22 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.123 -0.49 . . . . 61.21 110.863 -179.959 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.693 HD13 ' HB2' ' A' ' 39' ' ' ALA . 13.4 mm -72.58 103.33 1.62 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.192 -0.458 . . . . 74.42 111.154 179.96 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 3.4 m -64.65 -39.3 93.44 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.12 -0.491 . . . . 64.23 110.897 -179.91 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' TYR . . . . . 0.476 ' CZ ' HG21 ' A' ' 38' ' ' VAL . 32.7 p90 -174.37 146.74 1.1 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.113 -0.494 . . . . 74.4 110.911 -179.863 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 31' ' ' LYS . . . . . 0.535 ' HG3' HD22 ' A' ' 37' ' ' LEU . 18.7 tttt -82.51 145.73 29.62 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.138 -0.483 . . . . 71.32 110.919 179.886 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 29.8 t60 -134.88 153.08 52.19 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.236 -0.438 . . . . 72.45 110.83 179.952 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -58.52 -174.51 0.51 Allowed Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.738 -0.744 . . . . 54.4 112.532 -179.99 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 71.4 mm-40 65.94 12.15 8.21 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.864 0.364 . . . . 74.25 110.936 -179.909 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 68.16 28.62 73.27 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.735 -0.745 . . . . 62.32 112.533 -179.94 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' TRP . . . . . 0.615 ' C ' HD23 ' A' ' 37' ' ' LEU . 98.9 m95 -123.06 135.38 54.39 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.83 0.347 . . . . 74.14 110.907 -179.911 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.668 HD11 ' CG ' ' A' ' 52' ' ' GLU . 0.4 OUTLIER -123.13 135.85 54.53 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.187 -0.46 . . . . 74.4 110.883 -179.963 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.557 HG22 HD23 ' A' ' 49' ' ' LEU . 39.3 t -84.43 114.9 25.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.177 -0.465 . . . . 73.43 111.145 179.814 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.693 ' HB2' HD13 ' A' ' 28' ' ' ILE . . . -136.4 168.57 19.2 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.189 -0.46 . . . . 61.42 111.15 179.838 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 1.4 pt-20 -125.64 155.01 41.47 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.211 -0.449 . . . . 64.14 110.829 -179.875 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -67.57 -175.19 0.49 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.15 -0.477 . . . . 61.43 110.87 -179.939 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 -68.9 -37.42 78.97 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.187 -0.461 . . . . 65.2 110.881 -179.962 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 1.6 t -57.02 -22.25 37.23 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.171 -0.468 . . . . 73.01 110.866 -179.816 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 66.89 12.42 59.82 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.699 -0.762 . . . . 74.1 112.489 179.986 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -109.65 -21.93 12.19 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.954 0.407 . . . . 63.21 110.871 -179.72 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.557 ' HD3' HD21 ' A' ' 18' ' ' LEU . 0.1 OUTLIER -112.41 123.92 51.36 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.132 -0.485 . . . . 73.2 110.892 179.962 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 9.7 m -129.69 144.61 51.37 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.247 -0.433 . . . . 72.11 111.117 179.986 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 48' ' ' GLY . . . . . 0.536 ' H ' HD12 ' A' ' 18' ' ' LEU . . . -166.35 -159.22 11.86 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.73 -0.748 . . . . 54.31 112.462 179.98 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.557 HD23 HG22 ' A' ' 38' ' ' VAL . 13.5 mt -99.41 134.52 42.15 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.883 0.373 . . . . 73.25 110.885 -179.893 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.411 ' HB ' ' HD2' ' A' ' 51' ' ' PRO . 10.3 m -134.01 153.43 79.73 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-O 121.606 0.717 . . . . 65.42 111.104 179.908 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 0.419 ' HG2' ' HB2' ' A' ' 54' ' ' PHE . 53.6 Cg_endo -69.8 147.56 62.88 Favored 'Trans proline' 0 N--CA 1.466 -0.134 0 C-N-CA 122.68 2.253 . . . . 75.44 112.357 179.934 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 52' ' ' GLU . . . . . 0.668 ' CG ' HD11 ' A' ' 37' ' ' LEU . 24.6 tt0 -93.07 -28.34 16.42 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.214 -0.448 . . . . 70.43 110.902 -179.965 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 2.5 mm-40 -87.17 11.17 14.69 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.154 -0.475 . . . . 72.21 110.945 -179.963 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 54' ' ' PHE . . . . . 0.419 ' HB2' ' HG2' ' A' ' 51' ' ' PRO . 0.9 OUTLIER -121.1 -9.9 9.1 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.104 -0.498 . . . . 71.4 110.858 -179.939 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.594 ' CG1' HD21 ' A' ' 20' ' ' LEU . 16.2 m -119.65 166.54 13.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.186 -0.461 . . . . 75.21 111.077 -179.996 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 56' ' ' SER . . . . . 0.728 ' CB ' HD21 ' A' ' 7' ' ' LEU . 38.4 t -136.61 119.83 16.7 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.166 -0.47 . . . . 64.02 110.834 -179.859 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 3.1 m-85 -58.33 129.85 43.96 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.118 -0.492 . . . . 74.42 110.892 -179.895 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.488 HD11 ' HB ' ' A' ' 5' ' ' VAL . 39.8 mt -96.51 150.25 4.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.095 -0.502 . . . . 73.04 111.121 179.886 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 1.4 mt-30 -130.97 160.95 64.41 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 121.59 0.71 . . . . 73.53 110.874 179.965 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.76 -48.89 0.62 Allowed 'Trans proline' 0 C--N 1.341 0.169 0 C-N-CA 122.705 2.27 . . . . 74.32 112.326 179.967 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -152.64 25.26 0.58 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.215 -0.448 . . . . 71.11 110.869 -179.949 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 5.8 mt -115.71 112.2 21.71 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.142 -0.481 . . . . 64.41 110.893 -179.947 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 16.3 pt-20 . . . . . 0 C--N 1.329 -0.297 0 CA-C-N 116.179 -0.464 . . . . 72.42 110.872 179.89 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' B' B ' -9' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.301 0 N-CA-C 112.463 -0.255 . . . . 71.21 112.463 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' B' B ' -8' ' ' LYS . . . . . . . . . . . . . 25.7 ttpt -125.83 67.32 1.18 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.86 0.362 . . . . 73.02 110.951 -180.0 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' -7' ' ' PHE . . . . . 0.446 ' HB3' HD11 ' A' ' 49' ' ' LEU . 8.4 m-85 -86.26 157.61 19.89 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.205 -0.452 . . . . 70.15 110.861 -179.998 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' -6' ' ' ILE . . . . . 0.51 ' O ' HG23 ' B' ' -6' ' ' ILE . 4.1 tp -163.66 88.12 1.21 Allowed Pre-proline 0 C--N 1.328 -0.326 0 CA-C-O 121.662 0.744 . . . . 75.31 111.158 179.922 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' -5' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.78 146.08 58.94 Favored 'Trans proline' 0 C--N 1.341 0.175 0 C-N-CA 122.7 2.267 . . . . 71.2 112.323 179.911 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' -4' ' ' SER . . . . . . . . . . . . . 29.9 t -143.81 67.79 1.28 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.197 -0.456 . . . . 65.33 110.864 -179.845 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' -3' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -179.6 154.75 0.73 Allowed Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.647 0.737 . . . . 74.52 110.855 -179.928 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' -2' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.79 119.76 6.65 Favored 'Trans proline' 0 C--N 1.342 0.188 0 C-N-CA 122.688 2.259 . . . . 74.31 112.37 179.973 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' -1' ' ' ALA . . . . . . . . . . . . . . . -55.54 151.52 20.69 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.572 0.701 . . . . 45.02 111.109 179.886 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 0' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.78 172.3 12.91 Favored 'Trans proline' 0 C--O 1.232 0.197 0 C-N-CA 122.684 2.256 . . . . 55.33 112.365 179.992 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 1' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -120.93 152.87 56.96 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-O 121.553 0.692 . . . . 71.52 110.86 179.943 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 2' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.75 164.45 34.49 Favored 'Trans proline' 0 C--N 1.341 0.151 0 C-N-CA 122.703 2.268 . . . . 71.43 112.357 179.872 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 3' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.79 -171.87 0.52 Allowed 'Trans proline' 0 C--N 1.341 0.177 0 C-N-CA 122.687 2.258 . . . . 62.2 112.313 179.97 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 4' ' ' SER . . . . . . . . . . . . . 85.2 p -137.98 151.15 47.64 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.185 -0.461 . . . . 70.42 110.86 -179.858 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 5' ' ' SER . . . . . . . . . . . . . 1.2 m 63.14 29.37 16.12 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.113 -0.494 . . . . 72.34 110.893 -179.821 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 6' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.33 -0.279 0 CA-C-N 116.103 -0.499 . . . . 42.5 111.068 179.906 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' -4' ' ' MET . . . . . . . . . . . . . 1.8 mmt . . . . . 0 C--O 1.231 0.092 0 CA-C-O 120.839 0.352 . . . . 60.03 110.885 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' -3' ' ' ALA . . . . . . . . . . . . . . . -73.75 -24.4 59.87 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.236 -0.438 . . . . 73.02 111.095 179.962 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' -2' ' ' ILE . . . . . 0.4 HG23 ' O ' ' A' ' 29' ' ' SER . 64.3 mt -92.27 113.11 26.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.214 -0.448 . . . . 73.04 111.127 179.959 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' -1' ' ' VAL . . . . . . . . . . . . . 9.0 p -64.97 -30.42 50.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.161 -0.472 . . . . 71.0 111.125 179.868 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 2.2 t-20 63.37 58.64 1.35 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.186 -0.461 . . . . 72.3 110.916 -179.978 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 56.6 tp60 -114.49 124.01 50.83 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.157 -0.474 . . . . 41.15 110.95 179.972 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 6.8 ptp180 -75.01 162.44 28.57 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.174 -0.466 . . . . 71.14 110.854 -179.905 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -156.59 154.05 29.59 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.189 -0.46 . . . . 52.52 111.119 179.929 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.607 ' HB ' HD11 ' A' ' 58' ' ' ILE . 11.3 p -105.46 148.48 9.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.225 -0.443 . . . . 52.45 111.119 179.973 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -87.4 113.46 23.13 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.165 -0.47 . . . . 34.03 111.088 179.889 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.693 HD21 ' HB2' ' A' ' 56' ' ' SER . 15.0 mt -79.04 -37.37 39.19 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.186 -0.461 . . . . 62.24 110.956 179.997 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 5.1 m-85 -142.09 143.33 33.01 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.169 -0.469 . . . . 74.13 110.934 -179.967 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 3.2 p-10 -67.03 132.9 48.84 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.158 -0.474 . . . . 71.13 110.858 179.934 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 5.6 t80 -130.53 145.92 51.95 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.177 -0.465 . . . . 72.11 110.886 -179.865 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 3.8 tp10 -117.13 135.91 23.22 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.618 0.723 . . . . 74.42 110.913 -179.958 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.67 141.07 44.6 Favored 'Trans proline' 0 C--N 1.341 0.167 0 C-N-CA 122.716 2.277 . . . . 74.52 112.314 -179.971 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -105.9 -9.29 17.21 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.213 -0.449 . . . . 72.31 110.883 179.96 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 57.5 m-80 -121.66 175.75 6.07 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.18 -0.464 . . . . 73.23 110.902 -179.962 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -92.99 23.33 4.31 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.2 -0.454 . . . . 72.3 110.869 179.905 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 1.1 p-10 -140.92 13.68 2.27 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.16 -0.473 . . . . 53.44 110.864 -179.932 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 28.5 mt-10 -105.1 167.79 9.48 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.186 -0.461 . . . . 73.34 110.874 -179.976 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.572 HD12 ' H ' ' A' ' 19' ' ' ARG . 30.2 tp -117.3 147.56 42.47 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.166 -0.47 . . . . 65.23 110.938 -179.996 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 19' ' ' ARG . . . . . 0.572 ' H ' HD12 ' A' ' 18' ' ' LEU . 1.9 mtt180 -82.68 156.63 23.72 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.21 -0.45 . . . . 73.34 110.824 179.956 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.548 HD21 ' CG1' ' A' ' 55' ' ' VAL . 3.2 tp -143.5 147.86 35.14 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.15 -0.477 . . . . 71.21 110.928 -179.973 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.655 ' HB3' ' CG ' ' A' ' 24' ' ' ASP . . . -139.64 138.7 36.33 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.167 -0.469 . . . . 74.25 111.043 179.83 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 -51.15 121.55 6.33 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.21 -0.45 . . . . 71.22 110.905 -179.945 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 96.73 -7.42 65.39 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.77 -0.728 . . . . 74.44 112.508 -179.907 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' ASP . . . . . 0.655 ' CG ' ' HB3' ' A' ' 21' ' ' ALA . 1.1 m-20 -79.49 147.73 32.12 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.811 0.338 . . . . 42.5 110.873 -179.982 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 3.2 mm -102.85 140.91 19.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.187 -0.46 . . . . 73.51 111.106 -179.966 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 1.6 m -143.04 158.15 17.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.14 -0.482 . . . . 75.54 111.139 179.803 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 43.7 m-85 -115.62 106.05 13.47 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.183 -0.462 . . . . 64.12 110.884 -179.972 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.886 HD13 ' HB2' ' A' ' 39' ' ' ALA . 22.3 mm -71.02 103.2 1.11 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.152 -0.476 . . . . 50.23 111.095 -179.99 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 29' ' ' SER . . . . . 0.4 ' O ' HG23 ' A' ' -2' ' ' ILE . 3.4 m -64.95 -39.28 93.25 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.186 -0.461 . . . . 60.44 110.872 -179.91 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 30' ' ' TYR . . . . . 0.472 ' CZ ' HG21 ' A' ' 38' ' ' VAL . 34.1 p90 -174.32 147.52 1.18 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.111 -0.495 . . . . 71.34 110.907 -179.917 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 31' ' ' LYS . . . . . 0.549 ' HG3' HD22 ' A' ' 37' ' ' LEU . 19.7 tttt -81.51 146.29 30.26 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.116 -0.493 . . . . 74.25 110.922 179.877 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 33.2 t60 -134.87 156.52 48.79 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.259 -0.428 . . . . 75.13 110.888 179.856 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -61.15 -174.06 1.25 Allowed Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.719 -0.753 . . . . 54.01 112.511 -179.982 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 45.4 mm-40 64.66 13.23 8.18 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.838 0.352 . . . . 74.14 110.92 -179.899 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 67.99 29.2 73.38 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.725 -0.75 . . . . 75.23 112.485 -179.986 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' TRP . . . . . 0.654 ' C ' HD23 ' A' ' 37' ' ' LEU . 98.9 m95 -123.29 138.34 54.64 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.83 0.347 . . . . 73.41 110.891 -179.881 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.71 HD11 ' CG ' ' A' ' 52' ' ' GLU . 0.5 OUTLIER -126.21 132.26 51.8 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.256 -0.429 . . . . 74.54 110.93 179.964 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.472 HG21 ' CZ ' ' A' ' 30' ' ' TYR . 51.8 t -77.38 115.75 19.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.206 -0.452 . . . . 74.22 111.143 179.858 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.886 ' HB2' HD13 ' A' ' 28' ' ' ILE . . . -133.95 158.86 42.41 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.178 -0.465 . . . . 62.02 111.092 179.886 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 1.9 pt-20 -120.5 153.55 36.51 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.2 -0.455 . . . . 63.15 110.911 -179.943 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -67.94 -175.05 0.52 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.195 -0.457 . . . . 74.04 110.892 -179.971 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -69.81 -38.41 76.59 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.153 -0.476 . . . . 73.43 110.924 179.999 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 15.4 m -56.43 -22.73 33.83 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.111 -0.495 . . . . 64.42 110.916 -179.873 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 68.85 9.27 59.13 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.755 -0.736 . . . . 60.52 112.485 -179.992 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 39.0 m -105.06 -20.21 13.59 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.983 0.421 . . . . 62.24 110.899 -179.767 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.521 ' HE2' HD11 ' A' ' 18' ' ' LEU . 0.1 OUTLIER -113.24 123.67 50.73 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.092 -0.504 . . . . 72.22 110.882 179.946 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 11.4 m -134.54 127.1 30.65 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.183 -0.462 . . . . 60.4 111.1 -179.992 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -147.34 -154.36 6.2 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.725 -0.75 . . . . 53.42 112.471 179.944 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 6.9 mt -106.1 127.22 53.04 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.878 0.37 . . . . 65.13 110.897 -179.91 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.45 ' CG1' HD23 ' A' ' 18' ' ' LEU . 14.4 m -124.5 154.26 69.58 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-O 121.588 0.709 . . . . 54.11 111.186 179.818 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 0.435 ' HG2' ' HB2' ' A' ' 54' ' ' PHE . 53.3 Cg_endo -69.77 147.12 62.11 Favored 'Trans proline' 0 N--CA 1.465 -0.151 0 C-N-CA 122.722 2.281 . . . . 71.25 112.316 179.997 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 52' ' ' GLU . . . . . 0.71 ' CG ' HD11 ' A' ' 37' ' ' LEU . 27.8 tt0 -92.02 -29.86 16.37 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.234 -0.439 . . . . 74.1 110.897 -179.997 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -84.91 9.89 13.18 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.132 -0.485 . . . . 74.4 110.878 -179.916 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' PHE . . . . . 0.435 ' HB2' ' HG2' ' A' ' 51' ' ' PRO . 1.0 OUTLIER -120.78 -8.46 9.44 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.177 -0.465 . . . . 73.42 110.887 -179.901 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.548 ' CG1' HD21 ' A' ' 20' ' ' LEU . 20.4 m -118.86 171.98 6.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.123 -0.49 . . . . 75.02 111.115 179.996 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 56' ' ' SER . . . . . 0.693 ' HB2' HD21 ' A' ' 7' ' ' LEU . 35.6 t -143.59 113.51 7.18 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.175 -0.466 . . . . 74.42 110.806 -179.774 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 2.9 m-85 -52.54 133.28 35.89 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.115 -0.493 . . . . 73.0 110.922 -179.914 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.607 HD11 ' HB ' ' A' ' 5' ' ' VAL . 46.0 mt -102.46 148.63 7.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.099 -0.5 . . . . 75.11 111.137 179.899 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 5.0 mt-30 -131.11 160.71 65.7 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 121.632 0.729 . . . . 75.44 110.834 179.971 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.78 -48.73 0.65 Allowed 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.705 2.27 . . . . 72.21 112.348 179.993 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 6.8 pt-20 -153.54 22.15 0.54 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.156 -0.475 . . . . 64.33 110.909 179.992 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 8.0 mt -112.5 162.79 15.23 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.165 -0.47 . . . . 71.14 110.914 -179.995 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 47.5 mm-40 . . . . . 0 C--N 1.329 -0.31 0 CA-C-N 116.188 -0.46 . . . . 72.45 110.869 179.93 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' B' B ' -9' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.339 0 N-CA-C 112.475 -0.25 . . . . 65.25 112.475 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' B' B ' -8' ' ' LYS . . . . . . . . . . . . . 66.6 mttt -123.06 47.35 1.99 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.795 0.331 . . . . 75.15 110.881 -179.987 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' -7' ' ' PHE . . . . . . . . . . . . . 11.3 m-85 -92.37 119.91 32.38 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.239 -0.437 . . . . 63.11 110.876 179.989 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' -6' ' ' ILE . . . . . 0.414 ' O ' HG23 ' B' ' -6' ' ' ILE . 8.4 tt -133.72 119.16 14.82 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 121.576 0.703 . . . . 75.42 111.171 179.974 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' -5' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.73 154.47 67.83 Favored 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 122.681 2.254 . . . . 72.02 112.318 179.92 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' -4' ' ' SER . . . . . . . . . . . . . 41.3 t -133.78 39.18 3.18 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.19 -0.459 . . . . 62.22 110.853 -179.843 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' -3' ' ' ARG . . . . . . . . . . . . . 5.9 ptm180 -174.48 154.48 1.98 Allowed Pre-proline 0 C--N 1.328 -0.334 0 CA-C-O 121.661 0.744 . . . . 73.23 110.838 -179.894 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' -2' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.79 137.9 36.46 Favored 'Trans proline' 0 C--N 1.342 0.189 0 C-N-CA 122.634 2.223 . . . . 62.01 112.334 179.996 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' -1' ' ' ALA . . . . . . . . . . . . . . . -63.39 154.74 77.84 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.519 0.676 . . . . 52.14 111.086 179.9 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 0' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.76 -170.55 0.4 Allowed 'Trans proline' 0 C--O 1.232 0.176 0 C-N-CA 122.675 2.25 . . . . 64.32 112.325 179.982 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 1' ' ' LYS . . . . . . . . . . . . . 27.8 mtpp -130.11 154.58 81.33 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-O 121.575 0.702 . . . . 73.32 110.87 179.942 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 2' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.74 165.55 30.57 Favored 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.732 2.288 . . . . 72.34 112.33 179.881 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 3' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.76 158.82 55.63 Favored 'Trans proline' 0 C--N 1.342 0.189 0 C-N-CA 122.71 2.273 . . . . 64.42 112.359 179.902 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 4' ' ' SER . . . . . . . . . . . . . 22.9 t -162.0 124.68 2.95 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.19 -0.459 . . . . 73.3 110.832 -179.863 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 5' ' ' SER . . . . . . . . . . . . . 11.5 p -127.49 126.97 43.24 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.118 -0.492 . . . . 73.33 110.821 -179.793 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 6' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.307 0 CA-C-N 116.158 -0.474 . . . . 74.11 111.078 179.924 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' -4' ' ' MET . . . . . . . . . . . . . 3.3 ttt . . . . . 0 C--O 1.23 0.075 0 CA-C-O 120.775 0.322 . . . . 75.14 110.86 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' -3' ' ' ALA . . . . . . . . . . . . . . . 57.73 64.26 1.6 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.205 -0.452 . . . . 44.14 111.102 179.932 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' -2' ' ' ILE . . . . . . . . . . . . . 4.5 mp -76.85 129.54 37.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.223 -0.444 . . . . 75.32 111.118 179.983 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' -1' ' ' VAL . . . . . . . . . . . . . 22.1 t -113.84 132.25 63.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.192 -0.458 . . . . 72.14 111.132 179.853 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 1.6 m120 -93.89 60.19 2.86 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.193 -0.458 . . . . 62.35 110.905 179.976 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 51.6 tp60 -99.38 131.16 45.59 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.137 -0.483 . . . . 73.22 110.891 -179.986 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 7.7 ptp180 -86.37 161.78 18.51 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.138 -0.483 . . . . 65.43 110.826 -179.909 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -153.3 154.46 34.63 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.154 -0.476 . . . . 71.15 111.101 179.892 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.641 ' HB ' HD11 ' A' ' 58' ' ' ILE . 9.2 p -103.9 153.09 6.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.226 -0.443 . . . . 75.54 111.115 179.981 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -92.06 113.68 26.02 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.149 -0.478 . . . . 60.14 111.086 179.891 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.663 HD21 ' HB2' ' A' ' 56' ' ' SER . 13.5 mt -79.59 -36.1 38.63 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.211 -0.449 . . . . 74.25 110.923 -179.977 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 2.8 m-85 -144.09 146.11 32.59 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.179 -0.464 . . . . 64.42 110.941 179.995 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 1.3 p30 -68.47 135.2 51.28 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.091 -0.504 . . . . 64.32 110.869 179.909 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 7.5 t80 -134.24 146.21 49.86 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.156 -0.475 . . . . 74.54 110.87 -179.915 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 68.5 tt0 -115.15 137.59 23.06 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-O 121.66 0.743 . . . . 62.24 110.867 -179.869 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.75 137.25 35.06 Favored 'Trans proline' 0 C--N 1.341 0.155 0 C-N-CA 122.665 2.243 . . . . 75.53 112.34 -179.986 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 7.9 mm-40 -97.66 -20.2 17.78 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.222 -0.445 . . . . 62.15 110.901 -179.987 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 32.2 m-80 -115.15 175.3 5.57 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.134 -0.484 . . . . 63.34 110.869 -179.967 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 26.2 m-20 -87.25 7.97 26.15 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.181 -0.463 . . . . 64.34 110.861 179.912 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -125.13 16.76 8.45 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.23 -0.441 . . . . 75.2 110.915 -179.888 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 16.4 mt-10 -108.37 156.59 19.25 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.164 -0.471 . . . . 73.31 110.888 179.986 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.631 HD11 ' HG3' ' A' ' 46' ' ' LYS . 0.5 OUTLIER -106.51 150.39 26.16 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.119 -0.491 . . . . 60.11 110.917 -179.969 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 19' ' ' ARG . . . . . 0.617 ' O ' HD23 ' A' ' 18' ' ' LEU . 26.1 mtm180 -85.16 153.27 22.76 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.167 -0.469 . . . . 70.23 110.852 179.976 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.548 HD21 ' CG1' ' A' ' 55' ' ' VAL . 1.7 tp -138.09 148.11 44.68 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.199 -0.455 . . . . 72.21 110.941 -179.968 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.612 ' HB3' ' CG ' ' A' ' 24' ' ' ASP . . . -140.18 139.24 35.66 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.231 -0.44 . . . . 52.42 111.147 179.786 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -50.29 119.72 3.93 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.249 -0.432 . . . . 74.4 110.88 -179.934 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 98.5 -6.86 61.28 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.773 -0.727 . . . . 61.41 112.456 179.973 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' ASP . . . . . 0.612 ' CG ' ' HB3' ' A' ' 21' ' ' ALA . 2.9 m-20 -75.78 152.78 37.29 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.792 0.329 . . . . 74.03 110.845 -179.997 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 1.3 mt -116.77 122.2 69.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.17 -0.468 . . . . 73.34 111.176 179.933 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.633 HG12 ' HA ' ' A' ' 41' ' ' ASN . 3.6 m -124.64 163.41 24.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.168 -0.469 . . . . 54.21 111.132 179.894 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 74.5 m-85 -116.35 110.1 18.24 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.145 -0.479 . . . . 72.43 110.853 -179.994 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.633 HD13 ' HB2' ' A' ' 39' ' ' ALA . 13.4 mm -71.85 103.0 1.31 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.117 -0.492 . . . . 65.22 111.106 179.955 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 5.4 m -65.53 -40.77 93.33 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.192 -0.458 . . . . 73.35 110.822 -179.904 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' TYR . . . . . 0.517 ' CZ ' HG21 ' A' ' 38' ' ' VAL . 33.4 p90 -174.27 149.87 1.43 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.154 -0.476 . . . . 75.34 110.958 -179.899 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 19.1 tttt -81.37 143.1 32.41 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.168 -0.469 . . . . 63.54 110.856 179.928 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 32.9 t60 -131.91 153.35 50.34 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.206 -0.452 . . . . 75.54 110.889 179.872 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -59.24 -174.69 0.69 Allowed Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.732 -0.747 . . . . 52.15 112.486 -179.932 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 29.8 mm-40 66.17 11.76 8.07 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.789 0.328 . . . . 73.43 110.88 -179.897 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 68.69 28.77 72.9 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.767 -0.73 . . . . 55.32 112.484 -179.947 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' TRP . . . . . 0.598 ' C ' HD23 ' A' ' 37' ' ' LEU . 98.0 m95 -122.9 136.36 54.83 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.744 0.307 . . . . 64.52 110.953 -179.958 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.712 HD11 ' CG ' ' A' ' 52' ' ' GLU . 1.4 mt -118.71 131.93 56.15 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.297 -0.411 . . . . 73.5 110.85 -179.985 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.657 HG22 HD23 ' A' ' 49' ' ' LEU . 23.4 t -81.34 109.35 15.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.151 -0.477 . . . . 71.11 111.116 179.804 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.633 ' HB2' HD13 ' A' ' 28' ' ' ILE . . . -132.71 165.4 24.59 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.16 -0.473 . . . . 75.33 111.084 179.847 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -115.93 156.32 26.42 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.216 -0.447 . . . . 71.31 110.907 -179.97 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 41' ' ' ASN . . . . . 0.633 ' HA ' HG12 ' A' ' 26' ' ' VAL . 0.0 OUTLIER -69.77 179.33 2.23 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.138 -0.483 . . . . 74.12 110.873 -179.904 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 61.3 tt0 -63.5 -39.8 95.4 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.223 -0.444 . . . . 63.53 110.956 179.96 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 1.5 t -55.73 -22.77 25.47 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.085 -0.507 . . . . 75.45 110.861 -179.819 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 66.15 11.87 56.47 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.754 -0.736 . . . . 33.22 112.503 -179.967 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 16.5 m -107.75 -18.72 13.75 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.969 0.414 . . . . 60.04 110.841 -179.73 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.631 ' HG3' HD11 ' A' ' 18' ' ' LEU . 4.0 ptmt -117.16 133.68 55.7 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.142 -0.481 . . . . 73.44 110.871 -179.999 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 47' ' ' THR . . . . . 0.423 ' C ' HD12 ' A' ' 18' ' ' LEU . 4.9 m -129.26 152.68 48.56 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.259 -0.428 . . . . 72.1 111.149 179.991 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -177.35 -161.04 25.15 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.744 -0.741 . . . . 75.2 112.515 179.976 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.657 HD23 HG22 ' A' ' 38' ' ' VAL . 6.7 mt -99.53 136.89 38.79 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.833 0.349 . . . . 63.23 110.873 -179.905 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 6.0 m -135.31 153.1 77.81 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.666 0.746 . . . . 51.43 111.116 179.839 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 0.423 ' HD2' HD22 ' A' ' 20' ' ' LEU . 53.6 Cg_endo -69.79 143.85 52.02 Favored 'Trans proline' 0 C--N 1.342 0.195 0 C-N-CA 122.63 2.22 . . . . 73.21 112.325 -179.999 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 52' ' ' GLU . . . . . 0.712 ' CG ' HD11 ' A' ' 37' ' ' LEU . 10.1 tm-20 -91.0 -27.2 18.81 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.221 -0.445 . . . . 71.23 110.874 -179.972 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -87.51 11.71 14.15 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.19 -0.459 . . . . 61.1 110.871 -179.958 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 54' ' ' PHE . . . . . 0.413 ' HB2' ' HG2' ' A' ' 51' ' ' PRO . 1.1 m-85 -121.23 -12.79 8.6 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.141 -0.481 . . . . 74.53 110.833 -179.895 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.548 ' CG1' HD21 ' A' ' 20' ' ' LEU . 17.3 m -116.69 168.73 7.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.141 -0.482 . . . . 71.14 111.14 179.988 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 56' ' ' SER . . . . . 0.663 ' HB2' HD21 ' A' ' 7' ' ' LEU . 45.2 t -138.83 116.52 11.43 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.172 -0.467 . . . . 74.23 110.854 -179.834 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 2.8 m-85 -51.87 134.53 31.21 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.1 -0.5 . . . . 70.43 110.909 -179.902 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.641 HD11 ' HB ' ' A' ' 5' ' ' VAL . 54.2 mt -104.04 146.61 11.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.087 -0.506 . . . . 73.32 111.153 179.905 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 2.5 mt-30 -131.18 160.56 66.44 Favored Pre-proline 0 C--N 1.328 -0.353 0 CA-C-O 121.576 0.703 . . . . 73.31 110.936 179.968 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.81 -48.67 0.66 Allowed 'Trans proline' 0 C--N 1.34 0.129 0 C-N-CA 122.716 2.278 . . . . 73.35 112.332 179.986 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 35.0 mt-10 -154.27 25.01 0.48 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.21 -0.45 . . . . 61.41 110.876 -179.991 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 7.1 mt -115.62 137.8 51.71 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.158 -0.473 . . . . 64.35 110.858 -179.933 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--N 1.33 -0.267 0 CA-C-N 116.17 -0.468 . . . . 72.52 110.917 179.888 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' -9' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.312 0 N-CA-C 112.489 -0.244 . . . . 74.44 112.489 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' B' B ' -8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 57.28 33.78 23.8 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.776 0.322 . . . . 61.14 110.883 -179.982 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' -7' ' ' PHE . . . . . 0.42 ' HB3' HD11 ' A' ' 49' ' ' LEU . 8.8 m-85 -67.78 144.53 55.34 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.255 -0.43 . . . . 54.5 110.886 179.965 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' -6' ' ' ILE . . . . . 0.466 ' O ' HG23 ' B' ' -6' ' ' ILE . 4.5 tt -155.47 84.87 3.47 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-O 121.65 0.738 . . . . 74.55 111.109 179.994 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' -5' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.74 132.21 22.89 Favored 'Trans proline' 0 C--N 1.342 0.202 0 C-N-CA 122.707 2.272 . . . . 63.43 112.351 179.877 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' -4' ' ' SER . . . . . . . . . . . . . 1.4 t -129.74 64.26 1.51 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.224 -0.444 . . . . 74.51 110.866 -179.858 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' -3' ' ' ARG . . . . . . . . . . . . . 4.9 ptm180 -178.32 155.0 0.94 Allowed Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.641 0.734 . . . . 73.42 110.839 -179.91 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' -2' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.76 129.49 17.69 Favored 'Trans proline' 0 C--N 1.342 0.194 0 C-N-CA 122.654 2.236 . . . . 74.32 112.384 179.973 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' -1' ' ' ALA . . . . . 0.506 ' HB1' ' HD2' ' B' ' 0' ' ' PRO . . . -61.34 157.85 41.95 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-O 121.55 0.691 . . . . 73.41 111.135 179.879 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 0' ' ' PRO . . . . . 0.506 ' HD2' ' HB1' ' B' ' -1' ' ' ALA . 53.7 Cg_endo -69.76 -176.24 1.42 Allowed 'Trans proline' 0 C--O 1.231 0.156 0 C-N-CA 122.71 2.273 . . . . 74.34 112.345 -179.985 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 1' ' ' LYS . . . . . . . . . . . . . 37.2 tttp -131.77 137.55 30.55 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-O 121.542 0.687 . . . . 73.23 110.918 179.887 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 2' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.75 162.01 43.73 Favored 'Trans proline' 0 C--O 1.232 0.204 0 C-N-CA 122.725 2.283 . . . . 72.14 112.338 179.941 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 3' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.8 102.55 1.05 Allowed 'Trans proline' 0 C--N 1.341 0.162 0 C-N-CA 122.684 2.256 . . . . 63.01 112.347 179.954 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 4' ' ' SER . . . . . . . . . . . . . 76.3 p -57.65 115.57 2.87 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.199 -0.455 . . . . 74.12 110.868 -179.819 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 5' ' ' SER . . . . . . . . . . . . . 3.3 p -83.52 178.34 8.04 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.119 -0.491 . . . . 74.45 110.872 -179.834 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 6' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.29 0 CA-C-N 116.103 -0.498 . . . . 62.31 111.056 179.909 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' -4' ' ' MET . . . . . . . . . . . . . 2.4 mpp? . . . . . 0 C--O 1.23 0.056 0 CA-C-O 120.825 0.345 . . . . 61.54 110.859 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' -3' ' ' ALA . . . . . . . . . . . . . . . -76.66 -30.63 56.87 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.205 -0.452 . . . . 44.31 111.087 179.892 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' -2' ' ' ILE . . . . . . . . . . . . . 5.3 mp -85.6 126.41 40.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.207 -0.451 . . . . 64.03 111.142 -179.997 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' -1' ' ' VAL . . . . . . . . . . . . . 11.9 p -84.26 -27.4 7.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.192 -0.458 . . . . 73.21 111.123 179.877 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 21.8 m-80 61.72 60.96 1.51 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.215 -0.448 . . . . 72.2 110.904 179.998 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 51.1 tp60 -120.29 127.26 52.21 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.186 -0.461 . . . . 70.12 110.914 -179.967 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 5.5 ptp180 -80.19 160.97 25.45 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.213 -0.448 . . . . 71.21 110.867 -179.886 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -155.42 154.43 31.91 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.204 -0.453 . . . . 74.04 111.116 179.955 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.493 ' HB ' HD11 ' A' ' 58' ' ' ILE . 10.7 p -104.28 149.6 7.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.258 -0.428 . . . . 60.4 111.117 -179.988 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -87.3 110.12 19.99 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.195 -0.457 . . . . 74.25 111.091 179.899 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.749 HD21 ' CB ' ' A' ' 56' ' ' SER . 16.6 mt -74.2 -37.45 63.88 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.226 -0.443 . . . . 60.12 110.912 -179.941 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 5.4 m-85 -142.34 154.87 45.03 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.196 -0.456 . . . . 72.41 110.945 179.992 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 1.6 p30 -78.94 137.49 37.65 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.112 -0.495 . . . . 53.11 110.898 179.882 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 9.9 t80 -138.84 145.49 40.1 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.211 -0.45 . . . . 64.02 110.871 -179.959 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 22.5 tt0 -114.28 135.46 22.2 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 121.617 0.722 . . . . 75.11 110.891 -179.926 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.409 ' HD3' ' HA ' ' A' ' 19' ' ' ARG . 53.2 Cg_endo -69.8 152.62 69.13 Favored 'Trans proline' 0 C--N 1.341 0.162 0 C-N-CA 122.702 2.268 . . . . 71.42 112.353 -179.996 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 22.4 tp10 -116.52 -20.72 9.51 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.205 -0.452 . . . . 72.21 110.898 -179.95 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 7.4 m-80 -106.53 176.04 5.3 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.14 -0.482 . . . . 71.52 110.834 -179.926 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 15.8 m-20 -92.2 21.41 5.15 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.177 -0.465 . . . . 74.34 110.851 179.923 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 1.2 p-10 -141.16 12.51 2.2 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.22 -0.445 . . . . 75.13 110.888 -179.876 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 -101.68 156.05 17.73 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.167 -0.469 . . . . 74.34 110.894 -179.985 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.619 HD12 ' H ' ' A' ' 19' ' ' ARG . 31.5 tp -108.46 144.94 35.4 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.142 -0.481 . . . . 71.21 110.89 -179.949 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 19' ' ' ARG . . . . . 0.619 ' H ' HD12 ' A' ' 18' ' ' LEU . 14.6 mtp180 -81.18 153.09 27.4 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.215 -0.448 . . . . 74.5 110.902 179.935 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.535 HD21 ' CG1' ' A' ' 55' ' ' VAL . 2.6 tp -138.99 148.42 43.44 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.236 -0.438 . . . . 72.24 110.904 -179.944 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.669 ' HB3' ' CG ' ' A' ' 24' ' ' ASP . . . -139.92 137.23 34.63 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.197 -0.456 . . . . 63.3 111.131 179.767 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -50.7 120.03 4.37 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.234 -0.439 . . . . 63.2 110.896 -179.91 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 97.9 -5.77 61.9 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.761 -0.733 . . . . 50.13 112.482 -179.945 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' ASP . . . . . 0.669 ' CG ' ' HB3' ' A' ' 21' ' ' ALA . 1.1 m-20 -81.77 147.29 29.49 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.785 0.326 . . . . 73.22 110.861 -179.944 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 3.4 mm -100.94 142.46 15.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.224 -0.444 . . . . 62.23 111.086 -179.982 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.425 HG11 HD11 ' A' ' 20' ' ' LEU . 1.4 m -145.27 158.24 13.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.181 -0.463 . . . . 43.33 111.128 179.859 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 65.0 m-85 -116.95 108.26 15.57 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.155 -0.475 . . . . 61.35 110.892 -179.964 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.732 HD13 ' HB2' ' A' ' 39' ' ' ALA . 16.5 mm -71.78 103.28 1.36 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.16 -0.473 . . . . 63.32 111.125 179.975 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 11.4 m -65.4 -40.17 93.09 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.119 -0.491 . . . . 72.14 110.833 -179.902 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' TYR . . . . . 0.508 ' CZ ' HG21 ' A' ' 38' ' ' VAL . 36.5 p90 -174.53 150.08 1.36 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.104 -0.498 . . . . 75.42 110.892 -179.873 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 31' ' ' LYS . . . . . 0.448 ' HG3' HD22 ' A' ' 37' ' ' LEU . 13.4 tttt -82.07 144.44 30.82 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.094 -0.503 . . . . 73.13 110.885 179.903 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 31.7 t60 -132.75 156.15 47.59 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.244 -0.434 . . . . 74.31 110.858 179.919 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -61.21 -174.31 1.34 Allowed Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.771 -0.728 . . . . 43.42 112.42 -179.926 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 63.1 mm-40 65.35 12.84 8.4 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.852 0.358 . . . . 64.43 110.946 -179.885 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 68.41 28.98 72.95 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.697 -0.763 . . . . 54.22 112.499 -179.997 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' TRP . . . . . 0.616 ' C ' HD23 ' A' ' 37' ' ' LEU . 98.8 m95 -123.45 137.54 54.77 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.857 0.36 . . . . 75.04 110.894 -179.912 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.748 HD11 ' CG ' ' A' ' 52' ' ' GLU . 0.6 OUTLIER -121.9 130.47 53.38 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.215 -0.448 . . . . 75.25 110.896 179.979 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.508 HG21 ' CZ ' ' A' ' 30' ' ' TYR . 42.8 t -77.32 116.01 20.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.175 -0.466 . . . . 61.24 111.087 179.845 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.732 ' HB2' HD13 ' A' ' 28' ' ' ILE . . . -138.05 161.79 35.83 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.18 -0.464 . . . . 65.21 111.101 179.85 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 1.2 pt-20 -113.45 156.86 22.76 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.209 -0.45 . . . . 72.52 110.867 -179.923 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -72.4 -176.26 1.82 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.13 -0.486 . . . . 74.04 110.883 -179.932 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 9.6 tt0 -68.16 -38.5 82.18 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.188 -0.46 . . . . 63.01 110.908 -179.975 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 1.5 t -57.02 -22.22 37.08 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.137 -0.483 . . . . 50.03 110.83 -179.827 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 65.8 12.77 57.84 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.737 -0.744 . . . . 75.31 112.483 -179.993 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -109.13 -15.99 14.2 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.972 0.415 . . . . 71.32 110.863 -179.779 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -120.11 135.08 55.08 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.137 -0.483 . . . . 74.0 110.941 179.949 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 5.6 m -136.36 140.28 43.15 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.252 -0.431 . . . . 72.11 111.156 179.985 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -161.8 -153.7 7.19 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.743 -0.741 . . . . 61.03 112.472 -179.997 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.448 HD11 ' HB3' ' B' ' -7' ' ' PHE . 9.0 mt -104.05 135.0 46.37 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.818 0.342 . . . . 71.14 110.928 -179.932 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 10.2 m -133.94 153.02 79.6 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 121.604 0.716 . . . . 54.5 111.152 179.825 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 0.414 ' HG2' ' HB2' ' A' ' 54' ' ' PHE . 53.3 Cg_endo -69.81 147.78 63.29 Favored 'Trans proline' 0 C--N 1.341 0.161 0 C-N-CA 122.618 2.212 . . . . 71.32 112.337 180.0 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 52' ' ' GLU . . . . . 0.748 ' CG ' HD11 ' A' ' 37' ' ' LEU . 15.5 tm-20 -92.77 -28.91 16.3 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.211 -0.45 . . . . 61.21 110.886 -179.97 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -86.59 10.55 15.14 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.15 -0.477 . . . . 62.33 110.881 -179.917 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 54' ' ' PHE . . . . . 0.414 ' HB2' ' HG2' ' A' ' 51' ' ' PRO . 0.9 OUTLIER -121.31 -4.31 9.42 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.152 -0.476 . . . . 72.44 110.852 -179.902 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.535 ' CG1' HD21 ' A' ' 20' ' ' LEU . 16.0 m -125.93 166.61 21.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.169 -0.468 . . . . 63.21 111.155 179.94 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 56' ' ' SER . . . . . 0.749 ' CB ' HD21 ' A' ' 7' ' ' LEU . 30.0 t -136.21 118.99 16.14 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.166 -0.47 . . . . 71.31 110.888 -179.836 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 -57.71 128.22 35.98 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.161 -0.472 . . . . 65.12 110.901 -179.847 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.493 HD11 ' HB ' ' A' ' 5' ' ' VAL . 49.6 mt -94.69 148.19 5.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.165 -0.47 . . . . 55.04 111.127 179.918 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 2.5 mt-30 -131.12 160.75 65.51 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.573 0.702 . . . . 74.41 110.957 179.923 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.77 -49.0 0.6 Allowed 'Trans proline' 0 C--N 1.341 0.162 0 C-N-CA 122.691 2.26 . . . . 73.45 112.345 -179.995 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 61.0 mt-10 -153.03 24.23 0.56 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.249 -0.432 . . . . 64.23 110.886 -179.997 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 6.8 mt -115.5 27.17 9.52 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.153 -0.476 . . . . 64.44 110.92 -179.999 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 29.5 tt0 . . . . . 0 C--N 1.329 -0.288 0 CA-C-N 116.135 -0.484 . . . . 74.43 110.852 179.897 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' B' B ' -9' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.314 0 N-CA-C 112.467 -0.253 . . . . 62.3 112.467 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' B' B ' -8' ' ' LYS . . . . . . . . . . . . . 23.2 mtmm -93.61 -44.23 8.3 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.768 0.318 . . . . 70.4 110.85 -179.954 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' -7' ' ' PHE . . . . . 0.448 ' HB3' HD11 ' A' ' 49' ' ' LEU . 18.0 m-85 -84.04 154.42 23.26 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.232 -0.44 . . . . 60.14 110.855 179.994 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' -6' ' ' ILE . . . . . . . . . . . . . 58.8 mt -149.91 93.33 3.96 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 121.59 0.71 . . . . 55.42 111.124 179.954 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' -5' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.75 122.1 8.78 Favored 'Trans proline' 0 C--O 1.232 0.178 0 C-N-CA 122.637 2.225 . . . . 61.1 112.351 179.894 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' -4' ' ' SER . . . . . . . . . . . . . 22.7 m -117.18 59.95 0.76 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.254 -0.43 . . . . 41.5 110.893 -179.868 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' -3' ' ' ARG . . . . . . . . . . . . . 8.8 ptm180 -176.69 153.36 1.15 Allowed Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 121.634 0.731 . . . . 73.3 110.867 -179.927 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' -2' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.77 145.56 57.42 Favored 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.661 2.24 . . . . 73.03 112.323 -179.964 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' -1' ' ' ALA . . . . . . . . . . . . . . . -75.93 141.92 72.18 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.567 0.699 . . . . 34.34 111.105 179.848 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 0' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.75 175.13 8.5 Favored 'Trans proline' 0 C--N 1.341 0.169 0 C-N-CA 122.712 2.275 . . . . 74.11 112.36 179.959 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 1' ' ' LYS . . . . . . . . . . . . . 16.7 ptmt -124.31 152.71 68.27 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-O 121.551 0.691 . . . . 72.25 110.93 179.891 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 2' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.7 163.54 37.83 Favored 'Trans proline' 0 C--O 1.232 0.202 0 C-N-CA 122.744 2.296 . . . . 71.41 112.349 179.877 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 3' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.71 167.96 22.87 Favored 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.741 2.294 . . . . 62.24 112.341 179.906 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 4' ' ' SER . . . . . . . . . . . . . 55.3 p -70.4 131.47 44.14 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.202 -0.453 . . . . 64.24 110.842 -179.86 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 5' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -127.85 128.21 44.81 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.139 -0.482 . . . . 63.44 110.847 -179.849 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 6' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.295 0 CA-C-N 116.115 -0.493 . . . . 72.1 111.087 179.875 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' -4' ' ' MET . . . . . . . . . . . . . 2.7 ptt? . . . . . 0 C--O 1.23 0.058 0 CA-C-O 120.777 0.322 . . . . 73.33 110.869 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' -3' ' ' ALA . . . . . . . . . . . . . . . -97.64 54.83 1.19 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.23 -0.441 . . . . 54.11 111.086 179.937 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' -2' ' ' ILE . . . . . . . . . . . . . 5.4 mp -136.5 129.25 45.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.212 -0.449 . . . . 74.21 111.139 179.997 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' -1' ' ' VAL . . . . . . . . . . . . . 14.9 p -97.35 -25.18 4.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.194 -0.457 . . . . 62.32 111.151 179.83 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 16.4 m120 60.02 60.32 2.16 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.162 -0.472 . . . . 65.31 110.892 -179.982 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 40.2 tp60 -115.41 128.49 56.09 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.148 -0.478 . . . . 71.41 110.899 -179.965 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 5.0 ptp180 -76.83 160.39 29.3 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.189 -0.46 . . . . 75.33 110.835 -179.898 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -155.33 149.83 26.17 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.208 -0.451 . . . . 51.14 111.094 179.913 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.611 ' HB ' HD11 ' A' ' 58' ' ' ILE . 8.7 p -105.41 142.21 19.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.25 -0.432 . . . . 70.11 111.14 179.985 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 6' ' ' ALA . . . . . 0.439 ' HA ' HG12 ' A' ' 55' ' ' VAL . . . -82.94 127.74 33.81 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.178 -0.465 . . . . 65.35 111.093 179.866 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.512 HD21 ' CB ' ' A' ' 56' ' ' SER . 7.6 mt -93.23 -31.68 14.65 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.221 -0.445 . . . . 72.23 110.889 -179.985 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 4.5 m-85 -144.18 136.12 26.22 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.185 -0.461 . . . . 50.44 110.924 -179.96 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 3.4 p30 -62.3 141.68 58.15 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.153 -0.476 . . . . 63.03 110.852 179.911 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 24.1 t80 -141.87 145.87 35.14 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.193 -0.458 . . . . 63.34 110.895 -179.918 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 28.6 tt0 -115.64 137.0 22.91 Favored Pre-proline 0 C--N 1.33 -0.257 0 CA-C-O 121.657 0.741 . . . . 64.04 110.912 -179.945 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.73 146.43 60.31 Favored 'Trans proline' 0 C--N 1.341 0.181 0 C-N-CA 122.687 2.258 . . . . 71.23 112.35 -179.961 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 7.3 mm-40 -107.87 -12.74 15.13 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.267 -0.424 . . . . 75.21 110.886 180.0 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 28.6 m-80 -118.98 175.48 5.74 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.185 -0.461 . . . . 71.44 110.906 -179.97 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 63.7 m-20 -90.83 15.87 10.44 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.206 -0.452 . . . . 53.53 110.833 -179.993 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 1.1 p-10 -134.08 16.74 3.81 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.192 -0.458 . . . . 72.43 110.873 -179.888 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 3.9 mm-40 -106.98 160.84 15.23 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.149 -0.478 . . . . 74.3 110.867 -179.969 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.649 HD21 ' HD2' ' A' ' 46' ' ' LYS . 0.5 OUTLIER -111.44 142.86 43.15 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.147 -0.479 . . . . 75.15 110.954 179.994 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 19' ' ' ARG . . . . . 0.553 ' H ' HD23 ' A' ' 18' ' ' LEU . 36.2 mtm-85 -78.44 156.8 29.21 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.21 -0.45 . . . . 73.42 110.872 179.981 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.539 HD22 ' HD2' ' A' ' 51' ' ' PRO . 3.1 tp -141.65 148.85 39.81 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.165 -0.47 . . . . 74.52 110.914 -179.993 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.436 ' O ' ' HB3' ' A' ' 6' ' ' ALA . . . -138.56 139.9 38.84 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.214 -0.448 . . . . 72.42 111.119 179.73 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -53.64 119.31 4.75 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.215 -0.448 . . . . 73.24 110.888 -179.917 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 93.16 0.83 67.54 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.726 -0.749 . . . . 55.23 112.469 -179.978 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 20.5 t70 -77.2 158.73 30.16 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.809 0.338 . . . . 75.32 110.84 -179.948 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 1.7 mm -111.14 121.32 63.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.164 -0.471 . . . . 74.4 111.168 179.996 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.523 HG11 HD11 ' A' ' 20' ' ' LEU . 3.7 m -130.59 155.7 41.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.25 -0.432 . . . . 72.34 111.16 179.827 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 66.2 m-85 -115.56 109.08 17.27 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.218 -0.446 . . . . 72.35 110.895 -179.94 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.744 HD13 ' HB2' ' A' ' 39' ' ' ALA . 16.5 mm -73.0 103.8 1.89 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.133 -0.485 . . . . 63.34 111.11 -179.989 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 2.6 m -64.48 -39.56 94.03 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.196 -0.456 . . . . 55.12 110.848 -179.882 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' TYR . . . . . 0.482 ' CZ ' HG21 ' A' ' 38' ' ' VAL . 32.5 p90 -174.1 146.79 1.19 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.124 -0.489 . . . . 73.2 110.946 -179.902 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 31' ' ' LYS . . . . . 0.489 ' HG3' HD22 ' A' ' 37' ' ' LEU . 21.0 tttt -80.2 146.27 31.84 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.119 -0.492 . . . . 74.13 110.917 179.935 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 31.8 t60 -136.53 152.74 50.85 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.246 -0.434 . . . . 63.14 110.809 179.941 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -58.19 -174.96 0.48 Allowed Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.76 -0.733 . . . . 51.12 112.491 -179.98 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 56.4 mm-40 65.88 12.2 8.21 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.777 0.322 . . . . 74.21 110.856 -179.92 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 68.12 28.73 73.26 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.721 -0.752 . . . . 62.03 112.475 179.995 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' TRP . . . . . 0.612 ' C ' HD23 ' A' ' 37' ' ' LEU . 98.6 m95 -122.76 136.18 54.79 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.797 0.332 . . . . 71.23 110.913 -179.921 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.684 HD11 ' CG ' ' A' ' 52' ' ' GLU . 0.6 OUTLIER -122.74 130.78 53.33 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.225 -0.443 . . . . 72.34 110.888 179.983 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.482 HG21 ' CZ ' ' A' ' 30' ' ' TYR . 40.7 t -78.72 111.71 15.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.155 -0.475 . . . . 63.12 111.152 179.808 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.744 ' HB2' HD13 ' A' ' 28' ' ' ILE . . . -131.57 168.28 17.95 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.167 -0.469 . . . . 62.13 111.054 179.915 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 40' ' ' GLU . . . . . 0.407 ' HA ' ' HA ' ' A' ' 47' ' ' THR . 0.8 OUTLIER -121.92 159.39 26.98 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.153 -0.476 . . . . 72.04 110.893 -179.931 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 41.7 p-10 -58.57 -174.82 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.131 -0.486 . . . . 74.43 110.901 -179.936 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 66.5 tt0 -78.03 -37.18 47.48 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.215 -0.448 . . . . 73.14 110.919 179.996 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 37.3 t -70.64 -22.32 62.52 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.146 -0.479 . . . . 60.15 110.892 -179.834 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 75.93 26.52 64.4 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.754 -0.736 . . . . 75.22 112.466 179.985 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 8.6 t -107.18 -20.66 13.23 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.915 0.388 . . . . 72.31 110.872 -179.753 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.649 ' HD2' HD21 ' A' ' 18' ' ' LEU . 0.0 OUTLIER -127.27 137.58 52.89 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.138 -0.483 . . . . 55.42 110.893 179.924 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 47' ' ' THR . . . . . 0.407 ' HA ' ' HA ' ' A' ' 40' ' ' GLU . 20.9 m -131.27 149.68 52.47 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.193 -0.458 . . . . 74.15 111.148 179.913 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 48' ' ' GLY . . . . . 0.557 ' N ' HD12 ' A' ' 18' ' ' LEU . . . -173.5 -162.16 24.94 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.726 -0.749 . . . . 73.51 112.448 179.975 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.445 HD23 HG22 ' A' ' 38' ' ' VAL . 10.4 mt -96.67 139.18 33.12 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.815 0.341 . . . . 74.2 110.972 -179.941 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.414 HG22 ' O ' ' A' ' 37' ' ' LEU . 11.5 m -137.3 152.96 74.36 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.664 0.745 . . . . 73.15 111.116 179.859 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 0.539 ' HD2' HD22 ' A' ' 20' ' ' LEU . 53.9 Cg_endo -69.81 147.78 63.31 Favored 'Trans proline' 0 C--N 1.341 0.18 0 C-N-CA 122.668 2.246 . . . . 72.5 112.311 179.959 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 52' ' ' GLU . . . . . 0.684 ' CG ' HD11 ' A' ' 37' ' ' LEU . 23.8 tt0 -93.11 -29.21 15.88 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.204 -0.453 . . . . 75.11 110.88 -179.987 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -85.72 7.97 21.57 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.149 -0.478 . . . . 65.1 110.887 -179.922 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 54' ' ' PHE . . . . . 0.428 ' HB2' ' HG2' ' A' ' 51' ' ' PRO . 1.1 m-85 -119.57 3.3 11.21 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.129 -0.487 . . . . 64.22 110.865 -179.902 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.532 ' CG1' HD21 ' A' ' 20' ' ' LEU . 21.3 m -134.62 164.55 33.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.119 -0.492 . . . . 55.3 111.161 179.959 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 56' ' ' SER . . . . . 0.512 ' CB ' HD21 ' A' ' 7' ' ' LEU . 32.2 t -136.36 118.61 15.58 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.18 -0.464 . . . . 65.45 110.837 -179.885 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 3.0 m-85 -54.32 135.2 45.08 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.144 -0.48 . . . . 74.14 110.921 -179.886 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.611 HD11 ' HB ' ' A' ' 5' ' ' VAL . 31.0 mt -101.92 150.74 6.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.088 -0.505 . . . . 74.25 111.144 179.918 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 1.6 mt-30 -131.11 161.0 64.35 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.672 0.748 . . . . 75.1 110.907 179.93 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.76 -48.4 0.73 Allowed 'Trans proline' 0 C--N 1.342 0.219 0 C-N-CA 122.684 2.256 . . . . 74.0 112.353 -179.98 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 6.0 tp10 -153.93 26.14 0.49 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.186 -0.461 . . . . 74.22 110.886 179.999 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 7.4 mt -114.87 155.34 27.01 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.125 -0.489 . . . . 72.21 110.918 -179.978 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--N 1.329 -0.285 0 CA-C-N 116.193 -0.458 . . . . 64.23 110.851 179.921 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' -9' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.368 0 N-CA-C 112.519 -0.232 . . . . 52.21 112.519 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' B' B ' -8' ' ' LYS . . . . . . . . . . . . . 45.6 tttm -120.13 54.0 1.05 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.808 0.337 . . . . 72.12 110.931 -179.976 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' -7' ' ' PHE . . . . . 0.401 ' O ' HD13 ' B' ' -6' ' ' ILE . 5.8 m-85 -105.1 131.64 52.35 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.231 -0.44 . . . . 63.42 110.823 -179.95 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' -6' ' ' ILE . . . . . 0.401 HD13 ' O ' ' B' ' -7' ' ' PHE . 34.2 mm -145.45 88.57 6.58 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-O 121.673 0.749 . . . . 63.14 111.139 179.967 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' -5' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.82 130.36 19.13 Favored 'Trans proline' 0 C--N 1.342 0.192 0 C-N-CA 122.702 2.268 . . . . 32.43 112.313 179.943 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' -4' ' ' SER . . . . . . . . . . . . . 27.4 t -129.4 65.56 1.47 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.165 -0.47 . . . . 72.22 110.86 -179.819 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' -3' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -179.74 154.98 0.72 Allowed Pre-proline 0 C--N 1.329 -0.326 0 CA-C-O 121.578 0.704 . . . . 71.14 110.914 -179.931 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' -2' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.74 131.74 21.89 Favored 'Trans proline' 0 C--N 1.341 0.155 0 C-N-CA 122.686 2.257 . . . . 72.34 112.347 179.974 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' -1' ' ' ALA . . . . . . . . . . . . . . . -65.16 151.91 92.73 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-O 121.526 0.679 . . . . 73.23 111.094 179.891 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 0' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.75 176.63 6.5 Favored 'Trans proline' 0 C--O 1.232 0.181 0 C-N-CA 122.651 2.234 . . . . 74.44 112.359 -179.989 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 1' ' ' LYS . . . . . . . . . . . . . 12.3 pttp -125.57 155.07 72.7 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.543 0.687 . . . . 74.05 110.91 179.886 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 2' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -69.74 163.89 36.57 Favored 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.668 2.246 . . . . 73.25 112.35 179.863 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 3' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.74 -26.91 27.22 Favored 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.691 2.26 . . . . 75.5 112.342 179.92 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 4' ' ' SER . . . . . . . . . . . . . 15.0 t -94.19 159.03 15.32 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.267 -0.424 . . . . 53.24 110.86 -179.856 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 5' ' ' SER . . . . . . . . . . . . . 13.6 t -134.77 144.22 47.56 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.106 -0.497 . . . . 71.03 110.84 -179.828 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 6' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.33 -0.272 0 CA-C-N 116.113 -0.494 . . . . 71.04 111.086 179.897 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' -4' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.23 0.073 0 CA-C-O 120.771 0.319 . . . . 60.42 110.834 . . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' -3' ' ' ALA . . . . . . . . . . . . . . . -78.19 90.49 4.3 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.248 -0.433 . . . . 71.41 111.141 179.897 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' -2' ' ' ILE . . . . . . . . . . . . . 76.7 mt -139.65 116.48 9.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.208 -0.451 . . . . 71.24 111.119 -179.996 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' -1' ' ' VAL . . . . . . . . . . . . . 51.6 t -68.02 -30.89 49.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.163 -0.471 . . . . 51.15 111.189 179.826 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 2.4 t-20 63.05 54.03 2.21 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.126 -0.488 . . . . 64.14 110.893 -179.985 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 48.4 tp60 -109.36 123.66 49.69 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.17 -0.468 . . . . 75.44 110.932 179.964 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 5.2 ptp180 -73.87 162.99 28.52 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.172 -0.467 . . . . 73.45 110.881 -179.931 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -156.61 153.8 29.18 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.198 -0.455 . . . . 62.13 111.133 179.911 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.516 ' HB ' HD11 ' A' ' 58' ' ' ILE . 10.7 p -103.96 149.63 7.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.224 -0.444 . . . . 64.51 111.169 179.937 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -88.68 106.06 18.09 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.193 -0.458 . . . . 51.22 111.082 179.877 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.726 HD21 ' CB ' ' A' ' 56' ' ' SER . 15.4 mt -71.33 -36.66 71.63 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.199 -0.455 . . . . 64.22 110.957 179.98 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 4.0 m-85 -143.56 152.65 41.69 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.211 -0.449 . . . . 61.53 110.886 -180.0 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 2.4 p30 -75.29 140.64 43.26 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.069 -0.514 . . . . 64.44 110.903 179.903 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 7.2 t80 -147.18 145.34 29.48 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.195 -0.457 . . . . 75.35 110.904 -179.852 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -114.06 144.61 31.93 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.641 0.734 . . . . 75.12 110.912 -179.949 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.82 148.75 65.36 Favored 'Trans proline' 0 C--N 1.341 0.144 0 C-N-CA 122.688 2.259 . . . . 61.52 112.356 -179.996 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 10.6 tp10 -109.87 -19.72 13.02 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.171 -0.468 . . . . 75.32 110.847 -179.911 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 10.7 m120 -110.95 176.3 5.08 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.173 -0.467 . . . . 63.11 110.844 -179.905 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -90.84 21.08 4.31 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.136 -0.484 . . . . 73.51 110.918 179.884 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -142.35 13.44 1.98 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.147 -0.479 . . . . 73.33 110.896 -179.893 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 17.0 mt-10 -102.43 158.25 16.34 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.163 -0.471 . . . . 74.32 110.906 -179.981 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.612 HD23 ' O ' ' A' ' 19' ' ' ARG . 0.4 OUTLIER -105.9 155.78 19.01 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.204 -0.453 . . . . 75.15 110.909 -179.97 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 19' ' ' ARG . . . . . 0.612 ' O ' HD23 ' A' ' 18' ' ' LEU . 0.9 OUTLIER -92.04 153.69 19.25 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.137 -0.483 . . . . 72.44 110.83 -179.965 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.589 HD21 ' CG1' ' A' ' 55' ' ' VAL . 2.3 tp -137.05 149.72 47.6 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.236 -0.438 . . . . 72.44 110.945 -179.995 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.679 ' HB3' ' CG ' ' A' ' 24' ' ' ASP . . . -142.9 136.9 29.1 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.207 -0.451 . . . . 44.21 111.116 179.793 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -50.15 119.98 4.09 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.235 -0.438 . . . . 75.12 110.855 -179.883 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 96.34 -0.91 62.04 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.749 -0.739 . . . . 54.23 112.473 -179.971 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 24' ' ' ASP . . . . . 0.679 ' CG ' ' HB3' ' A' ' 21' ' ' ALA . 1.1 m-20 -86.99 147.26 25.81 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.751 0.31 . . . . 70.02 110.853 -179.966 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 3.3 mm -102.59 142.08 17.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.221 -0.445 . . . . 73.02 111.155 179.987 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -143.22 159.45 17.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.196 -0.456 . . . . 72.2 111.145 179.876 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 44.0 m-85 -116.59 107.09 14.28 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.216 -0.447 . . . . 73.21 110.851 -179.953 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.792 HD13 ' HB2' ' A' ' 39' ' ' ALA . 17.6 mm -72.63 103.05 1.55 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.158 -0.474 . . . . 74.45 111.109 179.993 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 3.0 m -64.29 -39.32 93.7 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.161 -0.472 . . . . 52.41 110.861 -179.92 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 30' ' ' TYR . . . . . 0.498 ' CZ ' HG21 ' A' ' 38' ' ' VAL . 32.9 p90 -174.75 147.34 1.02 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.109 -0.496 . . . . 64.4 110.898 -179.828 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 31' ' ' LYS . . . . . 0.512 ' HG3' HD22 ' A' ' 37' ' ' LEU . 11.9 tttm -81.45 145.98 30.48 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.09 -0.504 . . . . 42.13 110.865 179.922 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 32.1 t60 -135.68 152.04 50.8 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.211 -0.45 . . . . 75.35 110.894 179.873 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -57.78 -175.35 0.44 Allowed Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.728 -0.749 . . . . 32.04 112.511 -179.986 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 4.4 mp0 66.55 11.94 8.42 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.826 0.346 . . . . 64.3 110.869 -179.908 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 68.18 28.82 73.19 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.751 -0.738 . . . . 74.52 112.507 -179.973 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 36' ' ' TRP . . . . . 0.58 ' C ' HD23 ' A' ' 37' ' ' LEU . 97.8 m95 -122.74 134.95 54.43 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.796 0.332 . . . . 75.31 110.902 -179.92 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.685 HD11 ' CG ' ' A' ' 52' ' ' GLU . 0.9 OUTLIER -121.73 132.61 54.72 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.241 -0.436 . . . . 63.23 110.9 179.983 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.498 HG21 ' CZ ' ' A' ' 30' ' ' TYR . 46.1 t -79.79 109.59 14.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.207 -0.451 . . . . 73.04 111.125 179.839 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.792 ' HB2' HD13 ' A' ' 28' ' ' ILE . . . -129.46 161.65 29.9 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.199 -0.455 . . . . 73.21 111.083 179.884 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 2.3 pm0 -118.51 158.38 25.48 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.204 -0.453 . . . . 75.24 110.936 -179.98 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 46.3 p-10 -58.16 -175.08 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.166 -0.47 . . . . 51.24 110.896 -179.946 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 15.6 tm-20 -78.01 -35.44 49.9 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.176 -0.465 . . . . 62.53 110.921 -179.99 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 40.1 t -69.59 -21.89 63.56 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.131 -0.486 . . . . 62.11 110.903 -179.826 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 76.33 26.13 64.39 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.71 -0.757 . . . . 33.04 112.529 -179.968 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -111.98 -22.51 11.01 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.926 0.393 . . . . 65.1 110.881 -179.747 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.601 ' HG2' HD11 ' A' ' 18' ' ' LEU . 3.0 ttmt -117.89 130.24 56.12 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.135 -0.484 . . . . 65.22 110.904 179.93 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 47' ' ' THR . . . . . 0.422 ' C ' HD12 ' A' ' 18' ' ' LEU . 4.6 m -127.77 150.36 49.84 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.251 -0.431 . . . . 74.54 111.163 179.927 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -177.69 -160.18 23.87 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.757 -0.735 . . . . 65.45 112.489 179.994 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.475 HD11 ' HB3' ' B' ' -7' ' ' PHE . 3.6 mt -102.04 141.15 35.33 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.874 0.368 . . . . 73.43 110.892 -179.95 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.442 ' HB ' ' HD2' ' A' ' 51' ' ' PRO . 16.1 m -138.11 154.5 74.17 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.611 0.719 . . . . 61.53 111.138 179.826 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 0.442 ' HD2' ' HB ' ' A' ' 50' ' ' VAL . 53.3 Cg_endo -69.74 143.14 49.99 Favored 'Trans proline' 0 C--N 1.341 0.132 0 C-N-CA 122.708 2.272 . . . . 73.35 112.315 179.976 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 52' ' ' GLU . . . . . 0.685 ' CG ' HD11 ' A' ' 37' ' ' LEU . 27.1 tt0 -90.5 -27.55 19.13 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.194 -0.457 . . . . 73.42 110.854 -179.947 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -86.19 9.61 17.04 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.17 -0.468 . . . . 73.41 110.923 -179.969 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 54' ' ' PHE . . . . . 0.407 ' HB2' ' HG2' ' A' ' 51' ' ' PRO . 1.1 m-85 -119.85 -13.75 9.04 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.124 -0.489 . . . . 63.25 110.852 -179.912 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.589 ' CG1' HD21 ' A' ' 20' ' ' LEU . 21.8 m -114.7 167.45 7.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.169 -0.469 . . . . 74.31 111.113 179.967 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 56' ' ' SER . . . . . 0.726 ' CB ' HD21 ' A' ' 7' ' ' LEU . 42.9 t -139.23 116.27 10.98 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.167 -0.469 . . . . 70.45 110.869 -179.899 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 2.6 m-85 -53.35 133.94 40.0 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.134 -0.484 . . . . 74.33 110.951 -179.913 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.516 HD11 ' HB ' ' A' ' 5' ' ' VAL . 39.4 mt -102.58 150.24 6.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.109 -0.496 . . . . 71.45 111.114 179.975 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 59' ' ' GLN . . . . . 0.403 ' HB2' ' HD2' ' A' ' 60' ' ' PRO . 0.1 OUTLIER -95.31 154.97 39.31 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-O 121.607 0.718 . . . . 71.55 110.94 179.925 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 60' ' ' PRO . . . . . 0.403 ' HD2' ' HB2' ' A' ' 59' ' ' GLN . 53.8 Cg_endo -69.76 -47.62 0.89 Allowed 'Trans proline' 0 C--N 1.341 0.165 0 C-N-CA 122.69 2.26 . . . . 72.1 112.321 179.985 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -161.39 39.02 0.14 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.262 -0.427 . . . . 63.42 110.912 -179.969 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 17.9 mt -102.98 -173.58 2.35 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.143 -0.481 . . . . 74.25 110.892 -179.969 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 3.0 tt0 . . . . . 0 C--N 1.33 -0.259 0 CA-C-N 116.175 -0.466 . . . . 74.32 110.913 179.92 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' B' B ' -9' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.339 0 N-CA-C 112.487 -0.245 . . . . 52.12 112.487 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' B' B ' -8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -114.86 -22.09 9.8 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.769 0.318 . . . . 65.4 110.893 -179.957 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' -7' ' ' PHE . . . . . 0.475 ' HB3' HD11 ' A' ' 49' ' ' LEU . 19.6 m-85 -57.49 168.46 0.81 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.232 -0.44 . . . . 74.33 110.919 179.954 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' -6' ' ' ILE . . . . . 0.442 ' O ' HG23 ' B' ' -6' ' ' ILE . 4.5 tt -173.52 90.05 0.37 Allowed Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 121.691 0.758 . . . . 72.54 111.118 179.996 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' -5' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.75 134.48 28.09 Favored 'Trans proline' 0 C--N 1.342 0.209 0 C-N-CA 122.662 2.241 . . . . 63.4 112.382 179.853 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' -4' ' ' SER . . . . . . . . . . . . . 33.1 t -134.37 66.5 1.54 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.214 -0.448 . . . . 53.33 110.834 -179.845 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' -3' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 179.87 155.34 0.69 Allowed Pre-proline 0 C--N 1.328 -0.34 0 CA-C-O 121.609 0.718 . . . . 75.13 110.905 -179.968 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' -2' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.8 123.14 9.79 Favored 'Trans proline' 0 N--CA 1.465 -0.187 0 C-N-CA 122.668 2.246 . . . . 64.55 112.331 -179.95 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' -1' ' ' ALA . . . . . . . . . . . . . . . -50.99 152.6 3.62 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-O 121.561 0.696 . . . . 53.53 111.1 179.886 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 0' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.76 165.15 31.94 Favored 'Trans proline' 0 C--N 1.341 0.166 0 C-N-CA 122.683 2.256 . . . . 73.52 112.367 179.959 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 1' ' ' LYS . . . . . . . . . . . . . 3.9 tppt? -116.02 135.93 22.86 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-O 121.594 0.711 . . . . 75.35 110.87 179.935 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 2' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.7 159.82 52.04 Favored 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.676 2.251 . . . . 72.52 112.337 179.856 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 3' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.78 -171.81 0.51 Allowed 'Trans proline' 0 C--N 1.342 0.212 0 C-N-CA 122.654 2.236 . . . . 74.42 112.373 179.903 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 4' ' ' SER . . . . . . . . . . . . . 57.7 m -98.33 122.77 41.91 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.228 -0.442 . . . . 73.15 110.881 -179.867 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 5' ' ' SER . . . . . . . . . . . . . 28.9 t -146.91 129.93 16.37 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.133 -0.485 . . . . 74.3 110.871 -179.824 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 6' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.307 0 CA-C-N 116.135 -0.484 . . . . 74.4 111.049 179.964 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' -4' ' ' MET . . . . . . . . . . . . . 4.0 mmt . . . . . 0 C--O 1.23 0.078 0 CA-C-O 120.763 0.316 . . . . 72.22 110.911 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' -3' ' ' ALA . . . . . . . . . . . . . . . -133.94 41.32 3.01 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.253 -0.431 . . . . 75.32 111.121 179.873 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' -2' ' ' ILE . . . . . 0.453 HG23 ' O ' ' A' ' 29' ' ' SER . 37.7 mm -106.24 123.18 60.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.246 -0.434 . . . . 73.32 111.127 -179.988 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' -1' ' ' VAL . . . . . . . . . . . . . 25.0 t -75.85 -36.48 32.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.2 -0.454 . . . . 64.31 111.169 179.816 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 63.84 50.07 2.71 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.177 -0.465 . . . . 74.21 110.892 179.993 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 49.4 tp60 -103.24 127.95 50.39 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.203 -0.453 . . . . 53.41 110.883 -179.978 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -73.4 158.59 34.71 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.172 -0.467 . . . . 72.04 110.878 -179.917 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -154.72 154.06 32.28 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.19 -0.459 . . . . 73.03 111.066 179.905 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.517 ' HB ' HD11 ' A' ' 58' ' ' ILE . 10.9 p -104.14 152.22 6.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.208 -0.451 . . . . 73.52 111.126 179.984 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -91.83 121.48 33.48 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.198 -0.456 . . . . 65.43 111.129 179.813 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.597 HD21 ' HB3' ' A' ' 56' ' ' SER . 12.6 mt -85.99 -33.82 20.98 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.22 -0.445 . . . . 73.35 110.886 -179.985 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 5.1 m-85 -144.98 142.59 29.93 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.224 -0.443 . . . . 72.01 110.941 -179.979 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 1.9 p-10 -67.46 140.66 57.11 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.132 -0.486 . . . . 74.14 110.892 179.899 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 15.5 t80 -140.94 146.53 37.48 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.182 -0.463 . . . . 72.51 110.918 -179.906 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -115.58 137.37 23.13 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-O 121.632 0.73 . . . . 74.33 110.866 -179.913 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.79 151.59 68.92 Favored 'Trans proline' 0 N--CA 1.465 -0.154 0 C-N-CA 122.701 2.267 . . . . 63.11 112.373 179.987 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 4.2 mt-10 -109.69 -19.44 13.17 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.232 -0.44 . . . . 64.44 110.917 -179.995 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 15.4 m120 -123.63 175.0 7.08 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.159 -0.473 . . . . 74.43 110.867 -179.931 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 41.5 m-20 -81.05 -1.14 42.86 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.165 -0.471 . . . . 75.25 110.867 179.937 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -112.47 16.35 19.87 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.216 -0.447 . . . . 72.13 110.885 -179.916 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 6.9 mt-10 -110.39 157.15 19.85 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.181 -0.463 . . . . 70.3 110.871 -179.964 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.554 HD12 ' H ' ' A' ' 19' ' ' ARG . 41.7 tp -112.19 147.79 35.42 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.145 -0.479 . . . . 74.02 110.9 -179.994 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 19' ' ' ARG . . . . . 0.554 ' H ' HD12 ' A' ' 18' ' ' LEU . 32.2 mtm180 -83.17 154.76 24.11 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.196 -0.456 . . . . 75.12 110.86 179.946 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.513 HD21 ' CG1' ' A' ' 55' ' ' VAL . 2.3 tp -142.25 147.94 37.29 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.199 -0.455 . . . . 71.24 110.913 -179.983 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -138.07 139.45 39.54 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.185 -0.461 . . . . 43.34 111.109 179.787 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -51.71 119.58 4.35 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.234 -0.439 . . . . 75.15 110.857 -179.929 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 97.34 -6.72 63.59 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.716 -0.755 . . . . 73.23 112.458 179.987 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -71.39 160.2 33.2 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.752 0.31 . . . . 74.35 110.867 -179.921 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 1.2 mt -123.11 114.04 40.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.205 -0.452 . . . . 74.04 111.122 179.999 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.401 HG11 HD11 ' A' ' 20' ' ' LEU . 12.1 m -117.43 166.92 11.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.12 -0.491 . . . . 73.33 111.131 179.863 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 63.7 m-85 -117.95 106.26 12.76 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.167 -0.469 . . . . 73.45 110.854 -179.943 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.85 HD13 ' HB2' ' A' ' 39' ' ' ALA . 21.3 mm -71.62 103.58 1.38 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.15 -0.477 . . . . 72.24 111.114 179.974 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 29' ' ' SER . . . . . 0.453 ' O ' HG23 ' A' ' -2' ' ' ILE . 10.5 m -65.0 -39.55 93.64 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.208 -0.451 . . . . 71.54 110.856 -179.923 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 30' ' ' TYR . . . . . 0.527 ' CZ ' HG21 ' A' ' 38' ' ' VAL . 54.0 p90 -175.41 160.95 2.66 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.116 -0.493 . . . . 70.31 110.88 -179.869 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 16.6 tttt -87.89 146.78 25.4 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.14 -0.482 . . . . 75.15 110.871 179.909 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 35.5 t60 -136.14 155.01 50.78 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.18 -0.463 . . . . 73.2 110.878 179.926 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -60.45 -175.99 1.36 Allowed Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.751 -0.737 . . . . 55.23 112.5 -179.98 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 19.0 mm100 66.53 11.66 8.22 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.898 0.38 . . . . 73.43 110.94 -179.897 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 69.36 27.96 73.06 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.704 -0.76 . . . . 52.43 112.499 -179.95 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 36' ' ' TRP . . . . . 0.678 ' C ' HD23 ' A' ' 37' ' ' LEU . 97.6 m95 -122.33 140.99 52.02 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.779 0.323 . . . . 74.13 110.911 -179.892 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.721 HD11 ' CG ' ' A' ' 52' ' ' GLU . 0.9 OUTLIER -123.9 130.3 52.37 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.227 -0.442 . . . . 55.34 110.935 179.949 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.527 HG21 ' CZ ' ' A' ' 30' ' ' TYR . 21.7 t -75.61 116.36 18.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.221 -0.445 . . . . 64.11 111.121 179.863 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.85 ' HB2' HD13 ' A' ' 28' ' ' ILE . . . -138.45 160.67 38.95 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.212 -0.449 . . . . 54.11 111.104 179.901 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 40' ' ' GLU . . . . . 0.469 ' HB3' HG23 ' A' ' 47' ' ' THR . 0.4 OUTLIER -121.54 155.87 34.06 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.231 -0.441 . . . . 75.34 110.886 -179.916 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -66.45 -175.35 0.36 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.159 -0.473 . . . . 70.13 110.882 -179.952 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 9.7 tt0 -69.98 -38.74 76.13 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.173 -0.467 . . . . 62.51 110.93 179.996 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 2.0 t -56.83 -22.55 37.4 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.102 -0.499 . . . . 52.42 110.862 -179.782 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 66.97 11.65 58.69 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.765 -0.731 . . . . 75.44 112.476 -179.993 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 1.4 p -103.82 -21.85 13.61 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.912 0.386 . . . . 71.14 110.818 -179.745 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.541 ' HE3' HD11 ' A' ' 18' ' ' LEU . 0.8 OUTLIER -117.63 123.21 45.6 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.156 -0.475 . . . . 74.53 110.89 179.964 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 47' ' ' THR . . . . . 0.469 HG23 ' HB3' ' A' ' 40' ' ' GLU . 9.8 m -129.93 133.83 47.08 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.188 -0.46 . . . . 73.21 111.135 179.994 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -152.43 -151.22 5.6 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.779 -0.724 . . . . 63.24 112.481 -179.995 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 18.3 mt -106.94 127.66 53.64 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.872 0.367 . . . . 61.12 110.93 -179.918 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.416 ' HB ' ' HD2' ' A' ' 51' ' ' PRO . 13.3 m -126.31 153.7 74.67 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.675 0.75 . . . . 73.34 111.1 179.872 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 0.493 ' HD2' HD22 ' A' ' 20' ' ' LEU . 53.7 Cg_endo -69.79 152.54 69.16 Favored 'Trans proline' 0 C--N 1.342 0.188 0 C-N-CA 122.675 2.25 . . . . 75.11 112.352 179.955 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 52' ' ' GLU . . . . . 0.721 ' CG ' HD11 ' A' ' 37' ' ' LEU . 13.9 tm-20 -96.21 -30.48 13.46 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.209 -0.45 . . . . 63.52 110.876 -179.952 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -85.14 8.41 18.26 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.148 -0.478 . . . . 75.15 110.892 -179.941 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 54' ' ' PHE . . . . . 0.415 ' HB2' ' HG2' ' A' ' 51' ' ' PRO . 1.0 OUTLIER -120.12 2.34 10.91 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.165 -0.471 . . . . 74.5 110.897 -179.954 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.513 ' CG1' HD21 ' A' ' 20' ' ' LEU . 15.8 m -132.57 170.85 19.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.162 -0.472 . . . . 71.44 111.118 179.989 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 56' ' ' SER . . . . . 0.597 ' HB3' HD21 ' A' ' 7' ' ' LEU . 9.6 t -143.09 120.96 11.97 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.157 -0.474 . . . . 43.13 110.855 -179.862 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 2.8 m-85 -56.82 135.18 55.62 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.129 -0.487 . . . . 62.51 110.913 -179.847 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.517 HD11 ' HB ' ' A' ' 5' ' ' VAL . 47.0 mt -103.51 149.04 7.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.121 -0.49 . . . . 72.44 111.111 179.938 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -130.95 160.99 64.2 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-O 121.628 0.728 . . . . 74.21 110.894 179.991 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.81 -48.28 0.74 Allowed 'Trans proline' 0 C--N 1.342 0.2 0 C-N-CA 122.694 2.262 . . . . 55.02 112.355 179.988 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 13.6 tt0 -157.09 36.41 0.29 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.235 -0.439 . . . . 73.23 110.879 179.975 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 10.0 mt -121.84 168.99 11.22 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.151 -0.477 . . . . 74.15 110.891 -179.974 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 57.8 mm-40 . . . . . 0 C--N 1.329 -0.296 0 CA-C-N 116.191 -0.459 . . . . 74.33 110.912 179.955 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' B' B ' -9' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.28 0 N-CA-C 112.466 -0.254 . . . . 75.44 112.466 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' B' B ' -8' ' ' LYS . . . . . . . . . . . . . 28.3 mmtp -98.81 -59.35 1.75 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.778 0.323 . . . . 72.34 110.885 -179.943 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' -7' ' ' PHE . . . . . . . . . . . . . 12.6 m-85 -103.67 115.51 30.63 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.236 -0.438 . . . . 72.43 110.821 -179.989 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' -6' ' ' ILE . . . . . . . . . . . . . 5.2 mp -136.43 113.27 10.23 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.65 0.738 . . . . 45.3 111.128 179.928 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' -5' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.74 160.67 48.84 Favored 'Trans proline' 0 C--N 1.341 0.158 0 C-N-CA 122.739 2.293 . . . . 64.24 112.333 179.883 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' -4' ' ' SER . . . . . . . . . . . . . 43.4 t -147.43 46.14 1.13 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.235 -0.439 . . . . 54.23 110.855 -179.84 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' -3' ' ' ARG . . . . . . . . . . . . . 1.5 ptp85 -179.32 155.15 0.78 Allowed Pre-proline 0 C--N 1.328 -0.331 0 CA-C-O 121.612 0.72 . . . . 74.53 110.861 -179.969 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' -2' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.78 129.26 17.26 Favored 'Trans proline' 0 C--N 1.341 0.148 0 C-N-CA 122.65 2.233 . . . . 73.51 112.349 -179.984 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' -1' ' ' ALA . . . . . . . . . . . . . . . -54.64 153.08 11.3 Favored Pre-proline 0 C--N 1.33 -0.266 0 CA-C-O 121.561 0.696 . . . . 75.31 111.095 179.902 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 0' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_endo -69.78 -174.74 0.97 Allowed 'Trans proline' 0 C--O 1.231 0.162 0 C-N-CA 122.707 2.271 . . . . 65.32 112.325 -179.989 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 1' ' ' LYS . . . . . . . . . . . . . 4.9 mtmp? -130.67 156.92 79.1 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 121.594 0.711 . . . . 71.44 110.887 179.904 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 2' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.8 166.12 28.73 Favored 'Trans proline' 0 C--N 1.342 0.192 0 C-N-CA 122.67 2.247 . . . . 65.25 112.365 179.879 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 3' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.71 80.74 0.85 Allowed 'Trans proline' 0 C--O 1.231 0.16 0 C-N-CA 122.666 2.244 . . . . 61.15 112.389 179.937 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 4' ' ' SER . . . . . . . . . . . . . 3.1 m -52.84 -65.83 0.49 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.238 -0.437 . . . . 74.43 110.823 -179.815 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 5' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER 56.37 40.52 29.72 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.098 -0.501 . . . . 65.23 110.849 -179.813 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 6' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.304 0 CA-C-N 116.123 -0.489 . . . . 64.43 111.084 179.888 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' -4' ' ' MET . . . . . . . . . . . . . 5.7 ttm . . . . . 0 C--O 1.231 0.093 0 CA-C-O 120.738 0.304 . . . . 64.21 110.887 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' -3' ' ' ALA . . . . . . . . . . . . . . . -108.07 27.43 9.27 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.235 -0.438 . . . . 72.11 111.111 179.919 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' -2' ' ' ILE . . . . . . . . . . . . . 56.0 mt -128.91 131.29 68.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.18 -0.464 . . . . 62.11 111.117 179.948 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' -1' ' ' VAL . . . . . . . . . . . . . 54.5 t -114.15 131.3 66.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.172 -0.467 . . . . 64.33 111.153 179.825 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 2.4 m120 -94.14 59.83 2.71 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.22 -0.446 . . . . 71.15 110.869 -179.988 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 51.2 tp60 -101.91 134.86 44.44 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.191 -0.459 . . . . 61.12 110.951 179.959 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 6.8 ptp180 -90.61 164.6 14.13 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.206 -0.452 . . . . 71.04 110.863 -179.902 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -156.48 152.58 27.56 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.185 -0.461 . . . . 73.1 111.108 179.94 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.682 ' HB ' HD11 ' A' ' 58' ' ' ILE . 10.9 p -104.08 151.84 6.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.231 -0.44 . . . . 53.23 111.15 179.958 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -89.25 116.85 27.79 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.143 -0.48 . . . . 74.11 111.128 179.876 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.732 HD21 ' HB2' ' A' ' 56' ' ' SER . 10.2 mt -84.52 -36.68 22.02 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.241 -0.436 . . . . 65.13 110.877 -179.955 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 6.4 m-85 -140.32 136.19 32.97 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.232 -0.44 . . . . 73.45 110.952 -179.989 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 1.6 p30 -62.65 139.23 58.64 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.118 -0.492 . . . . 73.24 110.879 179.93 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 10.8 t80 -145.51 145.99 31.27 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.211 -0.45 . . . . 74.15 110.869 -179.886 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -115.96 144.69 33.24 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.674 0.749 . . . . 71.41 110.895 -179.973 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.77 140.63 43.12 Favored 'Trans proline' 0 C--N 1.341 0.158 0 C-N-CA 122.689 2.26 . . . . 70.42 112.368 179.992 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 9.9 mt-10 -101.25 -21.45 14.9 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.194 -0.457 . . . . 63.23 110.875 -179.946 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 34.1 m-80 -110.29 176.66 4.97 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.14 -0.482 . . . . 74.33 110.876 -179.923 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -91.04 20.64 4.76 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.136 -0.484 . . . . 74.3 110.902 179.871 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -140.31 15.37 2.4 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.183 -0.462 . . . . 74.21 110.908 -179.924 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 16.3 mt-10 -107.37 158.07 17.46 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.171 -0.468 . . . . 64.41 110.899 -179.981 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.612 HD23 ' O ' ' A' ' 19' ' ' ARG . 0.3 OUTLIER -104.27 161.07 14.36 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.159 -0.473 . . . . 73.32 110.853 -179.902 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 19' ' ' ARG . . . . . 0.612 ' O ' HD23 ' A' ' 18' ' ' LEU . 0.9 OUTLIER -96.57 152.78 18.31 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.184 -0.462 . . . . 74.31 110.864 179.941 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.57 HD21 ' CG1' ' A' ' 55' ' ' VAL . 1.8 tp -137.79 149.49 46.43 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.137 -0.483 . . . . 71.04 110.91 -179.982 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.676 ' HB3' ' CG ' ' A' ' 24' ' ' ASP . . . -142.5 138.76 31.18 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.194 -0.457 . . . . 62.12 111.106 179.768 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -50.62 119.86 4.19 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.189 -0.46 . . . . 74.33 110.911 -179.945 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 96.7 -3.45 62.99 Favored Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.74 -0.743 . . . . 64.11 112.445 -179.979 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 24' ' ' ASP . . . . . 0.676 ' CG ' ' HB3' ' A' ' 21' ' ' ALA . 1.0 OUTLIER -84.63 146.45 27.48 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.721 0.296 . . . . 71.24 110.878 -179.943 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 3.5 mm -101.75 144.88 12.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.199 -0.455 . . . . 63.04 111.109 -179.991 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.418 HG11 HD11 ' A' ' 20' ' ' LEU . 1.5 m -146.58 158.31 10.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.148 -0.478 . . . . 72.01 111.108 179.848 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 54.3 m-85 -116.54 110.08 18.1 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.142 -0.481 . . . . 72.53 110.907 -179.995 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.686 HD13 ' HB2' ' A' ' 39' ' ' ALA . 14.7 mm -73.29 102.74 1.72 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.133 -0.485 . . . . 73.25 111.125 179.965 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 3.9 m -64.8 -40.35 95.08 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.196 -0.456 . . . . 74.11 110.837 -179.909 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 30' ' ' TYR . . . . . 0.524 ' CZ ' HG21 ' A' ' 38' ' ' VAL . 34.4 p90 -174.68 148.58 1.14 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.149 -0.478 . . . . 73.41 110.905 -179.926 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 31' ' ' LYS . . . . . 0.505 ' HG3' HD22 ' A' ' 37' ' ' LEU . 13.2 tttt -81.0 145.67 31.06 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.12 -0.491 . . . . 72.41 110.887 179.943 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 33.6 t60 -134.58 153.55 51.9 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.214 -0.448 . . . . 75.43 110.852 179.89 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -59.01 -174.12 0.57 Allowed Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.717 -0.754 . . . . 63.15 112.54 -179.97 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 77.9 mm-40 65.49 12.24 8.02 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.825 0.345 . . . . 61.34 110.911 -179.886 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 68.24 29.51 73.28 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.758 -0.734 . . . . 63.12 112.505 -179.98 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 36' ' ' TRP . . . . . 0.625 ' C ' HD23 ' A' ' 37' ' ' LEU . 98.4 m95 -123.51 135.97 54.32 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.81 0.338 . . . . 74.43 110.95 -179.936 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.708 HD11 ' CG ' ' A' ' 52' ' ' GLU . 1.4 mt -119.64 132.3 55.66 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.228 -0.442 . . . . 63.2 110.918 179.986 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.524 HG21 ' CZ ' ' A' ' 30' ' ' TYR . 60.0 t -79.27 109.11 13.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.206 -0.452 . . . . 75.31 111.15 179.825 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.686 ' HB2' HD13 ' A' ' 28' ' ' ILE . . . -129.93 163.02 27.29 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.191 -0.459 . . . . 73.31 111.11 179.924 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 1.5 pt-20 -119.02 156.4 29.7 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.232 -0.44 . . . . 74.22 110.86 -179.903 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -68.6 -175.2 0.64 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.129 -0.487 . . . . 64.42 110.877 -179.954 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 9.1 tm-20 -68.89 -37.81 79.23 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.211 -0.449 . . . . 73.14 110.883 -179.974 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 1.6 t -57.0 -22.61 39.84 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.16 -0.473 . . . . 75.33 110.869 -179.769 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 69.9 8.57 61.24 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.784 -0.722 . . . . 40.42 112.479 -179.97 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 30.9 t -108.15 -22.3 12.44 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.931 0.396 . . . . 54.01 110.86 -179.769 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.457 ' HG2' HD11 ' A' ' 18' ' ' LEU . 2.7 ttmt -107.09 123.84 48.81 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.13 -0.486 . . . . 75.53 110.906 179.977 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 4.3 m -125.7 152.22 45.57 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.244 -0.434 . . . . 70.23 111.142 -179.991 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -177.63 -162.42 27.71 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.746 -0.74 . . . . 24.41 112.476 179.933 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.485 HD23 HG22 ' A' ' 38' ' ' VAL . 5.8 mt -99.21 136.87 38.54 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.847 0.356 . . . . 73.33 110.966 -179.938 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 16.8 m -136.36 153.32 76.26 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-O 121.562 0.696 . . . . 64.53 111.183 179.845 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 0.428 ' HG2' ' HB2' ' A' ' 54' ' ' PHE . 54.2 Cg_endo -69.69 143.5 51.36 Favored 'Trans proline' 0 C--N 1.341 0.152 0 C-N-CA 122.677 2.252 . . . . 72.3 112.362 179.91 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 52' ' ' GLU . . . . . 0.708 ' CG ' HD11 ' A' ' 37' ' ' LEU . 15.5 tm-20 -90.19 -27.74 19.35 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.209 -0.45 . . . . 61.22 110.901 179.977 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 -86.31 10.44 14.84 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.134 -0.485 . . . . 71.5 110.892 -179.916 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 54' ' ' PHE . . . . . 0.428 ' HB2' ' HG2' ' A' ' 51' ' ' PRO . 1.0 OUTLIER -120.28 -9.56 9.5 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.138 -0.483 . . . . 74.14 110.898 -179.921 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.57 ' CG1' HD21 ' A' ' 20' ' ' LEU . 15.3 m -117.68 172.47 5.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.171 -0.468 . . . . 73.41 111.119 179.989 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 56' ' ' SER . . . . . 0.732 ' HB2' HD21 ' A' ' 7' ' ' LEU . 38.4 t -142.56 113.19 7.36 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.193 -0.458 . . . . 62.32 110.864 -179.885 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 3.1 m-85 -52.17 130.1 29.52 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.133 -0.485 . . . . 75.32 110.936 -179.908 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.682 HD11 ' HB ' ' A' ' 5' ' ' VAL . 54.5 mt -99.97 146.91 8.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.145 -0.479 . . . . 70.24 111.152 179.894 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 59' ' ' GLN . . . . . 0.423 ' NE2' HD12 ' A' ' 62' ' ' LEU . 8.1 mt-30 -131.02 160.94 64.53 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-O 121.594 0.712 . . . . 73.23 110.903 179.942 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.77 -86.58 0.0 OUTLIER 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 122.655 2.236 . . . . 72.12 112.319 -179.981 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 7.3 tt0 -117.37 23.64 11.66 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.188 -0.46 . . . . 72.03 110.871 -179.966 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.423 HD12 ' NE2' ' A' ' 59' ' ' GLN . 0.1 OUTLIER -134.4 168.52 18.77 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.187 -0.461 . . . . 71.54 110.867 -179.949 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 . . . . . 0 C--N 1.329 -0.284 0 CA-C-N 116.147 -0.479 . . . . 72.24 110.875 179.953 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' B' B ' -9' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.315 0 N-CA-C 112.484 -0.246 . . . . 41.15 112.484 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' B' B ' -8' ' ' LYS . . . . . . . . . . . . . 18.0 mmmt -111.2 121.08 44.36 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.784 0.326 . . . . 72.34 110.912 179.994 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' -7' ' ' PHE . . . . . 0.448 ' HB3' HD11 ' A' ' 49' ' ' LEU . 15.2 m-85 -74.4 144.56 44.29 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.253 -0.43 . . . . 75.13 110.877 179.983 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' -6' ' ' ILE . . . . . . . . . . . . . 2.4 pt -153.36 85.19 4.2 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.668 0.747 . . . . 73.44 111.108 179.956 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' -5' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.82 135.92 31.53 Favored 'Trans proline' 0 C--N 1.342 0.209 0 C-N-CA 122.712 2.275 . . . . 74.34 112.317 179.917 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' -4' ' ' SER . . . . . . . . . . . . . 2.5 m -132.0 62.13 1.64 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.255 -0.429 . . . . 63.22 110.879 -179.856 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' -3' ' ' ARG . . . . . . . . . . . . . 12.8 ptt85 -174.67 153.39 1.75 Allowed Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.669 0.747 . . . . 71.53 110.87 -179.958 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' -2' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.78 128.98 16.79 Favored 'Trans proline' 0 C--N 1.342 0.201 0 C-N-CA 122.665 2.243 . . . . 70.3 112.338 -179.976 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' -1' ' ' ALA . . . . . . . . . . . . . . . -61.74 152.21 76.35 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 121.616 0.722 . . . . 62.22 111.108 179.867 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 0' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.73 -179.85 3.19 Favored 'Trans proline' 0 C--N 1.341 0.181 0 C-N-CA 122.742 2.295 . . . . 73.54 112.331 -179.95 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 1' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -126.58 155.01 75.38 Favored Pre-proline 0 C--N 1.328 -0.362 0 CA-C-O 121.624 0.726 . . . . 72.35 110.857 179.909 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 2' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.76 163.55 37.85 Favored 'Trans proline' 0 C--N 1.342 0.225 0 C-N-CA 122.661 2.241 . . . . 71.23 112.329 179.908 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 3' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.76 104.94 1.4 Allowed 'Trans proline' 0 C--N 1.341 0.166 0 C-N-CA 122.712 2.275 . . . . 61.51 112.36 179.939 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 4' ' ' SER . . . . . . . . . . . . . 15.1 m -71.53 167.36 19.86 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.214 -0.448 . . . . 72.34 110.845 -179.827 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 5' ' ' SER . . . . . . . . . . . . . 6.0 p 54.8 30.82 14.36 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.154 -0.475 . . . . 73.53 110.879 -179.815 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 6' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.297 0 CA-C-N 116.138 -0.483 . . . . 55.22 111.115 179.906 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' -4' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.098 0 CA-C-O 120.766 0.317 . . . . 71.43 110.865 . . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' -3' ' ' ALA . . . . . . . . . . . . . . . -105.37 59.08 0.67 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.221 -0.445 . . . . 75.23 111.096 179.904 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' -2' ' ' ILE . . . . . . . . . . . . . 5.3 mp -104.6 125.72 59.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.218 -0.446 . . . . 62.03 111.088 179.983 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' -1' ' ' VAL . . . . . . . . . . . . . 7.7 p -103.39 -24.35 4.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.133 -0.485 . . . . 62.35 111.133 179.857 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 13.0 m120 61.93 59.11 1.77 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.14 -0.482 . . . . 72.5 110.915 -179.969 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 29.3 tp60 -111.88 127.42 55.83 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.135 -0.484 . . . . 61.24 110.945 179.983 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 6.3 ptm180 -76.63 162.43 27.75 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.203 -0.453 . . . . 63.44 110.88 -179.908 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -154.45 154.47 33.26 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.209 -0.451 . . . . 73.42 111.124 179.962 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.549 ' HB ' HD11 ' A' ' 58' ' ' ILE . 9.2 p -109.1 140.58 27.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.24 -0.436 . . . . 71.52 111.135 179.99 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -77.88 122.34 25.34 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.189 -0.46 . . . . 70.44 111.099 179.883 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.763 HD21 ' CB ' ' A' ' 56' ' ' SER . 16.6 mt -87.48 -34.79 18.54 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.195 -0.457 . . . . 72.34 110.914 -179.936 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 4.3 m-85 -144.58 149.86 36.5 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.161 -0.472 . . . . 73.4 110.871 -179.953 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -70.92 137.66 49.43 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.108 -0.496 . . . . 73.24 110.837 179.934 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 21.4 t80 -142.0 145.65 34.68 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.144 -0.48 . . . . 74.13 110.907 -179.916 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -119.41 137.29 25.22 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-O 121.679 0.752 . . . . 75.31 110.88 -179.929 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.433 ' HG3' ' HG3' ' A' ' 19' ' ' ARG . 53.6 Cg_endo -69.78 150.84 68.64 Favored 'Trans proline' 0 C--N 1.342 0.212 0 C-N-CA 122.636 2.224 . . . . 75.42 112.361 179.962 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 17.8 tp10 -109.28 -15.78 14.2 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.177 -0.465 . . . . 51.22 110.906 -179.98 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 9.8 m-80 -115.17 176.03 5.25 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.137 -0.483 . . . . 73.31 110.911 -179.925 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -92.26 20.87 5.62 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.197 -0.456 . . . . 73.24 110.857 179.948 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 1.2 p-10 -136.46 9.1 3.15 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.189 -0.46 . . . . 74.24 110.871 -179.907 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 12.0 mt-10 -105.63 157.44 17.4 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.177 -0.465 . . . . 61.23 110.908 179.989 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 55.5 tp -107.05 156.59 18.59 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.138 -0.483 . . . . 74.31 110.934 179.999 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 19' ' ' ARG . . . . . 0.433 ' HG3' ' HG3' ' A' ' 12' ' ' PRO . 0.7 OUTLIER -92.75 160.68 14.85 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.192 -0.458 . . . . 62.3 110.911 179.928 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.612 HD21 ' CG1' ' A' ' 55' ' ' VAL . 3.5 tp -142.27 149.24 39.29 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.196 -0.456 . . . . 70.21 110.946 -179.985 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.686 ' HB3' ' CG ' ' A' ' 24' ' ' ASP . . . -140.12 134.43 31.27 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.229 -0.441 . . . . 73.11 111.08 179.888 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -50.4 121.12 5.23 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.211 -0.45 . . . . 73.0 110.874 -179.929 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 96.59 -3.64 63.37 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.765 -0.731 . . . . 54.21 112.478 -179.971 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 24' ' ' ASP . . . . . 0.686 ' CG ' ' HB3' ' A' ' 21' ' ' ALA . 1.0 OUTLIER -85.08 146.9 26.92 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.805 0.336 . . . . 55.54 110.839 -179.944 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 3.3 mm -100.54 141.06 18.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.152 -0.476 . . . . 73.41 111.112 -179.973 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 1.5 m -142.78 158.0 18.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.168 -0.469 . . . . 65.45 111.165 179.821 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 44.6 m-85 -115.42 106.58 14.14 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.181 -0.463 . . . . 74.14 110.86 -179.937 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.836 HD13 ' HB2' ' A' ' 39' ' ' ALA . 19.6 mm -72.01 103.12 1.39 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.145 -0.479 . . . . 64.12 111.128 179.957 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 3.3 m -64.48 -39.47 93.85 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.161 -0.472 . . . . 73.41 110.878 -179.934 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 30' ' ' TYR . . . . . 0.47 ' CZ ' HG21 ' A' ' 38' ' ' VAL . 33.4 p90 -174.53 147.85 1.14 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.111 -0.495 . . . . 71.13 110.889 -179.895 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 31' ' ' LYS . . . . . 0.57 ' HG3' HD22 ' A' ' 37' ' ' LEU . 18.7 tttt -82.68 145.41 29.63 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.121 -0.491 . . . . 51.34 110.893 179.894 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 29.7 t60 -134.86 153.97 51.84 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.195 -0.457 . . . . 62.1 110.824 179.917 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -59.23 -174.26 0.65 Allowed Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.733 -0.746 . . . . 41.32 112.53 179.977 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 73.8 mm-40 65.59 12.44 8.23 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.803 0.335 . . . . 73.2 110.908 -179.895 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 68.22 28.82 73.16 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.721 -0.752 . . . . 60.31 112.504 -179.956 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 36' ' ' TRP . . . . . 0.638 ' C ' HD23 ' A' ' 37' ' ' LEU . 99.0 m95 -123.17 135.64 54.41 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.768 0.318 . . . . 64.24 110.938 -179.928 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.695 HD11 ' CG ' ' A' ' 52' ' ' GLU . 0.4 OUTLIER -124.46 131.89 53.49 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.254 -0.43 . . . . 61.5 110.902 179.969 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.47 HG21 ' CZ ' ' A' ' 30' ' ' TYR . 60.4 t -77.39 116.89 21.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.128 -0.487 . . . . 61.14 111.133 179.82 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.836 ' HB2' HD13 ' A' ' 28' ' ' ILE . . . -137.28 160.06 40.13 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.181 -0.463 . . . . 60.13 111.08 179.872 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 40' ' ' GLU . . . . . 0.449 ' HB3' HG23 ' A' ' 47' ' ' THR . 0.5 OUTLIER -121.76 160.15 25.18 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.225 -0.443 . . . . 72.15 110.924 -179.976 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -71.78 -175.27 1.35 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.142 -0.481 . . . . 74.11 110.924 -179.93 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -69.61 -38.34 77.23 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.205 -0.452 . . . . 62.52 110.876 -179.97 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 1.5 t -57.1 -22.58 40.75 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.155 -0.475 . . . . 74.23 110.867 -179.794 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 66.46 12.05 57.83 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.681 -0.771 . . . . 52.33 112.516 180.0 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 12.9 m -105.24 -21.06 13.32 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.945 0.402 . . . . 52.32 110.836 -179.707 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 1.4 ttmt -118.53 123.38 44.95 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.148 -0.478 . . . . 63.24 110.889 179.948 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 47' ' ' THR . . . . . 0.449 HG23 ' HB3' ' A' ' 40' ' ' GLU . 11.4 m -131.62 143.02 50.01 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.228 -0.442 . . . . 51.1 111.166 179.957 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -160.71 -151.77 6.34 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.788 -0.72 . . . . 44.42 112.511 179.979 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 8.4 mt -107.03 131.69 53.79 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.862 0.363 . . . . 72.31 110.906 -179.942 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.432 ' HB ' ' HD2' ' A' ' 51' ' ' PRO . 18.3 m -129.88 154.45 81.11 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-O 121.606 0.717 . . . . 70.14 111.164 179.829 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 0.432 ' HD2' ' HB ' ' A' ' 50' ' ' VAL . 53.6 Cg_endo -69.75 148.15 64.53 Favored 'Trans proline' 0 C--O 1.231 0.145 0 C-N-CA 122.713 2.276 . . . . 75.02 112.36 179.96 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 52' ' ' GLU . . . . . 0.695 ' CG ' HD11 ' A' ' 37' ' ' LEU . 30.1 tt0 -93.07 -29.5 15.76 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.256 -0.429 . . . . 75.41 110.854 -179.962 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -84.39 7.33 19.93 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.199 -0.455 . . . . 74.0 110.879 -179.943 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 54' ' ' PHE . . . . . 0.418 ' HB2' ' HG2' ' A' ' 51' ' ' PRO . 1.2 m-85 -120.41 3.47 10.78 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.155 -0.475 . . . . 74.14 110.862 -179.911 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.612 ' CG1' HD21 ' A' ' 20' ' ' LEU . 7.1 m -128.88 172.76 14.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.171 -0.468 . . . . 75.23 111.164 179.966 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 56' ' ' SER . . . . . 0.763 ' CB ' HD21 ' A' ' 7' ' ' LEU . 13.1 t -145.55 113.69 6.56 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.188 -0.46 . . . . 73.43 110.87 -179.828 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 2.5 m-85 -51.87 137.05 27.17 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.163 -0.471 . . . . 65.12 110.904 -179.866 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.549 HD11 ' HB ' ' A' ' 5' ' ' VAL . 24.6 mt -104.94 152.52 6.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.114 -0.493 . . . . 73.43 111.14 179.899 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 59' ' ' GLN . . . . . 0.417 ' HG2' HD12 ' A' ' 62' ' ' LEU . 0.0 OUTLIER -131.24 160.89 65.0 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-O 121.577 0.703 . . . . 73.21 110.912 179.986 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.74 -48.85 0.63 Allowed 'Trans proline' 0 C--N 1.341 0.165 0 C-N-CA 122.7 2.267 . . . . 62.4 112.357 179.94 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -151.67 21.33 0.71 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.228 -0.442 . . . . 74.31 110.889 -179.998 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.417 HD12 ' HG2' ' A' ' 59' ' ' GLN . 7.3 mt -111.54 169.82 8.55 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.162 -0.472 . . . . 74.45 110.892 -179.981 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 14.5 tt0 . . . . . 0 C--N 1.33 -0.25 0 CA-C-N 116.198 -0.456 . . . . 73.4 110.885 179.936 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' B' B ' -9' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.323 0 N-CA-C 112.487 -0.245 . . . . 64.4 112.487 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' B' B ' -8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -114.39 32.8 5.69 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.779 0.324 . . . . 74.22 110.867 -179.93 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' -7' ' ' PHE . . . . . . . . . . . . . 14.0 m-85 -128.47 114.32 16.63 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.245 -0.434 . . . . 54.0 110.89 179.989 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' -6' ' ' ILE . . . . . . . . . . . . . 60.2 mt -125.64 125.92 24.97 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 121.603 0.716 . . . . 53.42 111.147 179.971 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' -5' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.81 160.09 50.95 Favored 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.658 2.239 . . . . 74.32 112.324 179.902 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' -4' ' ' SER . . . . . . . . . . . . . 7.3 t -136.56 37.25 2.67 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.218 -0.447 . . . . 64.14 110.879 -179.855 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' -3' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -177.56 155.0 1.08 Allowed Pre-proline 0 C--N 1.33 -0.275 0 CA-C-O 121.542 0.687 . . . . 61.44 110.894 -179.919 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' -2' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.77 131.5 21.36 Favored 'Trans proline' 0 C--O 1.231 0.138 0 C-N-CA 122.682 2.254 . . . . 73.13 112.362 -179.971 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' -1' ' ' ALA . . . . . . . . . . . . . . . -55.5 154.47 12.19 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-O 121.591 0.71 . . . . 73.15 111.088 179.884 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 0' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.76 -170.24 0.38 Allowed 'Trans proline' 0 C--N 1.342 0.194 0 C-N-CA 122.66 2.24 . . . . 64.32 112.391 179.959 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 1' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -134.17 148.93 69.94 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-O 121.561 0.696 . . . . 65.2 110.946 179.887 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 2' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.8 163.35 38.63 Favored 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.699 2.266 . . . . 51.11 112.352 179.891 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 3' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.7 -178.89 2.53 Favored 'Trans proline' 0 C--N 1.342 0.198 0 C-N-CA 122.68 2.254 . . . . 72.3 112.367 179.971 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 4' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 51.67 53.31 12.94 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.236 -0.438 . . . . 62.41 110.891 -179.83 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 5' ' ' SER . . . . . . . . . . . . . 2.0 m -64.27 127.0 29.56 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.151 -0.477 . . . . 64.21 110.883 -179.834 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 6' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.33 -0.279 0 CA-C-N 116.131 -0.486 . . . . 75.31 111.123 179.899 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' -4' ' ' MET . . . . . . . . . . . . . 1.7 mpt? . . . . . 0 C--O 1.231 0.084 0 CA-C-O 120.758 0.313 . . . . 63.5 110.901 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' -3' ' ' ALA . . . . . . . . . . . . . . . 59.3 37.18 23.63 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.232 -0.44 . . . . 44.14 111.103 179.905 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' -2' ' ' ILE . . . . . . . . . . . . . 69.7 mt -133.31 119.56 35.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.243 -0.435 . . . . 75.31 111.17 -179.966 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' -1' ' ' VAL . . . . . . . . . . . . . 26.1 t -108.17 129.25 62.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.243 -0.435 . . . . 73.31 111.159 179.87 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 4.1 m120 -91.29 60.87 4.31 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.177 -0.465 . . . . 64.12 110.884 -179.983 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 33.0 tp60 -96.7 127.31 42.55 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.211 -0.45 . . . . 73.14 110.902 -179.993 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 5.6 ptp180 -80.7 162.05 24.32 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.216 -0.447 . . . . 74.03 110.863 -179.931 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -155.1 149.96 26.67 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.176 -0.465 . . . . 60.53 111.069 179.932 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.675 ' HB ' HD11 ' A' ' 58' ' ' ILE . 7.3 p -105.83 137.98 33.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.21 -0.45 . . . . 72.33 111.133 179.967 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 6' ' ' ALA . . . . . 0.459 ' HA ' HG12 ' A' ' 55' ' ' VAL . . . -78.56 128.3 33.33 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.216 -0.447 . . . . 64.44 111.047 179.91 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.568 HD21 ' HB3' ' A' ' 56' ' ' SER . 10.5 mt -93.32 -31.89 14.51 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.153 -0.476 . . . . 75.12 110.922 179.986 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 3.8 m-85 -144.37 135.91 25.71 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.193 -0.458 . . . . 72.51 110.934 179.995 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -60.11 149.58 32.17 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.122 -0.49 . . . . 75.51 110.899 179.883 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 30.7 t80 -149.01 147.1 28.16 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.181 -0.463 . . . . 74.12 110.881 -179.871 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 8.5 tm-20 -117.0 134.56 22.98 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 121.649 0.738 . . . . 71.04 110.913 -179.971 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.4 ' HD3' ' HA ' ' A' ' 19' ' ' ARG . 53.4 Cg_endo -69.76 141.57 45.56 Favored 'Trans proline' 0 C--O 1.232 0.19 0 C-N-CA 122.665 2.243 . . . . 53.22 112.353 -179.99 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 13.8 mp0 -102.99 -20.01 14.37 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.249 -0.432 . . . . 71.13 110.927 -179.997 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 9.8 m120 -111.29 175.7 5.32 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.123 -0.49 . . . . 74.4 110.848 -179.936 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -92.37 19.59 6.98 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.172 -0.467 . . . . 74.11 110.888 179.886 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -135.35 10.92 3.51 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.245 -0.434 . . . . 73.34 110.848 -179.886 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 6.3 mm-40 -101.53 164.39 11.78 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.204 -0.453 . . . . 70.43 110.904 179.977 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.638 HD12 ' H ' ' A' ' 19' ' ' ARG . 19.3 tp -115.71 141.52 47.97 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.129 -0.487 . . . . 62.3 110.885 -179.935 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 19' ' ' ARG . . . . . 0.638 ' H ' HD12 ' A' ' 18' ' ' LEU . 31.5 mtm180 -75.24 155.17 37.06 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.165 -0.471 . . . . 63.44 110.886 179.951 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.585 HD22 ' HD2' ' A' ' 51' ' ' PRO . 3.5 tp -140.7 149.58 42.37 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.213 -0.448 . . . . 71.43 110.889 -179.947 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.447 ' O ' ' HB3' ' A' ' 6' ' ' ALA . . . -139.98 139.76 36.13 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.199 -0.455 . . . . 62.31 111.099 179.786 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -53.91 119.24 4.76 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.194 -0.457 . . . . 63.12 110.917 -179.919 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 93.49 0.19 67.46 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.769 -0.729 . . . . 54.14 112.484 -179.969 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 23.8 t0 -76.88 159.24 30.19 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.798 0.333 . . . . 72.5 110.909 -179.986 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 1.7 mm -110.92 123.1 66.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.154 -0.475 . . . . 75.31 111.109 -179.969 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.468 HG11 HD11 ' A' ' 20' ' ' LEU . 3.6 m -132.26 152.82 37.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.166 -0.47 . . . . 65.14 111.121 179.878 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 68.9 m-85 -112.82 109.02 18.22 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.183 -0.462 . . . . 71.13 110.882 -179.976 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.705 HD13 ' HB2' ' A' ' 39' ' ' ALA . 19.0 mm -72.32 103.02 1.45 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.086 -0.506 . . . . 71.44 111.131 -179.997 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 2.9 m -64.59 -40.09 94.9 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.167 -0.47 . . . . 70.31 110.864 -179.893 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 30' ' ' TYR . . . . . 0.474 ' CZ ' HG21 ' A' ' 38' ' ' VAL . 31.7 p90 -173.91 146.09 1.18 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.139 -0.482 . . . . 73.03 110.916 -179.861 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 31' ' ' LYS . . . . . 0.525 ' HG3' HD22 ' A' ' 37' ' ' LEU . 19.2 tttt -79.87 147.26 31.79 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.148 -0.478 . . . . 75.44 110.925 179.871 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 32.3 t60 -137.4 154.54 49.96 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.227 -0.442 . . . . 65.32 110.85 179.939 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -59.37 -175.02 0.76 Allowed Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.746 -0.74 . . . . 61.22 112.494 -179.95 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 24.0 mm100 65.61 12.78 8.49 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.844 0.354 . . . . 74.44 110.93 -179.89 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 68.14 27.74 73.6 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.691 -0.766 . . . . 75.33 112.475 -179.991 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 36' ' ' TRP . . . . . 0.606 ' C ' HD23 ' A' ' 37' ' ' LEU . 98.5 m95 -122.01 137.42 54.81 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.82 0.343 . . . . 75.55 110.948 -179.915 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.683 HD11 ' CG ' ' A' ' 52' ' ' GLU . 0.5 OUTLIER -125.18 130.52 52.31 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.255 -0.429 . . . . 53.41 110.934 179.982 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.474 HG21 ' CZ ' ' A' ' 30' ' ' TYR . 44.1 t -77.27 115.16 18.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.164 -0.471 . . . . 74.45 111.132 179.878 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.705 ' HB2' HD13 ' A' ' 28' ' ' ILE . . . -137.0 166.16 24.31 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.133 -0.485 . . . . 72.21 111.12 179.919 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -117.62 156.68 27.74 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.233 -0.44 . . . . 64.52 110.886 -179.937 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -71.36 -176.85 1.61 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.151 -0.477 . . . . 70.21 110.852 -179.933 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 20.5 tt0 -67.45 -38.47 84.55 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.124 -0.489 . . . . 71.41 110.921 179.984 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 1.3 t -57.19 -22.14 38.41 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.144 -0.48 . . . . 75.45 110.847 -179.789 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 65.93 12.59 57.67 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.682 -0.771 . . . . 75.44 112.48 -179.995 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 13.4 t -109.42 -15.61 14.19 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.932 0.396 . . . . 74.25 110.885 -179.738 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 7.1 ptmt -119.98 134.85 55.12 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.127 -0.488 . . . . 62.43 110.912 179.935 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 6.4 m -135.06 143.72 46.86 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.252 -0.431 . . . . 63.12 111.162 179.969 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -164.68 -154.94 8.16 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.694 -0.765 . . . . 54.4 112.482 179.972 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.516 HD11 ' HB3' ' B' ' -7' ' ' PHE . 6.7 mt -104.8 129.41 53.09 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.849 0.357 . . . . 42.41 110.889 -179.89 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.44 ' HB ' ' HD2' ' A' ' 51' ' ' PRO . 16.8 m -127.73 154.25 77.89 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.666 0.746 . . . . 60.13 111.095 179.836 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 0.585 ' HD2' HD22 ' A' ' 20' ' ' LEU . 53.5 Cg_endo -69.77 149.45 66.85 Favored 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.666 2.244 . . . . 53.21 112.326 179.962 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 52' ' ' GLU . . . . . 0.683 ' CG ' HD11 ' A' ' 37' ' ' LEU . 28.3 tt0 -94.36 -30.17 14.64 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.231 -0.44 . . . . 64.32 110.925 -179.983 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -85.24 7.72 21.06 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.093 -0.503 . . . . 74.02 110.899 -179.942 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 54' ' ' PHE . . . . . 0.407 ' HB2' ' HG2' ' A' ' 51' ' ' PRO . 1.2 m-85 -119.29 4.57 11.25 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.126 -0.488 . . . . 65.14 110.908 -179.95 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.459 HG12 ' HA ' ' A' ' 6' ' ' ALA . 14.8 m -134.4 164.11 35.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.121 -0.49 . . . . 71.32 111.132 179.975 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 56' ' ' SER . . . . . 0.568 ' HB3' HD21 ' A' ' 7' ' ' LEU . 25.7 t -136.24 117.27 14.32 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.222 -0.444 . . . . 75.22 110.869 -179.85 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 2.9 m-85 -52.1 136.95 28.75 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.108 -0.496 . . . . 71.52 110.944 -179.892 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.675 HD11 ' HB ' ' A' ' 5' ' ' VAL . 32.1 mt -104.64 150.32 7.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.146 -0.479 . . . . 63.35 111.102 179.938 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 2.7 mt-30 -131.14 160.8 65.33 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-O 121.611 0.72 . . . . 73.43 110.95 179.914 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.72 -48.63 0.69 Allowed 'Trans proline' 0 C--N 1.341 0.159 0 C-N-CA 122.711 2.274 . . . . 74.34 112.32 -179.966 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -159.27 25.78 0.2 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.221 -0.445 . . . . 61.43 110.891 -179.956 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 11.4 mt -110.4 155.39 22.24 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.155 -0.475 . . . . 65.15 110.908 -179.981 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 10.9 tt0 . . . . . 0 C--N 1.329 -0.287 0 CA-C-N 116.188 -0.46 . . . . 72.22 110.892 179.942 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' B' B ' -9' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.351 0 N-CA-C 112.449 -0.26 . . . . 54.35 112.449 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' B' B ' -8' ' ' LYS . . . . . . . . . . . . . 14.7 mmmt -55.27 -55.26 33.41 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.787 0.327 . . . . 75.11 110.905 -179.985 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' -7' ' ' PHE . . . . . 0.516 ' HB3' HD11 ' A' ' 49' ' ' LEU . 8.4 m-85 -66.81 171.08 5.64 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.223 -0.444 . . . . 71.4 110.853 179.983 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' -6' ' ' ILE . . . . . 0.478 ' O ' HG23 ' B' ' -6' ' ' ILE . 3.8 tp -175.89 91.28 0.28 Allowed Pre-proline 0 C--N 1.328 -0.333 0 CA-C-O 121.634 0.731 . . . . 42.15 111.107 179.989 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' -5' ' ' PRO . . . . . 0.414 ' HD2' ' HA ' ' B' ' -6' ' ' ILE . 53.4 Cg_endo -69.79 139.4 40.03 Favored 'Trans proline' 0 C--N 1.341 0.156 0 C-N-CA 122.677 2.252 . . . . 74.44 112.344 179.868 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' -4' ' ' SER . . . . . . . . . . . . . 2.6 m -132.55 62.45 1.65 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.212 -0.449 . . . . 53.33 110.877 -179.839 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' -3' ' ' ARG . . . . . . . . . . . . . 13.6 ptp180 -179.63 155.41 0.75 Allowed Pre-proline 0 C--N 1.329 -0.32 0 CA-C-O 121.592 0.71 . . . . 71.1 110.852 -179.928 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' -2' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.72 135.42 30.49 Favored 'Trans proline' 0 C--N 1.341 0.169 0 C-N-CA 122.724 2.283 . . . . 75.42 112.33 179.995 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' -1' ' ' ALA . . . . . . . . . . . . . . . -68.15 153.02 96.04 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.615 0.722 . . . . 62.44 111.085 179.877 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 0' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_endo -69.81 174.63 9.27 Favored 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.672 2.248 . . . . 73.15 112.342 -179.954 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 1' ' ' LYS . . . . . . . . . . . . . 16.5 pttm -122.63 153.21 62.86 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.526 0.679 . . . . 74.12 110.933 179.887 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 2' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.76 164.16 35.58 Favored 'Trans proline' 0 C--O 1.232 0.19 0 C-N-CA 122.659 2.239 . . . . 73.23 112.385 179.901 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 3' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.71 -23.24 31.23 Favored 'Trans proline' 0 C--O 1.231 0.157 0 C-N-CA 122.692 2.261 . . . . 62.53 112.356 179.955 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 4' ' ' SER . . . . . . . . . . . . . 7.5 p -59.05 156.86 11.09 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.209 -0.451 . . . . 61.32 110.896 -179.885 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 5' ' ' SER . . . . . . . . . . . . . 42.0 p -64.92 -41.44 95.54 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.127 -0.488 . . . . 60.33 110.875 -179.815 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 6' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.321 0 CA-C-N 116.182 -0.463 . . . . 44.21 111.078 179.893 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' -4' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.232 0.136 0 CA-C-O 120.775 0.321 . . . . 73.12 110.885 . . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' -3' ' ' ALA . . . . . . . . . . . . . . . -127.64 63.37 1.37 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.269 -0.423 . . . . 63.41 111.094 179.93 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' -2' ' ' ILE . . . . . 0.405 HD12 ' N ' ' A' ' -2' ' ' ILE . 4.3 mp -121.59 126.72 75.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.206 -0.452 . . . . 73.21 111.116 179.982 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' -1' ' ' VAL . . . . . . . . . . . . . 25.3 t -109.72 131.8 59.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.207 -0.451 . . . . 63.35 111.125 179.828 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 5.3 m-80 -92.3 60.02 3.58 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.16 -0.473 . . . . 74.03 110.913 179.958 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 56.5 tp60 -99.48 128.77 45.61 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.192 -0.458 . . . . 70.02 110.895 -179.977 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -83.43 163.9 20.25 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.2 -0.455 . . . . 64.51 110.843 -179.938 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -154.58 152.25 29.8 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.168 -0.469 . . . . 62.31 111.086 179.958 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.534 ' HB ' HD11 ' A' ' 58' ' ' ILE . 10.0 p -104.13 149.08 8.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.262 -0.427 . . . . 54.24 111.15 179.975 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 6' ' ' ALA . . . . . 0.415 ' HB3' ' O ' ' A' ' 21' ' ' ALA . . . -90.4 117.78 29.37 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.218 -0.446 . . . . 64.04 111.105 179.873 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.744 HD21 ' HB3' ' A' ' 56' ' ' SER . 7.0 mt -84.52 -35.69 22.7 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.255 -0.429 . . . . 43.22 110.905 -179.963 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 5.4 m-85 -140.75 136.89 32.98 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.185 -0.461 . . . . 75.11 110.909 -179.96 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -64.06 137.88 58.19 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.076 -0.511 . . . . 65.3 110.91 179.924 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 18.5 t80 -137.33 145.37 43.29 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.204 -0.453 . . . . 63.22 110.851 -179.878 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 7.0 tt0 -115.69 136.13 22.78 Favored Pre-proline 0 C--N 1.33 -0.261 0 CA-C-O 121.671 0.748 . . . . 63.24 110.86 -179.925 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.42 ' HD3' ' HA ' ' A' ' 19' ' ' ARG . 53.7 Cg_endo -69.74 143.94 52.53 Favored 'Trans proline' 0 C--N 1.342 0.189 0 C-N-CA 122.718 2.279 . . . . 71.45 112.29 179.999 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -107.38 -7.51 16.63 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.21 -0.45 . . . . 71.43 110.873 179.965 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 59.3 m-80 -124.5 175.78 6.93 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.196 -0.457 . . . . 45.44 110.893 -179.95 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 8.9 p30 -93.58 24.2 4.18 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.205 -0.452 . . . . 64.12 110.887 179.917 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 1.2 p-10 -139.97 11.82 2.43 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.163 -0.471 . . . . 74.3 110.873 -179.899 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 10.0 mm-40 -106.38 163.35 12.92 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.186 -0.461 . . . . 70.12 110.864 -179.978 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.648 HD12 ' H ' ' A' ' 19' ' ' ARG . 20.7 tp -113.02 142.64 45.48 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.134 -0.485 . . . . 72.44 110.896 -179.951 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 19' ' ' ARG . . . . . 0.648 ' H ' HD12 ' A' ' 18' ' ' LEU . 6.6 mtp85 -79.03 153.45 30.23 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.192 -0.458 . . . . 75.32 110.89 179.94 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.553 HD21 ' CG1' ' A' ' 55' ' ' VAL . 2.3 tp -138.55 149.07 44.94 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.192 -0.458 . . . . 75.35 110.901 -179.973 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.687 ' HB3' ' OD2' ' A' ' 24' ' ' ASP . . . -140.7 139.76 34.78 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.205 -0.452 . . . . 42.2 111.151 179.766 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -50.62 122.85 7.78 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.222 -0.445 . . . . 75.33 110.865 -179.885 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 97.18 -13.48 64.67 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.777 -0.725 . . . . 73.32 112.478 -179.994 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 24' ' ' ASP . . . . . 0.687 ' OD2' ' HB3' ' A' ' 21' ' ' ALA . 7.2 m-20 -71.53 149.07 46.11 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.796 0.332 . . . . 72.12 110.87 -179.982 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 1.7 mt -116.62 119.83 63.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.182 -0.463 . . . . 74.41 111.093 -179.955 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 6.4 m -119.14 165.76 14.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.129 -0.487 . . . . 73.42 111.125 179.851 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 46.7 m-85 -114.47 106.92 14.85 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.145 -0.479 . . . . 64.45 110.869 -179.949 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.744 HD13 ' HB2' ' A' ' 39' ' ' ALA . 17.6 mm -70.71 102.91 1.01 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.187 -0.461 . . . . 64.34 111.136 179.967 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 3.6 m -65.19 -39.57 93.03 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.127 -0.488 . . . . 64.35 110.856 -179.898 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 30' ' ' TYR . . . . . 0.492 ' CZ ' HG21 ' A' ' 38' ' ' VAL . 32.1 p90 -174.38 146.83 1.1 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.162 -0.472 . . . . 74.13 110.876 -179.88 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 31' ' ' LYS . . . . . 0.512 ' HG3' HD22 ' A' ' 37' ' ' LEU . 18.7 tttt -80.77 146.17 31.12 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.122 -0.49 . . . . 52.32 110.906 179.886 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 33.7 t60 -135.27 155.97 49.75 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.223 -0.444 . . . . 70.32 110.86 179.899 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -60.84 -174.22 1.14 Allowed Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.754 -0.736 . . . . 74.33 112.519 -179.967 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 41.9 mm-40 64.79 13.21 8.3 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.859 0.362 . . . . 65.13 110.9 -179.914 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 67.94 28.98 73.3 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.715 -0.755 . . . . 72.14 112.489 -179.969 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 36' ' ' TRP . . . . . 0.637 ' C ' HD23 ' A' ' 37' ' ' LEU . 98.7 m95 -122.82 138.11 54.74 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.766 0.317 . . . . 74.12 110.909 -179.871 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.695 HD11 ' CG ' ' A' ' 52' ' ' GLU . 0.5 OUTLIER -125.96 130.47 51.3 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.25 -0.432 . . . . 74.5 110.931 179.934 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.492 HG21 ' CZ ' ' A' ' 30' ' ' TYR . 41.7 t -77.2 115.21 18.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.186 -0.461 . . . . 75.02 111.095 179.868 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.744 ' HB2' HD13 ' A' ' 28' ' ' ILE . . . -135.54 163.53 29.89 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.187 -0.46 . . . . 72.4 111.09 179.86 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 1.6 pm0 -121.58 160.49 24.23 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.211 -0.449 . . . . 53.54 110.826 -179.928 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 43.4 p-10 -58.91 -174.8 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.088 -0.505 . . . . 74.22 110.893 -179.94 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 15.2 tt0 -78.43 -38.63 40.9 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.188 -0.46 . . . . 74.13 110.914 179.998 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 4.4 m -68.73 -22.55 64.32 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.134 -0.485 . . . . 72.22 110.847 -179.785 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 76.61 26.76 62.38 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.704 -0.76 . . . . 71.33 112.52 -179.977 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 3.5 m -105.48 -22.19 13.06 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.946 0.403 . . . . 73.32 110.875 -179.717 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.401 ' HD2' HD11 ' A' ' 18' ' ' LEU . 0.0 OUTLIER -125.68 138.05 53.87 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.122 -0.49 . . . . 70.02 110.928 179.904 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 30.7 m -136.8 143.89 43.4 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.243 -0.435 . . . . 41.33 111.149 179.976 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -167.74 -155.62 9.44 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.736 -0.745 . . . . 63.32 112.513 179.938 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 7.0 mt -103.57 132.19 50.04 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.828 0.347 . . . . 72.1 110.908 -179.922 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.413 ' HB ' ' HD2' ' A' ' 51' ' ' PRO . 6.7 m -129.53 153.47 80.67 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 121.592 0.711 . . . . 62.24 111.161 179.85 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 0.448 ' HD2' HD22 ' A' ' 20' ' ' LEU . 54.0 Cg_endo -69.73 150.76 68.82 Favored 'Trans proline' 0 C--N 1.341 0.147 0 C-N-CA 122.741 2.294 . . . . 74.21 112.318 179.968 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 52' ' ' GLU . . . . . 0.695 ' CG ' HD11 ' A' ' 37' ' ' LEU . 28.2 tt0 -95.74 -28.89 14.56 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.186 -0.461 . . . . 54.14 110.833 -179.982 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -87.3 11.08 15.2 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.195 -0.457 . . . . 70.5 110.907 -179.909 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -121.01 -8.15 9.38 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.122 -0.49 . . . . 72.33 110.891 -179.931 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.553 ' CG1' HD21 ' A' ' 20' ' ' LEU . 12.3 m -120.02 172.84 6.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.154 -0.475 . . . . 73.34 111.153 -179.998 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 56' ' ' SER . . . . . 0.744 ' HB3' HD21 ' A' ' 7' ' ' LEU . 3.3 t -143.25 114.3 7.77 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.195 -0.457 . . . . 33.31 110.882 -179.868 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 2.6 m-85 -52.33 127.11 21.14 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.131 -0.486 . . . . 75.33 110.912 -179.868 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.534 HD11 ' HB ' ' A' ' 5' ' ' VAL . 42.6 mt -94.85 149.94 4.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.122 -0.49 . . . . 71.21 111.17 179.887 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 59' ' ' GLN . . . . . 0.403 ' HB2' ' HD2' ' A' ' 60' ' ' PRO . 0.0 OUTLIER -96.92 154.6 38.2 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.601 0.715 . . . . 73.32 110.933 179.951 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 60' ' ' PRO . . . . . 0.403 ' HD2' ' HB2' ' A' ' 59' ' ' GLN . 53.7 Cg_endo -69.72 -48.56 0.7 Allowed 'Trans proline' 0 C--N 1.341 0.157 0 C-N-CA 122.726 2.284 . . . . 64.42 112.352 179.992 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 18.9 tt0 -161.73 35.31 0.13 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.221 -0.445 . . . . 74.44 110.854 -179.978 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 14.4 mt -98.8 -179.76 4.39 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.165 -0.47 . . . . 74.44 110.906 179.993 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 75.3 mt-10 . . . . . 0 C--N 1.33 -0.262 0 CA-C-N 116.196 -0.457 . . . . 72.12 110.855 179.969 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' B' B ' -9' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.32 0 N-CA-C 112.518 -0.233 . . . . 73.24 112.518 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' B' B ' -8' ' ' LYS . . . . . . . . . . . . . 17.8 mmmt -121.17 -49.57 2.17 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.816 0.341 . . . . 73.24 110.904 -179.975 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' -7' ' ' PHE . . . . . . . . . . . . . 10.8 m-85 -108.2 124.0 49.61 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.18 -0.464 . . . . 73.55 110.93 179.979 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' -6' ' ' ILE . . . . . 0.411 ' O ' HG23 ' B' ' -6' ' ' ILE . 5.9 tt -138.78 119.3 9.79 Favored Pre-proline 0 C--N 1.328 -0.35 0 CA-C-O 121.615 0.721 . . . . 74.53 111.131 179.985 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' -5' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.82 154.26 67.72 Favored 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.674 2.249 . . . . 63.52 112.372 179.862 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' -4' ' ' SER . . . . . . . . . . . . . 45.2 t -132.45 41.89 3.16 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.246 -0.434 . . . . 54.42 110.877 -179.834 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' -3' ' ' ARG . . . . . . . . . . . . . 1.5 ptm180 -177.45 155.05 1.1 Allowed Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 121.618 0.723 . . . . 75.12 110.886 -179.952 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' -2' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.78 134.37 27.79 Favored 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.68 2.254 . . . . 74.21 112.35 -179.968 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' -1' ' ' ALA . . . . . . . . . . . . . . . -57.99 154.09 30.71 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 121.575 0.702 . . . . 44.35 111.098 179.887 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 0' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.78 -173.3 0.69 Allowed 'Trans proline' 0 C--N 1.342 0.2 0 C-N-CA 122.644 2.229 . . . . 73.52 112.35 -179.986 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 1' ' ' LYS . . . . . . . . . . . . . 33.8 mtpt -127.61 155.77 76.48 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-O 121.628 0.728 . . . . 73.4 110.875 179.908 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 2' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.79 165.07 32.23 Favored 'Trans proline' 0 C--N 1.342 0.21 0 C-N-CA 122.643 2.229 . . . . 74.11 112.351 179.912 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 3' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.79 -41.87 3.86 Favored 'Trans proline' 0 C--N 1.341 0.176 0 C-N-CA 122.686 2.258 . . . . 53.04 112.323 179.991 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 4' ' ' SER . . . . . . . . . . . . . 41.2 m -88.06 136.12 33.11 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.206 -0.452 . . . . 63.31 110.852 -179.836 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 5' ' ' SER . . . . . . . . . . . . . 1.8 t -126.25 102.03 7.0 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.146 -0.479 . . . . 34.43 110.873 -179.847 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 6' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.33 -0.282 0 CA-C-N 116.156 -0.474 . . . . 72.4 111.114 179.881 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' -4' ' ' MET . . . . . . . . . . . . . 40.3 mtp . . . . . 0 C--O 1.23 0.054 0 CA-C-O 120.762 0.315 . . . . 64.12 110.854 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' -3' ' ' ALA . . . . . . . . . . . . . . . -80.84 -32.86 34.92 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.234 -0.439 . . . . 54.44 111.134 179.898 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' -2' ' ' ILE . . . . . . . . . . . . . 85.0 mt -60.76 117.79 2.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.154 -0.475 . . . . 60.12 111.138 179.981 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' -1' ' ' VAL . . . . . . . . . . . . . 61.8 t -61.0 -34.88 61.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.174 -0.466 . . . . 71.33 111.142 179.89 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 2.6 t-20 63.82 45.19 4.52 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.172 -0.467 . . . . 71.31 110.896 180.0 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 7.9 tp-100 -109.51 134.06 52.35 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.168 -0.469 . . . . 73.24 110.931 179.965 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' ARG . . . . . 0.475 ' HG3' HD12 ' A' ' 58' ' ' ILE . 3.2 ptt-85 -84.15 162.4 20.26 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.213 -0.449 . . . . 71.34 110.858 -179.934 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -155.21 150.86 27.47 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.146 -0.479 . . . . 73.42 111.139 179.937 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 11.0 p -104.07 146.31 11.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.229 -0.441 . . . . 51.55 111.133 -179.991 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -84.82 111.14 19.37 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.187 -0.461 . . . . 21.02 111.099 179.88 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.743 HD21 ' CB ' ' A' ' 56' ' ' SER . 13.9 mt -76.42 -37.04 57.67 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.244 -0.435 . . . . 43.24 110.888 -179.946 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 4.0 m-85 -142.22 147.03 35.86 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.223 -0.444 . . . . 73.32 110.911 -179.96 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 3.5 p-10 -70.47 138.98 51.59 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.125 -0.489 . . . . 74.23 110.864 179.899 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 5.3 t80 -143.82 144.62 31.86 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.215 -0.448 . . . . 72.54 110.878 -179.89 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -112.98 145.2 32.58 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-O 121.688 0.756 . . . . 72.12 110.83 -179.892 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.81 139.7 40.68 Favored 'Trans proline' 0 C--N 1.342 0.226 0 C-N-CA 122.657 2.238 . . . . 74.41 112.347 179.985 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -101.37 -17.09 16.67 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.21 -0.45 . . . . 73.34 110.92 -179.984 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 9.0 m120 -116.26 176.53 5.06 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.104 -0.498 . . . . 71.35 110.923 -179.953 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 17.7 m-20 -91.51 21.55 4.54 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.218 -0.446 . . . . 61.24 110.894 179.907 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -141.97 17.52 2.12 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.191 -0.459 . . . . 65.42 110.867 -179.879 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 24.1 mt-10 -107.39 165.6 11.27 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.192 -0.458 . . . . 74.32 110.86 -179.976 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.553 HD11 ' HE3' ' A' ' 46' ' ' LYS . 28.7 tp -114.12 148.93 36.37 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.139 -0.482 . . . . 73.32 110.895 -179.931 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 19' ' ' ARG . . . . . 0.542 ' H ' HD12 ' A' ' 18' ' ' LEU . 0.8 OUTLIER -84.8 156.18 21.47 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.2 -0.454 . . . . 72.33 110.807 179.99 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.562 HD21 ' CG1' ' A' ' 55' ' ' VAL . 3.1 tp -140.26 150.17 43.75 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.131 -0.486 . . . . 42.42 110.932 179.984 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.666 ' HB3' ' CG ' ' A' ' 24' ' ' ASP . . . -141.42 137.29 32.12 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.191 -0.459 . . . . 52.01 111.102 179.827 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -50.79 121.88 6.54 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.265 -0.425 . . . . 55.23 110.867 -179.928 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 96.28 -6.51 66.05 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.697 -0.763 . . . . 54.52 112.476 -179.956 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 24' ' ' ASP . . . . . 0.666 ' CG ' ' HB3' ' A' ' 21' ' ' ALA . 1.0 OUTLIER -81.46 146.44 30.23 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.85 0.357 . . . . 75.01 110.838 -179.908 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 3.3 mm -100.81 142.52 15.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.186 -0.461 . . . . 73.22 111.165 179.999 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 1.4 m -144.95 158.55 13.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.155 -0.475 . . . . 64.41 111.09 179.918 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 51.6 m-85 -117.3 109.57 17.01 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.154 -0.476 . . . . 71.42 110.882 179.988 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.662 HD13 ' HB2' ' A' ' 39' ' ' ALA . 12.1 mm -73.11 102.7 1.63 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.113 -0.494 . . . . 63.51 111.082 -179.992 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 43.3 m -64.76 -39.57 93.83 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.159 -0.473 . . . . 71.31 110.891 -179.977 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 30' ' ' TYR . . . . . 0.54 ' CZ ' HG21 ' A' ' 38' ' ' VAL . 37.4 p90 -174.87 151.39 1.38 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.139 -0.482 . . . . 73.2 110.941 -179.856 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 31' ' ' LYS . . . . . 0.494 ' HG3' HD22 ' A' ' 37' ' ' LEU . 17.8 tttt -83.25 145.55 29.06 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.13 -0.486 . . . . 75.04 110.946 179.871 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 34.4 t60 -134.21 152.9 52.06 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.227 -0.442 . . . . 75.23 110.892 179.903 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -58.96 -173.98 0.55 Allowed Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.755 -0.736 . . . . 64.01 112.469 -179.954 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 27.6 mm-40 65.43 12.21 7.96 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.845 0.355 . . . . 73.23 110.943 -179.875 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 68.09 30.14 73.77 Favored Glycine 0 N--CA 1.452 -0.261 0 C-N-CA 120.702 -0.761 . . . . 63.04 112.496 -179.943 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 36' ' ' TRP . . . . . 0.633 ' C ' HD23 ' A' ' 37' ' ' LEU . 99.0 m95 -124.15 136.51 54.26 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.796 0.331 . . . . 62.04 110.95 -179.952 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.717 HD11 ' CG ' ' A' ' 52' ' ' GLU . 1.3 mt -120.58 133.36 55.39 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.252 -0.431 . . . . 35.31 110.951 179.962 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.54 HG21 ' CZ ' ' A' ' 30' ' ' TYR . 59.9 t -79.75 110.02 14.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.18 -0.464 . . . . 73.33 111.144 179.858 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.662 ' HB2' HD13 ' A' ' 28' ' ' ILE . . . -129.79 159.36 36.76 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.154 -0.475 . . . . 64.02 111.114 179.869 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 1.4 pt-20 -117.01 156.57 27.27 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.207 -0.451 . . . . 73.34 110.865 -179.919 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -70.18 -175.2 0.92 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.143 -0.48 . . . . 73.44 110.901 -179.983 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 -69.4 -38.21 77.83 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.167 -0.469 . . . . 70.25 110.895 179.965 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 1.5 t -56.37 -22.53 31.8 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.171 -0.468 . . . . 72.43 110.848 -179.786 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 69.16 9.53 60.61 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.757 -0.735 . . . . 62.12 112.476 -179.988 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -108.04 -20.82 13.05 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.947 0.403 . . . . 73.02 110.885 -179.751 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.553 ' HE3' HD11 ' A' ' 18' ' ' LEU . 4.0 ttpt -109.98 123.86 50.4 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.128 -0.487 . . . . 75.01 110.917 179.941 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 3.7 m -129.82 137.47 50.49 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.237 -0.438 . . . . 52.34 111.2 179.981 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -161.02 -157.48 8.77 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.765 -0.731 . . . . 62.45 112.508 179.976 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.454 HD23 HG22 ' A' ' 38' ' ' VAL . 8.7 mt -101.68 137.55 39.85 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.886 0.374 . . . . 72.02 110.866 -179.887 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.404 ' HB ' ' HD2' ' A' ' 51' ' ' PRO . 10.3 m -137.16 153.36 74.96 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 121.645 0.736 . . . . 70.45 111.1 179.825 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 0.427 ' HG2' ' HB2' ' A' ' 54' ' ' PHE . 53.4 Cg_endo -69.85 143.81 51.59 Favored 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 122.657 2.238 . . . . 73.02 112.306 179.961 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 52' ' ' GLU . . . . . 0.717 ' CG ' HD11 ' A' ' 37' ' ' LEU . 10.9 tm-20 -89.92 -28.09 19.42 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.189 -0.46 . . . . 72.05 110.903 179.983 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -85.97 10.35 14.33 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.17 -0.468 . . . . 73.02 110.847 -179.92 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 54' ' ' PHE . . . . . 0.427 ' HB2' ' HG2' ' A' ' 51' ' ' PRO . 0.9 OUTLIER -120.72 -8.96 9.41 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.174 -0.466 . . . . 72.52 110.875 -179.932 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.562 ' CG1' HD21 ' A' ' 20' ' ' LEU . 15.8 m -119.71 166.33 14.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.123 -0.489 . . . . 71.43 111.167 179.961 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 56' ' ' SER . . . . . 0.743 ' CB ' HD21 ' A' ' 7' ' ' LEU . 37.2 t -135.25 117.86 15.95 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.193 -0.458 . . . . 71.4 110.875 -179.868 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 3.3 m-85 -58.32 124.69 20.35 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.171 -0.468 . . . . 72.42 110.935 -179.896 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.475 HD12 ' HG3' ' A' ' 3' ' ' ARG . 22.8 mt -88.26 153.64 3.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.119 -0.491 . . . . 71.33 111.081 179.947 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 59' ' ' GLN . . . . . 0.407 ' HB2' ' HD2' ' A' ' 60' ' ' PRO . 8.1 pm0 -110.7 154.86 43.02 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 121.609 0.719 . . . . 72.31 110.929 179.95 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 60' ' ' PRO . . . . . 0.407 ' HD2' ' HB2' ' A' ' 59' ' ' GLN . 53.6 Cg_endo -69.77 -84.13 0.01 OUTLIER 'Trans proline' 0 C--N 1.341 0.148 0 C-N-CA 122.708 2.272 . . . . 54.43 112.346 -179.99 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 72.1 mt-10 -140.3 39.68 1.91 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.203 -0.453 . . . . 73.53 110.885 -179.989 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 1.7 pp -133.53 -179.09 5.31 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.125 -0.489 . . . . 73.44 110.904 -179.989 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 18.0 tp10 . . . . . 0 C--N 1.33 -0.271 0 CA-C-N 116.212 -0.449 . . . . 71.32 110.905 179.925 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' B' B ' -9' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.303 0 N-CA-C 112.457 -0.257 . . . . 75.4 112.457 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' B' B ' -8' ' ' LYS . . . . . . . . . . . . . 34.0 mtmt -91.5 -41.92 10.56 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.83 0.348 . . . . 75.04 110.91 -179.958 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' -7' ' ' PHE . . . . . 0.425 ' HB3' HD11 ' A' ' 49' ' ' LEU . 9.1 m-85 -88.01 133.6 33.92 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.229 -0.441 . . . . 73.54 110.913 179.926 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' -6' ' ' ILE . . . . . 0.416 HD13 ' O ' ' B' ' -7' ' ' PHE . 37.9 mm -145.51 87.22 7.05 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 121.63 0.729 . . . . 72.34 111.105 -179.997 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' -5' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.74 139.87 41.37 Favored 'Trans proline' 0 C--O 1.231 0.164 0 C-N-CA 122.707 2.272 . . . . 75.34 112.351 179.891 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' -4' ' ' SER . . . . . . . . . . . . . 27.5 t -132.96 66.16 1.57 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.227 -0.442 . . . . 61.13 110.903 -179.872 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' -3' ' ' ARG . . . . . . . . . . . . . 5.8 ptm180 -178.21 155.0 0.96 Allowed Pre-proline 0 C--N 1.329 -0.288 0 CA-C-O 121.6 0.714 . . . . 74.43 110.851 -179.95 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' -2' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.81 131.63 21.55 Favored 'Trans proline' 0 C--N 1.341 0.157 0 C-N-CA 122.654 2.236 . . . . 73.01 112.35 -179.978 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' -1' ' ' ALA . . . . . . . . . . . . . . . -70.47 151.67 95.56 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 121.62 0.724 . . . . 63.24 111.102 179.89 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 0' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.7 173.34 11.07 Favored 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.681 2.254 . . . . 75.14 112.363 -179.98 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 1' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -121.82 154.35 60.58 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 121.579 0.704 . . . . 74.42 110.891 179.865 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 2' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.74 159.82 51.99 Favored 'Trans proline' 0 C--O 1.232 0.186 0 C-N-CA 122.716 2.277 . . . . 74.42 112.345 179.89 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 3' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.73 -171.99 0.53 Allowed 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.735 2.29 . . . . 71.53 112.355 179.914 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 4' ' ' SER . . . . . . . . . . . . . 26.5 t -80.72 147.27 30.65 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.247 -0.433 . . . . 70.42 110.871 -179.835 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 5' ' ' SER . . . . . . . . . . . . . 12.6 t -143.85 123.66 13.43 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.152 -0.476 . . . . 72.32 110.807 -179.793 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 6' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.297 0 CA-C-N 116.103 -0.499 . . . . 73.23 111.128 179.888 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' -4' ' ' MET . . . . . . . . . . . . . 24.6 ttm . . . . . 0 C--O 1.23 0.079 0 CA-C-O 120.779 0.323 . . . . 62.3 110.861 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' -3' ' ' ALA . . . . . . . . . . . . . . . -124.66 117.15 23.62 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.25 -0.432 . . . . 75.11 111.108 179.902 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' -2' ' ' ILE . . . . . . . . . . . . . 85.7 mt -121.56 119.5 59.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.233 -0.44 . . . . 72.05 111.141 179.942 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' -1' ' ' VAL . . . . . . . . . . . . . 21.7 t -109.22 129.78 63.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.165 -0.47 . . . . 51.44 111.113 179.886 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 2.0 m120 -91.94 59.9 3.73 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.155 -0.475 . . . . 73.34 110.913 179.986 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 55.0 tp60 -96.71 127.92 43.16 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.18 -0.464 . . . . 74.45 110.945 179.988 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 7.7 ptp180 -82.0 164.15 21.64 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.188 -0.46 . . . . 74.51 110.821 -179.873 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -155.67 153.22 29.65 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.188 -0.46 . . . . 63.41 111.111 179.919 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.716 ' HB ' HD11 ' A' ' 58' ' ' ILE . 10.3 p -103.71 152.31 6.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.208 -0.451 . . . . 73.04 111.143 179.972 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -92.89 114.99 27.7 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.199 -0.455 . . . . 63.43 111.09 179.92 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.63 HD21 ' HB2' ' A' ' 56' ' ' SER . 7.0 mt -82.07 -35.64 28.47 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.224 -0.443 . . . . 71.54 110.925 -179.966 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 5.0 m-85 -141.82 137.83 31.77 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.207 -0.451 . . . . 75.53 110.979 179.965 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 3.0 p-10 -63.0 138.43 58.56 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.121 -0.491 . . . . 73.55 110.847 179.98 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 10.4 t80 -141.86 144.76 34.01 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.205 -0.452 . . . . 73.03 110.915 -179.927 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -113.1 144.33 30.92 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 121.656 0.741 . . . . 71.43 110.899 -179.925 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.75 132.39 23.25 Favored 'Trans proline' 0 C--N 1.342 0.193 0 C-N-CA 122.686 2.257 . . . . 65.03 112.324 179.991 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 15.3 mt-10 -94.47 -20.08 19.99 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.184 -0.462 . . . . 74.45 110.87 179.994 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 9.5 m120 -114.48 175.66 5.39 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.176 -0.465 . . . . 71.25 110.878 -179.929 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -86.85 8.66 21.98 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.199 -0.455 . . . . 52.23 110.899 179.896 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -129.44 20.52 5.68 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.186 -0.461 . . . . 71.53 110.905 -179.942 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 57.1 mt-10 -109.92 156.37 20.53 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.198 -0.455 . . . . 63.21 110.87 -179.962 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.535 HD23 ' O ' ' A' ' 19' ' ' ARG . 0.4 OUTLIER -105.13 153.83 20.99 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.16 -0.473 . . . . 74.23 110.927 -179.999 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 19' ' ' ARG . . . . . 0.535 ' O ' HD23 ' A' ' 18' ' ' LEU . 21.6 mtm180 -87.87 151.69 22.65 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.179 -0.464 . . . . 61.12 110.856 179.974 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.546 HD21 ' CG1' ' A' ' 55' ' ' VAL . 1.7 tp -137.47 148.7 46.27 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.171 -0.468 . . . . 64.12 110.94 179.981 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.612 ' HB3' ' CG ' ' A' ' 24' ' ' ASP . . . -141.62 140.28 33.27 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.197 -0.456 . . . . 72.13 111.107 179.795 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -50.62 120.28 4.56 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.234 -0.439 . . . . 73.32 110.912 -179.915 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 97.84 -7.11 62.78 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.716 -0.754 . . . . 62.05 112.474 -179.986 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 24' ' ' ASP . . . . . 0.612 ' CG ' ' HB3' ' A' ' 21' ' ' ALA . 2.1 m-20 -76.41 150.45 36.76 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.788 0.328 . . . . 54.11 110.84 -179.944 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 1.5 mt -116.91 120.08 63.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.201 -0.454 . . . . 73.32 111.118 -179.965 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 6.0 m -120.61 165.44 16.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.163 -0.472 . . . . 65.32 111.125 179.858 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 54.4 m-85 -115.57 107.4 15.09 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.162 -0.472 . . . . 65.25 110.887 179.987 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.782 HD13 ' HB2' ' A' ' 39' ' ' ALA . 17.4 mm -72.04 103.05 1.38 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.164 -0.471 . . . . 71.25 111.127 179.963 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 3.2 m -64.43 -39.25 93.48 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.196 -0.457 . . . . 72.03 110.856 -179.921 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 30' ' ' TYR . . . . . 0.507 ' CZ ' HG21 ' A' ' 38' ' ' VAL . 31.7 p90 -174.99 145.93 0.85 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.151 -0.477 . . . . 64.03 110.936 -179.862 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 31' ' ' LYS . . . . . 0.476 ' HG3' HD22 ' A' ' 37' ' ' LEU . 19.1 tttt -79.45 144.94 33.58 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.11 -0.496 . . . . 64.53 110.869 179.937 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 28.8 t60 -134.4 153.47 51.89 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.2 -0.455 . . . . 74.33 110.795 179.926 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -58.89 -174.05 0.54 Allowed Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.766 -0.731 . . . . 60.15 112.515 179.975 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 40.5 mm-40 64.59 13.4 8.24 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.834 0.35 . . . . 71.13 110.896 -179.892 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 67.32 28.57 73.7 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.743 -0.742 . . . . 33.53 112.456 179.975 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 36' ' ' TRP . . . . . 0.591 ' C ' HD23 ' A' ' 37' ' ' LEU . 98.5 m95 -121.96 135.82 54.88 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.805 0.336 . . . . 75.13 110.947 -179.951 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.673 HD11 ' CG ' ' A' ' 52' ' ' GLU . 0.9 OUTLIER -121.97 131.22 53.89 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.234 -0.439 . . . . 74.5 110.961 179.96 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.528 HG22 HD23 ' A' ' 49' ' ' LEU . 41.3 t -78.92 109.46 13.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.193 -0.458 . . . . 73.23 111.159 179.825 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.782 ' HB2' HD13 ' A' ' 28' ' ' ILE . . . -129.73 162.25 28.82 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.192 -0.458 . . . . 52.24 111.137 179.871 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 3.6 pm0 -118.17 159.9 22.5 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.233 -0.44 . . . . 43.41 110.893 -179.966 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 44.9 p-10 -58.88 -174.88 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.127 -0.488 . . . . 63.42 110.896 -179.946 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 6.1 tm-20 -78.05 -37.68 46.21 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.164 -0.471 . . . . 74.32 110.91 179.988 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 67.9 m -68.38 -21.89 64.68 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.127 -0.488 . . . . 72.31 110.863 -179.774 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 75.91 26.01 65.63 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.747 -0.74 . . . . 60.01 112.468 179.976 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 6.6 t -109.66 -21.27 12.51 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.931 0.396 . . . . 51.51 110.889 -179.747 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.511 ' HG3' HD11 ' A' ' 18' ' ' LEU . 0.9 OUTLIER -121.51 138.98 54.07 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.132 -0.485 . . . . 62.15 110.894 179.926 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 6.1 m -132.58 152.6 51.57 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.231 -0.441 . . . . 71.42 111.159 179.978 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -178.36 -161.91 27.15 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.717 -0.754 . . . . 63.03 112.454 179.938 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.528 HD23 HG22 ' A' ' 38' ' ' VAL . 5.8 mt -100.95 141.48 33.78 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.849 0.357 . . . . 74.24 110.915 -179.873 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.422 ' HB ' ' HD2' ' A' ' 51' ' ' PRO . 17.1 m -138.2 153.71 73.36 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-O 121.67 0.748 . . . . 63.03 111.091 179.876 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 0.451 ' HD2' HD22 ' A' ' 20' ' ' LEU . 53.7 Cg_endo -69.8 144.93 55.38 Favored 'Trans proline' 0 C--N 1.342 0.21 0 C-N-CA 122.661 2.241 . . . . 62.44 112.322 179.974 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 52' ' ' GLU . . . . . 0.673 ' CG ' HD11 ' A' ' 37' ' ' LEU . 25.8 tt0 -91.88 -26.93 18.24 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.22 -0.445 . . . . 62.04 110.914 180.0 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -87.89 10.59 18.18 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.168 -0.469 . . . . 35.15 110.918 -179.928 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 54' ' ' PHE . . . . . 0.421 ' HB2' ' HG2' ' A' ' 51' ' ' PRO . 1.0 OUTLIER -120.04 -14.22 8.91 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.121 -0.491 . . . . 75.33 110.898 -179.96 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.546 ' CG1' HD21 ' A' ' 20' ' ' LEU . 19.2 m -114.82 172.48 3.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.172 -0.467 . . . . 71.25 111.181 179.949 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 56' ' ' SER . . . . . 0.63 ' HB2' HD21 ' A' ' 7' ' ' LEU . 32.3 t -144.19 116.7 8.6 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.185 -0.461 . . . . 54.35 110.852 -179.842 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 2.8 m-85 -51.93 134.37 31.69 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.132 -0.486 . . . . 71.42 110.876 -179.827 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.716 HD11 ' HB ' ' A' ' 5' ' ' VAL . 52.2 mt -105.63 145.46 13.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.125 -0.489 . . . . 75.11 111.136 179.91 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 4.6 mt-30 -130.88 160.53 66.24 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 121.613 0.72 . . . . 74.53 110.888 179.994 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.75 -85.55 0.0 OUTLIER 'Trans proline' 0 C--N 1.341 0.165 0 C-N-CA 122.726 2.284 . . . . 73.5 112.348 179.982 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 30.9 tt0 -133.82 39.24 3.17 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.232 -0.44 . . . . 52.43 110.873 -179.981 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 12.5 mt -120.31 165.46 14.83 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.14 -0.482 . . . . 74.33 110.922 179.997 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 19.8 tt0 . . . . . 0 C--N 1.329 -0.283 0 CA-C-N 116.169 -0.469 . . . . 74.3 110.915 179.921 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' B' B ' -9' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.331 0 N-CA-C 112.517 -0.233 . . . . 51.35 112.517 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' B' B ' -8' ' ' LYS . . . . . . . . . . . . . 10.7 mptt -87.32 -59.94 2.11 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.823 0.344 . . . . 75.01 110.919 179.984 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' -7' ' ' PHE . . . . . . . . . . . . . 14.0 m-85 -68.43 137.92 54.88 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.243 -0.435 . . . . 74.11 110.835 179.981 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' -6' ' ' ILE . . . . . . . . . . . . . 55.8 mt -149.91 86.28 5.35 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-O 121.615 0.721 . . . . 73.5 111.13 179.921 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' -5' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.8 141.03 43.98 Favored 'Trans proline' 0 C--N 1.341 0.176 0 C-N-CA 122.64 2.226 . . . . 74.11 112.382 179.844 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' -4' ' ' SER . . . . . . . . . . . . . 2.6 t -139.5 65.89 1.42 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.25 -0.432 . . . . 73.41 110.884 -179.822 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' -3' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -178.56 154.51 0.87 Allowed Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.581 0.705 . . . . 74.55 110.9 -179.889 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' -2' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.77 124.2 10.85 Favored 'Trans proline' 0 C--N 1.342 0.2 0 C-N-CA 122.689 2.259 . . . . 63.22 112.333 -179.951 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' -1' ' ' ALA . . . . . . . . . . . . . . . -57.67 152.29 36.69 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.576 0.703 . . . . 52.24 111.099 179.897 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 0' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.77 172.79 12.0 Favored 'Trans proline' 0 C--N 1.342 0.194 0 C-N-CA 122.712 2.275 . . . . 75.44 112.341 -179.966 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 1' ' ' LYS . . . . . . . . . . . . . 12.7 ptmt -119.83 153.45 54.74 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.549 0.69 . . . . 74.21 110.874 179.907 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 2' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.81 162.53 41.76 Favored 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.631 2.221 . . . . 63.1 112.327 179.887 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 3' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.76 155.42 65.99 Favored 'Trans proline' 0 C--N 1.342 0.205 0 C-N-CA 122.655 2.236 . . . . 73.11 112.367 179.938 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 4' ' ' SER . . . . . . . . . . . . . 11.2 t -82.91 89.12 6.82 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.226 -0.443 . . . . 74.42 110.823 -179.827 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 5' ' ' SER . . . . . . . . . . . . . 11.4 t -127.9 164.98 21.08 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.146 -0.479 . . . . 70.12 110.848 -179.833 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 6' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.312 0 CA-C-N 116.123 -0.489 . . . . 74.2 111.117 179.893 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' -4' ' ' MET . . . . . . . . . . . . . 1.1 mpp? . . . . . 0 C--O 1.231 0.118 0 CA-C-O 120.811 0.339 . . . . 54.23 110.842 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' -3' ' ' ALA . . . . . . . . . . . . . . . -160.32 154.82 23.74 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.257 -0.428 . . . . 54.13 111.084 179.954 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' -2' ' ' ILE . . . . . . . . . . . . . 5.4 mp -115.61 125.98 72.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.205 -0.452 . . . . 73.34 111.14 179.948 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' -1' ' ' VAL . . . . . . . . . . . . . 14.5 p -91.78 -27.02 4.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.177 -0.465 . . . . 73.11 111.114 179.85 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 6.4 m-80 61.72 45.78 7.61 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.165 -0.471 . . . . 72.23 110.84 -179.992 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 55.7 tp60 -101.4 131.82 47.29 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.218 -0.446 . . . . 53.05 110.894 179.962 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 5.5 ptm180 -81.99 164.3 21.56 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.233 -0.44 . . . . 72.52 110.883 -179.967 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -156.76 155.33 31.43 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.2 -0.454 . . . . 61.12 111.118 179.939 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.639 ' HB ' HD11 ' A' ' 58' ' ' ILE . 10.5 p -104.95 152.31 6.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.256 -0.429 . . . . 74.11 111.164 179.985 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -90.65 112.27 23.93 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.222 -0.445 . . . . 75.43 111.045 179.919 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.757 HD21 ' HB3' ' A' ' 56' ' ' SER . 11.6 mt -78.54 -37.64 42.41 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.218 -0.447 . . . . 71.13 110.908 -179.984 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 5.5 m-85 -141.77 146.07 35.53 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.199 -0.455 . . . . 74.11 110.947 -179.957 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 4.0 p-10 -70.61 134.88 48.0 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.115 -0.493 . . . . 62.31 110.909 179.897 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 7.0 t80 -135.15 145.99 48.34 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.199 -0.455 . . . . 73.43 110.893 -179.897 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 5.7 tp10 -115.84 136.04 22.82 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 121.643 0.735 . . . . 74.52 110.892 -179.934 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.415 ' HD3' ' HA ' ' A' ' 19' ' ' ARG . 53.7 Cg_endo -69.8 148.27 64.43 Favored 'Trans proline' 0 C--N 1.341 0.177 0 C-N-CA 122.694 2.263 . . . . 43.13 112.341 -179.998 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -105.94 -21.73 13.08 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.201 -0.454 . . . . 61.45 110.877 -179.977 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 26.2 m120 -112.07 175.52 5.39 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.187 -0.46 . . . . 44.41 110.949 -179.964 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -88.34 10.34 20.18 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.227 -0.442 . . . . 55.12 110.899 179.905 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -126.22 14.03 7.77 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.169 -0.469 . . . . 73.13 110.936 -179.946 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 25.5 mt-10 -107.62 153.19 23.25 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.178 -0.464 . . . . 71.35 110.88 -179.98 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.544 HD23 ' O ' ' A' ' 19' ' ' ARG . 0.3 OUTLIER -103.25 151.56 22.53 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.137 -0.483 . . . . 72.02 110.911 -179.979 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 19' ' ' ARG . . . . . 0.544 ' O ' HD23 ' A' ' 18' ' ' LEU . 0.3 OUTLIER -88.73 155.26 19.68 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.175 -0.466 . . . . 74.34 110.856 179.997 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.541 HD21 ' CG1' ' A' ' 55' ' ' VAL . 2.0 tp -139.0 148.73 43.83 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.187 -0.46 . . . . 62.11 110.905 -179.959 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.648 ' HB3' ' CG ' ' A' ' 24' ' ' ASP . . . -140.46 137.96 34.3 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.185 -0.461 . . . . 74.31 111.101 179.769 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -50.24 120.36 4.45 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.188 -0.46 . . . . 75.21 110.91 -179.902 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 96.09 -0.32 62.18 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.74 -0.743 . . . . 75.24 112.497 -179.952 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 24' ' ' ASP . . . . . 0.648 ' CG ' ' HB3' ' A' ' 21' ' ' ALA . 1.3 m-20 -86.6 145.99 26.52 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.81 0.338 . . . . 51.51 110.856 -179.951 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 3.1 mm -102.65 139.9 22.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.176 -0.466 . . . . 60.55 111.138 -179.997 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 1.1 m -141.91 162.44 20.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.204 -0.453 . . . . 62.22 111.125 179.873 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 63.7 m-85 -118.92 108.84 15.27 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.201 -0.454 . . . . 72.54 110.872 -179.987 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.776 HD13 ' HB2' ' A' ' 39' ' ' ALA . 17.2 mm -73.13 103.35 1.82 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.139 -0.482 . . . . 64.2 111.122 179.976 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 5.9 m -64.88 -40.39 95.03 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.184 -0.462 . . . . 74.2 110.892 -179.946 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 30' ' ' TYR . . . . . 0.511 ' CZ ' HG21 ' A' ' 38' ' ' VAL . 36.2 p90 -174.61 149.7 1.28 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.142 -0.481 . . . . 74.4 110.918 -179.897 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 31' ' ' LYS . . . . . 0.491 ' HG3' HD22 ' A' ' 37' ' ' LEU . 20.5 tttt -81.56 144.24 31.42 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.152 -0.476 . . . . 74.14 110.894 179.919 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 31.5 t60 -133.25 153.34 51.65 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.242 -0.435 . . . . 73.5 110.918 179.849 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -59.09 -174.54 0.62 Allowed Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.778 -0.725 . . . . 74.12 112.42 -179.898 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 5.1 mt-30 65.95 11.99 8.1 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.88 0.371 . . . . 75.03 110.917 -179.909 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 68.36 28.99 72.99 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.753 -0.737 . . . . 51.54 112.502 -179.971 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 36' ' ' TRP . . . . . 0.634 ' C ' HD23 ' A' ' 37' ' ' LEU . 98.6 m95 -123.35 136.54 54.71 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.821 0.344 . . . . 75.52 110.941 -179.922 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.695 HD11 ' CG ' ' A' ' 52' ' ' GLU . 1.4 mt -120.24 132.73 55.47 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.249 -0.432 . . . . 63.42 110.926 179.959 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.511 HG21 ' CZ ' ' A' ' 30' ' ' TYR . 37.6 t -80.4 109.31 14.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.216 -0.447 . . . . 64.33 111.138 179.829 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.776 ' HB2' HD13 ' A' ' 28' ' ' ILE . . . -130.56 164.54 24.68 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.167 -0.469 . . . . 51.54 111.142 179.854 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 1.2 pt-20 -119.67 156.06 31.18 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.232 -0.44 . . . . 64.32 110.885 -179.933 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -67.54 -175.06 0.47 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.134 -0.485 . . . . 72.23 110.898 -179.916 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 6.9 tt0 -68.87 -37.62 79.19 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.221 -0.445 . . . . 72.23 110.827 -179.956 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 1.7 t -56.87 -22.46 37.13 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.19 -0.459 . . . . 62.32 110.885 -179.805 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 69.44 9.43 61.34 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.766 -0.73 . . . . 52.33 112.489 -179.996 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 7.4 m -108.78 -24.27 11.37 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.97 0.415 . . . . 73.5 110.853 -179.732 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.463 ' HG2' HD11 ' A' ' 18' ' ' LEU . 0.1 OUTLIER -105.51 123.61 48.18 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.149 -0.478 . . . . 74.42 110.857 179.932 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 3.4 m -124.47 152.59 43.16 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.223 -0.444 . . . . 74.24 111.175 179.928 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -177.29 -161.71 26.3 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.723 -0.751 . . . . 73.53 112.485 179.968 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.49 HD23 HG22 ' A' ' 38' ' ' VAL . 5.5 mt -100.59 134.44 43.55 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.876 0.369 . . . . 72.02 110.885 -179.861 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.403 ' HB ' ' HD2' ' A' ' 51' ' ' PRO . 10.4 m -133.77 153.23 79.92 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-O 121.632 0.729 . . . . 61.42 111.135 179.866 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 0.411 ' HG2' ' HB2' ' A' ' 54' ' ' PHE . 53.8 Cg_endo -69.77 144.97 55.66 Favored 'Trans proline' 0 C--N 1.342 0.207 0 C-N-CA 122.667 2.245 . . . . 73.14 112.343 179.928 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 52' ' ' GLU . . . . . 0.695 ' CG ' HD11 ' A' ' 37' ' ' LEU . 12.0 tm-20 -91.05 -28.85 17.69 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.233 -0.44 . . . . 64.33 110.868 -179.961 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 2.1 mm-40 -85.11 9.05 15.93 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.198 -0.456 . . . . 54.31 110.927 -179.965 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 54' ' ' PHE . . . . . 0.411 ' HB2' ' HG2' ' A' ' 51' ' ' PRO . 1.1 m-85 -120.33 -2.76 10.03 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.13 -0.486 . . . . 75.42 110.895 -179.922 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.541 ' CG1' HD21 ' A' ' 20' ' ' LEU . 13.0 m -125.27 171.66 13.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.14 -0.482 . . . . 71.22 111.138 179.949 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 56' ' ' SER . . . . . 0.757 ' HB3' HD21 ' A' ' 7' ' ' LEU . 4.1 t -142.94 117.14 9.52 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.179 -0.464 . . . . 72.1 110.86 -179.845 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 3.1 m-85 -55.05 133.39 48.65 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.14 -0.482 . . . . 72.41 110.926 -179.924 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.639 HD11 ' HB ' ' A' ' 5' ' ' VAL . 46.8 mt -103.92 148.59 8.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.105 -0.498 . . . . 72.14 111.142 179.895 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -131.01 160.81 65.12 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-O 121.646 0.736 . . . . 71.41 110.881 179.939 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.78 -85.81 0.0 OUTLIER 'Trans proline' 0 C--N 1.342 0.215 0 C-N-CA 122.71 2.273 . . . . 54.33 112.328 -179.981 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 23.3 mt-10 -128.77 23.74 5.76 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.234 -0.439 . . . . 65.34 110.874 -179.969 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 3.2 pp -136.53 177.64 7.69 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.174 -0.467 . . . . 73.25 110.937 -179.989 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 14.5 tp10 . . . . . 0 C--N 1.329 -0.298 0 CA-C-N 116.197 -0.456 . . . . 72.03 110.903 179.955 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' B' B ' -9' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.316 0 N-CA-C 112.497 -0.241 . . . . 71.11 112.497 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' B' B ' -8' ' ' LYS . . . . . . . . . . . . . 12.3 pttt -52.87 -42.84 65.63 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.788 0.328 . . . . 74.01 110.872 -179.953 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' -7' ' ' PHE . . . . . 0.474 ' HB3' HD11 ' A' ' 49' ' ' LEU . 13.4 m-85 -98.34 162.87 12.95 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.223 -0.444 . . . . 65.31 110.904 179.965 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' -6' ' ' ILE . . . . . 0.51 ' O ' HG23 ' B' ' -6' ' ' ILE . 4.0 tp -171.9 87.94 0.44 Allowed Pre-proline 0 C--N 1.328 -0.329 0 CA-C-O 121.632 0.73 . . . . 72.53 111.155 179.944 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' -5' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.73 146.33 60.06 Favored 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 122.677 2.251 . . . . 75.41 112.377 179.844 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' -4' ' ' SER . . . . . . . . . . . . . 28.6 t -141.7 63.6 1.42 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.21 -0.45 . . . . 74.45 110.853 -179.841 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' -3' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -179.32 155.42 0.79 Allowed Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.576 0.703 . . . . 73.43 110.886 -179.954 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' -2' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.76 129.13 17.07 Favored 'Trans proline' 0 C--N 1.341 0.175 0 C-N-CA 122.661 2.24 . . . . 74.24 112.337 -179.969 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' -1' ' ' ALA . . . . . . . . . . . . . . . -62.61 152.33 81.49 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-O 121.614 0.721 . . . . 51.41 111.107 179.875 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 0' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.72 175.81 7.58 Favored 'Trans proline' 0 C--N 1.341 0.17 0 C-N-CA 122.696 2.264 . . . . 44.35 112.337 -179.968 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 1' ' ' LYS . . . . . . . . . . . . . 14.2 pttm -123.55 154.36 66.36 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-O 121.647 0.737 . . . . 70.3 110.86 179.92 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 2' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.72 163.41 38.34 Favored 'Trans proline' 0 C--N 1.342 0.195 0 C-N-CA 122.722 2.281 . . . . 55.32 112.353 179.899 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 3' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.72 -170.69 0.41 Allowed 'Trans proline' 0 C--N 1.341 0.152 0 C-N-CA 122.7 2.266 . . . . 65.21 112.332 179.961 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 4' ' ' SER . . . . . . . . . . . . . 1.7 t -98.19 123.63 42.35 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.208 -0.451 . . . . 61.14 110.89 -179.886 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 5' ' ' SER . . . . . . . . . . . . . 47.3 t -122.5 158.24 30.24 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.152 -0.476 . . . . 75.41 110.872 -179.835 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 6' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.328 -0.329 0 CA-C-N 116.139 -0.482 . . . . 72.34 111.073 179.904 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' -4' ' ' MET . . . . . . . . . . . . . 6.1 tpp . . . . . 0 C--O 1.231 0.106 0 CA-C-O 120.784 0.326 . . . . 74.3 110.865 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' -3' ' ' ALA . . . . . . . . . . . . . . . -99.99 27.56 5.45 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.245 -0.434 . . . . 75.44 111.101 179.894 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' -2' ' ' ILE . . . . . . . . . . . . . 78.3 mt -116.3 129.02 73.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.226 -0.443 . . . . 70.22 111.082 179.998 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' -1' ' ' VAL . . . . . . . . . . . . . 14.7 p -86.16 -27.13 6.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.119 -0.491 . . . . 65.25 111.069 179.895 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 33.6 m-80 59.83 54.08 4.51 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.205 -0.452 . . . . 62.54 110.862 -179.992 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 50.8 tp60 -112.91 126.64 55.69 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.206 -0.452 . . . . 62.31 110.932 -179.999 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 5.6 ptp180 -78.82 161.4 26.81 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.278 -0.419 . . . . 60.24 110.902 -179.931 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -156.24 154.86 31.4 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.233 -0.44 . . . . 53.33 111.122 179.942 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.574 ' HB ' HD11 ' A' ' 58' ' ' ILE . 11.1 p -104.94 151.26 7.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.209 -0.451 . . . . 54.11 111.102 -179.972 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -89.3 111.08 21.81 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.163 -0.471 . . . . 74.3 111.065 179.915 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.721 HD21 ' HB2' ' A' ' 56' ' ' SER . 11.5 mt -75.82 -38.63 57.95 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.221 -0.445 . . . . 63.35 110.875 -179.949 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 4.1 m-85 -141.86 148.95 39.62 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.172 -0.467 . . . . 75.33 110.892 -179.946 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 3.7 p-10 -71.28 131.49 43.53 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.142 -0.481 . . . . 60.14 110.89 179.894 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 1.8 t80 -129.54 146.15 51.39 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.228 -0.442 . . . . 74.24 110.866 -179.906 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 32.5 tt0 -116.2 137.06 23.18 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-O 121.654 0.74 . . . . 74.41 110.919 -179.911 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.7 148.27 65.1 Favored 'Trans proline' 0 C--N 1.341 0.154 0 C-N-CA 122.689 2.259 . . . . 72.24 112.373 -179.99 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 18.1 mm-40 -110.79 -18.62 13.08 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.264 -0.425 . . . . 71.12 110.903 179.993 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 9.8 m120 -112.59 176.25 5.09 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.154 -0.475 . . . . 65.24 110.842 -179.925 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 7.9 p-10 -91.54 20.11 5.66 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.162 -0.472 . . . . 65.13 110.848 179.907 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -138.68 14.68 2.72 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.241 -0.436 . . . . 74.42 110.904 -179.907 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 30.3 mt-10 -103.7 164.7 11.5 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.169 -0.469 . . . . 73.15 110.907 -179.966 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.568 HD12 ' H ' ' A' ' 19' ' ' ARG . 39.2 tp -115.35 146.78 41.22 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.181 -0.463 . . . . 40.13 110.936 -179.975 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 19' ' ' ARG . . . . . 0.568 ' H ' HD12 ' A' ' 18' ' ' LEU . 34.6 mtm-85 -82.25 156.8 24.17 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.242 -0.436 . . . . 62.24 110.913 179.93 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.54 HD21 ' CG1' ' A' ' 55' ' ' VAL . 2.9 tp -142.27 147.55 36.62 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.203 -0.453 . . . . 53.32 110.946 179.985 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.716 ' HB3' ' OD2' ' A' ' 24' ' ' ASP . . . -138.79 137.77 36.97 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.231 -0.44 . . . . 60.24 111.113 179.791 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -50.82 120.89 5.2 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.228 -0.442 . . . . 75.21 110.883 -179.923 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 97.25 -5.65 63.13 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.722 -0.751 . . . . 52.32 112.457 179.985 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 24' ' ' ASP . . . . . 0.716 ' OD2' ' HB3' ' A' ' 21' ' ' ALA . 5.7 m-20 -81.34 147.82 29.67 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.811 0.339 . . . . 50.13 110.862 -179.94 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 3.4 mm -101.46 141.56 17.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.231 -0.44 . . . . 71.53 111.125 -179.977 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.413 HG11 HD11 ' A' ' 20' ' ' LEU . 1.5 m -144.79 158.38 14.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.187 -0.461 . . . . 71.1 111.117 179.883 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 57.8 m-85 -117.47 108.38 15.46 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.15 -0.477 . . . . 74.52 110.892 179.965 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.857 HD13 ' HB2' ' A' ' 39' ' ' ALA . 20.1 mm -72.44 103.11 1.51 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.128 -0.487 . . . . 65.03 111.117 -179.996 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 5.7 m -65.05 -40.21 94.44 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.162 -0.472 . . . . 73.5 110.872 -179.922 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 30' ' ' TYR . . . . . 0.513 ' CZ ' HG21 ' A' ' 38' ' ' VAL . 33.9 p90 -174.61 149.11 1.22 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.155 -0.475 . . . . 74.24 110.944 -179.885 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 31' ' ' LYS . . . . . 0.528 ' HG3' HD22 ' A' ' 37' ' ' LEU . 19.0 tttt -81.32 143.25 32.35 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.192 -0.458 . . . . 71.34 110.94 179.874 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 33.4 t60 -131.73 155.36 47.82 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.241 -0.436 . . . . 70.43 110.823 179.932 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -60.79 -174.11 1.11 Allowed Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.728 -0.749 . . . . 51.35 112.493 -179.958 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 84.7 mm-40 65.43 12.55 8.22 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.833 0.349 . . . . 72.31 110.939 -179.849 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 68.53 29.19 72.89 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.739 -0.743 . . . . 73.13 112.496 -179.955 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 36' ' ' TRP . . . . . 0.652 ' C ' HD23 ' A' ' 37' ' ' LEU . 99.0 m95 -123.69 136.8 54.68 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.819 0.342 . . . . 70.45 110.906 -179.929 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.709 HD11 ' CG ' ' A' ' 52' ' ' GLU . 1.3 mt -121.09 130.57 53.81 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.258 -0.428 . . . . 72.11 110.939 179.972 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.513 HG21 ' CZ ' ' A' ' 30' ' ' TYR . 47.4 t -76.9 112.36 14.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.197 -0.456 . . . . 51.31 111.139 179.866 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.857 ' HB2' HD13 ' A' ' 28' ' ' ILE . . . -133.88 159.96 39.1 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.182 -0.463 . . . . 73.41 111.106 179.869 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -114.09 155.57 25.75 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.204 -0.453 . . . . 64.14 110.841 -179.909 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -70.56 -175.32 1.02 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.098 -0.501 . . . . 52.41 110.883 -179.951 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -69.86 -39.13 76.56 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.151 -0.477 . . . . 74.13 110.861 -179.956 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 11.8 m -56.29 -22.51 30.72 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.152 -0.476 . . . . 71.42 110.852 -179.809 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 66.81 11.4 57.69 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.754 -0.736 . . . . 50.32 112.498 -179.972 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 47.5 t -108.22 -14.35 14.72 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.956 0.407 . . . . 74.43 110.838 -179.708 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 6.1 ptmt -121.37 135.43 55.08 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.161 -0.472 . . . . 74.43 110.881 179.991 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 5.4 m -137.15 141.16 42.24 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.233 -0.439 . . . . 75.43 111.146 179.986 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -161.97 -154.81 7.67 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.711 -0.757 . . . . 72.22 112.499 179.947 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.506 HD11 ' HB3' ' B' ' -7' ' ' PHE . 6.8 mt -104.82 131.48 52.24 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.811 0.339 . . . . 53.53 110.936 -179.918 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.4 ' HB ' ' HD2' ' A' ' 51' ' ' PRO . 10.8 m -129.64 153.13 80.7 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-O 121.606 0.717 . . . . 63.21 111.185 179.812 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 0.429 ' HG2' ' HB2' ' A' ' 54' ' ' PHE . 53.5 Cg_endo -69.76 144.84 55.31 Favored 'Trans proline' 0 C--N 1.342 0.189 0 C-N-CA 122.691 2.261 . . . . 63.14 112.37 179.957 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 52' ' ' GLU . . . . . 0.709 ' CG ' HD11 ' A' ' 37' ' ' LEU . 8.3 tm-20 -90.48 -29.11 18.13 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.208 -0.451 . . . . 61.52 110.854 -179.949 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -85.25 9.87 14.03 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.19 -0.459 . . . . 74.13 110.914 -179.932 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 54' ' ' PHE . . . . . 0.429 ' HB2' ' HG2' ' A' ' 51' ' ' PRO . 1.0 OUTLIER -120.87 -7.82 9.47 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.136 -0.484 . . . . 74.55 110.862 -179.913 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.54 ' CG1' HD21 ' A' ' 20' ' ' LEU . 19.2 m -119.79 170.54 9.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.149 -0.478 . . . . 75.03 111.102 179.983 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 56' ' ' SER . . . . . 0.721 ' HB2' HD21 ' A' ' 7' ' ' LEU . 31.2 t -141.61 113.27 7.74 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.143 -0.481 . . . . 54.3 110.878 -179.858 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 3.1 m-85 -52.93 130.79 34.57 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.145 -0.48 . . . . 74.34 110.888 -179.841 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.574 HD11 ' HB ' ' A' ' 5' ' ' VAL . 51.4 mt -99.01 148.19 6.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.123 -0.489 . . . . 52.55 111.17 179.874 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 59' ' ' GLN . . . . . 0.4 ' HB2' ' HD2' ' A' ' 60' ' ' PRO . 7.1 pt20 -114.87 154.88 46.94 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 121.634 0.731 . . . . 75.14 110.882 179.975 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 60' ' ' PRO . . . . . 0.4 ' HD2' ' HB2' ' A' ' 59' ' ' GLN . 53.7 Cg_endo -69.79 -85.23 0.0 OUTLIER 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.699 2.266 . . . . 53.24 112.301 179.991 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 30.6 mt-10 -133.61 46.91 2.51 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.242 -0.435 . . . . 75.34 110.889 -179.967 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 18.6 mt -98.91 160.02 14.55 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.16 -0.473 . . . . 62.32 110.9 -179.972 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 . . . . . 0 C--N 1.329 -0.286 0 CA-C-N 116.185 -0.461 . . . . 70.43 110.945 179.975 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' B' B ' -9' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.302 0 N-CA-C 112.507 -0.237 . . . . 52.52 112.507 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' B' B ' -8' ' ' LYS . . . . . . . . . . . . . 22.4 ttpt -94.47 -36.48 11.85 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.81 0.338 . . . . 54.34 110.9 -179.967 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' -7' ' ' PHE . . . . . 0.506 ' HB3' HD11 ' A' ' 49' ' ' LEU . 9.8 m-85 -79.57 151.29 30.75 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.183 -0.462 . . . . 64.21 110.916 179.946 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' -6' ' ' ILE . . . . . . . . . . . . . 1.6 pt -153.08 86.14 4.16 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-O 121.627 0.727 . . . . 63.0 111.15 179.995 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' -5' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.74 139.59 40.66 Favored 'Trans proline' 0 C--O 1.231 0.173 0 C-N-CA 122.683 2.256 . . . . 72.33 112.345 179.898 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' -4' ' ' SER . . . . . . . . . . . . . 1.5 t -135.24 65.63 1.55 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.222 -0.445 . . . . 71.41 110.88 -179.845 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' -3' ' ' ARG . . . . . . . . . . . . . 5.4 ptm180 -178.2 154.46 0.93 Allowed Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.569 0.699 . . . . 74.32 110.876 -179.964 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' -2' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.77 131.55 21.47 Favored 'Trans proline' 0 C--N 1.341 0.138 0 C-N-CA 122.682 2.255 . . . . 73.02 112.321 -179.953 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' -1' ' ' ALA . . . . . . . . . . . . . . . -68.84 152.49 96.73 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.526 0.679 . . . . 45.43 111.127 179.859 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 0' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.81 171.51 14.39 Favored 'Trans proline' 0 C--N 1.341 0.157 0 C-N-CA 122.666 2.244 . . . . 65.53 112.318 -179.958 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 1' ' ' LYS . . . . . . . . . . . . . 21.1 mmmt -119.58 153.81 54.3 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.612 0.72 . . . . 50.01 110.835 179.955 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 2' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.72 163.5 37.99 Favored 'Trans proline' 0 C--N 1.342 0.205 0 C-N-CA 122.694 2.263 . . . . 75.35 112.358 179.863 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 3' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.71 150.56 68.7 Favored 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.728 2.286 . . . . 61.43 112.333 179.937 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 4' ' ' SER . . . . . . . . . . . . . 1.7 t -81.96 -28.57 32.65 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.195 -0.457 . . . . 73.33 110.87 -179.873 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 5' ' ' SER . . . . . . . . . . . . . 43.9 p -58.46 -33.74 70.09 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.172 -0.467 . . . . 61.43 110.848 -179.843 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 6' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.308 0 CA-C-N 116.167 -0.47 . . . . 72.53 111.142 179.873 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 44.9 tp60 . . . . . 0 C--O 1.231 0.13 0 CA-C-O 120.791 0.329 . . . . 75.22 110.926 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 7.6 ptt180 -74.65 162.11 29.05 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.216 -0.447 . . . . 61.12 110.892 -179.896 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -157.1 155.0 30.34 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.195 -0.457 . . . . 74.3 111.105 179.954 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.485 ' HB ' HD11 ' A' ' 58' ' ' ILE . 10.8 p -104.01 150.31 7.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.233 -0.44 . . . . 62.42 111.171 179.959 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -89.13 105.4 17.77 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.175 -0.466 . . . . 75.04 111.027 179.947 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 0.771 HD21 ' HB3' ' A' ' 56' ' ' SER . 15.5 mt -70.17 -36.82 74.94 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.2 -0.455 . . . . 75.23 110.937 179.998 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 3.5 m-85 -143.79 156.67 44.57 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.187 -0.461 . . . . 63.34 110.958 179.996 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -79.03 135.53 36.91 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.167 -0.47 . . . . 75.04 110.871 179.938 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 9.3 t80 -135.97 146.0 46.78 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.227 -0.442 . . . . 74.24 110.873 -179.894 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 28.8 tt0 -116.04 136.12 22.9 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-O 121.654 0.74 . . . . 75.22 110.855 -179.917 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.8 146.05 58.78 Favored 'Trans proline' 0 C--N 1.342 0.189 0 C-N-CA 122.661 2.241 . . . . 73.52 112.311 -179.972 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 7.8 mm-40 -107.93 -18.74 13.72 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.196 -0.457 . . . . 74.33 110.853 -179.967 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 35.5 m-80 -111.45 176.06 5.17 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.146 -0.479 . . . . 73.13 110.893 -179.934 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -92.16 20.89 5.51 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.169 -0.469 . . . . 73.13 110.865 179.906 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -138.24 12.29 2.81 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.179 -0.464 . . . . 64.21 110.906 -179.938 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 20.4 mt-10 -105.49 156.17 18.47 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.168 -0.469 . . . . 73.21 110.909 -179.998 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.53 HD23 ' O ' ' A' ' 19' ' ' ARG . 0.3 OUTLIER -105.53 151.44 24.29 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.206 -0.452 . . . . 71.25 110.879 -179.943 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . 0.53 ' O ' HD23 ' A' ' 18' ' ' LEU . 12.6 mtp180 -87.79 150.86 23.3 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.17 -0.468 . . . . 73.2 110.861 179.985 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.562 HD11 HG11 ' A' ' 26' ' ' VAL . 2.3 tp -135.17 149.57 49.98 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.242 -0.435 . . . . 71.14 110.927 -179.981 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.664 ' HB3' ' CG ' ' A' ' 24' ' ' ASP . . . -140.24 136.81 33.74 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.219 -0.446 . . . . 61.25 111.124 179.798 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 3.0 tt0 -50.45 120.24 4.45 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.218 -0.447 . . . . 51.2 110.889 -179.927 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 96.16 -0.56 62.2 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.696 -0.764 . . . . 53.45 112.499 -179.98 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . 0.664 ' CG ' ' HB3' ' A' ' 21' ' ' ALA . 1.1 m-20 -87.32 147.46 25.49 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.823 0.344 . . . . 65.52 110.865 -179.975 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 3.2 mm -100.62 141.04 18.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.173 -0.467 . . . . 74.4 111.131 -179.97 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.562 HG11 HD11 ' A' ' 20' ' ' LEU . 1.4 m -142.75 158.25 18.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.202 -0.454 . . . . 71.14 111.135 179.879 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 58.4 m-85 -117.19 108.11 15.27 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.165 -0.47 . . . . 70.24 110.905 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.724 HD13 ' HB2' ' A' ' 39' ' ' ALA . 16.6 mm -72.75 102.7 1.52 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.147 -0.479 . . . . 65.21 111.165 179.983 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 4.6 m -64.82 -40.88 95.91 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.19 -0.459 . . . . 71.35 110.861 -179.853 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' TYR . . . . . 0.518 ' CZ ' HG21 ' A' ' 38' ' ' VAL . 36.3 p90 -173.86 149.27 1.52 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.113 -0.494 . . . . 75.05 110.895 -179.931 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . 0.447 ' HG3' HD22 ' A' ' 37' ' ' LEU . 9.4 tttm -80.82 145.09 31.6 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.076 -0.511 . . . . 51.12 110.898 179.892 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 27.5 t60 -132.75 155.9 48.04 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.232 -0.44 . . . . 74.54 110.882 179.85 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -61.75 -174.21 1.65 Allowed Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.675 -0.774 . . . . 75.53 112.514 -179.946 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 57.1 mm-40 64.87 13.28 8.42 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.87 0.367 . . . . 64.33 110.874 -179.909 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 68.16 29.98 73.59 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.737 -0.744 . . . . 71.44 112.473 -179.984 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' TRP . . . . . 0.643 ' C ' HD23 ' A' ' 37' ' ' LEU . 98.3 m95 -123.58 137.52 54.74 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.83 0.348 . . . . 73.02 110.921 -179.929 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.715 HD11 ' CG ' ' A' ' 52' ' ' GLU . 1.6 mt -120.57 133.19 55.41 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.247 -0.433 . . . . 74.44 110.951 179.98 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.518 HG21 ' CZ ' ' A' ' 30' ' ' TYR . 75.8 t -79.95 109.09 14.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.214 -0.448 . . . . 73.31 111.161 179.851 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . 0.724 ' HB2' HD13 ' A' ' 28' ' ' ILE . . . -129.46 160.99 31.43 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.243 -0.435 . . . . 44.33 111.07 179.945 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 3.3 pm0 -119.02 159.3 24.12 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.225 -0.443 . . . . 71.01 110.878 -179.933 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -71.95 -175.26 1.39 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.139 -0.482 . . . . 53.34 110.854 -179.924 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -69.63 -38.58 77.24 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.147 -0.479 . . . . 63.41 110.893 -179.989 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 1.5 t -56.03 -22.64 28.45 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.149 -0.478 . . . . 52.42 110.843 -179.77 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 69.76 9.02 61.65 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.814 -0.708 . . . . 74.42 112.474 179.982 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 3.7 t -108.88 -19.86 13.25 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.923 0.392 . . . . 74.12 110.871 -179.755 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.449 ' HG2' HD11 ' A' ' 18' ' ' LEU . 1.1 ttmt -109.85 123.62 49.9 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.134 -0.485 . . . . 72.44 110.94 179.913 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 6.1 m -126.82 152.58 46.77 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.269 -0.423 . . . . 71.24 111.116 -179.99 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -177.21 -161.16 25.3 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.744 -0.741 . . . . 63.43 112.484 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.464 HD23 HG22 ' A' ' 38' ' ' VAL . 4.8 mt -100.7 138.74 37.35 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.835 0.35 . . . . 75.43 110.885 -179.901 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.42 ' HB ' ' HD2' ' A' ' 51' ' ' PRO . 6.1 m -137.36 153.56 74.76 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-O 121.634 0.73 . . . . 72.1 111.143 179.82 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . 0.42 ' HD2' ' HB ' ' A' ' 50' ' ' VAL . 53.8 Cg_endo -69.8 142.9 48.99 Favored 'Trans proline' 0 C--N 1.341 0.184 0 C-N-CA 122.639 2.226 . . . . 73.02 112.332 179.977 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . 0.715 ' CG ' HD11 ' A' ' 37' ' ' LEU . 15.7 tm-20 -89.88 -27.3 19.98 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.18 -0.464 . . . . 64.11 110.92 -179.992 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -87.12 12.08 12.38 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.111 -0.495 . . . . 74.22 110.895 -179.97 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . 0.42 ' HB2' ' HG2' ' A' ' 51' ' ' PRO . 1.0 OUTLIER -121.89 -8.81 8.86 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.154 -0.475 . . . . 73.54 110.883 -179.912 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.538 ' CG1' HD21 ' A' ' 20' ' ' LEU . 17.2 m -120.42 169.83 11.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.125 -0.489 . . . . 74.2 111.127 179.968 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . 0.771 ' HB3' HD21 ' A' ' 7' ' ' LEU . 3.8 t -138.69 115.27 10.58 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.19 -0.459 . . . . 64.35 110.869 -179.854 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 3.0 m-85 -54.2 128.8 32.59 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.183 -0.462 . . . . 74.33 110.924 -179.889 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.485 HD11 ' HB ' ' A' ' 5' ' ' VAL . 45.6 mt -97.06 148.65 5.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.114 -0.494 . . . . 64.2 111.15 179.939 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 4.3 mt-30 . . . . . 0 C--N 1.329 -0.297 0 CA-C-O 121.616 0.722 . . . . 74.43 110.873 179.985 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' B' B ' -7' ' ' PHE . . . . . 0.444 ' HB3' HD11 ' A' ' 49' ' ' LEU . 13.5 m-85 . . . . . 0 C--O 1.232 0.165 0 CA-C-O 120.807 0.337 . . . . 74.42 110.888 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' -6' ' ' ILE . . . . . . . . . . . . . 2.7 pt -153.21 84.13 4.47 Favored Pre-proline 0 C--N 1.328 -0.344 0 CA-C-O 121.656 0.741 . . . . 74.22 111.12 179.977 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' -5' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.71 134.52 28.3 Favored 'Trans proline' 0 C--N 1.342 0.207 0 C-N-CA 122.682 2.254 . . . . 71.0 112.342 179.857 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' -4' ' ' SER . . . . . . . . . . . . . 26.3 t -131.5 65.4 1.57 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.193 -0.458 . . . . 74.42 110.87 -179.863 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' -3' ' ' ARG . . . . . . . . . . . . . 6.9 ptm180 -178.66 155.0 0.87 Allowed Pre-proline 0 C--N 1.33 -0.282 0 CA-C-O 121.625 0.726 . . . . 75.13 110.84 -179.95 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' -2' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.83 129.3 17.29 Favored 'Trans proline' 0 C--N 1.341 0.17 0 C-N-CA 122.718 2.279 . . . . 62.11 112.313 -179.964 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' -1' ' ' ALA . . . . . . . . . . . . . . . -63.5 154.48 79.27 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-O 121.525 0.678 . . . . 71.53 111.157 179.847 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 0' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.78 176.75 6.36 Favored 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.663 2.242 . . . . 72.11 112.334 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 1' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -125.07 146.99 55.5 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.561 0.696 . . . . 73.33 110.882 179.951 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 2' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo . . . . . 0 C--N 1.341 0.158 0 C-N-CA 122.646 2.231 . . . . 71.35 112.363 179.873 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 51.6 tp60 . . . . . 0 C--O 1.231 0.105 0 CA-C-O 120.821 0.343 . . . . 74.42 110.92 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 5.9 ptt180 -89.58 164.67 14.67 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.202 -0.454 . . . . 71.43 110.896 -179.949 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -155.56 152.39 28.75 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.235 -0.439 . . . . 64.43 111.114 179.98 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.66 ' HB ' HD11 ' A' ' 58' ' ' ILE . 10.7 p -104.17 147.91 9.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.245 -0.434 . . . . 62.43 111.164 179.918 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . 0.423 ' HB3' ' O ' ' A' ' 21' ' ' ALA . . . -87.75 112.61 22.6 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.152 -0.477 . . . . 74.3 111.082 179.913 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 0.703 HD21 ' CB ' ' A' ' 56' ' ' SER . 10.4 mt -77.91 -37.77 47.12 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.2 -0.454 . . . . 74.13 110.962 179.987 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 4.0 m-85 -140.59 141.39 35.19 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.171 -0.468 . . . . 72.41 110.908 -179.972 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 2.2 p30 -65.13 132.99 50.59 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.128 -0.487 . . . . 73.3 110.898 179.899 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 2.1 t80 -129.83 146.34 51.57 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.204 -0.453 . . . . 65.51 110.888 -179.89 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 47.2 tt0 -117.03 137.06 23.51 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-O 121.62 0.724 . . . . 53.14 110.864 -179.893 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.79 150.99 68.79 Favored 'Trans proline' 0 C--N 1.342 0.189 0 C-N-CA 122.676 2.25 . . . . 74.25 112.311 -179.96 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 6.3 mm-40 -113.9 -15.82 12.3 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.206 -0.452 . . . . 72.25 110.913 179.981 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 31.2 m-80 -114.92 175.97 5.26 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.208 -0.451 . . . . 70.2 110.863 -179.936 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 27.1 m-20 -91.02 18.39 6.79 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.144 -0.48 . . . . 74.23 110.893 179.927 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -138.22 17.04 2.79 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.163 -0.472 . . . . 53.04 110.946 -179.916 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 24.9 mt-10 -105.49 164.87 11.55 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.132 -0.486 . . . . 74.41 110.93 179.979 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.558 HD12 ' H ' ' A' ' 19' ' ' ARG . 41.3 tp -115.84 147.06 41.45 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.176 -0.465 . . . . 64.4 110.94 -179.978 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . 0.558 ' H ' HD12 ' A' ' 18' ' ' LEU . 0.5 OUTLIER -83.07 159.32 22.16 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.219 -0.446 . . . . 71.0 110.823 179.986 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.556 HD21 ' CG1' ' A' ' 55' ' ' VAL . 3.1 tp -143.87 147.96 34.79 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.179 -0.464 . . . . 64.21 110.939 179.995 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.652 ' HB3' ' CG ' ' A' ' 24' ' ' ASP . . . -139.6 138.73 36.42 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.186 -0.461 . . . . 75.41 111.07 179.811 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -51.35 122.53 7.98 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.189 -0.46 . . . . 72.3 110.907 -179.933 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 95.85 -6.7 67.28 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.727 -0.749 . . . . 64.01 112.449 -179.983 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . 0.652 ' CG ' ' HB3' ' A' ' 21' ' ' ALA . 1.1 m-20 -80.38 145.94 31.76 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.764 0.316 . . . . 54.31 110.887 -179.967 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 3.2 mm -101.96 140.7 19.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.195 -0.457 . . . . 70.24 111.104 -179.957 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 1.5 m -143.23 158.47 17.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.135 -0.484 . . . . 63.44 111.132 179.868 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 57.4 m-85 -115.59 108.92 17.04 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.2 -0.455 . . . . 74.52 110.902 179.996 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.684 HD13 ' HB2' ' A' ' 39' ' ' ALA . 17.2 mm -72.42 102.61 1.41 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.153 -0.476 . . . . 64.31 111.101 179.999 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 8.1 m -65.06 -40.35 94.6 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.191 -0.459 . . . . 64.34 110.901 -179.946 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' TYR . . . . . 0.525 ' CZ ' HG21 ' A' ' 38' ' ' VAL . 33.9 p90 -174.67 148.6 1.15 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.144 -0.48 . . . . 64.34 110.923 -179.881 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . 0.528 ' HG3' HD22 ' A' ' 37' ' ' LEU . 10.3 tttm -81.27 143.94 31.91 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.122 -0.49 . . . . 75.54 110.838 179.942 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 32.0 t60 -132.45 155.13 49.09 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.205 -0.452 . . . . 75.21 110.845 179.879 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -60.49 -174.04 1.01 Allowed Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.755 -0.736 . . . . 63.42 112.481 -179.962 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 16.8 mm100 65.32 12.69 8.27 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.878 0.37 . . . . 64.14 110.947 -179.892 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 68.36 29.31 73.08 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.747 -0.74 . . . . 71.23 112.462 -180.0 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' TRP . . . . . 0.639 ' C ' HD23 ' A' ' 37' ' ' LEU . 98.8 m95 -123.55 135.75 54.17 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.781 0.324 . . . . 74.01 110.918 -179.93 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.714 HD11 ' CG ' ' A' ' 52' ' ' GLU . 1.3 mt -120.3 130.62 54.54 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.195 -0.457 . . . . 75.33 110.907 179.987 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.525 HG21 ' CZ ' ' A' ' 30' ' ' TYR . 82.6 t -76.18 112.11 13.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.184 -0.462 . . . . 75.2 111.138 179.821 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . 0.684 ' HB2' HD13 ' A' ' 28' ' ' ILE . . . -133.0 157.9 44.04 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.121 -0.491 . . . . 62.41 111.055 179.892 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -114.41 156.23 24.88 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.196 -0.456 . . . . 64.4 110.88 -179.929 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -71.7 -175.35 1.34 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.16 -0.473 . . . . 51.24 110.9 -179.92 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -70.0 -39.45 75.86 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.208 -0.451 . . . . 74.31 110.915 -179.982 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 14.4 m -55.82 -22.29 24.02 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.177 -0.465 . . . . 75.32 110.892 -179.824 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 66.35 11.77 56.88 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.724 -0.75 . . . . 32.24 112.525 -179.974 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 3.5 m -107.76 -14.98 14.67 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.935 0.398 . . . . 74.33 110.843 -179.714 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -121.43 134.85 55.09 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.112 -0.494 . . . . 74.3 110.868 179.937 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 5.2 m -138.67 137.93 37.31 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.216 -0.447 . . . . 60.02 111.127 179.967 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -158.11 -154.49 7.16 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.75 -0.738 . . . . 43.45 112.502 179.942 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.491 HD11 ' HB3' ' B' ' -7' ' ' PHE . 6.2 mt -104.62 130.95 52.55 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.845 0.355 . . . . 64.12 110.902 -179.881 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 11.7 m -129.0 153.1 80.23 Favored Pre-proline 0 C--N 1.33 -0.264 0 CA-C-O 121.619 0.723 . . . . 45.2 111.141 179.801 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . 0.437 ' HG2' ' HB2' ' A' ' 54' ' ' PHE . 53.8 Cg_endo -69.76 144.72 54.94 Favored 'Trans proline' 0 C--N 1.341 0.166 0 C-N-CA 122.661 2.241 . . . . 62.13 112.319 179.966 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . 0.714 ' CG ' HD11 ' A' ' 37' ' ' LEU . 13.5 tm-20 -90.44 -28.71 18.43 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.218 -0.446 . . . . 71.31 110.922 179.985 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -85.67 10.05 14.5 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.158 -0.474 . . . . 73.44 110.904 -179.954 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . 0.437 ' HB2' ' HG2' ' A' ' 51' ' ' PRO . 1.0 OUTLIER -121.02 -5.8 9.53 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.108 -0.496 . . . . 65.05 110.88 -179.969 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.556 ' CG1' HD21 ' A' ' 20' ' ' LEU . 15.4 m -122.75 167.52 16.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.16 -0.473 . . . . 70.15 111.108 179.998 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . 0.703 ' CB ' HD21 ' A' ' 7' ' ' LEU . 47.9 t -138.27 117.35 12.56 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.158 -0.474 . . . . 70.43 110.85 -179.854 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 2.7 m-85 -53.44 134.12 40.47 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.133 -0.485 . . . . 73.44 110.936 -179.889 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.66 HD11 ' HB ' ' A' ' 5' ' ' VAL . 41.4 mt -104.48 146.54 11.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.098 -0.501 . . . . 44.32 111.123 179.905 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 1.3 mt-30 . . . . . 0 C--N 1.329 -0.283 0 CA-C-O 121.626 0.727 . . . . 71.43 110.889 179.922 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' B' B ' -7' ' ' PHE . . . . . 0.491 ' HB3' HD11 ' A' ' 49' ' ' LEU . 9.0 m-85 . . . . . 0 C--O 1.232 0.152 0 CA-C-O 120.808 0.337 . . . . 74.54 110.864 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' -6' ' ' ILE . . . . . 0.423 HD13 ' O ' ' B' ' -7' ' ' PHE . 37.3 mm -145.62 87.69 6.82 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 121.646 0.736 . . . . 71.53 111.135 179.933 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' -5' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.76 130.99 20.31 Favored 'Trans proline' 0 C--N 1.342 0.192 0 C-N-CA 122.649 2.233 . . . . 62.21 112.347 179.845 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' -4' ' ' SER . . . . . . . . . . . . . 30.9 t -124.27 62.21 1.11 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.164 -0.471 . . . . 75.25 110.879 -179.86 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' -3' ' ' ARG . . . . . . . . . . . . . 9.2 ptm180 -174.63 153.74 1.81 Allowed Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.643 0.735 . . . . 71.04 110.862 -179.93 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' -2' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.74 136.33 32.77 Favored 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.672 2.248 . . . . 73.31 112.343 179.996 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' -1' ' ' ALA . . . . . . . . . . . . . . . -71.84 152.76 93.2 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-O 121.605 0.717 . . . . 34.54 111.083 179.904 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 0' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.81 178.02 5.02 Favored 'Trans proline' 0 C--N 1.342 0.2 0 C-N-CA 122.602 2.201 . . . . 74.4 112.369 -179.965 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 1' ' ' LYS . . . . . . . . . . . . . 9.3 pttm -125.2 154.34 71.8 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-O 121.583 0.706 . . . . 74.01 110.898 179.945 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 2' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo . . . . . 0 C--N 1.341 0.182 0 C-N-CA 122.711 2.274 . . . . 74.24 112.313 179.909 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 57.8 tp60 . . . . . 0 C--O 1.231 0.103 0 CA-C-O 120.766 0.317 . . . . 71.23 110.899 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -79.08 160.67 26.98 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.189 -0.459 . . . . 73.13 110.834 -179.905 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -156.33 153.61 29.29 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.147 -0.478 . . . . 64.33 111.097 179.925 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.553 ' HB ' HD11 ' A' ' 58' ' ' ILE . 10.8 p -104.33 151.16 6.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.23 -0.441 . . . . 63.02 111.099 179.995 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -89.82 106.83 18.73 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.161 -0.472 . . . . 71.23 111.104 179.895 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 0.723 HD21 ' CB ' ' A' ' 56' ' ' SER . 16.6 mt -71.4 -39.5 71.11 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.267 -0.424 . . . . 73.13 110.883 -179.951 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 5.6 m-85 -138.84 149.98 45.52 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.224 -0.444 . . . . 70.34 110.875 179.996 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 1.7 p30 -73.74 136.05 43.64 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.066 -0.515 . . . . 65.1 110.88 179.907 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 9.0 t80 -139.83 144.66 37.4 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.192 -0.458 . . . . 75.34 110.881 -179.884 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -113.16 144.75 31.76 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.645 0.736 . . . . 73.45 110.886 -179.907 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.78 141.6 45.61 Favored 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.722 2.281 . . . . 63.13 112.339 -179.981 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 6.3 mm-40 -102.02 -24.05 14.03 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.235 -0.438 . . . . 53.41 110.869 -179.967 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 40.7 m-80 -112.31 175.58 5.37 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.163 -0.471 . . . . 73.04 110.921 -179.963 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -83.07 2.06 37.03 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.204 -0.453 . . . . 34.5 110.869 179.875 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 1.1 p-10 -124.01 23.05 8.65 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.213 -0.448 . . . . 52.35 110.854 -179.903 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 5.4 mt-10 -108.86 156.72 19.34 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.198 -0.455 . . . . 70.4 110.894 179.998 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.485 HD12 ' H ' ' A' ' 19' ' ' ARG . 54.4 tp -108.05 151.61 25.62 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.162 -0.472 . . . . 42.05 110.876 -179.956 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . 0.485 ' H ' HD12 ' A' ' 18' ' ' LEU . 9.7 mtt-85 -88.79 154.11 20.53 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.153 -0.476 . . . . 75.13 110.851 179.988 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.567 HD21 ' CG1' ' A' ' 55' ' ' VAL . 2.6 tp -140.51 149.04 41.97 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.177 -0.465 . . . . 73.41 110.945 -179.974 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.659 ' HB3' ' CG ' ' A' ' 24' ' ' ASP . . . -141.22 137.52 32.65 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.185 -0.461 . . . . 72.13 111.112 179.798 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -50.76 121.03 5.32 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.224 -0.444 . . . . 75.31 110.902 -179.897 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 96.65 -4.86 64.05 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.717 -0.754 . . . . 73.55 112.512 -179.947 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . 0.659 ' CG ' ' HB3' ' A' ' 21' ' ' ALA . 1.1 m-20 -82.78 146.74 28.8 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.816 0.341 . . . . 75.52 110.85 -179.972 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 3.2 mm -101.67 141.06 18.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.176 -0.465 . . . . 65.15 111.163 179.989 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 1.3 m -143.23 158.68 17.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.177 -0.465 . . . . 65.15 111.104 179.85 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 37.8 m-85 -115.83 106.71 14.14 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.134 -0.485 . . . . 73.31 110.838 -179.931 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.657 HD13 ' HB2' ' A' ' 39' ' ' ALA . 13.0 mm -72.13 103.3 1.47 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.157 -0.474 . . . . 72.11 111.126 179.959 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 3.4 m -64.55 -39.59 94.04 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.18 -0.464 . . . . 73.02 110.84 -179.891 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' TYR . . . . . 0.478 ' CZ ' HG21 ' A' ' 38' ' ' VAL . 32.8 p90 -174.16 148.06 1.29 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.145 -0.48 . . . . 70.01 110.907 -179.883 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . 0.565 ' HG3' HD22 ' A' ' 37' ' ' LEU . 19.1 tttt -82.57 145.85 29.5 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.089 -0.505 . . . . 62.23 110.919 179.894 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 34.5 t60 -135.49 153.54 51.7 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.236 -0.438 . . . . 72.11 110.842 179.923 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -58.6 -174.44 0.52 Allowed Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.751 -0.738 . . . . 31.34 112.518 -179.973 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 2.5 mt-30 65.78 12.22 8.16 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.803 0.335 . . . . 71.1 110.908 -179.873 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 68.24 28.85 73.14 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.76 -0.733 . . . . 61.31 112.494 -179.955 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' TRP . . . . . 0.628 ' C ' HD23 ' A' ' 37' ' ' LEU . 99.1 m95 -123.56 136.0 54.3 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.773 0.32 . . . . 71.44 110.939 -179.919 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.681 HD11 ' CG ' ' A' ' 52' ' ' GLU . 0.4 OUTLIER -124.11 132.06 53.61 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.261 -0.427 . . . . 65.42 110.938 179.969 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.489 HG22 HD23 ' A' ' 49' ' ' LEU . 47.1 t -78.2 116.97 22.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.194 -0.457 . . . . 62.12 111.169 179.807 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . 0.657 ' HB2' HD13 ' A' ' 28' ' ' ILE . . . -136.66 166.31 23.84 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.178 -0.464 . . . . 73.41 111.085 179.866 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -127.53 153.93 45.76 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.212 -0.449 . . . . 62.35 110.879 -179.911 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -66.32 -174.77 0.3 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.172 -0.467 . . . . 63.44 110.895 -179.962 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -69.62 -37.93 77.03 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.157 -0.474 . . . . 74.4 110.879 -179.97 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 9.5 m -57.0 -22.52 39.23 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.141 -0.481 . . . . 72.4 110.895 -179.827 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 67.54 10.9 58.82 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.713 -0.756 . . . . 75.51 112.5 -179.973 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 1.9 t -106.48 -21.77 12.98 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.966 0.412 . . . . 62.33 110.868 -179.722 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 1.7 ttmt -114.07 124.02 51.08 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.131 -0.486 . . . . 74.33 110.88 179.936 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 15.6 m -133.79 144.52 49.07 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.193 -0.458 . . . . 75.51 111.117 -179.991 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -164.48 -152.96 7.22 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.72 -0.752 . . . . 63.32 112.458 179.971 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.489 HD23 HG22 ' A' ' 38' ' ' VAL . 12.6 mt -103.89 134.08 47.78 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.852 0.358 . . . . 74.31 110.876 -179.912 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.423 ' HB ' ' HD2' ' A' ' 51' ' ' PRO . 21.9 m -134.15 154.05 79.89 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-O 121.668 0.746 . . . . 74.14 111.069 179.857 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . 0.423 ' HD2' ' HB ' ' A' ' 50' ' ' VAL . 53.4 Cg_endo -69.77 146.43 60.09 Favored 'Trans proline' 0 C--N 1.342 0.209 0 C-N-CA 122.656 2.237 . . . . 72.33 112.3 179.974 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . 0.681 ' CG ' HD11 ' A' ' 37' ' ' LEU . 28.0 tt0 -91.87 -29.31 16.78 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.187 -0.461 . . . . 73.32 110.903 179.982 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -85.23 9.8 14.16 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.187 -0.46 . . . . 71.14 110.934 -179.964 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . 0.418 ' HB2' ' HG2' ' A' ' 51' ' ' PRO . 1.0 OUTLIER -120.19 -7.97 9.76 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.13 -0.486 . . . . 73.25 110.858 -179.932 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.567 ' CG1' HD21 ' A' ' 20' ' ' LEU . 15.8 m -121.21 161.32 21.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.151 -0.477 . . . . 62.51 111.119 179.981 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . 0.723 ' CB ' HD21 ' A' ' 7' ' ' LEU . 25.4 t -131.68 114.74 15.15 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.149 -0.478 . . . . 74.04 110.833 -179.855 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 3.0 m-85 -54.72 127.02 26.36 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.182 -0.463 . . . . 63.02 110.916 -179.877 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.553 HD11 ' HB ' ' A' ' 5' ' ' VAL . 40.6 mt -94.85 143.16 12.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.121 -0.49 . . . . 72.52 111.117 179.953 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--N 1.329 -0.326 0 CA-C-O 121.62 0.724 . . . . 42.0 110.914 179.976 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' -7' ' ' PHE . . . . . . . . . . . . . 6.7 m-85 . . . . . 0 C--O 1.232 0.136 0 CA-C-O 120.79 0.328 . . . . 74.11 110.909 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' B' B ' -6' ' ' ILE . . . . . . . . . . . . . 1.9 pt -152.98 88.28 3.87 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.68 0.752 . . . . 74.22 111.122 179.977 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' -5' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.74 135.64 31.01 Favored 'Trans proline' 0 C--N 1.342 0.227 0 C-N-CA 122.702 2.268 . . . . 63.02 112.368 179.859 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' -4' ' ' SER . . . . . . . . . . . . . 2.9 m -133.88 60.37 1.71 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.228 -0.442 . . . . 65.43 110.825 -179.814 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' -3' ' ' ARG . . . . . . . . . . . . . 9.9 ptt85 -174.62 153.41 1.77 Allowed Pre-proline 0 C--N 1.329 -0.288 0 CA-C-O 121.651 0.739 . . . . 72.25 110.836 -179.951 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' -2' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.75 128.05 15.48 Favored 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.645 2.23 . . . . 61.22 112.383 -179.991 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' -1' ' ' ALA . . . . . . . . . . . . . . . -62.61 155.18 70.46 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-O 121.564 0.697 . . . . 72.3 111.086 179.92 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 0' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.73 -169.24 0.31 Allowed 'Trans proline' 0 C--N 1.341 0.17 0 C-N-CA 122.66 2.24 . . . . 70.11 112.369 179.995 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 1' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -138.88 154.12 72.5 Favored Pre-proline 0 C--N 1.328 -0.347 0 CA-C-O 121.568 0.699 . . . . 74.34 110.89 179.909 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 2' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo . . . . . 0 C--N 1.342 0.185 0 C-N-CA 122.67 2.247 . . . . 74.42 112.354 179.914 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 31.0 tp60 . . . . . 0 C--O 1.231 0.102 0 CA-C-O 120.826 0.346 . . . . 74.4 110.921 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 4.4 ptp180 -89.87 163.1 15.14 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.18 -0.463 . . . . 74.51 110.863 -179.891 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -155.07 153.17 30.49 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.192 -0.458 . . . . 41.2 111.089 179.893 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.694 ' HB ' HD11 ' A' ' 58' ' ' ILE . 10.7 p -103.85 150.02 7.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.221 -0.445 . . . . 75.01 111.179 179.932 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -88.33 105.57 17.66 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.207 -0.452 . . . . 74.11 111.112 179.885 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 0.734 HD21 ' HB2' ' A' ' 56' ' ' SER . 15.2 mt -69.68 -37.27 76.6 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.218 -0.446 . . . . 64.24 110.911 -179.95 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 2.9 m-85 -143.92 157.46 44.34 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.147 -0.479 . . . . 72.52 110.92 -179.988 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 3.7 p30 -78.84 134.84 36.92 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.128 -0.487 . . . . 74.41 110.9 179.896 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 2.5 t80 -134.42 146.03 49.45 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.201 -0.454 . . . . 74.53 110.894 -179.902 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 6.6 tt0 -116.5 136.14 23.06 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-O 121.626 0.727 . . . . 63.33 110.907 -179.881 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . 0.409 ' HD3' ' HA ' ' A' ' 19' ' ' ARG . 53.3 Cg_endo -69.81 151.52 68.82 Favored 'Trans proline' 0 C--N 1.341 0.175 0 C-N-CA 122.677 2.251 . . . . 75.32 112.319 -179.939 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 1.9 mm-40 -112.9 -17.28 12.53 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.211 -0.45 . . . . 74.41 110.885 -179.989 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . 0.415 HD21 ' NE ' ' B' ' -3' ' ' ARG . 34.3 m-80 -115.21 176.15 5.19 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.148 -0.478 . . . . 74.0 110.892 -179.958 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 70.3 m-20 -91.86 21.07 5.12 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.222 -0.444 . . . . 62.42 110.898 179.91 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 1.1 p-10 -137.23 12.76 3.05 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.171 -0.468 . . . . 61.21 110.894 -179.984 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 48.7 mt-10 -106.82 160.12 15.73 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.178 -0.464 . . . . 74.31 110.841 -179.969 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.599 HD12 ' H ' ' A' ' 19' ' ' ARG . 20.7 tp -110.88 147.21 35.08 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.095 -0.502 . . . . 72.14 110.917 179.989 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . 0.599 ' H ' HD12 ' A' ' 18' ' ' LEU . 1.4 mtt180 -83.28 155.85 23.4 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.166 -0.47 . . . . 73.14 110.849 179.96 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.553 HD21 ' CG1' ' A' ' 55' ' ' VAL . 3.0 tp -139.37 149.71 44.46 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.213 -0.449 . . . . 64.33 110.917 179.984 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.657 ' HB3' ' CG ' ' A' ' 24' ' ' ASP . . . -139.96 136.44 33.8 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.155 -0.475 . . . . 74.04 111.082 179.772 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -50.77 120.96 5.24 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.193 -0.458 . . . . 61.5 110.848 -179.913 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 96.86 -3.9 62.9 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.744 -0.741 . . . . 44.23 112.456 179.992 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . 0.657 ' CG ' ' HB3' ' A' ' 21' ' ' ALA . 1.0 OUTLIER -84.25 146.34 27.84 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.829 0.347 . . . . 74.22 110.823 -179.932 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 3.3 mm -100.52 142.34 15.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.177 -0.465 . . . . 74.3 111.177 179.957 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 1.7 m -145.14 157.38 13.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.206 -0.452 . . . . 53.34 111.111 179.886 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 61.1 m-85 -115.98 110.69 19.3 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.18 -0.464 . . . . 72.11 110.871 -179.988 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.698 HD13 ' HB2' ' A' ' 39' ' ' ALA . 15.5 mm -72.43 102.27 1.35 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.091 -0.504 . . . . 45.01 111.121 179.964 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 5.0 m -65.07 -40.17 94.31 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.234 -0.439 . . . . 71.15 110.831 -179.924 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' TYR . . . . . 0.541 ' CZ ' HG21 ' A' ' 38' ' ' VAL . 35.9 p90 -174.58 149.24 1.25 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.186 -0.461 . . . . 74.31 110.947 -179.913 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 32.5 tttt -80.87 143.18 32.92 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.124 -0.489 . . . . 73.11 110.863 179.945 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 23.2 t60 -129.44 157.42 42.02 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.238 -0.437 . . . . 73.34 110.891 179.87 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -64.18 -174.66 3.64 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.744 -0.741 . . . . 65.1 112.467 -179.959 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 17.9 mm100 65.47 12.69 8.35 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.836 0.351 . . . . 74.11 110.922 -179.893 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 69.72 29.49 71.16 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.745 -0.74 . . . . 50.13 112.505 -179.949 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' TRP . . . . . 0.654 ' C ' HD23 ' A' ' 37' ' ' LEU . 97.0 m95 -122.91 138.35 54.69 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.821 0.343 . . . . 75.14 110.938 -179.935 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.707 HD11 ' CG ' ' A' ' 52' ' ' GLU . 1.3 mt -121.13 133.24 55.2 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.223 -0.444 . . . . 64.21 110.935 179.966 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.541 HG21 ' CZ ' ' A' ' 30' ' ' TYR . 95.9 t -80.06 109.37 14.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.21 -0.45 . . . . 72.34 111.124 179.814 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . 0.698 ' HB2' HD13 ' A' ' 28' ' ' ILE . . . -129.19 158.46 38.95 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.175 -0.466 . . . . 50.44 111.126 179.822 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 1.4 pt-20 -117.05 157.31 26.05 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.234 -0.439 . . . . 55.22 110.843 -179.954 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -71.54 -175.04 1.21 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.126 -0.488 . . . . 75.33 110.891 -179.926 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 2.6 tt0 -69.45 -38.3 77.72 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.199 -0.455 . . . . 52.21 110.919 179.981 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 1.6 t -56.36 -22.58 32.0 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.165 -0.471 . . . . 73.12 110.827 -179.799 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 68.58 10.39 60.45 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.689 -0.767 . . . . 70.24 112.516 -179.933 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 3.1 t -107.14 -22.15 12.73 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.886 0.374 . . . . 74.14 110.83 -179.73 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.427 ' HE3' HD11 ' A' ' 18' ' ' LEU . 3.7 ttpt -110.31 123.9 50.67 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.158 -0.474 . . . . 74.0 110.933 179.932 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 9.3 m -131.89 130.38 41.55 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.24 -0.437 . . . . 52.4 111.136 179.998 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -153.57 -157.05 7.9 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.777 -0.725 . . . . 64.32 112.504 179.979 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 11.9 mt -100.32 133.33 44.88 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.821 0.343 . . . . 44.32 110.909 -179.925 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.458 ' CG1' HD23 ' A' ' 18' ' ' LEU . 6.0 m -131.97 153.62 81.45 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 121.685 0.755 . . . . 63.22 111.086 179.838 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . 0.417 ' HD2' ' HB ' ' A' ' 50' ' ' VAL . 54.0 Cg_endo -69.75 144.2 53.3 Favored 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.697 2.265 . . . . 63.24 112.353 179.918 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . 0.707 ' CG ' HD11 ' A' ' 37' ' ' LEU . 6.9 tm-20 -90.63 -27.8 18.83 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.226 -0.443 . . . . 74.11 110.885 -179.982 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -86.76 11.12 13.87 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.165 -0.471 . . . . 70.1 110.93 -179.974 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . 0.408 ' HB2' ' HG2' ' A' ' 51' ' ' PRO . 1.1 m-85 -121.74 -7.48 9.05 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.139 -0.482 . . . . 74.24 110.854 -179.91 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.553 ' CG1' HD21 ' A' ' 20' ' ' LEU . 16.1 m -121.88 168.08 14.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.161 -0.472 . . . . 72.34 111.13 -179.983 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . 0.734 ' HB2' HD21 ' A' ' 7' ' ' LEU . 43.9 t -136.93 117.06 13.4 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.212 -0.449 . . . . 61.3 110.896 -179.851 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 2.9 m-85 -56.25 124.3 17.49 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.15 -0.477 . . . . 72.22 110.903 -179.849 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.694 HD11 ' HB ' ' A' ' 5' ' ' VAL . 35.3 mt -94.52 141.87 14.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.11 -0.496 . . . . 73.21 111.136 179.931 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.329 -0.298 0 CA-C-O 121.583 0.706 . . . . 74.03 110.922 179.923 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' -7' ' ' PHE . . . . . 0.573 ' O ' HD13 ' B' ' -6' ' ' ILE . 7.4 m-85 . . . . . 0 C--O 1.231 0.126 0 CA-C-O 120.819 0.342 . . . . 75.42 110.871 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' -6' ' ' ILE . . . . . 0.573 HD13 ' O ' ' B' ' -7' ' ' PHE . 30.0 mm -138.22 94.83 10.78 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 121.681 0.753 . . . . 62.32 111.155 179.939 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' -5' ' ' PRO . . . . . 0.43 ' HD2' ' HA ' ' B' ' -6' ' ' ILE . 53.8 Cg_endo -69.76 140.37 42.51 Favored 'Trans proline' 0 C--N 1.342 0.194 0 C-N-CA 122.673 2.249 . . . . 73.55 112.357 179.884 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' -4' ' ' SER . . . . . . . . . . . . . 3.0 m -131.3 60.66 1.66 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.172 -0.467 . . . . 63.12 110.818 -179.811 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' -3' ' ' ARG . . . . . 0.415 ' NE ' HD21 ' A' ' 14' ' ' ASN . 14.2 ptp180 -178.87 154.96 0.83 Allowed Pre-proline 0 C--N 1.328 -0.332 0 CA-C-O 121.628 0.728 . . . . 75.53 110.875 -179.917 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' -2' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.79 140.54 42.83 Favored 'Trans proline' 0 C--N 1.342 0.189 0 C-N-CA 122.665 2.243 . . . . 52.43 112.352 -179.996 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' -1' ' ' ALA . . . . . 0.438 ' HB1' ' HD2' ' B' ' 0' ' ' PRO . . . -71.93 156.3 91.08 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-O 121.603 0.716 . . . . 73.32 111.094 179.903 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 0' ' ' PRO . . . . . 0.438 ' HD2' ' HB1' ' B' ' -1' ' ' ALA . 54.0 Cg_endo -69.79 -177.94 2.12 Favored 'Trans proline' 0 C--O 1.231 0.168 0 C-N-CA 122.696 2.264 . . . . 71.35 112.352 -179.996 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 1' ' ' LYS . . . . . . . . . . . . . 3.5 ttpt -129.31 145.49 57.02 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-O 121.576 0.703 . . . . 72.11 110.915 179.939 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 2' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo . . . . . 0 C--N 1.342 0.185 0 C-N-CA 122.718 2.279 . . . . 73.4 112.322 179.904 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 50.3 tp60 . . . . . 0 C--O 1.231 0.103 0 CA-C-O 120.809 0.338 . . . . 73.14 110.885 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 8.9 ptp180 -87.14 163.69 16.81 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.228 -0.442 . . . . 74.52 110.85 -179.934 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -155.18 154.08 31.72 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.192 -0.458 . . . . 73.53 111.07 179.948 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.622 ' HB ' HD11 ' A' ' 58' ' ' ILE . 11.6 p -104.03 149.26 7.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.187 -0.46 . . . . 65.22 111.088 -179.998 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -88.24 105.03 17.27 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.124 -0.489 . . . . 50.13 111.143 179.863 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 0.686 HD21 ' HB2' ' A' ' 56' ' ' SER . 17.6 mt -69.17 -39.21 78.87 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.199 -0.455 . . . . 75.22 110.919 -179.952 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 3.3 m-85 -141.3 156.4 45.86 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.208 -0.451 . . . . 55.14 110.937 179.998 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 1.7 p-10 -79.06 135.05 36.75 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.11 -0.495 . . . . 75.43 110.853 179.914 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 2.1 t80 -134.09 146.06 49.95 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.191 -0.459 . . . . 75.3 110.926 -179.926 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 29.7 tt0 -115.72 135.47 22.68 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.603 0.716 . . . . 74.22 110.922 -179.945 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . 0.404 ' HD3' ' HA ' ' A' ' 19' ' ' ARG . 53.3 Cg_endo -69.76 147.64 63.32 Favored 'Trans proline' 0 C--N 1.341 0.154 0 C-N-CA 122.701 2.267 . . . . 73.02 112.347 -179.969 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 13.6 mt-10 -107.72 -18.82 13.73 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.247 -0.433 . . . . 71.41 110.894 -179.98 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 31.1 m-80 -112.8 175.46 5.43 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.133 -0.485 . . . . 70.04 110.899 -179.933 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 36.5 m-20 -90.05 13.4 14.98 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.191 -0.459 . . . . 72.24 110.836 179.949 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 1.2 p-10 -131.32 14.96 5.07 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.232 -0.44 . . . . 74.43 110.895 -179.901 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 23.9 mt-10 -104.29 159.49 15.67 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.122 -0.49 . . . . 74.22 110.9 -179.993 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.508 HD12 ' H ' ' A' ' 48' ' ' GLY . 0.4 OUTLIER -109.62 143.21 39.66 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.213 -0.449 . . . . 75.55 110.924 -179.989 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . 0.404 ' HA ' ' HD3' ' A' ' 12' ' ' PRO . 0.0 OUTLIER -81.67 156.37 25.11 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.204 -0.453 . . . . 72.52 110.878 179.951 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.552 HD21 ' CG1' ' A' ' 55' ' ' VAL . 2.7 tp -141.48 148.6 39.72 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.198 -0.455 . . . . 74.43 110.893 -179.976 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.646 ' HB3' ' CG ' ' A' ' 24' ' ' ASP . . . -139.87 136.58 34.09 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.197 -0.456 . . . . 42.14 111.041 179.836 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -50.57 121.83 6.32 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.183 -0.462 . . . . 61.31 110.85 -179.912 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 95.53 -0.77 63.54 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.787 -0.721 . . . . 74.54 112.474 -179.982 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . 0.646 ' CG ' ' HB3' ' A' ' 21' ' ' ALA . 1.4 m-20 -86.27 146.04 26.69 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.753 0.311 . . . . 54.34 110.872 -179.964 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 3.2 mm -101.2 137.93 27.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.183 -0.462 . . . . 71.42 111.137 -179.99 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 1.3 m -141.49 158.96 22.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.2 -0.455 . . . . 52.14 111.13 179.873 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 67.1 m-85 -116.5 108.98 16.68 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.185 -0.462 . . . . 72.54 110.905 179.977 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.614 HD13 ' HB2' ' A' ' 39' ' ' ALA . 11.3 mm -72.17 103.24 1.47 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.115 -0.493 . . . . 74.02 111.139 179.986 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 3.5 m -65.06 -39.96 94.04 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.196 -0.456 . . . . 54.21 110.841 -179.88 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' TYR . . . . . 0.496 ' CZ ' HG21 ' A' ' 38' ' ' VAL . 34.6 p90 -174.0 147.19 1.26 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.143 -0.48 . . . . 63.14 110.95 -179.892 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . 0.502 ' HG3' HD22 ' A' ' 37' ' ' LEU . 21.4 tttt -80.36 146.04 31.74 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.105 -0.498 . . . . 74.12 110.929 179.922 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 36.0 t60 -136.39 152.53 50.72 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.273 -0.421 . . . . 55.21 110.876 179.921 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -58.01 -174.71 0.43 Allowed Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.737 -0.744 . . . . 73.14 112.432 -179.893 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 58.1 mm-40 65.94 12.08 8.16 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.817 0.341 . . . . 74.35 110.899 -179.867 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 68.01 29.07 73.29 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.747 -0.739 . . . . 70.51 112.463 -179.981 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' TRP . . . . . 0.606 ' C ' HD23 ' A' ' 37' ' ' LEU . 98.7 m95 -123.19 135.97 54.54 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.792 0.329 . . . . 73.32 110.908 -179.898 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.685 HD11 ' CG ' ' A' ' 52' ' ' GLU . 0.7 OUTLIER -121.8 130.22 53.24 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.224 -0.444 . . . . 73.43 110.937 179.965 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.544 HG22 HD23 ' A' ' 49' ' ' LEU . 39.9 t -78.46 111.33 15.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.197 -0.456 . . . . 52.1 111.142 179.837 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . 0.614 ' HB2' HD13 ' A' ' 28' ' ' ILE . . . -133.15 167.75 19.78 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.169 -0.469 . . . . 54.34 111.151 179.857 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 1.1 pt-20 -119.12 156.06 30.43 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.283 -0.417 . . . . 73.5 110.901 -179.963 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -71.02 -176.55 1.41 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.125 -0.489 . . . . 72.04 110.904 -179.944 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 4.0 tm-20 -67.51 -38.32 84.11 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.159 -0.473 . . . . 72.41 110.914 179.991 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 1.3 t -57.26 -22.19 39.66 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.166 -0.47 . . . . 74.44 110.831 -179.811 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 65.71 12.89 57.95 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.733 -0.746 . . . . 55.4 112.518 -179.942 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 1.4 t -109.19 -17.31 13.88 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.954 0.407 . . . . 50.15 110.837 -179.733 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -118.89 135.26 54.66 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.121 -0.491 . . . . 72.54 110.87 179.973 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 6.4 m -136.08 144.65 45.27 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.221 -0.445 . . . . 75.25 111.132 179.936 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . 0.508 ' H ' HD12 ' A' ' 18' ' ' LEU . . . -166.55 -159.55 12.45 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.76 -0.733 . . . . 54.33 112.449 -180.0 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.544 HD23 HG22 ' A' ' 38' ' ' VAL . 6.4 mt -98.96 134.92 41.11 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.913 0.387 . . . . 70.25 110.934 -179.97 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.45 HG22 ' O ' ' A' ' 37' ' ' LEU . 31.1 m -133.39 153.63 80.58 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-O 121.661 0.743 . . . . 64.03 111.13 179.826 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . 0.429 ' HD2' HD22 ' A' ' 20' ' ' LEU . 53.5 Cg_endo -69.82 142.15 46.89 Favored 'Trans proline' 0 C--N 1.341 0.167 0 C-N-CA 122.665 2.243 . . . . 74.2 112.325 -179.995 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . 0.685 ' CG ' HD11 ' A' ' 37' ' ' LEU . 26.9 tt0 -89.29 -27.7 20.37 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.244 -0.434 . . . . 62.11 110.902 -179.983 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -86.22 9.86 16.36 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.15 -0.477 . . . . 74.54 110.921 -179.972 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . 0.421 ' HB2' ' HG2' ' A' ' 51' ' ' PRO . 1.1 m-85 -119.88 -13.53 9.05 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.128 -0.487 . . . . 74.01 110.875 -179.937 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.552 ' CG1' HD21 ' A' ' 20' ' ' LEU . 19.5 m -115.49 166.37 9.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.142 -0.481 . . . . 74.32 111.088 179.987 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . 0.686 ' HB2' HD21 ' A' ' 7' ' ' LEU . 35.1 t -138.25 117.58 12.79 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.125 -0.489 . . . . 74.44 110.884 -179.835 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 2.6 m-85 -52.72 133.25 36.87 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.164 -0.471 . . . . 70.03 110.929 -179.847 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.622 HD11 ' HB ' ' A' ' 5' ' ' VAL . 51.8 mt -102.11 147.73 8.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.121 -0.49 . . . . 74.4 111.082 179.953 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.329 -0.289 0 CA-C-O 121.561 0.696 . . . . 73.42 110.953 179.879 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' -7' ' ' PHE . . . . . 0.421 ' HB3' HD11 ' A' ' 49' ' ' LEU . 7.8 m-85 . . . . . 0 C--O 1.231 0.125 0 CA-C-O 120.779 0.323 . . . . 74.24 110.909 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' -6' ' ' ILE . . . . . . . . . . . . . 2.1 pt -153.36 85.36 4.18 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-O 121.56 0.695 . . . . 75.44 111.136 179.998 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' -5' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.76 126.78 13.71 Favored 'Trans proline' 0 C--O 1.231 0.163 0 C-N-CA 122.649 2.233 . . . . 61.34 112.368 179.88 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' -4' ' ' SER . . . . . . . . . . . . . 30.4 t -122.04 57.94 1.04 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.255 -0.43 . . . . 53.42 110.886 -179.852 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' -3' ' ' ARG . . . . . . . . . . . . . 6.9 ptm180 -174.42 153.96 1.94 Allowed Pre-proline 0 C--N 1.329 -0.326 0 CA-C-O 121.602 0.715 . . . . 71.43 110.896 -179.928 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' -2' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.71 142.48 48.25 Favored 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.678 2.252 . . . . 64.13 112.372 179.964 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' -1' ' ' ALA . . . . . . . . . . . . . . . -75.16 154.52 86.4 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.627 0.727 . . . . 65.32 111.076 179.917 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 0' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.78 -177.35 1.84 Allowed 'Trans proline' 0 C--N 1.342 0.213 0 C-N-CA 122.679 2.253 . . . . 62.35 112.375 -179.967 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 1' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -127.56 150.76 73.8 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 121.544 0.688 . . . . 72.34 110.905 179.93 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 2' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo . . . . . 0 C--N 1.342 0.191 0 C-N-CA 122.647 2.231 . . . . 65.54 112.393 179.87 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 52.4 tp60 . . . . . 0 C--O 1.231 0.107 0 CA-C-O 120.765 0.316 . . . . 74.11 110.876 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 5.4 ptp180 -77.56 163.43 26.28 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.209 -0.45 . . . . 64.44 110.873 -179.936 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -158.37 154.73 27.46 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.202 -0.454 . . . . 63.32 111.11 179.981 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.488 ' HB ' HD11 ' A' ' 58' ' ' ILE . 10.8 p -105.66 150.48 8.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.242 -0.435 . . . . 73.34 111.087 179.985 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -89.26 107.86 19.29 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.166 -0.47 . . . . 55.54 111.115 179.859 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 0.728 HD21 ' CB ' ' A' ' 56' ' ' SER . 18.4 mt -71.72 -39.25 70.26 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.247 -0.433 . . . . 60.12 110.943 -179.983 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 4.5 m-85 -140.33 152.74 46.07 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.143 -0.48 . . . . 73.32 110.943 -179.989 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 1.1 p30 -75.29 137.33 41.1 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.136 -0.483 . . . . 75.24 110.92 179.891 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 15.0 t80 -140.19 145.81 37.94 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.249 -0.432 . . . . 63.41 110.877 -179.889 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -114.55 142.7 28.61 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 121.634 0.731 . . . . 74.11 110.918 -179.94 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.78 134.21 27.39 Favored 'Trans proline' 0 C--N 1.341 0.16 0 C-N-CA 122.676 2.251 . . . . 50.25 112.336 -179.973 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 5.4 mt-10 -96.57 -16.99 20.76 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.239 -0.437 . . . . 72.22 110.872 -179.993 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 48.3 m-80 -115.55 175.77 5.37 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.165 -0.47 . . . . 61.52 110.865 -179.939 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 84.5 m-20 -88.77 13.36 12.65 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.169 -0.469 . . . . 73.04 110.854 179.972 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -135.37 21.09 3.4 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.171 -0.468 . . . . 71.12 110.869 -179.951 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 13.0 mt-10 -106.86 161.7 14.46 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.176 -0.465 . . . . 72.4 110.888 -179.989 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.557 HD21 ' HD3' ' A' ' 46' ' ' LYS . 0.4 OUTLIER -111.29 143.42 42.09 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.202 -0.454 . . . . 74.11 110.899 -179.999 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . 0.438 ' H ' HD23 ' A' ' 18' ' ' LEU . 16.2 mtm180 -79.58 156.68 27.59 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.193 -0.458 . . . . 71.31 110.903 179.941 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.594 HD21 ' CG1' ' A' ' 55' ' ' VAL . 3.2 tp -142.93 148.78 37.47 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.217 -0.447 . . . . 72.03 110.894 -179.942 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.668 ' HB3' ' CG ' ' A' ' 24' ' ' ASP . . . -141.25 137.01 32.24 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.152 -0.476 . . . . 74.13 111.109 179.821 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -51.09 121.24 5.82 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.237 -0.438 . . . . 62.13 110.874 -179.899 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 97.03 -6.45 64.06 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.738 -0.744 . . . . 54.11 112.464 -179.979 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . 0.668 ' CG ' ' HB3' ' A' ' 21' ' ' ALA . 1.1 m-20 -81.04 146.39 30.67 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.76 0.314 . . . . 71.21 110.876 -179.939 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 3.3 mm -100.86 139.79 21.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.211 -0.449 . . . . 74.24 111.139 -179.975 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 1.4 m -143.12 158.17 17.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.192 -0.458 . . . . 74.52 111.104 179.841 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 55.7 m-85 -116.15 108.48 16.22 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.123 -0.49 . . . . 61.21 110.863 -179.959 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.693 HD13 ' HB2' ' A' ' 39' ' ' ALA . 13.4 mm -72.58 103.33 1.62 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.192 -0.458 . . . . 74.42 111.154 179.96 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 3.4 m -64.65 -39.3 93.44 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.12 -0.491 . . . . 64.23 110.897 -179.91 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' TYR . . . . . 0.476 ' CZ ' HG21 ' A' ' 38' ' ' VAL . 32.7 p90 -174.37 146.74 1.1 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.113 -0.494 . . . . 74.4 110.911 -179.863 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . 0.535 ' HG3' HD22 ' A' ' 37' ' ' LEU . 18.7 tttt -82.51 145.73 29.62 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.138 -0.483 . . . . 71.32 110.919 179.886 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 29.8 t60 -134.88 153.08 52.19 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.236 -0.438 . . . . 72.45 110.83 179.952 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -58.52 -174.51 0.51 Allowed Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.738 -0.744 . . . . 54.4 112.532 -179.99 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 71.4 mm-40 65.94 12.15 8.21 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.864 0.364 . . . . 74.25 110.936 -179.909 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 68.16 28.62 73.27 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.735 -0.745 . . . . 62.32 112.533 -179.94 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' TRP . . . . . 0.615 ' C ' HD23 ' A' ' 37' ' ' LEU . 98.9 m95 -123.06 135.38 54.39 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.83 0.347 . . . . 74.14 110.907 -179.911 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.668 HD11 ' CG ' ' A' ' 52' ' ' GLU . 0.4 OUTLIER -123.13 135.85 54.53 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.187 -0.46 . . . . 74.4 110.883 -179.963 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.557 HG22 HD23 ' A' ' 49' ' ' LEU . 39.3 t -84.43 114.9 25.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.177 -0.465 . . . . 73.43 111.145 179.814 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . 0.693 ' HB2' HD13 ' A' ' 28' ' ' ILE . . . -136.4 168.57 19.2 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.189 -0.46 . . . . 61.42 111.15 179.838 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 1.4 pt-20 -125.64 155.01 41.47 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.211 -0.449 . . . . 64.14 110.829 -179.875 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -67.57 -175.19 0.49 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.15 -0.477 . . . . 61.43 110.87 -179.939 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 -68.9 -37.42 78.97 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.187 -0.461 . . . . 65.2 110.881 -179.962 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 1.6 t -57.02 -22.25 37.23 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.171 -0.468 . . . . 73.01 110.866 -179.816 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 66.89 12.42 59.82 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.699 -0.762 . . . . 74.1 112.489 179.986 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -109.65 -21.93 12.19 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.954 0.407 . . . . 63.21 110.871 -179.72 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.557 ' HD3' HD21 ' A' ' 18' ' ' LEU . 0.1 OUTLIER -112.41 123.92 51.36 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.132 -0.485 . . . . 73.2 110.892 179.962 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 9.7 m -129.69 144.61 51.37 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.247 -0.433 . . . . 72.11 111.117 179.986 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . 0.536 ' H ' HD12 ' A' ' 18' ' ' LEU . . . -166.35 -159.22 11.86 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.73 -0.748 . . . . 54.31 112.462 179.98 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.557 HD23 HG22 ' A' ' 38' ' ' VAL . 13.5 mt -99.41 134.52 42.15 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.883 0.373 . . . . 73.25 110.885 -179.893 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.411 ' HB ' ' HD2' ' A' ' 51' ' ' PRO . 10.3 m -134.01 153.43 79.73 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-O 121.606 0.717 . . . . 65.42 111.104 179.908 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . 0.419 ' HG2' ' HB2' ' A' ' 54' ' ' PHE . 53.6 Cg_endo -69.8 147.56 62.88 Favored 'Trans proline' 0 N--CA 1.466 -0.134 0 C-N-CA 122.68 2.253 . . . . 75.44 112.357 179.934 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . 0.668 ' CG ' HD11 ' A' ' 37' ' ' LEU . 24.6 tt0 -93.07 -28.34 16.42 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.214 -0.448 . . . . 70.43 110.902 -179.965 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 2.5 mm-40 -87.17 11.17 14.69 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.154 -0.475 . . . . 72.21 110.945 -179.963 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . 0.419 ' HB2' ' HG2' ' A' ' 51' ' ' PRO . 0.9 OUTLIER -121.1 -9.9 9.1 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.104 -0.498 . . . . 71.4 110.858 -179.939 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.594 ' CG1' HD21 ' A' ' 20' ' ' LEU . 16.2 m -119.65 166.54 13.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.186 -0.461 . . . . 75.21 111.077 -179.996 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . 0.728 ' CB ' HD21 ' A' ' 7' ' ' LEU . 38.4 t -136.61 119.83 16.7 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.166 -0.47 . . . . 64.02 110.834 -179.859 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 3.1 m-85 -58.33 129.85 43.96 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.118 -0.492 . . . . 74.42 110.892 -179.895 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.488 HD11 ' HB ' ' A' ' 5' ' ' VAL . 39.8 mt -96.51 150.25 4.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.095 -0.502 . . . . 73.04 111.121 179.886 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 1.4 mt-30 . . . . . 0 C--N 1.329 -0.31 0 CA-C-O 121.59 0.71 . . . . 73.53 110.874 179.965 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' B' B ' -7' ' ' PHE . . . . . 0.446 ' HB3' HD11 ' A' ' 49' ' ' LEU . 8.4 m-85 . . . . . 0 C--O 1.232 0.136 0 CA-C-O 120.825 0.345 . . . . 70.15 110.861 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' -6' ' ' ILE . . . . . 0.51 ' O ' HG23 ' B' ' -6' ' ' ILE . 4.1 tp -163.66 88.12 1.21 Allowed Pre-proline 0 C--N 1.328 -0.326 0 CA-C-O 121.662 0.744 . . . . 75.31 111.158 179.922 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' -5' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.78 146.08 58.94 Favored 'Trans proline' 0 C--N 1.341 0.175 0 C-N-CA 122.7 2.267 . . . . 71.2 112.323 179.911 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' -4' ' ' SER . . . . . . . . . . . . . 29.9 t -143.81 67.79 1.28 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.197 -0.456 . . . . 65.33 110.864 -179.845 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' -3' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -179.6 154.75 0.73 Allowed Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.647 0.737 . . . . 74.52 110.855 -179.928 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' -2' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.79 119.76 6.65 Favored 'Trans proline' 0 C--N 1.342 0.188 0 C-N-CA 122.688 2.259 . . . . 74.31 112.37 179.973 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' -1' ' ' ALA . . . . . . . . . . . . . . . -55.54 151.52 20.69 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.572 0.701 . . . . 45.02 111.109 179.886 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 0' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.78 172.3 12.91 Favored 'Trans proline' 0 C--O 1.232 0.197 0 C-N-CA 122.684 2.256 . . . . 55.33 112.365 179.992 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 1' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -120.93 152.87 56.96 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-O 121.553 0.692 . . . . 71.52 110.86 179.943 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 2' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo . . . . . 0 C--N 1.341 0.151 0 C-N-CA 122.703 2.268 . . . . 71.43 112.357 179.872 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 56.6 tp60 . . . . . 0 C--O 1.231 0.112 0 CA-C-O 120.801 0.334 . . . . 41.15 110.95 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 6.8 ptp180 -75.01 162.44 28.57 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.174 -0.466 . . . . 71.14 110.854 -179.905 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -156.59 154.05 29.59 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.189 -0.46 . . . . 52.52 111.119 179.929 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.607 ' HB ' HD11 ' A' ' 58' ' ' ILE . 11.3 p -105.46 148.48 9.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.225 -0.443 . . . . 52.45 111.119 179.973 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -87.4 113.46 23.13 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.165 -0.47 . . . . 34.03 111.088 179.889 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 0.693 HD21 ' HB2' ' A' ' 56' ' ' SER . 15.0 mt -79.04 -37.37 39.19 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.186 -0.461 . . . . 62.24 110.956 179.997 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 5.1 m-85 -142.09 143.33 33.01 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.169 -0.469 . . . . 74.13 110.934 -179.967 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 3.2 p-10 -67.03 132.9 48.84 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.158 -0.474 . . . . 71.13 110.858 179.934 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 5.6 t80 -130.53 145.92 51.95 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.177 -0.465 . . . . 72.11 110.886 -179.865 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 3.8 tp10 -117.13 135.91 23.22 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.618 0.723 . . . . 74.42 110.913 -179.958 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.67 141.07 44.6 Favored 'Trans proline' 0 C--N 1.341 0.167 0 C-N-CA 122.716 2.277 . . . . 74.52 112.314 -179.971 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -105.9 -9.29 17.21 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.213 -0.449 . . . . 72.31 110.883 179.96 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 57.5 m-80 -121.66 175.75 6.07 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.18 -0.464 . . . . 73.23 110.902 -179.962 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -92.99 23.33 4.31 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.2 -0.454 . . . . 72.3 110.869 179.905 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 1.1 p-10 -140.92 13.68 2.27 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.16 -0.473 . . . . 53.44 110.864 -179.932 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 28.5 mt-10 -105.1 167.79 9.48 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.186 -0.461 . . . . 73.34 110.874 -179.976 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.572 HD12 ' H ' ' A' ' 19' ' ' ARG . 30.2 tp -117.3 147.56 42.47 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.166 -0.47 . . . . 65.23 110.938 -179.996 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . 0.572 ' H ' HD12 ' A' ' 18' ' ' LEU . 1.9 mtt180 -82.68 156.63 23.72 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.21 -0.45 . . . . 73.34 110.824 179.956 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.548 HD21 ' CG1' ' A' ' 55' ' ' VAL . 3.2 tp -143.5 147.86 35.14 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.15 -0.477 . . . . 71.21 110.928 -179.973 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.655 ' HB3' ' CG ' ' A' ' 24' ' ' ASP . . . -139.64 138.7 36.33 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.167 -0.469 . . . . 74.25 111.043 179.83 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 -51.15 121.55 6.33 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.21 -0.45 . . . . 71.22 110.905 -179.945 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 96.73 -7.42 65.39 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.77 -0.728 . . . . 74.44 112.508 -179.907 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . 0.655 ' CG ' ' HB3' ' A' ' 21' ' ' ALA . 1.1 m-20 -79.49 147.73 32.12 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.811 0.338 . . . . 42.5 110.873 -179.982 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 3.2 mm -102.85 140.91 19.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.187 -0.46 . . . . 73.51 111.106 -179.966 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 1.6 m -143.04 158.15 17.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.14 -0.482 . . . . 75.54 111.139 179.803 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 43.7 m-85 -115.62 106.05 13.47 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.183 -0.462 . . . . 64.12 110.884 -179.972 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.886 HD13 ' HB2' ' A' ' 39' ' ' ALA . 22.3 mm -71.02 103.2 1.11 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.152 -0.476 . . . . 50.23 111.095 -179.99 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 3.4 m -64.95 -39.28 93.25 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.186 -0.461 . . . . 60.44 110.872 -179.91 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' TYR . . . . . 0.472 ' CZ ' HG21 ' A' ' 38' ' ' VAL . 34.1 p90 -174.32 147.52 1.18 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.111 -0.495 . . . . 71.34 110.907 -179.917 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . 0.549 ' HG3' HD22 ' A' ' 37' ' ' LEU . 19.7 tttt -81.51 146.29 30.26 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.116 -0.493 . . . . 74.25 110.922 179.877 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 33.2 t60 -134.87 156.52 48.79 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.259 -0.428 . . . . 75.13 110.888 179.856 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -61.15 -174.06 1.25 Allowed Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.719 -0.753 . . . . 54.01 112.511 -179.982 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 45.4 mm-40 64.66 13.23 8.18 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.838 0.352 . . . . 74.14 110.92 -179.899 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 67.99 29.2 73.38 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.725 -0.75 . . . . 75.23 112.485 -179.986 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' TRP . . . . . 0.654 ' C ' HD23 ' A' ' 37' ' ' LEU . 98.9 m95 -123.29 138.34 54.64 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.83 0.347 . . . . 73.41 110.891 -179.881 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.71 HD11 ' CG ' ' A' ' 52' ' ' GLU . 0.5 OUTLIER -126.21 132.26 51.8 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.256 -0.429 . . . . 74.54 110.93 179.964 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.472 HG21 ' CZ ' ' A' ' 30' ' ' TYR . 51.8 t -77.38 115.75 19.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.206 -0.452 . . . . 74.22 111.143 179.858 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . 0.886 ' HB2' HD13 ' A' ' 28' ' ' ILE . . . -133.95 158.86 42.41 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.178 -0.465 . . . . 62.02 111.092 179.886 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 1.9 pt-20 -120.5 153.55 36.51 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.2 -0.455 . . . . 63.15 110.911 -179.943 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -67.94 -175.05 0.52 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.195 -0.457 . . . . 74.04 110.892 -179.971 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -69.81 -38.41 76.59 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.153 -0.476 . . . . 73.43 110.924 179.999 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 15.4 m -56.43 -22.73 33.83 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.111 -0.495 . . . . 64.42 110.916 -179.873 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 68.85 9.27 59.13 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.755 -0.736 . . . . 60.52 112.485 -179.992 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 39.0 m -105.06 -20.21 13.59 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.983 0.421 . . . . 62.24 110.899 -179.767 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.521 ' HE2' HD11 ' A' ' 18' ' ' LEU . 0.1 OUTLIER -113.24 123.67 50.73 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.092 -0.504 . . . . 72.22 110.882 179.946 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 11.4 m -134.54 127.1 30.65 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.183 -0.462 . . . . 60.4 111.1 -179.992 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -147.34 -154.36 6.2 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.725 -0.75 . . . . 53.42 112.471 179.944 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 6.9 mt -106.1 127.22 53.04 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.878 0.37 . . . . 65.13 110.897 -179.91 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.45 ' CG1' HD23 ' A' ' 18' ' ' LEU . 14.4 m -124.5 154.26 69.58 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-O 121.588 0.709 . . . . 54.11 111.186 179.818 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . 0.435 ' HG2' ' HB2' ' A' ' 54' ' ' PHE . 53.3 Cg_endo -69.77 147.12 62.11 Favored 'Trans proline' 0 N--CA 1.465 -0.151 0 C-N-CA 122.722 2.281 . . . . 71.25 112.316 179.997 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . 0.71 ' CG ' HD11 ' A' ' 37' ' ' LEU . 27.8 tt0 -92.02 -29.86 16.37 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.234 -0.439 . . . . 74.1 110.897 -179.997 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -84.91 9.89 13.18 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.132 -0.485 . . . . 74.4 110.878 -179.916 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . 0.435 ' HB2' ' HG2' ' A' ' 51' ' ' PRO . 1.0 OUTLIER -120.78 -8.46 9.44 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.177 -0.465 . . . . 73.42 110.887 -179.901 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.548 ' CG1' HD21 ' A' ' 20' ' ' LEU . 20.4 m -118.86 171.98 6.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.123 -0.49 . . . . 75.02 111.115 179.996 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . 0.693 ' HB2' HD21 ' A' ' 7' ' ' LEU . 35.6 t -143.59 113.51 7.18 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.175 -0.466 . . . . 74.42 110.806 -179.774 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 2.9 m-85 -52.54 133.28 35.89 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.115 -0.493 . . . . 73.0 110.922 -179.914 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.607 HD11 ' HB ' ' A' ' 5' ' ' VAL . 46.0 mt -102.46 148.63 7.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.099 -0.5 . . . . 75.11 111.137 179.899 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 5.0 mt-30 . . . . . 0 C--N 1.329 -0.306 0 CA-C-O 121.632 0.729 . . . . 75.44 110.834 179.971 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' B' B ' -7' ' ' PHE . . . . . . . . . . . . . 11.3 m-85 . . . . . 0 C--O 1.231 0.087 0 CA-C-O 120.862 0.363 . . . . 63.11 110.876 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' B' B ' -6' ' ' ILE . . . . . 0.414 ' O ' HG23 ' B' ' -6' ' ' ILE . 8.4 tt -133.72 119.16 14.82 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 121.576 0.703 . . . . 75.42 111.171 179.974 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' -5' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.73 154.47 67.83 Favored 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 122.681 2.254 . . . . 72.02 112.318 179.92 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' -4' ' ' SER . . . . . . . . . . . . . 41.3 t -133.78 39.18 3.18 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.19 -0.459 . . . . 62.22 110.853 -179.843 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' -3' ' ' ARG . . . . . . . . . . . . . 5.9 ptm180 -174.48 154.48 1.98 Allowed Pre-proline 0 C--N 1.328 -0.334 0 CA-C-O 121.661 0.744 . . . . 73.23 110.838 -179.894 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' -2' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.79 137.9 36.46 Favored 'Trans proline' 0 C--N 1.342 0.189 0 C-N-CA 122.634 2.223 . . . . 62.01 112.334 179.996 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' -1' ' ' ALA . . . . . . . . . . . . . . . -63.39 154.74 77.84 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.519 0.676 . . . . 52.14 111.086 179.9 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 0' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.76 -170.55 0.4 Allowed 'Trans proline' 0 C--O 1.232 0.176 0 C-N-CA 122.675 2.25 . . . . 64.32 112.325 179.982 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 1' ' ' LYS . . . . . . . . . . . . . 27.8 mtpp -130.11 154.58 81.33 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-O 121.575 0.702 . . . . 73.32 110.87 179.942 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 2' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo . . . . . 0 C--N 1.342 0.186 0 C-N-CA 122.732 2.288 . . . . 72.34 112.33 179.881 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 51.6 tp60 . . . . . 0 C--O 1.23 0.075 0 CA-C-O 120.824 0.345 . . . . 73.22 110.891 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 7.7 ptp180 -86.37 161.78 18.51 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.138 -0.483 . . . . 65.43 110.826 -179.909 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -153.3 154.46 34.63 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.154 -0.476 . . . . 71.15 111.101 179.892 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.641 ' HB ' HD11 ' A' ' 58' ' ' ILE . 9.2 p -103.9 153.09 6.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.226 -0.443 . . . . 75.54 111.115 179.981 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -92.06 113.68 26.02 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.149 -0.478 . . . . 60.14 111.086 179.891 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 0.663 HD21 ' HB2' ' A' ' 56' ' ' SER . 13.5 mt -79.59 -36.1 38.63 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.211 -0.449 . . . . 74.25 110.923 -179.977 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 2.8 m-85 -144.09 146.11 32.59 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.179 -0.464 . . . . 64.42 110.941 179.995 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 1.3 p30 -68.47 135.2 51.28 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.091 -0.504 . . . . 64.32 110.869 179.909 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 7.5 t80 -134.24 146.21 49.86 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.156 -0.475 . . . . 74.54 110.87 -179.915 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 68.5 tt0 -115.15 137.59 23.06 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-O 121.66 0.743 . . . . 62.24 110.867 -179.869 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.75 137.25 35.06 Favored 'Trans proline' 0 C--N 1.341 0.155 0 C-N-CA 122.665 2.243 . . . . 75.53 112.34 -179.986 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 7.9 mm-40 -97.66 -20.2 17.78 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.222 -0.445 . . . . 62.15 110.901 -179.987 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 32.2 m-80 -115.15 175.3 5.57 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.134 -0.484 . . . . 63.34 110.869 -179.967 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 26.2 m-20 -87.25 7.97 26.15 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.181 -0.463 . . . . 64.34 110.861 179.912 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -125.13 16.76 8.45 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.23 -0.441 . . . . 75.2 110.915 -179.888 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 16.4 mt-10 -108.37 156.59 19.25 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.164 -0.471 . . . . 73.31 110.888 179.986 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.631 HD11 ' HG3' ' A' ' 46' ' ' LYS . 0.5 OUTLIER -106.51 150.39 26.16 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.119 -0.491 . . . . 60.11 110.917 -179.969 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . 0.617 ' O ' HD23 ' A' ' 18' ' ' LEU . 26.1 mtm180 -85.16 153.27 22.76 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.167 -0.469 . . . . 70.23 110.852 179.976 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.548 HD21 ' CG1' ' A' ' 55' ' ' VAL . 1.7 tp -138.09 148.11 44.68 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.199 -0.455 . . . . 72.21 110.941 -179.968 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.612 ' HB3' ' CG ' ' A' ' 24' ' ' ASP . . . -140.18 139.24 35.66 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.231 -0.44 . . . . 52.42 111.147 179.786 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -50.29 119.72 3.93 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.249 -0.432 . . . . 74.4 110.88 -179.934 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 98.5 -6.86 61.28 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.773 -0.727 . . . . 61.41 112.456 179.973 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . 0.612 ' CG ' ' HB3' ' A' ' 21' ' ' ALA . 2.9 m-20 -75.78 152.78 37.29 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.792 0.329 . . . . 74.03 110.845 -179.997 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 1.3 mt -116.77 122.2 69.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.17 -0.468 . . . . 73.34 111.176 179.933 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.633 HG12 ' HA ' ' A' ' 41' ' ' ASN . 3.6 m -124.64 163.41 24.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.168 -0.469 . . . . 54.21 111.132 179.894 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 74.5 m-85 -116.35 110.1 18.24 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.145 -0.479 . . . . 72.43 110.853 -179.994 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.633 HD13 ' HB2' ' A' ' 39' ' ' ALA . 13.4 mm -71.85 103.0 1.31 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.117 -0.492 . . . . 65.22 111.106 179.955 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 5.4 m -65.53 -40.77 93.33 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.192 -0.458 . . . . 73.35 110.822 -179.904 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' TYR . . . . . 0.517 ' CZ ' HG21 ' A' ' 38' ' ' VAL . 33.4 p90 -174.27 149.87 1.43 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.154 -0.476 . . . . 75.34 110.958 -179.899 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 19.1 tttt -81.37 143.1 32.41 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.168 -0.469 . . . . 63.54 110.856 179.928 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 32.9 t60 -131.91 153.35 50.34 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.206 -0.452 . . . . 75.54 110.889 179.872 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -59.24 -174.69 0.69 Allowed Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.732 -0.747 . . . . 52.15 112.486 -179.932 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 29.8 mm-40 66.17 11.76 8.07 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.789 0.328 . . . . 73.43 110.88 -179.897 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 68.69 28.77 72.9 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.767 -0.73 . . . . 55.32 112.484 -179.947 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' TRP . . . . . 0.598 ' C ' HD23 ' A' ' 37' ' ' LEU . 98.0 m95 -122.9 136.36 54.83 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.744 0.307 . . . . 64.52 110.953 -179.958 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.712 HD11 ' CG ' ' A' ' 52' ' ' GLU . 1.4 mt -118.71 131.93 56.15 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.297 -0.411 . . . . 73.5 110.85 -179.985 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.657 HG22 HD23 ' A' ' 49' ' ' LEU . 23.4 t -81.34 109.35 15.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.151 -0.477 . . . . 71.11 111.116 179.804 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . 0.633 ' HB2' HD13 ' A' ' 28' ' ' ILE . . . -132.71 165.4 24.59 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.16 -0.473 . . . . 75.33 111.084 179.847 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -115.93 156.32 26.42 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.216 -0.447 . . . . 71.31 110.907 -179.97 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . 0.633 ' HA ' HG12 ' A' ' 26' ' ' VAL . 0.0 OUTLIER -69.77 179.33 2.23 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.138 -0.483 . . . . 74.12 110.873 -179.904 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 61.3 tt0 -63.5 -39.8 95.4 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.223 -0.444 . . . . 63.53 110.956 179.96 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 1.5 t -55.73 -22.77 25.47 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.085 -0.507 . . . . 75.45 110.861 -179.819 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 66.15 11.87 56.47 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.754 -0.736 . . . . 33.22 112.503 -179.967 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 16.5 m -107.75 -18.72 13.75 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.969 0.414 . . . . 60.04 110.841 -179.73 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.631 ' HG3' HD11 ' A' ' 18' ' ' LEU . 4.0 ptmt -117.16 133.68 55.7 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.142 -0.481 . . . . 73.44 110.871 -179.999 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . 0.423 ' C ' HD12 ' A' ' 18' ' ' LEU . 4.9 m -129.26 152.68 48.56 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.259 -0.428 . . . . 72.1 111.149 179.991 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -177.35 -161.04 25.15 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.744 -0.741 . . . . 75.2 112.515 179.976 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.657 HD23 HG22 ' A' ' 38' ' ' VAL . 6.7 mt -99.53 136.89 38.79 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.833 0.349 . . . . 63.23 110.873 -179.905 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 6.0 m -135.31 153.1 77.81 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.666 0.746 . . . . 51.43 111.116 179.839 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . 0.423 ' HD2' HD22 ' A' ' 20' ' ' LEU . 53.6 Cg_endo -69.79 143.85 52.02 Favored 'Trans proline' 0 C--N 1.342 0.195 0 C-N-CA 122.63 2.22 . . . . 73.21 112.325 -179.999 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . 0.712 ' CG ' HD11 ' A' ' 37' ' ' LEU . 10.1 tm-20 -91.0 -27.2 18.81 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.221 -0.445 . . . . 71.23 110.874 -179.972 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -87.51 11.71 14.15 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.19 -0.459 . . . . 61.1 110.871 -179.958 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . 0.413 ' HB2' ' HG2' ' A' ' 51' ' ' PRO . 1.1 m-85 -121.23 -12.79 8.6 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.141 -0.481 . . . . 74.53 110.833 -179.895 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.548 ' CG1' HD21 ' A' ' 20' ' ' LEU . 17.3 m -116.69 168.73 7.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.141 -0.482 . . . . 71.14 111.14 179.988 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . 0.663 ' HB2' HD21 ' A' ' 7' ' ' LEU . 45.2 t -138.83 116.52 11.43 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.172 -0.467 . . . . 74.23 110.854 -179.834 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 2.8 m-85 -51.87 134.53 31.21 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.1 -0.5 . . . . 70.43 110.909 -179.902 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.641 HD11 ' HB ' ' A' ' 5' ' ' VAL . 54.2 mt -104.04 146.61 11.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.087 -0.506 . . . . 73.32 111.153 179.905 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 2.5 mt-30 . . . . . 0 C--N 1.328 -0.353 0 CA-C-O 121.576 0.703 . . . . 73.31 110.936 179.968 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' B' B ' -7' ' ' PHE . . . . . 0.42 ' HB3' HD11 ' A' ' 49' ' ' LEU . 8.8 m-85 . . . . . 0 C--O 1.231 0.124 0 CA-C-O 120.795 0.331 . . . . 54.5 110.886 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' -6' ' ' ILE . . . . . 0.466 ' O ' HG23 ' B' ' -6' ' ' ILE . 4.5 tt -155.47 84.87 3.47 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-O 121.65 0.738 . . . . 74.55 111.109 179.994 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' -5' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.74 132.21 22.89 Favored 'Trans proline' 0 C--N 1.342 0.202 0 C-N-CA 122.707 2.272 . . . . 63.43 112.351 179.877 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' -4' ' ' SER . . . . . . . . . . . . . 1.4 t -129.74 64.26 1.51 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.224 -0.444 . . . . 74.51 110.866 -179.858 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' -3' ' ' ARG . . . . . . . . . . . . . 4.9 ptm180 -178.32 155.0 0.94 Allowed Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.641 0.734 . . . . 73.42 110.839 -179.91 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' -2' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.76 129.49 17.69 Favored 'Trans proline' 0 C--N 1.342 0.194 0 C-N-CA 122.654 2.236 . . . . 74.32 112.384 179.973 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' -1' ' ' ALA . . . . . 0.506 ' HB1' ' HD2' ' B' ' 0' ' ' PRO . . . -61.34 157.85 41.95 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-O 121.55 0.691 . . . . 73.41 111.135 179.879 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 0' ' ' PRO . . . . . 0.506 ' HD2' ' HB1' ' B' ' -1' ' ' ALA . 53.7 Cg_endo -69.76 -176.24 1.42 Allowed 'Trans proline' 0 C--O 1.231 0.156 0 C-N-CA 122.71 2.273 . . . . 74.34 112.345 -179.985 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 1' ' ' LYS . . . . . . . . . . . . . 37.2 tttp -131.77 137.55 30.55 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-O 121.542 0.687 . . . . 73.23 110.918 179.887 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 2' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo . . . . . 0 C--O 1.232 0.204 0 C-N-CA 122.725 2.283 . . . . 72.14 112.338 179.941 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 51.1 tp60 . . . . . 0 C--O 1.231 0.114 0 CA-C-O 120.827 0.346 . . . . 70.12 110.914 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 5.5 ptp180 -80.19 160.97 25.45 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.213 -0.448 . . . . 71.21 110.867 -179.886 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -155.42 154.43 31.91 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.204 -0.453 . . . . 74.04 111.116 179.955 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.493 ' HB ' HD11 ' A' ' 58' ' ' ILE . 10.7 p -104.28 149.6 7.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.258 -0.428 . . . . 60.4 111.117 -179.988 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -87.3 110.12 19.99 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.195 -0.457 . . . . 74.25 111.091 179.899 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 0.749 HD21 ' CB ' ' A' ' 56' ' ' SER . 16.6 mt -74.2 -37.45 63.88 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.226 -0.443 . . . . 60.12 110.912 -179.941 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 5.4 m-85 -142.34 154.87 45.03 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.196 -0.456 . . . . 72.41 110.945 179.992 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 1.6 p30 -78.94 137.49 37.65 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.112 -0.495 . . . . 53.11 110.898 179.882 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 9.9 t80 -138.84 145.49 40.1 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.211 -0.45 . . . . 64.02 110.871 -179.959 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 22.5 tt0 -114.28 135.46 22.2 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 121.617 0.722 . . . . 75.11 110.891 -179.926 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . 0.409 ' HD3' ' HA ' ' A' ' 19' ' ' ARG . 53.2 Cg_endo -69.8 152.62 69.13 Favored 'Trans proline' 0 C--N 1.341 0.162 0 C-N-CA 122.702 2.268 . . . . 71.42 112.353 -179.996 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 22.4 tp10 -116.52 -20.72 9.51 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.205 -0.452 . . . . 72.21 110.898 -179.95 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 7.4 m-80 -106.53 176.04 5.3 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.14 -0.482 . . . . 71.52 110.834 -179.926 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 15.8 m-20 -92.2 21.41 5.15 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.177 -0.465 . . . . 74.34 110.851 179.923 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 1.2 p-10 -141.16 12.51 2.2 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.22 -0.445 . . . . 75.13 110.888 -179.876 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 -101.68 156.05 17.73 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.167 -0.469 . . . . 74.34 110.894 -179.985 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.619 HD12 ' H ' ' A' ' 19' ' ' ARG . 31.5 tp -108.46 144.94 35.4 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.142 -0.481 . . . . 71.21 110.89 -179.949 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . 0.619 ' H ' HD12 ' A' ' 18' ' ' LEU . 14.6 mtp180 -81.18 153.09 27.4 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.215 -0.448 . . . . 74.5 110.902 179.935 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.535 HD21 ' CG1' ' A' ' 55' ' ' VAL . 2.6 tp -138.99 148.42 43.44 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.236 -0.438 . . . . 72.24 110.904 -179.944 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.669 ' HB3' ' CG ' ' A' ' 24' ' ' ASP . . . -139.92 137.23 34.63 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.197 -0.456 . . . . 63.3 111.131 179.767 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -50.7 120.03 4.37 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.234 -0.439 . . . . 63.2 110.896 -179.91 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 97.9 -5.77 61.9 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.761 -0.733 . . . . 50.13 112.482 -179.945 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . 0.669 ' CG ' ' HB3' ' A' ' 21' ' ' ALA . 1.1 m-20 -81.77 147.29 29.49 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.785 0.326 . . . . 73.22 110.861 -179.944 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 3.4 mm -100.94 142.46 15.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.224 -0.444 . . . . 62.23 111.086 -179.982 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.425 HG11 HD11 ' A' ' 20' ' ' LEU . 1.4 m -145.27 158.24 13.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.181 -0.463 . . . . 43.33 111.128 179.859 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 65.0 m-85 -116.95 108.26 15.57 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.155 -0.475 . . . . 61.35 110.892 -179.964 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.732 HD13 ' HB2' ' A' ' 39' ' ' ALA . 16.5 mm -71.78 103.28 1.36 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.16 -0.473 . . . . 63.32 111.125 179.975 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 11.4 m -65.4 -40.17 93.09 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.119 -0.491 . . . . 72.14 110.833 -179.902 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' TYR . . . . . 0.508 ' CZ ' HG21 ' A' ' 38' ' ' VAL . 36.5 p90 -174.53 150.08 1.36 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.104 -0.498 . . . . 75.42 110.892 -179.873 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . 0.448 ' HG3' HD22 ' A' ' 37' ' ' LEU . 13.4 tttt -82.07 144.44 30.82 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.094 -0.503 . . . . 73.13 110.885 179.903 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 31.7 t60 -132.75 156.15 47.59 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.244 -0.434 . . . . 74.31 110.858 179.919 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -61.21 -174.31 1.34 Allowed Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.771 -0.728 . . . . 43.42 112.42 -179.926 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 63.1 mm-40 65.35 12.84 8.4 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.852 0.358 . . . . 64.43 110.946 -179.885 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 68.41 28.98 72.95 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.697 -0.763 . . . . 54.22 112.499 -179.997 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' TRP . . . . . 0.616 ' C ' HD23 ' A' ' 37' ' ' LEU . 98.8 m95 -123.45 137.54 54.77 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.857 0.36 . . . . 75.04 110.894 -179.912 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.748 HD11 ' CG ' ' A' ' 52' ' ' GLU . 0.6 OUTLIER -121.9 130.47 53.38 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.215 -0.448 . . . . 75.25 110.896 179.979 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.508 HG21 ' CZ ' ' A' ' 30' ' ' TYR . 42.8 t -77.32 116.01 20.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.175 -0.466 . . . . 61.24 111.087 179.845 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . 0.732 ' HB2' HD13 ' A' ' 28' ' ' ILE . . . -138.05 161.79 35.83 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.18 -0.464 . . . . 65.21 111.101 179.85 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 1.2 pt-20 -113.45 156.86 22.76 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.209 -0.45 . . . . 72.52 110.867 -179.923 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -72.4 -176.26 1.82 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.13 -0.486 . . . . 74.04 110.883 -179.932 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 9.6 tt0 -68.16 -38.5 82.18 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.188 -0.46 . . . . 63.01 110.908 -179.975 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 1.5 t -57.02 -22.22 37.08 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.137 -0.483 . . . . 50.03 110.83 -179.827 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 65.8 12.77 57.84 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.737 -0.744 . . . . 75.31 112.483 -179.993 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -109.13 -15.99 14.2 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.972 0.415 . . . . 71.32 110.863 -179.779 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -120.11 135.08 55.08 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.137 -0.483 . . . . 74.0 110.941 179.949 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 5.6 m -136.36 140.28 43.15 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.252 -0.431 . . . . 72.11 111.156 179.985 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -161.8 -153.7 7.19 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.743 -0.741 . . . . 61.03 112.472 -179.997 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.448 HD11 ' HB3' ' B' ' -7' ' ' PHE . 9.0 mt -104.05 135.0 46.37 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.818 0.342 . . . . 71.14 110.928 -179.932 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 10.2 m -133.94 153.02 79.6 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 121.604 0.716 . . . . 54.5 111.152 179.825 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . 0.414 ' HG2' ' HB2' ' A' ' 54' ' ' PHE . 53.3 Cg_endo -69.81 147.78 63.29 Favored 'Trans proline' 0 C--N 1.341 0.161 0 C-N-CA 122.618 2.212 . . . . 71.32 112.337 180.0 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . 0.748 ' CG ' HD11 ' A' ' 37' ' ' LEU . 15.5 tm-20 -92.77 -28.91 16.3 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.211 -0.45 . . . . 61.21 110.886 -179.97 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -86.59 10.55 15.14 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.15 -0.477 . . . . 62.33 110.881 -179.917 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . 0.414 ' HB2' ' HG2' ' A' ' 51' ' ' PRO . 0.9 OUTLIER -121.31 -4.31 9.42 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.152 -0.476 . . . . 72.44 110.852 -179.902 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.535 ' CG1' HD21 ' A' ' 20' ' ' LEU . 16.0 m -125.93 166.61 21.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.169 -0.468 . . . . 63.21 111.155 179.94 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . 0.749 ' CB ' HD21 ' A' ' 7' ' ' LEU . 30.0 t -136.21 118.99 16.14 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.166 -0.47 . . . . 71.31 110.888 -179.836 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 -57.71 128.22 35.98 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.161 -0.472 . . . . 65.12 110.901 -179.847 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.493 HD11 ' HB ' ' A' ' 5' ' ' VAL . 49.6 mt -94.69 148.19 5.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.165 -0.47 . . . . 55.04 111.127 179.918 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 2.5 mt-30 . . . . . 0 C--N 1.329 -0.315 0 CA-C-O 121.573 0.702 . . . . 74.41 110.957 179.923 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' B' B ' -7' ' ' PHE . . . . . 0.448 ' HB3' HD11 ' A' ' 49' ' ' LEU . 18.0 m-85 . . . . . 0 C--O 1.231 0.086 0 CA-C-O 120.85 0.357 . . . . 60.14 110.855 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' -6' ' ' ILE . . . . . . . . . . . . . 58.8 mt -149.91 93.33 3.96 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 121.59 0.71 . . . . 55.42 111.124 179.954 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' -5' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.75 122.1 8.78 Favored 'Trans proline' 0 C--O 1.232 0.178 0 C-N-CA 122.637 2.225 . . . . 61.1 112.351 179.894 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' -4' ' ' SER . . . . . . . . . . . . . 22.7 m -117.18 59.95 0.76 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.254 -0.43 . . . . 41.5 110.893 -179.868 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' -3' ' ' ARG . . . . . . . . . . . . . 8.8 ptm180 -176.69 153.36 1.15 Allowed Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 121.634 0.731 . . . . 73.3 110.867 -179.927 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' -2' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.77 145.56 57.42 Favored 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.661 2.24 . . . . 73.03 112.323 -179.964 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' -1' ' ' ALA . . . . . . . . . . . . . . . -75.93 141.92 72.18 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.567 0.699 . . . . 34.34 111.105 179.848 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 0' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.75 175.13 8.5 Favored 'Trans proline' 0 C--N 1.341 0.169 0 C-N-CA 122.712 2.275 . . . . 74.11 112.36 179.959 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 1' ' ' LYS . . . . . . . . . . . . . 16.7 ptmt -124.31 152.71 68.27 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-O 121.551 0.691 . . . . 72.25 110.93 179.891 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 2' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo . . . . . 0 C--O 1.232 0.202 0 C-N-CA 122.744 2.296 . . . . 71.41 112.349 179.877 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 40.2 tp60 . . . . . 0 C--O 1.232 0.141 0 CA-C-O 120.755 0.312 . . . . 71.41 110.899 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 5.0 ptp180 -76.83 160.39 29.3 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.189 -0.46 . . . . 75.33 110.835 -179.898 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -155.33 149.83 26.17 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.208 -0.451 . . . . 51.14 111.094 179.913 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.611 ' HB ' HD11 ' A' ' 58' ' ' ILE . 8.7 p -105.41 142.21 19.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.25 -0.432 . . . . 70.11 111.14 179.985 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . 0.439 ' HA ' HG12 ' A' ' 55' ' ' VAL . . . -82.94 127.74 33.81 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.178 -0.465 . . . . 65.35 111.093 179.866 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 0.512 HD21 ' CB ' ' A' ' 56' ' ' SER . 7.6 mt -93.23 -31.68 14.65 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.221 -0.445 . . . . 72.23 110.889 -179.985 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 4.5 m-85 -144.18 136.12 26.22 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.185 -0.461 . . . . 50.44 110.924 -179.96 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 3.4 p30 -62.3 141.68 58.15 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.153 -0.476 . . . . 63.03 110.852 179.911 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 24.1 t80 -141.87 145.87 35.14 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.193 -0.458 . . . . 63.34 110.895 -179.918 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 28.6 tt0 -115.64 137.0 22.91 Favored Pre-proline 0 C--N 1.33 -0.257 0 CA-C-O 121.657 0.741 . . . . 64.04 110.912 -179.945 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.73 146.43 60.31 Favored 'Trans proline' 0 C--N 1.341 0.181 0 C-N-CA 122.687 2.258 . . . . 71.23 112.35 -179.961 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 7.3 mm-40 -107.87 -12.74 15.13 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.267 -0.424 . . . . 75.21 110.886 180.0 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 28.6 m-80 -118.98 175.48 5.74 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.185 -0.461 . . . . 71.44 110.906 -179.97 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 63.7 m-20 -90.83 15.87 10.44 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.206 -0.452 . . . . 53.53 110.833 -179.993 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 1.1 p-10 -134.08 16.74 3.81 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.192 -0.458 . . . . 72.43 110.873 -179.888 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 3.9 mm-40 -106.98 160.84 15.23 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.149 -0.478 . . . . 74.3 110.867 -179.969 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.649 HD21 ' HD2' ' A' ' 46' ' ' LYS . 0.5 OUTLIER -111.44 142.86 43.15 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.147 -0.479 . . . . 75.15 110.954 179.994 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . 0.553 ' H ' HD23 ' A' ' 18' ' ' LEU . 36.2 mtm-85 -78.44 156.8 29.21 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.21 -0.45 . . . . 73.42 110.872 179.981 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.539 HD22 ' HD2' ' A' ' 51' ' ' PRO . 3.1 tp -141.65 148.85 39.81 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.165 -0.47 . . . . 74.52 110.914 -179.993 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.436 ' O ' ' HB3' ' A' ' 6' ' ' ALA . . . -138.56 139.9 38.84 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.214 -0.448 . . . . 72.42 111.119 179.73 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -53.64 119.31 4.75 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.215 -0.448 . . . . 73.24 110.888 -179.917 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 93.16 0.83 67.54 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.726 -0.749 . . . . 55.23 112.469 -179.978 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 20.5 t70 -77.2 158.73 30.16 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.809 0.338 . . . . 75.32 110.84 -179.948 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 1.7 mm -111.14 121.32 63.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.164 -0.471 . . . . 74.4 111.168 179.996 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.523 HG11 HD11 ' A' ' 20' ' ' LEU . 3.7 m -130.59 155.7 41.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.25 -0.432 . . . . 72.34 111.16 179.827 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 66.2 m-85 -115.56 109.08 17.27 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.218 -0.446 . . . . 72.35 110.895 -179.94 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.744 HD13 ' HB2' ' A' ' 39' ' ' ALA . 16.5 mm -73.0 103.8 1.89 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.133 -0.485 . . . . 63.34 111.11 -179.989 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 2.6 m -64.48 -39.56 94.03 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.196 -0.456 . . . . 55.12 110.848 -179.882 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' TYR . . . . . 0.482 ' CZ ' HG21 ' A' ' 38' ' ' VAL . 32.5 p90 -174.1 146.79 1.19 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.124 -0.489 . . . . 73.2 110.946 -179.902 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . 0.489 ' HG3' HD22 ' A' ' 37' ' ' LEU . 21.0 tttt -80.2 146.27 31.84 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.119 -0.492 . . . . 74.13 110.917 179.935 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 31.8 t60 -136.53 152.74 50.85 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.246 -0.434 . . . . 63.14 110.809 179.941 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -58.19 -174.96 0.48 Allowed Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.76 -0.733 . . . . 51.12 112.491 -179.98 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 56.4 mm-40 65.88 12.2 8.21 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.777 0.322 . . . . 74.21 110.856 -179.92 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 68.12 28.73 73.26 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.721 -0.752 . . . . 62.03 112.475 179.995 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' TRP . . . . . 0.612 ' C ' HD23 ' A' ' 37' ' ' LEU . 98.6 m95 -122.76 136.18 54.79 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.797 0.332 . . . . 71.23 110.913 -179.921 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.684 HD11 ' CG ' ' A' ' 52' ' ' GLU . 0.6 OUTLIER -122.74 130.78 53.33 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.225 -0.443 . . . . 72.34 110.888 179.983 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.482 HG21 ' CZ ' ' A' ' 30' ' ' TYR . 40.7 t -78.72 111.71 15.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.155 -0.475 . . . . 63.12 111.152 179.808 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . 0.744 ' HB2' HD13 ' A' ' 28' ' ' ILE . . . -131.57 168.28 17.95 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.167 -0.469 . . . . 62.13 111.054 179.915 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . 0.407 ' HA ' ' HA ' ' A' ' 47' ' ' THR . 0.8 OUTLIER -121.92 159.39 26.98 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.153 -0.476 . . . . 72.04 110.893 -179.931 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 41.7 p-10 -58.57 -174.82 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.131 -0.486 . . . . 74.43 110.901 -179.936 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 66.5 tt0 -78.03 -37.18 47.48 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.215 -0.448 . . . . 73.14 110.919 179.996 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 37.3 t -70.64 -22.32 62.52 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.146 -0.479 . . . . 60.15 110.892 -179.834 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 75.93 26.52 64.4 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.754 -0.736 . . . . 75.22 112.466 179.985 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 8.6 t -107.18 -20.66 13.23 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.915 0.388 . . . . 72.31 110.872 -179.753 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.649 ' HD2' HD21 ' A' ' 18' ' ' LEU . 0.0 OUTLIER -127.27 137.58 52.89 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.138 -0.483 . . . . 55.42 110.893 179.924 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . 0.407 ' HA ' ' HA ' ' A' ' 40' ' ' GLU . 20.9 m -131.27 149.68 52.47 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.193 -0.458 . . . . 74.15 111.148 179.913 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . 0.557 ' N ' HD12 ' A' ' 18' ' ' LEU . . . -173.5 -162.16 24.94 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.726 -0.749 . . . . 73.51 112.448 179.975 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.445 HD23 HG22 ' A' ' 38' ' ' VAL . 10.4 mt -96.67 139.18 33.12 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.815 0.341 . . . . 74.2 110.972 -179.941 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.414 HG22 ' O ' ' A' ' 37' ' ' LEU . 11.5 m -137.3 152.96 74.36 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.664 0.745 . . . . 73.15 111.116 179.859 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . 0.539 ' HD2' HD22 ' A' ' 20' ' ' LEU . 53.9 Cg_endo -69.81 147.78 63.31 Favored 'Trans proline' 0 C--N 1.341 0.18 0 C-N-CA 122.668 2.246 . . . . 72.5 112.311 179.959 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . 0.684 ' CG ' HD11 ' A' ' 37' ' ' LEU . 23.8 tt0 -93.11 -29.21 15.88 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.204 -0.453 . . . . 75.11 110.88 -179.987 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -85.72 7.97 21.57 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.149 -0.478 . . . . 65.1 110.887 -179.922 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . 0.428 ' HB2' ' HG2' ' A' ' 51' ' ' PRO . 1.1 m-85 -119.57 3.3 11.21 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.129 -0.487 . . . . 64.22 110.865 -179.902 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.532 ' CG1' HD21 ' A' ' 20' ' ' LEU . 21.3 m -134.62 164.55 33.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.119 -0.492 . . . . 55.3 111.161 179.959 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . 0.512 ' CB ' HD21 ' A' ' 7' ' ' LEU . 32.2 t -136.36 118.61 15.58 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.18 -0.464 . . . . 65.45 110.837 -179.885 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 3.0 m-85 -54.32 135.2 45.08 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.144 -0.48 . . . . 74.14 110.921 -179.886 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.611 HD11 ' HB ' ' A' ' 5' ' ' VAL . 31.0 mt -101.92 150.74 6.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.088 -0.505 . . . . 74.25 111.144 179.918 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 1.6 mt-30 . . . . . 0 C--N 1.329 -0.311 0 CA-C-O 121.672 0.748 . . . . 75.1 110.907 179.93 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' B' B ' -7' ' ' PHE . . . . . 0.401 ' O ' HD13 ' B' ' -6' ' ' ILE . 5.8 m-85 . . . . . 0 C--O 1.231 0.12 0 CA-C-O 120.858 0.361 . . . . 63.42 110.823 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' -6' ' ' ILE . . . . . 0.401 HD13 ' O ' ' B' ' -7' ' ' PHE . 34.2 mm -145.45 88.57 6.58 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-O 121.673 0.749 . . . . 63.14 111.139 179.967 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' -5' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.82 130.36 19.13 Favored 'Trans proline' 0 C--N 1.342 0.192 0 C-N-CA 122.702 2.268 . . . . 32.43 112.313 179.943 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' -4' ' ' SER . . . . . . . . . . . . . 27.4 t -129.4 65.56 1.47 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.165 -0.47 . . . . 72.22 110.86 -179.819 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' -3' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -179.74 154.98 0.72 Allowed Pre-proline 0 C--N 1.329 -0.326 0 CA-C-O 121.578 0.704 . . . . 71.14 110.914 -179.931 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' -2' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.74 131.74 21.89 Favored 'Trans proline' 0 C--N 1.341 0.155 0 C-N-CA 122.686 2.257 . . . . 72.34 112.347 179.974 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' -1' ' ' ALA . . . . . . . . . . . . . . . -65.16 151.91 92.73 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-O 121.526 0.679 . . . . 73.23 111.094 179.891 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 0' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.75 176.63 6.5 Favored 'Trans proline' 0 C--O 1.232 0.181 0 C-N-CA 122.651 2.234 . . . . 74.44 112.359 -179.989 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 1' ' ' LYS . . . . . . . . . . . . . 12.3 pttp -125.57 155.07 72.7 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.543 0.687 . . . . 74.05 110.91 179.886 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 2' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo . . . . . 0 C--N 1.341 0.183 0 C-N-CA 122.668 2.246 . . . . 73.25 112.35 179.863 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 48.4 tp60 . . . . . 0 C--O 1.231 0.099 0 CA-C-O 120.765 0.317 . . . . 75.44 110.932 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 5.2 ptp180 -73.87 162.99 28.52 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.172 -0.467 . . . . 73.45 110.881 -179.931 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -156.61 153.8 29.18 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.198 -0.455 . . . . 62.13 111.133 179.911 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.516 ' HB ' HD11 ' A' ' 58' ' ' ILE . 10.7 p -103.96 149.63 7.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.224 -0.444 . . . . 64.51 111.169 179.937 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -88.68 106.06 18.09 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.193 -0.458 . . . . 51.22 111.082 179.877 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 0.726 HD21 ' CB ' ' A' ' 56' ' ' SER . 15.4 mt -71.33 -36.66 71.63 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.199 -0.455 . . . . 64.22 110.957 179.98 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 4.0 m-85 -143.56 152.65 41.69 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.211 -0.449 . . . . 61.53 110.886 -180.0 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 2.4 p30 -75.29 140.64 43.26 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.069 -0.514 . . . . 64.44 110.903 179.903 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 7.2 t80 -147.18 145.34 29.48 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.195 -0.457 . . . . 75.35 110.904 -179.852 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -114.06 144.61 31.93 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.641 0.734 . . . . 75.12 110.912 -179.949 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.82 148.75 65.36 Favored 'Trans proline' 0 C--N 1.341 0.144 0 C-N-CA 122.688 2.259 . . . . 61.52 112.356 -179.996 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 10.6 tp10 -109.87 -19.72 13.02 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.171 -0.468 . . . . 75.32 110.847 -179.911 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 9.2 m-80 -110.95 176.3 5.08 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.173 -0.467 . . . . 63.11 110.844 -179.905 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -90.84 21.08 4.31 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.136 -0.484 . . . . 73.51 110.918 179.884 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -142.35 13.44 1.98 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.147 -0.479 . . . . 73.33 110.896 -179.893 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 17.0 mt-10 -102.43 158.25 16.34 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.163 -0.471 . . . . 74.32 110.906 -179.981 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.612 HD23 ' O ' ' A' ' 19' ' ' ARG . 0.4 OUTLIER -105.9 155.78 19.01 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.204 -0.453 . . . . 75.15 110.909 -179.97 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . 0.612 ' O ' HD23 ' A' ' 18' ' ' LEU . 0.9 OUTLIER -92.04 153.69 19.25 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.137 -0.483 . . . . 72.44 110.83 -179.965 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.589 HD21 ' CG1' ' A' ' 55' ' ' VAL . 2.3 tp -137.05 149.72 47.6 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.236 -0.438 . . . . 72.44 110.945 -179.995 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.679 ' HB3' ' CG ' ' A' ' 24' ' ' ASP . . . -142.9 136.9 29.1 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.207 -0.451 . . . . 44.21 111.116 179.793 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -50.15 119.98 4.09 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.235 -0.438 . . . . 75.12 110.855 -179.883 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 96.34 -0.91 62.04 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.749 -0.739 . . . . 54.23 112.473 -179.971 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . 0.679 ' CG ' ' HB3' ' A' ' 21' ' ' ALA . 1.1 m-20 -86.99 147.26 25.81 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.751 0.31 . . . . 70.02 110.853 -179.966 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 3.3 mm -102.59 142.08 17.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.221 -0.445 . . . . 73.02 111.155 179.987 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -143.22 159.45 17.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.196 -0.456 . . . . 72.2 111.145 179.876 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 44.0 m-85 -116.59 107.09 14.28 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.216 -0.447 . . . . 73.21 110.851 -179.953 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.792 HD13 ' HB2' ' A' ' 39' ' ' ALA . 17.6 mm -72.63 103.05 1.55 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.158 -0.474 . . . . 74.45 111.109 179.993 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 3.0 m -64.29 -39.32 93.7 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.161 -0.472 . . . . 52.41 110.861 -179.92 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' TYR . . . . . 0.498 ' CZ ' HG21 ' A' ' 38' ' ' VAL . 32.9 p90 -174.75 147.34 1.02 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.109 -0.496 . . . . 64.4 110.898 -179.828 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . 0.512 ' HG3' HD22 ' A' ' 37' ' ' LEU . 11.9 tttm -81.45 145.98 30.48 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.09 -0.504 . . . . 42.13 110.865 179.922 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 32.1 t60 -135.68 152.04 50.8 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.211 -0.45 . . . . 75.35 110.894 179.873 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -57.78 -175.35 0.44 Allowed Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.728 -0.749 . . . . 32.04 112.511 -179.986 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 4.4 mp0 66.55 11.94 8.42 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.826 0.346 . . . . 64.3 110.869 -179.908 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 68.18 28.82 73.19 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.751 -0.738 . . . . 74.52 112.507 -179.973 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' TRP . . . . . 0.58 ' C ' HD23 ' A' ' 37' ' ' LEU . 97.8 m95 -122.74 134.95 54.43 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.796 0.332 . . . . 75.31 110.902 -179.92 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.685 HD11 ' CG ' ' A' ' 52' ' ' GLU . 0.9 OUTLIER -121.73 132.61 54.72 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.241 -0.436 . . . . 63.23 110.9 179.983 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.498 HG21 ' CZ ' ' A' ' 30' ' ' TYR . 46.1 t -79.79 109.59 14.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.207 -0.451 . . . . 73.04 111.125 179.839 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . 0.792 ' HB2' HD13 ' A' ' 28' ' ' ILE . . . -129.46 161.65 29.9 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.199 -0.455 . . . . 73.21 111.083 179.884 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 2.3 pm0 -118.51 158.38 25.48 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.204 -0.453 . . . . 75.24 110.936 -179.98 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 46.3 p-10 -58.16 -175.08 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.166 -0.47 . . . . 51.24 110.896 -179.946 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 15.6 tm-20 -78.01 -35.44 49.9 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.176 -0.465 . . . . 62.53 110.921 -179.99 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 40.1 t -69.59 -21.89 63.56 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.131 -0.486 . . . . 62.11 110.903 -179.826 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 76.33 26.13 64.39 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.71 -0.757 . . . . 33.04 112.529 -179.968 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -111.98 -22.51 11.01 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.926 0.393 . . . . 65.1 110.881 -179.747 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.601 ' HG2' HD11 ' A' ' 18' ' ' LEU . 3.0 ttmt -117.89 130.24 56.12 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.135 -0.484 . . . . 65.22 110.904 179.93 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . 0.422 ' C ' HD12 ' A' ' 18' ' ' LEU . 4.6 m -127.77 150.36 49.84 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.251 -0.431 . . . . 74.54 111.163 179.927 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -177.69 -160.18 23.87 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.757 -0.735 . . . . 65.45 112.489 179.994 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.475 HD11 ' HB3' ' B' ' -7' ' ' PHE . 3.6 mt -102.04 141.15 35.33 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.874 0.368 . . . . 73.43 110.892 -179.95 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.442 ' HB ' ' HD2' ' A' ' 51' ' ' PRO . 16.1 m -138.11 154.5 74.17 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.611 0.719 . . . . 61.53 111.138 179.826 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . 0.442 ' HD2' ' HB ' ' A' ' 50' ' ' VAL . 53.3 Cg_endo -69.74 143.14 49.99 Favored 'Trans proline' 0 C--N 1.341 0.132 0 C-N-CA 122.708 2.272 . . . . 73.35 112.315 179.976 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . 0.685 ' CG ' HD11 ' A' ' 37' ' ' LEU . 27.1 tt0 -90.5 -27.55 19.13 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.194 -0.457 . . . . 73.42 110.854 -179.947 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -86.19 9.61 17.04 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.17 -0.468 . . . . 73.41 110.923 -179.969 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . 0.407 ' HB2' ' HG2' ' A' ' 51' ' ' PRO . 1.1 m-85 -119.85 -13.75 9.04 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.124 -0.489 . . . . 63.25 110.852 -179.912 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.589 ' CG1' HD21 ' A' ' 20' ' ' LEU . 21.8 m -114.7 167.45 7.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.169 -0.469 . . . . 74.31 111.113 179.967 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . 0.726 ' CB ' HD21 ' A' ' 7' ' ' LEU . 42.9 t -139.23 116.27 10.98 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.167 -0.469 . . . . 70.45 110.869 -179.899 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 2.6 m-85 -53.35 133.94 40.0 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.134 -0.484 . . . . 74.33 110.951 -179.913 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.516 HD11 ' HB ' ' A' ' 5' ' ' VAL . 39.4 mt -102.58 150.24 6.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.109 -0.496 . . . . 71.45 111.114 179.975 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.329 -0.283 0 CA-C-O 121.607 0.718 . . . . 71.55 110.94 179.925 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' -7' ' ' PHE . . . . . 0.475 ' HB3' HD11 ' A' ' 49' ' ' LEU . 19.6 m-85 . . . . . 0 C--O 1.231 0.123 0 CA-C-O 120.815 0.341 . . . . 74.33 110.919 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' -6' ' ' ILE . . . . . 0.442 ' O ' HG23 ' B' ' -6' ' ' ILE . 4.5 tt -173.52 90.05 0.37 Allowed Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 121.691 0.758 . . . . 72.54 111.118 179.996 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' -5' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.75 134.48 28.09 Favored 'Trans proline' 0 C--N 1.342 0.209 0 C-N-CA 122.662 2.241 . . . . 63.4 112.382 179.853 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' -4' ' ' SER . . . . . . . . . . . . . 33.1 t -134.37 66.5 1.54 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.214 -0.448 . . . . 53.33 110.834 -179.845 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' -3' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 179.87 155.34 0.69 Allowed Pre-proline 0 C--N 1.328 -0.34 0 CA-C-O 121.609 0.718 . . . . 75.13 110.905 -179.968 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' -2' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.8 123.14 9.79 Favored 'Trans proline' 0 N--CA 1.465 -0.187 0 C-N-CA 122.668 2.246 . . . . 64.55 112.331 -179.95 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' -1' ' ' ALA . . . . . . . . . . . . . . . -50.99 152.6 3.62 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-O 121.561 0.696 . . . . 53.53 111.1 179.886 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 0' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.76 165.15 31.94 Favored 'Trans proline' 0 C--N 1.341 0.166 0 C-N-CA 122.683 2.256 . . . . 73.52 112.367 179.959 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 1' ' ' LYS . . . . . . . . . . . . . 3.9 tppt? -116.02 135.93 22.86 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-O 121.594 0.711 . . . . 75.35 110.87 179.935 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 2' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo . . . . . 0 C--N 1.341 0.179 0 C-N-CA 122.676 2.251 . . . . 72.52 112.337 179.856 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 49.4 tp60 . . . . . 0 C--O 1.231 0.079 0 CA-C-O 120.862 0.363 . . . . 53.41 110.883 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -73.4 158.59 34.71 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.172 -0.467 . . . . 72.04 110.878 -179.917 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -154.72 154.06 32.28 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.19 -0.459 . . . . 73.03 111.066 179.905 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.517 ' HB ' HD11 ' A' ' 58' ' ' ILE . 10.9 p -104.14 152.22 6.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.208 -0.451 . . . . 73.52 111.126 179.984 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -91.83 121.48 33.48 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.198 -0.456 . . . . 65.43 111.129 179.813 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 0.597 HD21 ' HB3' ' A' ' 56' ' ' SER . 12.6 mt -85.99 -33.82 20.98 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.22 -0.445 . . . . 73.35 110.886 -179.985 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 5.1 m-85 -144.98 142.59 29.93 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.224 -0.443 . . . . 72.01 110.941 -179.979 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 1.9 p-10 -67.46 140.66 57.11 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.132 -0.486 . . . . 74.14 110.892 179.899 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 15.5 t80 -140.94 146.53 37.48 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.182 -0.463 . . . . 72.51 110.918 -179.906 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -115.58 137.37 23.13 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-O 121.632 0.73 . . . . 74.33 110.866 -179.913 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.79 151.59 68.92 Favored 'Trans proline' 0 N--CA 1.465 -0.154 0 C-N-CA 122.701 2.267 . . . . 63.11 112.373 179.987 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 4.2 mt-10 -109.69 -19.44 13.17 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.232 -0.44 . . . . 64.44 110.917 -179.995 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 48.5 m-80 -123.63 175.0 7.08 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.159 -0.473 . . . . 74.43 110.867 -179.931 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 41.5 m-20 -81.05 -1.14 42.86 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.165 -0.471 . . . . 75.25 110.867 179.937 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -112.47 16.35 19.87 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.216 -0.447 . . . . 72.13 110.885 -179.916 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 6.9 mt-10 -110.39 157.15 19.85 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.181 -0.463 . . . . 70.3 110.871 -179.964 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.554 HD12 ' H ' ' A' ' 19' ' ' ARG . 41.7 tp -112.19 147.79 35.42 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.145 -0.479 . . . . 74.02 110.9 -179.994 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . 0.554 ' H ' HD12 ' A' ' 18' ' ' LEU . 32.2 mtm180 -83.17 154.76 24.11 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.196 -0.456 . . . . 75.12 110.86 179.946 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.513 HD21 ' CG1' ' A' ' 55' ' ' VAL . 2.3 tp -142.25 147.94 37.29 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.199 -0.455 . . . . 71.24 110.913 -179.983 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -138.07 139.45 39.54 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.185 -0.461 . . . . 43.34 111.109 179.787 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -51.71 119.58 4.35 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.234 -0.439 . . . . 75.15 110.857 -179.929 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 97.34 -6.72 63.59 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.716 -0.755 . . . . 73.23 112.458 179.987 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -71.39 160.2 33.2 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.752 0.31 . . . . 74.35 110.867 -179.921 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 1.2 mt -123.11 114.04 40.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.205 -0.452 . . . . 74.04 111.122 179.999 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.401 HG11 HD11 ' A' ' 20' ' ' LEU . 12.1 m -117.43 166.92 11.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.12 -0.491 . . . . 73.33 111.131 179.863 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 63.7 m-85 -117.95 106.26 12.76 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.167 -0.469 . . . . 73.45 110.854 -179.943 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.85 HD13 ' HB2' ' A' ' 39' ' ' ALA . 21.3 mm -71.62 103.58 1.38 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.15 -0.477 . . . . 72.24 111.114 179.974 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 10.5 m -65.0 -39.55 93.64 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.208 -0.451 . . . . 71.54 110.856 -179.923 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' TYR . . . . . 0.527 ' CZ ' HG21 ' A' ' 38' ' ' VAL . 54.0 p90 -175.41 160.95 2.66 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.116 -0.493 . . . . 70.31 110.88 -179.869 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 16.6 tttt -87.89 146.78 25.4 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.14 -0.482 . . . . 75.15 110.871 179.909 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 35.5 t60 -136.14 155.01 50.78 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.18 -0.463 . . . . 73.2 110.878 179.926 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -60.45 -175.99 1.36 Allowed Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.751 -0.737 . . . . 55.23 112.5 -179.98 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 19.0 mm100 66.53 11.66 8.22 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.898 0.38 . . . . 73.43 110.94 -179.897 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 69.36 27.96 73.06 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.704 -0.76 . . . . 52.43 112.499 -179.95 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' TRP . . . . . 0.678 ' C ' HD23 ' A' ' 37' ' ' LEU . 97.6 m95 -122.33 140.99 52.02 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.779 0.323 . . . . 74.13 110.911 -179.892 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.721 HD11 ' CG ' ' A' ' 52' ' ' GLU . 0.9 OUTLIER -123.9 130.3 52.37 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.227 -0.442 . . . . 55.34 110.935 179.949 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.527 HG21 ' CZ ' ' A' ' 30' ' ' TYR . 21.7 t -75.61 116.36 18.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.221 -0.445 . . . . 64.11 111.121 179.863 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . 0.85 ' HB2' HD13 ' A' ' 28' ' ' ILE . . . -138.45 160.67 38.95 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.212 -0.449 . . . . 54.11 111.104 179.901 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . 0.469 ' HB3' HG23 ' A' ' 47' ' ' THR . 0.4 OUTLIER -121.54 155.87 34.06 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.231 -0.441 . . . . 75.34 110.886 -179.916 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -66.45 -175.35 0.36 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.159 -0.473 . . . . 70.13 110.882 -179.952 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 9.7 tt0 -69.98 -38.74 76.13 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.173 -0.467 . . . . 62.51 110.93 179.996 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 2.0 t -56.83 -22.55 37.4 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.102 -0.499 . . . . 52.42 110.862 -179.782 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 66.97 11.65 58.69 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.765 -0.731 . . . . 75.44 112.476 -179.993 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 1.4 p -103.82 -21.85 13.61 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.912 0.386 . . . . 71.14 110.818 -179.745 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.541 ' HE3' HD11 ' A' ' 18' ' ' LEU . 0.8 OUTLIER -117.63 123.21 45.6 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.156 -0.475 . . . . 74.53 110.89 179.964 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . 0.469 HG23 ' HB3' ' A' ' 40' ' ' GLU . 9.8 m -129.93 133.83 47.08 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.188 -0.46 . . . . 73.21 111.135 179.994 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -152.43 -151.22 5.6 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.779 -0.724 . . . . 63.24 112.481 -179.995 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 18.3 mt -106.94 127.66 53.64 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.872 0.367 . . . . 61.12 110.93 -179.918 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.416 ' HB ' ' HD2' ' A' ' 51' ' ' PRO . 13.3 m -126.31 153.7 74.67 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.675 0.75 . . . . 73.34 111.1 179.872 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . 0.493 ' HD2' HD22 ' A' ' 20' ' ' LEU . 53.7 Cg_endo -69.79 152.54 69.16 Favored 'Trans proline' 0 C--N 1.342 0.188 0 C-N-CA 122.675 2.25 . . . . 75.11 112.352 179.955 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . 0.721 ' CG ' HD11 ' A' ' 37' ' ' LEU . 13.9 tm-20 -96.21 -30.48 13.46 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.209 -0.45 . . . . 63.52 110.876 -179.952 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -85.14 8.41 18.26 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.148 -0.478 . . . . 75.15 110.892 -179.941 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . 0.415 ' HB2' ' HG2' ' A' ' 51' ' ' PRO . 1.0 OUTLIER -120.12 2.34 10.91 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.165 -0.471 . . . . 74.5 110.897 -179.954 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.513 ' CG1' HD21 ' A' ' 20' ' ' LEU . 15.8 m -132.57 170.85 19.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.162 -0.472 . . . . 71.44 111.118 179.989 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . 0.597 ' HB3' HD21 ' A' ' 7' ' ' LEU . 9.6 t -143.09 120.96 11.97 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.157 -0.474 . . . . 43.13 110.855 -179.862 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 2.8 m-85 -56.82 135.18 55.62 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.129 -0.487 . . . . 62.51 110.913 -179.847 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.517 HD11 ' HB ' ' A' ' 5' ' ' VAL . 47.0 mt -103.51 149.04 7.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.121 -0.49 . . . . 72.44 111.111 179.938 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--N 1.329 -0.293 0 CA-C-O 121.628 0.728 . . . . 74.21 110.894 179.991 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' -7' ' ' PHE . . . . . . . . . . . . . 12.6 m-85 . . . . . 0 C--O 1.232 0.139 0 CA-C-O 120.824 0.345 . . . . 72.43 110.821 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' B' B ' -6' ' ' ILE . . . . . . . . . . . . . 5.2 mp -136.43 113.27 10.23 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.65 0.738 . . . . 45.3 111.128 179.928 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' -5' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.74 160.67 48.84 Favored 'Trans proline' 0 C--N 1.341 0.158 0 C-N-CA 122.739 2.293 . . . . 64.24 112.333 179.883 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' -4' ' ' SER . . . . . . . . . . . . . 43.4 t -147.43 46.14 1.13 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.235 -0.439 . . . . 54.23 110.855 -179.84 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' -3' ' ' ARG . . . . . . . . . . . . . 1.5 ptp85 -179.32 155.15 0.78 Allowed Pre-proline 0 C--N 1.328 -0.331 0 CA-C-O 121.612 0.72 . . . . 74.53 110.861 -179.969 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' -2' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.78 129.26 17.26 Favored 'Trans proline' 0 C--N 1.341 0.148 0 C-N-CA 122.65 2.233 . . . . 73.51 112.349 -179.984 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' -1' ' ' ALA . . . . . . . . . . . . . . . -54.64 153.08 11.3 Favored Pre-proline 0 C--N 1.33 -0.266 0 CA-C-O 121.561 0.696 . . . . 75.31 111.095 179.902 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 0' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_endo -69.78 -174.74 0.97 Allowed 'Trans proline' 0 C--O 1.231 0.162 0 C-N-CA 122.707 2.271 . . . . 65.32 112.325 -179.989 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 1' ' ' LYS . . . . . . . . . . . . . 4.9 mtmp? -130.67 156.92 79.1 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 121.594 0.711 . . . . 71.44 110.887 179.904 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 2' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo . . . . . 0 C--N 1.342 0.192 0 C-N-CA 122.67 2.247 . . . . 65.25 112.365 179.879 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 51.2 tp60 . . . . . 0 C--O 1.231 0.112 0 CA-C-O 120.753 0.311 . . . . 61.12 110.951 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 6.8 ptp180 -90.61 164.6 14.13 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.206 -0.452 . . . . 71.04 110.863 -179.902 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -156.48 152.58 27.56 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.185 -0.461 . . . . 73.1 111.108 179.94 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.682 ' HB ' HD11 ' A' ' 58' ' ' ILE . 10.9 p -104.08 151.84 6.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.231 -0.44 . . . . 53.23 111.15 179.958 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -89.25 116.85 27.79 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.143 -0.48 . . . . 74.11 111.128 179.876 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 0.732 HD21 ' HB2' ' A' ' 56' ' ' SER . 10.2 mt -84.52 -36.68 22.02 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.241 -0.436 . . . . 65.13 110.877 -179.955 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 6.4 m-85 -140.32 136.19 32.97 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.232 -0.44 . . . . 73.45 110.952 -179.989 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 1.6 p30 -62.65 139.23 58.64 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.118 -0.492 . . . . 73.24 110.879 179.93 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 10.8 t80 -145.51 145.99 31.27 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.211 -0.45 . . . . 74.15 110.869 -179.886 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -115.96 144.69 33.24 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.674 0.749 . . . . 71.41 110.895 -179.973 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.77 140.63 43.12 Favored 'Trans proline' 0 C--N 1.341 0.158 0 C-N-CA 122.689 2.26 . . . . 70.42 112.368 179.992 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 9.9 mt-10 -101.25 -21.45 14.9 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.194 -0.457 . . . . 63.23 110.875 -179.946 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 34.1 m-80 -110.29 176.66 4.97 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.14 -0.482 . . . . 74.33 110.876 -179.923 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -91.04 20.64 4.76 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.136 -0.484 . . . . 74.3 110.902 179.871 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -140.31 15.37 2.4 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.183 -0.462 . . . . 74.21 110.908 -179.924 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 16.3 mt-10 -107.37 158.07 17.46 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.171 -0.468 . . . . 64.41 110.899 -179.981 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.612 HD23 ' O ' ' A' ' 19' ' ' ARG . 0.3 OUTLIER -104.27 161.07 14.36 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.159 -0.473 . . . . 73.32 110.853 -179.902 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . 0.612 ' O ' HD23 ' A' ' 18' ' ' LEU . 0.9 OUTLIER -96.57 152.78 18.31 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.184 -0.462 . . . . 74.31 110.864 179.941 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.57 HD21 ' CG1' ' A' ' 55' ' ' VAL . 1.8 tp -137.79 149.49 46.43 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.137 -0.483 . . . . 71.04 110.91 -179.982 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.676 ' HB3' ' CG ' ' A' ' 24' ' ' ASP . . . -142.5 138.76 31.18 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.194 -0.457 . . . . 62.12 111.106 179.768 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -50.62 119.86 4.19 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.189 -0.46 . . . . 74.33 110.911 -179.945 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 96.7 -3.45 62.99 Favored Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.74 -0.743 . . . . 64.11 112.445 -179.979 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . 0.676 ' CG ' ' HB3' ' A' ' 21' ' ' ALA . 1.0 OUTLIER -84.63 146.45 27.48 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.721 0.296 . . . . 71.24 110.878 -179.943 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 3.5 mm -101.75 144.88 12.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.199 -0.455 . . . . 63.04 111.109 -179.991 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.418 HG11 HD11 ' A' ' 20' ' ' LEU . 1.5 m -146.58 158.31 10.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.148 -0.478 . . . . 72.01 111.108 179.848 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 54.3 m-85 -116.54 110.08 18.1 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.142 -0.481 . . . . 72.53 110.907 -179.995 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.686 HD13 ' HB2' ' A' ' 39' ' ' ALA . 14.7 mm -73.29 102.74 1.72 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.133 -0.485 . . . . 73.25 111.125 179.965 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 3.9 m -64.8 -40.35 95.08 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.196 -0.456 . . . . 74.11 110.837 -179.909 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' TYR . . . . . 0.524 ' CZ ' HG21 ' A' ' 38' ' ' VAL . 34.4 p90 -174.68 148.58 1.14 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.149 -0.478 . . . . 73.41 110.905 -179.926 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . 0.505 ' HG3' HD22 ' A' ' 37' ' ' LEU . 13.2 tttt -81.0 145.67 31.06 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.12 -0.491 . . . . 72.41 110.887 179.943 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 33.6 t60 -134.58 153.55 51.9 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.214 -0.448 . . . . 75.43 110.852 179.89 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -59.01 -174.12 0.57 Allowed Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.717 -0.754 . . . . 63.15 112.54 -179.97 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 77.9 mm-40 65.49 12.24 8.02 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.825 0.345 . . . . 61.34 110.911 -179.886 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 68.24 29.51 73.28 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.758 -0.734 . . . . 63.12 112.505 -179.98 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' TRP . . . . . 0.625 ' C ' HD23 ' A' ' 37' ' ' LEU . 98.4 m95 -123.51 135.97 54.32 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.81 0.338 . . . . 74.43 110.95 -179.936 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.708 HD11 ' CG ' ' A' ' 52' ' ' GLU . 1.4 mt -119.64 132.3 55.66 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.228 -0.442 . . . . 63.2 110.918 179.986 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.524 HG21 ' CZ ' ' A' ' 30' ' ' TYR . 60.0 t -79.27 109.11 13.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.206 -0.452 . . . . 75.31 111.15 179.825 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . 0.686 ' HB2' HD13 ' A' ' 28' ' ' ILE . . . -129.93 163.02 27.29 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.191 -0.459 . . . . 73.31 111.11 179.924 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 1.5 pt-20 -119.02 156.4 29.7 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.232 -0.44 . . . . 74.22 110.86 -179.903 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -68.6 -175.2 0.64 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.129 -0.487 . . . . 64.42 110.877 -179.954 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 9.1 tm-20 -68.89 -37.81 79.23 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.211 -0.449 . . . . 73.14 110.883 -179.974 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 1.6 t -57.0 -22.61 39.84 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.16 -0.473 . . . . 75.33 110.869 -179.769 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 69.9 8.57 61.24 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.784 -0.722 . . . . 40.42 112.479 -179.97 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 30.9 t -108.15 -22.3 12.44 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.931 0.396 . . . . 54.01 110.86 -179.769 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.457 ' HG2' HD11 ' A' ' 18' ' ' LEU . 2.7 ttmt -107.09 123.84 48.81 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.13 -0.486 . . . . 75.53 110.906 179.977 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 4.3 m -125.7 152.22 45.57 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.244 -0.434 . . . . 70.23 111.142 -179.991 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -177.63 -162.42 27.71 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.746 -0.74 . . . . 24.41 112.476 179.933 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.485 HD23 HG22 ' A' ' 38' ' ' VAL . 5.8 mt -99.21 136.87 38.54 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.847 0.356 . . . . 73.33 110.966 -179.938 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 16.8 m -136.36 153.32 76.26 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-O 121.562 0.696 . . . . 64.53 111.183 179.845 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . 0.428 ' HG2' ' HB2' ' A' ' 54' ' ' PHE . 54.2 Cg_endo -69.69 143.5 51.36 Favored 'Trans proline' 0 C--N 1.341 0.152 0 C-N-CA 122.677 2.252 . . . . 72.3 112.362 179.91 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . 0.708 ' CG ' HD11 ' A' ' 37' ' ' LEU . 15.5 tm-20 -90.19 -27.74 19.35 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.209 -0.45 . . . . 61.22 110.901 179.977 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 -86.31 10.44 14.84 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.134 -0.485 . . . . 71.5 110.892 -179.916 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . 0.428 ' HB2' ' HG2' ' A' ' 51' ' ' PRO . 1.0 OUTLIER -120.28 -9.56 9.5 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.138 -0.483 . . . . 74.14 110.898 -179.921 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.57 ' CG1' HD21 ' A' ' 20' ' ' LEU . 15.3 m -117.68 172.47 5.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.171 -0.468 . . . . 73.41 111.119 179.989 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . 0.732 ' HB2' HD21 ' A' ' 7' ' ' LEU . 38.4 t -142.56 113.19 7.36 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.193 -0.458 . . . . 62.32 110.864 -179.885 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 3.1 m-85 -52.17 130.1 29.52 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.133 -0.485 . . . . 75.32 110.936 -179.908 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.682 HD11 ' HB ' ' A' ' 5' ' ' VAL . 54.5 mt -99.97 146.91 8.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.145 -0.479 . . . . 70.24 111.152 179.894 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 8.1 mt-30 . . . . . 0 C--N 1.329 -0.284 0 CA-C-O 121.594 0.712 . . . . 73.23 110.903 179.942 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' B' B ' -7' ' ' PHE . . . . . 0.448 ' HB3' HD11 ' A' ' 49' ' ' LEU . 15.2 m-85 . . . . . 0 C--O 1.231 0.117 0 CA-C-O 120.841 0.353 . . . . 75.13 110.877 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' -6' ' ' ILE . . . . . . . . . . . . . 2.4 pt -153.36 85.19 4.2 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.668 0.747 . . . . 73.44 111.108 179.956 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' -5' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.82 135.92 31.53 Favored 'Trans proline' 0 C--N 1.342 0.209 0 C-N-CA 122.712 2.275 . . . . 74.34 112.317 179.917 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' -4' ' ' SER . . . . . . . . . . . . . 2.5 m -132.0 62.13 1.64 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.255 -0.429 . . . . 63.22 110.879 -179.856 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' -3' ' ' ARG . . . . . . . . . . . . . 12.8 ptt85 -174.67 153.39 1.75 Allowed Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.669 0.747 . . . . 71.53 110.87 -179.958 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' -2' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.78 128.98 16.79 Favored 'Trans proline' 0 C--N 1.342 0.201 0 C-N-CA 122.665 2.243 . . . . 70.3 112.338 -179.976 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' -1' ' ' ALA . . . . . . . . . . . . . . . -61.74 152.21 76.35 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 121.616 0.722 . . . . 62.22 111.108 179.867 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 0' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.73 -179.85 3.19 Favored 'Trans proline' 0 C--N 1.341 0.181 0 C-N-CA 122.742 2.295 . . . . 73.54 112.331 -179.95 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 1' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -126.58 155.01 75.38 Favored Pre-proline 0 C--N 1.328 -0.362 0 CA-C-O 121.624 0.726 . . . . 72.35 110.857 179.909 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 2' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo . . . . . 0 C--N 1.342 0.225 0 C-N-CA 122.661 2.241 . . . . 71.23 112.329 179.908 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 29.3 tp60 . . . . . 0 C--O 1.231 0.111 0 CA-C-O 120.739 0.304 . . . . 61.24 110.945 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 6.3 ptm180 -76.63 162.43 27.75 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.203 -0.453 . . . . 63.44 110.88 -179.908 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -154.45 154.47 33.26 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.209 -0.451 . . . . 73.42 111.124 179.962 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.549 ' HB ' HD11 ' A' ' 58' ' ' ILE . 9.2 p -109.1 140.58 27.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.24 -0.436 . . . . 71.52 111.135 179.99 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -77.88 122.34 25.34 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.189 -0.46 . . . . 70.44 111.099 179.883 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 0.763 HD21 ' CB ' ' A' ' 56' ' ' SER . 16.6 mt -87.48 -34.79 18.54 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.195 -0.457 . . . . 72.34 110.914 -179.936 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 4.3 m-85 -144.58 149.86 36.5 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.161 -0.472 . . . . 73.4 110.871 -179.953 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -70.92 137.66 49.43 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.108 -0.496 . . . . 73.24 110.837 179.934 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 21.4 t80 -142.0 145.65 34.68 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.144 -0.48 . . . . 74.13 110.907 -179.916 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -119.41 137.29 25.22 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-O 121.679 0.752 . . . . 75.31 110.88 -179.929 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . 0.433 ' HG3' ' HG3' ' A' ' 19' ' ' ARG . 53.6 Cg_endo -69.78 150.84 68.64 Favored 'Trans proline' 0 C--N 1.342 0.212 0 C-N-CA 122.636 2.224 . . . . 75.42 112.361 179.962 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 17.8 tp10 -109.28 -15.78 14.2 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.177 -0.465 . . . . 51.22 110.906 -179.98 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 9.8 m-80 -115.17 176.03 5.25 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.137 -0.483 . . . . 73.31 110.911 -179.925 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -92.26 20.87 5.62 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.197 -0.456 . . . . 73.24 110.857 179.948 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 1.2 p-10 -136.46 9.1 3.15 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.189 -0.46 . . . . 74.24 110.871 -179.907 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 12.0 mt-10 -105.63 157.44 17.4 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.177 -0.465 . . . . 61.23 110.908 179.989 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 55.5 tp -107.05 156.59 18.59 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.138 -0.483 . . . . 74.31 110.934 179.999 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . 0.433 ' HG3' ' HG3' ' A' ' 12' ' ' PRO . 0.7 OUTLIER -92.75 160.68 14.85 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.192 -0.458 . . . . 62.3 110.911 179.928 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.612 HD21 ' CG1' ' A' ' 55' ' ' VAL . 3.5 tp -142.27 149.24 39.29 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.196 -0.456 . . . . 70.21 110.946 -179.985 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.686 ' HB3' ' CG ' ' A' ' 24' ' ' ASP . . . -140.12 134.43 31.27 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.229 -0.441 . . . . 73.11 111.08 179.888 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -50.4 121.12 5.23 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.211 -0.45 . . . . 73.0 110.874 -179.929 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 96.59 -3.64 63.37 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.765 -0.731 . . . . 54.21 112.478 -179.971 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . 0.686 ' CG ' ' HB3' ' A' ' 21' ' ' ALA . 1.0 OUTLIER -85.08 146.9 26.92 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.805 0.336 . . . . 55.54 110.839 -179.944 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 3.3 mm -100.54 141.06 18.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.152 -0.476 . . . . 73.41 111.112 -179.973 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 1.5 m -142.78 158.0 18.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.168 -0.469 . . . . 65.45 111.165 179.821 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 44.6 m-85 -115.42 106.58 14.14 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.181 -0.463 . . . . 74.14 110.86 -179.937 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.836 HD13 ' HB2' ' A' ' 39' ' ' ALA . 19.6 mm -72.01 103.12 1.39 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.145 -0.479 . . . . 64.12 111.128 179.957 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 3.3 m -64.48 -39.47 93.85 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.161 -0.472 . . . . 73.41 110.878 -179.934 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' TYR . . . . . 0.47 ' CZ ' HG21 ' A' ' 38' ' ' VAL . 33.4 p90 -174.53 147.85 1.14 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.111 -0.495 . . . . 71.13 110.889 -179.895 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . 0.57 ' HG3' HD22 ' A' ' 37' ' ' LEU . 18.7 tttt -82.68 145.41 29.63 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.121 -0.491 . . . . 51.34 110.893 179.894 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 29.7 t60 -134.86 153.97 51.84 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.195 -0.457 . . . . 62.1 110.824 179.917 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -59.23 -174.26 0.65 Allowed Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.733 -0.746 . . . . 41.32 112.53 179.977 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 73.8 mm-40 65.59 12.44 8.23 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.803 0.335 . . . . 73.2 110.908 -179.895 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 68.22 28.82 73.16 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.721 -0.752 . . . . 60.31 112.504 -179.956 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' TRP . . . . . 0.638 ' C ' HD23 ' A' ' 37' ' ' LEU . 99.0 m95 -123.17 135.64 54.41 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.768 0.318 . . . . 64.24 110.938 -179.928 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.695 HD11 ' CG ' ' A' ' 52' ' ' GLU . 0.4 OUTLIER -124.46 131.89 53.49 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.254 -0.43 . . . . 61.5 110.902 179.969 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.47 HG21 ' CZ ' ' A' ' 30' ' ' TYR . 60.4 t -77.39 116.89 21.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.128 -0.487 . . . . 61.14 111.133 179.82 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . 0.836 ' HB2' HD13 ' A' ' 28' ' ' ILE . . . -137.28 160.06 40.13 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.181 -0.463 . . . . 60.13 111.08 179.872 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . 0.449 ' HB3' HG23 ' A' ' 47' ' ' THR . 0.5 OUTLIER -121.76 160.15 25.18 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.225 -0.443 . . . . 72.15 110.924 -179.976 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -71.78 -175.27 1.35 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.142 -0.481 . . . . 74.11 110.924 -179.93 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -69.61 -38.34 77.23 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.205 -0.452 . . . . 62.52 110.876 -179.97 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 1.5 t -57.1 -22.58 40.75 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.155 -0.475 . . . . 74.23 110.867 -179.794 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 66.46 12.05 57.83 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.681 -0.771 . . . . 52.33 112.516 180.0 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 12.9 m -105.24 -21.06 13.32 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.945 0.402 . . . . 52.32 110.836 -179.707 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 1.4 ttmt -118.53 123.38 44.95 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.148 -0.478 . . . . 63.24 110.889 179.948 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . 0.449 HG23 ' HB3' ' A' ' 40' ' ' GLU . 11.4 m -131.62 143.02 50.01 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.228 -0.442 . . . . 51.1 111.166 179.957 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -160.71 -151.77 6.34 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.788 -0.72 . . . . 44.42 112.511 179.979 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 8.4 mt -107.03 131.69 53.79 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.862 0.363 . . . . 72.31 110.906 -179.942 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.432 ' HB ' ' HD2' ' A' ' 51' ' ' PRO . 18.3 m -129.88 154.45 81.11 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-O 121.606 0.717 . . . . 70.14 111.164 179.829 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . 0.432 ' HD2' ' HB ' ' A' ' 50' ' ' VAL . 53.6 Cg_endo -69.75 148.15 64.53 Favored 'Trans proline' 0 C--O 1.231 0.145 0 C-N-CA 122.713 2.276 . . . . 75.02 112.36 179.96 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . 0.695 ' CG ' HD11 ' A' ' 37' ' ' LEU . 30.1 tt0 -93.07 -29.5 15.76 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.256 -0.429 . . . . 75.41 110.854 -179.962 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -84.39 7.33 19.93 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.199 -0.455 . . . . 74.0 110.879 -179.943 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . 0.418 ' HB2' ' HG2' ' A' ' 51' ' ' PRO . 1.2 m-85 -120.41 3.47 10.78 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.155 -0.475 . . . . 74.14 110.862 -179.911 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.612 ' CG1' HD21 ' A' ' 20' ' ' LEU . 7.1 m -128.88 172.76 14.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.171 -0.468 . . . . 75.23 111.164 179.966 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . 0.763 ' CB ' HD21 ' A' ' 7' ' ' LEU . 13.1 t -145.55 113.69 6.56 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.188 -0.46 . . . . 73.43 110.87 -179.828 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 2.5 m-85 -51.87 137.05 27.17 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.163 -0.471 . . . . 65.12 110.904 -179.866 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.549 HD11 ' HB ' ' A' ' 5' ' ' VAL . 24.6 mt -104.94 152.52 6.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.114 -0.493 . . . . 73.43 111.14 179.899 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.291 0 CA-C-O 121.577 0.703 . . . . 73.21 110.912 179.986 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' -7' ' ' PHE . . . . . . . . . . . . . 14.0 m-85 . . . . . 0 C--O 1.231 0.125 0 CA-C-O 120.817 0.341 . . . . 54.0 110.89 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' B' B ' -6' ' ' ILE . . . . . . . . . . . . . 60.2 mt -125.64 125.92 24.97 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 121.603 0.716 . . . . 53.42 111.147 179.971 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' -5' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.81 160.09 50.95 Favored 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.658 2.239 . . . . 74.32 112.324 179.902 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' -4' ' ' SER . . . . . . . . . . . . . 7.3 t -136.56 37.25 2.67 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.218 -0.447 . . . . 64.14 110.879 -179.855 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' -3' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -177.56 155.0 1.08 Allowed Pre-proline 0 C--N 1.33 -0.275 0 CA-C-O 121.542 0.687 . . . . 61.44 110.894 -179.919 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' -2' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.77 131.5 21.36 Favored 'Trans proline' 0 C--O 1.231 0.138 0 C-N-CA 122.682 2.254 . . . . 73.13 112.362 -179.971 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' -1' ' ' ALA . . . . . . . . . . . . . . . -55.5 154.47 12.19 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-O 121.591 0.71 . . . . 73.15 111.088 179.884 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 0' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.76 -170.24 0.38 Allowed 'Trans proline' 0 C--N 1.342 0.194 0 C-N-CA 122.66 2.24 . . . . 64.32 112.391 179.959 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 1' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -134.17 148.93 69.94 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-O 121.561 0.696 . . . . 65.2 110.946 179.887 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 2' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo . . . . . 0 C--N 1.341 0.182 0 C-N-CA 122.699 2.266 . . . . 51.11 112.352 179.891 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 33.0 tp60 . . . . . 0 C--O 1.231 0.125 0 CA-C-O 120.768 0.318 . . . . 73.14 110.902 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 5.6 ptp180 -80.7 162.05 24.32 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.216 -0.447 . . . . 74.03 110.863 -179.931 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -155.1 149.96 26.67 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.176 -0.465 . . . . 60.53 111.069 179.932 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.675 ' HB ' HD11 ' A' ' 58' ' ' ILE . 7.3 p -105.83 137.98 33.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.21 -0.45 . . . . 72.33 111.133 179.967 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . 0.459 ' HA ' HG12 ' A' ' 55' ' ' VAL . . . -78.56 128.3 33.33 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.216 -0.447 . . . . 64.44 111.047 179.91 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 0.568 HD21 ' HB3' ' A' ' 56' ' ' SER . 10.5 mt -93.32 -31.89 14.51 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.153 -0.476 . . . . 75.12 110.922 179.986 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 3.8 m-85 -144.37 135.91 25.71 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.193 -0.458 . . . . 72.51 110.934 179.995 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -60.11 149.58 32.17 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.122 -0.49 . . . . 75.51 110.899 179.883 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 30.7 t80 -149.01 147.1 28.16 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.181 -0.463 . . . . 74.12 110.881 -179.871 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 8.5 tm-20 -117.0 134.56 22.98 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 121.649 0.738 . . . . 71.04 110.913 -179.971 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . 0.4 ' HD3' ' HA ' ' A' ' 19' ' ' ARG . 53.4 Cg_endo -69.76 141.57 45.56 Favored 'Trans proline' 0 C--O 1.232 0.19 0 C-N-CA 122.665 2.243 . . . . 53.22 112.353 -179.99 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 13.8 mp0 -102.99 -20.01 14.37 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.249 -0.432 . . . . 71.13 110.927 -179.997 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 34.1 m-80 -111.29 175.7 5.32 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.123 -0.49 . . . . 74.4 110.848 -179.936 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -92.37 19.59 6.98 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.172 -0.467 . . . . 74.11 110.888 179.886 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -135.35 10.92 3.51 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.245 -0.434 . . . . 73.34 110.848 -179.886 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 6.3 mm-40 -101.53 164.39 11.78 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.204 -0.453 . . . . 70.43 110.904 179.977 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.638 HD12 ' H ' ' A' ' 19' ' ' ARG . 19.3 tp -115.71 141.52 47.97 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.129 -0.487 . . . . 62.3 110.885 -179.935 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . 0.638 ' H ' HD12 ' A' ' 18' ' ' LEU . 31.5 mtm180 -75.24 155.17 37.06 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.165 -0.471 . . . . 63.44 110.886 179.951 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.585 HD22 ' HD2' ' A' ' 51' ' ' PRO . 3.5 tp -140.7 149.58 42.37 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.213 -0.448 . . . . 71.43 110.889 -179.947 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.447 ' O ' ' HB3' ' A' ' 6' ' ' ALA . . . -139.98 139.76 36.13 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.199 -0.455 . . . . 62.31 111.099 179.786 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -53.91 119.24 4.76 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.194 -0.457 . . . . 63.12 110.917 -179.919 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 93.49 0.19 67.46 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.769 -0.729 . . . . 54.14 112.484 -179.969 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 23.8 t0 -76.88 159.24 30.19 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.798 0.333 . . . . 72.5 110.909 -179.986 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 1.7 mm -110.92 123.1 66.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.154 -0.475 . . . . 75.31 111.109 -179.969 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.468 HG11 HD11 ' A' ' 20' ' ' LEU . 3.6 m -132.26 152.82 37.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.166 -0.47 . . . . 65.14 111.121 179.878 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 68.9 m-85 -112.82 109.02 18.22 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.183 -0.462 . . . . 71.13 110.882 -179.976 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.705 HD13 ' HB2' ' A' ' 39' ' ' ALA . 19.0 mm -72.32 103.02 1.45 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.086 -0.506 . . . . 71.44 111.131 -179.997 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 2.9 m -64.59 -40.09 94.9 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.167 -0.47 . . . . 70.31 110.864 -179.893 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' TYR . . . . . 0.474 ' CZ ' HG21 ' A' ' 38' ' ' VAL . 31.7 p90 -173.91 146.09 1.18 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.139 -0.482 . . . . 73.03 110.916 -179.861 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . 0.525 ' HG3' HD22 ' A' ' 37' ' ' LEU . 19.2 tttt -79.87 147.26 31.79 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.148 -0.478 . . . . 75.44 110.925 179.871 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 32.3 t60 -137.4 154.54 49.96 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.227 -0.442 . . . . 65.32 110.85 179.939 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -59.37 -175.02 0.76 Allowed Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.746 -0.74 . . . . 61.22 112.494 -179.95 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 24.0 mm100 65.61 12.78 8.49 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.844 0.354 . . . . 74.44 110.93 -179.89 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 68.14 27.74 73.6 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.691 -0.766 . . . . 75.33 112.475 -179.991 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' TRP . . . . . 0.606 ' C ' HD23 ' A' ' 37' ' ' LEU . 98.5 m95 -122.01 137.42 54.81 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.82 0.343 . . . . 75.55 110.948 -179.915 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.683 HD11 ' CG ' ' A' ' 52' ' ' GLU . 0.5 OUTLIER -125.18 130.52 52.31 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.255 -0.429 . . . . 53.41 110.934 179.982 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.474 HG21 ' CZ ' ' A' ' 30' ' ' TYR . 44.1 t -77.27 115.16 18.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.164 -0.471 . . . . 74.45 111.132 179.878 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . 0.705 ' HB2' HD13 ' A' ' 28' ' ' ILE . . . -137.0 166.16 24.31 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.133 -0.485 . . . . 72.21 111.12 179.919 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -117.62 156.68 27.74 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.233 -0.44 . . . . 64.52 110.886 -179.937 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -71.36 -176.85 1.61 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.151 -0.477 . . . . 70.21 110.852 -179.933 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 20.5 tt0 -67.45 -38.47 84.55 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.124 -0.489 . . . . 71.41 110.921 179.984 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 1.3 t -57.19 -22.14 38.41 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.144 -0.48 . . . . 75.45 110.847 -179.789 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 65.93 12.59 57.67 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.682 -0.771 . . . . 75.44 112.48 -179.995 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 13.4 t -109.42 -15.61 14.19 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.932 0.396 . . . . 74.25 110.885 -179.738 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 7.1 ptmt -119.98 134.85 55.12 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.127 -0.488 . . . . 62.43 110.912 179.935 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 6.4 m -135.06 143.72 46.86 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.252 -0.431 . . . . 63.12 111.162 179.969 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -164.68 -154.94 8.16 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.694 -0.765 . . . . 54.4 112.482 179.972 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.516 HD11 ' HB3' ' B' ' -7' ' ' PHE . 6.7 mt -104.8 129.41 53.09 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.849 0.357 . . . . 42.41 110.889 -179.89 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.44 ' HB ' ' HD2' ' A' ' 51' ' ' PRO . 16.8 m -127.73 154.25 77.89 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.666 0.746 . . . . 60.13 111.095 179.836 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . 0.585 ' HD2' HD22 ' A' ' 20' ' ' LEU . 53.5 Cg_endo -69.77 149.45 66.85 Favored 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.666 2.244 . . . . 53.21 112.326 179.962 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . 0.683 ' CG ' HD11 ' A' ' 37' ' ' LEU . 28.3 tt0 -94.36 -30.17 14.64 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.231 -0.44 . . . . 64.32 110.925 -179.983 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -85.24 7.72 21.06 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.093 -0.503 . . . . 74.02 110.899 -179.942 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . 0.407 ' HB2' ' HG2' ' A' ' 51' ' ' PRO . 1.2 m-85 -119.29 4.57 11.25 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.126 -0.488 . . . . 65.14 110.908 -179.95 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.459 HG12 ' HA ' ' A' ' 6' ' ' ALA . 14.8 m -134.4 164.11 35.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.121 -0.49 . . . . 71.32 111.132 179.975 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . 0.568 ' HB3' HD21 ' A' ' 7' ' ' LEU . 25.7 t -136.24 117.27 14.32 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.222 -0.444 . . . . 75.22 110.869 -179.85 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 2.9 m-85 -52.1 136.95 28.75 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.108 -0.496 . . . . 71.52 110.944 -179.892 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.675 HD11 ' HB ' ' A' ' 5' ' ' VAL . 32.1 mt -104.64 150.32 7.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.146 -0.479 . . . . 63.35 111.102 179.938 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 2.7 mt-30 . . . . . 0 C--N 1.329 -0.291 0 CA-C-O 121.611 0.72 . . . . 73.43 110.95 179.914 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' B' B ' -7' ' ' PHE . . . . . 0.516 ' HB3' HD11 ' A' ' 49' ' ' LEU . 8.4 m-85 . . . . . 0 C--O 1.231 0.125 0 CA-C-O 120.834 0.35 . . . . 71.4 110.853 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' -6' ' ' ILE . . . . . 0.478 ' O ' HG23 ' B' ' -6' ' ' ILE . 3.8 tp -175.89 91.28 0.28 Allowed Pre-proline 0 C--N 1.328 -0.333 0 CA-C-O 121.634 0.731 . . . . 42.15 111.107 179.989 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' -5' ' ' PRO . . . . . 0.414 ' HD2' ' HA ' ' B' ' -6' ' ' ILE . 53.4 Cg_endo -69.79 139.4 40.03 Favored 'Trans proline' 0 C--N 1.341 0.156 0 C-N-CA 122.677 2.252 . . . . 74.44 112.344 179.868 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' -4' ' ' SER . . . . . . . . . . . . . 2.6 m -132.55 62.45 1.65 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.212 -0.449 . . . . 53.33 110.877 -179.839 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' -3' ' ' ARG . . . . . . . . . . . . . 13.6 ptp180 -179.63 155.41 0.75 Allowed Pre-proline 0 C--N 1.329 -0.32 0 CA-C-O 121.592 0.71 . . . . 71.1 110.852 -179.928 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' -2' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.72 135.42 30.49 Favored 'Trans proline' 0 C--N 1.341 0.169 0 C-N-CA 122.724 2.283 . . . . 75.42 112.33 179.995 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' -1' ' ' ALA . . . . . . . . . . . . . . . -68.15 153.02 96.04 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.615 0.722 . . . . 62.44 111.085 179.877 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 0' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_endo -69.81 174.63 9.27 Favored 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.672 2.248 . . . . 73.15 112.342 -179.954 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 1' ' ' LYS . . . . . . . . . . . . . 16.5 pttm -122.63 153.21 62.86 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.526 0.679 . . . . 74.12 110.933 179.887 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 2' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo . . . . . 0 C--O 1.232 0.19 0 C-N-CA 122.659 2.239 . . . . 73.23 112.385 179.901 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 56.5 tp60 . . . . . 0 C--O 1.231 0.102 0 CA-C-O 120.757 0.313 . . . . 70.02 110.895 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -83.43 163.9 20.25 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.2 -0.455 . . . . 64.51 110.843 -179.938 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -154.58 152.25 29.8 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.168 -0.469 . . . . 62.31 111.086 179.958 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.534 ' HB ' HD11 ' A' ' 58' ' ' ILE . 10.0 p -104.13 149.08 8.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.262 -0.427 . . . . 54.24 111.15 179.975 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . 0.415 ' HB3' ' O ' ' A' ' 21' ' ' ALA . . . -90.4 117.78 29.37 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.218 -0.446 . . . . 64.04 111.105 179.873 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 0.744 HD21 ' HB3' ' A' ' 56' ' ' SER . 7.0 mt -84.52 -35.69 22.7 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.255 -0.429 . . . . 43.22 110.905 -179.963 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 5.4 m-85 -140.75 136.89 32.98 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.185 -0.461 . . . . 75.11 110.909 -179.96 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -64.06 137.88 58.19 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.076 -0.511 . . . . 65.3 110.91 179.924 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 18.5 t80 -137.33 145.37 43.29 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.204 -0.453 . . . . 63.22 110.851 -179.878 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 7.0 tt0 -115.69 136.13 22.78 Favored Pre-proline 0 C--N 1.33 -0.261 0 CA-C-O 121.671 0.748 . . . . 63.24 110.86 -179.925 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . 0.42 ' HD3' ' HA ' ' A' ' 19' ' ' ARG . 53.7 Cg_endo -69.74 143.94 52.53 Favored 'Trans proline' 0 C--N 1.342 0.189 0 C-N-CA 122.718 2.279 . . . . 71.45 112.29 179.999 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -107.38 -7.51 16.63 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.21 -0.45 . . . . 71.43 110.873 179.965 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 59.3 m-80 -124.5 175.78 6.93 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.196 -0.457 . . . . 45.44 110.893 -179.95 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 8.9 p30 -93.58 24.2 4.18 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.205 -0.452 . . . . 64.12 110.887 179.917 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 1.2 p-10 -139.97 11.82 2.43 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.163 -0.471 . . . . 74.3 110.873 -179.899 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 10.0 mm-40 -106.38 163.35 12.92 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.186 -0.461 . . . . 70.12 110.864 -179.978 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.648 HD12 ' H ' ' A' ' 19' ' ' ARG . 20.7 tp -113.02 142.64 45.48 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.134 -0.485 . . . . 72.44 110.896 -179.951 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . 0.648 ' H ' HD12 ' A' ' 18' ' ' LEU . 6.6 mtp85 -79.03 153.45 30.23 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.192 -0.458 . . . . 75.32 110.89 179.94 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.553 HD21 ' CG1' ' A' ' 55' ' ' VAL . 2.3 tp -138.55 149.07 44.94 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.192 -0.458 . . . . 75.35 110.901 -179.973 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.687 ' HB3' ' OD2' ' A' ' 24' ' ' ASP . . . -140.7 139.76 34.78 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.205 -0.452 . . . . 42.2 111.151 179.766 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -50.62 122.85 7.78 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.222 -0.445 . . . . 75.33 110.865 -179.885 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 97.18 -13.48 64.67 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.777 -0.725 . . . . 73.32 112.478 -179.994 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . 0.687 ' OD2' ' HB3' ' A' ' 21' ' ' ALA . 7.2 m-20 -71.53 149.07 46.11 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.796 0.332 . . . . 72.12 110.87 -179.982 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 1.7 mt -116.62 119.83 63.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.182 -0.463 . . . . 74.41 111.093 -179.955 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 6.4 m -119.14 165.76 14.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.129 -0.487 . . . . 73.42 111.125 179.851 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 46.7 m-85 -114.47 106.92 14.85 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.145 -0.479 . . . . 64.45 110.869 -179.949 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.744 HD13 ' HB2' ' A' ' 39' ' ' ALA . 17.6 mm -70.71 102.91 1.01 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.187 -0.461 . . . . 64.34 111.136 179.967 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 3.6 m -65.19 -39.57 93.03 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.127 -0.488 . . . . 64.35 110.856 -179.898 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' TYR . . . . . 0.492 ' CZ ' HG21 ' A' ' 38' ' ' VAL . 32.1 p90 -174.38 146.83 1.1 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.162 -0.472 . . . . 74.13 110.876 -179.88 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . 0.512 ' HG3' HD22 ' A' ' 37' ' ' LEU . 18.7 tttt -80.77 146.17 31.12 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.122 -0.49 . . . . 52.32 110.906 179.886 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 33.7 t60 -135.27 155.97 49.75 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.223 -0.444 . . . . 70.32 110.86 179.899 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -60.84 -174.22 1.14 Allowed Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.754 -0.736 . . . . 74.33 112.519 -179.967 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 41.9 mm-40 64.79 13.21 8.3 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.859 0.362 . . . . 65.13 110.9 -179.914 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 67.94 28.98 73.3 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.715 -0.755 . . . . 72.14 112.489 -179.969 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' TRP . . . . . 0.637 ' C ' HD23 ' A' ' 37' ' ' LEU . 98.7 m95 -122.82 138.11 54.74 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.766 0.317 . . . . 74.12 110.909 -179.871 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.695 HD11 ' CG ' ' A' ' 52' ' ' GLU . 0.5 OUTLIER -125.96 130.47 51.3 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.25 -0.432 . . . . 74.5 110.931 179.934 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.492 HG21 ' CZ ' ' A' ' 30' ' ' TYR . 41.7 t -77.2 115.21 18.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.186 -0.461 . . . . 75.02 111.095 179.868 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . 0.744 ' HB2' HD13 ' A' ' 28' ' ' ILE . . . -135.54 163.53 29.89 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.187 -0.46 . . . . 72.4 111.09 179.86 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 1.6 pm0 -121.58 160.49 24.23 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.211 -0.449 . . . . 53.54 110.826 -179.928 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 43.4 p-10 -58.91 -174.8 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.088 -0.505 . . . . 74.22 110.893 -179.94 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 15.2 tt0 -78.43 -38.63 40.9 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.188 -0.46 . . . . 74.13 110.914 179.998 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 4.4 m -68.73 -22.55 64.32 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.134 -0.485 . . . . 72.22 110.847 -179.785 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 76.61 26.76 62.38 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.704 -0.76 . . . . 71.33 112.52 -179.977 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 3.5 m -105.48 -22.19 13.06 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.946 0.403 . . . . 73.32 110.875 -179.717 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.401 ' HD2' HD11 ' A' ' 18' ' ' LEU . 0.0 OUTLIER -125.68 138.05 53.87 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.122 -0.49 . . . . 70.02 110.928 179.904 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 30.7 m -136.8 143.89 43.4 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.243 -0.435 . . . . 41.33 111.149 179.976 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -167.74 -155.62 9.44 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.736 -0.745 . . . . 63.32 112.513 179.938 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 7.0 mt -103.57 132.19 50.04 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.828 0.347 . . . . 72.1 110.908 -179.922 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.413 ' HB ' ' HD2' ' A' ' 51' ' ' PRO . 6.7 m -129.53 153.47 80.67 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 121.592 0.711 . . . . 62.24 111.161 179.85 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . 0.448 ' HD2' HD22 ' A' ' 20' ' ' LEU . 54.0 Cg_endo -69.73 150.76 68.82 Favored 'Trans proline' 0 C--N 1.341 0.147 0 C-N-CA 122.741 2.294 . . . . 74.21 112.318 179.968 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . 0.695 ' CG ' HD11 ' A' ' 37' ' ' LEU . 28.2 tt0 -95.74 -28.89 14.56 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.186 -0.461 . . . . 54.14 110.833 -179.982 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -87.3 11.08 15.2 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.195 -0.457 . . . . 70.5 110.907 -179.909 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -121.01 -8.15 9.38 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.122 -0.49 . . . . 72.33 110.891 -179.931 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.553 ' CG1' HD21 ' A' ' 20' ' ' LEU . 12.3 m -120.02 172.84 6.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.154 -0.475 . . . . 73.34 111.153 -179.998 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . 0.744 ' HB3' HD21 ' A' ' 7' ' ' LEU . 3.3 t -143.25 114.3 7.77 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.195 -0.457 . . . . 33.31 110.882 -179.868 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 2.6 m-85 -52.33 127.11 21.14 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.131 -0.486 . . . . 75.33 110.912 -179.868 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.534 HD11 ' HB ' ' A' ' 5' ' ' VAL . 42.6 mt -94.85 149.94 4.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.122 -0.49 . . . . 71.21 111.17 179.887 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.316 0 CA-C-O 121.601 0.715 . . . . 73.32 110.933 179.951 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' -7' ' ' PHE . . . . . . . . . . . . . 10.8 m-85 . . . . . 0 C--O 1.232 0.133 0 CA-C-O 120.788 0.327 . . . . 73.55 110.93 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' B' B ' -6' ' ' ILE . . . . . 0.411 ' O ' HG23 ' B' ' -6' ' ' ILE . 5.9 tt -138.78 119.3 9.79 Favored Pre-proline 0 C--N 1.328 -0.35 0 CA-C-O 121.615 0.721 . . . . 74.53 111.131 179.985 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' -5' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.82 154.26 67.72 Favored 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.674 2.249 . . . . 63.52 112.372 179.862 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' -4' ' ' SER . . . . . . . . . . . . . 45.2 t -132.45 41.89 3.16 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.246 -0.434 . . . . 54.42 110.877 -179.834 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' -3' ' ' ARG . . . . . . . . . . . . . 1.5 ptm180 -177.45 155.05 1.1 Allowed Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 121.618 0.723 . . . . 75.12 110.886 -179.952 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' -2' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.78 134.37 27.79 Favored 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.68 2.254 . . . . 74.21 112.35 -179.968 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' -1' ' ' ALA . . . . . . . . . . . . . . . -57.99 154.09 30.71 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 121.575 0.702 . . . . 44.35 111.098 179.887 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 0' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.78 -173.3 0.69 Allowed 'Trans proline' 0 C--N 1.342 0.2 0 C-N-CA 122.644 2.229 . . . . 73.52 112.35 -179.986 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 1' ' ' LYS . . . . . . . . . . . . . 33.8 mtpt -127.61 155.77 76.48 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-O 121.628 0.728 . . . . 73.4 110.875 179.908 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 2' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo . . . . . 0 C--N 1.342 0.21 0 C-N-CA 122.643 2.229 . . . . 74.11 112.351 179.912 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 32.8 tp60 . . . . . 0 C--O 1.231 0.09 0 CA-C-O 120.806 0.336 . . . . 73.24 110.931 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 3' ' ' ARG . . . . . 0.475 ' HG3' HD12 ' A' ' 58' ' ' ILE . 3.2 ptt-85 -84.15 162.4 20.26 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.213 -0.449 . . . . 71.34 110.858 -179.934 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -155.21 150.86 27.47 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.146 -0.479 . . . . 73.42 111.139 179.937 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 11.0 p -104.07 146.31 11.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.229 -0.441 . . . . 51.55 111.133 -179.991 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -84.82 111.14 19.37 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.187 -0.461 . . . . 21.02 111.099 179.88 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 0.743 HD21 ' CB ' ' A' ' 56' ' ' SER . 13.9 mt -76.42 -37.04 57.67 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.244 -0.435 . . . . 43.24 110.888 -179.946 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 4.0 m-85 -142.22 147.03 35.86 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.223 -0.444 . . . . 73.32 110.911 -179.96 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 3.5 p-10 -70.47 138.98 51.59 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.125 -0.489 . . . . 74.23 110.864 179.899 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 5.3 t80 -143.82 144.62 31.86 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.215 -0.448 . . . . 72.54 110.878 -179.89 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -112.98 145.2 32.58 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-O 121.688 0.756 . . . . 72.12 110.83 -179.892 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.81 139.7 40.68 Favored 'Trans proline' 0 C--N 1.342 0.226 0 C-N-CA 122.657 2.238 . . . . 74.41 112.347 179.985 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -101.37 -17.09 16.67 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.21 -0.45 . . . . 73.34 110.92 -179.984 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 31.0 m-80 -116.26 176.53 5.06 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.104 -0.498 . . . . 71.35 110.923 -179.953 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 17.7 m-20 -91.51 21.55 4.54 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.218 -0.446 . . . . 61.24 110.894 179.907 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -141.97 17.52 2.12 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.191 -0.459 . . . . 65.42 110.867 -179.879 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 24.1 mt-10 -107.39 165.6 11.27 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.192 -0.458 . . . . 74.32 110.86 -179.976 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.553 HD11 ' HE3' ' A' ' 46' ' ' LYS . 28.7 tp -114.12 148.93 36.37 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.139 -0.482 . . . . 73.32 110.895 -179.931 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . 0.542 ' H ' HD12 ' A' ' 18' ' ' LEU . 0.8 OUTLIER -84.8 156.18 21.47 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.2 -0.454 . . . . 72.33 110.807 179.99 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.562 HD21 ' CG1' ' A' ' 55' ' ' VAL . 3.1 tp -140.26 150.17 43.75 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.131 -0.486 . . . . 42.42 110.932 179.984 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.666 ' HB3' ' CG ' ' A' ' 24' ' ' ASP . . . -141.42 137.29 32.12 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.191 -0.459 . . . . 52.01 111.102 179.827 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -50.79 121.88 6.54 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.265 -0.425 . . . . 55.23 110.867 -179.928 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 96.28 -6.51 66.05 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.697 -0.763 . . . . 54.52 112.476 -179.956 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . 0.666 ' CG ' ' HB3' ' A' ' 21' ' ' ALA . 1.0 OUTLIER -81.46 146.44 30.23 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.85 0.357 . . . . 75.01 110.838 -179.908 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 3.3 mm -100.81 142.52 15.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.186 -0.461 . . . . 73.22 111.165 179.999 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 1.4 m -144.95 158.55 13.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.155 -0.475 . . . . 64.41 111.09 179.918 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 51.6 m-85 -117.3 109.57 17.01 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.154 -0.476 . . . . 71.42 110.882 179.988 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.662 HD13 ' HB2' ' A' ' 39' ' ' ALA . 12.1 mm -73.11 102.7 1.63 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.113 -0.494 . . . . 63.51 111.082 -179.992 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 43.3 m -64.76 -39.57 93.83 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.159 -0.473 . . . . 71.31 110.891 -179.977 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' TYR . . . . . 0.54 ' CZ ' HG21 ' A' ' 38' ' ' VAL . 37.4 p90 -174.87 151.39 1.38 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.139 -0.482 . . . . 73.2 110.941 -179.856 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . 0.494 ' HG3' HD22 ' A' ' 37' ' ' LEU . 17.8 tttt -83.25 145.55 29.06 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.13 -0.486 . . . . 75.04 110.946 179.871 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 34.4 t60 -134.21 152.9 52.06 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.227 -0.442 . . . . 75.23 110.892 179.903 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -58.96 -173.98 0.55 Allowed Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.755 -0.736 . . . . 64.01 112.469 -179.954 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 27.6 mm-40 65.43 12.21 7.96 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.845 0.355 . . . . 73.23 110.943 -179.875 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 68.09 30.14 73.77 Favored Glycine 0 N--CA 1.452 -0.261 0 C-N-CA 120.702 -0.761 . . . . 63.04 112.496 -179.943 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' TRP . . . . . 0.633 ' C ' HD23 ' A' ' 37' ' ' LEU . 99.0 m95 -124.15 136.51 54.26 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.796 0.331 . . . . 62.04 110.95 -179.952 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.717 HD11 ' CG ' ' A' ' 52' ' ' GLU . 1.3 mt -120.58 133.36 55.39 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.252 -0.431 . . . . 35.31 110.951 179.962 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.54 HG21 ' CZ ' ' A' ' 30' ' ' TYR . 59.9 t -79.75 110.02 14.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.18 -0.464 . . . . 73.33 111.144 179.858 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . 0.662 ' HB2' HD13 ' A' ' 28' ' ' ILE . . . -129.79 159.36 36.76 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.154 -0.475 . . . . 64.02 111.114 179.869 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 1.4 pt-20 -117.01 156.57 27.27 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.207 -0.451 . . . . 73.34 110.865 -179.919 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -70.18 -175.2 0.92 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.143 -0.48 . . . . 73.44 110.901 -179.983 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 -69.4 -38.21 77.83 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.167 -0.469 . . . . 70.25 110.895 179.965 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 1.5 t -56.37 -22.53 31.8 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.171 -0.468 . . . . 72.43 110.848 -179.786 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 69.16 9.53 60.61 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.757 -0.735 . . . . 62.12 112.476 -179.988 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -108.04 -20.82 13.05 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.947 0.403 . . . . 73.02 110.885 -179.751 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.553 ' HE3' HD11 ' A' ' 18' ' ' LEU . 4.0 ttpt -109.98 123.86 50.4 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.128 -0.487 . . . . 75.01 110.917 179.941 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 3.7 m -129.82 137.47 50.49 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.237 -0.438 . . . . 52.34 111.2 179.981 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -161.02 -157.48 8.77 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.765 -0.731 . . . . 62.45 112.508 179.976 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.454 HD23 HG22 ' A' ' 38' ' ' VAL . 8.7 mt -101.68 137.55 39.85 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.886 0.374 . . . . 72.02 110.866 -179.887 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.404 ' HB ' ' HD2' ' A' ' 51' ' ' PRO . 10.3 m -137.16 153.36 74.96 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 121.645 0.736 . . . . 70.45 111.1 179.825 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . 0.427 ' HG2' ' HB2' ' A' ' 54' ' ' PHE . 53.4 Cg_endo -69.85 143.81 51.59 Favored 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 122.657 2.238 . . . . 73.02 112.306 179.961 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . 0.717 ' CG ' HD11 ' A' ' 37' ' ' LEU . 10.9 tm-20 -89.92 -28.09 19.42 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.189 -0.46 . . . . 72.05 110.903 179.983 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -85.97 10.35 14.33 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.17 -0.468 . . . . 73.02 110.847 -179.92 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . 0.427 ' HB2' ' HG2' ' A' ' 51' ' ' PRO . 0.9 OUTLIER -120.72 -8.96 9.41 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.174 -0.466 . . . . 72.52 110.875 -179.932 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.562 ' CG1' HD21 ' A' ' 20' ' ' LEU . 15.8 m -119.71 166.33 14.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.123 -0.489 . . . . 71.43 111.167 179.961 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . 0.743 ' CB ' HD21 ' A' ' 7' ' ' LEU . 37.2 t -135.25 117.86 15.95 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.193 -0.458 . . . . 71.4 110.875 -179.868 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 3.3 m-85 -58.32 124.69 20.35 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.171 -0.468 . . . . 72.42 110.935 -179.896 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.475 HD12 ' HG3' ' A' ' 3' ' ' ARG . 22.8 mt -88.26 153.64 3.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.119 -0.491 . . . . 71.33 111.081 179.947 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 8.1 pm0 . . . . . 0 C--N 1.329 -0.314 0 CA-C-O 121.609 0.719 . . . . 72.31 110.929 179.95 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' B' B ' -7' ' ' PHE . . . . . 0.425 ' HB3' HD11 ' A' ' 49' ' ' LEU . 9.1 m-85 . . . . . 0 C--O 1.231 0.095 0 CA-C-O 120.823 0.345 . . . . 73.54 110.913 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' -6' ' ' ILE . . . . . 0.416 HD13 ' O ' ' B' ' -7' ' ' PHE . 37.9 mm -145.51 87.22 7.05 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 121.63 0.729 . . . . 72.34 111.105 -179.997 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' -5' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.74 139.87 41.37 Favored 'Trans proline' 0 C--O 1.231 0.164 0 C-N-CA 122.707 2.272 . . . . 75.34 112.351 179.891 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' -4' ' ' SER . . . . . . . . . . . . . 27.5 t -132.96 66.16 1.57 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.227 -0.442 . . . . 61.13 110.903 -179.872 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' -3' ' ' ARG . . . . . . . . . . . . . 5.8 ptm180 -178.21 155.0 0.96 Allowed Pre-proline 0 C--N 1.329 -0.288 0 CA-C-O 121.6 0.714 . . . . 74.43 110.851 -179.95 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' -2' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.81 131.63 21.55 Favored 'Trans proline' 0 C--N 1.341 0.157 0 C-N-CA 122.654 2.236 . . . . 73.01 112.35 -179.978 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' -1' ' ' ALA . . . . . . . . . . . . . . . -70.47 151.67 95.56 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 121.62 0.724 . . . . 63.24 111.102 179.89 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 0' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.7 173.34 11.07 Favored 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.681 2.254 . . . . 75.14 112.363 -179.98 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 1' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -121.82 154.35 60.58 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 121.579 0.704 . . . . 74.42 110.891 179.865 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 2' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo . . . . . 0 C--O 1.232 0.186 0 C-N-CA 122.716 2.277 . . . . 74.42 112.345 179.89 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 55.0 tp60 . . . . . 0 C--O 1.231 0.087 0 CA-C-O 120.802 0.334 . . . . 74.45 110.945 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 7.7 ptp180 -82.0 164.15 21.64 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.188 -0.46 . . . . 74.51 110.821 -179.873 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -155.67 153.22 29.65 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.188 -0.46 . . . . 63.41 111.111 179.919 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.716 ' HB ' HD11 ' A' ' 58' ' ' ILE . 10.3 p -103.71 152.31 6.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.208 -0.451 . . . . 73.04 111.143 179.972 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -92.89 114.99 27.7 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.199 -0.455 . . . . 63.43 111.09 179.92 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 0.63 HD21 ' HB2' ' A' ' 56' ' ' SER . 7.0 mt -82.07 -35.64 28.47 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.224 -0.443 . . . . 71.54 110.925 -179.966 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 5.0 m-85 -141.82 137.83 31.77 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.207 -0.451 . . . . 75.53 110.979 179.965 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 3.0 p-10 -63.0 138.43 58.56 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.121 -0.491 . . . . 73.55 110.847 179.98 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 10.4 t80 -141.86 144.76 34.01 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.205 -0.452 . . . . 73.03 110.915 -179.927 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -113.1 144.33 30.92 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 121.656 0.741 . . . . 71.43 110.899 -179.925 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.75 132.39 23.25 Favored 'Trans proline' 0 C--N 1.342 0.193 0 C-N-CA 122.686 2.257 . . . . 65.03 112.324 179.991 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 15.3 mt-10 -94.47 -20.08 19.99 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.184 -0.462 . . . . 74.45 110.87 179.994 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 33.5 m-80 -114.48 175.66 5.39 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.176 -0.465 . . . . 71.25 110.878 -179.929 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -86.85 8.66 21.98 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.199 -0.455 . . . . 52.23 110.899 179.896 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -129.44 20.52 5.68 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.186 -0.461 . . . . 71.53 110.905 -179.942 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 57.1 mt-10 -109.92 156.37 20.53 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.198 -0.455 . . . . 63.21 110.87 -179.962 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.535 HD23 ' O ' ' A' ' 19' ' ' ARG . 0.4 OUTLIER -105.13 153.83 20.99 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.16 -0.473 . . . . 74.23 110.927 -179.999 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . 0.535 ' O ' HD23 ' A' ' 18' ' ' LEU . 21.6 mtm180 -87.87 151.69 22.65 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.179 -0.464 . . . . 61.12 110.856 179.974 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.546 HD21 ' CG1' ' A' ' 55' ' ' VAL . 1.7 tp -137.47 148.7 46.27 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.171 -0.468 . . . . 64.12 110.94 179.981 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.612 ' HB3' ' CG ' ' A' ' 24' ' ' ASP . . . -141.62 140.28 33.27 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.197 -0.456 . . . . 72.13 111.107 179.795 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -50.62 120.28 4.56 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.234 -0.439 . . . . 73.32 110.912 -179.915 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 97.84 -7.11 62.78 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.716 -0.754 . . . . 62.05 112.474 -179.986 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . 0.612 ' CG ' ' HB3' ' A' ' 21' ' ' ALA . 2.1 m-20 -76.41 150.45 36.76 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.788 0.328 . . . . 54.11 110.84 -179.944 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 1.5 mt -116.91 120.08 63.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.201 -0.454 . . . . 73.32 111.118 -179.965 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 6.0 m -120.61 165.44 16.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.163 -0.472 . . . . 65.32 111.125 179.858 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 54.4 m-85 -115.57 107.4 15.09 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.162 -0.472 . . . . 65.25 110.887 179.987 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.782 HD13 ' HB2' ' A' ' 39' ' ' ALA . 17.4 mm -72.04 103.05 1.38 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.164 -0.471 . . . . 71.25 111.127 179.963 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 3.2 m -64.43 -39.25 93.48 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.196 -0.457 . . . . 72.03 110.856 -179.921 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' TYR . . . . . 0.507 ' CZ ' HG21 ' A' ' 38' ' ' VAL . 31.7 p90 -174.99 145.93 0.85 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.151 -0.477 . . . . 64.03 110.936 -179.862 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . 0.476 ' HG3' HD22 ' A' ' 37' ' ' LEU . 19.1 tttt -79.45 144.94 33.58 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.11 -0.496 . . . . 64.53 110.869 179.937 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 28.8 t60 -134.4 153.47 51.89 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.2 -0.455 . . . . 74.33 110.795 179.926 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -58.89 -174.05 0.54 Allowed Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.766 -0.731 . . . . 60.15 112.515 179.975 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 40.5 mm-40 64.59 13.4 8.24 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.834 0.35 . . . . 71.13 110.896 -179.892 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 67.32 28.57 73.7 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.743 -0.742 . . . . 33.53 112.456 179.975 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' TRP . . . . . 0.591 ' C ' HD23 ' A' ' 37' ' ' LEU . 98.5 m95 -121.96 135.82 54.88 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.805 0.336 . . . . 75.13 110.947 -179.951 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.673 HD11 ' CG ' ' A' ' 52' ' ' GLU . 0.9 OUTLIER -121.97 131.22 53.89 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.234 -0.439 . . . . 74.5 110.961 179.96 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.528 HG22 HD23 ' A' ' 49' ' ' LEU . 41.3 t -78.92 109.46 13.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.193 -0.458 . . . . 73.23 111.159 179.825 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . 0.782 ' HB2' HD13 ' A' ' 28' ' ' ILE . . . -129.73 162.25 28.82 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.192 -0.458 . . . . 52.24 111.137 179.871 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 3.6 pm0 -118.17 159.9 22.5 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.233 -0.44 . . . . 43.41 110.893 -179.966 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 44.9 p-10 -58.88 -174.88 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.127 -0.488 . . . . 63.42 110.896 -179.946 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 6.1 tm-20 -78.05 -37.68 46.21 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.164 -0.471 . . . . 74.32 110.91 179.988 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 67.9 m -68.38 -21.89 64.68 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.127 -0.488 . . . . 72.31 110.863 -179.774 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 75.91 26.01 65.63 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.747 -0.74 . . . . 60.01 112.468 179.976 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 6.6 t -109.66 -21.27 12.51 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.931 0.396 . . . . 51.51 110.889 -179.747 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.511 ' HG3' HD11 ' A' ' 18' ' ' LEU . 0.9 OUTLIER -121.51 138.98 54.07 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.132 -0.485 . . . . 62.15 110.894 179.926 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 6.1 m -132.58 152.6 51.57 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.231 -0.441 . . . . 71.42 111.159 179.978 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -178.36 -161.91 27.15 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.717 -0.754 . . . . 63.03 112.454 179.938 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.528 HD23 HG22 ' A' ' 38' ' ' VAL . 5.8 mt -100.95 141.48 33.78 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.849 0.357 . . . . 74.24 110.915 -179.873 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.422 ' HB ' ' HD2' ' A' ' 51' ' ' PRO . 17.1 m -138.2 153.71 73.36 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-O 121.67 0.748 . . . . 63.03 111.091 179.876 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . 0.451 ' HD2' HD22 ' A' ' 20' ' ' LEU . 53.7 Cg_endo -69.8 144.93 55.38 Favored 'Trans proline' 0 C--N 1.342 0.21 0 C-N-CA 122.661 2.241 . . . . 62.44 112.322 179.974 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . 0.673 ' CG ' HD11 ' A' ' 37' ' ' LEU . 25.8 tt0 -91.88 -26.93 18.24 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.22 -0.445 . . . . 62.04 110.914 180.0 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -87.89 10.59 18.18 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.168 -0.469 . . . . 35.15 110.918 -179.928 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . 0.421 ' HB2' ' HG2' ' A' ' 51' ' ' PRO . 1.0 OUTLIER -120.04 -14.22 8.91 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.121 -0.491 . . . . 75.33 110.898 -179.96 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.546 ' CG1' HD21 ' A' ' 20' ' ' LEU . 19.2 m -114.82 172.48 3.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.172 -0.467 . . . . 71.25 111.181 179.949 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . 0.63 ' HB2' HD21 ' A' ' 7' ' ' LEU . 32.3 t -144.19 116.7 8.6 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.185 -0.461 . . . . 54.35 110.852 -179.842 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 2.8 m-85 -51.93 134.37 31.69 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.132 -0.486 . . . . 71.42 110.876 -179.827 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.716 HD11 ' HB ' ' A' ' 5' ' ' VAL . 52.2 mt -105.63 145.46 13.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.125 -0.489 . . . . 75.11 111.136 179.91 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 4.6 mt-30 . . . . . 0 C--N 1.329 -0.321 0 CA-C-O 121.613 0.72 . . . . 74.53 110.888 179.994 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' B' B ' -7' ' ' PHE . . . . . . . . . . . . . 14.0 m-85 . . . . . 0 C--O 1.231 0.125 0 CA-C-O 120.885 0.374 . . . . 74.11 110.835 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' B' B ' -6' ' ' ILE . . . . . . . . . . . . . 55.8 mt -149.91 86.28 5.35 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-O 121.615 0.721 . . . . 73.5 111.13 179.921 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' -5' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.8 141.03 43.98 Favored 'Trans proline' 0 C--N 1.341 0.176 0 C-N-CA 122.64 2.226 . . . . 74.11 112.382 179.844 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' -4' ' ' SER . . . . . . . . . . . . . 2.6 t -139.5 65.89 1.42 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.25 -0.432 . . . . 73.41 110.884 -179.822 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' -3' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -178.56 154.51 0.87 Allowed Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.581 0.705 . . . . 74.55 110.9 -179.889 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' -2' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.77 124.2 10.85 Favored 'Trans proline' 0 C--N 1.342 0.2 0 C-N-CA 122.689 2.259 . . . . 63.22 112.333 -179.951 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' -1' ' ' ALA . . . . . . . . . . . . . . . -57.67 152.29 36.69 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.576 0.703 . . . . 52.24 111.099 179.897 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 0' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.77 172.79 12.0 Favored 'Trans proline' 0 C--N 1.342 0.194 0 C-N-CA 122.712 2.275 . . . . 75.44 112.341 -179.966 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 1' ' ' LYS . . . . . . . . . . . . . 12.7 ptmt -119.83 153.45 54.74 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.549 0.69 . . . . 74.21 110.874 179.907 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 2' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo . . . . . 0 C--N 1.341 0.171 0 C-N-CA 122.631 2.221 . . . . 63.1 112.327 179.887 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 55.7 tp60 . . . . . 0 C--O 1.231 0.109 0 CA-C-O 120.791 0.329 . . . . 53.05 110.894 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 5.5 ptm180 -81.99 164.3 21.56 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.233 -0.44 . . . . 72.52 110.883 -179.967 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -156.76 155.33 31.43 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.2 -0.454 . . . . 61.12 111.118 179.939 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.639 ' HB ' HD11 ' A' ' 58' ' ' ILE . 10.5 p -104.95 152.31 6.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.256 -0.429 . . . . 74.11 111.164 179.985 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -90.65 112.27 23.93 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.222 -0.445 . . . . 75.43 111.045 179.919 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 0.757 HD21 ' HB3' ' A' ' 56' ' ' SER . 11.6 mt -78.54 -37.64 42.41 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.218 -0.447 . . . . 71.13 110.908 -179.984 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 5.5 m-85 -141.77 146.07 35.53 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.199 -0.455 . . . . 74.11 110.947 -179.957 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 4.0 p-10 -70.61 134.88 48.0 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.115 -0.493 . . . . 62.31 110.909 179.897 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 7.0 t80 -135.15 145.99 48.34 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.199 -0.455 . . . . 73.43 110.893 -179.897 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 5.7 tp10 -115.84 136.04 22.82 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 121.643 0.735 . . . . 74.52 110.892 -179.934 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . 0.415 ' HD3' ' HA ' ' A' ' 19' ' ' ARG . 53.7 Cg_endo -69.8 148.27 64.43 Favored 'Trans proline' 0 C--N 1.341 0.177 0 C-N-CA 122.694 2.263 . . . . 43.13 112.341 -179.998 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -105.94 -21.73 13.08 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.201 -0.454 . . . . 61.45 110.877 -179.977 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 68.1 m-80 -112.07 175.52 5.39 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.187 -0.46 . . . . 44.41 110.949 -179.964 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -88.34 10.34 20.18 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.227 -0.442 . . . . 55.12 110.899 179.905 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -126.22 14.03 7.77 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.169 -0.469 . . . . 73.13 110.936 -179.946 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 25.5 mt-10 -107.62 153.19 23.25 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.178 -0.464 . . . . 71.35 110.88 -179.98 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.544 HD23 ' O ' ' A' ' 19' ' ' ARG . 0.3 OUTLIER -103.25 151.56 22.53 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.137 -0.483 . . . . 72.02 110.911 -179.979 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . 0.544 ' O ' HD23 ' A' ' 18' ' ' LEU . 0.3 OUTLIER -88.73 155.26 19.68 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.175 -0.466 . . . . 74.34 110.856 179.997 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.541 HD21 ' CG1' ' A' ' 55' ' ' VAL . 2.0 tp -139.0 148.73 43.83 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.187 -0.46 . . . . 62.11 110.905 -179.959 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.648 ' HB3' ' CG ' ' A' ' 24' ' ' ASP . . . -140.46 137.96 34.3 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.185 -0.461 . . . . 74.31 111.101 179.769 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -50.24 120.36 4.45 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.188 -0.46 . . . . 75.21 110.91 -179.902 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 96.09 -0.32 62.18 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.74 -0.743 . . . . 75.24 112.497 -179.952 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . 0.648 ' CG ' ' HB3' ' A' ' 21' ' ' ALA . 1.3 m-20 -86.6 145.99 26.52 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.81 0.338 . . . . 51.51 110.856 -179.951 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 3.1 mm -102.65 139.9 22.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.176 -0.466 . . . . 60.55 111.138 -179.997 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 1.1 m -141.91 162.44 20.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.204 -0.453 . . . . 62.22 111.125 179.873 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 63.7 m-85 -118.92 108.84 15.27 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.201 -0.454 . . . . 72.54 110.872 -179.987 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.776 HD13 ' HB2' ' A' ' 39' ' ' ALA . 17.2 mm -73.13 103.35 1.82 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.139 -0.482 . . . . 64.2 111.122 179.976 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 5.9 m -64.88 -40.39 95.03 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.184 -0.462 . . . . 74.2 110.892 -179.946 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' TYR . . . . . 0.511 ' CZ ' HG21 ' A' ' 38' ' ' VAL . 36.2 p90 -174.61 149.7 1.28 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.142 -0.481 . . . . 74.4 110.918 -179.897 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . 0.491 ' HG3' HD22 ' A' ' 37' ' ' LEU . 20.5 tttt -81.56 144.24 31.42 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.152 -0.476 . . . . 74.14 110.894 179.919 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 31.5 t60 -133.25 153.34 51.65 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.242 -0.435 . . . . 73.5 110.918 179.849 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -59.09 -174.54 0.62 Allowed Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.778 -0.725 . . . . 74.12 112.42 -179.898 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 5.1 mt-30 65.95 11.99 8.1 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.88 0.371 . . . . 75.03 110.917 -179.909 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 68.36 28.99 72.99 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.753 -0.737 . . . . 51.54 112.502 -179.971 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' TRP . . . . . 0.634 ' C ' HD23 ' A' ' 37' ' ' LEU . 98.6 m95 -123.35 136.54 54.71 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.821 0.344 . . . . 75.52 110.941 -179.922 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.695 HD11 ' CG ' ' A' ' 52' ' ' GLU . 1.4 mt -120.24 132.73 55.47 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.249 -0.432 . . . . 63.42 110.926 179.959 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.511 HG21 ' CZ ' ' A' ' 30' ' ' TYR . 37.6 t -80.4 109.31 14.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.216 -0.447 . . . . 64.33 111.138 179.829 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . 0.776 ' HB2' HD13 ' A' ' 28' ' ' ILE . . . -130.56 164.54 24.68 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.167 -0.469 . . . . 51.54 111.142 179.854 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 1.2 pt-20 -119.67 156.06 31.18 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.232 -0.44 . . . . 64.32 110.885 -179.933 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -67.54 -175.06 0.47 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.134 -0.485 . . . . 72.23 110.898 -179.916 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 6.9 tt0 -68.87 -37.62 79.19 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.221 -0.445 . . . . 72.23 110.827 -179.956 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 1.7 t -56.87 -22.46 37.13 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.19 -0.459 . . . . 62.32 110.885 -179.805 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 69.44 9.43 61.34 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.766 -0.73 . . . . 52.33 112.489 -179.996 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 7.4 m -108.78 -24.27 11.37 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.97 0.415 . . . . 73.5 110.853 -179.732 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.463 ' HG2' HD11 ' A' ' 18' ' ' LEU . 0.1 OUTLIER -105.51 123.61 48.18 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.149 -0.478 . . . . 74.42 110.857 179.932 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 3.4 m -124.47 152.59 43.16 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.223 -0.444 . . . . 74.24 111.175 179.928 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -177.29 -161.71 26.3 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.723 -0.751 . . . . 73.53 112.485 179.968 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.49 HD23 HG22 ' A' ' 38' ' ' VAL . 5.5 mt -100.59 134.44 43.55 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.876 0.369 . . . . 72.02 110.885 -179.861 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.403 ' HB ' ' HD2' ' A' ' 51' ' ' PRO . 10.4 m -133.77 153.23 79.92 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-O 121.632 0.729 . . . . 61.42 111.135 179.866 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . 0.411 ' HG2' ' HB2' ' A' ' 54' ' ' PHE . 53.8 Cg_endo -69.77 144.97 55.66 Favored 'Trans proline' 0 C--N 1.342 0.207 0 C-N-CA 122.667 2.245 . . . . 73.14 112.343 179.928 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . 0.695 ' CG ' HD11 ' A' ' 37' ' ' LEU . 12.0 tm-20 -91.05 -28.85 17.69 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.233 -0.44 . . . . 64.33 110.868 -179.961 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 2.1 mm-40 -85.11 9.05 15.93 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.198 -0.456 . . . . 54.31 110.927 -179.965 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . 0.411 ' HB2' ' HG2' ' A' ' 51' ' ' PRO . 1.1 m-85 -120.33 -2.76 10.03 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.13 -0.486 . . . . 75.42 110.895 -179.922 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.541 ' CG1' HD21 ' A' ' 20' ' ' LEU . 13.0 m -125.27 171.66 13.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.14 -0.482 . . . . 71.22 111.138 179.949 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . 0.757 ' HB3' HD21 ' A' ' 7' ' ' LEU . 4.1 t -142.94 117.14 9.52 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.179 -0.464 . . . . 72.1 110.86 -179.845 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 3.1 m-85 -55.05 133.39 48.65 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.14 -0.482 . . . . 72.41 110.926 -179.924 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.639 HD11 ' HB ' ' A' ' 5' ' ' VAL . 46.8 mt -103.92 148.59 8.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.105 -0.498 . . . . 72.14 111.142 179.895 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--N 1.33 -0.282 0 CA-C-O 121.646 0.736 . . . . 71.41 110.881 179.939 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' -7' ' ' PHE . . . . . 0.474 ' HB3' HD11 ' A' ' 49' ' ' LEU . 13.4 m-85 . . . . . 0 C--O 1.231 0.129 0 CA-C-O 120.836 0.351 . . . . 65.31 110.904 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' -6' ' ' ILE . . . . . 0.51 ' O ' HG23 ' B' ' -6' ' ' ILE . 4.0 tp -171.9 87.94 0.44 Allowed Pre-proline 0 C--N 1.328 -0.329 0 CA-C-O 121.632 0.73 . . . . 72.53 111.155 179.944 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' -5' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.73 146.33 60.06 Favored 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 122.677 2.251 . . . . 75.41 112.377 179.844 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' -4' ' ' SER . . . . . . . . . . . . . 28.6 t -141.7 63.6 1.42 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.21 -0.45 . . . . 74.45 110.853 -179.841 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' -3' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -179.32 155.42 0.79 Allowed Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.576 0.703 . . . . 73.43 110.886 -179.954 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' -2' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.76 129.13 17.07 Favored 'Trans proline' 0 C--N 1.341 0.175 0 C-N-CA 122.661 2.24 . . . . 74.24 112.337 -179.969 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' -1' ' ' ALA . . . . . . . . . . . . . . . -62.61 152.33 81.49 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-O 121.614 0.721 . . . . 51.41 111.107 179.875 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 0' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.72 175.81 7.58 Favored 'Trans proline' 0 C--N 1.341 0.17 0 C-N-CA 122.696 2.264 . . . . 44.35 112.337 -179.968 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 1' ' ' LYS . . . . . . . . . . . . . 14.2 pttm -123.55 154.36 66.36 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-O 121.647 0.737 . . . . 70.3 110.86 179.92 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 2' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo . . . . . 0 C--N 1.342 0.195 0 C-N-CA 122.722 2.281 . . . . 55.32 112.353 179.899 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 50.8 tp60 . . . . . 0 C--O 1.232 0.165 0 CA-C-O 120.798 0.332 . . . . 62.31 110.932 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 5.6 ptp180 -78.82 161.4 26.81 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.278 -0.419 . . . . 60.24 110.902 -179.931 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -156.24 154.86 31.4 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.233 -0.44 . . . . 53.33 111.122 179.942 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.574 ' HB ' HD11 ' A' ' 58' ' ' ILE . 11.1 p -104.94 151.26 7.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.209 -0.451 . . . . 54.11 111.102 -179.972 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -89.3 111.08 21.81 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.163 -0.471 . . . . 74.3 111.065 179.915 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 0.721 HD21 ' HB2' ' A' ' 56' ' ' SER . 11.5 mt -75.82 -38.63 57.95 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.221 -0.445 . . . . 63.35 110.875 -179.949 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 4.1 m-85 -141.86 148.95 39.62 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.172 -0.467 . . . . 75.33 110.892 -179.946 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 3.7 p-10 -71.28 131.49 43.53 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.142 -0.481 . . . . 60.14 110.89 179.894 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 1.8 t80 -129.54 146.15 51.39 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.228 -0.442 . . . . 74.24 110.866 -179.906 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 32.5 tt0 -116.2 137.06 23.18 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-O 121.654 0.74 . . . . 74.41 110.919 -179.911 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.7 148.27 65.1 Favored 'Trans proline' 0 C--N 1.341 0.154 0 C-N-CA 122.689 2.259 . . . . 72.24 112.373 -179.99 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 18.1 mm-40 -110.79 -18.62 13.08 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.264 -0.425 . . . . 71.12 110.903 179.993 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 33.9 m-80 -112.59 176.25 5.09 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.154 -0.475 . . . . 65.24 110.842 -179.925 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 7.9 p-10 -91.54 20.11 5.66 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.162 -0.472 . . . . 65.13 110.848 179.907 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -138.68 14.68 2.72 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.241 -0.436 . . . . 74.42 110.904 -179.907 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 30.3 mt-10 -103.7 164.7 11.5 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.169 -0.469 . . . . 73.15 110.907 -179.966 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.568 HD12 ' H ' ' A' ' 19' ' ' ARG . 39.2 tp -115.35 146.78 41.22 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.181 -0.463 . . . . 40.13 110.936 -179.975 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . 0.568 ' H ' HD12 ' A' ' 18' ' ' LEU . 34.6 mtm-85 -82.25 156.8 24.17 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.242 -0.436 . . . . 62.24 110.913 179.93 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.54 HD21 ' CG1' ' A' ' 55' ' ' VAL . 2.9 tp -142.27 147.55 36.62 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.203 -0.453 . . . . 53.32 110.946 179.985 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.716 ' HB3' ' OD2' ' A' ' 24' ' ' ASP . . . -138.79 137.77 36.97 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.231 -0.44 . . . . 60.24 111.113 179.791 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -50.82 120.89 5.2 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.228 -0.442 . . . . 75.21 110.883 -179.923 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 97.25 -5.65 63.13 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.722 -0.751 . . . . 52.32 112.457 179.985 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . 0.716 ' OD2' ' HB3' ' A' ' 21' ' ' ALA . 5.7 m-20 -81.34 147.82 29.67 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.811 0.339 . . . . 50.13 110.862 -179.94 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 3.4 mm -101.46 141.56 17.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.231 -0.44 . . . . 71.53 111.125 -179.977 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.413 HG11 HD11 ' A' ' 20' ' ' LEU . 1.5 m -144.79 158.38 14.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.187 -0.461 . . . . 71.1 111.117 179.883 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 57.8 m-85 -117.47 108.38 15.46 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.15 -0.477 . . . . 74.52 110.892 179.965 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.857 HD13 ' HB2' ' A' ' 39' ' ' ALA . 20.1 mm -72.44 103.11 1.51 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.128 -0.487 . . . . 65.03 111.117 -179.996 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 5.7 m -65.05 -40.21 94.44 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.162 -0.472 . . . . 73.5 110.872 -179.922 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' TYR . . . . . 0.513 ' CZ ' HG21 ' A' ' 38' ' ' VAL . 33.9 p90 -174.61 149.11 1.22 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.155 -0.475 . . . . 74.24 110.944 -179.885 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . 0.528 ' HG3' HD22 ' A' ' 37' ' ' LEU . 19.0 tttt -81.32 143.25 32.35 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.192 -0.458 . . . . 71.34 110.94 179.874 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 33.4 t60 -131.73 155.36 47.82 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.241 -0.436 . . . . 70.43 110.823 179.932 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -60.79 -174.11 1.11 Allowed Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.728 -0.749 . . . . 51.35 112.493 -179.958 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 84.7 mm-40 65.43 12.55 8.22 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.833 0.349 . . . . 72.31 110.939 -179.849 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 68.53 29.19 72.89 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.739 -0.743 . . . . 73.13 112.496 -179.955 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' TRP . . . . . 0.652 ' C ' HD23 ' A' ' 37' ' ' LEU . 99.0 m95 -123.69 136.8 54.68 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.819 0.342 . . . . 70.45 110.906 -179.929 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.709 HD11 ' CG ' ' A' ' 52' ' ' GLU . 1.3 mt -121.09 130.57 53.81 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.258 -0.428 . . . . 72.11 110.939 179.972 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.513 HG21 ' CZ ' ' A' ' 30' ' ' TYR . 47.4 t -76.9 112.36 14.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.197 -0.456 . . . . 51.31 111.139 179.866 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . 0.857 ' HB2' HD13 ' A' ' 28' ' ' ILE . . . -133.88 159.96 39.1 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.182 -0.463 . . . . 73.41 111.106 179.869 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -114.09 155.57 25.75 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.204 -0.453 . . . . 64.14 110.841 -179.909 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -70.56 -175.32 1.02 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.098 -0.501 . . . . 52.41 110.883 -179.951 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -69.86 -39.13 76.56 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.151 -0.477 . . . . 74.13 110.861 -179.956 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 11.8 m -56.29 -22.51 30.72 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.152 -0.476 . . . . 71.42 110.852 -179.809 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 66.81 11.4 57.69 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.754 -0.736 . . . . 50.32 112.498 -179.972 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 47.5 t -108.22 -14.35 14.72 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.956 0.407 . . . . 74.43 110.838 -179.708 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 6.1 ptmt -121.37 135.43 55.08 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.161 -0.472 . . . . 74.43 110.881 179.991 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 5.4 m -137.15 141.16 42.24 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.233 -0.439 . . . . 75.43 111.146 179.986 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -161.97 -154.81 7.67 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.711 -0.757 . . . . 72.22 112.499 179.947 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.506 HD11 ' HB3' ' B' ' -7' ' ' PHE . 6.8 mt -104.82 131.48 52.24 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.811 0.339 . . . . 53.53 110.936 -179.918 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.4 ' HB ' ' HD2' ' A' ' 51' ' ' PRO . 10.8 m -129.64 153.13 80.7 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-O 121.606 0.717 . . . . 63.21 111.185 179.812 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . 0.429 ' HG2' ' HB2' ' A' ' 54' ' ' PHE . 53.5 Cg_endo -69.76 144.84 55.31 Favored 'Trans proline' 0 C--N 1.342 0.189 0 C-N-CA 122.691 2.261 . . . . 63.14 112.37 179.957 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . 0.709 ' CG ' HD11 ' A' ' 37' ' ' LEU . 8.3 tm-20 -90.48 -29.11 18.13 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.208 -0.451 . . . . 61.52 110.854 -179.949 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -85.25 9.87 14.03 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.19 -0.459 . . . . 74.13 110.914 -179.932 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . 0.429 ' HB2' ' HG2' ' A' ' 51' ' ' PRO . 1.0 OUTLIER -120.87 -7.82 9.47 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.136 -0.484 . . . . 74.55 110.862 -179.913 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.54 ' CG1' HD21 ' A' ' 20' ' ' LEU . 19.2 m -119.79 170.54 9.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.149 -0.478 . . . . 75.03 111.102 179.983 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . 0.721 ' HB2' HD21 ' A' ' 7' ' ' LEU . 31.2 t -141.61 113.27 7.74 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.143 -0.481 . . . . 54.3 110.878 -179.858 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 3.1 m-85 -52.93 130.79 34.57 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.145 -0.48 . . . . 74.34 110.888 -179.841 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.574 HD11 ' HB ' ' A' ' 5' ' ' VAL . 51.4 mt -99.01 148.19 6.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.123 -0.489 . . . . 52.55 111.17 179.874 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 7.1 pt20 . . . . . 0 C--N 1.329 -0.323 0 CA-C-O 121.634 0.731 . . . . 75.14 110.882 179.975 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' B' B ' -7' ' ' PHE . . . . . 0.506 ' HB3' HD11 ' A' ' 49' ' ' LEU . 9.8 m-85 . . . . . 0 C--O 1.232 0.14 0 CA-C-O 120.821 0.343 . . . . 64.21 110.916 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' -6' ' ' ILE . . . . . . . . . . . . . 1.6 pt -153.08 86.14 4.16 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-O 121.627 0.727 . . . . 63.0 111.15 179.995 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' -5' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.74 139.59 40.66 Favored 'Trans proline' 0 C--O 1.231 0.173 0 C-N-CA 122.683 2.256 . . . . 72.33 112.345 179.898 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' -4' ' ' SER . . . . . . . . . . . . . 1.5 t -135.24 65.63 1.55 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.222 -0.445 . . . . 71.41 110.88 -179.845 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' -3' ' ' ARG . . . . . . . . . . . . . 5.4 ptm180 -178.2 154.46 0.93 Allowed Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.569 0.699 . . . . 74.32 110.876 -179.964 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' -2' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.77 131.55 21.47 Favored 'Trans proline' 0 C--N 1.341 0.138 0 C-N-CA 122.682 2.255 . . . . 73.02 112.321 -179.953 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' -1' ' ' ALA . . . . . . . . . . . . . . . -68.84 152.49 96.73 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.526 0.679 . . . . 45.43 111.127 179.859 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 0' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.81 171.51 14.39 Favored 'Trans proline' 0 C--N 1.341 0.157 0 C-N-CA 122.666 2.244 . . . . 65.53 112.318 -179.958 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 1' ' ' LYS . . . . . . . . . . . . . 21.1 mmmt -119.58 153.81 54.3 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.612 0.72 . . . . 50.01 110.835 179.955 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 2' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo . . . . . 0 C--N 1.342 0.205 0 C-N-CA 122.694 2.263 . . . . 75.35 112.358 179.863 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' -4' ' ' MET . . . . . . . . . . . . . 23.2 mmt . . . . . 0 C--O 1.23 0.074 0 CA-C-O 120.756 0.312 . . . . 52.33 110.902 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' -3' ' ' ALA . . . . . . . . . . . . . . . -77.55 69.93 3.86 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.219 -0.446 . . . . 75.41 111.044 179.975 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' -2' ' ' ILE . . . . . . . . . . . . . 60.5 mt -128.34 136.58 59.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.245 -0.434 . . . . 65.2 111.145 179.937 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' -1' ' ' VAL . . . . . . . . . . . . . 54.5 t -104.31 -29.07 2.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.137 -0.483 . . . . 74.14 111.133 179.869 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 15.5 m120 62.19 54.12 2.73 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.132 -0.485 . . . . 65.51 110.948 -179.94 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 44.9 tp60 -109.13 124.3 50.59 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.151 -0.477 . . . . 75.22 110.926 -179.977 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 7.6 ptt180 -74.65 162.11 29.05 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.216 -0.447 . . . . 61.12 110.892 -179.896 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -157.1 155.0 30.34 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.195 -0.457 . . . . 74.3 111.105 179.954 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.485 ' HB ' HD11 ' A' ' 58' ' ' ILE . 10.8 p -104.01 150.31 7.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.233 -0.44 . . . . 62.42 111.171 179.959 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -89.13 105.4 17.77 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.175 -0.466 . . . . 75.04 111.027 179.947 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.771 HD21 ' HB3' ' A' ' 56' ' ' SER . 15.5 mt -70.17 -36.82 74.94 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.2 -0.455 . . . . 75.23 110.937 179.998 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 3.5 m-85 -143.79 156.67 44.57 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.187 -0.461 . . . . 63.34 110.958 179.996 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -79.03 135.53 36.91 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.167 -0.47 . . . . 75.04 110.871 179.938 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 9.3 t80 -135.97 146.0 46.78 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.227 -0.442 . . . . 74.24 110.873 -179.894 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 28.8 tt0 -116.04 136.12 22.9 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-O 121.654 0.74 . . . . 75.22 110.855 -179.917 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.8 146.05 58.78 Favored 'Trans proline' 0 C--N 1.342 0.189 0 C-N-CA 122.661 2.241 . . . . 73.52 112.311 -179.972 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 7.8 mm-40 -107.93 -18.74 13.72 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.196 -0.457 . . . . 74.33 110.853 -179.967 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 35.5 m-80 -111.45 176.06 5.17 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.146 -0.479 . . . . 73.13 110.893 -179.934 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -92.16 20.89 5.51 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.169 -0.469 . . . . 73.13 110.865 179.906 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -138.24 12.29 2.81 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.179 -0.464 . . . . 64.21 110.906 -179.938 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 20.4 mt-10 -105.49 156.17 18.47 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.168 -0.469 . . . . 73.21 110.909 -179.998 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.53 HD23 ' O ' ' A' ' 19' ' ' ARG . 0.3 OUTLIER -105.53 151.44 24.29 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.206 -0.452 . . . . 71.25 110.879 -179.943 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . 0.53 ' O ' HD23 ' A' ' 18' ' ' LEU . 12.6 mtp180 -87.79 150.86 23.3 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.17 -0.468 . . . . 73.2 110.861 179.985 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.562 HD11 HG11 ' A' ' 26' ' ' VAL . 2.3 tp -135.17 149.57 49.98 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.242 -0.435 . . . . 71.14 110.927 -179.981 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.664 ' HB3' ' CG ' ' A' ' 24' ' ' ASP . . . -140.24 136.81 33.74 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.219 -0.446 . . . . 61.25 111.124 179.798 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 3.0 tt0 -50.45 120.24 4.45 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.218 -0.447 . . . . 51.2 110.889 -179.927 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 96.16 -0.56 62.2 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.696 -0.764 . . . . 53.45 112.499 -179.98 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . 0.664 ' CG ' ' HB3' ' A' ' 21' ' ' ALA . 1.1 m-20 -87.32 147.46 25.49 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.823 0.344 . . . . 65.52 110.865 -179.975 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 3.2 mm -100.62 141.04 18.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.173 -0.467 . . . . 74.4 111.131 -179.97 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.562 HG11 HD11 ' A' ' 20' ' ' LEU . 1.4 m -142.75 158.25 18.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.202 -0.454 . . . . 71.14 111.135 179.879 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 58.4 m-85 -117.19 108.11 15.27 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.165 -0.47 . . . . 70.24 110.905 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.724 HD13 ' HB2' ' A' ' 39' ' ' ALA . 16.6 mm -72.75 102.7 1.52 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.147 -0.479 . . . . 65.21 111.165 179.983 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 4.6 m -64.82 -40.88 95.91 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.19 -0.459 . . . . 71.35 110.861 -179.853 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' TYR . . . . . 0.518 ' CZ ' HG21 ' A' ' 38' ' ' VAL . 36.3 p90 -173.86 149.27 1.52 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.113 -0.494 . . . . 75.05 110.895 -179.931 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . 0.447 ' HG3' HD22 ' A' ' 37' ' ' LEU . 9.4 tttm -80.82 145.09 31.6 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.076 -0.511 . . . . 51.12 110.898 179.892 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 27.5 t60 -132.75 155.9 48.04 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.232 -0.44 . . . . 74.54 110.882 179.85 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -61.75 -174.21 1.65 Allowed Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.675 -0.774 . . . . 75.53 112.514 -179.946 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 57.1 mm-40 64.87 13.28 8.42 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.87 0.367 . . . . 64.33 110.874 -179.909 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 68.16 29.98 73.59 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.737 -0.744 . . . . 71.44 112.473 -179.984 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' TRP . . . . . 0.643 ' C ' HD23 ' A' ' 37' ' ' LEU . 98.3 m95 -123.58 137.52 54.74 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.83 0.348 . . . . 73.02 110.921 -179.929 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.715 HD11 ' CG ' ' A' ' 52' ' ' GLU . 1.6 mt -120.57 133.19 55.41 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.247 -0.433 . . . . 74.44 110.951 179.98 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.518 HG21 ' CZ ' ' A' ' 30' ' ' TYR . 75.8 t -79.95 109.09 14.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.214 -0.448 . . . . 73.31 111.161 179.851 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.724 ' HB2' HD13 ' A' ' 28' ' ' ILE . . . -129.46 160.99 31.43 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.243 -0.435 . . . . 44.33 111.07 179.945 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 3.3 pm0 -119.02 159.3 24.12 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.225 -0.443 . . . . 71.01 110.878 -179.933 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -71.95 -175.26 1.39 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.139 -0.482 . . . . 53.34 110.854 -179.924 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -69.63 -38.58 77.24 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.147 -0.479 . . . . 63.41 110.893 -179.989 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 1.5 t -56.03 -22.64 28.45 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.149 -0.478 . . . . 52.42 110.843 -179.77 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 69.76 9.02 61.65 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.814 -0.708 . . . . 74.42 112.474 179.982 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 3.7 t -108.88 -19.86 13.25 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.923 0.392 . . . . 74.12 110.871 -179.755 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.449 ' HG2' HD11 ' A' ' 18' ' ' LEU . 1.1 ttmt -109.85 123.62 49.9 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.134 -0.485 . . . . 72.44 110.94 179.913 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 6.1 m -126.82 152.58 46.77 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.269 -0.423 . . . . 71.24 111.116 -179.99 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -177.21 -161.16 25.3 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.744 -0.741 . . . . 63.43 112.484 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.464 HD23 HG22 ' A' ' 38' ' ' VAL . 4.8 mt -100.7 138.74 37.35 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.835 0.35 . . . . 75.43 110.885 -179.901 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.42 ' HB ' ' HD2' ' A' ' 51' ' ' PRO . 6.1 m -137.36 153.56 74.76 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-O 121.634 0.73 . . . . 72.1 111.143 179.82 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 0.42 ' HD2' ' HB ' ' A' ' 50' ' ' VAL . 53.8 Cg_endo -69.8 142.9 48.99 Favored 'Trans proline' 0 C--N 1.341 0.184 0 C-N-CA 122.639 2.226 . . . . 73.02 112.332 179.977 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . 0.715 ' CG ' HD11 ' A' ' 37' ' ' LEU . 15.7 tm-20 -89.88 -27.3 19.98 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.18 -0.464 . . . . 64.11 110.92 -179.992 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -87.12 12.08 12.38 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.111 -0.495 . . . . 74.22 110.895 -179.97 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . 0.42 ' HB2' ' HG2' ' A' ' 51' ' ' PRO . 1.0 OUTLIER -121.89 -8.81 8.86 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.154 -0.475 . . . . 73.54 110.883 -179.912 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.538 ' CG1' HD21 ' A' ' 20' ' ' LEU . 17.2 m -120.42 169.83 11.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.125 -0.489 . . . . 74.2 111.127 179.968 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . 0.771 ' HB3' HD21 ' A' ' 7' ' ' LEU . 3.8 t -138.69 115.27 10.58 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.19 -0.459 . . . . 64.35 110.869 -179.854 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 3.0 m-85 -54.2 128.8 32.59 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.183 -0.462 . . . . 74.33 110.924 -179.889 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.485 HD11 ' HB ' ' A' ' 5' ' ' VAL . 45.6 mt -97.06 148.65 5.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.114 -0.494 . . . . 64.2 111.15 179.939 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 4.3 mt-30 -131.17 160.91 64.83 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 121.616 0.722 . . . . 74.43 110.873 179.985 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.76 -48.07 0.8 Allowed 'Trans proline' 0 C--N 1.341 0.175 0 C-N-CA 122.751 2.301 . . . . 65.23 112.352 -179.99 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 29.6 tt0 -156.57 25.18 0.34 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.17 -0.468 . . . . 61.02 110.892 -179.981 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 8.1 mt -116.92 172.26 7.37 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.178 -0.464 . . . . 73.23 110.936 -179.957 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 . . . . . 0 C--N 1.329 -0.288 0 CA-C-N 116.205 -0.452 . . . . 40.42 110.871 179.918 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' B' B ' -9' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.26 0 N-CA-C 112.49 -0.244 . . . . 73.22 112.49 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' B' B ' -8' ' ' LYS . . . . . . . . . . . . . 19.5 mmtm -74.3 -62.77 1.4 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.793 0.33 . . . . 74.11 110.894 -179.982 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' -7' ' ' PHE . . . . . 0.444 ' HB3' HD11 ' A' ' 49' ' ' LEU . 13.5 m-85 -75.43 142.75 42.96 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.234 -0.439 . . . . 74.42 110.888 179.991 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' -6' ' ' ILE . . . . . . . . . . . . . 2.7 pt -153.21 84.13 4.47 Favored Pre-proline 0 C--N 1.328 -0.344 0 CA-C-O 121.656 0.741 . . . . 74.22 111.12 179.977 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' -5' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.71 134.52 28.3 Favored 'Trans proline' 0 C--N 1.342 0.207 0 C-N-CA 122.682 2.254 . . . . 71.0 112.342 179.857 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' -4' ' ' SER . . . . . . . . . . . . . 26.3 t -131.5 65.4 1.57 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.193 -0.458 . . . . 74.42 110.87 -179.863 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' -3' ' ' ARG . . . . . . . . . . . . . 6.9 ptm180 -178.66 155.0 0.87 Allowed Pre-proline 0 C--N 1.33 -0.282 0 CA-C-O 121.625 0.726 . . . . 75.13 110.84 -179.95 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' -2' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.83 129.3 17.29 Favored 'Trans proline' 0 C--N 1.341 0.17 0 C-N-CA 122.718 2.279 . . . . 62.11 112.313 -179.964 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' -1' ' ' ALA . . . . . . . . . . . . . . . -63.5 154.48 79.27 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-O 121.525 0.678 . . . . 71.53 111.157 179.847 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 0' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.78 176.75 6.36 Favored 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.663 2.242 . . . . 72.11 112.334 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 1' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -125.07 146.99 55.5 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.561 0.696 . . . . 73.33 110.882 179.951 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 2' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.72 163.27 38.86 Favored 'Trans proline' 0 C--N 1.341 0.158 0 C-N-CA 122.646 2.231 . . . . 71.35 112.363 179.873 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 3' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.78 -170.02 0.37 Allowed 'Trans proline' 0 C--N 1.341 0.157 0 C-N-CA 122.711 2.274 . . . . 71.2 112.339 179.939 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 4' ' ' SER . . . . . . . . . . . . . 13.6 p -113.35 -29.81 7.11 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.19 -0.459 . . . . 72.23 110.825 -179.815 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 5' ' ' SER . . . . . . . . . . . . . 3.5 t -56.89 -67.27 0.33 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.152 -0.476 . . . . 73.54 110.843 -179.792 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 6' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.328 -0.334 0 CA-C-N 116.134 -0.484 . . . . 75.14 111.098 179.892 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' -4' ' ' MET . . . . . . . . . . . . . 5.8 mmt . . . . . 0 C--O 1.231 0.102 0 CA-C-O 120.81 0.338 . . . . 61.51 110.864 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' -3' ' ' ALA . . . . . . . . . . . . . . . -108.05 114.12 27.79 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.243 -0.435 . . . . 61.52 111.074 179.93 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' -2' ' ' ILE . . . . . . . . . . . . . 91.6 mt -84.36 131.31 34.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.213 -0.448 . . . . 62.41 111.17 179.945 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' -1' ' ' VAL . . . . . . . . . . . . . 42.4 t -117.21 131.58 69.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.19 -0.459 . . . . 74.24 111.081 179.912 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 18.6 m120 -94.77 60.04 2.46 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.162 -0.472 . . . . 71.45 110.887 179.944 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 51.6 tp60 -103.35 134.5 46.63 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.193 -0.458 . . . . 74.42 110.92 179.96 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 5.9 ptt180 -89.58 164.67 14.67 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.202 -0.454 . . . . 71.43 110.896 -179.949 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -155.56 152.39 28.75 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.235 -0.439 . . . . 64.43 111.114 179.98 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.66 ' HB ' HD11 ' A' ' 58' ' ' ILE . 10.7 p -104.17 147.91 9.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.245 -0.434 . . . . 62.43 111.164 179.918 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . 0.423 ' HB3' ' O ' ' A' ' 21' ' ' ALA . . . -87.75 112.61 22.6 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.152 -0.477 . . . . 74.3 111.082 179.913 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.703 HD21 ' CB ' ' A' ' 56' ' ' SER . 10.4 mt -77.91 -37.77 47.12 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.2 -0.454 . . . . 74.13 110.962 179.987 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 4.0 m-85 -140.59 141.39 35.19 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.171 -0.468 . . . . 72.41 110.908 -179.972 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 2.2 p30 -65.13 132.99 50.59 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.128 -0.487 . . . . 73.3 110.898 179.899 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 2.1 t80 -129.83 146.34 51.57 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.204 -0.453 . . . . 65.51 110.888 -179.89 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 47.2 tt0 -117.03 137.06 23.51 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-O 121.62 0.724 . . . . 53.14 110.864 -179.893 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.79 150.99 68.79 Favored 'Trans proline' 0 C--N 1.342 0.189 0 C-N-CA 122.676 2.25 . . . . 74.25 112.311 -179.96 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 6.3 mm-40 -113.9 -15.82 12.3 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.206 -0.452 . . . . 72.25 110.913 179.981 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 31.2 m-80 -114.92 175.97 5.26 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.208 -0.451 . . . . 70.2 110.863 -179.936 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 27.1 m-20 -91.02 18.39 6.79 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.144 -0.48 . . . . 74.23 110.893 179.927 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -138.22 17.04 2.79 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.163 -0.472 . . . . 53.04 110.946 -179.916 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 24.9 mt-10 -105.49 164.87 11.55 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.132 -0.486 . . . . 74.41 110.93 179.979 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.558 HD12 ' H ' ' A' ' 19' ' ' ARG . 41.3 tp -115.84 147.06 41.45 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.176 -0.465 . . . . 64.4 110.94 -179.978 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . 0.558 ' H ' HD12 ' A' ' 18' ' ' LEU . 0.5 OUTLIER -83.07 159.32 22.16 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.219 -0.446 . . . . 71.0 110.823 179.986 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.556 HD21 ' CG1' ' A' ' 55' ' ' VAL . 3.1 tp -143.87 147.96 34.79 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.179 -0.464 . . . . 64.21 110.939 179.995 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.652 ' HB3' ' CG ' ' A' ' 24' ' ' ASP . . . -139.6 138.73 36.42 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.186 -0.461 . . . . 75.41 111.07 179.811 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -51.35 122.53 7.98 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.189 -0.46 . . . . 72.3 110.907 -179.933 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 95.85 -6.7 67.28 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.727 -0.749 . . . . 64.01 112.449 -179.983 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . 0.652 ' CG ' ' HB3' ' A' ' 21' ' ' ALA . 1.1 m-20 -80.38 145.94 31.76 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.764 0.316 . . . . 54.31 110.887 -179.967 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 3.2 mm -101.96 140.7 19.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.195 -0.457 . . . . 70.24 111.104 -179.957 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 1.5 m -143.23 158.47 17.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.135 -0.484 . . . . 63.44 111.132 179.868 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 57.4 m-85 -115.59 108.92 17.04 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.2 -0.455 . . . . 74.52 110.902 179.996 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.684 HD13 ' HB2' ' A' ' 39' ' ' ALA . 17.2 mm -72.42 102.61 1.41 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.153 -0.476 . . . . 64.31 111.101 179.999 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 8.1 m -65.06 -40.35 94.6 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.191 -0.459 . . . . 64.34 110.901 -179.946 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' TYR . . . . . 0.525 ' CZ ' HG21 ' A' ' 38' ' ' VAL . 33.9 p90 -174.67 148.6 1.15 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.144 -0.48 . . . . 64.34 110.923 -179.881 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . 0.528 ' HG3' HD22 ' A' ' 37' ' ' LEU . 10.3 tttm -81.27 143.94 31.91 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.122 -0.49 . . . . 75.54 110.838 179.942 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 32.0 t60 -132.45 155.13 49.09 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.205 -0.452 . . . . 75.21 110.845 179.879 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -60.49 -174.04 1.01 Allowed Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.755 -0.736 . . . . 63.42 112.481 -179.962 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 16.8 mm100 65.32 12.69 8.27 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.878 0.37 . . . . 64.14 110.947 -179.892 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 68.36 29.31 73.08 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.747 -0.74 . . . . 71.23 112.462 -180.0 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' TRP . . . . . 0.639 ' C ' HD23 ' A' ' 37' ' ' LEU . 98.8 m95 -123.55 135.75 54.17 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.781 0.324 . . . . 74.01 110.918 -179.93 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.714 HD11 ' CG ' ' A' ' 52' ' ' GLU . 1.3 mt -120.3 130.62 54.54 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.195 -0.457 . . . . 75.33 110.907 179.987 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.525 HG21 ' CZ ' ' A' ' 30' ' ' TYR . 82.6 t -76.18 112.11 13.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.184 -0.462 . . . . 75.2 111.138 179.821 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.684 ' HB2' HD13 ' A' ' 28' ' ' ILE . . . -133.0 157.9 44.04 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.121 -0.491 . . . . 62.41 111.055 179.892 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -114.41 156.23 24.88 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.196 -0.456 . . . . 64.4 110.88 -179.929 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -71.7 -175.35 1.34 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.16 -0.473 . . . . 51.24 110.9 -179.92 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -70.0 -39.45 75.86 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.208 -0.451 . . . . 74.31 110.915 -179.982 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 14.4 m -55.82 -22.29 24.02 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.177 -0.465 . . . . 75.32 110.892 -179.824 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 66.35 11.77 56.88 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.724 -0.75 . . . . 32.24 112.525 -179.974 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 3.5 m -107.76 -14.98 14.67 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.935 0.398 . . . . 74.33 110.843 -179.714 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -121.43 134.85 55.09 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.112 -0.494 . . . . 74.3 110.868 179.937 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 5.2 m -138.67 137.93 37.31 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.216 -0.447 . . . . 60.02 111.127 179.967 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -158.11 -154.49 7.16 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.75 -0.738 . . . . 43.45 112.502 179.942 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.491 HD11 ' HB3' ' B' ' -7' ' ' PHE . 6.2 mt -104.62 130.95 52.55 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.845 0.355 . . . . 64.12 110.902 -179.881 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 11.7 m -129.0 153.1 80.23 Favored Pre-proline 0 C--N 1.33 -0.264 0 CA-C-O 121.619 0.723 . . . . 45.2 111.141 179.801 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 0.437 ' HG2' ' HB2' ' A' ' 54' ' ' PHE . 53.8 Cg_endo -69.76 144.72 54.94 Favored 'Trans proline' 0 C--N 1.341 0.166 0 C-N-CA 122.661 2.241 . . . . 62.13 112.319 179.966 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . 0.714 ' CG ' HD11 ' A' ' 37' ' ' LEU . 13.5 tm-20 -90.44 -28.71 18.43 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.218 -0.446 . . . . 71.31 110.922 179.985 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -85.67 10.05 14.5 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.158 -0.474 . . . . 73.44 110.904 -179.954 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . 0.437 ' HB2' ' HG2' ' A' ' 51' ' ' PRO . 1.0 OUTLIER -121.02 -5.8 9.53 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.108 -0.496 . . . . 65.05 110.88 -179.969 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.556 ' CG1' HD21 ' A' ' 20' ' ' LEU . 15.4 m -122.75 167.52 16.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.16 -0.473 . . . . 70.15 111.108 179.998 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . 0.703 ' CB ' HD21 ' A' ' 7' ' ' LEU . 47.9 t -138.27 117.35 12.56 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.158 -0.474 . . . . 70.43 110.85 -179.854 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 2.7 m-85 -53.44 134.12 40.47 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.133 -0.485 . . . . 73.44 110.936 -179.889 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.66 HD11 ' HB ' ' A' ' 5' ' ' VAL . 41.4 mt -104.48 146.54 11.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.098 -0.501 . . . . 44.32 111.123 179.905 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 1.3 mt-30 -131.2 160.67 65.96 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-O 121.626 0.727 . . . . 71.43 110.889 179.922 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.78 -48.87 0.63 Allowed 'Trans proline' 0 C--N 1.342 0.208 0 C-N-CA 122.658 2.239 . . . . 72.01 112.348 -179.992 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 20.6 mm-40 -151.27 23.56 0.73 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.219 -0.446 . . . . 74.34 110.888 -179.979 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 6.5 mt -113.93 166.97 11.05 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.151 -0.477 . . . . 73.31 110.923 -179.979 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 16.9 pt-20 . . . . . 0 C--N 1.329 -0.295 0 CA-C-N 116.202 -0.454 . . . . 61.0 110.884 179.928 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' B' B ' -9' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.304 0 N-CA-C 112.504 -0.238 . . . . 70.11 112.504 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' B' B ' -8' ' ' LYS . . . . . . . . . . . . . 23.0 mttt -113.73 79.45 1.25 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.811 0.338 . . . . 53.32 110.865 -179.934 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' -7' ' ' PHE . . . . . 0.491 ' HB3' HD11 ' A' ' 49' ' ' LEU . 9.0 m-85 -82.34 139.82 33.89 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.211 -0.449 . . . . 74.54 110.864 179.986 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' -6' ' ' ILE . . . . . 0.423 HD13 ' O ' ' B' ' -7' ' ' PHE . 37.3 mm -145.62 87.69 6.82 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 121.646 0.736 . . . . 71.53 111.135 179.933 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' -5' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.76 130.99 20.31 Favored 'Trans proline' 0 C--N 1.342 0.192 0 C-N-CA 122.649 2.233 . . . . 62.21 112.347 179.845 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' -4' ' ' SER . . . . . . . . . . . . . 30.9 t -124.27 62.21 1.11 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.164 -0.471 . . . . 75.25 110.879 -179.86 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' -3' ' ' ARG . . . . . . . . . . . . . 9.2 ptm180 -174.63 153.74 1.81 Allowed Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.643 0.735 . . . . 71.04 110.862 -179.93 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' -2' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.74 136.33 32.77 Favored 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.672 2.248 . . . . 73.31 112.343 179.996 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' -1' ' ' ALA . . . . . . . . . . . . . . . -71.84 152.76 93.2 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-O 121.605 0.717 . . . . 34.54 111.083 179.904 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 0' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.81 178.02 5.02 Favored 'Trans proline' 0 C--N 1.342 0.2 0 C-N-CA 122.602 2.201 . . . . 74.4 112.369 -179.965 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 1' ' ' LYS . . . . . . . . . . . . . 9.3 pttm -125.2 154.34 71.8 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-O 121.583 0.706 . . . . 74.01 110.898 179.945 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 2' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.7 164.0 36.13 Favored 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.711 2.274 . . . . 74.24 112.313 179.909 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 3' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.74 174.99 8.68 Favored 'Trans proline' 0 C--N 1.342 0.213 0 C-N-CA 122.694 2.262 . . . . 71.44 112.334 179.924 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 4' ' ' SER . . . . . . . . . . . . . 16.5 m -117.84 140.83 49.15 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.219 -0.446 . . . . 62.24 110.871 -179.872 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 5' ' ' SER . . . . . . . . . . . . . 10.0 t -100.68 146.93 26.58 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.142 -0.481 . . . . 55.03 110.856 -179.82 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 6' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.313 0 CA-C-N 116.104 -0.498 . . . . 73.55 111.106 179.95 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' -4' ' ' MET . . . . . . . . . . . . . 42.1 mmm . . . . . 0 C--O 1.231 0.113 0 CA-C-O 120.795 0.331 . . . . 73.13 110.882 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' -3' ' ' ALA . . . . . . . . . . . . . . . -107.14 63.73 0.63 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.266 -0.425 . . . . 73.03 111.073 179.942 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' -2' ' ' ILE . . . . . . . . . . . . . 5.3 mp -125.79 118.04 50.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.217 -0.447 . . . . 60.01 111.145 179.939 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' -1' ' ' VAL . . . . . . . . . . . . . 12.1 p -69.54 -29.65 42.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.202 -0.453 . . . . 73.42 111.151 179.83 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 1.9 t-20 63.25 50.43 2.99 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.156 -0.474 . . . . 63.42 110.929 179.998 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 57.8 tp60 -105.64 127.24 52.94 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.172 -0.467 . . . . 71.23 110.899 -179.966 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -79.08 160.67 26.98 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.189 -0.459 . . . . 73.13 110.834 -179.905 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -156.33 153.61 29.29 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.147 -0.478 . . . . 64.33 111.097 179.925 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.553 ' HB ' HD11 ' A' ' 58' ' ' ILE . 10.8 p -104.33 151.16 6.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.23 -0.441 . . . . 63.02 111.099 179.995 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -89.82 106.83 18.73 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.161 -0.472 . . . . 71.23 111.104 179.895 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.723 HD21 ' CB ' ' A' ' 56' ' ' SER . 16.6 mt -71.4 -39.5 71.11 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.267 -0.424 . . . . 73.13 110.883 -179.951 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 5.6 m-85 -138.84 149.98 45.52 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.224 -0.444 . . . . 70.34 110.875 179.996 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 1.7 p30 -73.74 136.05 43.64 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.066 -0.515 . . . . 65.1 110.88 179.907 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 9.0 t80 -139.83 144.66 37.4 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.192 -0.458 . . . . 75.34 110.881 -179.884 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -113.16 144.75 31.76 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.645 0.736 . . . . 73.45 110.886 -179.907 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.78 141.6 45.61 Favored 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.722 2.281 . . . . 63.13 112.339 -179.981 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 6.3 mm-40 -102.02 -24.05 14.03 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.235 -0.438 . . . . 53.41 110.869 -179.967 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 40.7 m-80 -112.31 175.58 5.37 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.163 -0.471 . . . . 73.04 110.921 -179.963 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -83.07 2.06 37.03 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.204 -0.453 . . . . 34.5 110.869 179.875 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 1.1 p-10 -124.01 23.05 8.65 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.213 -0.448 . . . . 52.35 110.854 -179.903 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 5.4 mt-10 -108.86 156.72 19.34 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.198 -0.455 . . . . 70.4 110.894 179.998 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.485 HD12 ' H ' ' A' ' 19' ' ' ARG . 54.4 tp -108.05 151.61 25.62 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.162 -0.472 . . . . 42.05 110.876 -179.956 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . 0.485 ' H ' HD12 ' A' ' 18' ' ' LEU . 9.7 mtt-85 -88.79 154.11 20.53 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.153 -0.476 . . . . 75.13 110.851 179.988 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.567 HD21 ' CG1' ' A' ' 55' ' ' VAL . 2.6 tp -140.51 149.04 41.97 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.177 -0.465 . . . . 73.41 110.945 -179.974 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.659 ' HB3' ' CG ' ' A' ' 24' ' ' ASP . . . -141.22 137.52 32.65 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.185 -0.461 . . . . 72.13 111.112 179.798 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -50.76 121.03 5.32 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.224 -0.444 . . . . 75.31 110.902 -179.897 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 96.65 -4.86 64.05 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.717 -0.754 . . . . 73.55 112.512 -179.947 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . 0.659 ' CG ' ' HB3' ' A' ' 21' ' ' ALA . 1.1 m-20 -82.78 146.74 28.8 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.816 0.341 . . . . 75.52 110.85 -179.972 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 3.2 mm -101.67 141.06 18.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.176 -0.465 . . . . 65.15 111.163 179.989 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 1.3 m -143.23 158.68 17.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.177 -0.465 . . . . 65.15 111.104 179.85 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 37.8 m-85 -115.83 106.71 14.14 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.134 -0.485 . . . . 73.31 110.838 -179.931 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.657 HD13 ' HB2' ' A' ' 39' ' ' ALA . 13.0 mm -72.13 103.3 1.47 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.157 -0.474 . . . . 72.11 111.126 179.959 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 3.4 m -64.55 -39.59 94.04 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.18 -0.464 . . . . 73.02 110.84 -179.891 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' TYR . . . . . 0.478 ' CZ ' HG21 ' A' ' 38' ' ' VAL . 32.8 p90 -174.16 148.06 1.29 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.145 -0.48 . . . . 70.01 110.907 -179.883 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . 0.565 ' HG3' HD22 ' A' ' 37' ' ' LEU . 19.1 tttt -82.57 145.85 29.5 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.089 -0.505 . . . . 62.23 110.919 179.894 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 34.5 t60 -135.49 153.54 51.7 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.236 -0.438 . . . . 72.11 110.842 179.923 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -58.6 -174.44 0.52 Allowed Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.751 -0.738 . . . . 31.34 112.518 -179.973 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 2.5 mt-30 65.78 12.22 8.16 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.803 0.335 . . . . 71.1 110.908 -179.873 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 68.24 28.85 73.14 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.76 -0.733 . . . . 61.31 112.494 -179.955 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' TRP . . . . . 0.628 ' C ' HD23 ' A' ' 37' ' ' LEU . 99.1 m95 -123.56 136.0 54.3 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.773 0.32 . . . . 71.44 110.939 -179.919 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.681 HD11 ' CG ' ' A' ' 52' ' ' GLU . 0.4 OUTLIER -124.11 132.06 53.61 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.261 -0.427 . . . . 65.42 110.938 179.969 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.489 HG22 HD23 ' A' ' 49' ' ' LEU . 47.1 t -78.2 116.97 22.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.194 -0.457 . . . . 62.12 111.169 179.807 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.657 ' HB2' HD13 ' A' ' 28' ' ' ILE . . . -136.66 166.31 23.84 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.178 -0.464 . . . . 73.41 111.085 179.866 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -127.53 153.93 45.76 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.212 -0.449 . . . . 62.35 110.879 -179.911 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -66.32 -174.77 0.3 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.172 -0.467 . . . . 63.44 110.895 -179.962 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -69.62 -37.93 77.03 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.157 -0.474 . . . . 74.4 110.879 -179.97 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 9.5 m -57.0 -22.52 39.23 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.141 -0.481 . . . . 72.4 110.895 -179.827 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 67.54 10.9 58.82 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.713 -0.756 . . . . 75.51 112.5 -179.973 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 1.9 t -106.48 -21.77 12.98 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.966 0.412 . . . . 62.33 110.868 -179.722 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 1.7 ttmt -114.07 124.02 51.08 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.131 -0.486 . . . . 74.33 110.88 179.936 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 15.6 m -133.79 144.52 49.07 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.193 -0.458 . . . . 75.51 111.117 -179.991 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -164.48 -152.96 7.22 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.72 -0.752 . . . . 63.32 112.458 179.971 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.489 HD23 HG22 ' A' ' 38' ' ' VAL . 12.6 mt -103.89 134.08 47.78 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.852 0.358 . . . . 74.31 110.876 -179.912 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.423 ' HB ' ' HD2' ' A' ' 51' ' ' PRO . 21.9 m -134.15 154.05 79.89 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-O 121.668 0.746 . . . . 74.14 111.069 179.857 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 0.423 ' HD2' ' HB ' ' A' ' 50' ' ' VAL . 53.4 Cg_endo -69.77 146.43 60.09 Favored 'Trans proline' 0 C--N 1.342 0.209 0 C-N-CA 122.656 2.237 . . . . 72.33 112.3 179.974 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . 0.681 ' CG ' HD11 ' A' ' 37' ' ' LEU . 28.0 tt0 -91.87 -29.31 16.78 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.187 -0.461 . . . . 73.32 110.903 179.982 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -85.23 9.8 14.16 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.187 -0.46 . . . . 71.14 110.934 -179.964 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . 0.418 ' HB2' ' HG2' ' A' ' 51' ' ' PRO . 1.0 OUTLIER -120.19 -7.97 9.76 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.13 -0.486 . . . . 73.25 110.858 -179.932 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.567 ' CG1' HD21 ' A' ' 20' ' ' LEU . 15.8 m -121.21 161.32 21.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.151 -0.477 . . . . 62.51 111.119 179.981 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . 0.723 ' CB ' HD21 ' A' ' 7' ' ' LEU . 25.4 t -131.68 114.74 15.15 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.149 -0.478 . . . . 74.04 110.833 -179.855 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 3.0 m-85 -54.72 127.02 26.36 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.182 -0.463 . . . . 63.02 110.916 -179.877 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.553 HD11 ' HB ' ' A' ' 5' ' ' VAL . 40.6 mt -94.85 143.16 12.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.121 -0.49 . . . . 72.52 111.117 179.953 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -131.3 161.01 64.48 Favored Pre-proline 0 C--N 1.329 -0.326 0 CA-C-O 121.62 0.724 . . . . 42.0 110.914 179.976 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.77 -48.6 0.68 Allowed 'Trans proline' 0 C--N 1.341 0.181 0 C-N-CA 122.682 2.255 . . . . 70.11 112.355 179.956 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -158.65 26.9 0.23 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.255 -0.43 . . . . 72.25 110.905 -179.976 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 16.9 mt -112.35 139.25 48.06 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.187 -0.461 . . . . 73.5 110.916 -179.956 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.304 0 CA-C-N 116.183 -0.462 . . . . 54.44 110.871 179.941 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' -9' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.346 0 N-CA-C 112.512 -0.235 . . . . 35.5 112.512 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' B' B ' -8' ' ' LYS . . . . . . . . . . . . . 5.0 mtpm? -73.12 -49.85 26.09 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.848 0.356 . . . . 61.15 110.904 -179.994 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' -7' ' ' PHE . . . . . . . . . . . . . 6.7 m-85 -67.44 143.08 56.43 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.175 -0.466 . . . . 74.11 110.909 179.977 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' -6' ' ' ILE . . . . . . . . . . . . . 1.9 pt -152.98 88.28 3.87 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.68 0.752 . . . . 74.22 111.122 179.977 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' -5' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.74 135.64 31.01 Favored 'Trans proline' 0 C--N 1.342 0.227 0 C-N-CA 122.702 2.268 . . . . 63.02 112.368 179.859 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' -4' ' ' SER . . . . . . . . . . . . . 2.9 m -133.88 60.37 1.71 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.228 -0.442 . . . . 65.43 110.825 -179.814 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' -3' ' ' ARG . . . . . . . . . . . . . 9.9 ptt85 -174.62 153.41 1.77 Allowed Pre-proline 0 C--N 1.329 -0.288 0 CA-C-O 121.651 0.739 . . . . 72.25 110.836 -179.951 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' -2' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.75 128.05 15.48 Favored 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.645 2.23 . . . . 61.22 112.383 -179.991 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' -1' ' ' ALA . . . . . . . . . . . . . . . -62.61 155.18 70.46 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-O 121.564 0.697 . . . . 72.3 111.086 179.92 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 0' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.73 -169.24 0.31 Allowed 'Trans proline' 0 C--N 1.341 0.17 0 C-N-CA 122.66 2.24 . . . . 70.11 112.369 179.995 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 1' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -138.88 154.12 72.5 Favored Pre-proline 0 C--N 1.328 -0.347 0 CA-C-O 121.568 0.699 . . . . 74.34 110.89 179.909 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 2' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.76 163.29 38.83 Favored 'Trans proline' 0 C--N 1.342 0.185 0 C-N-CA 122.67 2.247 . . . . 74.42 112.354 179.914 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 3' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.76 -35.48 12.57 Favored 'Trans proline' 0 C--N 1.341 0.148 0 C-N-CA 122.707 2.271 . . . . 54.23 112.316 179.988 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 4' ' ' SER . . . . . . . . . . . . . 2.1 m 63.0 43.6 6.52 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.229 -0.442 . . . . 70.05 110.843 -179.872 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 5' ' ' SER . . . . . . . . . . . . . 2.2 p -93.16 -43.52 8.81 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.126 -0.488 . . . . 60.43 110.868 -179.836 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 6' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.306 0 CA-C-N 116.182 -0.463 . . . . 55.2 111.098 179.862 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' -4' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--O 1.23 0.053 0 CA-C-O 120.788 0.328 . . . . 51.13 110.864 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' -3' ' ' ALA . . . . . . . . . . . . . . . -70.21 -31.84 69.47 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.203 -0.453 . . . . 44.44 111.111 179.903 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' -2' ' ' ILE . . . . . . . . . . . . . 58.5 mt -87.88 131.14 36.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.212 -0.449 . . . . 62.43 111.146 179.97 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' -1' ' ' VAL . . . . . . . . . . . . . 12.0 p -112.88 130.91 65.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.221 -0.445 . . . . 74.1 111.105 179.872 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 1.8 m120 -93.59 59.45 2.89 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.147 -0.478 . . . . 65.42 110.872 179.999 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 31.0 tp60 -101.62 134.3 44.97 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.17 -0.468 . . . . 74.4 110.921 179.993 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 4.4 ptp180 -89.87 163.1 15.14 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.18 -0.463 . . . . 74.51 110.863 -179.891 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -155.07 153.17 30.49 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.192 -0.458 . . . . 41.2 111.089 179.893 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.694 ' HB ' HD11 ' A' ' 58' ' ' ILE . 10.7 p -103.85 150.02 7.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.221 -0.445 . . . . 75.01 111.179 179.932 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -88.33 105.57 17.66 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.207 -0.452 . . . . 74.11 111.112 179.885 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.734 HD21 ' HB2' ' A' ' 56' ' ' SER . 15.2 mt -69.68 -37.27 76.6 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.218 -0.446 . . . . 64.24 110.911 -179.95 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 2.9 m-85 -143.92 157.46 44.34 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.147 -0.479 . . . . 72.52 110.92 -179.988 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 3.7 p30 -78.84 134.84 36.92 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.128 -0.487 . . . . 74.41 110.9 179.896 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 2.5 t80 -134.42 146.03 49.45 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.201 -0.454 . . . . 74.53 110.894 -179.902 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 6.6 tt0 -116.5 136.14 23.06 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-O 121.626 0.727 . . . . 63.33 110.907 -179.881 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.409 ' HD3' ' HA ' ' A' ' 19' ' ' ARG . 53.3 Cg_endo -69.81 151.52 68.82 Favored 'Trans proline' 0 C--N 1.341 0.175 0 C-N-CA 122.677 2.251 . . . . 75.32 112.319 -179.939 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 1.9 mm-40 -112.9 -17.28 12.53 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.211 -0.45 . . . . 74.41 110.885 -179.989 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . 0.415 HD21 ' NE ' ' B' ' -3' ' ' ARG . 34.3 m-80 -115.21 176.15 5.19 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.148 -0.478 . . . . 74.0 110.892 -179.958 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 70.3 m-20 -91.86 21.07 5.12 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.222 -0.444 . . . . 62.42 110.898 179.91 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 1.1 p-10 -137.23 12.76 3.05 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.171 -0.468 . . . . 61.21 110.894 -179.984 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 48.7 mt-10 -106.82 160.12 15.73 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.178 -0.464 . . . . 74.31 110.841 -179.969 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.599 HD12 ' H ' ' A' ' 19' ' ' ARG . 20.7 tp -110.88 147.21 35.08 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.095 -0.502 . . . . 72.14 110.917 179.989 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . 0.599 ' H ' HD12 ' A' ' 18' ' ' LEU . 1.4 mtt180 -83.28 155.85 23.4 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.166 -0.47 . . . . 73.14 110.849 179.96 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.553 HD21 ' CG1' ' A' ' 55' ' ' VAL . 3.0 tp -139.37 149.71 44.46 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.213 -0.449 . . . . 64.33 110.917 179.984 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.657 ' HB3' ' CG ' ' A' ' 24' ' ' ASP . . . -139.96 136.44 33.8 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.155 -0.475 . . . . 74.04 111.082 179.772 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -50.77 120.96 5.24 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.193 -0.458 . . . . 61.5 110.848 -179.913 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 96.86 -3.9 62.9 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.744 -0.741 . . . . 44.23 112.456 179.992 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . 0.657 ' CG ' ' HB3' ' A' ' 21' ' ' ALA . 1.0 OUTLIER -84.25 146.34 27.84 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.829 0.347 . . . . 74.22 110.823 -179.932 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 3.3 mm -100.52 142.34 15.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.177 -0.465 . . . . 74.3 111.177 179.957 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 1.7 m -145.14 157.38 13.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.206 -0.452 . . . . 53.34 111.111 179.886 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 61.1 m-85 -115.98 110.69 19.3 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.18 -0.464 . . . . 72.11 110.871 -179.988 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.698 HD13 ' HB2' ' A' ' 39' ' ' ALA . 15.5 mm -72.43 102.27 1.35 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.091 -0.504 . . . . 45.01 111.121 179.964 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 5.0 m -65.07 -40.17 94.31 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.234 -0.439 . . . . 71.15 110.831 -179.924 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' TYR . . . . . 0.541 ' CZ ' HG21 ' A' ' 38' ' ' VAL . 35.9 p90 -174.58 149.24 1.25 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.186 -0.461 . . . . 74.31 110.947 -179.913 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 32.5 tttt -80.87 143.18 32.92 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.124 -0.489 . . . . 73.11 110.863 179.945 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 23.2 t60 -129.44 157.42 42.02 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.238 -0.437 . . . . 73.34 110.891 179.87 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -64.18 -174.66 3.64 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.744 -0.741 . . . . 65.1 112.467 -179.959 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 17.9 mm100 65.47 12.69 8.35 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.836 0.351 . . . . 74.11 110.922 -179.893 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 69.72 29.49 71.16 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.745 -0.74 . . . . 50.13 112.505 -179.949 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' TRP . . . . . 0.654 ' C ' HD23 ' A' ' 37' ' ' LEU . 97.0 m95 -122.91 138.35 54.69 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.821 0.343 . . . . 75.14 110.938 -179.935 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.707 HD11 ' CG ' ' A' ' 52' ' ' GLU . 1.3 mt -121.13 133.24 55.2 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.223 -0.444 . . . . 64.21 110.935 179.966 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.541 HG21 ' CZ ' ' A' ' 30' ' ' TYR . 95.9 t -80.06 109.37 14.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.21 -0.45 . . . . 72.34 111.124 179.814 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.698 ' HB2' HD13 ' A' ' 28' ' ' ILE . . . -129.19 158.46 38.95 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.175 -0.466 . . . . 50.44 111.126 179.822 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 1.4 pt-20 -117.05 157.31 26.05 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.234 -0.439 . . . . 55.22 110.843 -179.954 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -71.54 -175.04 1.21 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.126 -0.488 . . . . 75.33 110.891 -179.926 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 2.6 tt0 -69.45 -38.3 77.72 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.199 -0.455 . . . . 52.21 110.919 179.981 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 1.6 t -56.36 -22.58 32.0 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.165 -0.471 . . . . 73.12 110.827 -179.799 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 68.58 10.39 60.45 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.689 -0.767 . . . . 70.24 112.516 -179.933 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 3.1 t -107.14 -22.15 12.73 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.886 0.374 . . . . 74.14 110.83 -179.73 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.427 ' HE3' HD11 ' A' ' 18' ' ' LEU . 3.7 ttpt -110.31 123.9 50.67 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.158 -0.474 . . . . 74.0 110.933 179.932 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 9.3 m -131.89 130.38 41.55 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.24 -0.437 . . . . 52.4 111.136 179.998 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -153.57 -157.05 7.9 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.777 -0.725 . . . . 64.32 112.504 179.979 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 11.9 mt -100.32 133.33 44.88 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.821 0.343 . . . . 44.32 110.909 -179.925 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.458 ' CG1' HD23 ' A' ' 18' ' ' LEU . 6.0 m -131.97 153.62 81.45 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 121.685 0.755 . . . . 63.22 111.086 179.838 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 0.417 ' HD2' ' HB ' ' A' ' 50' ' ' VAL . 54.0 Cg_endo -69.75 144.2 53.3 Favored 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.697 2.265 . . . . 63.24 112.353 179.918 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . 0.707 ' CG ' HD11 ' A' ' 37' ' ' LEU . 6.9 tm-20 -90.63 -27.8 18.83 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.226 -0.443 . . . . 74.11 110.885 -179.982 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -86.76 11.12 13.87 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.165 -0.471 . . . . 70.1 110.93 -179.974 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . 0.408 ' HB2' ' HG2' ' A' ' 51' ' ' PRO . 1.1 m-85 -121.74 -7.48 9.05 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.139 -0.482 . . . . 74.24 110.854 -179.91 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.553 ' CG1' HD21 ' A' ' 20' ' ' LEU . 16.1 m -121.88 168.08 14.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.161 -0.472 . . . . 72.34 111.13 -179.983 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . 0.734 ' HB2' HD21 ' A' ' 7' ' ' LEU . 43.9 t -136.93 117.06 13.4 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.212 -0.449 . . . . 61.3 110.896 -179.851 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 2.9 m-85 -56.25 124.3 17.49 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.15 -0.477 . . . . 72.22 110.903 -179.849 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.694 HD11 ' HB ' ' A' ' 5' ' ' VAL . 35.3 mt -94.52 141.87 14.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.11 -0.496 . . . . 73.21 111.136 179.931 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -131.09 160.96 64.51 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.583 0.706 . . . . 74.03 110.922 179.923 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.77 -48.43 0.72 Allowed 'Trans proline' 0 C--N 1.341 0.161 0 C-N-CA 122.661 2.241 . . . . 64.02 112.381 179.968 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 29.1 mt-10 -150.78 22.23 0.79 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.172 -0.467 . . . . 61.53 110.867 -179.991 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 5.3 mt -112.56 168.99 9.21 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.162 -0.472 . . . . 51.45 110.845 -179.949 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 3.7 pt-20 . . . . . 0 C--N 1.33 -0.261 0 CA-C-N 116.141 -0.481 . . . . 61.52 110.882 179.927 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' B' B ' -9' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.32 0 N-CA-C 112.52 -0.232 . . . . 63.34 112.52 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' B' B ' -8' ' ' LYS . . . . . . . . . . . . . 52.0 mttt -88.34 -28.8 20.77 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.836 0.35 . . . . 64.42 110.918 -179.963 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' -7' ' ' PHE . . . . . 0.573 ' O ' HD13 ' B' ' -6' ' ' ILE . 7.4 m-85 -67.83 127.18 31.85 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.214 -0.448 . . . . 75.42 110.871 179.954 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' -6' ' ' ILE . . . . . 0.573 HD13 ' O ' ' B' ' -7' ' ' PHE . 30.0 mm -138.22 94.83 10.78 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 121.681 0.753 . . . . 62.32 111.155 179.939 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' -5' ' ' PRO . . . . . 0.43 ' HD2' ' HA ' ' B' ' -6' ' ' ILE . 53.8 Cg_endo -69.76 140.37 42.51 Favored 'Trans proline' 0 C--N 1.342 0.194 0 C-N-CA 122.673 2.249 . . . . 73.55 112.357 179.884 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' -4' ' ' SER . . . . . . . . . . . . . 3.0 m -131.3 60.66 1.66 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.172 -0.467 . . . . 63.12 110.818 -179.811 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' -3' ' ' ARG . . . . . 0.415 ' NE ' HD21 ' A' ' 14' ' ' ASN . 14.2 ptp180 -178.87 154.96 0.83 Allowed Pre-proline 0 C--N 1.328 -0.332 0 CA-C-O 121.628 0.728 . . . . 75.53 110.875 -179.917 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' -2' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.79 140.54 42.83 Favored 'Trans proline' 0 C--N 1.342 0.189 0 C-N-CA 122.665 2.243 . . . . 52.43 112.352 -179.996 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' -1' ' ' ALA . . . . . 0.438 ' HB1' ' HD2' ' B' ' 0' ' ' PRO . . . -71.93 156.3 91.08 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-O 121.603 0.716 . . . . 73.32 111.094 179.903 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 0' ' ' PRO . . . . . 0.438 ' HD2' ' HB1' ' B' ' -1' ' ' ALA . 54.0 Cg_endo -69.79 -177.94 2.12 Favored 'Trans proline' 0 C--O 1.231 0.168 0 C-N-CA 122.696 2.264 . . . . 71.35 112.352 -179.996 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 1' ' ' LYS . . . . . . . . . . . . . 3.5 ttpt -129.31 145.49 57.02 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-O 121.576 0.703 . . . . 72.11 110.915 179.939 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 2' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.73 163.53 37.9 Favored 'Trans proline' 0 C--N 1.342 0.185 0 C-N-CA 122.718 2.279 . . . . 73.4 112.322 179.904 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 3' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.72 -178.48 2.35 Favored 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.712 2.275 . . . . 63.11 112.376 179.901 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 4' ' ' SER . . . . . . . . . . . . . 1.5 t -86.66 141.98 28.55 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.225 -0.443 . . . . 54.41 110.865 -179.84 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 5' ' ' SER . . . . . . . . . . . . . 35.3 t -162.24 142.3 9.9 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.129 -0.487 . . . . 74.3 110.878 -179.835 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 6' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.328 -0.326 0 CA-C-N 116.147 -0.479 . . . . 65.02 111.109 179.929 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' -4' ' ' MET . . . . . . . . . . . . . 6.4 mmm . . . . . 0 C--O 1.231 0.082 0 CA-C-O 120.8 0.333 . . . . 72.5 110.873 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' -3' ' ' ALA . . . . . . . . . . . . . . . 56.81 45.61 21.33 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.249 -0.432 . . . . 54.34 111.121 179.905 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' -2' ' ' ILE . . . . . . . . . . . . . 91.9 mt -115.87 128.09 73.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.235 -0.439 . . . . 74.43 111.158 179.974 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' -1' ' ' VAL . . . . . . . . . . . . . 70.9 t -114.78 131.14 67.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.144 -0.48 . . . . 71.1 111.114 179.847 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 1.6 m120 -94.06 60.78 2.86 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.137 -0.483 . . . . 71.21 110.848 -179.993 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 50.3 tp60 -101.51 133.47 46.11 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.205 -0.452 . . . . 73.14 110.885 179.989 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 8.9 ptp180 -87.14 163.69 16.81 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.228 -0.442 . . . . 74.52 110.85 -179.934 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -155.18 154.08 31.72 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.192 -0.458 . . . . 73.53 111.07 179.948 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.622 ' HB ' HD11 ' A' ' 58' ' ' ILE . 11.6 p -104.03 149.26 7.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.187 -0.46 . . . . 65.22 111.088 -179.998 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -88.24 105.03 17.27 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.124 -0.489 . . . . 50.13 111.143 179.863 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.686 HD21 ' HB2' ' A' ' 56' ' ' SER . 17.6 mt -69.17 -39.21 78.87 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.199 -0.455 . . . . 75.22 110.919 -179.952 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 3.3 m-85 -141.3 156.4 45.86 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.208 -0.451 . . . . 55.14 110.937 179.998 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 1.7 p-10 -79.06 135.05 36.75 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.11 -0.495 . . . . 75.43 110.853 179.914 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 2.1 t80 -134.09 146.06 49.95 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.191 -0.459 . . . . 75.3 110.926 -179.926 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 29.7 tt0 -115.72 135.47 22.68 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.603 0.716 . . . . 74.22 110.922 -179.945 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.404 ' HD3' ' HA ' ' A' ' 19' ' ' ARG . 53.3 Cg_endo -69.76 147.64 63.32 Favored 'Trans proline' 0 C--N 1.341 0.154 0 C-N-CA 122.701 2.267 . . . . 73.02 112.347 -179.969 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 13.6 mt-10 -107.72 -18.82 13.73 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.247 -0.433 . . . . 71.41 110.894 -179.98 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 31.1 m-80 -112.8 175.46 5.43 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.133 -0.485 . . . . 70.04 110.899 -179.933 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 36.5 m-20 -90.05 13.4 14.98 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.191 -0.459 . . . . 72.24 110.836 179.949 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 1.2 p-10 -131.32 14.96 5.07 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.232 -0.44 . . . . 74.43 110.895 -179.901 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 23.9 mt-10 -104.29 159.49 15.67 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.122 -0.49 . . . . 74.22 110.9 -179.993 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.508 HD12 ' H ' ' A' ' 48' ' ' GLY . 0.4 OUTLIER -109.62 143.21 39.66 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.213 -0.449 . . . . 75.55 110.924 -179.989 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . 0.404 ' HA ' ' HD3' ' A' ' 12' ' ' PRO . 0.0 OUTLIER -81.67 156.37 25.11 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.204 -0.453 . . . . 72.52 110.878 179.951 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.552 HD21 ' CG1' ' A' ' 55' ' ' VAL . 2.7 tp -141.48 148.6 39.72 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.198 -0.455 . . . . 74.43 110.893 -179.976 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.646 ' HB3' ' CG ' ' A' ' 24' ' ' ASP . . . -139.87 136.58 34.09 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.197 -0.456 . . . . 42.14 111.041 179.836 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -50.57 121.83 6.32 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.183 -0.462 . . . . 61.31 110.85 -179.912 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 95.53 -0.77 63.54 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.787 -0.721 . . . . 74.54 112.474 -179.982 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . 0.646 ' CG ' ' HB3' ' A' ' 21' ' ' ALA . 1.4 m-20 -86.27 146.04 26.69 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.753 0.311 . . . . 54.34 110.872 -179.964 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 3.2 mm -101.2 137.93 27.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.183 -0.462 . . . . 71.42 111.137 -179.99 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 1.3 m -141.49 158.96 22.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.2 -0.455 . . . . 52.14 111.13 179.873 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 67.1 m-85 -116.5 108.98 16.68 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.185 -0.462 . . . . 72.54 110.905 179.977 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.614 HD13 ' HB2' ' A' ' 39' ' ' ALA . 11.3 mm -72.17 103.24 1.47 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.115 -0.493 . . . . 74.02 111.139 179.986 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 3.5 m -65.06 -39.96 94.04 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.196 -0.456 . . . . 54.21 110.841 -179.88 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' TYR . . . . . 0.496 ' CZ ' HG21 ' A' ' 38' ' ' VAL . 34.6 p90 -174.0 147.19 1.26 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.143 -0.48 . . . . 63.14 110.95 -179.892 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . 0.502 ' HG3' HD22 ' A' ' 37' ' ' LEU . 21.4 tttt -80.36 146.04 31.74 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.105 -0.498 . . . . 74.12 110.929 179.922 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 36.0 t60 -136.39 152.53 50.72 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.273 -0.421 . . . . 55.21 110.876 179.921 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -58.01 -174.71 0.43 Allowed Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.737 -0.744 . . . . 73.14 112.432 -179.893 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 58.1 mm-40 65.94 12.08 8.16 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.817 0.341 . . . . 74.35 110.899 -179.867 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 68.01 29.07 73.29 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.747 -0.739 . . . . 70.51 112.463 -179.981 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' TRP . . . . . 0.606 ' C ' HD23 ' A' ' 37' ' ' LEU . 98.7 m95 -123.19 135.97 54.54 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.792 0.329 . . . . 73.32 110.908 -179.898 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.685 HD11 ' CG ' ' A' ' 52' ' ' GLU . 0.7 OUTLIER -121.8 130.22 53.24 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.224 -0.444 . . . . 73.43 110.937 179.965 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.544 HG22 HD23 ' A' ' 49' ' ' LEU . 39.9 t -78.46 111.33 15.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.197 -0.456 . . . . 52.1 111.142 179.837 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.614 ' HB2' HD13 ' A' ' 28' ' ' ILE . . . -133.15 167.75 19.78 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.169 -0.469 . . . . 54.34 111.151 179.857 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 1.1 pt-20 -119.12 156.06 30.43 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.283 -0.417 . . . . 73.5 110.901 -179.963 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -71.02 -176.55 1.41 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.125 -0.489 . . . . 72.04 110.904 -179.944 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 4.0 tm-20 -67.51 -38.32 84.11 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.159 -0.473 . . . . 72.41 110.914 179.991 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 1.3 t -57.26 -22.19 39.66 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.166 -0.47 . . . . 74.44 110.831 -179.811 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 65.71 12.89 57.95 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.733 -0.746 . . . . 55.4 112.518 -179.942 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 1.4 t -109.19 -17.31 13.88 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.954 0.407 . . . . 50.15 110.837 -179.733 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -118.89 135.26 54.66 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.121 -0.491 . . . . 72.54 110.87 179.973 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 6.4 m -136.08 144.65 45.27 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.221 -0.445 . . . . 75.25 111.132 179.936 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . 0.508 ' H ' HD12 ' A' ' 18' ' ' LEU . . . -166.55 -159.55 12.45 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.76 -0.733 . . . . 54.33 112.449 -180.0 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.544 HD23 HG22 ' A' ' 38' ' ' VAL . 6.4 mt -98.96 134.92 41.11 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.913 0.387 . . . . 70.25 110.934 -179.97 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.45 HG22 ' O ' ' A' ' 37' ' ' LEU . 31.1 m -133.39 153.63 80.58 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-O 121.661 0.743 . . . . 64.03 111.13 179.826 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 0.429 ' HD2' HD22 ' A' ' 20' ' ' LEU . 53.5 Cg_endo -69.82 142.15 46.89 Favored 'Trans proline' 0 C--N 1.341 0.167 0 C-N-CA 122.665 2.243 . . . . 74.2 112.325 -179.995 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . 0.685 ' CG ' HD11 ' A' ' 37' ' ' LEU . 26.9 tt0 -89.29 -27.7 20.37 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.244 -0.434 . . . . 62.11 110.902 -179.983 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -86.22 9.86 16.36 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.15 -0.477 . . . . 74.54 110.921 -179.972 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . 0.421 ' HB2' ' HG2' ' A' ' 51' ' ' PRO . 1.1 m-85 -119.88 -13.53 9.05 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.128 -0.487 . . . . 74.01 110.875 -179.937 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.552 ' CG1' HD21 ' A' ' 20' ' ' LEU . 19.5 m -115.49 166.37 9.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.142 -0.481 . . . . 74.32 111.088 179.987 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . 0.686 ' HB2' HD21 ' A' ' 7' ' ' LEU . 35.1 t -138.25 117.58 12.79 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.125 -0.489 . . . . 74.44 110.884 -179.835 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 2.6 m-85 -52.72 133.25 36.87 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.164 -0.471 . . . . 70.03 110.929 -179.847 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.622 HD11 ' HB ' ' A' ' 5' ' ' VAL . 51.8 mt -102.11 147.73 8.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.121 -0.49 . . . . 74.4 111.082 179.953 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -131.14 160.97 64.55 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 121.561 0.696 . . . . 73.42 110.953 179.879 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.77 -48.52 0.7 Allowed 'Trans proline' 0 C--N 1.341 0.149 0 C-N-CA 122.711 2.274 . . . . 70.2 112.333 179.988 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 3.5 mp0 -153.57 25.78 0.51 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.237 -0.438 . . . . 73.03 110.879 -179.95 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 8.1 mt -115.23 172.01 7.34 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.17 -0.468 . . . . 71.33 110.917 -179.984 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 23.0 mt-10 . . . . . 0 C--N 1.329 -0.291 0 CA-C-N 116.169 -0.469 . . . . 53.44 110.897 179.959 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' B' B ' -9' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.346 0 N-CA-C 112.48 -0.248 . . . . 72.31 112.48 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' B' B ' -8' ' ' LYS . . . . . . . . . . . . . 38.6 mttt -129.49 23.67 5.48 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.786 0.327 . . . . 64.43 110.847 -179.938 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' -7' ' ' PHE . . . . . 0.421 ' HB3' HD11 ' A' ' 49' ' ' LEU . 7.8 m-85 -62.58 141.25 58.56 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.259 -0.428 . . . . 74.24 110.909 179.967 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' -6' ' ' ILE . . . . . . . . . . . . . 2.1 pt -153.36 85.36 4.18 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-O 121.56 0.695 . . . . 75.44 111.136 179.998 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' -5' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.76 126.78 13.71 Favored 'Trans proline' 0 C--O 1.231 0.163 0 C-N-CA 122.649 2.233 . . . . 61.34 112.368 179.88 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' -4' ' ' SER . . . . . . . . . . . . . 30.4 t -122.04 57.94 1.04 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.255 -0.43 . . . . 53.42 110.886 -179.852 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' -3' ' ' ARG . . . . . . . . . . . . . 6.9 ptm180 -174.42 153.96 1.94 Allowed Pre-proline 0 C--N 1.329 -0.326 0 CA-C-O 121.602 0.715 . . . . 71.43 110.896 -179.928 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' -2' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.71 142.48 48.25 Favored 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.678 2.252 . . . . 64.13 112.372 179.964 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' -1' ' ' ALA . . . . . . . . . . . . . . . -75.16 154.52 86.4 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.627 0.727 . . . . 65.32 111.076 179.917 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 0' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.78 -177.35 1.84 Allowed 'Trans proline' 0 C--N 1.342 0.213 0 C-N-CA 122.679 2.253 . . . . 62.35 112.375 -179.967 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 1' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -127.56 150.76 73.8 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 121.544 0.688 . . . . 72.34 110.905 179.93 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 2' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.8 164.7 33.6 Favored 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.647 2.231 . . . . 65.54 112.393 179.87 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 3' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.71 173.81 10.38 Favored 'Trans proline' 0 C--O 1.231 0.17 0 C-N-CA 122.718 2.279 . . . . 75.14 112.38 179.938 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 4' ' ' SER . . . . . . . . . . . . . 48.1 t -104.84 87.82 2.75 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.227 -0.442 . . . . 70.32 110.838 -179.851 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 5' ' ' SER . . . . . . . . . . . . . 1.7 m -91.27 79.48 5.67 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.127 -0.488 . . . . 62.13 110.935 -179.88 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 6' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.304 0 CA-C-N 116.134 -0.485 . . . . 74.43 111.087 179.964 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' -4' ' ' MET . . . . . . . . . . . . . 4.9 ppp? . . . . . 0 C--O 1.23 0.053 0 CA-C-O 120.791 0.329 . . . . 65.13 110.861 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' -3' ' ' ALA . . . . . . . . . . . . . . . -90.02 106.16 18.29 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.188 -0.46 . . . . 62.03 111.075 179.965 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' -2' ' ' ILE . . . . . . . . . . . . . 57.1 mt -79.07 114.38 19.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.198 -0.456 . . . . 73.52 111.144 179.961 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' -1' ' ' VAL . . . . . . . . . . . . . 7.6 p -73.78 -28.66 24.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.196 -0.456 . . . . 60.44 111.117 179.827 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 1.8 t-20 63.6 54.71 1.84 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.189 -0.459 . . . . 72.33 110.865 -179.975 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 52.4 tp60 -108.7 127.2 53.78 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.17 -0.468 . . . . 74.11 110.876 -179.951 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 5.4 ptp180 -77.56 163.43 26.28 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.209 -0.45 . . . . 64.44 110.873 -179.936 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -158.37 154.73 27.46 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.202 -0.454 . . . . 63.32 111.11 179.981 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.488 ' HB ' HD11 ' A' ' 58' ' ' ILE . 10.8 p -105.66 150.48 8.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.242 -0.435 . . . . 73.34 111.087 179.985 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -89.26 107.86 19.29 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.166 -0.47 . . . . 55.54 111.115 179.859 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.728 HD21 ' CB ' ' A' ' 56' ' ' SER . 18.4 mt -71.72 -39.25 70.26 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.247 -0.433 . . . . 60.12 110.943 -179.983 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 4.5 m-85 -140.33 152.74 46.07 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.143 -0.48 . . . . 73.32 110.943 -179.989 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 1.1 p30 -75.29 137.33 41.1 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.136 -0.483 . . . . 75.24 110.92 179.891 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 15.0 t80 -140.19 145.81 37.94 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.249 -0.432 . . . . 63.41 110.877 -179.889 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -114.55 142.7 28.61 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 121.634 0.731 . . . . 74.11 110.918 -179.94 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.78 134.21 27.39 Favored 'Trans proline' 0 C--N 1.341 0.16 0 C-N-CA 122.676 2.251 . . . . 50.25 112.336 -179.973 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 5.4 mt-10 -96.57 -16.99 20.76 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.239 -0.437 . . . . 72.22 110.872 -179.993 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 48.3 m-80 -115.55 175.77 5.37 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.165 -0.47 . . . . 61.52 110.865 -179.939 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 84.5 m-20 -88.77 13.36 12.65 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.169 -0.469 . . . . 73.04 110.854 179.972 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -135.37 21.09 3.4 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.171 -0.468 . . . . 71.12 110.869 -179.951 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 13.0 mt-10 -106.86 161.7 14.46 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.176 -0.465 . . . . 72.4 110.888 -179.989 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.557 HD21 ' HD3' ' A' ' 46' ' ' LYS . 0.4 OUTLIER -111.29 143.42 42.09 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.202 -0.454 . . . . 74.11 110.899 -179.999 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . 0.438 ' H ' HD23 ' A' ' 18' ' ' LEU . 16.2 mtm180 -79.58 156.68 27.59 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.193 -0.458 . . . . 71.31 110.903 179.941 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.594 HD21 ' CG1' ' A' ' 55' ' ' VAL . 3.2 tp -142.93 148.78 37.47 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.217 -0.447 . . . . 72.03 110.894 -179.942 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.668 ' HB3' ' CG ' ' A' ' 24' ' ' ASP . . . -141.25 137.01 32.24 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.152 -0.476 . . . . 74.13 111.109 179.821 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -51.09 121.24 5.82 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.237 -0.438 . . . . 62.13 110.874 -179.899 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 97.03 -6.45 64.06 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.738 -0.744 . . . . 54.11 112.464 -179.979 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . 0.668 ' CG ' ' HB3' ' A' ' 21' ' ' ALA . 1.1 m-20 -81.04 146.39 30.67 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.76 0.314 . . . . 71.21 110.876 -179.939 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 3.3 mm -100.86 139.79 21.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.211 -0.449 . . . . 74.24 111.139 -179.975 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 1.4 m -143.12 158.17 17.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.192 -0.458 . . . . 74.52 111.104 179.841 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 55.7 m-85 -116.15 108.48 16.22 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.123 -0.49 . . . . 61.21 110.863 -179.959 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.693 HD13 ' HB2' ' A' ' 39' ' ' ALA . 13.4 mm -72.58 103.33 1.62 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.192 -0.458 . . . . 74.42 111.154 179.96 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 3.4 m -64.65 -39.3 93.44 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.12 -0.491 . . . . 64.23 110.897 -179.91 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' TYR . . . . . 0.476 ' CZ ' HG21 ' A' ' 38' ' ' VAL . 32.7 p90 -174.37 146.74 1.1 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.113 -0.494 . . . . 74.4 110.911 -179.863 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . 0.535 ' HG3' HD22 ' A' ' 37' ' ' LEU . 18.7 tttt -82.51 145.73 29.62 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.138 -0.483 . . . . 71.32 110.919 179.886 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 29.8 t60 -134.88 153.08 52.19 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.236 -0.438 . . . . 72.45 110.83 179.952 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -58.52 -174.51 0.51 Allowed Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.738 -0.744 . . . . 54.4 112.532 -179.99 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 71.4 mm-40 65.94 12.15 8.21 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.864 0.364 . . . . 74.25 110.936 -179.909 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 68.16 28.62 73.27 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.735 -0.745 . . . . 62.32 112.533 -179.94 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' TRP . . . . . 0.615 ' C ' HD23 ' A' ' 37' ' ' LEU . 98.9 m95 -123.06 135.38 54.39 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.83 0.347 . . . . 74.14 110.907 -179.911 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.668 HD11 ' CG ' ' A' ' 52' ' ' GLU . 0.4 OUTLIER -123.13 135.85 54.53 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.187 -0.46 . . . . 74.4 110.883 -179.963 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.557 HG22 HD23 ' A' ' 49' ' ' LEU . 39.3 t -84.43 114.9 25.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.177 -0.465 . . . . 73.43 111.145 179.814 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.693 ' HB2' HD13 ' A' ' 28' ' ' ILE . . . -136.4 168.57 19.2 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.189 -0.46 . . . . 61.42 111.15 179.838 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 1.4 pt-20 -125.64 155.01 41.47 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.211 -0.449 . . . . 64.14 110.829 -179.875 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -67.57 -175.19 0.49 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.15 -0.477 . . . . 61.43 110.87 -179.939 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 -68.9 -37.42 78.97 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.187 -0.461 . . . . 65.2 110.881 -179.962 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 1.6 t -57.02 -22.25 37.23 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.171 -0.468 . . . . 73.01 110.866 -179.816 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 66.89 12.42 59.82 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.699 -0.762 . . . . 74.1 112.489 179.986 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -109.65 -21.93 12.19 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.954 0.407 . . . . 63.21 110.871 -179.72 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.557 ' HD3' HD21 ' A' ' 18' ' ' LEU . 0.1 OUTLIER -112.41 123.92 51.36 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.132 -0.485 . . . . 73.2 110.892 179.962 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 9.7 m -129.69 144.61 51.37 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.247 -0.433 . . . . 72.11 111.117 179.986 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . 0.536 ' H ' HD12 ' A' ' 18' ' ' LEU . . . -166.35 -159.22 11.86 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.73 -0.748 . . . . 54.31 112.462 179.98 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.557 HD23 HG22 ' A' ' 38' ' ' VAL . 13.5 mt -99.41 134.52 42.15 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.883 0.373 . . . . 73.25 110.885 -179.893 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.411 ' HB ' ' HD2' ' A' ' 51' ' ' PRO . 10.3 m -134.01 153.43 79.73 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-O 121.606 0.717 . . . . 65.42 111.104 179.908 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 0.419 ' HG2' ' HB2' ' A' ' 54' ' ' PHE . 53.6 Cg_endo -69.8 147.56 62.88 Favored 'Trans proline' 0 N--CA 1.466 -0.134 0 C-N-CA 122.68 2.253 . . . . 75.44 112.357 179.934 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . 0.668 ' CG ' HD11 ' A' ' 37' ' ' LEU . 24.6 tt0 -93.07 -28.34 16.42 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.214 -0.448 . . . . 70.43 110.902 -179.965 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 2.5 mm-40 -87.17 11.17 14.69 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.154 -0.475 . . . . 72.21 110.945 -179.963 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . 0.419 ' HB2' ' HG2' ' A' ' 51' ' ' PRO . 0.9 OUTLIER -121.1 -9.9 9.1 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.104 -0.498 . . . . 71.4 110.858 -179.939 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.594 ' CG1' HD21 ' A' ' 20' ' ' LEU . 16.2 m -119.65 166.54 13.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.186 -0.461 . . . . 75.21 111.077 -179.996 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . 0.728 ' CB ' HD21 ' A' ' 7' ' ' LEU . 38.4 t -136.61 119.83 16.7 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.166 -0.47 . . . . 64.02 110.834 -179.859 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 3.1 m-85 -58.33 129.85 43.96 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.118 -0.492 . . . . 74.42 110.892 -179.895 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.488 HD11 ' HB ' ' A' ' 5' ' ' VAL . 39.8 mt -96.51 150.25 4.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.095 -0.502 . . . . 73.04 111.121 179.886 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 1.4 mt-30 -130.97 160.95 64.41 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 121.59 0.71 . . . . 73.53 110.874 179.965 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.76 -48.89 0.62 Allowed 'Trans proline' 0 C--N 1.341 0.169 0 C-N-CA 122.705 2.27 . . . . 74.32 112.326 179.967 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -152.64 25.26 0.58 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.215 -0.448 . . . . 71.11 110.869 -179.949 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 5.8 mt -115.71 112.2 21.71 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.142 -0.481 . . . . 64.41 110.893 -179.947 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 16.3 pt-20 . . . . . 0 C--N 1.329 -0.297 0 CA-C-N 116.179 -0.464 . . . . 72.42 110.872 179.89 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' B' B ' -9' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.301 0 N-CA-C 112.463 -0.255 . . . . 71.21 112.463 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' B' B ' -8' ' ' LYS . . . . . . . . . . . . . 25.7 ttpt -125.83 67.32 1.18 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.86 0.362 . . . . 73.02 110.951 -180.0 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' -7' ' ' PHE . . . . . 0.446 ' HB3' HD11 ' A' ' 49' ' ' LEU . 8.4 m-85 -86.26 157.61 19.89 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.205 -0.452 . . . . 70.15 110.861 -179.998 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' -6' ' ' ILE . . . . . 0.51 ' O ' HG23 ' B' ' -6' ' ' ILE . 4.1 tp -163.66 88.12 1.21 Allowed Pre-proline 0 C--N 1.328 -0.326 0 CA-C-O 121.662 0.744 . . . . 75.31 111.158 179.922 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' -5' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.78 146.08 58.94 Favored 'Trans proline' 0 C--N 1.341 0.175 0 C-N-CA 122.7 2.267 . . . . 71.2 112.323 179.911 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' -4' ' ' SER . . . . . . . . . . . . . 29.9 t -143.81 67.79 1.28 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.197 -0.456 . . . . 65.33 110.864 -179.845 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' -3' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -179.6 154.75 0.73 Allowed Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.647 0.737 . . . . 74.52 110.855 -179.928 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' -2' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.79 119.76 6.65 Favored 'Trans proline' 0 C--N 1.342 0.188 0 C-N-CA 122.688 2.259 . . . . 74.31 112.37 179.973 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' -1' ' ' ALA . . . . . . . . . . . . . . . -55.54 151.52 20.69 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.572 0.701 . . . . 45.02 111.109 179.886 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 0' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.78 172.3 12.91 Favored 'Trans proline' 0 C--O 1.232 0.197 0 C-N-CA 122.684 2.256 . . . . 55.33 112.365 179.992 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 1' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -120.93 152.87 56.96 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-O 121.553 0.692 . . . . 71.52 110.86 179.943 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 2' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.75 164.45 34.49 Favored 'Trans proline' 0 C--N 1.341 0.151 0 C-N-CA 122.703 2.268 . . . . 71.43 112.357 179.872 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 3' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.79 -171.87 0.52 Allowed 'Trans proline' 0 C--N 1.341 0.177 0 C-N-CA 122.687 2.258 . . . . 62.2 112.313 179.97 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 4' ' ' SER . . . . . . . . . . . . . 85.2 p -137.98 151.15 47.64 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.185 -0.461 . . . . 70.42 110.86 -179.858 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 5' ' ' SER . . . . . . . . . . . . . 1.2 m 63.14 29.37 16.12 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.113 -0.494 . . . . 72.34 110.893 -179.821 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 6' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.33 -0.279 0 CA-C-N 116.103 -0.499 . . . . 42.5 111.068 179.906 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' -4' ' ' MET . . . . . . . . . . . . . 1.8 mmt . . . . . 0 C--O 1.231 0.092 0 CA-C-O 120.839 0.352 . . . . 60.03 110.885 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' -3' ' ' ALA . . . . . . . . . . . . . . . -73.75 -24.4 59.87 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.236 -0.438 . . . . 73.02 111.095 179.962 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' -2' ' ' ILE . . . . . 0.4 HG23 ' O ' ' A' ' 29' ' ' SER . 64.3 mt -92.27 113.11 26.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.214 -0.448 . . . . 73.04 111.127 179.959 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' -1' ' ' VAL . . . . . . . . . . . . . 9.0 p -64.97 -30.42 50.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.161 -0.472 . . . . 71.0 111.125 179.868 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 2.2 t-20 63.37 58.64 1.35 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.186 -0.461 . . . . 72.3 110.916 -179.978 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 56.6 tp60 -114.49 124.01 50.83 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.157 -0.474 . . . . 41.15 110.95 179.972 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 6.8 ptp180 -75.01 162.44 28.57 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.174 -0.466 . . . . 71.14 110.854 -179.905 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -156.59 154.05 29.59 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.189 -0.46 . . . . 52.52 111.119 179.929 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.607 ' HB ' HD11 ' A' ' 58' ' ' ILE . 11.3 p -105.46 148.48 9.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.225 -0.443 . . . . 52.45 111.119 179.973 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -87.4 113.46 23.13 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.165 -0.47 . . . . 34.03 111.088 179.889 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.693 HD21 ' HB2' ' A' ' 56' ' ' SER . 15.0 mt -79.04 -37.37 39.19 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.186 -0.461 . . . . 62.24 110.956 179.997 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 5.1 m-85 -142.09 143.33 33.01 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.169 -0.469 . . . . 74.13 110.934 -179.967 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 3.2 p-10 -67.03 132.9 48.84 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.158 -0.474 . . . . 71.13 110.858 179.934 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 5.6 t80 -130.53 145.92 51.95 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.177 -0.465 . . . . 72.11 110.886 -179.865 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 3.8 tp10 -117.13 135.91 23.22 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.618 0.723 . . . . 74.42 110.913 -179.958 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.67 141.07 44.6 Favored 'Trans proline' 0 C--N 1.341 0.167 0 C-N-CA 122.716 2.277 . . . . 74.52 112.314 -179.971 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -105.9 -9.29 17.21 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.213 -0.449 . . . . 72.31 110.883 179.96 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 57.5 m-80 -121.66 175.75 6.07 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.18 -0.464 . . . . 73.23 110.902 -179.962 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -92.99 23.33 4.31 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.2 -0.454 . . . . 72.3 110.869 179.905 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 1.1 p-10 -140.92 13.68 2.27 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.16 -0.473 . . . . 53.44 110.864 -179.932 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 28.5 mt-10 -105.1 167.79 9.48 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.186 -0.461 . . . . 73.34 110.874 -179.976 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.572 HD12 ' H ' ' A' ' 19' ' ' ARG . 30.2 tp -117.3 147.56 42.47 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.166 -0.47 . . . . 65.23 110.938 -179.996 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . 0.572 ' H ' HD12 ' A' ' 18' ' ' LEU . 1.9 mtt180 -82.68 156.63 23.72 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.21 -0.45 . . . . 73.34 110.824 179.956 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.548 HD21 ' CG1' ' A' ' 55' ' ' VAL . 3.2 tp -143.5 147.86 35.14 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.15 -0.477 . . . . 71.21 110.928 -179.973 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.655 ' HB3' ' CG ' ' A' ' 24' ' ' ASP . . . -139.64 138.7 36.33 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.167 -0.469 . . . . 74.25 111.043 179.83 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 -51.15 121.55 6.33 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.21 -0.45 . . . . 71.22 110.905 -179.945 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 96.73 -7.42 65.39 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.77 -0.728 . . . . 74.44 112.508 -179.907 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . 0.655 ' CG ' ' HB3' ' A' ' 21' ' ' ALA . 1.1 m-20 -79.49 147.73 32.12 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.811 0.338 . . . . 42.5 110.873 -179.982 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 3.2 mm -102.85 140.91 19.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.187 -0.46 . . . . 73.51 111.106 -179.966 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 1.6 m -143.04 158.15 17.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.14 -0.482 . . . . 75.54 111.139 179.803 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 43.7 m-85 -115.62 106.05 13.47 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.183 -0.462 . . . . 64.12 110.884 -179.972 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.886 HD13 ' HB2' ' A' ' 39' ' ' ALA . 22.3 mm -71.02 103.2 1.11 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.152 -0.476 . . . . 50.23 111.095 -179.99 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . 0.4 ' O ' HG23 ' A' ' -2' ' ' ILE . 3.4 m -64.95 -39.28 93.25 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.186 -0.461 . . . . 60.44 110.872 -179.91 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' TYR . . . . . 0.472 ' CZ ' HG21 ' A' ' 38' ' ' VAL . 34.1 p90 -174.32 147.52 1.18 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.111 -0.495 . . . . 71.34 110.907 -179.917 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . 0.549 ' HG3' HD22 ' A' ' 37' ' ' LEU . 19.7 tttt -81.51 146.29 30.26 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.116 -0.493 . . . . 74.25 110.922 179.877 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 33.2 t60 -134.87 156.52 48.79 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.259 -0.428 . . . . 75.13 110.888 179.856 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -61.15 -174.06 1.25 Allowed Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.719 -0.753 . . . . 54.01 112.511 -179.982 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 45.4 mm-40 64.66 13.23 8.18 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.838 0.352 . . . . 74.14 110.92 -179.899 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 67.99 29.2 73.38 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.725 -0.75 . . . . 75.23 112.485 -179.986 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' TRP . . . . . 0.654 ' C ' HD23 ' A' ' 37' ' ' LEU . 98.9 m95 -123.29 138.34 54.64 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.83 0.347 . . . . 73.41 110.891 -179.881 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.71 HD11 ' CG ' ' A' ' 52' ' ' GLU . 0.5 OUTLIER -126.21 132.26 51.8 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.256 -0.429 . . . . 74.54 110.93 179.964 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.472 HG21 ' CZ ' ' A' ' 30' ' ' TYR . 51.8 t -77.38 115.75 19.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.206 -0.452 . . . . 74.22 111.143 179.858 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.886 ' HB2' HD13 ' A' ' 28' ' ' ILE . . . -133.95 158.86 42.41 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.178 -0.465 . . . . 62.02 111.092 179.886 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 1.9 pt-20 -120.5 153.55 36.51 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.2 -0.455 . . . . 63.15 110.911 -179.943 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -67.94 -175.05 0.52 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.195 -0.457 . . . . 74.04 110.892 -179.971 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -69.81 -38.41 76.59 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.153 -0.476 . . . . 73.43 110.924 179.999 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 15.4 m -56.43 -22.73 33.83 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.111 -0.495 . . . . 64.42 110.916 -179.873 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 68.85 9.27 59.13 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.755 -0.736 . . . . 60.52 112.485 -179.992 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 39.0 m -105.06 -20.21 13.59 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.983 0.421 . . . . 62.24 110.899 -179.767 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.521 ' HE2' HD11 ' A' ' 18' ' ' LEU . 0.1 OUTLIER -113.24 123.67 50.73 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.092 -0.504 . . . . 72.22 110.882 179.946 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 11.4 m -134.54 127.1 30.65 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.183 -0.462 . . . . 60.4 111.1 -179.992 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -147.34 -154.36 6.2 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.725 -0.75 . . . . 53.42 112.471 179.944 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 6.9 mt -106.1 127.22 53.04 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.878 0.37 . . . . 65.13 110.897 -179.91 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.45 ' CG1' HD23 ' A' ' 18' ' ' LEU . 14.4 m -124.5 154.26 69.58 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-O 121.588 0.709 . . . . 54.11 111.186 179.818 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 0.435 ' HG2' ' HB2' ' A' ' 54' ' ' PHE . 53.3 Cg_endo -69.77 147.12 62.11 Favored 'Trans proline' 0 N--CA 1.465 -0.151 0 C-N-CA 122.722 2.281 . . . . 71.25 112.316 179.997 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . 0.71 ' CG ' HD11 ' A' ' 37' ' ' LEU . 27.8 tt0 -92.02 -29.86 16.37 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.234 -0.439 . . . . 74.1 110.897 -179.997 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -84.91 9.89 13.18 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.132 -0.485 . . . . 74.4 110.878 -179.916 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . 0.435 ' HB2' ' HG2' ' A' ' 51' ' ' PRO . 1.0 OUTLIER -120.78 -8.46 9.44 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.177 -0.465 . . . . 73.42 110.887 -179.901 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.548 ' CG1' HD21 ' A' ' 20' ' ' LEU . 20.4 m -118.86 171.98 6.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.123 -0.49 . . . . 75.02 111.115 179.996 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . 0.693 ' HB2' HD21 ' A' ' 7' ' ' LEU . 35.6 t -143.59 113.51 7.18 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.175 -0.466 . . . . 74.42 110.806 -179.774 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 2.9 m-85 -52.54 133.28 35.89 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.115 -0.493 . . . . 73.0 110.922 -179.914 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.607 HD11 ' HB ' ' A' ' 5' ' ' VAL . 46.0 mt -102.46 148.63 7.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.099 -0.5 . . . . 75.11 111.137 179.899 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 5.0 mt-30 -131.11 160.71 65.7 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 121.632 0.729 . . . . 75.44 110.834 179.971 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.78 -48.73 0.65 Allowed 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.705 2.27 . . . . 72.21 112.348 179.993 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 6.8 pt-20 -153.54 22.15 0.54 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.156 -0.475 . . . . 64.33 110.909 179.992 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 8.0 mt -112.5 162.79 15.23 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.165 -0.47 . . . . 71.14 110.914 -179.995 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 47.5 mm-40 . . . . . 0 C--N 1.329 -0.31 0 CA-C-N 116.188 -0.46 . . . . 72.45 110.869 179.93 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' B' B ' -9' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.339 0 N-CA-C 112.475 -0.25 . . . . 65.25 112.475 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' B' B ' -8' ' ' LYS . . . . . . . . . . . . . 66.6 mttt -123.06 47.35 1.99 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.795 0.331 . . . . 75.15 110.881 -179.987 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' -7' ' ' PHE . . . . . . . . . . . . . 11.3 m-85 -92.37 119.91 32.38 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.239 -0.437 . . . . 63.11 110.876 179.989 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' -6' ' ' ILE . . . . . 0.414 ' O ' HG23 ' B' ' -6' ' ' ILE . 8.4 tt -133.72 119.16 14.82 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 121.576 0.703 . . . . 75.42 111.171 179.974 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' -5' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.73 154.47 67.83 Favored 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 122.681 2.254 . . . . 72.02 112.318 179.92 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' -4' ' ' SER . . . . . . . . . . . . . 41.3 t -133.78 39.18 3.18 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.19 -0.459 . . . . 62.22 110.853 -179.843 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' -3' ' ' ARG . . . . . . . . . . . . . 5.9 ptm180 -174.48 154.48 1.98 Allowed Pre-proline 0 C--N 1.328 -0.334 0 CA-C-O 121.661 0.744 . . . . 73.23 110.838 -179.894 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' -2' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.79 137.9 36.46 Favored 'Trans proline' 0 C--N 1.342 0.189 0 C-N-CA 122.634 2.223 . . . . 62.01 112.334 179.996 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' -1' ' ' ALA . . . . . . . . . . . . . . . -63.39 154.74 77.84 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.519 0.676 . . . . 52.14 111.086 179.9 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 0' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.76 -170.55 0.4 Allowed 'Trans proline' 0 C--O 1.232 0.176 0 C-N-CA 122.675 2.25 . . . . 64.32 112.325 179.982 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 1' ' ' LYS . . . . . . . . . . . . . 27.8 mtpp -130.11 154.58 81.33 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-O 121.575 0.702 . . . . 73.32 110.87 179.942 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 2' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.74 165.55 30.57 Favored 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.732 2.288 . . . . 72.34 112.33 179.881 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 3' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.76 158.82 55.63 Favored 'Trans proline' 0 C--N 1.342 0.189 0 C-N-CA 122.71 2.273 . . . . 64.42 112.359 179.902 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 4' ' ' SER . . . . . . . . . . . . . 22.9 t -162.0 124.68 2.95 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.19 -0.459 . . . . 73.3 110.832 -179.863 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 5' ' ' SER . . . . . . . . . . . . . 11.5 p -127.49 126.97 43.24 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.118 -0.492 . . . . 73.33 110.821 -179.793 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 6' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.307 0 CA-C-N 116.158 -0.474 . . . . 74.11 111.078 179.924 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' -4' ' ' MET . . . . . . . . . . . . . 3.3 ttt . . . . . 0 C--O 1.23 0.075 0 CA-C-O 120.775 0.322 . . . . 75.14 110.86 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' -3' ' ' ALA . . . . . . . . . . . . . . . 57.73 64.26 1.6 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.205 -0.452 . . . . 44.14 111.102 179.932 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' -2' ' ' ILE . . . . . . . . . . . . . 4.5 mp -76.85 129.54 37.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.223 -0.444 . . . . 75.32 111.118 179.983 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' -1' ' ' VAL . . . . . . . . . . . . . 22.1 t -113.84 132.25 63.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.192 -0.458 . . . . 72.14 111.132 179.853 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 1.6 m120 -93.89 60.19 2.86 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.193 -0.458 . . . . 62.35 110.905 179.976 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 51.6 tp60 -99.38 131.16 45.59 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.137 -0.483 . . . . 73.22 110.891 -179.986 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 7.7 ptp180 -86.37 161.78 18.51 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.138 -0.483 . . . . 65.43 110.826 -179.909 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -153.3 154.46 34.63 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.154 -0.476 . . . . 71.15 111.101 179.892 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.641 ' HB ' HD11 ' A' ' 58' ' ' ILE . 9.2 p -103.9 153.09 6.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.226 -0.443 . . . . 75.54 111.115 179.981 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -92.06 113.68 26.02 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.149 -0.478 . . . . 60.14 111.086 179.891 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.663 HD21 ' HB2' ' A' ' 56' ' ' SER . 13.5 mt -79.59 -36.1 38.63 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.211 -0.449 . . . . 74.25 110.923 -179.977 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 2.8 m-85 -144.09 146.11 32.59 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.179 -0.464 . . . . 64.42 110.941 179.995 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 1.3 p30 -68.47 135.2 51.28 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.091 -0.504 . . . . 64.32 110.869 179.909 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 7.5 t80 -134.24 146.21 49.86 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.156 -0.475 . . . . 74.54 110.87 -179.915 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 68.5 tt0 -115.15 137.59 23.06 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-O 121.66 0.743 . . . . 62.24 110.867 -179.869 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.75 137.25 35.06 Favored 'Trans proline' 0 C--N 1.341 0.155 0 C-N-CA 122.665 2.243 . . . . 75.53 112.34 -179.986 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 7.9 mm-40 -97.66 -20.2 17.78 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.222 -0.445 . . . . 62.15 110.901 -179.987 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 32.2 m-80 -115.15 175.3 5.57 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.134 -0.484 . . . . 63.34 110.869 -179.967 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 26.2 m-20 -87.25 7.97 26.15 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.181 -0.463 . . . . 64.34 110.861 179.912 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -125.13 16.76 8.45 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.23 -0.441 . . . . 75.2 110.915 -179.888 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 16.4 mt-10 -108.37 156.59 19.25 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.164 -0.471 . . . . 73.31 110.888 179.986 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.631 HD11 ' HG3' ' A' ' 46' ' ' LYS . 0.5 OUTLIER -106.51 150.39 26.16 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.119 -0.491 . . . . 60.11 110.917 -179.969 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . 0.617 ' O ' HD23 ' A' ' 18' ' ' LEU . 26.1 mtm180 -85.16 153.27 22.76 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.167 -0.469 . . . . 70.23 110.852 179.976 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.548 HD21 ' CG1' ' A' ' 55' ' ' VAL . 1.7 tp -138.09 148.11 44.68 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.199 -0.455 . . . . 72.21 110.941 -179.968 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.612 ' HB3' ' CG ' ' A' ' 24' ' ' ASP . . . -140.18 139.24 35.66 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.231 -0.44 . . . . 52.42 111.147 179.786 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -50.29 119.72 3.93 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.249 -0.432 . . . . 74.4 110.88 -179.934 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 98.5 -6.86 61.28 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.773 -0.727 . . . . 61.41 112.456 179.973 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . 0.612 ' CG ' ' HB3' ' A' ' 21' ' ' ALA . 2.9 m-20 -75.78 152.78 37.29 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.792 0.329 . . . . 74.03 110.845 -179.997 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 1.3 mt -116.77 122.2 69.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.17 -0.468 . . . . 73.34 111.176 179.933 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.633 HG12 ' HA ' ' A' ' 41' ' ' ASN . 3.6 m -124.64 163.41 24.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.168 -0.469 . . . . 54.21 111.132 179.894 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 74.5 m-85 -116.35 110.1 18.24 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.145 -0.479 . . . . 72.43 110.853 -179.994 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.633 HD13 ' HB2' ' A' ' 39' ' ' ALA . 13.4 mm -71.85 103.0 1.31 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.117 -0.492 . . . . 65.22 111.106 179.955 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 5.4 m -65.53 -40.77 93.33 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.192 -0.458 . . . . 73.35 110.822 -179.904 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' TYR . . . . . 0.517 ' CZ ' HG21 ' A' ' 38' ' ' VAL . 33.4 p90 -174.27 149.87 1.43 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.154 -0.476 . . . . 75.34 110.958 -179.899 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 19.1 tttt -81.37 143.1 32.41 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.168 -0.469 . . . . 63.54 110.856 179.928 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 32.9 t60 -131.91 153.35 50.34 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.206 -0.452 . . . . 75.54 110.889 179.872 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -59.24 -174.69 0.69 Allowed Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.732 -0.747 . . . . 52.15 112.486 -179.932 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 29.8 mm-40 66.17 11.76 8.07 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.789 0.328 . . . . 73.43 110.88 -179.897 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 68.69 28.77 72.9 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.767 -0.73 . . . . 55.32 112.484 -179.947 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' TRP . . . . . 0.598 ' C ' HD23 ' A' ' 37' ' ' LEU . 98.0 m95 -122.9 136.36 54.83 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.744 0.307 . . . . 64.52 110.953 -179.958 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.712 HD11 ' CG ' ' A' ' 52' ' ' GLU . 1.4 mt -118.71 131.93 56.15 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.297 -0.411 . . . . 73.5 110.85 -179.985 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.657 HG22 HD23 ' A' ' 49' ' ' LEU . 23.4 t -81.34 109.35 15.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.151 -0.477 . . . . 71.11 111.116 179.804 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.633 ' HB2' HD13 ' A' ' 28' ' ' ILE . . . -132.71 165.4 24.59 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.16 -0.473 . . . . 75.33 111.084 179.847 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -115.93 156.32 26.42 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.216 -0.447 . . . . 71.31 110.907 -179.97 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . 0.633 ' HA ' HG12 ' A' ' 26' ' ' VAL . 0.0 OUTLIER -69.77 179.33 2.23 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.138 -0.483 . . . . 74.12 110.873 -179.904 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 61.3 tt0 -63.5 -39.8 95.4 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.223 -0.444 . . . . 63.53 110.956 179.96 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 1.5 t -55.73 -22.77 25.47 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.085 -0.507 . . . . 75.45 110.861 -179.819 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 66.15 11.87 56.47 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.754 -0.736 . . . . 33.22 112.503 -179.967 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 16.5 m -107.75 -18.72 13.75 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.969 0.414 . . . . 60.04 110.841 -179.73 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.631 ' HG3' HD11 ' A' ' 18' ' ' LEU . 4.0 ptmt -117.16 133.68 55.7 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.142 -0.481 . . . . 73.44 110.871 -179.999 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . 0.423 ' C ' HD12 ' A' ' 18' ' ' LEU . 4.9 m -129.26 152.68 48.56 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.259 -0.428 . . . . 72.1 111.149 179.991 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -177.35 -161.04 25.15 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.744 -0.741 . . . . 75.2 112.515 179.976 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.657 HD23 HG22 ' A' ' 38' ' ' VAL . 6.7 mt -99.53 136.89 38.79 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.833 0.349 . . . . 63.23 110.873 -179.905 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 6.0 m -135.31 153.1 77.81 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.666 0.746 . . . . 51.43 111.116 179.839 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 0.423 ' HD2' HD22 ' A' ' 20' ' ' LEU . 53.6 Cg_endo -69.79 143.85 52.02 Favored 'Trans proline' 0 C--N 1.342 0.195 0 C-N-CA 122.63 2.22 . . . . 73.21 112.325 -179.999 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . 0.712 ' CG ' HD11 ' A' ' 37' ' ' LEU . 10.1 tm-20 -91.0 -27.2 18.81 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.221 -0.445 . . . . 71.23 110.874 -179.972 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -87.51 11.71 14.15 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.19 -0.459 . . . . 61.1 110.871 -179.958 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . 0.413 ' HB2' ' HG2' ' A' ' 51' ' ' PRO . 1.1 m-85 -121.23 -12.79 8.6 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.141 -0.481 . . . . 74.53 110.833 -179.895 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.548 ' CG1' HD21 ' A' ' 20' ' ' LEU . 17.3 m -116.69 168.73 7.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.141 -0.482 . . . . 71.14 111.14 179.988 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . 0.663 ' HB2' HD21 ' A' ' 7' ' ' LEU . 45.2 t -138.83 116.52 11.43 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.172 -0.467 . . . . 74.23 110.854 -179.834 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 2.8 m-85 -51.87 134.53 31.21 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.1 -0.5 . . . . 70.43 110.909 -179.902 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.641 HD11 ' HB ' ' A' ' 5' ' ' VAL . 54.2 mt -104.04 146.61 11.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.087 -0.506 . . . . 73.32 111.153 179.905 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 2.5 mt-30 -131.18 160.56 66.44 Favored Pre-proline 0 C--N 1.328 -0.353 0 CA-C-O 121.576 0.703 . . . . 73.31 110.936 179.968 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.81 -48.67 0.66 Allowed 'Trans proline' 0 C--N 1.34 0.129 0 C-N-CA 122.716 2.278 . . . . 73.35 112.332 179.986 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 35.0 mt-10 -154.27 25.01 0.48 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.21 -0.45 . . . . 61.41 110.876 -179.991 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 7.1 mt -115.62 137.8 51.71 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.158 -0.473 . . . . 64.35 110.858 -179.933 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--N 1.33 -0.267 0 CA-C-N 116.17 -0.468 . . . . 72.52 110.917 179.888 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' -9' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.312 0 N-CA-C 112.489 -0.244 . . . . 74.44 112.489 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' B' B ' -8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 57.28 33.78 23.8 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.776 0.322 . . . . 61.14 110.883 -179.982 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' -7' ' ' PHE . . . . . 0.42 ' HB3' HD11 ' A' ' 49' ' ' LEU . 8.8 m-85 -67.78 144.53 55.34 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.255 -0.43 . . . . 54.5 110.886 179.965 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' -6' ' ' ILE . . . . . 0.466 ' O ' HG23 ' B' ' -6' ' ' ILE . 4.5 tt -155.47 84.87 3.47 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-O 121.65 0.738 . . . . 74.55 111.109 179.994 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' -5' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.74 132.21 22.89 Favored 'Trans proline' 0 C--N 1.342 0.202 0 C-N-CA 122.707 2.272 . . . . 63.43 112.351 179.877 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' -4' ' ' SER . . . . . . . . . . . . . 1.4 t -129.74 64.26 1.51 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.224 -0.444 . . . . 74.51 110.866 -179.858 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' -3' ' ' ARG . . . . . . . . . . . . . 4.9 ptm180 -178.32 155.0 0.94 Allowed Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.641 0.734 . . . . 73.42 110.839 -179.91 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' -2' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.76 129.49 17.69 Favored 'Trans proline' 0 C--N 1.342 0.194 0 C-N-CA 122.654 2.236 . . . . 74.32 112.384 179.973 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' -1' ' ' ALA . . . . . 0.506 ' HB1' ' HD2' ' B' ' 0' ' ' PRO . . . -61.34 157.85 41.95 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-O 121.55 0.691 . . . . 73.41 111.135 179.879 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 0' ' ' PRO . . . . . 0.506 ' HD2' ' HB1' ' B' ' -1' ' ' ALA . 53.7 Cg_endo -69.76 -176.24 1.42 Allowed 'Trans proline' 0 C--O 1.231 0.156 0 C-N-CA 122.71 2.273 . . . . 74.34 112.345 -179.985 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 1' ' ' LYS . . . . . . . . . . . . . 37.2 tttp -131.77 137.55 30.55 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-O 121.542 0.687 . . . . 73.23 110.918 179.887 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 2' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.75 162.01 43.73 Favored 'Trans proline' 0 C--O 1.232 0.204 0 C-N-CA 122.725 2.283 . . . . 72.14 112.338 179.941 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 3' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.8 102.55 1.05 Allowed 'Trans proline' 0 C--N 1.341 0.162 0 C-N-CA 122.684 2.256 . . . . 63.01 112.347 179.954 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 4' ' ' SER . . . . . . . . . . . . . 76.3 p -57.65 115.57 2.87 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.199 -0.455 . . . . 74.12 110.868 -179.819 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 5' ' ' SER . . . . . . . . . . . . . 3.3 p -83.52 178.34 8.04 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.119 -0.491 . . . . 74.45 110.872 -179.834 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 6' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.29 0 CA-C-N 116.103 -0.498 . . . . 62.31 111.056 179.909 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' -4' ' ' MET . . . . . . . . . . . . . 2.4 mpp? . . . . . 0 C--O 1.23 0.056 0 CA-C-O 120.825 0.345 . . . . 61.54 110.859 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' -3' ' ' ALA . . . . . . . . . . . . . . . -76.66 -30.63 56.87 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.205 -0.452 . . . . 44.31 111.087 179.892 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' -2' ' ' ILE . . . . . . . . . . . . . 5.3 mp -85.6 126.41 40.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.207 -0.451 . . . . 64.03 111.142 -179.997 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' -1' ' ' VAL . . . . . . . . . . . . . 11.9 p -84.26 -27.4 7.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.192 -0.458 . . . . 73.21 111.123 179.877 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 14.1 m120 61.72 60.96 1.51 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.215 -0.448 . . . . 72.2 110.904 179.998 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 51.1 tp60 -120.29 127.26 52.21 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.186 -0.461 . . . . 70.12 110.914 -179.967 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 5.5 ptp180 -80.19 160.97 25.45 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.213 -0.448 . . . . 71.21 110.867 -179.886 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -155.42 154.43 31.91 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.204 -0.453 . . . . 74.04 111.116 179.955 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.493 ' HB ' HD11 ' A' ' 58' ' ' ILE . 10.7 p -104.28 149.6 7.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.258 -0.428 . . . . 60.4 111.117 -179.988 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -87.3 110.12 19.99 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.195 -0.457 . . . . 74.25 111.091 179.899 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.749 HD21 ' CB ' ' A' ' 56' ' ' SER . 16.6 mt -74.2 -37.45 63.88 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.226 -0.443 . . . . 60.12 110.912 -179.941 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 5.4 m-85 -142.34 154.87 45.03 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.196 -0.456 . . . . 72.41 110.945 179.992 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 1.6 p30 -78.94 137.49 37.65 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.112 -0.495 . . . . 53.11 110.898 179.882 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 9.9 t80 -138.84 145.49 40.1 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.211 -0.45 . . . . 64.02 110.871 -179.959 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 22.5 tt0 -114.28 135.46 22.2 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 121.617 0.722 . . . . 75.11 110.891 -179.926 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.409 ' HD3' ' HA ' ' A' ' 19' ' ' ARG . 53.2 Cg_endo -69.8 152.62 69.13 Favored 'Trans proline' 0 C--N 1.341 0.162 0 C-N-CA 122.702 2.268 . . . . 71.42 112.353 -179.996 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 22.4 tp10 -116.52 -20.72 9.51 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.205 -0.452 . . . . 72.21 110.898 -179.95 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 7.4 m-80 -106.53 176.04 5.3 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.14 -0.482 . . . . 71.52 110.834 -179.926 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 15.8 m-20 -92.2 21.41 5.15 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.177 -0.465 . . . . 74.34 110.851 179.923 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 1.2 p-10 -141.16 12.51 2.2 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.22 -0.445 . . . . 75.13 110.888 -179.876 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 -101.68 156.05 17.73 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.167 -0.469 . . . . 74.34 110.894 -179.985 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.619 HD12 ' H ' ' A' ' 19' ' ' ARG . 31.5 tp -108.46 144.94 35.4 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.142 -0.481 . . . . 71.21 110.89 -179.949 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . 0.619 ' H ' HD12 ' A' ' 18' ' ' LEU . 14.6 mtp180 -81.18 153.09 27.4 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.215 -0.448 . . . . 74.5 110.902 179.935 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.535 HD21 ' CG1' ' A' ' 55' ' ' VAL . 2.6 tp -138.99 148.42 43.44 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.236 -0.438 . . . . 72.24 110.904 -179.944 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.669 ' HB3' ' CG ' ' A' ' 24' ' ' ASP . . . -139.92 137.23 34.63 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.197 -0.456 . . . . 63.3 111.131 179.767 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -50.7 120.03 4.37 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.234 -0.439 . . . . 63.2 110.896 -179.91 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 97.9 -5.77 61.9 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.761 -0.733 . . . . 50.13 112.482 -179.945 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . 0.669 ' CG ' ' HB3' ' A' ' 21' ' ' ALA . 1.1 m-20 -81.77 147.29 29.49 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.785 0.326 . . . . 73.22 110.861 -179.944 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 3.4 mm -100.94 142.46 15.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.224 -0.444 . . . . 62.23 111.086 -179.982 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.425 HG11 HD11 ' A' ' 20' ' ' LEU . 1.4 m -145.27 158.24 13.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.181 -0.463 . . . . 43.33 111.128 179.859 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 65.0 m-85 -116.95 108.26 15.57 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.155 -0.475 . . . . 61.35 110.892 -179.964 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.732 HD13 ' HB2' ' A' ' 39' ' ' ALA . 16.5 mm -71.78 103.28 1.36 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.16 -0.473 . . . . 63.32 111.125 179.975 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 11.4 m -65.4 -40.17 93.09 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.119 -0.491 . . . . 72.14 110.833 -179.902 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' TYR . . . . . 0.508 ' CZ ' HG21 ' A' ' 38' ' ' VAL . 36.5 p90 -174.53 150.08 1.36 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.104 -0.498 . . . . 75.42 110.892 -179.873 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . 0.448 ' HG3' HD22 ' A' ' 37' ' ' LEU . 13.4 tttt -82.07 144.44 30.82 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.094 -0.503 . . . . 73.13 110.885 179.903 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 31.7 t60 -132.75 156.15 47.59 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.244 -0.434 . . . . 74.31 110.858 179.919 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -61.21 -174.31 1.34 Allowed Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.771 -0.728 . . . . 43.42 112.42 -179.926 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 63.1 mm-40 65.35 12.84 8.4 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.852 0.358 . . . . 64.43 110.946 -179.885 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 68.41 28.98 72.95 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.697 -0.763 . . . . 54.22 112.499 -179.997 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' TRP . . . . . 0.616 ' C ' HD23 ' A' ' 37' ' ' LEU . 98.8 m95 -123.45 137.54 54.77 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.857 0.36 . . . . 75.04 110.894 -179.912 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.748 HD11 ' CG ' ' A' ' 52' ' ' GLU . 0.6 OUTLIER -121.9 130.47 53.38 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.215 -0.448 . . . . 75.25 110.896 179.979 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.508 HG21 ' CZ ' ' A' ' 30' ' ' TYR . 42.8 t -77.32 116.01 20.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.175 -0.466 . . . . 61.24 111.087 179.845 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.732 ' HB2' HD13 ' A' ' 28' ' ' ILE . . . -138.05 161.79 35.83 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.18 -0.464 . . . . 65.21 111.101 179.85 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 1.2 pt-20 -113.45 156.86 22.76 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.209 -0.45 . . . . 72.52 110.867 -179.923 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -72.4 -176.26 1.82 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.13 -0.486 . . . . 74.04 110.883 -179.932 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 9.6 tt0 -68.16 -38.5 82.18 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.188 -0.46 . . . . 63.01 110.908 -179.975 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 1.5 t -57.02 -22.22 37.08 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.137 -0.483 . . . . 50.03 110.83 -179.827 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 65.8 12.77 57.84 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.737 -0.744 . . . . 75.31 112.483 -179.993 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -109.13 -15.99 14.2 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.972 0.415 . . . . 71.32 110.863 -179.779 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -120.11 135.08 55.08 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.137 -0.483 . . . . 74.0 110.941 179.949 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 5.6 m -136.36 140.28 43.15 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.252 -0.431 . . . . 72.11 111.156 179.985 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -161.8 -153.7 7.19 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.743 -0.741 . . . . 61.03 112.472 -179.997 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.448 HD11 ' HB3' ' B' ' -7' ' ' PHE . 9.0 mt -104.05 135.0 46.37 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.818 0.342 . . . . 71.14 110.928 -179.932 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 10.2 m -133.94 153.02 79.6 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 121.604 0.716 . . . . 54.5 111.152 179.825 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 0.414 ' HG2' ' HB2' ' A' ' 54' ' ' PHE . 53.3 Cg_endo -69.81 147.78 63.29 Favored 'Trans proline' 0 C--N 1.341 0.161 0 C-N-CA 122.618 2.212 . . . . 71.32 112.337 180.0 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . 0.748 ' CG ' HD11 ' A' ' 37' ' ' LEU . 15.5 tm-20 -92.77 -28.91 16.3 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.211 -0.45 . . . . 61.21 110.886 -179.97 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -86.59 10.55 15.14 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.15 -0.477 . . . . 62.33 110.881 -179.917 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . 0.414 ' HB2' ' HG2' ' A' ' 51' ' ' PRO . 0.9 OUTLIER -121.31 -4.31 9.42 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.152 -0.476 . . . . 72.44 110.852 -179.902 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.535 ' CG1' HD21 ' A' ' 20' ' ' LEU . 16.0 m -125.93 166.61 21.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.169 -0.468 . . . . 63.21 111.155 179.94 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . 0.749 ' CB ' HD21 ' A' ' 7' ' ' LEU . 30.0 t -136.21 118.99 16.14 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.166 -0.47 . . . . 71.31 110.888 -179.836 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 -57.71 128.22 35.98 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.161 -0.472 . . . . 65.12 110.901 -179.847 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.493 HD11 ' HB ' ' A' ' 5' ' ' VAL . 49.6 mt -94.69 148.19 5.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.165 -0.47 . . . . 55.04 111.127 179.918 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 2.5 mt-30 -131.12 160.75 65.51 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.573 0.702 . . . . 74.41 110.957 179.923 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.77 -49.0 0.6 Allowed 'Trans proline' 0 C--N 1.341 0.162 0 C-N-CA 122.691 2.26 . . . . 73.45 112.345 -179.995 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 61.0 mt-10 -153.03 24.23 0.56 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.249 -0.432 . . . . 64.23 110.886 -179.997 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 6.8 mt -115.5 27.17 9.52 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.153 -0.476 . . . . 64.44 110.92 -179.999 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 29.5 tt0 . . . . . 0 C--N 1.329 -0.288 0 CA-C-N 116.135 -0.484 . . . . 74.43 110.852 179.897 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' B' B ' -9' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.314 0 N-CA-C 112.467 -0.253 . . . . 62.3 112.467 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' B' B ' -8' ' ' LYS . . . . . . . . . . . . . 23.2 mtmm -93.61 -44.23 8.3 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.768 0.318 . . . . 70.4 110.85 -179.954 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' -7' ' ' PHE . . . . . 0.448 ' HB3' HD11 ' A' ' 49' ' ' LEU . 18.0 m-85 -84.04 154.42 23.26 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.232 -0.44 . . . . 60.14 110.855 179.994 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' -6' ' ' ILE . . . . . . . . . . . . . 58.8 mt -149.91 93.33 3.96 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 121.59 0.71 . . . . 55.42 111.124 179.954 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' -5' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.75 122.1 8.78 Favored 'Trans proline' 0 C--O 1.232 0.178 0 C-N-CA 122.637 2.225 . . . . 61.1 112.351 179.894 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' -4' ' ' SER . . . . . . . . . . . . . 22.7 m -117.18 59.95 0.76 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.254 -0.43 . . . . 41.5 110.893 -179.868 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' -3' ' ' ARG . . . . . . . . . . . . . 8.8 ptm180 -176.69 153.36 1.15 Allowed Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 121.634 0.731 . . . . 73.3 110.867 -179.927 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' -2' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.77 145.56 57.42 Favored 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.661 2.24 . . . . 73.03 112.323 -179.964 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' -1' ' ' ALA . . . . . . . . . . . . . . . -75.93 141.92 72.18 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.567 0.699 . . . . 34.34 111.105 179.848 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 0' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.75 175.13 8.5 Favored 'Trans proline' 0 C--N 1.341 0.169 0 C-N-CA 122.712 2.275 . . . . 74.11 112.36 179.959 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 1' ' ' LYS . . . . . . . . . . . . . 16.7 ptmt -124.31 152.71 68.27 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-O 121.551 0.691 . . . . 72.25 110.93 179.891 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 2' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.7 163.54 37.83 Favored 'Trans proline' 0 C--O 1.232 0.202 0 C-N-CA 122.744 2.296 . . . . 71.41 112.349 179.877 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 3' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.71 167.96 22.87 Favored 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.741 2.294 . . . . 62.24 112.341 179.906 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 4' ' ' SER . . . . . . . . . . . . . 55.3 p -70.4 131.47 44.14 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.202 -0.453 . . . . 64.24 110.842 -179.86 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 5' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -127.85 128.21 44.81 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.139 -0.482 . . . . 63.44 110.847 -179.849 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 6' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.295 0 CA-C-N 116.115 -0.493 . . . . 72.1 111.087 179.875 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' -4' ' ' MET . . . . . . . . . . . . . 2.7 ptt? . . . . . 0 C--O 1.23 0.058 0 CA-C-O 120.777 0.322 . . . . 73.33 110.869 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' -3' ' ' ALA . . . . . . . . . . . . . . . -97.64 54.83 1.19 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.23 -0.441 . . . . 54.11 111.086 179.937 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' -2' ' ' ILE . . . . . . . . . . . . . 5.4 mp -136.5 129.25 45.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.212 -0.449 . . . . 74.21 111.139 179.997 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' -1' ' ' VAL . . . . . . . . . . . . . 14.9 p -97.35 -25.18 4.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.194 -0.457 . . . . 62.32 111.151 179.83 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 16.4 m120 60.02 60.32 2.16 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.162 -0.472 . . . . 65.31 110.892 -179.982 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 40.2 tp60 -115.41 128.49 56.09 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.148 -0.478 . . . . 71.41 110.899 -179.965 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 5.0 ptp180 -76.83 160.39 29.3 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.189 -0.46 . . . . 75.33 110.835 -179.898 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -155.33 149.83 26.17 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.208 -0.451 . . . . 51.14 111.094 179.913 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.611 ' HB ' HD11 ' A' ' 58' ' ' ILE . 8.7 p -105.41 142.21 19.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.25 -0.432 . . . . 70.11 111.14 179.985 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . 0.439 ' HA ' HG12 ' A' ' 55' ' ' VAL . . . -82.94 127.74 33.81 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.178 -0.465 . . . . 65.35 111.093 179.866 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.512 HD21 ' CB ' ' A' ' 56' ' ' SER . 7.6 mt -93.23 -31.68 14.65 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.221 -0.445 . . . . 72.23 110.889 -179.985 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 4.5 m-85 -144.18 136.12 26.22 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.185 -0.461 . . . . 50.44 110.924 -179.96 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 3.4 p30 -62.3 141.68 58.15 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.153 -0.476 . . . . 63.03 110.852 179.911 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 24.1 t80 -141.87 145.87 35.14 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.193 -0.458 . . . . 63.34 110.895 -179.918 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 28.6 tt0 -115.64 137.0 22.91 Favored Pre-proline 0 C--N 1.33 -0.257 0 CA-C-O 121.657 0.741 . . . . 64.04 110.912 -179.945 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.73 146.43 60.31 Favored 'Trans proline' 0 C--N 1.341 0.181 0 C-N-CA 122.687 2.258 . . . . 71.23 112.35 -179.961 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 7.3 mm-40 -107.87 -12.74 15.13 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.267 -0.424 . . . . 75.21 110.886 180.0 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 28.6 m-80 -118.98 175.48 5.74 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.185 -0.461 . . . . 71.44 110.906 -179.97 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 63.7 m-20 -90.83 15.87 10.44 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.206 -0.452 . . . . 53.53 110.833 -179.993 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 1.1 p-10 -134.08 16.74 3.81 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.192 -0.458 . . . . 72.43 110.873 -179.888 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 3.9 mm-40 -106.98 160.84 15.23 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.149 -0.478 . . . . 74.3 110.867 -179.969 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.649 HD21 ' HD2' ' A' ' 46' ' ' LYS . 0.5 OUTLIER -111.44 142.86 43.15 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.147 -0.479 . . . . 75.15 110.954 179.994 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . 0.553 ' H ' HD23 ' A' ' 18' ' ' LEU . 36.2 mtm-85 -78.44 156.8 29.21 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.21 -0.45 . . . . 73.42 110.872 179.981 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.539 HD22 ' HD2' ' A' ' 51' ' ' PRO . 3.1 tp -141.65 148.85 39.81 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.165 -0.47 . . . . 74.52 110.914 -179.993 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.436 ' O ' ' HB3' ' A' ' 6' ' ' ALA . . . -138.56 139.9 38.84 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.214 -0.448 . . . . 72.42 111.119 179.73 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -53.64 119.31 4.75 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.215 -0.448 . . . . 73.24 110.888 -179.917 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 93.16 0.83 67.54 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.726 -0.749 . . . . 55.23 112.469 -179.978 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 20.5 t70 -77.2 158.73 30.16 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.809 0.338 . . . . 75.32 110.84 -179.948 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 1.7 mm -111.14 121.32 63.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.164 -0.471 . . . . 74.4 111.168 179.996 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.523 HG11 HD11 ' A' ' 20' ' ' LEU . 3.7 m -130.59 155.7 41.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.25 -0.432 . . . . 72.34 111.16 179.827 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 66.2 m-85 -115.56 109.08 17.27 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.218 -0.446 . . . . 72.35 110.895 -179.94 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.744 HD13 ' HB2' ' A' ' 39' ' ' ALA . 16.5 mm -73.0 103.8 1.89 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.133 -0.485 . . . . 63.34 111.11 -179.989 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 2.6 m -64.48 -39.56 94.03 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.196 -0.456 . . . . 55.12 110.848 -179.882 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' TYR . . . . . 0.482 ' CZ ' HG21 ' A' ' 38' ' ' VAL . 32.5 p90 -174.1 146.79 1.19 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.124 -0.489 . . . . 73.2 110.946 -179.902 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . 0.489 ' HG3' HD22 ' A' ' 37' ' ' LEU . 21.0 tttt -80.2 146.27 31.84 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.119 -0.492 . . . . 74.13 110.917 179.935 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 31.8 t60 -136.53 152.74 50.85 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.246 -0.434 . . . . 63.14 110.809 179.941 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -58.19 -174.96 0.48 Allowed Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.76 -0.733 . . . . 51.12 112.491 -179.98 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 56.4 mm-40 65.88 12.2 8.21 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.777 0.322 . . . . 74.21 110.856 -179.92 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 68.12 28.73 73.26 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.721 -0.752 . . . . 62.03 112.475 179.995 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' TRP . . . . . 0.612 ' C ' HD23 ' A' ' 37' ' ' LEU . 98.6 m95 -122.76 136.18 54.79 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.797 0.332 . . . . 71.23 110.913 -179.921 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.684 HD11 ' CG ' ' A' ' 52' ' ' GLU . 0.6 OUTLIER -122.74 130.78 53.33 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.225 -0.443 . . . . 72.34 110.888 179.983 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.482 HG21 ' CZ ' ' A' ' 30' ' ' TYR . 40.7 t -78.72 111.71 15.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.155 -0.475 . . . . 63.12 111.152 179.808 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.744 ' HB2' HD13 ' A' ' 28' ' ' ILE . . . -131.57 168.28 17.95 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.167 -0.469 . . . . 62.13 111.054 179.915 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . 0.407 ' HA ' ' HA ' ' A' ' 47' ' ' THR . 0.8 OUTLIER -121.92 159.39 26.98 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.153 -0.476 . . . . 72.04 110.893 -179.931 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 41.7 p-10 -58.57 -174.82 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.131 -0.486 . . . . 74.43 110.901 -179.936 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 66.5 tt0 -78.03 -37.18 47.48 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.215 -0.448 . . . . 73.14 110.919 179.996 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 37.3 t -70.64 -22.32 62.52 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.146 -0.479 . . . . 60.15 110.892 -179.834 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 75.93 26.52 64.4 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.754 -0.736 . . . . 75.22 112.466 179.985 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 8.6 t -107.18 -20.66 13.23 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.915 0.388 . . . . 72.31 110.872 -179.753 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.649 ' HD2' HD21 ' A' ' 18' ' ' LEU . 0.0 OUTLIER -127.27 137.58 52.89 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.138 -0.483 . . . . 55.42 110.893 179.924 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . 0.407 ' HA ' ' HA ' ' A' ' 40' ' ' GLU . 20.9 m -131.27 149.68 52.47 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.193 -0.458 . . . . 74.15 111.148 179.913 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . 0.557 ' N ' HD12 ' A' ' 18' ' ' LEU . . . -173.5 -162.16 24.94 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.726 -0.749 . . . . 73.51 112.448 179.975 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.445 HD23 HG22 ' A' ' 38' ' ' VAL . 10.4 mt -96.67 139.18 33.12 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.815 0.341 . . . . 74.2 110.972 -179.941 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.414 HG22 ' O ' ' A' ' 37' ' ' LEU . 11.5 m -137.3 152.96 74.36 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.664 0.745 . . . . 73.15 111.116 179.859 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 0.539 ' HD2' HD22 ' A' ' 20' ' ' LEU . 53.9 Cg_endo -69.81 147.78 63.31 Favored 'Trans proline' 0 C--N 1.341 0.18 0 C-N-CA 122.668 2.246 . . . . 72.5 112.311 179.959 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . 0.684 ' CG ' HD11 ' A' ' 37' ' ' LEU . 23.8 tt0 -93.11 -29.21 15.88 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.204 -0.453 . . . . 75.11 110.88 -179.987 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -85.72 7.97 21.57 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.149 -0.478 . . . . 65.1 110.887 -179.922 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . 0.428 ' HB2' ' HG2' ' A' ' 51' ' ' PRO . 1.1 m-85 -119.57 3.3 11.21 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.129 -0.487 . . . . 64.22 110.865 -179.902 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.532 ' CG1' HD21 ' A' ' 20' ' ' LEU . 21.3 m -134.62 164.55 33.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.119 -0.492 . . . . 55.3 111.161 179.959 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . 0.512 ' CB ' HD21 ' A' ' 7' ' ' LEU . 32.2 t -136.36 118.61 15.58 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.18 -0.464 . . . . 65.45 110.837 -179.885 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 3.0 m-85 -54.32 135.2 45.08 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.144 -0.48 . . . . 74.14 110.921 -179.886 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.611 HD11 ' HB ' ' A' ' 5' ' ' VAL . 31.0 mt -101.92 150.74 6.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.088 -0.505 . . . . 74.25 111.144 179.918 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 1.6 mt-30 -131.11 161.0 64.35 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.672 0.748 . . . . 75.1 110.907 179.93 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.76 -48.4 0.73 Allowed 'Trans proline' 0 C--N 1.342 0.219 0 C-N-CA 122.684 2.256 . . . . 74.0 112.353 -179.98 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 6.0 tp10 -153.93 26.14 0.49 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.186 -0.461 . . . . 74.22 110.886 179.999 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 7.4 mt -114.87 155.34 27.01 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.125 -0.489 . . . . 72.21 110.918 -179.978 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--N 1.329 -0.285 0 CA-C-N 116.193 -0.458 . . . . 64.23 110.851 179.921 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' -9' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.368 0 N-CA-C 112.519 -0.232 . . . . 52.21 112.519 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' B' B ' -8' ' ' LYS . . . . . . . . . . . . . 45.6 tttm -120.13 54.0 1.05 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.808 0.337 . . . . 72.12 110.931 -179.976 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' -7' ' ' PHE . . . . . 0.401 ' O ' HD13 ' B' ' -6' ' ' ILE . 5.8 m-85 -105.1 131.64 52.35 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.231 -0.44 . . . . 63.42 110.823 -179.95 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' -6' ' ' ILE . . . . . 0.401 HD13 ' O ' ' B' ' -7' ' ' PHE . 34.2 mm -145.45 88.57 6.58 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-O 121.673 0.749 . . . . 63.14 111.139 179.967 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' -5' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.82 130.36 19.13 Favored 'Trans proline' 0 C--N 1.342 0.192 0 C-N-CA 122.702 2.268 . . . . 32.43 112.313 179.943 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' -4' ' ' SER . . . . . . . . . . . . . 27.4 t -129.4 65.56 1.47 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.165 -0.47 . . . . 72.22 110.86 -179.819 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' -3' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -179.74 154.98 0.72 Allowed Pre-proline 0 C--N 1.329 -0.326 0 CA-C-O 121.578 0.704 . . . . 71.14 110.914 -179.931 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' -2' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.74 131.74 21.89 Favored 'Trans proline' 0 C--N 1.341 0.155 0 C-N-CA 122.686 2.257 . . . . 72.34 112.347 179.974 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' -1' ' ' ALA . . . . . . . . . . . . . . . -65.16 151.91 92.73 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-O 121.526 0.679 . . . . 73.23 111.094 179.891 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 0' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.75 176.63 6.5 Favored 'Trans proline' 0 C--O 1.232 0.181 0 C-N-CA 122.651 2.234 . . . . 74.44 112.359 -179.989 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 1' ' ' LYS . . . . . . . . . . . . . 12.3 pttp -125.57 155.07 72.7 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.543 0.687 . . . . 74.05 110.91 179.886 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 2' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -69.74 163.89 36.57 Favored 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.668 2.246 . . . . 73.25 112.35 179.863 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 3' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.74 -26.91 27.22 Favored 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.691 2.26 . . . . 75.5 112.342 179.92 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 4' ' ' SER . . . . . . . . . . . . . 15.0 t -94.19 159.03 15.32 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.267 -0.424 . . . . 53.24 110.86 -179.856 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 5' ' ' SER . . . . . . . . . . . . . 13.6 t -134.77 144.22 47.56 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.106 -0.497 . . . . 71.03 110.84 -179.828 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 6' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.33 -0.272 0 CA-C-N 116.113 -0.494 . . . . 71.04 111.086 179.897 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' -4' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.23 0.073 0 CA-C-O 120.771 0.319 . . . . 60.42 110.834 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' -3' ' ' ALA . . . . . . . . . . . . . . . -78.19 90.49 4.3 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.248 -0.433 . . . . 71.41 111.141 179.897 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' -2' ' ' ILE . . . . . . . . . . . . . 76.7 mt -139.65 116.48 9.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.208 -0.451 . . . . 71.24 111.119 -179.996 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' -1' ' ' VAL . . . . . . . . . . . . . 51.6 t -68.02 -30.89 49.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.163 -0.471 . . . . 51.15 111.189 179.826 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 2.4 t-20 63.05 54.03 2.21 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.126 -0.488 . . . . 64.14 110.893 -179.985 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 48.4 tp60 -109.36 123.66 49.69 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.17 -0.468 . . . . 75.44 110.932 179.964 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 5.2 ptp180 -73.87 162.99 28.52 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.172 -0.467 . . . . 73.45 110.881 -179.931 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -156.61 153.8 29.18 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.198 -0.455 . . . . 62.13 111.133 179.911 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.516 ' HB ' HD11 ' A' ' 58' ' ' ILE . 10.7 p -103.96 149.63 7.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.224 -0.444 . . . . 64.51 111.169 179.937 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -88.68 106.06 18.09 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.193 -0.458 . . . . 51.22 111.082 179.877 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.726 HD21 ' CB ' ' A' ' 56' ' ' SER . 15.4 mt -71.33 -36.66 71.63 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.199 -0.455 . . . . 64.22 110.957 179.98 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 4.0 m-85 -143.56 152.65 41.69 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.211 -0.449 . . . . 61.53 110.886 -180.0 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 2.4 p30 -75.29 140.64 43.26 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.069 -0.514 . . . . 64.44 110.903 179.903 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 7.2 t80 -147.18 145.34 29.48 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.195 -0.457 . . . . 75.35 110.904 -179.852 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -114.06 144.61 31.93 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.641 0.734 . . . . 75.12 110.912 -179.949 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.82 148.75 65.36 Favored 'Trans proline' 0 C--N 1.341 0.144 0 C-N-CA 122.688 2.259 . . . . 61.52 112.356 -179.996 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 10.6 tp10 -109.87 -19.72 13.02 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.171 -0.468 . . . . 75.32 110.847 -179.911 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 9.2 m-80 -110.95 176.3 5.08 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.173 -0.467 . . . . 63.11 110.844 -179.905 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -90.84 21.08 4.31 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.136 -0.484 . . . . 73.51 110.918 179.884 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -142.35 13.44 1.98 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.147 -0.479 . . . . 73.33 110.896 -179.893 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 17.0 mt-10 -102.43 158.25 16.34 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.163 -0.471 . . . . 74.32 110.906 -179.981 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.612 HD23 ' O ' ' A' ' 19' ' ' ARG . 0.4 OUTLIER -105.9 155.78 19.01 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.204 -0.453 . . . . 75.15 110.909 -179.97 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . 0.612 ' O ' HD23 ' A' ' 18' ' ' LEU . 0.9 OUTLIER -92.04 153.69 19.25 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.137 -0.483 . . . . 72.44 110.83 -179.965 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.589 HD21 ' CG1' ' A' ' 55' ' ' VAL . 2.3 tp -137.05 149.72 47.6 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.236 -0.438 . . . . 72.44 110.945 -179.995 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.679 ' HB3' ' CG ' ' A' ' 24' ' ' ASP . . . -142.9 136.9 29.1 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.207 -0.451 . . . . 44.21 111.116 179.793 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -50.15 119.98 4.09 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.235 -0.438 . . . . 75.12 110.855 -179.883 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 96.34 -0.91 62.04 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.749 -0.739 . . . . 54.23 112.473 -179.971 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . 0.679 ' CG ' ' HB3' ' A' ' 21' ' ' ALA . 1.1 m-20 -86.99 147.26 25.81 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.751 0.31 . . . . 70.02 110.853 -179.966 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 3.3 mm -102.59 142.08 17.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.221 -0.445 . . . . 73.02 111.155 179.987 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -143.22 159.45 17.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.196 -0.456 . . . . 72.2 111.145 179.876 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 44.0 m-85 -116.59 107.09 14.28 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.216 -0.447 . . . . 73.21 110.851 -179.953 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.792 HD13 ' HB2' ' A' ' 39' ' ' ALA . 17.6 mm -72.63 103.05 1.55 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.158 -0.474 . . . . 74.45 111.109 179.993 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 3.0 m -64.29 -39.32 93.7 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.161 -0.472 . . . . 52.41 110.861 -179.92 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' TYR . . . . . 0.498 ' CZ ' HG21 ' A' ' 38' ' ' VAL . 32.9 p90 -174.75 147.34 1.02 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.109 -0.496 . . . . 64.4 110.898 -179.828 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . 0.512 ' HG3' HD22 ' A' ' 37' ' ' LEU . 11.9 tttm -81.45 145.98 30.48 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.09 -0.504 . . . . 42.13 110.865 179.922 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 32.1 t60 -135.68 152.04 50.8 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.211 -0.45 . . . . 75.35 110.894 179.873 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -57.78 -175.35 0.44 Allowed Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.728 -0.749 . . . . 32.04 112.511 -179.986 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 4.4 mp0 66.55 11.94 8.42 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.826 0.346 . . . . 64.3 110.869 -179.908 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 68.18 28.82 73.19 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.751 -0.738 . . . . 74.52 112.507 -179.973 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' TRP . . . . . 0.58 ' C ' HD23 ' A' ' 37' ' ' LEU . 97.8 m95 -122.74 134.95 54.43 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.796 0.332 . . . . 75.31 110.902 -179.92 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.685 HD11 ' CG ' ' A' ' 52' ' ' GLU . 0.9 OUTLIER -121.73 132.61 54.72 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.241 -0.436 . . . . 63.23 110.9 179.983 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.498 HG21 ' CZ ' ' A' ' 30' ' ' TYR . 46.1 t -79.79 109.59 14.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.207 -0.451 . . . . 73.04 111.125 179.839 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.792 ' HB2' HD13 ' A' ' 28' ' ' ILE . . . -129.46 161.65 29.9 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.199 -0.455 . . . . 73.21 111.083 179.884 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 2.3 pm0 -118.51 158.38 25.48 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.204 -0.453 . . . . 75.24 110.936 -179.98 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 46.3 p-10 -58.16 -175.08 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.166 -0.47 . . . . 51.24 110.896 -179.946 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 15.6 tm-20 -78.01 -35.44 49.9 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.176 -0.465 . . . . 62.53 110.921 -179.99 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 40.1 t -69.59 -21.89 63.56 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.131 -0.486 . . . . 62.11 110.903 -179.826 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 76.33 26.13 64.39 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.71 -0.757 . . . . 33.04 112.529 -179.968 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -111.98 -22.51 11.01 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.926 0.393 . . . . 65.1 110.881 -179.747 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.601 ' HG2' HD11 ' A' ' 18' ' ' LEU . 3.0 ttmt -117.89 130.24 56.12 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.135 -0.484 . . . . 65.22 110.904 179.93 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . 0.422 ' C ' HD12 ' A' ' 18' ' ' LEU . 4.6 m -127.77 150.36 49.84 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.251 -0.431 . . . . 74.54 111.163 179.927 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -177.69 -160.18 23.87 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.757 -0.735 . . . . 65.45 112.489 179.994 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.475 HD11 ' HB3' ' B' ' -7' ' ' PHE . 3.6 mt -102.04 141.15 35.33 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.874 0.368 . . . . 73.43 110.892 -179.95 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.442 ' HB ' ' HD2' ' A' ' 51' ' ' PRO . 16.1 m -138.11 154.5 74.17 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.611 0.719 . . . . 61.53 111.138 179.826 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 0.442 ' HD2' ' HB ' ' A' ' 50' ' ' VAL . 53.3 Cg_endo -69.74 143.14 49.99 Favored 'Trans proline' 0 C--N 1.341 0.132 0 C-N-CA 122.708 2.272 . . . . 73.35 112.315 179.976 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . 0.685 ' CG ' HD11 ' A' ' 37' ' ' LEU . 27.1 tt0 -90.5 -27.55 19.13 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.194 -0.457 . . . . 73.42 110.854 -179.947 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -86.19 9.61 17.04 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.17 -0.468 . . . . 73.41 110.923 -179.969 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . 0.407 ' HB2' ' HG2' ' A' ' 51' ' ' PRO . 1.1 m-85 -119.85 -13.75 9.04 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.124 -0.489 . . . . 63.25 110.852 -179.912 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.589 ' CG1' HD21 ' A' ' 20' ' ' LEU . 21.8 m -114.7 167.45 7.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.169 -0.469 . . . . 74.31 111.113 179.967 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . 0.726 ' CB ' HD21 ' A' ' 7' ' ' LEU . 42.9 t -139.23 116.27 10.98 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.167 -0.469 . . . . 70.45 110.869 -179.899 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 2.6 m-85 -53.35 133.94 40.0 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.134 -0.484 . . . . 74.33 110.951 -179.913 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.516 HD11 ' HB ' ' A' ' 5' ' ' VAL . 39.4 mt -102.58 150.24 6.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.109 -0.496 . . . . 71.45 111.114 179.975 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . 0.403 ' HB2' ' HD2' ' A' ' 60' ' ' PRO . 0.1 OUTLIER -95.31 154.97 39.31 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-O 121.607 0.718 . . . . 71.55 110.94 179.925 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . 0.403 ' HD2' ' HB2' ' A' ' 59' ' ' GLN . 53.8 Cg_endo -69.76 -47.62 0.89 Allowed 'Trans proline' 0 C--N 1.341 0.165 0 C-N-CA 122.69 2.26 . . . . 72.1 112.321 179.985 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -161.39 39.02 0.14 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.262 -0.427 . . . . 63.42 110.912 -179.969 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 17.9 mt -102.98 -173.58 2.35 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.143 -0.481 . . . . 74.25 110.892 -179.969 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 3.0 tt0 . . . . . 0 C--N 1.33 -0.259 0 CA-C-N 116.175 -0.466 . . . . 74.32 110.913 179.92 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' B' B ' -9' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.339 0 N-CA-C 112.487 -0.245 . . . . 52.12 112.487 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' B' B ' -8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -114.86 -22.09 9.8 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.769 0.318 . . . . 65.4 110.893 -179.957 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' -7' ' ' PHE . . . . . 0.475 ' HB3' HD11 ' A' ' 49' ' ' LEU . 19.6 m-85 -57.49 168.46 0.81 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.232 -0.44 . . . . 74.33 110.919 179.954 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' -6' ' ' ILE . . . . . 0.442 ' O ' HG23 ' B' ' -6' ' ' ILE . 4.5 tt -173.52 90.05 0.37 Allowed Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 121.691 0.758 . . . . 72.54 111.118 179.996 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' -5' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.75 134.48 28.09 Favored 'Trans proline' 0 C--N 1.342 0.209 0 C-N-CA 122.662 2.241 . . . . 63.4 112.382 179.853 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' -4' ' ' SER . . . . . . . . . . . . . 33.1 t -134.37 66.5 1.54 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.214 -0.448 . . . . 53.33 110.834 -179.845 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' -3' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 179.87 155.34 0.69 Allowed Pre-proline 0 C--N 1.328 -0.34 0 CA-C-O 121.609 0.718 . . . . 75.13 110.905 -179.968 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' -2' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.8 123.14 9.79 Favored 'Trans proline' 0 N--CA 1.465 -0.187 0 C-N-CA 122.668 2.246 . . . . 64.55 112.331 -179.95 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' -1' ' ' ALA . . . . . . . . . . . . . . . -50.99 152.6 3.62 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-O 121.561 0.696 . . . . 53.53 111.1 179.886 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 0' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.76 165.15 31.94 Favored 'Trans proline' 0 C--N 1.341 0.166 0 C-N-CA 122.683 2.256 . . . . 73.52 112.367 179.959 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 1' ' ' LYS . . . . . . . . . . . . . 3.9 tppt? -116.02 135.93 22.86 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-O 121.594 0.711 . . . . 75.35 110.87 179.935 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 2' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.7 159.82 52.04 Favored 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.676 2.251 . . . . 72.52 112.337 179.856 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 3' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.78 -171.81 0.51 Allowed 'Trans proline' 0 C--N 1.342 0.212 0 C-N-CA 122.654 2.236 . . . . 74.42 112.373 179.903 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 4' ' ' SER . . . . . . . . . . . . . 57.7 m -98.33 122.77 41.91 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.228 -0.442 . . . . 73.15 110.881 -179.867 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 5' ' ' SER . . . . . . . . . . . . . 28.9 t -146.91 129.93 16.37 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.133 -0.485 . . . . 74.3 110.871 -179.824 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 6' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.307 0 CA-C-N 116.135 -0.484 . . . . 74.4 111.049 179.964 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' -4' ' ' MET . . . . . . . . . . . . . 4.0 mmt . . . . . 0 C--O 1.23 0.078 0 CA-C-O 120.763 0.316 . . . . 72.22 110.911 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' -3' ' ' ALA . . . . . . . . . . . . . . . -133.94 41.32 3.01 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.253 -0.431 . . . . 75.32 111.121 179.873 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' -2' ' ' ILE . . . . . 0.453 HG23 ' O ' ' A' ' 29' ' ' SER . 37.7 mm -106.24 123.18 60.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.246 -0.434 . . . . 73.32 111.127 -179.988 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' -1' ' ' VAL . . . . . . . . . . . . . 25.0 t -75.85 -36.48 32.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.2 -0.454 . . . . 64.31 111.169 179.816 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 63.84 50.07 2.71 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.177 -0.465 . . . . 74.21 110.892 179.993 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 49.4 tp60 -103.24 127.95 50.39 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.203 -0.453 . . . . 53.41 110.883 -179.978 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -73.4 158.59 34.71 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.172 -0.467 . . . . 72.04 110.878 -179.917 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -154.72 154.06 32.28 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.19 -0.459 . . . . 73.03 111.066 179.905 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.517 ' HB ' HD11 ' A' ' 58' ' ' ILE . 10.9 p -104.14 152.22 6.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.208 -0.451 . . . . 73.52 111.126 179.984 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -91.83 121.48 33.48 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.198 -0.456 . . . . 65.43 111.129 179.813 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.597 HD21 ' HB3' ' A' ' 56' ' ' SER . 12.6 mt -85.99 -33.82 20.98 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.22 -0.445 . . . . 73.35 110.886 -179.985 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 5.1 m-85 -144.98 142.59 29.93 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.224 -0.443 . . . . 72.01 110.941 -179.979 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 1.9 p-10 -67.46 140.66 57.11 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.132 -0.486 . . . . 74.14 110.892 179.899 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 15.5 t80 -140.94 146.53 37.48 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.182 -0.463 . . . . 72.51 110.918 -179.906 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -115.58 137.37 23.13 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-O 121.632 0.73 . . . . 74.33 110.866 -179.913 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.79 151.59 68.92 Favored 'Trans proline' 0 N--CA 1.465 -0.154 0 C-N-CA 122.701 2.267 . . . . 63.11 112.373 179.987 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 4.2 mt-10 -109.69 -19.44 13.17 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.232 -0.44 . . . . 64.44 110.917 -179.995 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 48.5 m-80 -123.63 175.0 7.08 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.159 -0.473 . . . . 74.43 110.867 -179.931 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 41.5 m-20 -81.05 -1.14 42.86 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.165 -0.471 . . . . 75.25 110.867 179.937 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -112.47 16.35 19.87 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.216 -0.447 . . . . 72.13 110.885 -179.916 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 6.9 mt-10 -110.39 157.15 19.85 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.181 -0.463 . . . . 70.3 110.871 -179.964 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.554 HD12 ' H ' ' A' ' 19' ' ' ARG . 41.7 tp -112.19 147.79 35.42 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.145 -0.479 . . . . 74.02 110.9 -179.994 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . 0.554 ' H ' HD12 ' A' ' 18' ' ' LEU . 32.2 mtm180 -83.17 154.76 24.11 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.196 -0.456 . . . . 75.12 110.86 179.946 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.513 HD21 ' CG1' ' A' ' 55' ' ' VAL . 2.3 tp -142.25 147.94 37.29 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.199 -0.455 . . . . 71.24 110.913 -179.983 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -138.07 139.45 39.54 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.185 -0.461 . . . . 43.34 111.109 179.787 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -51.71 119.58 4.35 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.234 -0.439 . . . . 75.15 110.857 -179.929 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 97.34 -6.72 63.59 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.716 -0.755 . . . . 73.23 112.458 179.987 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -71.39 160.2 33.2 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.752 0.31 . . . . 74.35 110.867 -179.921 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 1.2 mt -123.11 114.04 40.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.205 -0.452 . . . . 74.04 111.122 179.999 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.401 HG11 HD11 ' A' ' 20' ' ' LEU . 12.1 m -117.43 166.92 11.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.12 -0.491 . . . . 73.33 111.131 179.863 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 63.7 m-85 -117.95 106.26 12.76 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.167 -0.469 . . . . 73.45 110.854 -179.943 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.85 HD13 ' HB2' ' A' ' 39' ' ' ALA . 21.3 mm -71.62 103.58 1.38 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.15 -0.477 . . . . 72.24 111.114 179.974 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . 0.453 ' O ' HG23 ' A' ' -2' ' ' ILE . 10.5 m -65.0 -39.55 93.64 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.208 -0.451 . . . . 71.54 110.856 -179.923 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' TYR . . . . . 0.527 ' CZ ' HG21 ' A' ' 38' ' ' VAL . 54.0 p90 -175.41 160.95 2.66 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.116 -0.493 . . . . 70.31 110.88 -179.869 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 16.6 tttt -87.89 146.78 25.4 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.14 -0.482 . . . . 75.15 110.871 179.909 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 35.5 t60 -136.14 155.01 50.78 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.18 -0.463 . . . . 73.2 110.878 179.926 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -60.45 -175.99 1.36 Allowed Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.751 -0.737 . . . . 55.23 112.5 -179.98 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 19.0 mm100 66.53 11.66 8.22 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.898 0.38 . . . . 73.43 110.94 -179.897 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 69.36 27.96 73.06 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.704 -0.76 . . . . 52.43 112.499 -179.95 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' TRP . . . . . 0.678 ' C ' HD23 ' A' ' 37' ' ' LEU . 97.6 m95 -122.33 140.99 52.02 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.779 0.323 . . . . 74.13 110.911 -179.892 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.721 HD11 ' CG ' ' A' ' 52' ' ' GLU . 0.9 OUTLIER -123.9 130.3 52.37 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.227 -0.442 . . . . 55.34 110.935 179.949 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.527 HG21 ' CZ ' ' A' ' 30' ' ' TYR . 21.7 t -75.61 116.36 18.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.221 -0.445 . . . . 64.11 111.121 179.863 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.85 ' HB2' HD13 ' A' ' 28' ' ' ILE . . . -138.45 160.67 38.95 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.212 -0.449 . . . . 54.11 111.104 179.901 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . 0.469 ' HB3' HG23 ' A' ' 47' ' ' THR . 0.4 OUTLIER -121.54 155.87 34.06 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.231 -0.441 . . . . 75.34 110.886 -179.916 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -66.45 -175.35 0.36 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.159 -0.473 . . . . 70.13 110.882 -179.952 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 9.7 tt0 -69.98 -38.74 76.13 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.173 -0.467 . . . . 62.51 110.93 179.996 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 2.0 t -56.83 -22.55 37.4 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.102 -0.499 . . . . 52.42 110.862 -179.782 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 66.97 11.65 58.69 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.765 -0.731 . . . . 75.44 112.476 -179.993 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 1.4 p -103.82 -21.85 13.61 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.912 0.386 . . . . 71.14 110.818 -179.745 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.541 ' HE3' HD11 ' A' ' 18' ' ' LEU . 0.8 OUTLIER -117.63 123.21 45.6 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.156 -0.475 . . . . 74.53 110.89 179.964 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . 0.469 HG23 ' HB3' ' A' ' 40' ' ' GLU . 9.8 m -129.93 133.83 47.08 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.188 -0.46 . . . . 73.21 111.135 179.994 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -152.43 -151.22 5.6 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.779 -0.724 . . . . 63.24 112.481 -179.995 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 18.3 mt -106.94 127.66 53.64 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.872 0.367 . . . . 61.12 110.93 -179.918 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.416 ' HB ' ' HD2' ' A' ' 51' ' ' PRO . 13.3 m -126.31 153.7 74.67 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.675 0.75 . . . . 73.34 111.1 179.872 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 0.493 ' HD2' HD22 ' A' ' 20' ' ' LEU . 53.7 Cg_endo -69.79 152.54 69.16 Favored 'Trans proline' 0 C--N 1.342 0.188 0 C-N-CA 122.675 2.25 . . . . 75.11 112.352 179.955 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . 0.721 ' CG ' HD11 ' A' ' 37' ' ' LEU . 13.9 tm-20 -96.21 -30.48 13.46 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.209 -0.45 . . . . 63.52 110.876 -179.952 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -85.14 8.41 18.26 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.148 -0.478 . . . . 75.15 110.892 -179.941 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . 0.415 ' HB2' ' HG2' ' A' ' 51' ' ' PRO . 1.0 OUTLIER -120.12 2.34 10.91 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.165 -0.471 . . . . 74.5 110.897 -179.954 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.513 ' CG1' HD21 ' A' ' 20' ' ' LEU . 15.8 m -132.57 170.85 19.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.162 -0.472 . . . . 71.44 111.118 179.989 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . 0.597 ' HB3' HD21 ' A' ' 7' ' ' LEU . 9.6 t -143.09 120.96 11.97 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.157 -0.474 . . . . 43.13 110.855 -179.862 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 2.8 m-85 -56.82 135.18 55.62 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.129 -0.487 . . . . 62.51 110.913 -179.847 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.517 HD11 ' HB ' ' A' ' 5' ' ' VAL . 47.0 mt -103.51 149.04 7.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.121 -0.49 . . . . 72.44 111.111 179.938 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -130.95 160.99 64.2 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-O 121.628 0.728 . . . . 74.21 110.894 179.991 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.81 -48.28 0.74 Allowed 'Trans proline' 0 C--N 1.342 0.2 0 C-N-CA 122.694 2.262 . . . . 55.02 112.355 179.988 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 13.6 tt0 -157.09 36.41 0.29 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.235 -0.439 . . . . 73.23 110.879 179.975 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 10.0 mt -121.84 168.99 11.22 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.151 -0.477 . . . . 74.15 110.891 -179.974 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 57.8 mm-40 . . . . . 0 C--N 1.329 -0.296 0 CA-C-N 116.191 -0.459 . . . . 74.33 110.912 179.955 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' B' B ' -9' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.28 0 N-CA-C 112.466 -0.254 . . . . 75.44 112.466 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' B' B ' -8' ' ' LYS . . . . . . . . . . . . . 28.3 mmtp -98.81 -59.35 1.75 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.778 0.323 . . . . 72.34 110.885 -179.943 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' -7' ' ' PHE . . . . . . . . . . . . . 12.6 m-85 -103.67 115.51 30.63 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.236 -0.438 . . . . 72.43 110.821 -179.989 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' -6' ' ' ILE . . . . . . . . . . . . . 5.2 mp -136.43 113.27 10.23 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.65 0.738 . . . . 45.3 111.128 179.928 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' -5' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.74 160.67 48.84 Favored 'Trans proline' 0 C--N 1.341 0.158 0 C-N-CA 122.739 2.293 . . . . 64.24 112.333 179.883 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' -4' ' ' SER . . . . . . . . . . . . . 43.4 t -147.43 46.14 1.13 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.235 -0.439 . . . . 54.23 110.855 -179.84 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' -3' ' ' ARG . . . . . . . . . . . . . 1.5 ptp85 -179.32 155.15 0.78 Allowed Pre-proline 0 C--N 1.328 -0.331 0 CA-C-O 121.612 0.72 . . . . 74.53 110.861 -179.969 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' -2' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.78 129.26 17.26 Favored 'Trans proline' 0 C--N 1.341 0.148 0 C-N-CA 122.65 2.233 . . . . 73.51 112.349 -179.984 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' -1' ' ' ALA . . . . . . . . . . . . . . . -54.64 153.08 11.3 Favored Pre-proline 0 C--N 1.33 -0.266 0 CA-C-O 121.561 0.696 . . . . 75.31 111.095 179.902 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 0' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_endo -69.78 -174.74 0.97 Allowed 'Trans proline' 0 C--O 1.231 0.162 0 C-N-CA 122.707 2.271 . . . . 65.32 112.325 -179.989 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 1' ' ' LYS . . . . . . . . . . . . . 4.9 mtmp? -130.67 156.92 79.1 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 121.594 0.711 . . . . 71.44 110.887 179.904 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 2' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.8 166.12 28.73 Favored 'Trans proline' 0 C--N 1.342 0.192 0 C-N-CA 122.67 2.247 . . . . 65.25 112.365 179.879 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 3' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.71 80.74 0.85 Allowed 'Trans proline' 0 C--O 1.231 0.16 0 C-N-CA 122.666 2.244 . . . . 61.15 112.389 179.937 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 4' ' ' SER . . . . . . . . . . . . . 3.1 m -52.84 -65.83 0.49 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.238 -0.437 . . . . 74.43 110.823 -179.815 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 5' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER 56.37 40.52 29.72 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.098 -0.501 . . . . 65.23 110.849 -179.813 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 6' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.304 0 CA-C-N 116.123 -0.489 . . . . 64.43 111.084 179.888 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' -4' ' ' MET . . . . . . . . . . . . . 5.7 ttm . . . . . 0 C--O 1.231 0.093 0 CA-C-O 120.738 0.304 . . . . 64.21 110.887 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' -3' ' ' ALA . . . . . . . . . . . . . . . -108.07 27.43 9.27 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.235 -0.438 . . . . 72.11 111.111 179.919 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' -2' ' ' ILE . . . . . . . . . . . . . 56.0 mt -128.91 131.29 68.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.18 -0.464 . . . . 62.11 111.117 179.948 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' -1' ' ' VAL . . . . . . . . . . . . . 54.5 t -114.15 131.3 66.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.172 -0.467 . . . . 64.33 111.153 179.825 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 2.4 m120 -94.14 59.83 2.71 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.22 -0.446 . . . . 71.15 110.869 -179.988 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 51.2 tp60 -101.91 134.86 44.44 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.191 -0.459 . . . . 61.12 110.951 179.959 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 6.8 ptp180 -90.61 164.6 14.13 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.206 -0.452 . . . . 71.04 110.863 -179.902 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -156.48 152.58 27.56 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.185 -0.461 . . . . 73.1 111.108 179.94 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.682 ' HB ' HD11 ' A' ' 58' ' ' ILE . 10.9 p -104.08 151.84 6.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.231 -0.44 . . . . 53.23 111.15 179.958 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -89.25 116.85 27.79 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.143 -0.48 . . . . 74.11 111.128 179.876 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.732 HD21 ' HB2' ' A' ' 56' ' ' SER . 10.2 mt -84.52 -36.68 22.02 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.241 -0.436 . . . . 65.13 110.877 -179.955 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 6.4 m-85 -140.32 136.19 32.97 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.232 -0.44 . . . . 73.45 110.952 -179.989 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 1.6 p30 -62.65 139.23 58.64 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.118 -0.492 . . . . 73.24 110.879 179.93 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 10.8 t80 -145.51 145.99 31.27 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.211 -0.45 . . . . 74.15 110.869 -179.886 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -115.96 144.69 33.24 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.674 0.749 . . . . 71.41 110.895 -179.973 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.77 140.63 43.12 Favored 'Trans proline' 0 C--N 1.341 0.158 0 C-N-CA 122.689 2.26 . . . . 70.42 112.368 179.992 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 9.9 mt-10 -101.25 -21.45 14.9 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.194 -0.457 . . . . 63.23 110.875 -179.946 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 34.1 m-80 -110.29 176.66 4.97 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.14 -0.482 . . . . 74.33 110.876 -179.923 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -91.04 20.64 4.76 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.136 -0.484 . . . . 74.3 110.902 179.871 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -140.31 15.37 2.4 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.183 -0.462 . . . . 74.21 110.908 -179.924 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 16.3 mt-10 -107.37 158.07 17.46 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.171 -0.468 . . . . 64.41 110.899 -179.981 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.612 HD23 ' O ' ' A' ' 19' ' ' ARG . 0.3 OUTLIER -104.27 161.07 14.36 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.159 -0.473 . . . . 73.32 110.853 -179.902 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . 0.612 ' O ' HD23 ' A' ' 18' ' ' LEU . 0.9 OUTLIER -96.57 152.78 18.31 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.184 -0.462 . . . . 74.31 110.864 179.941 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.57 HD21 ' CG1' ' A' ' 55' ' ' VAL . 1.8 tp -137.79 149.49 46.43 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.137 -0.483 . . . . 71.04 110.91 -179.982 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.676 ' HB3' ' CG ' ' A' ' 24' ' ' ASP . . . -142.5 138.76 31.18 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.194 -0.457 . . . . 62.12 111.106 179.768 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -50.62 119.86 4.19 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.189 -0.46 . . . . 74.33 110.911 -179.945 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 96.7 -3.45 62.99 Favored Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.74 -0.743 . . . . 64.11 112.445 -179.979 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . 0.676 ' CG ' ' HB3' ' A' ' 21' ' ' ALA . 1.0 OUTLIER -84.63 146.45 27.48 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.721 0.296 . . . . 71.24 110.878 -179.943 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 3.5 mm -101.75 144.88 12.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.199 -0.455 . . . . 63.04 111.109 -179.991 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.418 HG11 HD11 ' A' ' 20' ' ' LEU . 1.5 m -146.58 158.31 10.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.148 -0.478 . . . . 72.01 111.108 179.848 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 54.3 m-85 -116.54 110.08 18.1 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.142 -0.481 . . . . 72.53 110.907 -179.995 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.686 HD13 ' HB2' ' A' ' 39' ' ' ALA . 14.7 mm -73.29 102.74 1.72 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.133 -0.485 . . . . 73.25 111.125 179.965 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 3.9 m -64.8 -40.35 95.08 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.196 -0.456 . . . . 74.11 110.837 -179.909 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' TYR . . . . . 0.524 ' CZ ' HG21 ' A' ' 38' ' ' VAL . 34.4 p90 -174.68 148.58 1.14 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.149 -0.478 . . . . 73.41 110.905 -179.926 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . 0.505 ' HG3' HD22 ' A' ' 37' ' ' LEU . 13.2 tttt -81.0 145.67 31.06 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.12 -0.491 . . . . 72.41 110.887 179.943 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 33.6 t60 -134.58 153.55 51.9 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.214 -0.448 . . . . 75.43 110.852 179.89 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -59.01 -174.12 0.57 Allowed Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.717 -0.754 . . . . 63.15 112.54 -179.97 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 77.9 mm-40 65.49 12.24 8.02 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.825 0.345 . . . . 61.34 110.911 -179.886 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 68.24 29.51 73.28 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.758 -0.734 . . . . 63.12 112.505 -179.98 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' TRP . . . . . 0.625 ' C ' HD23 ' A' ' 37' ' ' LEU . 98.4 m95 -123.51 135.97 54.32 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.81 0.338 . . . . 74.43 110.95 -179.936 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.708 HD11 ' CG ' ' A' ' 52' ' ' GLU . 1.4 mt -119.64 132.3 55.66 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.228 -0.442 . . . . 63.2 110.918 179.986 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.524 HG21 ' CZ ' ' A' ' 30' ' ' TYR . 60.0 t -79.27 109.11 13.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.206 -0.452 . . . . 75.31 111.15 179.825 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.686 ' HB2' HD13 ' A' ' 28' ' ' ILE . . . -129.93 163.02 27.29 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.191 -0.459 . . . . 73.31 111.11 179.924 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 1.5 pt-20 -119.02 156.4 29.7 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.232 -0.44 . . . . 74.22 110.86 -179.903 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -68.6 -175.2 0.64 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.129 -0.487 . . . . 64.42 110.877 -179.954 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 9.1 tm-20 -68.89 -37.81 79.23 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.211 -0.449 . . . . 73.14 110.883 -179.974 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 1.6 t -57.0 -22.61 39.84 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.16 -0.473 . . . . 75.33 110.869 -179.769 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 69.9 8.57 61.24 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.784 -0.722 . . . . 40.42 112.479 -179.97 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 30.9 t -108.15 -22.3 12.44 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.931 0.396 . . . . 54.01 110.86 -179.769 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.457 ' HG2' HD11 ' A' ' 18' ' ' LEU . 2.7 ttmt -107.09 123.84 48.81 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.13 -0.486 . . . . 75.53 110.906 179.977 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 4.3 m -125.7 152.22 45.57 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.244 -0.434 . . . . 70.23 111.142 -179.991 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -177.63 -162.42 27.71 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.746 -0.74 . . . . 24.41 112.476 179.933 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.485 HD23 HG22 ' A' ' 38' ' ' VAL . 5.8 mt -99.21 136.87 38.54 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.847 0.356 . . . . 73.33 110.966 -179.938 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 16.8 m -136.36 153.32 76.26 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-O 121.562 0.696 . . . . 64.53 111.183 179.845 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 0.428 ' HG2' ' HB2' ' A' ' 54' ' ' PHE . 54.2 Cg_endo -69.69 143.5 51.36 Favored 'Trans proline' 0 C--N 1.341 0.152 0 C-N-CA 122.677 2.252 . . . . 72.3 112.362 179.91 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . 0.708 ' CG ' HD11 ' A' ' 37' ' ' LEU . 15.5 tm-20 -90.19 -27.74 19.35 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.209 -0.45 . . . . 61.22 110.901 179.977 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 -86.31 10.44 14.84 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.134 -0.485 . . . . 71.5 110.892 -179.916 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . 0.428 ' HB2' ' HG2' ' A' ' 51' ' ' PRO . 1.0 OUTLIER -120.28 -9.56 9.5 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.138 -0.483 . . . . 74.14 110.898 -179.921 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.57 ' CG1' HD21 ' A' ' 20' ' ' LEU . 15.3 m -117.68 172.47 5.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.171 -0.468 . . . . 73.41 111.119 179.989 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . 0.732 ' HB2' HD21 ' A' ' 7' ' ' LEU . 38.4 t -142.56 113.19 7.36 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.193 -0.458 . . . . 62.32 110.864 -179.885 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 3.1 m-85 -52.17 130.1 29.52 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.133 -0.485 . . . . 75.32 110.936 -179.908 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.682 HD11 ' HB ' ' A' ' 5' ' ' VAL . 54.5 mt -99.97 146.91 8.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.145 -0.479 . . . . 70.24 111.152 179.894 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . 0.423 ' NE2' HD12 ' A' ' 62' ' ' LEU . 8.1 mt-30 -131.02 160.94 64.53 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-O 121.594 0.712 . . . . 73.23 110.903 179.942 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.77 -86.58 0.0 OUTLIER 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 122.655 2.236 . . . . 72.12 112.319 -179.981 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 7.3 tt0 -117.37 23.64 11.66 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.188 -0.46 . . . . 72.03 110.871 -179.966 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.423 HD12 ' NE2' ' A' ' 59' ' ' GLN . 0.1 OUTLIER -134.4 168.52 18.77 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.187 -0.461 . . . . 71.54 110.867 -179.949 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 . . . . . 0 C--N 1.329 -0.284 0 CA-C-N 116.147 -0.479 . . . . 72.24 110.875 179.953 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' B' B ' -9' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.315 0 N-CA-C 112.484 -0.246 . . . . 41.15 112.484 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' B' B ' -8' ' ' LYS . . . . . . . . . . . . . 18.0 mmmt -111.2 121.08 44.36 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.784 0.326 . . . . 72.34 110.912 179.994 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' -7' ' ' PHE . . . . . 0.448 ' HB3' HD11 ' A' ' 49' ' ' LEU . 15.2 m-85 -74.4 144.56 44.29 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.253 -0.43 . . . . 75.13 110.877 179.983 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' -6' ' ' ILE . . . . . . . . . . . . . 2.4 pt -153.36 85.19 4.2 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.668 0.747 . . . . 73.44 111.108 179.956 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' -5' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.82 135.92 31.53 Favored 'Trans proline' 0 C--N 1.342 0.209 0 C-N-CA 122.712 2.275 . . . . 74.34 112.317 179.917 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' -4' ' ' SER . . . . . . . . . . . . . 2.5 m -132.0 62.13 1.64 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.255 -0.429 . . . . 63.22 110.879 -179.856 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' -3' ' ' ARG . . . . . . . . . . . . . 12.8 ptt85 -174.67 153.39 1.75 Allowed Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.669 0.747 . . . . 71.53 110.87 -179.958 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' -2' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.78 128.98 16.79 Favored 'Trans proline' 0 C--N 1.342 0.201 0 C-N-CA 122.665 2.243 . . . . 70.3 112.338 -179.976 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' -1' ' ' ALA . . . . . . . . . . . . . . . -61.74 152.21 76.35 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 121.616 0.722 . . . . 62.22 111.108 179.867 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 0' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.73 -179.85 3.19 Favored 'Trans proline' 0 C--N 1.341 0.181 0 C-N-CA 122.742 2.295 . . . . 73.54 112.331 -179.95 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 1' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -126.58 155.01 75.38 Favored Pre-proline 0 C--N 1.328 -0.362 0 CA-C-O 121.624 0.726 . . . . 72.35 110.857 179.909 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 2' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.76 163.55 37.85 Favored 'Trans proline' 0 C--N 1.342 0.225 0 C-N-CA 122.661 2.241 . . . . 71.23 112.329 179.908 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 3' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.76 104.94 1.4 Allowed 'Trans proline' 0 C--N 1.341 0.166 0 C-N-CA 122.712 2.275 . . . . 61.51 112.36 179.939 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 4' ' ' SER . . . . . . . . . . . . . 15.1 m -71.53 167.36 19.86 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.214 -0.448 . . . . 72.34 110.845 -179.827 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 5' ' ' SER . . . . . . . . . . . . . 6.0 p 54.8 30.82 14.36 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.154 -0.475 . . . . 73.53 110.879 -179.815 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 6' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.297 0 CA-C-N 116.138 -0.483 . . . . 55.22 111.115 179.906 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' -4' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.098 0 CA-C-O 120.766 0.317 . . . . 71.43 110.865 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' -3' ' ' ALA . . . . . . . . . . . . . . . -105.37 59.08 0.67 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.221 -0.445 . . . . 75.23 111.096 179.904 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' -2' ' ' ILE . . . . . . . . . . . . . 5.3 mp -104.6 125.72 59.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.218 -0.446 . . . . 62.03 111.088 179.983 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' -1' ' ' VAL . . . . . . . . . . . . . 7.7 p -103.39 -24.35 4.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.133 -0.485 . . . . 62.35 111.133 179.857 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 13.0 m120 61.93 59.11 1.77 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.14 -0.482 . . . . 72.5 110.915 -179.969 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 29.3 tp60 -111.88 127.42 55.83 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.135 -0.484 . . . . 61.24 110.945 179.983 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 6.3 ptm180 -76.63 162.43 27.75 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.203 -0.453 . . . . 63.44 110.88 -179.908 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -154.45 154.47 33.26 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.209 -0.451 . . . . 73.42 111.124 179.962 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.549 ' HB ' HD11 ' A' ' 58' ' ' ILE . 9.2 p -109.1 140.58 27.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.24 -0.436 . . . . 71.52 111.135 179.99 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -77.88 122.34 25.34 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.189 -0.46 . . . . 70.44 111.099 179.883 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.763 HD21 ' CB ' ' A' ' 56' ' ' SER . 16.6 mt -87.48 -34.79 18.54 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.195 -0.457 . . . . 72.34 110.914 -179.936 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 4.3 m-85 -144.58 149.86 36.5 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.161 -0.472 . . . . 73.4 110.871 -179.953 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -70.92 137.66 49.43 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.108 -0.496 . . . . 73.24 110.837 179.934 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 21.4 t80 -142.0 145.65 34.68 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.144 -0.48 . . . . 74.13 110.907 -179.916 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -119.41 137.29 25.22 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-O 121.679 0.752 . . . . 75.31 110.88 -179.929 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.433 ' HG3' ' HG3' ' A' ' 19' ' ' ARG . 53.6 Cg_endo -69.78 150.84 68.64 Favored 'Trans proline' 0 C--N 1.342 0.212 0 C-N-CA 122.636 2.224 . . . . 75.42 112.361 179.962 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 17.8 tp10 -109.28 -15.78 14.2 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.177 -0.465 . . . . 51.22 110.906 -179.98 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 9.8 m-80 -115.17 176.03 5.25 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.137 -0.483 . . . . 73.31 110.911 -179.925 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -92.26 20.87 5.62 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.197 -0.456 . . . . 73.24 110.857 179.948 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 1.2 p-10 -136.46 9.1 3.15 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.189 -0.46 . . . . 74.24 110.871 -179.907 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 12.0 mt-10 -105.63 157.44 17.4 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.177 -0.465 . . . . 61.23 110.908 179.989 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 55.5 tp -107.05 156.59 18.59 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.138 -0.483 . . . . 74.31 110.934 179.999 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . 0.433 ' HG3' ' HG3' ' A' ' 12' ' ' PRO . 0.7 OUTLIER -92.75 160.68 14.85 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.192 -0.458 . . . . 62.3 110.911 179.928 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.612 HD21 ' CG1' ' A' ' 55' ' ' VAL . 3.5 tp -142.27 149.24 39.29 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.196 -0.456 . . . . 70.21 110.946 -179.985 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.686 ' HB3' ' CG ' ' A' ' 24' ' ' ASP . . . -140.12 134.43 31.27 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.229 -0.441 . . . . 73.11 111.08 179.888 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -50.4 121.12 5.23 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.211 -0.45 . . . . 73.0 110.874 -179.929 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 96.59 -3.64 63.37 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.765 -0.731 . . . . 54.21 112.478 -179.971 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . 0.686 ' CG ' ' HB3' ' A' ' 21' ' ' ALA . 1.0 OUTLIER -85.08 146.9 26.92 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.805 0.336 . . . . 55.54 110.839 -179.944 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 3.3 mm -100.54 141.06 18.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.152 -0.476 . . . . 73.41 111.112 -179.973 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 1.5 m -142.78 158.0 18.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.168 -0.469 . . . . 65.45 111.165 179.821 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 44.6 m-85 -115.42 106.58 14.14 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.181 -0.463 . . . . 74.14 110.86 -179.937 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.836 HD13 ' HB2' ' A' ' 39' ' ' ALA . 19.6 mm -72.01 103.12 1.39 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.145 -0.479 . . . . 64.12 111.128 179.957 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 3.3 m -64.48 -39.47 93.85 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.161 -0.472 . . . . 73.41 110.878 -179.934 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' TYR . . . . . 0.47 ' CZ ' HG21 ' A' ' 38' ' ' VAL . 33.4 p90 -174.53 147.85 1.14 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.111 -0.495 . . . . 71.13 110.889 -179.895 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . 0.57 ' HG3' HD22 ' A' ' 37' ' ' LEU . 18.7 tttt -82.68 145.41 29.63 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.121 -0.491 . . . . 51.34 110.893 179.894 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 29.7 t60 -134.86 153.97 51.84 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.195 -0.457 . . . . 62.1 110.824 179.917 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -59.23 -174.26 0.65 Allowed Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.733 -0.746 . . . . 41.32 112.53 179.977 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 73.8 mm-40 65.59 12.44 8.23 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.803 0.335 . . . . 73.2 110.908 -179.895 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 68.22 28.82 73.16 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.721 -0.752 . . . . 60.31 112.504 -179.956 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' TRP . . . . . 0.638 ' C ' HD23 ' A' ' 37' ' ' LEU . 99.0 m95 -123.17 135.64 54.41 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.768 0.318 . . . . 64.24 110.938 -179.928 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.695 HD11 ' CG ' ' A' ' 52' ' ' GLU . 0.4 OUTLIER -124.46 131.89 53.49 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.254 -0.43 . . . . 61.5 110.902 179.969 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.47 HG21 ' CZ ' ' A' ' 30' ' ' TYR . 60.4 t -77.39 116.89 21.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.128 -0.487 . . . . 61.14 111.133 179.82 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.836 ' HB2' HD13 ' A' ' 28' ' ' ILE . . . -137.28 160.06 40.13 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.181 -0.463 . . . . 60.13 111.08 179.872 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . 0.449 ' HB3' HG23 ' A' ' 47' ' ' THR . 0.5 OUTLIER -121.76 160.15 25.18 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.225 -0.443 . . . . 72.15 110.924 -179.976 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -71.78 -175.27 1.35 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.142 -0.481 . . . . 74.11 110.924 -179.93 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -69.61 -38.34 77.23 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.205 -0.452 . . . . 62.52 110.876 -179.97 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 1.5 t -57.1 -22.58 40.75 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.155 -0.475 . . . . 74.23 110.867 -179.794 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 66.46 12.05 57.83 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.681 -0.771 . . . . 52.33 112.516 180.0 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 12.9 m -105.24 -21.06 13.32 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.945 0.402 . . . . 52.32 110.836 -179.707 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 1.4 ttmt -118.53 123.38 44.95 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.148 -0.478 . . . . 63.24 110.889 179.948 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . 0.449 HG23 ' HB3' ' A' ' 40' ' ' GLU . 11.4 m -131.62 143.02 50.01 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.228 -0.442 . . . . 51.1 111.166 179.957 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -160.71 -151.77 6.34 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.788 -0.72 . . . . 44.42 112.511 179.979 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 8.4 mt -107.03 131.69 53.79 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.862 0.363 . . . . 72.31 110.906 -179.942 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.432 ' HB ' ' HD2' ' A' ' 51' ' ' PRO . 18.3 m -129.88 154.45 81.11 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-O 121.606 0.717 . . . . 70.14 111.164 179.829 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 0.432 ' HD2' ' HB ' ' A' ' 50' ' ' VAL . 53.6 Cg_endo -69.75 148.15 64.53 Favored 'Trans proline' 0 C--O 1.231 0.145 0 C-N-CA 122.713 2.276 . . . . 75.02 112.36 179.96 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . 0.695 ' CG ' HD11 ' A' ' 37' ' ' LEU . 30.1 tt0 -93.07 -29.5 15.76 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.256 -0.429 . . . . 75.41 110.854 -179.962 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -84.39 7.33 19.93 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.199 -0.455 . . . . 74.0 110.879 -179.943 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . 0.418 ' HB2' ' HG2' ' A' ' 51' ' ' PRO . 1.2 m-85 -120.41 3.47 10.78 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.155 -0.475 . . . . 74.14 110.862 -179.911 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.612 ' CG1' HD21 ' A' ' 20' ' ' LEU . 7.1 m -128.88 172.76 14.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.171 -0.468 . . . . 75.23 111.164 179.966 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . 0.763 ' CB ' HD21 ' A' ' 7' ' ' LEU . 13.1 t -145.55 113.69 6.56 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.188 -0.46 . . . . 73.43 110.87 -179.828 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 2.5 m-85 -51.87 137.05 27.17 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.163 -0.471 . . . . 65.12 110.904 -179.866 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.549 HD11 ' HB ' ' A' ' 5' ' ' VAL . 24.6 mt -104.94 152.52 6.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.114 -0.493 . . . . 73.43 111.14 179.899 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . 0.417 ' HG2' HD12 ' A' ' 62' ' ' LEU . 0.0 OUTLIER -131.24 160.89 65.0 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-O 121.577 0.703 . . . . 73.21 110.912 179.986 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.74 -48.85 0.63 Allowed 'Trans proline' 0 C--N 1.341 0.165 0 C-N-CA 122.7 2.267 . . . . 62.4 112.357 179.94 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -151.67 21.33 0.71 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.228 -0.442 . . . . 74.31 110.889 -179.998 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.417 HD12 ' HG2' ' A' ' 59' ' ' GLN . 7.3 mt -111.54 169.82 8.55 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.162 -0.472 . . . . 74.45 110.892 -179.981 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 14.5 tt0 . . . . . 0 C--N 1.33 -0.25 0 CA-C-N 116.198 -0.456 . . . . 73.4 110.885 179.936 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' B' B ' -9' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.323 0 N-CA-C 112.487 -0.245 . . . . 64.4 112.487 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' B' B ' -8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -114.39 32.8 5.69 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.779 0.324 . . . . 74.22 110.867 -179.93 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' -7' ' ' PHE . . . . . . . . . . . . . 14.0 m-85 -128.47 114.32 16.63 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.245 -0.434 . . . . 54.0 110.89 179.989 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' -6' ' ' ILE . . . . . . . . . . . . . 60.2 mt -125.64 125.92 24.97 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 121.603 0.716 . . . . 53.42 111.147 179.971 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' -5' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.81 160.09 50.95 Favored 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.658 2.239 . . . . 74.32 112.324 179.902 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' -4' ' ' SER . . . . . . . . . . . . . 7.3 t -136.56 37.25 2.67 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.218 -0.447 . . . . 64.14 110.879 -179.855 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' -3' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -177.56 155.0 1.08 Allowed Pre-proline 0 C--N 1.33 -0.275 0 CA-C-O 121.542 0.687 . . . . 61.44 110.894 -179.919 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' -2' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.77 131.5 21.36 Favored 'Trans proline' 0 C--O 1.231 0.138 0 C-N-CA 122.682 2.254 . . . . 73.13 112.362 -179.971 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' -1' ' ' ALA . . . . . . . . . . . . . . . -55.5 154.47 12.19 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-O 121.591 0.71 . . . . 73.15 111.088 179.884 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 0' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.76 -170.24 0.38 Allowed 'Trans proline' 0 C--N 1.342 0.194 0 C-N-CA 122.66 2.24 . . . . 64.32 112.391 179.959 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 1' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -134.17 148.93 69.94 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-O 121.561 0.696 . . . . 65.2 110.946 179.887 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 2' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.8 163.35 38.63 Favored 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.699 2.266 . . . . 51.11 112.352 179.891 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 3' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.7 -178.89 2.53 Favored 'Trans proline' 0 C--N 1.342 0.198 0 C-N-CA 122.68 2.254 . . . . 72.3 112.367 179.971 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 4' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 51.67 53.31 12.94 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.236 -0.438 . . . . 62.41 110.891 -179.83 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 5' ' ' SER . . . . . . . . . . . . . 2.0 m -64.27 127.0 29.56 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.151 -0.477 . . . . 64.21 110.883 -179.834 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 6' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.33 -0.279 0 CA-C-N 116.131 -0.486 . . . . 75.31 111.123 179.899 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' -4' ' ' MET . . . . . . . . . . . . . 1.7 mpt? . . . . . 0 C--O 1.231 0.084 0 CA-C-O 120.758 0.313 . . . . 63.5 110.901 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' -3' ' ' ALA . . . . . . . . . . . . . . . 59.3 37.18 23.63 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.232 -0.44 . . . . 44.14 111.103 179.905 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' -2' ' ' ILE . . . . . . . . . . . . . 69.7 mt -133.31 119.56 35.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.243 -0.435 . . . . 75.31 111.17 -179.966 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' -1' ' ' VAL . . . . . . . . . . . . . 26.1 t -108.17 129.25 62.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.243 -0.435 . . . . 73.31 111.159 179.87 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 2.1 m-80 -91.29 60.87 4.31 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.177 -0.465 . . . . 64.12 110.884 -179.983 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 33.0 tp60 -96.7 127.31 42.55 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.211 -0.45 . . . . 73.14 110.902 -179.993 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 5.6 ptp180 -80.7 162.05 24.32 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.216 -0.447 . . . . 74.03 110.863 -179.931 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -155.1 149.96 26.67 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.176 -0.465 . . . . 60.53 111.069 179.932 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.675 ' HB ' HD11 ' A' ' 58' ' ' ILE . 7.3 p -105.83 137.98 33.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.21 -0.45 . . . . 72.33 111.133 179.967 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . 0.459 ' HA ' HG12 ' A' ' 55' ' ' VAL . . . -78.56 128.3 33.33 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.216 -0.447 . . . . 64.44 111.047 179.91 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.568 HD21 ' HB3' ' A' ' 56' ' ' SER . 10.5 mt -93.32 -31.89 14.51 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.153 -0.476 . . . . 75.12 110.922 179.986 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 3.8 m-85 -144.37 135.91 25.71 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.193 -0.458 . . . . 72.51 110.934 179.995 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -60.11 149.58 32.17 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.122 -0.49 . . . . 75.51 110.899 179.883 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 30.7 t80 -149.01 147.1 28.16 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.181 -0.463 . . . . 74.12 110.881 -179.871 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 8.5 tm-20 -117.0 134.56 22.98 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 121.649 0.738 . . . . 71.04 110.913 -179.971 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.4 ' HD3' ' HA ' ' A' ' 19' ' ' ARG . 53.4 Cg_endo -69.76 141.57 45.56 Favored 'Trans proline' 0 C--O 1.232 0.19 0 C-N-CA 122.665 2.243 . . . . 53.22 112.353 -179.99 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 13.8 mp0 -102.99 -20.01 14.37 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.249 -0.432 . . . . 71.13 110.927 -179.997 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 34.1 m-80 -111.29 175.7 5.32 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.123 -0.49 . . . . 74.4 110.848 -179.936 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -92.37 19.59 6.98 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.172 -0.467 . . . . 74.11 110.888 179.886 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -135.35 10.92 3.51 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.245 -0.434 . . . . 73.34 110.848 -179.886 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 6.3 mm-40 -101.53 164.39 11.78 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.204 -0.453 . . . . 70.43 110.904 179.977 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.638 HD12 ' H ' ' A' ' 19' ' ' ARG . 19.3 tp -115.71 141.52 47.97 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.129 -0.487 . . . . 62.3 110.885 -179.935 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . 0.638 ' H ' HD12 ' A' ' 18' ' ' LEU . 31.5 mtm180 -75.24 155.17 37.06 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.165 -0.471 . . . . 63.44 110.886 179.951 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.585 HD22 ' HD2' ' A' ' 51' ' ' PRO . 3.5 tp -140.7 149.58 42.37 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.213 -0.448 . . . . 71.43 110.889 -179.947 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.447 ' O ' ' HB3' ' A' ' 6' ' ' ALA . . . -139.98 139.76 36.13 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.199 -0.455 . . . . 62.31 111.099 179.786 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -53.91 119.24 4.76 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.194 -0.457 . . . . 63.12 110.917 -179.919 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 93.49 0.19 67.46 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.769 -0.729 . . . . 54.14 112.484 -179.969 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 23.8 t0 -76.88 159.24 30.19 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.798 0.333 . . . . 72.5 110.909 -179.986 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 1.7 mm -110.92 123.1 66.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.154 -0.475 . . . . 75.31 111.109 -179.969 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.468 HG11 HD11 ' A' ' 20' ' ' LEU . 3.6 m -132.26 152.82 37.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.166 -0.47 . . . . 65.14 111.121 179.878 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 68.9 m-85 -112.82 109.02 18.22 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.183 -0.462 . . . . 71.13 110.882 -179.976 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.705 HD13 ' HB2' ' A' ' 39' ' ' ALA . 19.0 mm -72.32 103.02 1.45 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.086 -0.506 . . . . 71.44 111.131 -179.997 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 2.9 m -64.59 -40.09 94.9 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.167 -0.47 . . . . 70.31 110.864 -179.893 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' TYR . . . . . 0.474 ' CZ ' HG21 ' A' ' 38' ' ' VAL . 31.7 p90 -173.91 146.09 1.18 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.139 -0.482 . . . . 73.03 110.916 -179.861 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . 0.525 ' HG3' HD22 ' A' ' 37' ' ' LEU . 19.2 tttt -79.87 147.26 31.79 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.148 -0.478 . . . . 75.44 110.925 179.871 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 32.3 t60 -137.4 154.54 49.96 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.227 -0.442 . . . . 65.32 110.85 179.939 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -59.37 -175.02 0.76 Allowed Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.746 -0.74 . . . . 61.22 112.494 -179.95 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 24.0 mm100 65.61 12.78 8.49 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.844 0.354 . . . . 74.44 110.93 -179.89 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 68.14 27.74 73.6 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.691 -0.766 . . . . 75.33 112.475 -179.991 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' TRP . . . . . 0.606 ' C ' HD23 ' A' ' 37' ' ' LEU . 98.5 m95 -122.01 137.42 54.81 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.82 0.343 . . . . 75.55 110.948 -179.915 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.683 HD11 ' CG ' ' A' ' 52' ' ' GLU . 0.5 OUTLIER -125.18 130.52 52.31 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.255 -0.429 . . . . 53.41 110.934 179.982 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.474 HG21 ' CZ ' ' A' ' 30' ' ' TYR . 44.1 t -77.27 115.16 18.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.164 -0.471 . . . . 74.45 111.132 179.878 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.705 ' HB2' HD13 ' A' ' 28' ' ' ILE . . . -137.0 166.16 24.31 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.133 -0.485 . . . . 72.21 111.12 179.919 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -117.62 156.68 27.74 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.233 -0.44 . . . . 64.52 110.886 -179.937 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -71.36 -176.85 1.61 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.151 -0.477 . . . . 70.21 110.852 -179.933 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 20.5 tt0 -67.45 -38.47 84.55 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.124 -0.489 . . . . 71.41 110.921 179.984 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 1.3 t -57.19 -22.14 38.41 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.144 -0.48 . . . . 75.45 110.847 -179.789 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 65.93 12.59 57.67 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.682 -0.771 . . . . 75.44 112.48 -179.995 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 13.4 t -109.42 -15.61 14.19 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.932 0.396 . . . . 74.25 110.885 -179.738 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 7.1 ptmt -119.98 134.85 55.12 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.127 -0.488 . . . . 62.43 110.912 179.935 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 6.4 m -135.06 143.72 46.86 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.252 -0.431 . . . . 63.12 111.162 179.969 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -164.68 -154.94 8.16 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.694 -0.765 . . . . 54.4 112.482 179.972 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.516 HD11 ' HB3' ' B' ' -7' ' ' PHE . 6.7 mt -104.8 129.41 53.09 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.849 0.357 . . . . 42.41 110.889 -179.89 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.44 ' HB ' ' HD2' ' A' ' 51' ' ' PRO . 16.8 m -127.73 154.25 77.89 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.666 0.746 . . . . 60.13 111.095 179.836 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 0.585 ' HD2' HD22 ' A' ' 20' ' ' LEU . 53.5 Cg_endo -69.77 149.45 66.85 Favored 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.666 2.244 . . . . 53.21 112.326 179.962 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . 0.683 ' CG ' HD11 ' A' ' 37' ' ' LEU . 28.3 tt0 -94.36 -30.17 14.64 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.231 -0.44 . . . . 64.32 110.925 -179.983 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -85.24 7.72 21.06 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.093 -0.503 . . . . 74.02 110.899 -179.942 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . 0.407 ' HB2' ' HG2' ' A' ' 51' ' ' PRO . 1.2 m-85 -119.29 4.57 11.25 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.126 -0.488 . . . . 65.14 110.908 -179.95 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.459 HG12 ' HA ' ' A' ' 6' ' ' ALA . 14.8 m -134.4 164.11 35.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.121 -0.49 . . . . 71.32 111.132 179.975 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . 0.568 ' HB3' HD21 ' A' ' 7' ' ' LEU . 25.7 t -136.24 117.27 14.32 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.222 -0.444 . . . . 75.22 110.869 -179.85 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 2.9 m-85 -52.1 136.95 28.75 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.108 -0.496 . . . . 71.52 110.944 -179.892 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.675 HD11 ' HB ' ' A' ' 5' ' ' VAL . 32.1 mt -104.64 150.32 7.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.146 -0.479 . . . . 63.35 111.102 179.938 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 2.7 mt-30 -131.14 160.8 65.33 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-O 121.611 0.72 . . . . 73.43 110.95 179.914 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.72 -48.63 0.69 Allowed 'Trans proline' 0 C--N 1.341 0.159 0 C-N-CA 122.711 2.274 . . . . 74.34 112.32 -179.966 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -159.27 25.78 0.2 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.221 -0.445 . . . . 61.43 110.891 -179.956 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 11.4 mt -110.4 155.39 22.24 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.155 -0.475 . . . . 65.15 110.908 -179.981 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 10.9 tt0 . . . . . 0 C--N 1.329 -0.287 0 CA-C-N 116.188 -0.46 . . . . 72.22 110.892 179.942 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' B' B ' -9' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.351 0 N-CA-C 112.449 -0.26 . . . . 54.35 112.449 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' B' B ' -8' ' ' LYS . . . . . . . . . . . . . 14.7 mmmt -55.27 -55.26 33.41 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.787 0.327 . . . . 75.11 110.905 -179.985 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' -7' ' ' PHE . . . . . 0.516 ' HB3' HD11 ' A' ' 49' ' ' LEU . 8.4 m-85 -66.81 171.08 5.64 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.223 -0.444 . . . . 71.4 110.853 179.983 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' -6' ' ' ILE . . . . . 0.478 ' O ' HG23 ' B' ' -6' ' ' ILE . 3.8 tp -175.89 91.28 0.28 Allowed Pre-proline 0 C--N 1.328 -0.333 0 CA-C-O 121.634 0.731 . . . . 42.15 111.107 179.989 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' -5' ' ' PRO . . . . . 0.414 ' HD2' ' HA ' ' B' ' -6' ' ' ILE . 53.4 Cg_endo -69.79 139.4 40.03 Favored 'Trans proline' 0 C--N 1.341 0.156 0 C-N-CA 122.677 2.252 . . . . 74.44 112.344 179.868 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' -4' ' ' SER . . . . . . . . . . . . . 2.6 m -132.55 62.45 1.65 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.212 -0.449 . . . . 53.33 110.877 -179.839 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' -3' ' ' ARG . . . . . . . . . . . . . 13.6 ptp180 -179.63 155.41 0.75 Allowed Pre-proline 0 C--N 1.329 -0.32 0 CA-C-O 121.592 0.71 . . . . 71.1 110.852 -179.928 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' -2' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.72 135.42 30.49 Favored 'Trans proline' 0 C--N 1.341 0.169 0 C-N-CA 122.724 2.283 . . . . 75.42 112.33 179.995 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' -1' ' ' ALA . . . . . . . . . . . . . . . -68.15 153.02 96.04 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.615 0.722 . . . . 62.44 111.085 179.877 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 0' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_endo -69.81 174.63 9.27 Favored 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.672 2.248 . . . . 73.15 112.342 -179.954 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 1' ' ' LYS . . . . . . . . . . . . . 16.5 pttm -122.63 153.21 62.86 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.526 0.679 . . . . 74.12 110.933 179.887 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 2' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.76 164.16 35.58 Favored 'Trans proline' 0 C--O 1.232 0.19 0 C-N-CA 122.659 2.239 . . . . 73.23 112.385 179.901 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 3' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.71 -23.24 31.23 Favored 'Trans proline' 0 C--O 1.231 0.157 0 C-N-CA 122.692 2.261 . . . . 62.53 112.356 179.955 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 4' ' ' SER . . . . . . . . . . . . . 7.5 p -59.05 156.86 11.09 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.209 -0.451 . . . . 61.32 110.896 -179.885 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 5' ' ' SER . . . . . . . . . . . . . 42.0 p -64.92 -41.44 95.54 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.127 -0.488 . . . . 60.33 110.875 -179.815 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 6' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.321 0 CA-C-N 116.182 -0.463 . . . . 44.21 111.078 179.893 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' -4' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.232 0.136 0 CA-C-O 120.775 0.321 . . . . 73.12 110.885 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' -3' ' ' ALA . . . . . . . . . . . . . . . -127.64 63.37 1.37 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.269 -0.423 . . . . 63.41 111.094 179.93 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' -2' ' ' ILE . . . . . 0.405 HD12 ' N ' ' A' ' -2' ' ' ILE . 4.3 mp -121.59 126.72 75.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.206 -0.452 . . . . 73.21 111.116 179.982 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' -1' ' ' VAL . . . . . . . . . . . . . 25.3 t -109.72 131.8 59.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.207 -0.451 . . . . 63.35 111.125 179.828 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 5.3 m-80 -92.3 60.02 3.58 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.16 -0.473 . . . . 74.03 110.913 179.958 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 56.5 tp60 -99.48 128.77 45.61 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.192 -0.458 . . . . 70.02 110.895 -179.977 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -83.43 163.9 20.25 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.2 -0.455 . . . . 64.51 110.843 -179.938 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -154.58 152.25 29.8 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.168 -0.469 . . . . 62.31 111.086 179.958 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.534 ' HB ' HD11 ' A' ' 58' ' ' ILE . 10.0 p -104.13 149.08 8.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.262 -0.427 . . . . 54.24 111.15 179.975 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . 0.415 ' HB3' ' O ' ' A' ' 21' ' ' ALA . . . -90.4 117.78 29.37 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.218 -0.446 . . . . 64.04 111.105 179.873 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.744 HD21 ' HB3' ' A' ' 56' ' ' SER . 7.0 mt -84.52 -35.69 22.7 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.255 -0.429 . . . . 43.22 110.905 -179.963 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 5.4 m-85 -140.75 136.89 32.98 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.185 -0.461 . . . . 75.11 110.909 -179.96 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -64.06 137.88 58.19 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.076 -0.511 . . . . 65.3 110.91 179.924 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 18.5 t80 -137.33 145.37 43.29 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.204 -0.453 . . . . 63.22 110.851 -179.878 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 7.0 tt0 -115.69 136.13 22.78 Favored Pre-proline 0 C--N 1.33 -0.261 0 CA-C-O 121.671 0.748 . . . . 63.24 110.86 -179.925 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.42 ' HD3' ' HA ' ' A' ' 19' ' ' ARG . 53.7 Cg_endo -69.74 143.94 52.53 Favored 'Trans proline' 0 C--N 1.342 0.189 0 C-N-CA 122.718 2.279 . . . . 71.45 112.29 179.999 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -107.38 -7.51 16.63 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.21 -0.45 . . . . 71.43 110.873 179.965 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 59.3 m-80 -124.5 175.78 6.93 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.196 -0.457 . . . . 45.44 110.893 -179.95 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 8.9 p30 -93.58 24.2 4.18 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.205 -0.452 . . . . 64.12 110.887 179.917 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 1.2 p-10 -139.97 11.82 2.43 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.163 -0.471 . . . . 74.3 110.873 -179.899 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 10.0 mm-40 -106.38 163.35 12.92 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.186 -0.461 . . . . 70.12 110.864 -179.978 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.648 HD12 ' H ' ' A' ' 19' ' ' ARG . 20.7 tp -113.02 142.64 45.48 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.134 -0.485 . . . . 72.44 110.896 -179.951 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . 0.648 ' H ' HD12 ' A' ' 18' ' ' LEU . 6.6 mtp85 -79.03 153.45 30.23 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.192 -0.458 . . . . 75.32 110.89 179.94 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.553 HD21 ' CG1' ' A' ' 55' ' ' VAL . 2.3 tp -138.55 149.07 44.94 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.192 -0.458 . . . . 75.35 110.901 -179.973 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.687 ' HB3' ' OD2' ' A' ' 24' ' ' ASP . . . -140.7 139.76 34.78 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.205 -0.452 . . . . 42.2 111.151 179.766 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -50.62 122.85 7.78 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.222 -0.445 . . . . 75.33 110.865 -179.885 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 97.18 -13.48 64.67 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.777 -0.725 . . . . 73.32 112.478 -179.994 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . 0.687 ' OD2' ' HB3' ' A' ' 21' ' ' ALA . 7.2 m-20 -71.53 149.07 46.11 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.796 0.332 . . . . 72.12 110.87 -179.982 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 1.7 mt -116.62 119.83 63.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.182 -0.463 . . . . 74.41 111.093 -179.955 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 6.4 m -119.14 165.76 14.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.129 -0.487 . . . . 73.42 111.125 179.851 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 46.7 m-85 -114.47 106.92 14.85 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.145 -0.479 . . . . 64.45 110.869 -179.949 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.744 HD13 ' HB2' ' A' ' 39' ' ' ALA . 17.6 mm -70.71 102.91 1.01 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.187 -0.461 . . . . 64.34 111.136 179.967 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 3.6 m -65.19 -39.57 93.03 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.127 -0.488 . . . . 64.35 110.856 -179.898 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' TYR . . . . . 0.492 ' CZ ' HG21 ' A' ' 38' ' ' VAL . 32.1 p90 -174.38 146.83 1.1 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.162 -0.472 . . . . 74.13 110.876 -179.88 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . 0.512 ' HG3' HD22 ' A' ' 37' ' ' LEU . 18.7 tttt -80.77 146.17 31.12 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.122 -0.49 . . . . 52.32 110.906 179.886 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 33.7 t60 -135.27 155.97 49.75 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.223 -0.444 . . . . 70.32 110.86 179.899 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -60.84 -174.22 1.14 Allowed Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.754 -0.736 . . . . 74.33 112.519 -179.967 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 41.9 mm-40 64.79 13.21 8.3 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.859 0.362 . . . . 65.13 110.9 -179.914 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 67.94 28.98 73.3 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.715 -0.755 . . . . 72.14 112.489 -179.969 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' TRP . . . . . 0.637 ' C ' HD23 ' A' ' 37' ' ' LEU . 98.7 m95 -122.82 138.11 54.74 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.766 0.317 . . . . 74.12 110.909 -179.871 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.695 HD11 ' CG ' ' A' ' 52' ' ' GLU . 0.5 OUTLIER -125.96 130.47 51.3 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.25 -0.432 . . . . 74.5 110.931 179.934 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.492 HG21 ' CZ ' ' A' ' 30' ' ' TYR . 41.7 t -77.2 115.21 18.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.186 -0.461 . . . . 75.02 111.095 179.868 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.744 ' HB2' HD13 ' A' ' 28' ' ' ILE . . . -135.54 163.53 29.89 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.187 -0.46 . . . . 72.4 111.09 179.86 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 1.6 pm0 -121.58 160.49 24.23 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.211 -0.449 . . . . 53.54 110.826 -179.928 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 43.4 p-10 -58.91 -174.8 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.088 -0.505 . . . . 74.22 110.893 -179.94 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 15.2 tt0 -78.43 -38.63 40.9 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.188 -0.46 . . . . 74.13 110.914 179.998 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 4.4 m -68.73 -22.55 64.32 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.134 -0.485 . . . . 72.22 110.847 -179.785 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 76.61 26.76 62.38 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.704 -0.76 . . . . 71.33 112.52 -179.977 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 3.5 m -105.48 -22.19 13.06 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.946 0.403 . . . . 73.32 110.875 -179.717 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.401 ' HD2' HD11 ' A' ' 18' ' ' LEU . 0.0 OUTLIER -125.68 138.05 53.87 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.122 -0.49 . . . . 70.02 110.928 179.904 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 30.7 m -136.8 143.89 43.4 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.243 -0.435 . . . . 41.33 111.149 179.976 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -167.74 -155.62 9.44 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.736 -0.745 . . . . 63.32 112.513 179.938 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 7.0 mt -103.57 132.19 50.04 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.828 0.347 . . . . 72.1 110.908 -179.922 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.413 ' HB ' ' HD2' ' A' ' 51' ' ' PRO . 6.7 m -129.53 153.47 80.67 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 121.592 0.711 . . . . 62.24 111.161 179.85 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 0.448 ' HD2' HD22 ' A' ' 20' ' ' LEU . 54.0 Cg_endo -69.73 150.76 68.82 Favored 'Trans proline' 0 C--N 1.341 0.147 0 C-N-CA 122.741 2.294 . . . . 74.21 112.318 179.968 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . 0.695 ' CG ' HD11 ' A' ' 37' ' ' LEU . 28.2 tt0 -95.74 -28.89 14.56 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.186 -0.461 . . . . 54.14 110.833 -179.982 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -87.3 11.08 15.2 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.195 -0.457 . . . . 70.5 110.907 -179.909 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -121.01 -8.15 9.38 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.122 -0.49 . . . . 72.33 110.891 -179.931 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.553 ' CG1' HD21 ' A' ' 20' ' ' LEU . 12.3 m -120.02 172.84 6.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.154 -0.475 . . . . 73.34 111.153 -179.998 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . 0.744 ' HB3' HD21 ' A' ' 7' ' ' LEU . 3.3 t -143.25 114.3 7.77 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.195 -0.457 . . . . 33.31 110.882 -179.868 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 2.6 m-85 -52.33 127.11 21.14 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.131 -0.486 . . . . 75.33 110.912 -179.868 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.534 HD11 ' HB ' ' A' ' 5' ' ' VAL . 42.6 mt -94.85 149.94 4.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.122 -0.49 . . . . 71.21 111.17 179.887 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . 0.403 ' HB2' ' HD2' ' A' ' 60' ' ' PRO . 0.0 OUTLIER -96.92 154.6 38.2 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.601 0.715 . . . . 73.32 110.933 179.951 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . 0.403 ' HD2' ' HB2' ' A' ' 59' ' ' GLN . 53.7 Cg_endo -69.72 -48.56 0.7 Allowed 'Trans proline' 0 C--N 1.341 0.157 0 C-N-CA 122.726 2.284 . . . . 64.42 112.352 179.992 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 18.9 tt0 -161.73 35.31 0.13 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.221 -0.445 . . . . 74.44 110.854 -179.978 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 14.4 mt -98.8 -179.76 4.39 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.165 -0.47 . . . . 74.44 110.906 179.993 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 75.3 mt-10 . . . . . 0 C--N 1.33 -0.262 0 CA-C-N 116.196 -0.457 . . . . 72.12 110.855 179.969 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' B' B ' -9' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.32 0 N-CA-C 112.518 -0.233 . . . . 73.24 112.518 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' B' B ' -8' ' ' LYS . . . . . . . . . . . . . 17.8 mmmt -121.17 -49.57 2.17 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.816 0.341 . . . . 73.24 110.904 -179.975 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' -7' ' ' PHE . . . . . . . . . . . . . 10.8 m-85 -108.2 124.0 49.61 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.18 -0.464 . . . . 73.55 110.93 179.979 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' -6' ' ' ILE . . . . . 0.411 ' O ' HG23 ' B' ' -6' ' ' ILE . 5.9 tt -138.78 119.3 9.79 Favored Pre-proline 0 C--N 1.328 -0.35 0 CA-C-O 121.615 0.721 . . . . 74.53 111.131 179.985 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' -5' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.82 154.26 67.72 Favored 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.674 2.249 . . . . 63.52 112.372 179.862 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' -4' ' ' SER . . . . . . . . . . . . . 45.2 t -132.45 41.89 3.16 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.246 -0.434 . . . . 54.42 110.877 -179.834 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' -3' ' ' ARG . . . . . . . . . . . . . 1.5 ptm180 -177.45 155.05 1.1 Allowed Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 121.618 0.723 . . . . 75.12 110.886 -179.952 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' -2' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.78 134.37 27.79 Favored 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.68 2.254 . . . . 74.21 112.35 -179.968 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' -1' ' ' ALA . . . . . . . . . . . . . . . -57.99 154.09 30.71 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 121.575 0.702 . . . . 44.35 111.098 179.887 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 0' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.78 -173.3 0.69 Allowed 'Trans proline' 0 C--N 1.342 0.2 0 C-N-CA 122.644 2.229 . . . . 73.52 112.35 -179.986 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 1' ' ' LYS . . . . . . . . . . . . . 33.8 mtpt -127.61 155.77 76.48 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-O 121.628 0.728 . . . . 73.4 110.875 179.908 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 2' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.79 165.07 32.23 Favored 'Trans proline' 0 C--N 1.342 0.21 0 C-N-CA 122.643 2.229 . . . . 74.11 112.351 179.912 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 3' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.79 -41.87 3.86 Favored 'Trans proline' 0 C--N 1.341 0.176 0 C-N-CA 122.686 2.258 . . . . 53.04 112.323 179.991 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 4' ' ' SER . . . . . . . . . . . . . 41.2 m -88.06 136.12 33.11 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.206 -0.452 . . . . 63.31 110.852 -179.836 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 5' ' ' SER . . . . . . . . . . . . . 1.8 t -126.25 102.03 7.0 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.146 -0.479 . . . . 34.43 110.873 -179.847 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 6' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.33 -0.282 0 CA-C-N 116.156 -0.474 . . . . 72.4 111.114 179.881 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' -4' ' ' MET . . . . . . . . . . . . . 40.3 mtp . . . . . 0 C--O 1.23 0.054 0 CA-C-O 120.762 0.315 . . . . 64.12 110.854 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' -3' ' ' ALA . . . . . . . . . . . . . . . -80.84 -32.86 34.92 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.234 -0.439 . . . . 54.44 111.134 179.898 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' -2' ' ' ILE . . . . . . . . . . . . . 85.0 mt -60.76 117.79 2.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.154 -0.475 . . . . 60.12 111.138 179.981 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' -1' ' ' VAL . . . . . . . . . . . . . 61.8 t -61.0 -34.88 61.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.174 -0.466 . . . . 71.33 111.142 179.89 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 2.6 t-20 63.82 45.19 4.52 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.172 -0.467 . . . . 71.31 110.896 180.0 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 32.8 tp60 -109.51 134.06 52.35 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.168 -0.469 . . . . 73.24 110.931 179.965 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . 0.475 ' HG3' HD12 ' A' ' 58' ' ' ILE . 3.2 ptt-85 -84.15 162.4 20.26 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.213 -0.449 . . . . 71.34 110.858 -179.934 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -155.21 150.86 27.47 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.146 -0.479 . . . . 73.42 111.139 179.937 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 11.0 p -104.07 146.31 11.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.229 -0.441 . . . . 51.55 111.133 -179.991 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -84.82 111.14 19.37 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.187 -0.461 . . . . 21.02 111.099 179.88 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.743 HD21 ' CB ' ' A' ' 56' ' ' SER . 13.9 mt -76.42 -37.04 57.67 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.244 -0.435 . . . . 43.24 110.888 -179.946 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 4.0 m-85 -142.22 147.03 35.86 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.223 -0.444 . . . . 73.32 110.911 -179.96 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 3.5 p-10 -70.47 138.98 51.59 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.125 -0.489 . . . . 74.23 110.864 179.899 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 5.3 t80 -143.82 144.62 31.86 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.215 -0.448 . . . . 72.54 110.878 -179.89 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -112.98 145.2 32.58 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-O 121.688 0.756 . . . . 72.12 110.83 -179.892 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.81 139.7 40.68 Favored 'Trans proline' 0 C--N 1.342 0.226 0 C-N-CA 122.657 2.238 . . . . 74.41 112.347 179.985 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -101.37 -17.09 16.67 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.21 -0.45 . . . . 73.34 110.92 -179.984 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 31.0 m-80 -116.26 176.53 5.06 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.104 -0.498 . . . . 71.35 110.923 -179.953 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 17.7 m-20 -91.51 21.55 4.54 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.218 -0.446 . . . . 61.24 110.894 179.907 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -141.97 17.52 2.12 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.191 -0.459 . . . . 65.42 110.867 -179.879 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 24.1 mt-10 -107.39 165.6 11.27 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.192 -0.458 . . . . 74.32 110.86 -179.976 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.553 HD11 ' HE3' ' A' ' 46' ' ' LYS . 28.7 tp -114.12 148.93 36.37 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.139 -0.482 . . . . 73.32 110.895 -179.931 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . 0.542 ' H ' HD12 ' A' ' 18' ' ' LEU . 0.8 OUTLIER -84.8 156.18 21.47 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.2 -0.454 . . . . 72.33 110.807 179.99 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.562 HD21 ' CG1' ' A' ' 55' ' ' VAL . 3.1 tp -140.26 150.17 43.75 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.131 -0.486 . . . . 42.42 110.932 179.984 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.666 ' HB3' ' CG ' ' A' ' 24' ' ' ASP . . . -141.42 137.29 32.12 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.191 -0.459 . . . . 52.01 111.102 179.827 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -50.79 121.88 6.54 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.265 -0.425 . . . . 55.23 110.867 -179.928 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 96.28 -6.51 66.05 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.697 -0.763 . . . . 54.52 112.476 -179.956 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . 0.666 ' CG ' ' HB3' ' A' ' 21' ' ' ALA . 1.0 OUTLIER -81.46 146.44 30.23 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.85 0.357 . . . . 75.01 110.838 -179.908 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 3.3 mm -100.81 142.52 15.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.186 -0.461 . . . . 73.22 111.165 179.999 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 1.4 m -144.95 158.55 13.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.155 -0.475 . . . . 64.41 111.09 179.918 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 51.6 m-85 -117.3 109.57 17.01 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.154 -0.476 . . . . 71.42 110.882 179.988 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.662 HD13 ' HB2' ' A' ' 39' ' ' ALA . 12.1 mm -73.11 102.7 1.63 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.113 -0.494 . . . . 63.51 111.082 -179.992 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 43.3 m -64.76 -39.57 93.83 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.159 -0.473 . . . . 71.31 110.891 -179.977 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' TYR . . . . . 0.54 ' CZ ' HG21 ' A' ' 38' ' ' VAL . 37.4 p90 -174.87 151.39 1.38 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.139 -0.482 . . . . 73.2 110.941 -179.856 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . 0.494 ' HG3' HD22 ' A' ' 37' ' ' LEU . 17.8 tttt -83.25 145.55 29.06 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.13 -0.486 . . . . 75.04 110.946 179.871 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 34.4 t60 -134.21 152.9 52.06 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.227 -0.442 . . . . 75.23 110.892 179.903 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -58.96 -173.98 0.55 Allowed Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.755 -0.736 . . . . 64.01 112.469 -179.954 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 27.6 mm-40 65.43 12.21 7.96 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.845 0.355 . . . . 73.23 110.943 -179.875 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 68.09 30.14 73.77 Favored Glycine 0 N--CA 1.452 -0.261 0 C-N-CA 120.702 -0.761 . . . . 63.04 112.496 -179.943 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' TRP . . . . . 0.633 ' C ' HD23 ' A' ' 37' ' ' LEU . 99.0 m95 -124.15 136.51 54.26 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.796 0.331 . . . . 62.04 110.95 -179.952 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.717 HD11 ' CG ' ' A' ' 52' ' ' GLU . 1.3 mt -120.58 133.36 55.39 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.252 -0.431 . . . . 35.31 110.951 179.962 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.54 HG21 ' CZ ' ' A' ' 30' ' ' TYR . 59.9 t -79.75 110.02 14.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.18 -0.464 . . . . 73.33 111.144 179.858 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.662 ' HB2' HD13 ' A' ' 28' ' ' ILE . . . -129.79 159.36 36.76 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.154 -0.475 . . . . 64.02 111.114 179.869 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 1.4 pt-20 -117.01 156.57 27.27 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.207 -0.451 . . . . 73.34 110.865 -179.919 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -70.18 -175.2 0.92 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.143 -0.48 . . . . 73.44 110.901 -179.983 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 -69.4 -38.21 77.83 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.167 -0.469 . . . . 70.25 110.895 179.965 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 1.5 t -56.37 -22.53 31.8 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.171 -0.468 . . . . 72.43 110.848 -179.786 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 69.16 9.53 60.61 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.757 -0.735 . . . . 62.12 112.476 -179.988 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -108.04 -20.82 13.05 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.947 0.403 . . . . 73.02 110.885 -179.751 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.553 ' HE3' HD11 ' A' ' 18' ' ' LEU . 4.0 ttpt -109.98 123.86 50.4 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.128 -0.487 . . . . 75.01 110.917 179.941 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 3.7 m -129.82 137.47 50.49 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.237 -0.438 . . . . 52.34 111.2 179.981 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -161.02 -157.48 8.77 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.765 -0.731 . . . . 62.45 112.508 179.976 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.454 HD23 HG22 ' A' ' 38' ' ' VAL . 8.7 mt -101.68 137.55 39.85 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.886 0.374 . . . . 72.02 110.866 -179.887 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.404 ' HB ' ' HD2' ' A' ' 51' ' ' PRO . 10.3 m -137.16 153.36 74.96 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 121.645 0.736 . . . . 70.45 111.1 179.825 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 0.427 ' HG2' ' HB2' ' A' ' 54' ' ' PHE . 53.4 Cg_endo -69.85 143.81 51.59 Favored 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 122.657 2.238 . . . . 73.02 112.306 179.961 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . 0.717 ' CG ' HD11 ' A' ' 37' ' ' LEU . 10.9 tm-20 -89.92 -28.09 19.42 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.189 -0.46 . . . . 72.05 110.903 179.983 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -85.97 10.35 14.33 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.17 -0.468 . . . . 73.02 110.847 -179.92 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . 0.427 ' HB2' ' HG2' ' A' ' 51' ' ' PRO . 0.9 OUTLIER -120.72 -8.96 9.41 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.174 -0.466 . . . . 72.52 110.875 -179.932 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.562 ' CG1' HD21 ' A' ' 20' ' ' LEU . 15.8 m -119.71 166.33 14.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.123 -0.489 . . . . 71.43 111.167 179.961 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . 0.743 ' CB ' HD21 ' A' ' 7' ' ' LEU . 37.2 t -135.25 117.86 15.95 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.193 -0.458 . . . . 71.4 110.875 -179.868 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 3.3 m-85 -58.32 124.69 20.35 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.171 -0.468 . . . . 72.42 110.935 -179.896 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.475 HD12 ' HG3' ' A' ' 3' ' ' ARG . 22.8 mt -88.26 153.64 3.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.119 -0.491 . . . . 71.33 111.081 179.947 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . 0.407 ' HB2' ' HD2' ' A' ' 60' ' ' PRO . 8.1 pm0 -110.7 154.86 43.02 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 121.609 0.719 . . . . 72.31 110.929 179.95 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . 0.407 ' HD2' ' HB2' ' A' ' 59' ' ' GLN . 53.6 Cg_endo -69.77 -84.13 0.01 OUTLIER 'Trans proline' 0 C--N 1.341 0.148 0 C-N-CA 122.708 2.272 . . . . 54.43 112.346 -179.99 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 72.1 mt-10 -140.3 39.68 1.91 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.203 -0.453 . . . . 73.53 110.885 -179.989 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 1.7 pp -133.53 -179.09 5.31 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.125 -0.489 . . . . 73.44 110.904 -179.989 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 18.0 tp10 . . . . . 0 C--N 1.33 -0.271 0 CA-C-N 116.212 -0.449 . . . . 71.32 110.905 179.925 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' B' B ' -9' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.303 0 N-CA-C 112.457 -0.257 . . . . 75.4 112.457 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' B' B ' -8' ' ' LYS . . . . . . . . . . . . . 34.0 mtmt -91.5 -41.92 10.56 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.83 0.348 . . . . 75.04 110.91 -179.958 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' -7' ' ' PHE . . . . . 0.425 ' HB3' HD11 ' A' ' 49' ' ' LEU . 9.1 m-85 -88.01 133.6 33.92 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.229 -0.441 . . . . 73.54 110.913 179.926 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' -6' ' ' ILE . . . . . 0.416 HD13 ' O ' ' B' ' -7' ' ' PHE . 37.9 mm -145.51 87.22 7.05 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 121.63 0.729 . . . . 72.34 111.105 -179.997 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' -5' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.74 139.87 41.37 Favored 'Trans proline' 0 C--O 1.231 0.164 0 C-N-CA 122.707 2.272 . . . . 75.34 112.351 179.891 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' -4' ' ' SER . . . . . . . . . . . . . 27.5 t -132.96 66.16 1.57 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.227 -0.442 . . . . 61.13 110.903 -179.872 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' -3' ' ' ARG . . . . . . . . . . . . . 5.8 ptm180 -178.21 155.0 0.96 Allowed Pre-proline 0 C--N 1.329 -0.288 0 CA-C-O 121.6 0.714 . . . . 74.43 110.851 -179.95 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' -2' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.81 131.63 21.55 Favored 'Trans proline' 0 C--N 1.341 0.157 0 C-N-CA 122.654 2.236 . . . . 73.01 112.35 -179.978 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' -1' ' ' ALA . . . . . . . . . . . . . . . -70.47 151.67 95.56 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 121.62 0.724 . . . . 63.24 111.102 179.89 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 0' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.7 173.34 11.07 Favored 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.681 2.254 . . . . 75.14 112.363 -179.98 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 1' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -121.82 154.35 60.58 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 121.579 0.704 . . . . 74.42 110.891 179.865 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 2' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.74 159.82 51.99 Favored 'Trans proline' 0 C--O 1.232 0.186 0 C-N-CA 122.716 2.277 . . . . 74.42 112.345 179.89 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 3' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.73 -171.99 0.53 Allowed 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.735 2.29 . . . . 71.53 112.355 179.914 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 4' ' ' SER . . . . . . . . . . . . . 26.5 t -80.72 147.27 30.65 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.247 -0.433 . . . . 70.42 110.871 -179.835 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 5' ' ' SER . . . . . . . . . . . . . 12.6 t -143.85 123.66 13.43 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.152 -0.476 . . . . 72.32 110.807 -179.793 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 6' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.297 0 CA-C-N 116.103 -0.499 . . . . 73.23 111.128 179.888 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' -4' ' ' MET . . . . . . . . . . . . . 24.6 ttm . . . . . 0 C--O 1.23 0.079 0 CA-C-O 120.779 0.323 . . . . 62.3 110.861 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' -3' ' ' ALA . . . . . . . . . . . . . . . -124.66 117.15 23.62 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.25 -0.432 . . . . 75.11 111.108 179.902 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' -2' ' ' ILE . . . . . . . . . . . . . 85.7 mt -121.56 119.5 59.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.233 -0.44 . . . . 72.05 111.141 179.942 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' -1' ' ' VAL . . . . . . . . . . . . . 21.7 t -109.22 129.78 63.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.165 -0.47 . . . . 51.44 111.113 179.886 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 2.0 m120 -91.94 59.9 3.73 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.155 -0.475 . . . . 73.34 110.913 179.986 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 55.0 tp60 -96.71 127.92 43.16 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.18 -0.464 . . . . 74.45 110.945 179.988 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 7.7 ptp180 -82.0 164.15 21.64 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.188 -0.46 . . . . 74.51 110.821 -179.873 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -155.67 153.22 29.65 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.188 -0.46 . . . . 63.41 111.111 179.919 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.716 ' HB ' HD11 ' A' ' 58' ' ' ILE . 10.3 p -103.71 152.31 6.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.208 -0.451 . . . . 73.04 111.143 179.972 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -92.89 114.99 27.7 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.199 -0.455 . . . . 63.43 111.09 179.92 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.63 HD21 ' HB2' ' A' ' 56' ' ' SER . 7.0 mt -82.07 -35.64 28.47 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.224 -0.443 . . . . 71.54 110.925 -179.966 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 5.0 m-85 -141.82 137.83 31.77 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.207 -0.451 . . . . 75.53 110.979 179.965 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 3.0 p-10 -63.0 138.43 58.56 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.121 -0.491 . . . . 73.55 110.847 179.98 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 10.4 t80 -141.86 144.76 34.01 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.205 -0.452 . . . . 73.03 110.915 -179.927 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -113.1 144.33 30.92 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 121.656 0.741 . . . . 71.43 110.899 -179.925 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.75 132.39 23.25 Favored 'Trans proline' 0 C--N 1.342 0.193 0 C-N-CA 122.686 2.257 . . . . 65.03 112.324 179.991 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 15.3 mt-10 -94.47 -20.08 19.99 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.184 -0.462 . . . . 74.45 110.87 179.994 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 33.5 m-80 -114.48 175.66 5.39 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.176 -0.465 . . . . 71.25 110.878 -179.929 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -86.85 8.66 21.98 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.199 -0.455 . . . . 52.23 110.899 179.896 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -129.44 20.52 5.68 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.186 -0.461 . . . . 71.53 110.905 -179.942 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 57.1 mt-10 -109.92 156.37 20.53 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.198 -0.455 . . . . 63.21 110.87 -179.962 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.535 HD23 ' O ' ' A' ' 19' ' ' ARG . 0.4 OUTLIER -105.13 153.83 20.99 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.16 -0.473 . . . . 74.23 110.927 -179.999 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . 0.535 ' O ' HD23 ' A' ' 18' ' ' LEU . 21.6 mtm180 -87.87 151.69 22.65 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.179 -0.464 . . . . 61.12 110.856 179.974 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.546 HD21 ' CG1' ' A' ' 55' ' ' VAL . 1.7 tp -137.47 148.7 46.27 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.171 -0.468 . . . . 64.12 110.94 179.981 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.612 ' HB3' ' CG ' ' A' ' 24' ' ' ASP . . . -141.62 140.28 33.27 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.197 -0.456 . . . . 72.13 111.107 179.795 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -50.62 120.28 4.56 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.234 -0.439 . . . . 73.32 110.912 -179.915 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 97.84 -7.11 62.78 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.716 -0.754 . . . . 62.05 112.474 -179.986 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . 0.612 ' CG ' ' HB3' ' A' ' 21' ' ' ALA . 2.1 m-20 -76.41 150.45 36.76 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.788 0.328 . . . . 54.11 110.84 -179.944 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 1.5 mt -116.91 120.08 63.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.201 -0.454 . . . . 73.32 111.118 -179.965 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 6.0 m -120.61 165.44 16.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.163 -0.472 . . . . 65.32 111.125 179.858 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 54.4 m-85 -115.57 107.4 15.09 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.162 -0.472 . . . . 65.25 110.887 179.987 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.782 HD13 ' HB2' ' A' ' 39' ' ' ALA . 17.4 mm -72.04 103.05 1.38 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.164 -0.471 . . . . 71.25 111.127 179.963 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 3.2 m -64.43 -39.25 93.48 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.196 -0.457 . . . . 72.03 110.856 -179.921 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' TYR . . . . . 0.507 ' CZ ' HG21 ' A' ' 38' ' ' VAL . 31.7 p90 -174.99 145.93 0.85 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.151 -0.477 . . . . 64.03 110.936 -179.862 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . 0.476 ' HG3' HD22 ' A' ' 37' ' ' LEU . 19.1 tttt -79.45 144.94 33.58 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.11 -0.496 . . . . 64.53 110.869 179.937 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 28.8 t60 -134.4 153.47 51.89 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.2 -0.455 . . . . 74.33 110.795 179.926 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -58.89 -174.05 0.54 Allowed Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.766 -0.731 . . . . 60.15 112.515 179.975 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 40.5 mm-40 64.59 13.4 8.24 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.834 0.35 . . . . 71.13 110.896 -179.892 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 67.32 28.57 73.7 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.743 -0.742 . . . . 33.53 112.456 179.975 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' TRP . . . . . 0.591 ' C ' HD23 ' A' ' 37' ' ' LEU . 98.5 m95 -121.96 135.82 54.88 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.805 0.336 . . . . 75.13 110.947 -179.951 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.673 HD11 ' CG ' ' A' ' 52' ' ' GLU . 0.9 OUTLIER -121.97 131.22 53.89 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.234 -0.439 . . . . 74.5 110.961 179.96 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.528 HG22 HD23 ' A' ' 49' ' ' LEU . 41.3 t -78.92 109.46 13.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.193 -0.458 . . . . 73.23 111.159 179.825 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.782 ' HB2' HD13 ' A' ' 28' ' ' ILE . . . -129.73 162.25 28.82 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.192 -0.458 . . . . 52.24 111.137 179.871 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 3.6 pm0 -118.17 159.9 22.5 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.233 -0.44 . . . . 43.41 110.893 -179.966 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 44.9 p-10 -58.88 -174.88 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.127 -0.488 . . . . 63.42 110.896 -179.946 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 6.1 tm-20 -78.05 -37.68 46.21 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.164 -0.471 . . . . 74.32 110.91 179.988 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 67.9 m -68.38 -21.89 64.68 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.127 -0.488 . . . . 72.31 110.863 -179.774 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 75.91 26.01 65.63 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.747 -0.74 . . . . 60.01 112.468 179.976 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 6.6 t -109.66 -21.27 12.51 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.931 0.396 . . . . 51.51 110.889 -179.747 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.511 ' HG3' HD11 ' A' ' 18' ' ' LEU . 0.9 OUTLIER -121.51 138.98 54.07 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.132 -0.485 . . . . 62.15 110.894 179.926 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 6.1 m -132.58 152.6 51.57 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.231 -0.441 . . . . 71.42 111.159 179.978 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -178.36 -161.91 27.15 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.717 -0.754 . . . . 63.03 112.454 179.938 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.528 HD23 HG22 ' A' ' 38' ' ' VAL . 5.8 mt -100.95 141.48 33.78 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.849 0.357 . . . . 74.24 110.915 -179.873 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.422 ' HB ' ' HD2' ' A' ' 51' ' ' PRO . 17.1 m -138.2 153.71 73.36 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-O 121.67 0.748 . . . . 63.03 111.091 179.876 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 0.451 ' HD2' HD22 ' A' ' 20' ' ' LEU . 53.7 Cg_endo -69.8 144.93 55.38 Favored 'Trans proline' 0 C--N 1.342 0.21 0 C-N-CA 122.661 2.241 . . . . 62.44 112.322 179.974 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . 0.673 ' CG ' HD11 ' A' ' 37' ' ' LEU . 25.8 tt0 -91.88 -26.93 18.24 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.22 -0.445 . . . . 62.04 110.914 180.0 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -87.89 10.59 18.18 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.168 -0.469 . . . . 35.15 110.918 -179.928 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . 0.421 ' HB2' ' HG2' ' A' ' 51' ' ' PRO . 1.0 OUTLIER -120.04 -14.22 8.91 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.121 -0.491 . . . . 75.33 110.898 -179.96 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.546 ' CG1' HD21 ' A' ' 20' ' ' LEU . 19.2 m -114.82 172.48 3.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.172 -0.467 . . . . 71.25 111.181 179.949 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . 0.63 ' HB2' HD21 ' A' ' 7' ' ' LEU . 32.3 t -144.19 116.7 8.6 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.185 -0.461 . . . . 54.35 110.852 -179.842 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 2.8 m-85 -51.93 134.37 31.69 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.132 -0.486 . . . . 71.42 110.876 -179.827 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.716 HD11 ' HB ' ' A' ' 5' ' ' VAL . 52.2 mt -105.63 145.46 13.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.125 -0.489 . . . . 75.11 111.136 179.91 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 4.6 mt-30 -130.88 160.53 66.24 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 121.613 0.72 . . . . 74.53 110.888 179.994 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.75 -85.55 0.0 OUTLIER 'Trans proline' 0 C--N 1.341 0.165 0 C-N-CA 122.726 2.284 . . . . 73.5 112.348 179.982 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 30.9 tt0 -133.82 39.24 3.17 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.232 -0.44 . . . . 52.43 110.873 -179.981 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 12.5 mt -120.31 165.46 14.83 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.14 -0.482 . . . . 74.33 110.922 179.997 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 19.8 tt0 . . . . . 0 C--N 1.329 -0.283 0 CA-C-N 116.169 -0.469 . . . . 74.3 110.915 179.921 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' B' B ' -9' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.331 0 N-CA-C 112.517 -0.233 . . . . 51.35 112.517 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' B' B ' -8' ' ' LYS . . . . . . . . . . . . . 10.7 mptt -87.32 -59.94 2.11 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.823 0.344 . . . . 75.01 110.919 179.984 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' -7' ' ' PHE . . . . . . . . . . . . . 14.0 m-85 -68.43 137.92 54.88 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.243 -0.435 . . . . 74.11 110.835 179.981 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' -6' ' ' ILE . . . . . . . . . . . . . 55.8 mt -149.91 86.28 5.35 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-O 121.615 0.721 . . . . 73.5 111.13 179.921 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' -5' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.8 141.03 43.98 Favored 'Trans proline' 0 C--N 1.341 0.176 0 C-N-CA 122.64 2.226 . . . . 74.11 112.382 179.844 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' -4' ' ' SER . . . . . . . . . . . . . 2.6 t -139.5 65.89 1.42 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.25 -0.432 . . . . 73.41 110.884 -179.822 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' -3' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -178.56 154.51 0.87 Allowed Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.581 0.705 . . . . 74.55 110.9 -179.889 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' -2' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.77 124.2 10.85 Favored 'Trans proline' 0 C--N 1.342 0.2 0 C-N-CA 122.689 2.259 . . . . 63.22 112.333 -179.951 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' -1' ' ' ALA . . . . . . . . . . . . . . . -57.67 152.29 36.69 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.576 0.703 . . . . 52.24 111.099 179.897 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 0' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.77 172.79 12.0 Favored 'Trans proline' 0 C--N 1.342 0.194 0 C-N-CA 122.712 2.275 . . . . 75.44 112.341 -179.966 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 1' ' ' LYS . . . . . . . . . . . . . 12.7 ptmt -119.83 153.45 54.74 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.549 0.69 . . . . 74.21 110.874 179.907 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 2' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.81 162.53 41.76 Favored 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.631 2.221 . . . . 63.1 112.327 179.887 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 3' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.76 155.42 65.99 Favored 'Trans proline' 0 C--N 1.342 0.205 0 C-N-CA 122.655 2.236 . . . . 73.11 112.367 179.938 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 4' ' ' SER . . . . . . . . . . . . . 11.2 t -82.91 89.12 6.82 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.226 -0.443 . . . . 74.42 110.823 -179.827 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 5' ' ' SER . . . . . . . . . . . . . 11.4 t -127.9 164.98 21.08 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.146 -0.479 . . . . 70.12 110.848 -179.833 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 6' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.312 0 CA-C-N 116.123 -0.489 . . . . 74.2 111.117 179.893 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' -4' ' ' MET . . . . . . . . . . . . . 1.1 mpp? . . . . . 0 C--O 1.231 0.118 0 CA-C-O 120.811 0.339 . . . . 54.23 110.842 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' -3' ' ' ALA . . . . . . . . . . . . . . . -160.32 154.82 23.74 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.257 -0.428 . . . . 54.13 111.084 179.954 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' -2' ' ' ILE . . . . . . . . . . . . . 5.4 mp -115.61 125.98 72.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.205 -0.452 . . . . 73.34 111.14 179.948 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' -1' ' ' VAL . . . . . . . . . . . . . 14.5 p -91.78 -27.02 4.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.177 -0.465 . . . . 73.11 111.114 179.85 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 6.4 m-80 61.72 45.78 7.61 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.165 -0.471 . . . . 72.23 110.84 -179.992 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 55.7 tp60 -101.4 131.82 47.29 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.218 -0.446 . . . . 53.05 110.894 179.962 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 5.5 ptm180 -81.99 164.3 21.56 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.233 -0.44 . . . . 72.52 110.883 -179.967 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -156.76 155.33 31.43 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.2 -0.454 . . . . 61.12 111.118 179.939 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.639 ' HB ' HD11 ' A' ' 58' ' ' ILE . 10.5 p -104.95 152.31 6.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.256 -0.429 . . . . 74.11 111.164 179.985 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -90.65 112.27 23.93 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.222 -0.445 . . . . 75.43 111.045 179.919 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.757 HD21 ' HB3' ' A' ' 56' ' ' SER . 11.6 mt -78.54 -37.64 42.41 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.218 -0.447 . . . . 71.13 110.908 -179.984 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 5.5 m-85 -141.77 146.07 35.53 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.199 -0.455 . . . . 74.11 110.947 -179.957 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 4.0 p-10 -70.61 134.88 48.0 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.115 -0.493 . . . . 62.31 110.909 179.897 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 7.0 t80 -135.15 145.99 48.34 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.199 -0.455 . . . . 73.43 110.893 -179.897 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 5.7 tp10 -115.84 136.04 22.82 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 121.643 0.735 . . . . 74.52 110.892 -179.934 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.415 ' HD3' ' HA ' ' A' ' 19' ' ' ARG . 53.7 Cg_endo -69.8 148.27 64.43 Favored 'Trans proline' 0 C--N 1.341 0.177 0 C-N-CA 122.694 2.263 . . . . 43.13 112.341 -179.998 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -105.94 -21.73 13.08 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.201 -0.454 . . . . 61.45 110.877 -179.977 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 68.1 m-80 -112.07 175.52 5.39 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.187 -0.46 . . . . 44.41 110.949 -179.964 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -88.34 10.34 20.18 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.227 -0.442 . . . . 55.12 110.899 179.905 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -126.22 14.03 7.77 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.169 -0.469 . . . . 73.13 110.936 -179.946 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 25.5 mt-10 -107.62 153.19 23.25 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.178 -0.464 . . . . 71.35 110.88 -179.98 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.544 HD23 ' O ' ' A' ' 19' ' ' ARG . 0.3 OUTLIER -103.25 151.56 22.53 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.137 -0.483 . . . . 72.02 110.911 -179.979 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . 0.544 ' O ' HD23 ' A' ' 18' ' ' LEU . 0.3 OUTLIER -88.73 155.26 19.68 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.175 -0.466 . . . . 74.34 110.856 179.997 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.541 HD21 ' CG1' ' A' ' 55' ' ' VAL . 2.0 tp -139.0 148.73 43.83 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.187 -0.46 . . . . 62.11 110.905 -179.959 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.648 ' HB3' ' CG ' ' A' ' 24' ' ' ASP . . . -140.46 137.96 34.3 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.185 -0.461 . . . . 74.31 111.101 179.769 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -50.24 120.36 4.45 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.188 -0.46 . . . . 75.21 110.91 -179.902 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 96.09 -0.32 62.18 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.74 -0.743 . . . . 75.24 112.497 -179.952 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . 0.648 ' CG ' ' HB3' ' A' ' 21' ' ' ALA . 1.3 m-20 -86.6 145.99 26.52 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.81 0.338 . . . . 51.51 110.856 -179.951 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 3.1 mm -102.65 139.9 22.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.176 -0.466 . . . . 60.55 111.138 -179.997 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 1.1 m -141.91 162.44 20.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.204 -0.453 . . . . 62.22 111.125 179.873 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 63.7 m-85 -118.92 108.84 15.27 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.201 -0.454 . . . . 72.54 110.872 -179.987 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.776 HD13 ' HB2' ' A' ' 39' ' ' ALA . 17.2 mm -73.13 103.35 1.82 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.139 -0.482 . . . . 64.2 111.122 179.976 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 5.9 m -64.88 -40.39 95.03 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.184 -0.462 . . . . 74.2 110.892 -179.946 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' TYR . . . . . 0.511 ' CZ ' HG21 ' A' ' 38' ' ' VAL . 36.2 p90 -174.61 149.7 1.28 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.142 -0.481 . . . . 74.4 110.918 -179.897 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . 0.491 ' HG3' HD22 ' A' ' 37' ' ' LEU . 20.5 tttt -81.56 144.24 31.42 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.152 -0.476 . . . . 74.14 110.894 179.919 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 31.5 t60 -133.25 153.34 51.65 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.242 -0.435 . . . . 73.5 110.918 179.849 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -59.09 -174.54 0.62 Allowed Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.778 -0.725 . . . . 74.12 112.42 -179.898 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 5.1 mt-30 65.95 11.99 8.1 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.88 0.371 . . . . 75.03 110.917 -179.909 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 68.36 28.99 72.99 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.753 -0.737 . . . . 51.54 112.502 -179.971 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' TRP . . . . . 0.634 ' C ' HD23 ' A' ' 37' ' ' LEU . 98.6 m95 -123.35 136.54 54.71 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.821 0.344 . . . . 75.52 110.941 -179.922 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.695 HD11 ' CG ' ' A' ' 52' ' ' GLU . 1.4 mt -120.24 132.73 55.47 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.249 -0.432 . . . . 63.42 110.926 179.959 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.511 HG21 ' CZ ' ' A' ' 30' ' ' TYR . 37.6 t -80.4 109.31 14.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.216 -0.447 . . . . 64.33 111.138 179.829 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.776 ' HB2' HD13 ' A' ' 28' ' ' ILE . . . -130.56 164.54 24.68 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.167 -0.469 . . . . 51.54 111.142 179.854 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 1.2 pt-20 -119.67 156.06 31.18 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.232 -0.44 . . . . 64.32 110.885 -179.933 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -67.54 -175.06 0.47 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.134 -0.485 . . . . 72.23 110.898 -179.916 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 6.9 tt0 -68.87 -37.62 79.19 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.221 -0.445 . . . . 72.23 110.827 -179.956 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 1.7 t -56.87 -22.46 37.13 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.19 -0.459 . . . . 62.32 110.885 -179.805 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 69.44 9.43 61.34 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.766 -0.73 . . . . 52.33 112.489 -179.996 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 7.4 m -108.78 -24.27 11.37 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.97 0.415 . . . . 73.5 110.853 -179.732 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.463 ' HG2' HD11 ' A' ' 18' ' ' LEU . 0.1 OUTLIER -105.51 123.61 48.18 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.149 -0.478 . . . . 74.42 110.857 179.932 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 3.4 m -124.47 152.59 43.16 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.223 -0.444 . . . . 74.24 111.175 179.928 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -177.29 -161.71 26.3 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.723 -0.751 . . . . 73.53 112.485 179.968 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.49 HD23 HG22 ' A' ' 38' ' ' VAL . 5.5 mt -100.59 134.44 43.55 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.876 0.369 . . . . 72.02 110.885 -179.861 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.403 ' HB ' ' HD2' ' A' ' 51' ' ' PRO . 10.4 m -133.77 153.23 79.92 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-O 121.632 0.729 . . . . 61.42 111.135 179.866 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 0.411 ' HG2' ' HB2' ' A' ' 54' ' ' PHE . 53.8 Cg_endo -69.77 144.97 55.66 Favored 'Trans proline' 0 C--N 1.342 0.207 0 C-N-CA 122.667 2.245 . . . . 73.14 112.343 179.928 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . 0.695 ' CG ' HD11 ' A' ' 37' ' ' LEU . 12.0 tm-20 -91.05 -28.85 17.69 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.233 -0.44 . . . . 64.33 110.868 -179.961 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 2.1 mm-40 -85.11 9.05 15.93 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.198 -0.456 . . . . 54.31 110.927 -179.965 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . 0.411 ' HB2' ' HG2' ' A' ' 51' ' ' PRO . 1.1 m-85 -120.33 -2.76 10.03 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.13 -0.486 . . . . 75.42 110.895 -179.922 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.541 ' CG1' HD21 ' A' ' 20' ' ' LEU . 13.0 m -125.27 171.66 13.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.14 -0.482 . . . . 71.22 111.138 179.949 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . 0.757 ' HB3' HD21 ' A' ' 7' ' ' LEU . 4.1 t -142.94 117.14 9.52 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.179 -0.464 . . . . 72.1 110.86 -179.845 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 3.1 m-85 -55.05 133.39 48.65 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.14 -0.482 . . . . 72.41 110.926 -179.924 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.639 HD11 ' HB ' ' A' ' 5' ' ' VAL . 46.8 mt -103.92 148.59 8.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.105 -0.498 . . . . 72.14 111.142 179.895 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -131.01 160.81 65.12 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-O 121.646 0.736 . . . . 71.41 110.881 179.939 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.78 -85.81 0.0 OUTLIER 'Trans proline' 0 C--N 1.342 0.215 0 C-N-CA 122.71 2.273 . . . . 54.33 112.328 -179.981 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 23.3 mt-10 -128.77 23.74 5.76 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.234 -0.439 . . . . 65.34 110.874 -179.969 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 3.2 pp -136.53 177.64 7.69 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.174 -0.467 . . . . 73.25 110.937 -179.989 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 14.5 tp10 . . . . . 0 C--N 1.329 -0.298 0 CA-C-N 116.197 -0.456 . . . . 72.03 110.903 179.955 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' B' B ' -9' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.316 0 N-CA-C 112.497 -0.241 . . . . 71.11 112.497 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' B' B ' -8' ' ' LYS . . . . . . . . . . . . . 12.3 pttt -52.87 -42.84 65.63 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.788 0.328 . . . . 74.01 110.872 -179.953 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' -7' ' ' PHE . . . . . 0.474 ' HB3' HD11 ' A' ' 49' ' ' LEU . 13.4 m-85 -98.34 162.87 12.95 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.223 -0.444 . . . . 65.31 110.904 179.965 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' -6' ' ' ILE . . . . . 0.51 ' O ' HG23 ' B' ' -6' ' ' ILE . 4.0 tp -171.9 87.94 0.44 Allowed Pre-proline 0 C--N 1.328 -0.329 0 CA-C-O 121.632 0.73 . . . . 72.53 111.155 179.944 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' -5' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.73 146.33 60.06 Favored 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 122.677 2.251 . . . . 75.41 112.377 179.844 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' -4' ' ' SER . . . . . . . . . . . . . 28.6 t -141.7 63.6 1.42 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.21 -0.45 . . . . 74.45 110.853 -179.841 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' -3' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -179.32 155.42 0.79 Allowed Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.576 0.703 . . . . 73.43 110.886 -179.954 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' -2' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.76 129.13 17.07 Favored 'Trans proline' 0 C--N 1.341 0.175 0 C-N-CA 122.661 2.24 . . . . 74.24 112.337 -179.969 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' -1' ' ' ALA . . . . . . . . . . . . . . . -62.61 152.33 81.49 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-O 121.614 0.721 . . . . 51.41 111.107 179.875 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 0' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.72 175.81 7.58 Favored 'Trans proline' 0 C--N 1.341 0.17 0 C-N-CA 122.696 2.264 . . . . 44.35 112.337 -179.968 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 1' ' ' LYS . . . . . . . . . . . . . 14.2 pttm -123.55 154.36 66.36 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-O 121.647 0.737 . . . . 70.3 110.86 179.92 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 2' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.72 163.41 38.34 Favored 'Trans proline' 0 C--N 1.342 0.195 0 C-N-CA 122.722 2.281 . . . . 55.32 112.353 179.899 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 3' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.72 -170.69 0.41 Allowed 'Trans proline' 0 C--N 1.341 0.152 0 C-N-CA 122.7 2.266 . . . . 65.21 112.332 179.961 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 4' ' ' SER . . . . . . . . . . . . . 1.7 t -98.19 123.63 42.35 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.208 -0.451 . . . . 61.14 110.89 -179.886 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 5' ' ' SER . . . . . . . . . . . . . 47.3 t -122.5 158.24 30.24 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.152 -0.476 . . . . 75.41 110.872 -179.835 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 6' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.328 -0.329 0 CA-C-N 116.139 -0.482 . . . . 72.34 111.073 179.904 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' -4' ' ' MET . . . . . . . . . . . . . 6.1 tpp . . . . . 0 C--O 1.231 0.106 0 CA-C-O 120.784 0.326 . . . . 74.3 110.865 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' -3' ' ' ALA . . . . . . . . . . . . . . . -99.99 27.56 5.45 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.245 -0.434 . . . . 75.44 111.101 179.894 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' -2' ' ' ILE . . . . . . . . . . . . . 78.3 mt -116.3 129.02 73.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.226 -0.443 . . . . 70.22 111.082 179.998 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' -1' ' ' VAL . . . . . . . . . . . . . 14.7 p -86.16 -27.13 6.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.119 -0.491 . . . . 65.25 111.069 179.895 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 20.9 m120 59.83 54.08 4.51 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.205 -0.452 . . . . 62.54 110.862 -179.992 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 50.8 tp60 -112.91 126.64 55.69 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.206 -0.452 . . . . 62.31 110.932 -179.999 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 5.6 ptp180 -78.82 161.4 26.81 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.278 -0.419 . . . . 60.24 110.902 -179.931 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -156.24 154.86 31.4 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.233 -0.44 . . . . 53.33 111.122 179.942 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.574 ' HB ' HD11 ' A' ' 58' ' ' ILE . 11.1 p -104.94 151.26 7.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.209 -0.451 . . . . 54.11 111.102 -179.972 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -89.3 111.08 21.81 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.163 -0.471 . . . . 74.3 111.065 179.915 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.721 HD21 ' HB2' ' A' ' 56' ' ' SER . 11.5 mt -75.82 -38.63 57.95 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.221 -0.445 . . . . 63.35 110.875 -179.949 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 4.1 m-85 -141.86 148.95 39.62 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.172 -0.467 . . . . 75.33 110.892 -179.946 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 3.7 p-10 -71.28 131.49 43.53 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.142 -0.481 . . . . 60.14 110.89 179.894 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 1.8 t80 -129.54 146.15 51.39 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.228 -0.442 . . . . 74.24 110.866 -179.906 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 32.5 tt0 -116.2 137.06 23.18 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-O 121.654 0.74 . . . . 74.41 110.919 -179.911 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.7 148.27 65.1 Favored 'Trans proline' 0 C--N 1.341 0.154 0 C-N-CA 122.689 2.259 . . . . 72.24 112.373 -179.99 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 18.1 mm-40 -110.79 -18.62 13.08 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.264 -0.425 . . . . 71.12 110.903 179.993 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 33.9 m-80 -112.59 176.25 5.09 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.154 -0.475 . . . . 65.24 110.842 -179.925 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 7.9 p-10 -91.54 20.11 5.66 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.162 -0.472 . . . . 65.13 110.848 179.907 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -138.68 14.68 2.72 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.241 -0.436 . . . . 74.42 110.904 -179.907 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 30.3 mt-10 -103.7 164.7 11.5 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.169 -0.469 . . . . 73.15 110.907 -179.966 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.568 HD12 ' H ' ' A' ' 19' ' ' ARG . 39.2 tp -115.35 146.78 41.22 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.181 -0.463 . . . . 40.13 110.936 -179.975 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . 0.568 ' H ' HD12 ' A' ' 18' ' ' LEU . 34.6 mtm-85 -82.25 156.8 24.17 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.242 -0.436 . . . . 62.24 110.913 179.93 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.54 HD21 ' CG1' ' A' ' 55' ' ' VAL . 2.9 tp -142.27 147.55 36.62 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.203 -0.453 . . . . 53.32 110.946 179.985 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.716 ' HB3' ' OD2' ' A' ' 24' ' ' ASP . . . -138.79 137.77 36.97 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.231 -0.44 . . . . 60.24 111.113 179.791 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -50.82 120.89 5.2 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.228 -0.442 . . . . 75.21 110.883 -179.923 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 97.25 -5.65 63.13 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.722 -0.751 . . . . 52.32 112.457 179.985 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . 0.716 ' OD2' ' HB3' ' A' ' 21' ' ' ALA . 5.7 m-20 -81.34 147.82 29.67 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.811 0.339 . . . . 50.13 110.862 -179.94 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 3.4 mm -101.46 141.56 17.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.231 -0.44 . . . . 71.53 111.125 -179.977 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.413 HG11 HD11 ' A' ' 20' ' ' LEU . 1.5 m -144.79 158.38 14.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.187 -0.461 . . . . 71.1 111.117 179.883 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 57.8 m-85 -117.47 108.38 15.46 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.15 -0.477 . . . . 74.52 110.892 179.965 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.857 HD13 ' HB2' ' A' ' 39' ' ' ALA . 20.1 mm -72.44 103.11 1.51 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.128 -0.487 . . . . 65.03 111.117 -179.996 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 5.7 m -65.05 -40.21 94.44 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.162 -0.472 . . . . 73.5 110.872 -179.922 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' TYR . . . . . 0.513 ' CZ ' HG21 ' A' ' 38' ' ' VAL . 33.9 p90 -174.61 149.11 1.22 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.155 -0.475 . . . . 74.24 110.944 -179.885 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . 0.528 ' HG3' HD22 ' A' ' 37' ' ' LEU . 19.0 tttt -81.32 143.25 32.35 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.192 -0.458 . . . . 71.34 110.94 179.874 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 33.4 t60 -131.73 155.36 47.82 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.241 -0.436 . . . . 70.43 110.823 179.932 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -60.79 -174.11 1.11 Allowed Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.728 -0.749 . . . . 51.35 112.493 -179.958 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 84.7 mm-40 65.43 12.55 8.22 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.833 0.349 . . . . 72.31 110.939 -179.849 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 68.53 29.19 72.89 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.739 -0.743 . . . . 73.13 112.496 -179.955 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' TRP . . . . . 0.652 ' C ' HD23 ' A' ' 37' ' ' LEU . 99.0 m95 -123.69 136.8 54.68 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.819 0.342 . . . . 70.45 110.906 -179.929 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.709 HD11 ' CG ' ' A' ' 52' ' ' GLU . 1.3 mt -121.09 130.57 53.81 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.258 -0.428 . . . . 72.11 110.939 179.972 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.513 HG21 ' CZ ' ' A' ' 30' ' ' TYR . 47.4 t -76.9 112.36 14.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.197 -0.456 . . . . 51.31 111.139 179.866 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.857 ' HB2' HD13 ' A' ' 28' ' ' ILE . . . -133.88 159.96 39.1 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.182 -0.463 . . . . 73.41 111.106 179.869 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -114.09 155.57 25.75 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.204 -0.453 . . . . 64.14 110.841 -179.909 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -70.56 -175.32 1.02 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.098 -0.501 . . . . 52.41 110.883 -179.951 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -69.86 -39.13 76.56 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.151 -0.477 . . . . 74.13 110.861 -179.956 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 11.8 m -56.29 -22.51 30.72 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.152 -0.476 . . . . 71.42 110.852 -179.809 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 66.81 11.4 57.69 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.754 -0.736 . . . . 50.32 112.498 -179.972 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 47.5 t -108.22 -14.35 14.72 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.956 0.407 . . . . 74.43 110.838 -179.708 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 6.1 ptmt -121.37 135.43 55.08 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.161 -0.472 . . . . 74.43 110.881 179.991 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 5.4 m -137.15 141.16 42.24 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.233 -0.439 . . . . 75.43 111.146 179.986 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -161.97 -154.81 7.67 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.711 -0.757 . . . . 72.22 112.499 179.947 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.506 HD11 ' HB3' ' B' ' -7' ' ' PHE . 6.8 mt -104.82 131.48 52.24 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.811 0.339 . . . . 53.53 110.936 -179.918 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.4 ' HB ' ' HD2' ' A' ' 51' ' ' PRO . 10.8 m -129.64 153.13 80.7 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-O 121.606 0.717 . . . . 63.21 111.185 179.812 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 0.429 ' HG2' ' HB2' ' A' ' 54' ' ' PHE . 53.5 Cg_endo -69.76 144.84 55.31 Favored 'Trans proline' 0 C--N 1.342 0.189 0 C-N-CA 122.691 2.261 . . . . 63.14 112.37 179.957 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . 0.709 ' CG ' HD11 ' A' ' 37' ' ' LEU . 8.3 tm-20 -90.48 -29.11 18.13 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.208 -0.451 . . . . 61.52 110.854 -179.949 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -85.25 9.87 14.03 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.19 -0.459 . . . . 74.13 110.914 -179.932 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . 0.429 ' HB2' ' HG2' ' A' ' 51' ' ' PRO . 1.0 OUTLIER -120.87 -7.82 9.47 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.136 -0.484 . . . . 74.55 110.862 -179.913 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.54 ' CG1' HD21 ' A' ' 20' ' ' LEU . 19.2 m -119.79 170.54 9.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.149 -0.478 . . . . 75.03 111.102 179.983 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . 0.721 ' HB2' HD21 ' A' ' 7' ' ' LEU . 31.2 t -141.61 113.27 7.74 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.143 -0.481 . . . . 54.3 110.878 -179.858 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 3.1 m-85 -52.93 130.79 34.57 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.145 -0.48 . . . . 74.34 110.888 -179.841 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.574 HD11 ' HB ' ' A' ' 5' ' ' VAL . 51.4 mt -99.01 148.19 6.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.123 -0.489 . . . . 52.55 111.17 179.874 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . 0.4 ' HB2' ' HD2' ' A' ' 60' ' ' PRO . 7.1 pt20 -114.87 154.88 46.94 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 121.634 0.731 . . . . 75.14 110.882 179.975 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . 0.4 ' HD2' ' HB2' ' A' ' 59' ' ' GLN . 53.7 Cg_endo -69.79 -85.23 0.0 OUTLIER 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.699 2.266 . . . . 53.24 112.301 179.991 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 30.6 mt-10 -133.61 46.91 2.51 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.242 -0.435 . . . . 75.34 110.889 -179.967 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 18.6 mt -98.91 160.02 14.55 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.16 -0.473 . . . . 62.32 110.9 -179.972 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 . . . . . 0 C--N 1.329 -0.286 0 CA-C-N 116.185 -0.461 . . . . 70.43 110.945 179.975 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' B' B ' -9' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.302 0 N-CA-C 112.507 -0.237 . . . . 52.52 112.507 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' B' B ' -8' ' ' LYS . . . . . . . . . . . . . 22.4 ttpt -94.47 -36.48 11.85 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.81 0.338 . . . . 54.34 110.9 -179.967 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' -7' ' ' PHE . . . . . 0.506 ' HB3' HD11 ' A' ' 49' ' ' LEU . 9.8 m-85 -79.57 151.29 30.75 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.183 -0.462 . . . . 64.21 110.916 179.946 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' -6' ' ' ILE . . . . . . . . . . . . . 1.6 pt -153.08 86.14 4.16 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-O 121.627 0.727 . . . . 63.0 111.15 179.995 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' -5' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.74 139.59 40.66 Favored 'Trans proline' 0 C--O 1.231 0.173 0 C-N-CA 122.683 2.256 . . . . 72.33 112.345 179.898 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' -4' ' ' SER . . . . . . . . . . . . . 1.5 t -135.24 65.63 1.55 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.222 -0.445 . . . . 71.41 110.88 -179.845 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' -3' ' ' ARG . . . . . . . . . . . . . 5.4 ptm180 -178.2 154.46 0.93 Allowed Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.569 0.699 . . . . 74.32 110.876 -179.964 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' -2' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.77 131.55 21.47 Favored 'Trans proline' 0 C--N 1.341 0.138 0 C-N-CA 122.682 2.255 . . . . 73.02 112.321 -179.953 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' -1' ' ' ALA . . . . . . . . . . . . . . . -68.84 152.49 96.73 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.526 0.679 . . . . 45.43 111.127 179.859 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 0' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.81 171.51 14.39 Favored 'Trans proline' 0 C--N 1.341 0.157 0 C-N-CA 122.666 2.244 . . . . 65.53 112.318 -179.958 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 1' ' ' LYS . . . . . . . . . . . . . 21.1 mmmt -119.58 153.81 54.3 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.612 0.72 . . . . 50.01 110.835 179.955 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 2' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.72 163.5 37.99 Favored 'Trans proline' 0 C--N 1.342 0.205 0 C-N-CA 122.694 2.263 . . . . 75.35 112.358 179.863 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 3' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.71 150.56 68.7 Favored 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.728 2.286 . . . . 61.43 112.333 179.937 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 4' ' ' SER . . . . . . . . . . . . . 1.7 t -81.96 -28.57 32.65 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.195 -0.457 . . . . 73.33 110.87 -179.873 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 5' ' ' SER . . . . . . . . . . . . . 43.9 p -58.46 -33.74 70.09 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.172 -0.467 . . . . 61.43 110.848 -179.843 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 6' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.308 0 CA-C-N 116.167 -0.47 . . . . 72.53 111.142 179.873 . . . . . . . . 0 0 . 1 stop_ save_